Citrus Sinensis ID: 001614
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1044 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.286 | 0.142 | 0.540 | 3e-97 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.291 | 0.175 | 0.461 | 2e-77 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.279 | 0.162 | 0.467 | 3e-77 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.272 | 0.192 | 0.468 | 7e-76 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.272 | 0.215 | 0.471 | 2e-75 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.272 | 0.108 | 0.458 | 9e-75 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.272 | 0.217 | 0.468 | 9e-75 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.291 | 0.116 | 0.449 | 1e-74 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.282 | 0.187 | 0.463 | 7e-74 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.282 | 0.187 | 0.459 | 3e-73 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 357 bits (916), Expect = 3e-97, Method: Compositional matrix adjust.
Identities = 186/344 (54%), Positives = 226/344 (65%), Gaps = 45/344 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ ERNIL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI-------------NNTIDLSGPETDG 852
IVHRDLKPDN+LI GHIKLTDFGLSKIG+I N + S T+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 853 IMPSDAH-----------------------YPEYQQT----DNRNRHSAVGTPDYLAPEI 885
M D+ YP+ + T + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL--NRKIPWPCVPSDMSFE 943
LLGT HG DWW++GIIL+EF+TG PPF ++PE+IF +IL +R++ W P ++S E
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISSE 1820
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKM 987
A+DLI + L DP +RLGANGA EVK HPFF VNWD+L Q+M
Sbjct: 1821 AKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEM 1864
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 150/325 (46%), Positives = 204/325 (62%), Gaps = 21/325 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
DSV + GVS P + E +DFE IK IS GA+G VFL R ++T FA+K + K
Sbjct: 433 DSV-EGRGVSQPSQKTPSE----EDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 487
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 488 NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 547
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 548 LPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 607
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 608 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 653
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IIL+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RLG
Sbjct: 654 IILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLG 713
Query: 962 ANGAAEVKAHPFFKGVNWDSLALQK 986
+ A EVK HPFF G++W L QK
Sbjct: 714 TSSAYEVKQHPFFMGLDWTGLLRQK 738
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 144/308 (46%), Positives = 196/308 (63%), Gaps = 16/308 (5%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K+ S +DFE IK IS GA+G VFL R ++T FA+K + K ++I +N I++ ER+I
Sbjct: 504 KKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDI 563
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+ R+Y AE VLAL
Sbjct: 564 LTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLAL 623
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L Y
Sbjct: 624 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------Y 669
Query: 861 PEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
+ + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++
Sbjct: 670 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 729
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
PE +F +++ +I WP + +AQDL ++ L +P +RLG A EVK HPFF G++
Sbjct: 730 PEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLD 789
Query: 979 WDSLALQK 986
W L QK
Sbjct: 790 WTGLLRQK 797
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 7e-76, Method: Compositional matrix adjust.
Identities = 141/301 (46%), Positives = 190/301 (63%), Gaps = 16/301 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R + T FA+K + K ++I +N I ++ ER+IL NP
Sbjct: 398 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENP 457
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D++R+Y AE VLALEYLH+ G
Sbjct: 458 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYG 517
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSK+GL+N T +L Y + + D
Sbjct: 518 IVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNL--------------YEGHIEKD 563
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 564 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 623
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ I WP + ++QDLI R L + +RLG GA EVK H FF ++W+ L Q
Sbjct: 624 VISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLRQ 683
Query: 986 K 986
K
Sbjct: 684 K 684
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 142/301 (47%), Positives = 187/301 (62%), Gaps = 16/301 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 388 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 447
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 448 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 507
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 508 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 553
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++ +G DWW++G+IL+EF+ G PF ++PE +F
Sbjct: 554 AREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQ 613
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 614 VVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLALDWAGLLRH 673
Query: 986 K 986
K
Sbjct: 674 K 674
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 282 bits (722), Expect = 9e-75, Method: Compositional matrix adjust.
Identities = 138/301 (45%), Positives = 191/301 (63%), Gaps = 16/301 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+ R + + FA+K + K ++I +N I++ ER+IL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV + SF R +L +VMEY+ GGD +L++ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNL--------------YEGHIEKD 737
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 738 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 797
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ +I WP +AQDLI L +P +RLG GA EVK H FF+ ++W+SL Q
Sbjct: 798 VISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQ 857
Query: 986 K 986
K
Sbjct: 858 K 858
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 282 bits (722), Expect = 9e-75, Method: Compositional matrix adjust.
Identities = 141/301 (46%), Positives = 187/301 (62%), Gaps = 16/301 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 366 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 425
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 426 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLALEYLHNYG 485
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 486 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 531
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F
Sbjct: 532 AREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQ 591
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 592 VVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFLALDWAGLLRH 651
Query: 986 K 986
K
Sbjct: 652 K 652
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 146/325 (44%), Positives = 202/325 (62%), Gaps = 21/325 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 548 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 603 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 662
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 663 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 722
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 723 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 768
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IIL+EF+ G PF ++PE +F +++ +I WP +AQ+LI L +P +RLG
Sbjct: 769 IILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNPLERLG 828
Query: 962 ANGAAEVKAHPFFKGVNWDSLALQK 986
GA EVK H FF+ ++W+SL QK
Sbjct: 829 TGGAYEVKQHRFFRSLDWNSLLRQK 853
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 279 bits (714), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 144/311 (46%), Positives = 194/311 (62%), Gaps = 16/311 (5%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S K+ +DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ E
Sbjct: 363 SKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVE 422
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
R+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE V
Sbjct: 423 RDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETV 482
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 483 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL------------ 530
Query: 858 AHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 531 --YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 588
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
++PE +F +++ I WP + EAQ LI+ L +P RLGA GA EVK H FF+
Sbjct: 589 GDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFR 648
Query: 976 GVNWDSLALQK 986
++W L QK
Sbjct: 649 DLDWTGLLRQK 659
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 143/311 (45%), Positives = 193/311 (62%), Gaps = 16/311 (5%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S K+ DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ E
Sbjct: 365 SKAKKPPGESDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVE 424
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
R+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE V
Sbjct: 425 RDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETV 484
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 485 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL------------ 532
Query: 858 AHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 533 --YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 590
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
++PE +F +++ I WP + +AQ LI+ L +P RLGA GA EVK H FF+
Sbjct: 591 GDTPEELFGQVISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFR 650
Query: 976 GVNWDSLALQK 986
++W L QK
Sbjct: 651 DLDWTGLLRQK 661
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1044 | ||||||
| 359492673 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.926 | 0.871 | 0.699 | 0.0 | |
| 255538590 | 1106 | kinase, putative [Ricinus communis] gi|2 | 0.881 | 0.831 | 0.711 | 0.0 | |
| 145324180 | 1067 | protein kinase-like protein [Arabidopsis | 0.913 | 0.894 | 0.586 | 0.0 | |
| 145336472 | 1042 | protein kinase-like protein [Arabidopsis | 0.913 | 0.915 | 0.586 | 0.0 | |
| 110740013 | 1042 | similar to IRE homolog 1 [Arabidopsis th | 0.913 | 0.915 | 0.585 | 0.0 | |
| 7767670 | 1092 | F27F5.23 [Arabidopsis thaliana] | 0.913 | 0.873 | 0.572 | 0.0 | |
| 297852258 | 1101 | predicted protein [Arabidopsis lyrata su | 0.906 | 0.859 | 0.565 | 0.0 | |
| 302142471 | 948 | unnamed protein product [Vitis vinifera] | 0.554 | 0.610 | 0.772 | 0.0 | |
| 168043284 | 1008 | predicted protein [Physcomitrella patens | 0.798 | 0.827 | 0.507 | 0.0 | |
| 356520647 | 1296 | PREDICTED: uncharacterized protein LOC10 | 0.805 | 0.648 | 0.486 | 0.0 |
| >gi|359492673|ref|XP_002282958.2| PREDICTED: uncharacterized protein LOC100259179 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1330 bits (3441), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 697/996 (69%), Positives = 782/996 (78%), Gaps = 29/996 (2%)
Query: 12 GIPSGLNRIKTRGGVSKP---------DELTESRSYGVSRPPQKHKQKTVAQGHVKLANS 62
GIP+GLNRIKTR SK D+ ESR G+SRPP K +GH K A S
Sbjct: 16 GIPTGLNRIKTRRESSKDQLNWKPDDDDKFHESRPRGISRPPANQKHN---KGHAKFAGS 72
Query: 63 FTEEVRKGKKIAQWFTSYISK-----FNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 117
E KGKKIA+WFTS++SK F+ V P ++S S+ K D E RTK EG H
Sbjct: 73 I-EGFHKGKKIARWFTSHLSKDSSQGFDDVPPKVQDSNSKVKAPDKEGSTRTKQWKEGKH 131
Query: 118 LNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAA 177
L KQS E +SS KV KGLKSFSHELGPKGGIP S+PRAHSYNDLKELL +LHSRFDAA
Sbjct: 132 LTGKQSSPEGLSSIKVPKGLKSFSHELGPKGGIPPSHPRAHSYNDLKELLGSLHSRFDAA 191
Query: 178 KEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQ 237
KEVVN EL++ D+M+ L++ DS S G++M E LLILAQQC+EMT FR CETIVQ
Sbjct: 192 KEVVNVELSSLTGDIMDALQRNDS--SPGQKMAEGLLILAQQCMEMTPSEFRIKCETIVQ 249
Query: 238 DLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVE 297
LTEKRQ CQ +KWL TRMLFILTRCTRLL FQK+SEPI EKSLH F KCLES+PAVE
Sbjct: 250 GLTEKRQHCQTAFLKWLFTRMLFILTRCTRLLRFQKDSEPIDEKSLHNFTKCLESIPAVE 309
Query: 298 TSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKS 354
+W P +S DY S K++AK ++ + +VS++ E + C E D TS S
Sbjct: 310 MNWAPYSRIVDSGSDYDSNGKSDAKHELQWRNRVSSLLEQTWCRSEEPADKSGITSRKDS 369
Query: 355 VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICE 414
+ + Q Q SQ +Q G+ + + GS HE + LDGSDSVICRICE
Sbjct: 370 MVLVQKPLSQNSQIDFLPHIEQDGDYPGKSMNSFED--GSLHEPERGLDGSDSVICRICE 427
Query: 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENS 474
E VP SHLESHSYICAYADKC+L LD+DERL KL+EILEQI ES N + SPENS
Sbjct: 428 ENVPTSHLESHSYICAYADKCDLKYLDIDERLSKLAEILEQIIESRNLNFQASFCSPENS 487
Query: 475 RTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKL 533
R Q NSA+ +G SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KL
Sbjct: 488 RMQITNSAVISEGCSPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKL 547
Query: 534 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 593
S YGA SSTGSMTS+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD
Sbjct: 548 SQYGAPSSTGSMTSMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDL 607
Query: 594 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 652
SKEGS +FLLACM DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S
Sbjct: 608 SKEGSCDFLLACMEDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSD 667
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 712
++ KE+SRL+ D+ S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 668 NRIKESSRLLFDNASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTG 727
Query: 713 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772
DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGG
Sbjct: 728 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGG 787
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
DLYSLLRK+GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFG
Sbjct: 788 DLYSLLRKLGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFG 847
Query: 833 LSKIGLINNTIDLSGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890
LSKIGLIN+T+DLSGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTE
Sbjct: 848 LSKIGLINSTVDLSGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTE 907
Query: 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 950
HGYAADWWSVGIILFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINR
Sbjct: 908 HGYAADWWSVGIILFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINR 967
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
FLIHDP+ RLGANG +EVK HPFFKGVNWD+LALQK
Sbjct: 968 FLIHDPDLRLGANGLSEVKTHPFFKGVNWDTLALQK 1003
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538590|ref|XP_002510360.1| kinase, putative [Ricinus communis] gi|223551061|gb|EEF52547.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1324 bits (3427), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 671/943 (71%), Positives = 755/943 (80%), Gaps = 23/943 (2%)
Query: 65 EEVRKGKKIAQWFTSYISKFNI-----VSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLN 119
+E KGKKI +W SY SK VS N E E K +D + RR K + NHL+
Sbjct: 60 KEFHKGKKITRWLASYFSKGTSQVTADVSSNIEKRSLEHKTLDKFEQRRIKFVNGENHLD 119
Query: 120 EKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKE 179
Q E +S SK SKGLKSFSHELGP+GGIP + PRAHSY+DLKELL + HSRFDAAKE
Sbjct: 120 GNQPSVEILSQSKASKGLKSFSHELGPRGGIPPAQPRAHSYSDLKELLGSFHSRFDAAKE 179
Query: 180 VVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDL 239
VVN+ELA+FA+D M+VLE +DS E +M EDLLILAQ C+EM FR CE IVQDL
Sbjct: 180 VVNAELASFARDAMDVLEIIDSSLQEELKMAEDLLILAQLCMEMACSQFRLKCEIIVQDL 239
Query: 240 TEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETS 299
TEKR QCQ GLVKWL TRMLFILTRCTRLL FQK++EPI EKSL K KKCLESVP+V+ S
Sbjct: 240 TEKRLQCQTGLVKWLYTRMLFILTRCTRLLQFQKDTEPIDEKSLRKLKKCLESVPSVDMS 299
Query: 300 WVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSVF 356
WV + ++DLD A QK + K+K+ GQ +S++PE C ES D TS S+
Sbjct: 300 WVANHVIDDTDLDDALNQKGDIKRKLQGQNNLSSLPEAVCCGSQESDDQSGVTSGKDSLD 359
Query: 357 IEQNFPPQKSQHYSRMQEQQ------------SHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
EQ QKS++ S + +Q + + + K S EQ + LDG
Sbjct: 360 FEQKLSCQKSRNESLFEVRQFCETDKSAISNSVNNSSCSLHDQEKFLDDSLQEQERVLDG 419
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE+VPISHLESHSYICAYADKC+LNCLDVDERL L+E+LEQI ES N +
Sbjct: 420 SDLVICRICEEIVPISHLESHSYICAYADKCDLNCLDVDERLSNLAEMLEQIVESRNMNV 479
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
H GSPENSR Q+ NSA T + SPKISEWRNKGVEGMFEDIHEMDTA IDDSHL +N
Sbjct: 480 HQSHGSPENSRPQNANSATT-EACSPKISEWRNKGVEGMFEDIHEMDTAFIDDSHLPPVN 538
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+GHLG+KL YGA SSTGSMTS+SSTNTPKAGHFD FWLE N+P+ELEDV QMI LADI
Sbjct: 539 LKGHLGMKLCNYGAPSSTGSMTSLSSTNTPKAGHFDSFWLEHNNPSELEDVPQMINLADI 598
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
AR VA+TD SKEGS EFLLACM DLQDVLQHSKLKALVIDTFG RIEKLLREKY+LAC++
Sbjct: 599 ARSVANTDLSKEGSYEFLLACMQDLQDVLQHSKLKALVIDTFGGRIEKLLREKYLLACDI 658
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
D KSP S SK KENSRL+LD+ SQSS +STP+HSSHKERTSIDDFEIIKPISRGAFG+V
Sbjct: 659 TDAKSPKSDSKLKENSRLLLDNASQSSAMSTPVHSSHKERTSIDDFEIIKPISRGAFGKV 718
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
FLARKR TGDLFAIKVLKKLDM+RKND++RILAERNILITVRNPFVVRFFYSFTCRDNLY
Sbjct: 719 FLARKRITGDLFAIKVLKKLDMLRKNDVQRILAERNILITVRNPFVVRFFYSFTCRDNLY 778
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHD
Sbjct: 779 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHD 838
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883
GHIKLTDFGLSKIGLIN+T+DL+GPET+ SDAH P + QT+ NR SAVGTPDYLAP
Sbjct: 839 GHIKLTDFGLSKIGLINSTMDLAGPETNEDEVSDAHNP-HIQTEETNRQSAVGTPDYLAP 897
Query: 884 EILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFE 943
EILLGTEHGYAADWWSVGIILFE ITGIPPFTAE PEIIFDNILNRKIPWP VP MS+E
Sbjct: 898 EILLGTEHGYAADWWSVGIILFELITGIPPFTAERPEIIFDNILNRKIPWPPVPESMSYE 957
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
AQDLINR + +DP+QRLG+NG+AEVK++PFF+G++WD+LALQK
Sbjct: 958 AQDLINRLITYDPDQRLGSNGSAEVKSYPFFRGIDWDNLALQK 1000
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324180|ref|NP_001077679.1| protein kinase-like protein [Arabidopsis thaliana] gi|332193965|gb|AEE32086.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1091 bits (2822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/995 (58%), Positives = 719/995 (72%), Gaps = 41/995 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGP--RPEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQK
Sbjct: 933 LVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQK 967
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145336472|ref|NP_175130.2| protein kinase-like protein [Arabidopsis thaliana] gi|332193964|gb|AEE32085.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1090 bits (2820), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/995 (58%), Positives = 719/995 (72%), Gaps = 41/995 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQK
Sbjct: 933 LVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQK 967
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110740013|dbj|BAF01910.1| similar to IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1086 bits (2809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 583/995 (58%), Positives = 718/995 (72%), Gaps = 41/995 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y Q+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPECQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQK
Sbjct: 933 LVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQK 967
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7767670|gb|AAF69167.1|AC007915_19 F27F5.23 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/1020 (57%), Positives = 719/1020 (70%), Gaps = 66/1020 (6%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFYSFTCRDNL 762
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFYSFTCRDNL
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLMLLMQVRFFYSFTCRDNL 752
Query: 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822
YLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA+
Sbjct: 753 YLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAY 812
Query: 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 882
+GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLA
Sbjct: 813 NGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLA 872
Query: 883 PEILLGTEHG----------------YAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
PEILLGTEHG YAADWWS GI+LFE +TGIPPFTA PE IFDNI
Sbjct: 873 PEILLGTEHGLDTTFKSGFHEAPVNCYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNI 932
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
LN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQK
Sbjct: 933 LNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQK 992
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852258|ref|XP_002894010.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297339852|gb|EFH70269.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1066 bits (2756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/1036 (56%), Positives = 724/1036 (69%), Gaps = 90/1036 (8%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVS--KPDELTESRSYGVSRPPQKHKQKT-VAQ 54
A +N D G IPSGLNRIKTR S +P++ +++ V +PP QK V +
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGLRPEDSSDT----VVKPPFNRNQKIIVPR 57
Query: 55 GHVKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPN---TENSGSEDKDVDVEDPRRTKL 111
G+ + S +E RKG K+++W SY K++ P + + SED KL
Sbjct: 58 GYGRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSED----------IKL 106
Query: 112 RHEGNHLNEKQSLAEHVSSSKV----SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELL 167
R G + + + + VS + + S G+KSFSHELGP+GG+ + YPR HSYNDLKELL
Sbjct: 107 R--GKNCGKDEEMIIKVSETNLPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELL 164
Query: 168 DTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCL 227
+LHSRFD AKE V+ +L F DV +EKMD P E +EM E+LL +A+ C+EMTS
Sbjct: 165 GSLHSRFDVAKETVDKKLDVFVIDVKEAMEKMDPPCPEDREMAEELLDVARACMEMTSAQ 224
Query: 228 FRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFK 287
RA CE+IV DLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK
Sbjct: 225 LRATCESIVHDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFK 284
Query: 288 KCLESVPAVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLD 347
+CLE +PA+ET W +P +S Y YQ+ A +K ++ S E + + D
Sbjct: 285 ECLERIPALETDWGSTPRVDDSGSGYPKYQRDEAGQKFKRRETESLESETTFDYVIPN-D 343
Query: 348 HTSENKS---VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
H++ + +Q FP Q+ Q S++ +Q+ ++ + E P ++ L
Sbjct: 344 HSNNAATEGYAVAKQEFPSQEPQFDSKVVQQRFYLSD----EYEHKMLNEPVKE---LGR 396
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE VP+SHLE HSYICAYADKCE+NCLDVDERLLKL EILEQI +S + +S
Sbjct: 397 SDYVICRICEEEVPLSHLEPHSYICAYADKCEINCLDVDERLLKLEEILEQIIDSRSLNS 456
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
G ENS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ +N
Sbjct: 457 FTQAGGLENSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIN 514
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+ H+G K+ + SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED+Q M++L+DI
Sbjct: 515 LKSHVGAKICHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLQLMMDLSDI 573
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
ARC A TD SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL
Sbjct: 574 ARCGASTDLSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLYAREL 633
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
+KS K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+V
Sbjct: 634 TADKSSVGNVKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKV 684
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFY 754
FLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFY
Sbjct: 685 FLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLILLMQVRFFY 744
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLK
Sbjct: 745 SFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLK 804
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
PDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D + +H+ + Q + R RHSA
Sbjct: 805 PDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTGSHHFQKNQEEERIRHSA 864
Query: 875 VGTPDYLAPEILLGTEH------------------------GYAADWWSVGIILFEFITG 910
VGTPDYLAPEILLGTEH GYA+DWWSVGI+LFE ITG
Sbjct: 865 VGTPDYLAPEILLGTEHGLDTTLYLGFSEAIGNYIQLLGLAGYASDWWSVGIVLFELITG 924
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
IPPFTA PEIIFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+
Sbjct: 925 IPPFTAARPEIIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKS 984
Query: 971 HPFFKGVNWDSLALQK 986
HPFF+GV+WD+LALQK
Sbjct: 985 HPFFQGVDWDNLALQK 1000
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142471|emb|CBI19674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2411), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/623 (77%), Positives = 521/623 (83%), Gaps = 44/623 (7%)
Query: 376 QSHIVEGRIVEVTKSNCGSPHEQGQSL-------DGSDSVICRICEEVVPISHLESHSYI 428
Q IV GR++ N E G L DGSDSVICRICEE VP SHLESHSYI
Sbjct: 252 QIMIVMGRVM----PNMNYSGETGYLLSLSKLGADGSDSVICRICEENVPTSHLESHSYI 307
Query: 429 CAYADKCELNCLDVDERLLKLSEILEQISES-CNSSSHPILGSPENSRTQSMNSAITYDG 487
CAYADKC+L LD+DERL KL+EILEQI ES C
Sbjct: 308 CAYADKCDLKYLDIDERLSKLAEILEQIIESRC--------------------------- 340
Query: 488 YSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMT 546
SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMT
Sbjct: 341 -SPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMT 399
Query: 547 SVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACM 605
S+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM
Sbjct: 400 SMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACM 459
Query: 606 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS 665
DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+
Sbjct: 460 EDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDN 519
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIKVLKKLDM
Sbjct: 520 ASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIKVLKKLDM 579
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCLE
Sbjct: 580 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCLE 639
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
EDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+DL
Sbjct: 640 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVDL 699
Query: 846 SGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
SGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGII
Sbjct: 700 SGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGII 759
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
LFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGAN
Sbjct: 760 LFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGAN 819
Query: 964 GAAEVKAHPFFKGVNWDSLALQK 986
G +EVK HPFFKGVNWD+LALQK
Sbjct: 820 GLSEVKTHPFFKGVNWDTLALQK 842
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168043284|ref|XP_001774115.1| predicted protein [Physcomitrella patens subsp. patens] gi|162674522|gb|EDQ61029.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/908 (50%), Positives = 571/908 (62%), Gaps = 74/908 (8%)
Query: 129 SSSKVSKGLKSFSHELGPKGGIPSSYPRAHSY---NDLKELLDTLHSRFDAAKEVVNSEL 185
++ K +KSFSHEL P+G + R ++ NDL+E + TL +RF+ AKE VN+EL
Sbjct: 15 TNGKRPTDIKSFSHELDPRGLRSHEFFRPQNFGGFNDLEEFVRTLKARFNTAKEEVNAEL 74
Query: 186 ATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQ 245
A FA DV+ LEK +S KE EDLLILA++C M S FR NCE IV DL EKRQ+
Sbjct: 75 AVFAGDVVEALEKNADATSVWKERAEDLLILAKECAMMDSQEFRKNCEGIVHDLDEKRQE 134
Query: 246 CQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPG 305
+G +K L T+MLFILTRCTRLL +QK + E L + +K VE W P
Sbjct: 135 LSMGTLKQLHTKMLFILTRCTRLLQYQKRN--FLELDLLRLQK-------VEKFWHP--- 182
Query: 306 TAESDLDYASYQKANA----KKKISGQ-----QKVSTVPEISDCSCSE-SLDHTSENK-S 354
QK A K K S Q V T D S + +L+ E++
Sbjct: 183 --------VDNQKVTASEPVKSKPSSQDHFRPNDVPTARWTQDESTPKPALESIKESELK 234
Query: 355 VFIE-----QNFPPQK--SQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSL-DGSD 406
VF+E +NF +K S++ S ++ + + P + D +
Sbjct: 235 VFVERPTSWKNFEKEKTGSENQSSPEKPSPQVAPSTKERTQPAGSLQPTPVKRHWGDDTP 294
Query: 407 SVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHP 466
VICRICEE VP HLE HS +CA+AD+C+ + +DERL +L+ LE+I ES +S
Sbjct: 295 IVICRICEEEVPTVHLEEHSRVCAFADRCDHKGMGIDERLKRLAGTLERIVESYTPTSSA 354
Query: 467 ILGS--PENSRTQSMNSAITYDGYSPKIS-EWRNKGVEGMFEDIHEMDTACIDDSH--LG 521
++ S P+ +T A G + E + E M ED+HE+DTA I D
Sbjct: 355 VVASVSPDTKKTPIYGLASEKPGMHERGGGELLRRVSEDMLEDLHEIDTASILDEPRIFN 414
Query: 522 SLNLRGHLGLKLSGYGA-----------SSSTGSMTSVSSTNTPKAGHFDPFWLERNHPA 570
S+ + G K+ A SSS GS+T S TPK D +RN A
Sbjct: 415 SIACKSRFGPKVDTVAALPSSVGSQLAPSSSVGSLTPRSPLATPKNSQIDSLLADRNSFA 474
Query: 571 ELEDVQQMIELADIARCVADTDFS-KEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRI 629
ELED+QQ+ EL DIA C+ADT+ S + +EF++ CM DL+DVLQ + + AL +DTFG RI
Sbjct: 475 ELEDLQQINELVDIALCIADTNESHPKAAEFIVLCMEDLKDVLQQNTVDALTVDTFGRRI 534
Query: 630 EKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDF 689
+KL REKY L E + P S E S L LD S +TP+H ++K+RT+I DF
Sbjct: 535 DKLCREKYQLILEASGKYVPESLVNSAEGS-LSLDEEGSHSSKNTPVHPTYKDRTTIHDF 593
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
EIIKPISRGAFGRVFLARKR TGDLFAIKVL+K DMIRKN +E + AERNILI+VRNPFV
Sbjct: 594 EIIKPISRGAFGRVFLARKRITGDLFAIKVLRKADMIRKNAVESVKAERNILISVRNPFV 653
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIV 809
VRFFYSFTC +NLYLVMEYLNGGDL+SLLR + CL E+ +R+YIAELVLALEYLH LGIV
Sbjct: 654 VRFFYSFTCTENLYLVMEYLNGGDLFSLLRNLTCLGEEASRVYIAELVLALEYLHGLGIV 713
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI-----------MPSDA 858
HRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP G +PS
Sbjct: 714 HRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVGGAALMEEITKHHRIPS-G 772
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
P+ ++ R + SAVGTPDYLAPEILLG HG AADWWS G+ILFE +TG+PPF AE
Sbjct: 773 ELPQQRER--RQQRSAVGTPDYLAPEILLGNSHGPAADWWSTGVILFEMLTGVPPFNAEH 830
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
PEIIFDNILNR IPWP VP +MS+EAQD I+R L DP+ RLGA GAAEVKAHPFFKG+N
Sbjct: 831 PEIIFDNILNRNIPWPYVPEEMSYEAQDFIDRLLTEDPDYRLGAKGAAEVKAHPFFKGLN 890
Query: 979 WDSLALQK 986
WD+LA+QK
Sbjct: 891 WDTLAMQK 898
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520647|ref|XP_003528972.1| PREDICTED: uncharacterized protein LOC100816852 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2056), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/905 (48%), Positives = 578/905 (63%), Gaps = 64/905 (7%)
Query: 137 LKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVL 196
+KSFSHEL KG P + + N+L+E+L + ++FD AKE VNS+LA FA D++ +L
Sbjct: 292 IKSFSHELNSKGVWPFPFSKPRRLNNLEEILVVIRAKFDKAKEDVNSDLAIFAADLVGIL 351
Query: 197 EKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLST 256
EK E +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K L T
Sbjct: 352 EKNADTHPEWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLKQLHT 411
Query: 257 RMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPSPGTA 307
RMLFILTRCTRLL F KES EP+ + LH KC+ +T +A
Sbjct: 412 RMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKCIPPSVGRDTK----SSSA 467
Query: 308 ESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQNFP- 362
L +S + + ++ + G +K PE +D ++ + +S + + FP
Sbjct: 468 TKVLKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKHFNSSSGRNRMASWKKFPS 527
Query: 363 -----PQ-----KSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGS------- 405
P+ K Q+Y R++ ++ + +V + H SLD +
Sbjct: 528 PTGRSPKEAVQLKDQNYGRIESSKASNNKRFSSDVDTAKPSELHPVKDSLDHASKHQHKV 587
Query: 406 ---------------DSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLS 450
+S+ICRICEE VP SH+E HS ICA AD+C+ L V+ERL +++
Sbjct: 588 SWGHWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICALADRCDQKGLSVNERLGRIA 647
Query: 451 EILEQISESCNSS-SHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHE 509
E LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M + E
Sbjct: 648 ETLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPE 707
Query: 510 MDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERN 567
D + D G ++ + G K +SS GSMT S TP+ D +
Sbjct: 708 ADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKG 767
Query: 568 HPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKALVIDTFG 626
+E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL ++TFG
Sbjct: 768 AYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDALTVETFG 827
Query: 627 SRIEKLLREKYILACELLD-EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTS 685
+RIEKL+REKY+ E++D EK T + + S ++P+HSS ++RTS
Sbjct: 828 TRIEKLIREKYLQLTEMVDVEKIDTESTVDDDLLE----DDVVRSLRTSPIHSS-RDRTS 882
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
IDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIKVLKK DMIRKN +E ILAER+ILITVR
Sbjct: 883 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILITVR 942
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
NPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLALEYLHS
Sbjct: 943 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLALEYLHS 1002
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDAH--YP 861
L +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D +
Sbjct: 1003 LHVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDETDVFT 1062
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF AE P+
Sbjct: 1063 SEDQRERRKKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNAEHPQT 1122
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981
IFDNILNRKIPWP VP +MS +AQDLI+R L DPNQRLG+ GA+EVK H FFK +NWD+
Sbjct: 1123 IFDNILNRKIPWPAVPEEMSPQAQDLIDRLLTEDPNQRLGSKGASEVKQHVFFKDINWDT 1182
Query: 982 LALQK 986
LA QK
Sbjct: 1183 LARQK 1187
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1044 | ||||||
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.793 | 0.776 | 0.619 | 2.2e-272 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.585 | 0.471 | 0.540 | 2.7e-201 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.593 | 0.502 | 0.512 | 7.5e-191 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.790 | 0.706 | 0.452 | 1.2e-177 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.258 | 0.197 | 0.436 | 1.4e-87 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.157 | 0.078 | 0.682 | 1.3e-86 | |
| POMBASE|SPCC1450.11c | 1338 | cek1 "serine/threonine protein | 0.163 | 0.127 | 0.569 | 3.9e-74 | |
| POMBASE|SPAPB18E9.02c | 1318 | ppk18 "serine/threonine protei | 0.187 | 0.148 | 0.492 | 7.9e-74 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.274 | 0.393 | 0.474 | 1.3e-73 | |
| CGD|CAL0002056 | 1923 | RIM15 [Candida albicans (taxid | 0.203 | 0.110 | 0.424 | 7.9e-73 |
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2619 (927.0 bits), Expect = 2.2e-272, P = 2.2e-272
Identities = 524/846 (61%), Positives = 629/846 (74%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HELGP+GG+ + YPR HSYNDLKELL +LHSRFD AKE V+ +L F +DV +EKMD
Sbjct: 139 HELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFDVAKETVDKKLDVFVRDVKEAMEKMDP 198
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL +++LFI
Sbjct: 199 SCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWLFSQLLFI 258
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYASYQKANA 321
LT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y YQ+ A
Sbjct: 259 LTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYPEYQRNEA 318
Query: 322 KKKISGQQKVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRMQEQQSHIVE 381
+K + K S E + DH N + + + K + S + S +VE
Sbjct: 319 GQKFKRRDKESLESETA-LDYVVPNDH-GNNAA---REGYAAAKQEFPSHEPQFDSKVVE 373
Query: 382 GRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLD 441
R + +E G+ L GSD VICRICEE VP+ HLE HSYICAYADKCE+NC+D
Sbjct: 374 QRFYLSDEYEDKMSNEPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYADKCEINCVD 433
Query: 442 VDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVE 501
VDERLLKL EILEQI +S + +S G ENS + S + +G SPKI+EWRNKG+E
Sbjct: 434 VDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLRK--SGVASEGCSPKINEWRNKGLE 491
Query: 502 GMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDP 561
GMFED+HEMDTA ID+S+ ++L+ H+G K NTP+ HFD
Sbjct: 492 GMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTNTPRTSHFDS 551
Query: 562 FWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKAL 620
+WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q VL+ KLKAL
Sbjct: 552 YWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAVLKQGKLKAL 610
Query: 621 VIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSH 680
VIDTFG RIEKLL EKY+ A EL +KS S KE S +L+ S +TP
Sbjct: 611 VIDTFGGRIEKLLCEKYLHARELTADKS--SVGNIKE-SEDVLEHAS-----ATP-QLLL 661
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNI
Sbjct: 662 KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNI 721
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
LITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLAL
Sbjct: 722 LITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLAL 781
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+
Sbjct: 782 EYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHH 841
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGIPPFTA PE
Sbjct: 842 FQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPE 901
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+W+
Sbjct: 902 KIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWE 961
Query: 981 SLALQK 986
+LALQK
Sbjct: 962 NLALQK 967
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1627 (577.8 bits), Expect = 2.7e-201, Sum P(3) = 2.7e-201
Identities = 343/635 (54%), Positives = 420/635 (66%)
Query: 360 NFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPI 419
NFPP K H + H + + G EQ + S++CRICEE VP
Sbjct: 565 NFPPAKDSH--EHSSKHRHNI----------SWGYWGEQ-PLISEESSIMCRICEEEVPT 611
Query: 420 SHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSPENSRTQS 478
+H+E HS +C ADK + L VDERL+ ++ L++I+E+ + S SP+ + +
Sbjct: 612 THVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKDSLAAAESPDGMKVSN 671
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHLGLKLXXX 536
+ D SP++S+W KG E M + E D + +DD L ++ R G K
Sbjct: 672 SHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSDQG 731
Query: 537 XXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKE 596
TP+ + + + +D+ QM ELADIA+C AD +
Sbjct: 732 MTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPGDD 791
Query: 597 GS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKY 655
S FLL+C+ DL+ V+ K AL ++TFG+RIEKL+REKY+ CEL+D++ S
Sbjct: 792 QSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLSTV 851
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
+ + D V +S S P+H ++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLF
Sbjct: 852 IDEDAPLEDDVVRSLRTS-PVHP--RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIKVLKK DMIRKN +E ILAER+ILI VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 776 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
SLLR +GCLEED+ R+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGTEH 891
+GLIN+T DL+GP G D +Q + R + SAVGTPDYLAPEILLGT H
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
G ADWWSVGIILFE I GIPPF AE P+ IFDNILNRKIPWP VP +MS EA D+I+RF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
L DP+QRLGA GAAEVK H FFK +NWD+LA QK
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQK 1183
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1541 (547.5 bits), Expect = 7.5e-191, Sum P(3) = 7.5e-191
Identities = 327/638 (51%), Positives = 417/638 (65%)
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
K V I + K S + Q H+ + R ++ G H+ + S+ICRI
Sbjct: 500 KLVAISDDMAVAKLPEVSSAKASQEHMSKNRH-NISWGYWG--HQS--CISEESSIICRI 554
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSP 471
CEE +P +H+E HS ICA ADK + + VDERL+ ++ LE+I+++ S + SP
Sbjct: 555 CEEEIPTTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKDSLAAVESP 614
Query: 472 ENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHL 529
E + + + D SPK+S+W +G E M + E D + +DD L S++ R
Sbjct: 615 EGMKISNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRF 674
Query: 530 GLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVA 589
G K TP+ + + + +D QM ELADIARC A
Sbjct: 675 GPKSDQGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAA 734
Query: 590 DT-DFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKS 648
+ + + LL+C+ DL+ V+ K AL+++TFG+RIEKL++EKY+ CEL+D++
Sbjct: 735 NAIPVDDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK 794
Query: 649 PTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 708
T E++ L D V +S S P+H ++R SIDDFE++K ISRGAFG V LARK
Sbjct: 795 GTIID---EDAPLE-DDVVRSLRTS-PVHL--RDRISIDDFEVMKSISRGAFGHVILARK 847
Query: 709 RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768
TTGDLFAIKVL+K DMIRKN +E ILAER+ILI RNPFVVRFFYSFTC +NLYLVMEY
Sbjct: 848 NTTGDLFAIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEY 907
Query: 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828
LNGGD YS+LRK+GCL+E AR+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGH+KL
Sbjct: 908 LNGGDFYSMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKL 967
Query: 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 888
TDFGLSK+GLINNT DLSGP + P+ D++ SAVGTPDYLAPEILLG
Sbjct: 968 TDFGLSKVGLINNTDDLSGPVSSATSLLVEEKPKLPTLDHKR--SAVGTPDYLAPEILLG 1025
Query: 889 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 948
T HG ADWWSVGIIL+EF+ GIPPF A+ P+ IFDNILNR I WP VP DMS EA+DLI
Sbjct: 1026 TGHGATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDLI 1085
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
+R L DP+QRLGA GAAEVK H FFK ++W++LA QK
Sbjct: 1086 DRLLTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQK 1123
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1704 (604.9 bits), Expect = 1.2e-177, Sum P(2) = 1.2e-177
Identities = 396/875 (45%), Positives = 533/875 (60%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HEL KG P R+ + ++E++ + ++FD KE V+++L FA ++ LE
Sbjct: 201 HELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADLGVFAGYLVTTLESTPE 260
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
+ E + LEDLL+ A+QC M + F CE IVQ L +KRQ+ +G +K R+LFI
Sbjct: 261 SNKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLKQAHNRLLFI 320
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDL-DYASYQKAN 320
LTRC RL+ F+KES + E L + L + V + + DL QK N
Sbjct: 321 LTRCNRLVQFRKESGYVEEHILGMHQ--LSDLGVYPEQMVEI--SRQQDLLREKEIQKIN 376
Query: 321 AKKKISGQQKVSTVPEISD---CSCSESLDHTSENKSVFIEQNFPP--QKSQHYSRMQEQ 375
K+ ++G+Q +D + + S D TS N + + P +K++ + +
Sbjct: 377 EKQNLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKNRSLNNTPKA 436
Query: 376 QSHI-VEGRIV-EVTKSNCGSPHEQGQSLDGS---------------DSVICRICEEVVP 418
+ ++ ++ + N SP Q S D S +S+ICRICE +P
Sbjct: 437 KGESKIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVTYDNSMICRICEVEIP 496
Query: 419 ISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQS 478
+ H+E HS IC AD+C+L ++V+ RL +++E LE+I ES S + +S S
Sbjct: 497 VVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKSSVTPRAVADSARLS 556
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDI-HEMDTACIDDSHLGSLNLRGHLGLKLXXXX 537
NS+ D + E + + M + + +T +D+ LN+ + +
Sbjct: 557 -NSSRQED-----LDEISQRCSDDMLDCVPRSQNTFSLDE-----LNILNEMSM---TNG 602
Query: 538 XXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEG 597
TP+ D R +ELE+ QQ+ +L DIAR VA+ +
Sbjct: 603 TKDSSAGSLTPPSPATPRNSQVDLLLSGRKTISELENYQQINKLLDIARSVANVNVCGYS 662
Query: 598 S-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD-EKSPTSFSKY 655
S +F++ + +L+ V+Q K ALV++TFG RIEKLL+EKYI C L+D EK +S +
Sbjct: 663 SLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDEKVDSSNAMP 722
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
E S D+V ++PL+ K+RTSI+DFEIIKPISRGAFGRVFLA+KR TGDLF
Sbjct: 723 DEESSADEDTVRSLR--ASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKKRATGDLF 780
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIKVLKK DMIRKN +E ILAERNILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDL+
Sbjct: 781 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLF 840
Query: 776 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
SLLR +GCL+ED+ARIYIAE+VLALEYLHS+ I+HRDLKPDNLLI DGHIKLTDFGLSK
Sbjct: 841 SLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKLTDFGLSK 900
Query: 836 IGLINNTIDLSGPET---DGIMPSDAHYPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH 891
+GLIN+T DLSG + G D ++ Q D+R +H+ VGTPDYLAPEILLG H
Sbjct: 901 VGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPEILLGMGH 960
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
G ADWWSVG+ILFE + GIPPF AE+P+ IF+NI+NR IPWP VP ++S+EA DLIN+
Sbjct: 961 GKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEAHDLINKL 1020
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
L +P QRLGA GA EVK H FFK +NWD+LA QK
Sbjct: 1021 LTENPVQRLGATGAGEVKQHHFFKDINWDTLARQK 1055
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 1.4e-87, Sum P(4) = 1.4e-87
Identities = 128/293 (43%), Positives = 186/293 (63%)
Query: 564 LERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVID 623
L R++ E + +IEL +IA + KE L +H + D++++ K +
Sbjct: 676 LTRSNDIPHEKRKMIIELREIALFAVENGI-KEN----LKMIHIMNDIIKNFDPKDDNRE 730
Query: 624 TFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS-----VSQSS------GV 672
+I+ L+ +K + A + D+ +S ++ NS IL S +SQ+
Sbjct: 731 -LAIKIQSLISDK-VNALKRADDVINSSPRIFRTNSPRILKSPREEELSQTPLGGRLRSD 788
Query: 673 STPLHSS---HKER--TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727
S P+H + +K + +I DFE IKPI++G +G+VFLA+K TGD++AIK LKK DMI+
Sbjct: 789 SDPVHQTQIEYKPKGVPTISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKRLKKSDMIK 848
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
KN ++ + ERNIL NPFVV+ +YSF ++ YLVMEYL GGD +SLL+ +G ++E+
Sbjct: 849 KNQLDHVKVERNILAYTSNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDEN 908
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
+A++ IAE VLALEYLHS GIVHRD+KPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 909 MAKMIIAETVLALEYLHSHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLLD 961
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 1.3e-86, Sum P(6) = 1.3e-86
Identities = 112/164 (68%), Positives = 130/164 (79%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
SS+ SI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ E
Sbjct: 1516 SSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVE 1575
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
RNIL V+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE V
Sbjct: 1576 RNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETV 1635
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
L LEYLH IVHRDLKPDN+LI GHIKLTDFGLSKIG+I++
Sbjct: 1636 LCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDD 1679
|
|
| POMBASE|SPCC1450.11c cek1 "serine/threonine protein kinase Cek1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.9e-74, Sum P(3) = 3.9e-74
Identities = 98/172 (56%), Positives = 130/172 (75%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
S S + T + +S E SI+D++I+KPIS+GAFG V+LA+KRTTGD FAIK+LKK +MI
Sbjct: 567 SPSPRIHTIVPNSAPEHPSINDYKILKPISKGAFGSVYLAQKRTTGDYFAIKILKKSNMI 626
Query: 727 RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
KN + + AER IL++ +PFV + +Y+F +D LYLVMEYLNGGD SLL+ +G L+
Sbjct: 627 AKNQVINVRAERAILMSQGESPFVAKLYYTFQSKDYLYLVMEYLNGGDCGSLLKTMGVLD 686
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
D R YIAE VL L LH GI+HRD+KP+NLLI+ +GH+KLTDFGLS++G
Sbjct: 687 LDWIRTYIAETVLCLGDLHDRGIIHRDIKPENLLISQNGHLKLTDFGLSRVG 738
|
|
| POMBASE|SPAPB18E9.02c ppk18 "serine/threonine protein kinase Ppk18 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 7.9e-74, Sum P(3) = 7.9e-74
Identities = 98/199 (49%), Positives = 138/199 (69%)
Query: 666 VSQSSGVSTPLH--SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+S+ G+ST SS K SI D+EIIKPIS+G FG V+L+RK TTG+++AIKVL+K+
Sbjct: 541 LSRQIGISTLSSNISSGKGTPSIQDYEIIKPISKGTFGTVYLSRKNTTGEIYAIKVLRKV 600
Query: 724 DMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
DMI KN + + AER +L+ + FV + +Y+F RD LYLVME++NGGD SLL+ +
Sbjct: 601 DMISKNQVANVKAERAVLMAQEESAFVAKLYYAFQSRDYLYLVMEFMNGGDCASLLKSLY 660
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ E A+IYIAE+ L LE+LH LGI+HRD+KPDN+L++ GH+KL DFGLS++GL
Sbjct: 661 TIPESWAKIYIAEVALGLEHLHRLGIIHRDIKPDNILMSITGHLKLADFGLSQLGLTTRQ 720
Query: 843 IDLSGPETDGIMPSDAHYP 861
+ L + + + P P
Sbjct: 721 LRLQKGKNNILSPPSFQSP 739
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 684 (245.8 bits), Expect = 1.3e-73, Sum P(3) = 1.3e-73
Identities = 142/299 (47%), Positives = 190/299 (63%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 376 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 435
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 436 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 495
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L +G + D E+ D
Sbjct: 496 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY----EGHIEKDTR--EF--VD 547
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F ++
Sbjct: 548 KQ----VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQVV 603
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
+ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L K
Sbjct: 604 SDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFWTLDWAGLLRHK 662
|
|
| CGD|CAL0002056 RIM15 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 7.9e-73, Sum P(4) = 7.9e-73
Identities = 93/219 (42%), Positives = 137/219 (62%)
Query: 672 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI 731
VST I D+++IKPIS+GAFG VFL +++ TGD AIK LKK DMI KN +
Sbjct: 880 VSTQQPQPRLSTGGIRDYQVIKPISKGAFGSVFLGKRKLTGDYVAIKCLKKRDMIAKNQV 939
Query: 732 ERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR 790
+ +ER +++ + P+V + + SF RD LYLVMEYLNGGD +LL+ +G + D
Sbjct: 940 LNVKSERAVMMRQSDSPYVAQLYSSFQSRDYLYLVMEYLNGGDCANLLKTLGVIGVDWTP 999
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL----S 846
YIAE+++ ++ LH+ GI+HRDLKPDN+LI +GH+KLTDFGLS++G++ S
Sbjct: 1000 RYIAEIIVGVDDLHNRGIIHRDLKPDNILIDKNGHLKLTDFGLSRLGVVGRQQTQQHRKS 1059
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
GI + E +++ + + +GTP L+P +
Sbjct: 1060 STNEQGIELFRSMLSE--ESNQKKVNPGIGTPFSLSPSL 1096
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1044 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-148 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-120 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-119 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-112 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-111 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-107 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-101 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-100 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-97 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-94 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-94 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-87 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-86 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-85 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-84 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-84 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-83 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-82 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-80 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-79 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-77 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-76 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-74 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-74 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-73 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-73 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-72 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-72 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-72 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-72 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-71 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-70 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-69 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-68 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-68 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-68 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-68 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-68 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-67 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-67 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-66 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-65 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-64 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-64 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-64 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-64 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-64 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-63 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-62 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-61 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-60 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-60 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-60 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-60 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-59 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-59 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-58 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-58 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-57 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-56 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-56 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-53 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-51 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-49 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-48 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-48 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-46 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-46 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-45 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-43 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-43 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-42 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-40 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-40 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-39 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-36 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-36 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-35 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-35 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-31 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-29 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-29 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-28 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-27 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-27 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-20 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-11 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 7e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.003 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 442 bits (1140), Expect = e-148
Identities = 166/285 (58%), Positives = 210/285 (73%), Gaps = 20/285 (7%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
IS+GA+GRVFLA+K++TGD++AIKV+KK DMIRKN ++++L ER+IL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF + NLYLVMEYL GGDL SLL VG L+EDVARIYIAE+VLALEYLHS GI+HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
PDN+LI +GH+KLTDFGLSK+GL+ I+L+ E + D R
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE---------------DKR----I 161
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTPDY+APE++LG H DWWS+G IL+EF+ GIPPF E+PE IF NILN KI WP
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979
S EA DLI++ L+ DP +RLGA E+K HPFFKG++W
Sbjct: 222 EDVEV-SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 367 bits (944), Expect = e-120
Identities = 131/280 (46%), Positives = 183/280 (65%), Gaps = 30/280 (10%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G+FG+V L RK+ TG L+A+KVLKK +I++ ++E L ERNIL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
+F + LYLV+EY GG+L+S L K G E+ AR Y AE+VLALEYLHSLGI++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P+N+L+ DGHIKLTDFGL+K ++ ++
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS---------------------------SEGSRTNTF 153
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
GTP+YLAPE+LLG +G A DWWS+G++L+E +TG PPF AE + I++ IL + +
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF- 212
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
P +S EA+DLI+ L DP +RLG+ GA E+KAHPFF
Sbjct: 213 --PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (941), Expect = e-119
Identities = 155/291 (53%), Positives = 195/291 (67%), Gaps = 33/291 (11%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVV 750
+KPIS+GAFG V+LA+KR+TGD FAIKVLKK DMI KN + + AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+ +YSF +D LYLVMEYLNGGD SL++ +G L ED A+ YIAE+VL +E LH GI+H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF--------------------------- 153
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
VGTPDYLAPE +LG +DWWS+G ++FEF+ G PPF AE+P+ +FDNIL+R+
Sbjct: 154 ----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
Query: 931 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
I WP V S EA DLINR L DP +RLGANG E+K+HPFFK +NWD
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 350 bits (899), Expect = e-112
Identities = 140/301 (46%), Positives = 194/301 (64%), Gaps = 10/301 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE+IK I RGAFG V+L R + TG ++A+KVL+K DMI++N I + AER+IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P++V+ +YSF ++LYLVMEY+ GGDL +LL + E+ AR YIAELVLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN---TIDLSGPETDGIMPSDAHYPEY 863
G +HRD+KPDN+LI DGHIKL DFGL K + L+ +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ +S VGTPDY+APE+L GT +G DWWS+G+IL+E + G PPF +++ + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 924 DNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981
+ I+N K P D +S EA DLI R L DP RLG+ E+K+HPFFKG++W++
Sbjct: 240 NKIINWKESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWEN 295
Query: 982 L 982
L
Sbjct: 296 L 296
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 345 bits (887), Expect = e-111
Identities = 131/302 (43%), Positives = 187/302 (61%), Gaps = 36/302 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE IK + G+FGRV L R + +G +A+K+L K +++ +E +L E+ IL ++R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+V + SF NLYLVMEY+ GG+L+S LRK G E VAR Y A++VLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+NLL+ DG+IK+TDFG +K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRT------------------------ 155
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
++ GTP+YLAPEI+L +G A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 156 -----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 984
L K+ PS S +A+DLI L D +RLG NG ++K HP+F G++W +L L
Sbjct: 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL-L 266
Query: 985 QK 986
Q+
Sbjct: 267 QR 268
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 335 bits (861), Expect = e-107
Identities = 144/300 (48%), Positives = 196/300 (65%), Gaps = 12/300 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFE IK IS GA+G V+L R + T FA+K + K ++I +N I+++ ER+IL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PFVV F SF + +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L +G + D +Q
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKDTREFLDKQV 176
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F +
Sbjct: 177 --------CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986
++ I WP + +AQDLI+R L +P +RLG GA EVK H FF G++W+ L QK
Sbjct: 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK 288
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 322 bits (827), Expect = e-101
Identities = 136/311 (43%), Positives = 190/311 (61%), Gaps = 19/311 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE IK I RGAFG V L +K+ TG ++A+K L+K +M+ K + + AER+IL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV+ +YSF + LYL+MEYL GGD+ +LL K E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSDAHYP 861
G +HRD+KPDNLL+ GHIKL+DFGL GL + LS P
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPS-NFLDFISKP 178
Query: 862 EYQ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+T RNR +S VGTPDY+APE+ L T + DWWS+G+I++E + G PP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
F +++P+ + I+N K P ++ S EA+DLI R + +RLG NG E+K+H
Sbjct: 239 FCSDNPQETYRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 972 PFFKGVNWDSL 982
PFFKGV+W+ +
Sbjct: 297 PFFKGVDWEHI 307
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 316 bits (811), Expect = e-100
Identities = 129/287 (44%), Positives = 173/287 (60%), Gaps = 34/287 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EI++ + G+FG+V+LAR + TG L AIKV+KK + K D ERIL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+VR + F D LYLVMEY GGDL+ LL+K G L ED AR Y+ +++ ALEYLHS GI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRDLKP+N+L+ DGH+KL DFGL++ Q
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR----------------------------QLDPG 150
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNIL 927
+ VGTP+Y+APE+LLG +G A D WS+G+IL+E +TG PPF + +F I
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
K P+P D+S EA+DLI + L+ DP +RL A E HPFF
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = 3e-97
Identities = 133/307 (43%), Positives = 188/307 (61%), Gaps = 24/307 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F+ IK + +G GRVFL R + TG LFA+KVL K +MI++N ++R+L E+ IL T+ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH 804
PF+ + SF L LVM+Y GG+L+ LL++ CL E+VAR Y AE++LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET-----DGIMPSDAH 859
LGIV+RDLKP+N+L+ GHI L+DF LSK S E S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK---------QSDVEPPPVSKALRKGSRRS 171
Query: 860 YPEYQQTD------NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
++ + +S VGT +Y+APE++ G HG A DWW++GI+L+E + G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHP 972
F + + F NIL +++ +P P S A+DLI + L+ DP++RLG GAAE+K HP
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290
Query: 973 FFKGVNW 979
FF+GVNW
Sbjct: 291 FFRGVNW 297
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (774), Expect = 1e-94
Identities = 109/290 (37%), Positives = 170/290 (58%), Gaps = 12/290 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVR 745
DDF+ K I G+F V LA+++ T +AIK+L K +I++ ++ + E+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P +++ +Y+F +NLY V+EY G+L +RK G L+E R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GI+HRDLKP+N+L+ D HIK+TDFG +K+ + D+ + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL---DPNSSPESNKGDATNIDSQIEKNR- 176
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R S VGT +Y++PE+L G ++D W++G I+++ +TG PPF + + F
Sbjct: 177 ---RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 974
IL + + P + +A+DLI + L+ DP RLG N G E+KAHPFF
Sbjct: 234 ILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 303 bits (777), Expect = 6e-94
Identities = 145/335 (43%), Positives = 195/335 (58%), Gaps = 29/335 (8%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK I GAFG V L RK T L+A+K L+K D++ +N + AER+IL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++G EED+AR YIAEL A+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINN-----TIDLSGPETDGIM 854
+HRD+KPDN+LI DGHIKLTDFGL SK + +++ S E I
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS-EEWSEID 181
Query: 855 PSDAHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
E ++ R HS VGTP+Y+APE+LL T + DWWSVG+IL+E + G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 912 PPFTAESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
PPF A++P ++N + IP + +S EA DLI R L RLG NGA E
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIP-SQ--AKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 968 VKAHPFFKGVNWDSLALQKMTQATSYHALVKFQVD 1002
+KAHPFFKG+++ SL + Q Y + D
Sbjct: 298 IKAHPFFKGIDFASLIRR---QKAPYIPKITHPTD 329
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 283 bits (725), Expect = 6e-87
Identities = 119/300 (39%), Positives = 182/300 (60%), Gaps = 38/300 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DF+I+ + +G +G+VFLA+K+ TG++ A+K +KK + + N++ +L ER+IL T ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
++V+ Y+F + LYL MEY+ GGD +LL +G L ED AR Y+AE+ A++ LH LG
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDLKP+N LI GHIKLTDFGLSK + +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA--------------------- 155
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+S VG+PDY+APE+L G + + D+WS+G +L+EF+ G PPF+ +P ++N+
Sbjct: 156 ----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 928 NRK--IPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
K + P ++S EA DLI + LI+DP++R G ++K HPFFK V+W+ L
Sbjct: 212 YWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFG--SLEDIKNHPFFKEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 1e-86
Identities = 106/298 (35%), Positives = 173/298 (58%), Gaps = 33/298 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 751
K + +G+FG+V LA + T +L+A+KVLKK +++ +D+E + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +D L+ VMEY+NGGDL +++ G +E AR Y AE+VL L++LH GI++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG--------------------------GVTTS 154
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL +G A DWW++G++L+E + G PF + + +F +IL ++
Sbjct: 155 -TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKM 987
+ P +S EA+ ++ FL +P +RLG G ++K HPFF+ ++WD L +++
Sbjct: 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI 268
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 276 bits (708), Expect = 4e-85
Identities = 116/304 (38%), Positives = 173/304 (56%), Gaps = 35/304 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD E IK + G FGRV L R R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF++R F++ + LY++MEY+ GG+L+S LR G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
GTP+YLAPE++ H A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 159 --------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 984
L K+ + P + A+DLI + L+ D +RLG NGA +VK H +FK V+WD +
Sbjct: 211 LAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267
Query: 985 QKMT 988
+K+
Sbjct: 268 RKLK 271
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 2e-84
Identities = 126/312 (40%), Positives = 184/312 (58%), Gaps = 42/312 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE+++ + GA+G+VFL RK G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
VR PF+V Y+F L+L+++Y+NGG+L++ L + E R+YIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 863 YQQTDNRNR-HSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE-- 917
+ R +S GT +Y+APE++ G G+ A DWWS+G++ FE +TG PFT +
Sbjct: 157 ---AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
Query: 918 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
S I IL K P P MS EA+D I + L DP +RLGANGA E+K HPFF+
Sbjct: 214 QNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 976 GVNWDSLALQKM 987
G++WD LA +++
Sbjct: 271 GIDWDDLAAKRI 282
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 2e-84
Identities = 136/332 (40%), Positives = 191/332 (57%), Gaps = 52/332 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DF +K I +GAFG V L +K+ TG ++A+K L K +M +K+ + + AER++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV +YSF LYL+ME+L GGDL ++L K EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLS---------------------------KIGLI 839
G +HRD+KPDN+LI GHIKL+DFGLS + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR----HSAVGTPDYLAPEILLGTEHGYAA 895
++I+L+ D I T +NR +S VGTPDY+APEI L +G
Sbjct: 181 VDSINLTMSSKDQI-----------ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---CVPSD--MSFEAQDLINR 950
DWWS+G I+FE + G PPF +E+ + I+N W P D +S EA+DLI R
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIRR 285
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
LI + RLG GA E+K+HPFF+GV+WD++
Sbjct: 286 -LITNAENRLGRGGAHEIKSHPFFRGVDWDTI 316
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 8e-83
Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 36/291 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+E+++ + G+FG V+ A+ + TG + A+K+LKK + + E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+VR +F +D+LYLVMEY GGDL+ L + G L ED A+ +++ LEYLHS GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLKP+N+L+ +G +K+ DFGL+K L +++
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 869 RNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFD 924
+ + VGTP Y+APE+LL G +G D WS+G+IL+E +TG PPF+ E +
Sbjct: 154 -SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 925 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
IL + + S S EA+DLI + L DP++R A E+ HP+F
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 267 bits (686), Expect = 2e-82
Identities = 104/293 (35%), Positives = 169/293 (57%), Gaps = 39/293 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ G FGRV L + ++ FA+K +KK ++ E I +E+ IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
+F + +Y++MEY GG+L+++LR G +E AR YIA +VLA EYLH+ GI++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HS 873
P+NLL+ +G++KL DFG +K + + + +
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-----------------------------KLKSGQKTWT 151
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFDNIL--NR 929
GTP+Y+APEI+L + ++ D+WS+GI+L+E +TG PPF E P I+++IL N
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWD 980
K+ + P+ + A+DLI + L +P +RLG G ++K H +F G +W+
Sbjct: 212 KLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 3e-80
Identities = 119/307 (38%), Positives = 182/307 (59%), Gaps = 38/307 (12%)
Query: 681 KERTS---IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
K TS + DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ ++ + E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
++IL+ + +PF+V SF + +Y ++E++ GG+L++ LRK G DVA+ Y AELV
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LA EYLHS I++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------------------- 166
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
P+ T GTP+YLAPE++ HG A DWW++G++L+EFI G PPF +
Sbjct: 167 -KVPDRTFT-------LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFK 975
+P I++ IL ++ + P+ A+DL+ L D +RLG G A+VK HP+F
Sbjct: 219 TPFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
Query: 976 GVNWDSL 982
G NWD L
Sbjct: 276 GANWDKL 282
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 8e-79
Identities = 127/302 (42%), Positives = 186/302 (61%), Gaps = 36/302 (11%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNP 747
+K + +G +G+VF RK T TG +FA+KVLKK ++R + D AERNIL V++P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
F+V Y+F LYL++EYL+GG+L+ L + G ED A Y++E+ LALE+LH G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I++RDLKP+N+L+ GH+KLTDFGL K + T+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT----------------------- 157
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
H+ GT +Y+APEIL+ + HG A DWWS+G ++++ +TG PPFTAE+ + D IL
Sbjct: 158 ----HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985
K+ +P ++ EA+DL+ + L +P+ RLGA AAEV++HPFF+ VNWD L +
Sbjct: 214 KGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270
Query: 986 KM 987
K+
Sbjct: 271 KV 272
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 258 bits (660), Expect = 1e-77
Identities = 136/309 (44%), Positives = 194/309 (62%), Gaps = 18/309 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 864
G +HRD+KPDNLL+ GH+KL+DFGL GL PSD +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 865 ---QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+T +NR +S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 918 SPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+P+ + ++N K P P VP +S +A+DLI RF D R+G+NG E+K+HPF
Sbjct: 240 TPQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295
Query: 974 FKGVNWDSL 982
F+GV+W +
Sbjct: 296 FEGVDWGHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 256 bits (654), Expect = 2e-76
Identities = 140/314 (44%), Positives = 189/314 (60%), Gaps = 22/314 (7%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK + GAFG V LARK T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VVR +YSF +DNLY VM+Y+ GGD+ SLL ++G ED+AR YIAEL A+E +H +G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL--------------SKIGLINNTIDLSGPETD--G 852
+HRD+KPDN+LI DGHIKLTDFGL S + +++D S D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 853 IMPSDAHYP-EYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
D P E + R HS VGTP+Y+APE+LL T + DWWSVG+IL+E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 909 TGIPPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
G PPF A++P ++N + P + +S EA DLI + L P RLG NGA E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 968 VKAHPFFKGVNWDS 981
+KAHPFFK +++ S
Sbjct: 302 IKAHPFFKTIDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 5e-74
Identities = 134/308 (43%), Positives = 195/308 (63%), Gaps = 16/308 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 864
G +HRD+KPDNLL+ GH+KL+DFGL GL + +PSD +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 865 ---QTDNRNRH----SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+T RNR S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 918 SPEIIFDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+P+ + ++N K I P VP +S +A+DLI RF + R+GA G E+K +PFF
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296
Query: 975 KGVNWDSL 982
+GV+W+ +
Sbjct: 297 EGVDWEHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 9e-74
Identities = 115/298 (38%), Positives = 174/298 (58%), Gaps = 32/298 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA+ + G +A+KVL+K +++K + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF D LY V++Y+NGG+L+ L++ E AR Y AE+ AL YLHSL I++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +GI S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIEHSK------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNILN+ +
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKMT 988
+ ++S A+ L+ L D +RLGA + E+K H FF +NWD L +K+T
Sbjct: 214 R---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKIT 268
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 2e-73
Identities = 127/305 (41%), Positives = 184/305 (60%), Gaps = 35/305 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFEI+K I RGAFG V + + + TG ++A+K+L K +M+++ + ER++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
LG VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLL----------ADGTVQSNV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ I+N K +P +D+S EA+DLI R LI P RLG NG + K HPFF+G++
Sbjct: 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGID 273
Query: 979 WDSLA 983
WD++
Sbjct: 274 WDNIR 278
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 2e-73
Identities = 127/309 (41%), Positives = 190/309 (61%), Gaps = 35/309 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE++K + GA+G+VFL RK T TG L+A+KVL+K +++K +E ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
VR +PF+V Y+F L+L+++Y++GG++++ L + ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGIV+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK--------------------------E 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
+ + +S GT +Y+APEI+ G HG A DWWS+GI++FE +TG PFT E
Sbjct: 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
Query: 922 IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 978
+ R + P PS + EAQDL+++ L DP +RLGA GA+E+K HPFFKG++
Sbjct: 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
Query: 979 WDSLALQKM 987
W++LAL+K+
Sbjct: 275 WEALALRKV 283
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 1e-72
Identities = 117/303 (38%), Positives = 175/303 (57%), Gaps = 35/303 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +DF++IK I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ ++V+ Y+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS+G +HRD+KPDN+L+ GH+KL DFG + + + +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKM---DANGMVRCD----- 201
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 919 PEIIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I++ K P D +S +A+DLI FL D RLG NG E+K+HPFFK
Sbjct: 252 LVGTYSKIMDHKNSL-TFPDDIEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309
Query: 977 VNW 979
W
Sbjct: 310 DQW 312
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (618), Expect = 2e-72
Identities = 112/295 (37%), Positives = 174/295 (58%), Gaps = 34/295 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +G+FG+V RKR T ++A+K ++K ++ ++++ LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF + LYLV+ ++NGG+L+ L++ G + AR Y AEL+ ALE LH +++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P+N+L+ + GHI L DFGL K+ + + D N +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD-------------------------DDKTN--TF 153
Query: 875 VGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GTP+YLAPE+LLG HGY A DWW++G++L+E +TG+PPF E+ ++ IL +
Sbjct: 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKM 987
+ P +A+DL+ L DP +RLG NGA E+K HPFF ++W L ++ +
Sbjct: 212 F---PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGI 263
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 5e-72
Identities = 106/287 (36%), Positives = 157/287 (54%), Gaps = 31/287 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
FE+++ I +GAFG+V + +KR T +FA+K + K + K + +L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V +YSF +N+YLV++ L GGDL Y L +KV E+ + +I E+VLALEYLHS G
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKG 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRD+KPDN+L+ GH+ +TDF ++ T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATK----------------------------VTP 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ S GTP Y+APE+L + A DWWS+G+ +E + G P+ S I
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
++ P+ S EA D IN+ L DP +RLG N ++K HP+F
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 6e-72
Identities = 139/326 (42%), Positives = 186/326 (57%), Gaps = 46/326 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK + GAFG V LA K T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++ E +AR YIAEL LA+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINNTIDLSGPETDGIMPSD-- 857
+HRD+KPDN+LI DGHIKLTDFGL SK + I D + PSD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI-----RQDSMEPSDLW 177
Query: 858 -----------AHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
E + T R HS VGTP+Y+APE+LL + DWWSVG+I
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 904 LFEFITGIPPFTAESPE------IIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHD 955
LFE + G PPF A +P I ++N L+ +P +S EA DLI + L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-------IPPQVKLSPEAVDLITK-LCCS 289
Query: 956 PNQRLGANGAAEVKAHPFFKGVNWDS 981
+RLG NGA ++KAHPFF V++ S
Sbjct: 290 AEERLGRNGADDIKAHPFFSEVDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 1e-71
Identities = 114/297 (38%), Positives = 165/297 (55%), Gaps = 32/297 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ TG +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL YLHS +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKM 987
+ P +S EA+ L+ L DP QRLG A E+ H FF +NW + +K+
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 7e-70
Identities = 113/306 (36%), Positives = 169/306 (55%), Gaps = 38/306 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 745
F + + RG FG+V LA + TG+L+AIK LKK D+I ++++E ++ E+ I T R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+PF+V F F D++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IV+RDLK DNLL+ +G +K+ DFGL K +G+ D
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------------EGMGFGD-------- 156
Query: 866 TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
R S GTP++LAPE+L T + A DWW +G++++E + G PF + E +FD
Sbjct: 157 -----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
+I+N ++ +P +S EA ++ R L +P +RLG+ A +VK PFF+ +NWD L
Sbjct: 212 SIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 983 ALQKMT 988
+K+
Sbjct: 269 LARKIK 274
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 1e-69
Identities = 102/299 (34%), Positives = 166/299 (55%), Gaps = 33/299 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K + I
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFGGK--------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 983
+ + + P +S EA + L P +RLG G +++ H FF+ ++W+ L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE 269
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 1e-68
Identities = 120/313 (38%), Positives = 189/313 (60%), Gaps = 42/313 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE++K + GA+G+VFL RK + +G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+R +PF+V Y+F L+L+++Y+NGG+L++ L + +E +IY E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------E 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE--- 917
+ + + +S GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT +
Sbjct: 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
Query: 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 974
S I IL + P+ P +MS A+D+I R L+ DP +RLG + A E+K HPFF
Sbjct: 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
Query: 975 KGVNWDSLALQKM 987
+ +NWD LA +K+
Sbjct: 272 QKINWDDLAAKKV 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-68
Identities = 121/298 (40%), Positives = 176/298 (59%), Gaps = 40/298 (13%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+K + +G+FG+VFL RK T G L+A+KVLKK + + D R ER+IL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPF 59
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLG 807
+V+ Y+F LYL++++L GGDL++ L K V EEDV + Y+AEL LAL++LHSLG
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG 118
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I++RDLKP+N+L+ +GHIKLTDFGLSK + D
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----------------------------ESID 150
Query: 868 NRNR-HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ + +S GT +Y+APE++ H +ADWWS G+++FE +TG PF + + I
Sbjct: 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
L K+ +P +S EAQ L+ +P RLGA +G E+K HPFF ++W+ L
Sbjct: 211 LKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-68
Identities = 119/300 (39%), Positives = 176/300 (58%), Gaps = 36/300 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVR 751
I +G FG+V+ RK+ T ++A+KVL K +++ K ++ + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+SF +LYLV +Y++GG+L+ L+K G ED A+ YIAELVLALE+LH IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GHI L DFGLSK L TDN+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---------------------------TDNKTT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929
++ GT +YLAPE+LL E GY D+WS+G+++FE G PF AE + ++ NI
Sbjct: 154 NTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKMT 988
K+ +P + +S E + + L +P RLGA A E+K HPFF ++WD L+ +++T
Sbjct: 213 KVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 2e-68
Identities = 111/298 (37%), Positives = 176/298 (59%), Gaps = 34/298 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
+ +G+FG+V LAR + +G L+A+KVLKK +++ +D+E + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F D L+ VME++NGGDL ++K +E AR Y AE+ AL +LH GI++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ H+GH KL DFG+ K G+ N G S +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFN-----------GKTTS----------------T 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 933
GTPDY+APEIL +G + DWW++G++L+E + G PF AE+ + +F+ ILN ++ +
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
Query: 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKMT 988
P+ +S +A D++ F+ +P RLG+ G + HPFFK ++W+ L +++
Sbjct: 216 ---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIE 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 9e-68
Identities = 109/291 (37%), Positives = 168/291 (57%), Gaps = 33/291 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751
K + +G+FG+V LA + T + FAIK LKK ++ +D+E + ER +L +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +F +++L+ VMEYLNGGDL ++ G +E AR Y AE++ L++LH GI++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------------KA 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL G ++ + DWWS G++L+E + G PF E + +FD+ILN
Sbjct: 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DR 212
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
P P +S EA+D +++ DP +RLG +G +++ HPFF+G++W+ L
Sbjct: 213 PH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 1e-67
Identities = 112/305 (36%), Positives = 169/305 (55%), Gaps = 40/305 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DF++ + RG FG V + R++ TGD++A+KV+KK ++ + + ER+IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLHS 805
P++ + Y+F +DNLYLVMEY GGDL SLL R +ED+A+ Y+AELVLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+G VHRD+KP+N+LI GHIKL DFG + + ++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSA-----------------ARLTANKMV----- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESP 919
N VGTPDY+APE+L +G DWWS+G+I +E I G PF +
Sbjct: 159 ----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
Query: 920 EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
++NI+N R + +P P +S + DLI L+ +RLG G + HPFF +
Sbjct: 215 AKTYNNIMNFQRFLKFPEDPK-VSSDFLDLIQS-LLCGQKERLGYEG---LCCHPFFSKI 269
Query: 978 NWDSL 982
+W+++
Sbjct: 270 DWNNI 274
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 6e-67
Identities = 106/300 (35%), Positives = 176/300 (58%), Gaps = 35/300 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+V LA + T +++AIKVLKK +++ +D++ + E+ IL + ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +D L+ VMEY+NGGDL +++ +E +R Y AE+ LAL +LH G+++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ +GH KL DFG+ K G++N
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--------------------------- 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL E+G + DWW++G++++E + G PPF A++ + +F++IL+ +
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLG----ANGAAEVKAHPFFKGVNWDSLALQKM 987
+P +S EA ++ F+ +PN+RLG G +K HPFFK ++W L +K+
Sbjct: 214 LYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKI 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 5e-66
Identities = 97/290 (33%), Positives = 152/290 (52%), Gaps = 33/290 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++ + + RG+FG V+LA + TG+L A+K ++ + +E + E IL ++++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 748 FVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+VR++ S ++ L + +EY++GG L SLL+K G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GIVHRD+K N+L+ DG +KL DFG +K T +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE--------------------- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
S GTP ++APE++ G E+G AAD WS+G + E TG PP++ +
Sbjct: 159 ----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
Query: 926 -ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
I + P P +P +S EA+D + + L DP +R A E+ HPF
Sbjct: 215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 2e-65
Identities = 111/298 (37%), Positives = 175/298 (58%), Gaps = 32/298 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA++++ G +A+KVL+K +++K + I+AERN+L+ +++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF + LY V++Y+NGG+L+ L++ C E AR Y AE+ A+ YLHSL I++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +G+ P +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGVEPEE------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNIL++ +
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA-AEVKAHPFFKGVNWDSLALQKMT 988
+P + A DL+ L D +RLGA E+K H FF +NWD L +++T
Sbjct: 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRIT 268
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 1e-64
Identities = 111/298 (37%), Positives = 167/298 (56%), Gaps = 32/298 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEYLHS +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKMT 988
+ P +S EA+ L+ L DP QRLG + A EV H FF +NW + +K+
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 4e-64
Identities = 108/293 (36%), Positives = 172/293 (58%), Gaps = 37/293 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L + +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--IYIAELVLALEYLHSLGIV 809
+ +F ++NL+ VMEYLNGGDL ++ C + D+ R Y AE++ L++LHS GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
+RDLK DN+L+ DGHIK+ DFG+ K ++ DA +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENML----------------GDAKTCTF------ 156
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929
GTPDY+APEILLG ++ + DWWS G++L+E + G PF E +F +I
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--- 208
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
++ PC P ++ EA+D++ + + +P +RLG G +++ HPFF+ ++W +L
Sbjct: 209 RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 7e-64
Identities = 122/304 (40%), Positives = 176/304 (57%), Gaps = 35/304 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFEIIK I RGAFG V + + + T ++A+K+L K +M+++ + ERN+L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ Y+F + LYLVM+Y GGDL +LL K L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + + DG + S
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQ----------DGTVQSSV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYA-----ADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ I+N + +P +D+S EA+DLI R LI +RLG NG + K H FF+G++
Sbjct: 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGID 273
Query: 979 WDSL 982
W+++
Sbjct: 274 WENI 277
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 8e-64
Identities = 116/298 (38%), Positives = 174/298 (58%), Gaps = 32/298 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LAR + +A+KVL+K +++K + + I++ERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+SF D LY V++Y+NGG+L+ L++ C E AR Y AE+ AL YLHSL IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GHI LTDFGL K + I N
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---------------ENIEH------------NGTT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + + ++DNILN+
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-- 211
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKMT 988
P P +++ A+ L+ L D +RLGA + E+K H FF +NWD L +K+T
Sbjct: 212 PLQLKP-NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKIT 268
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 8e-64
Identities = 116/297 (39%), Positives = 171/297 (57%), Gaps = 32/297 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ +G +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
YSF +D L VMEY+NGG+L+ L + ED R Y AE+V AL+YLHS IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ TD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------TDAATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKM 987
+ P +S +A+ L++ LI DPN+RLG + A E+ H FF GVNW + +K+
Sbjct: 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKL 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 3e-63
Identities = 122/304 (40%), Positives = 179/304 (58%), Gaps = 35/304 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFEI+K I RGAFG V + + + +FA+K+L K +M+++ + ER++L+ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLME----------DGTVQSSV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ I+N K +P +D+S +A+DLI R LI RLG NG + K HPFF G++
Sbjct: 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273
Query: 979 WDSL 982
WD++
Sbjct: 274 WDNI 277
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 5e-63
Identities = 120/303 (39%), Positives = 175/303 (57%), Gaps = 35/303 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS+G +HRD+KPDN+L+ GH+KL DFG +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----------KMNKEGMVRCD----- 201
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 919 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I+N K + +P +D+S EA++LI FL D RLG NG E+K H FFK
Sbjct: 252 LVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
Query: 977 VNW 979
W
Sbjct: 310 DQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 211 bits (541), Expect = 3e-62
Identities = 93/276 (33%), Positives = 151/276 (54%), Gaps = 34/276 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+EIIK I +G+FG+V+L R+++ G L+ +K + +M K + E L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYL 803
+++++ SF + L +VMEY +GGDL ++K E+ + +L LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRD+KP N+ + +G +KL DFG+SK+ +++T+DL+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA----------------- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ VGTP YL+PE+ + Y +D WS+G +L+E T PF E+ +
Sbjct: 161 --------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
IL + P P PS S E ++L++ L DP +R
Sbjct: 213 LKILKGQYP-PI-PSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 5e-62
Identities = 114/310 (36%), Positives = 166/310 (53%), Gaps = 38/310 (12%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERI 734
K + +DF I+ + G+FGRV LA + D AIK +K +I++ ++ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
+ER IL + +PF V + SF LYLV+E++ GG+ ++ LR+ DV Y A
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
++VL EYL SL IV+RDLKP+NLL+ DG IK+TDFG +K+
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------------------ 180
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
D R ++ GTP+Y+APEILL HG AADWW++GI ++E + G PPF
Sbjct: 181 -----------VDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHP 972
A P +I+ IL I + P + + L+ + L HD +R G GA VK HP
Sbjct: 229 YANEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285
Query: 973 FFKGVNWDSL 982
+F ++W SL
Sbjct: 286 WFGNIDWVSL 295
|
Length = 340 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 208 bits (533), Expect = 3e-61
Identities = 98/290 (33%), Positives = 149/290 (51%), Gaps = 41/290 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
FEI++ I +G FG V+ AR + TG AIKV+K + K E+I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSL 806
+V+++ S+ +D L++VME+ +GG L LL+ L E EL+ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI+HRD+K N+L+ DG +KL DFGLS Q +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------QLS 149
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 925
D + R++ VGTP ++APE++ G + Y AD WS+GI E G PP++ P + +F
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-- 207
Query: 926 ILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
P + + S E +D + + L +P +R A ++ HPF
Sbjct: 208 -KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 220 bits (561), Expect = 1e-60
Identities = 88/154 (57%), Positives = 120/154 (77%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
SI++F I+KPISRGAFG+V+L RK+ L+A+KV+KK DMI KN + ++ AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
++PF+V +YS +N+YLVMEYL GGD+ SLL G +E++A YI+E+ LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838
GI+HRDLKPDN+LI+++GHIKLTDFGLSK+ L
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 211 bits (537), Expect = 2e-60
Identities = 118/304 (38%), Positives = 174/304 (57%), Gaps = 37/304 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D++++K I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV+ F +F LY+VMEY+ GGDL +L+ + E A+ Y AE+VLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G++HRD+KPDN+L+ GH+KL DFG M D +T
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC-------------------MKMD-------ET 195
Query: 867 DNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+AVGTPDY++PE+L +G DWWSVG+ LFE + G PF A+S
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255
Query: 923 FDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG--VN 978
+ I++ K P D +S A++LI FL D RLG NG E+K HPFFK N
Sbjct: 256 YSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWN 313
Query: 979 WDSL 982
WD++
Sbjct: 314 WDNI 317
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 209 bits (532), Expect = 2e-60
Identities = 103/291 (35%), Positives = 169/291 (58%), Gaps = 33/291 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+V LA + G+ FA+K LKK ++ +D+E + E+ +L + NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+ +F +++L+ VME+LNGGDL ++ G + A Y AE+V L++LHS GI++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+++ DGHIK+ DFG+ K + DNR
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG--------------------------DNRAS 154
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL G ++ ++ DWWS G++L+E + G PF + + +F++I ++
Sbjct: 155 -TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RV 210
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
P P ++ E++D++ + DP +RLG G ++ HPFFK +NW +L
Sbjct: 211 DTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 209 bits (532), Expect = 2e-60
Identities = 107/297 (36%), Positives = 170/297 (57%), Gaps = 32/297 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA+++ G +A+KVL+K ++ + + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF + LY V++++NGG+L+ L++ E AR Y AE+ AL YLHS+ IV+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +GI SD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIAQSD------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE++ + DWW +G +L+E + G+PPF ++DNIL++ +
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKM 987
+ S A ++ L D +RLGA E++ HPFF+ ++W L +K+
Sbjct: 214 ---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 2e-59
Identities = 105/307 (34%), Positives = 175/307 (57%), Gaps = 43/307 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
I RG++ +V L + T ++A+KV+KK + DI+ + E+++ T N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+ V+E+++GGDL +++ L E+ AR Y AE+ LAL +LH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ +GHIKLTD+G+ K +GI P D +
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCK---------------EGIRPGDT------------TST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESPE-----IIFD 924
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF +++P+ +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDS 981
IL ++I +P +S +A ++ FL DP +RLG + G ++K+HPFF+ ++WD
Sbjct: 216 VILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 982 LALQKMT 988
L +++
Sbjct: 273 LEQKQVL 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 9e-59
Identities = 94/299 (31%), Positives = 147/299 (49%), Gaps = 33/299 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRD 812
+F +D+L LVM +NGGDL + VG E A Y A+++ LE+LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LKP+N+L+ G+++++D GL+ ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA-----------------------VELKGGKKI-----K 152
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GTP Y+APE+L G + ++ DW+++G L+E I G PF ++ + + R +
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 933 WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQKMT 988
P S EA+DL L DP +RLG G A EV+ HP FK +NW L +
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLE 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 103/298 (34%), Positives = 168/298 (56%), Gaps = 33/298 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K + DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----------DGV------------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PF E + +F +I
Sbjct: 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
+ + + P MS EA + + P +RLG G ++K H FF+ ++W+ L
Sbjct: 214 MEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 3e-58
Identities = 112/299 (37%), Positives = 167/299 (55%), Gaps = 33/299 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHR 811
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATM 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRL--GANGAAEVKAHPFFKGVNWDSLALQKMT 988
+ P +S EA+ L++ L DP QRL G + A E+ H FF G+ W + +K+
Sbjct: 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLV 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 4e-57
Identities = 102/299 (34%), Positives = 169/299 (56%), Gaps = 33/299 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K ++ DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----------DGV------------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 983
+ + + P +S EA + + P++RLG G +++ H FF+ ++WD L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-56
Identities = 107/306 (34%), Positives = 175/306 (57%), Gaps = 43/306 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
I RG++ +V L R + T ++A+KV+KK + DI+ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ +GHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCK---------------EGLRPGDT------------TST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESP-----EIIFD 924
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF ++++P + +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDS 981
IL ++I +P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD
Sbjct: 216 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272
Query: 982 LALQKM 987
+ +++
Sbjct: 273 MEQKQV 278
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 7e-56
Identities = 95/281 (33%), Positives = 136/281 (48%), Gaps = 69/281 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ G FG V+LAR + TG AIK++KK D + +E +L E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F ++LYLVMEY GG L LL++ G L ED + +++ LEYLHS GI+HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 814 KPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
KP+N+L+ D G +KL DFGLSK+ +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL---------------------------TSDKSLLK 151
Query: 873 SAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ VGTP Y+APE+LLG + +D WS+G+IL+E
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE------------------------- 186
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+ E +DLI + L DP +R A E+ H
Sbjct: 187 --------LP-ELKDLIRKMLQKDPEKRPSAK---EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 9e-56
Identities = 107/305 (35%), Positives = 174/305 (57%), Gaps = 41/305 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 753
I RG++ +V L R + ++A+KV+KK + DI+ + E+++ NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+LV+EY+NGGDL +++ L E+ AR Y AE+ +AL +LH GI++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ DGHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK---------------EGLGPGD------------TTST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--TAESPEI-----IFDNI 926
GTP+Y+APEIL G E+G++ DWW++G+++FE + G PF ++P++ +F I
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLA 983
L + I +P +S +A ++ FL DP +RLG G +++K+H FF+ ++WD L
Sbjct: 216 LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 984 LQKMT 988
+++T
Sbjct: 273 KKQVT 277
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 8e-53
Identities = 93/295 (31%), Positives = 147/295 (49%), Gaps = 39/295 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D E +K + +G+ G V+ R + TG ++A+K + + +++L E L + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCES 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 805
P+VV+ + +F + +V+EY++GG L LL+KVG + E V +++ L+YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP NLLI G +K+ DFG+SK+ + NT+D
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD--------------------- 155
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII-- 922
++ VGT Y++PE + G + YAAD WS+G+ L E G PF P
Sbjct: 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 923 FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I + P P + S E +D I+ L DP +R AAE+ HPF K
Sbjct: 212 MQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 99/284 (34%), Positives = 146/284 (51%), Gaps = 33/284 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G FG+V+ A TG+L A+K ++ D K I+ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
R+ +Y+ MEY +GG L LL L+E V R+Y +L+ L YLHS GIVHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P N+ + H+G IKL DFG + + + E Q S
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK----------------LKNNTTTMGEEVQ-------SL 163
Query: 875 VGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNILNR 929
GTP Y+APE++ G + HG AAD WS+G ++ E TG P++ E I+F
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
K P P +S E +D ++R L DP +R A+E+ HPF
Sbjct: 224 KPPIP-DSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 94/289 (32%), Positives = 148/289 (51%), Gaps = 37/289 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
++ ++ I GA G V+ A R TG AIK ++ +RK + E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 806
+V ++ S+ D L++VMEY++GG L ++ V E +A + E++ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K DN+L++ DG +KL DFG + L+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQ--------LT-------------------K 168
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ R+S VGTP ++APE++ ++G D WS+GI+ E G PP+ E P I
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ IP P S E +D +N+ L+ DP +R A E+ HPF K
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-49
Identities = 81/287 (28%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++++ I RGAFG V+ TGD AIK + I++ ++ I+ E ++L +++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V++ S D+LY+++EY G L +++K G E + +Y+ +++ L YLH G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
++HRD+K N+L DG +KL DFG++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL---------------------------NDV 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+++ S VGTP ++APE++ + A+D WS+G + E +TG PP+ +P I+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
P +P +S E +D + + DPN R A ++ HP+
Sbjct: 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 8e-49
Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRF 752
+ G+FG V+ GD FA+K + D + ++++ E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+ DNLY+ +E + GG L LL+K G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K N+L+ +G +KL DFG++K Q +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK----------------------------QVVEFSFAK 159
Query: 873 SAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
S G+P ++APE++ +G AAD WS+G + E TG PP++ I K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
P +P +S EA+D I + L DP+ R AAE+ HPF
Sbjct: 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 96/299 (32%), Positives = 147/299 (49%), Gaps = 33/299 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G +E+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA-----------------------VEIPEGETI 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ + ++ DWW +G +++E I G PF ++ + +
Sbjct: 159 RGR-----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 927 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSL 982
R S+ S A+ + + L DP RLG GA EVKAHPFF+ N+ L
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 89/289 (30%), Positives = 144/289 (49%), Gaps = 34/289 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F +++ I +G+FG V+ A + T + AIKV+ L+ +++IE I E L R+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEE-AEDEIEDIQQEIQFLSQCRS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P++ +++ SF L+++MEY GG LL K G L+E + E++L LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G +HRD+K N+L++ +G +KL DFG+S G + +T+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMS---------------------- 153
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P + S +D ++ L DP +R A E+ H F K
Sbjct: 211 PKNNPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (445), Expect = 5e-48
Identities = 106/306 (34%), Positives = 153/306 (50%), Gaps = 45/306 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N 746
+ I++ + G+FG V+LAR R A+KVL K + ++ER L E IL ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYL 803
P +V+ + F +LYLVMEY++GG L LL+K G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 804 HSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
HS GI+HRD+KP+N+L+ DG +KL DFGL+K+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL---------------------LPDPG 156
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPFTAES- 918
+ ++VGTP Y+APE+LLG Y ++D WS+GI L+E +TG+PPF E
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 919 ---PEIIFDNILNRKIPWPCVPSDMSF------EAQDLINRFLIHDPNQRLGANGAAEVK 969
IL P P S A DL+ + L DP RL ++
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL---SSSSDL 273
Query: 970 AHPFFK 975
+H
Sbjct: 274 SHDLLA 279
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 6e-48
Identities = 103/303 (33%), Positives = 152/303 (50%), Gaps = 41/303 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF---TAESPEIIFDNIL 927
H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF + I L
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 985
+ P S E + L+ L D N+RLG GA EVK HPFF+ ++W + LQ
Sbjct: 213 TMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
Query: 986 KMT 988
K
Sbjct: 270 KYP 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 101/300 (33%), Positives = 152/300 (50%), Gaps = 35/300 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G EE+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
V+RDLKP+N+L+ GHI+++D GL+ KI PE + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKI-----------PEGESI------------ 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R R VGT Y+APE+L + + D+W +G +++E I G PF ++ +
Sbjct: 159 ---RGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212
Query: 926 ILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
+ R + V + S EA+ + L DP QRLG GA EVK HPFF+ +N+ L
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 7e-46
Identities = 87/295 (29%), Positives = 149/295 (50%), Gaps = 34/295 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+F + +L LVM +NGGDL Y++ + E A Y A+++ LE+LH I++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RDLKP+N+L+ +DG+++++D GL+ E + ++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV--------------------------ELKDGQSKT 154
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
+ A GTP ++APE+L G E+ ++ D++++G+ L+E I PF A ++ + R
Sbjct: 155 KGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
Query: 931 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG-ANGA-AEVKAHPFFKGVNWDSL 982
+ D S ++ L DP +RLG +G ++ HP F+ +NW L
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 100/301 (33%), Positives = 149/301 (49%), Gaps = 35/301 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G EE A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ H PE Q
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-----------------------VHVPEGQTI 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ + ++ DWW++G +L+E I G PF +I + +
Sbjct: 159 KGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 927 --LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSL 982
L +++ S +A+ L L DP +RLG G A EVK HP FK +N+ L
Sbjct: 214 ERLVKEVQEE-YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272
Query: 983 A 983
Sbjct: 273 E 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 106/303 (34%), Positives = 157/303 (51%), Gaps = 45/303 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
Y+F D L +++ +NGGDL+ L + G E R Y E++L LE++H+ +V+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF----TAESPEIIFDNI 926
H++VGT Y+APE+L GT + +ADW+S+G +LF+ + G PF T + EI D +
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRM 210
Query: 927 -LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 983
L + +P S E + L+ L D ++RLG GA EVK H FFKG++W +
Sbjct: 211 TLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267
Query: 984 LQK 986
LQK
Sbjct: 268 LQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 88/299 (29%), Positives = 142/299 (47%), Gaps = 43/299 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
DD+E+I+ I GA V+ A + AIK ++D+ + ++ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK---RIDLEKCQTSVDELRKEVQAMSQCN 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEY 802
+P VV+++ SF D L+LVM YL+GG L +++ G L+E + + E++ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS G +HRD+K N+L+ DG +K+ DFG+S A +
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-----------------------ASLAD 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 920
+ R + VGTP ++APE+ + HGY AD WS GI E TG P++ P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPEV-MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213
Query: 921 IIFDNILNRKIPWPCVPSDMSFEA-----QDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ L P + + ++ + +I+ L DP++R A E+ H FF
Sbjct: 214 KVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 99/319 (31%), Positives = 147/319 (46%), Gaps = 70/319 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E ++ + G +G V+ AR + TG++ A+K ++ LD N+ E I L E ++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LD----NEEEGIPSTALREISLLKEL 55
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 803
++P +V+ LYLV EY + DL L K G L ++ + + +L+ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRDLKP N+LI DG +KL DFGL++ I P + E
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI---------------PLRTYTHE- 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 921
V T Y APEILLG++H A D WSVG I E ITG P F +S EI
Sbjct: 159 -----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EID 206
Query: 922 ----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHD 955
IF + +P + E DL+++ L ++
Sbjct: 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYN 266
Query: 956 PNQRLGANGAAEVKAHPFF 974
P +R+ A A + HP+F
Sbjct: 267 PAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 97/320 (30%), Positives = 139/320 (43%), Gaps = 68/320 (21%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVR 745
++I+ I GA G VF A+ R TG+ A+K K+ + R + L E L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 804
+P+VV+ F LVMEY+ DL +LR L E + Y+ L+ + Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+ GI+HRDLKP NLLI+ DG +K+ DFGL++ + +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLAR-----------------LFSEEEPRLYSH 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES----- 918
Q V T Y APE+L G D W+VG I E + G P F E+
Sbjct: 160 Q---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
Query: 919 ---------------PE---------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 954
P I F ++ IP + D S EA DL+ L++
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKGLLVY 268
Query: 955 DPNQRLGANGAAEVKAHPFF 974
DP++RL AAE HP+F
Sbjct: 269 DPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 85/286 (29%), Positives = 143/286 (50%), Gaps = 47/286 (16%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D+E+++ I +G+FG V R+++ G + K + +M K + +++++E NIL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 748 FVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 801
+VR++ R N LY+VMEY GGDL L++K +EE+ + +L+LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 802 YLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
H+ ++HRDLKP N+ + + ++KL DFGL+KI
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------------- 159
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
D+ + VGTP Y++PE L + +D WS+G +++E PPFTA
Sbjct: 160 -------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 917 ESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ L KI + +P S E ++I L DP++R
Sbjct: 213 RNQL-----QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 84/292 (28%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F+I++ + G++G V+ A + TG + AIKV+ + D++ I+ E +IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
P++V+++ S+ +L++VMEY G D+ + K L E+ + + + LEYL
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYL 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS +HRD+K N+L+ +G KL DFG+S
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--------------------------- 148
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922
R++ +GTP ++APE++ + AD WS+GI E G PP++ P I
Sbjct: 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
F I N+ P P S E D + + L+ DP +R A ++ HPF
Sbjct: 209 F-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER---PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 95/299 (31%), Positives = 145/299 (48%), Gaps = 33/299 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G +E A Y AEL LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA-----------------------VQIPEGETV 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ ++ ++ DWW +G +++E I G PF + + +
Sbjct: 159 RGR-----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
Query: 927 LNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSL 982
R K S +A+ + L +P +RLG NGAA VK HP FK +N+ L
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 98/299 (32%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D+E+I+ I G +G V+ AR TG+L AIKV+K + +D E I E ++L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIA----ELVLA 799
P +V +F S+ RD L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L YLH G +HRD+K N+L+ DG +KL DFG+S + TI
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATI---------------- 155
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
R S +GTP ++APE + + GY D W++GI E PP
Sbjct: 156 ---------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 917 ESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
P I P P + S D I + L DP +R A ++ HPF
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 89/294 (30%), Positives = 144/294 (48%), Gaps = 39/294 (13%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R+ +D+F I G+ G V +A ++TG A+K K+D+ ++ E + E I+
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMR 71
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 801
++P +V + S+ D L++VME+L GG L ++ EE +A + VL AL
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALS 129
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+LH+ G++HRD+K D++L+ DG +KL+DFG + +P
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-------------QVSKEVP------ 170
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 --------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I + P +S + ++R L+ DP QR AAE+ HPF
Sbjct: 223 AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-41
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 45/292 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 745
DF+++K + +G++G V+ ++ + +A LK++D+ + ER + E IL +V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-----EEDVARIYIAELVLAL 800
+P ++ + +F + L +VMEY GDL + K E+++ RI+I +L+ L
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGL 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ LH I+HRDLK N+L+ + +K+ D G+SK+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKV------------------------ 152
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ +GTP Y+APE+ G + Y +D WS+G +L+E T PPF A S +
Sbjct: 153 -----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+ + K +P +P S + Q+ I L P R + ++ A P
Sbjct: 208 DLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCD---KILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 102/325 (31%), Positives = 148/325 (45%), Gaps = 77/325 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 746
+E I I G +G+V+ AR + TG+L A LKK+ M + + I A R I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 747 PFVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 803
P +VR T + ++Y+V EY++ DL LL E + Y+ +L+ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS GI+HRD+K N+LI +DG +KL DFGL++ Y +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR-----------------------PYTKR 153
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
D NR V T Y PE+LLG T +G D WSVG IL E G P F +
Sbjct: 154 NSADYTNR---VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
Query: 920 -EIIFD-----NILNRKIPWPCVPSDMSF------------------------EAQDLIN 949
E IF+ N WP V S + + A DL++
Sbjct: 211 LEKIFELCGSPTDEN----WPGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFF 974
+ L DP +R+ A+ A + H +F
Sbjct: 266 KLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 97/301 (32%), Positives = 151/301 (50%), Gaps = 46/301 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD E + + G G V R TG + A+K ++ L+ I + ++IL E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LE-INEAIQKQILRELDILHKCNS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDV-ARIYIAELVLALEYLH 804
P++V F+ +F ++ + MEY++GG L +L++V G + E + +I +A ++ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I+HRD+KP N+L+ G IKL DFG+S L+N+
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAK------------------- 157
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--SPEI 921
+ VGT Y+APE + G ++ +D WS+G+ L E TG P+ E P+
Sbjct: 158 ---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 922 IFD---NILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
IF+ I+N P P +PS S + QD +N LI DP +R E+ HPF K
Sbjct: 209 IFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK---ELLEHPFIKKY 263
Query: 978 N 978
Sbjct: 264 E 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 67/325 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITVRN 746
+E++KPI GA+G V A + TG AIK K+ + + I+ RIL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 747 PFVVR---FFY--SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
++ S +++Y+V E + DL+ +++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLHS ++HRDLKP N+L+ + +K+ DFGL++ + + G +
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-------EDEKGFLT------ 164
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP- 919
EY V T Y APE+LL + A D WSVG I E +T P F
Sbjct: 165 EY-----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 920 ---EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRFL 952
+I + I + K P + S EA DL+ + L
Sbjct: 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGV 977
+ DP +R+ A E AHP+ +
Sbjct: 274 VFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 91/317 (28%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITVRN 746
++ + I G +G V+ AR + TG++ AIK K+ + +++ A R I L + +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 805
P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + HS
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GI+HRDLKP+NLLI +G +KL DFGL++ Y Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS----------------FGSPVRPYTHY-- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES------ 918
V T Y APE+LLG + D WSVG I E ++ P F +S
Sbjct: 159 ---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 919 --------------PEII---FDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPN 957
P+ + + +P P + + S +A DL+++ L +DP+
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 958 QRLGANGAAEVKAHPFF 974
+R+ A A AHP+F
Sbjct: 270 KRITAEQAL---AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 87/285 (30%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 750
K + +GAFGRV+L TG A+K + K ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+++ + L + MEY+ GG + L+ G L E V R Y +++ +EYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RD+K N+L G++KL DFG SK TI SG T +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK---RLQTICSSG------------------TGMK- 165
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNR 929
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 166 --SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IAT 221
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ P +PS +S +A++ + R + + +R A E+ H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 1e-38
Identities = 84/293 (28%), Positives = 143/293 (48%), Gaps = 33/293 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + + TG ++A K L K + +K+ + L E+ IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 812
+F + +L LVM +NGGDL + VG ++ R+ Y A++ + +LHS+ IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+KP+N+L+ G+ +L+D GL+ + + R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA-----------------------VELKDGKTITQR--- 154
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GT Y+APEIL + Y DW+++G ++E + G PF ++ + + R +
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 933 WPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAA-EVKAHPFFKGVNWDSL 982
+F E++D+ FL P RLG+ + + H FFK +N+ L
Sbjct: 213 DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 96/320 (30%), Positives = 143/320 (44%), Gaps = 71/320 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITV-R 745
+++IK + G FG V+LAR + TG+L AIK +KK + E + R + L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYL 803
+P +V+ F D LY V EY+ G +LY L+ RK E V R I +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H G HRDLKP+NLL++ +K+ DFGL++ E P Y +Y
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPP----YTDY 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF--TAESPE 920
V T Y APEILL T + D W++G I+ E T P F ++E +
Sbjct: 159 -----------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 921 I--IFD-----------------NILNRKIPWPCVPSDMSF-------EAQDLINRFLIH 954
+ I + L + P P+ + EA DLI L
Sbjct: 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 955 DPNQRLGANGAAEVKAHPFF 974
DP +R A++ HP+F
Sbjct: 267 DPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 34/234 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVR 745
+E++ + GA+G V R + TG++ AIK K+ + ++K L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQLR 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ +V +F + LYLV EY+ L L G L D R YI +L+ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP+N+L++ G +KL DFG ++ L + +Y
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRA-------RPASPLTDY-- 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y APE+L+G T +G D W++G I+ E + G P F +S
Sbjct: 162 ---------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 39/295 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
D +EII + GAFG+V+ A+ + TG A K++ + + ++E + E +IL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 804
+P +V + ++ + L++++E+ +GG L S++ ++ L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
T + R + +GTP ++APE++ + Y AD WS+GI L E PP +P
Sbjct: 155 STLQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ IL + P PS S D + L+ DP+ R AAE+ HPF
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 83/275 (30%), Positives = 139/275 (50%), Gaps = 34/275 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFEI+ I +G+FG VF ++ ++A+K + M R+ + E + E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSS 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLH 804
+++R++ SF + L +VMEY GDL+ LL R E+ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S I+HRD+K NL + ++K+ D G++K+ L +NT +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTN-------------------FA 158
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
T VGTP YL+PE+ + +D W++G++L+E TG PF A + +
Sbjct: 159 NT-------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I+ +P V S + LI++ L D QR
Sbjct: 212 KIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 92/303 (30%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
FE+++ I G +G+V+ AR + TG L AIK++ I +++ E I E NIL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 747 -PFVVRFFYSF------TCRDNLYLVMEYLNGG---DLYSLLRKVG-CLEEDVARIYIAE 795
P + F+ +F D L+LVME GG DL LRK G L+E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ L YLH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITG 910
+ T R R++ +GTP ++APE++ E + +D WS+GI E G
Sbjct: 162 ------QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
PP P I P P + S + D I+ LI + QR E+
Sbjct: 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR---PFMEELLE 271
Query: 971 HPF 973
HPF
Sbjct: 272 HPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-36
Identities = 61/113 (53%), Positives = 77/113 (68%), Gaps = 3/113 (2%)
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
+GTPDYLAPE+LLG HG A DWW++G+ LFEF+TGIPPF E+P+ +F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKM 987
+S AQ+ I L DP +R G E+K HP F GV+W++L Q M
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTM 650
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 98/319 (30%), Positives = 139/319 (43%), Gaps = 66/319 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E K + G + V+ AR + TG + AIK +K + RK + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYL 803
++P ++ F + N+ LV E++ DL +++ K L + Y+ + LEYL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRDLKP+NLLIA DG +KL DFGL++ S
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----------------SFGS------- 154
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP--- 919
NR V T Y APE+L G H G D WSVG I E + +P +S
Sbjct: 155 ---PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211
Query: 920 -EIIFDNILNRKIP--WPCVPSDMSF--------------------EAQDLINRFLIHDP 956
IF L WP V S + +A DL+ R L +P
Sbjct: 212 LGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 957 NQRLGANGAAEVKAHPFFK 975
N+R+ A A E HP+F
Sbjct: 271 NKRITARQALE---HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 90/281 (32%), Positives = 134/281 (47%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AIK + +K E I+ E ++ ++P +V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 37/280 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RGA+G V+ + TG + A+K++ LD +D+ I E +L +R P + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
++ S+ L+++MEY GG + +L+ K G + E + I E+++AL+Y+H +G++HR
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
D+K N+L+ + G++KL DFG++ Q ++ R
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAA--------------------------LLNQNSSK-R 158
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
+ VGTP ++APE++ G + AD WS+GI ++E TG PP++ I K
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218
Query: 931 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
P + + S ++ + L +P +RL A + K
Sbjct: 219 PPR--LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 95/297 (31%), Positives = 151/297 (50%), Gaps = 47/297 (15%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
RT +D+F IK I G+ G V +A +++G L A+K K+D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ VV + S+ D L++VME+L GG L ++ EE +A + +A L AL
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALSV 131
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ G++HRD+K D++L+ HDG +KL+DFG ++ +
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEV------------------- 170
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
Query: 920 -EIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
++I DN+ + K PS F ++R L+ DP QR A E+ HPF
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGF-----LDRLLVRDPAQRATAA---ELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 91/296 (30%), Positives = 146/296 (49%), Gaps = 39/296 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EII + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +P+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPY 70
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLG 807
+V+ +F L++++E+ GG + +++ ++ L E ++ +++ AL+YLHS+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLK N+L+ DG IKL DFG+S N L
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTL---------------------- 164
Query: 868 NRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+ R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P +
Sbjct: 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
I + P PS S E +D + L P R AA++ HPF V
Sbjct: 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 92/281 (32%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G VF A TG AIK ++++ ++ E I+ E ++ ++NP +V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIK---QINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF D L++VMEYL GG L ++ + C++E E + ALE+LH+ ++HRD+K
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 89/281 (31%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AIK ++++ ++ E I+ E ++ +NP +V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + AL++LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D ++R A E+ HPF K
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 100/323 (30%), Positives = 156/323 (48%), Gaps = 68/323 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRN- 746
+EI++ + +GA+G V+ A R T ++ A+K K D R D +R E L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYL 803
P +V+ ++ +YLV EY+ DL++++R LE DV + YI +L+ AL+Y+
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NILE-DVHKRYIMYQLLKALKYI 123
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID-LSGPETDGIMPSDAHYPE 862
HS ++HRDLKP N+L+ D +KL DFGL++ ++ L + ++ +
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPVLT------D 171
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG---------- 910
Y V T Y APEILLG+ Y D WSVG IL E + G
Sbjct: 172 Y-----------VATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 911 ---------IPPFTAE------SP--EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFL 952
I P +AE SP + D++ +R P + S +A DL+ + L
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 953 IHDPNQRLGANGAAEVKAHPFFK 975
+ +PN+RL A A E HP+
Sbjct: 280 VFNPNKRLTAEEALE---HPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 96/332 (28%), Positives = 139/332 (41%), Gaps = 91/332 (27%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR-- 745
+E + I GA+G V+ AR TG A LKK+ + L+E I L T+R
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVA---LKKVRVP--------LSEEGIPLSTLREI 49
Query: 746 ----------NPFVVRFF-YSFTCRDN----LYLVMEYLNGGDLYSLLRKV---GCLEED 787
+P +VR R + L LV E+++ DL + L K G L +
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPE 107
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ + +L+ +++LHS IVHRDLKP N+L+ DG +K+ DFGL++I
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI----------- 156
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
Y + S V T Y APE+LL + + D WSVG I E
Sbjct: 157 ------------Y-----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
Query: 908 ITGIPPFTAESPEI-----IFDNI---------LNRKIPWPCVPS-----------DMSF 942
P F S E IFD I N +P PS ++
Sbjct: 200 FRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICE 258
Query: 943 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
E DL+ + L +P++R+ A E HP+F
Sbjct: 259 EGLDLLKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 88/294 (29%), Positives = 150/294 (51%), Gaps = 41/294 (13%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R+ ++++ IK I G+ G V +AR++ +G A+K++ D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR 73
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 801
++ VV + S+ + L+++ME+L GG L ++ + EE +A + E VL AL
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALC 131
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHY 860
YLHS G++HRD+K D++L+ DG +KL+DFG ++I
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------------------------ 167
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
D R S VGTP ++APE++ T +G D WS+GI++ E + G PP+ ++SP
Sbjct: 168 ----SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + P +S +D + R L +P +R A E+ HPF
Sbjct: 224 QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 36/282 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ +F+I K I +G F V+ A G + A+K ++ +M+ + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALE 801
+P V+++ SF + L +V+E + GDL +++ + E Y +L ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++HS I+HRD+KP N+ I G +KL D GL + S T
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAA--------- 163
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 164 ----------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 922 --IFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRL 960
+ I K +P +P+D S E +DL++R + DP +R
Sbjct: 214 YSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 89/281 (31%), Positives = 136/281 (48%), Gaps = 34/281 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +NP +V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 176
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P I P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P +S +D +NR L D +R A E+ H F K
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 86/289 (29%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRN 746
+ I+ + +GAFG L R+ L V K++++ R ++ ER A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 804
P ++ ++ F + L + MEY NGG LY + +K EE++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
GI+HRD+K N+ + G IKL DFG+SKI + S+ E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-----------------LGSEYSMAE-- 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ VGTP Y++PE+ G ++ + +D W++G +L+E +T F A +P +
Sbjct: 160 --------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
I+ + V S S E L++ L DP +R A EV P
Sbjct: 212 KIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR---PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITV 744
E+ K + GAFG V+ + G+ A+K LK+ + E L E +I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA-ELVLAL 800
+P +VR T + LY+V EY+ GGDL LRK G L++ + +A ++ +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGM 115
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD----------------IYEDD--- 156
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
Y++ ++APE L + +D WS G++L+E T G P+ S
Sbjct: 157 -YYRKRGG-----GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E + + + + P P + E +L+ + +DP R
Sbjct: 211 EEVLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 85/289 (29%), Positives = 145/289 (50%), Gaps = 40/289 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIK------VLKKLDMIRKNDIERILAERNILITVRNPF 748
I G+FG V+L ++G+L A+K V +++ ++ + E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+V++ S D+L + +EY+ GG + +LL G EE + R ++ +++ L YLH+ GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L+ + G IK++DFG+SK N+ N
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---------------------TKTN 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF---D 924
R S G+ ++APE++ T + AD WS+G ++ E +TG PF + IF +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
N P +PS++S EA D + + D N+R AAE+ HPF
Sbjct: 227 NAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 74/279 (26%), Positives = 144/279 (51%), Gaps = 36/279 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 746
+ +K I G+FG+ L + + G + V+K++++ + + ER + + + + +++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQY---VIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 804
P +V++ SF NLY+VM+Y GGDLY + ++ ED + ++ LAL+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+K N+ + DG IKL DFG++++ +N+T++L+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA------------------ 158
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ +GTP YL+PEI + +D W++G +L+E T F A + + +
Sbjct: 159 -------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
I+ +P V S S++ ++L+++ +P R N
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 94/301 (31%), Positives = 143/301 (47%), Gaps = 46/301 (15%)
Query: 689 FEIIKP--ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL-------AERN 739
F+ +K I +G +GRV+LA TTG++ A+K ++ I R +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L + + +V++ T + L + +EY+ GG + S LR G EE + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L YLHS GI+HRDLK DNLL+ DG K++DFG+SK SD
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-------------------KSDDI 161
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF-TA 916
Y DN S G+ ++APE++ GY+A D WS+G ++ E G P+
Sbjct: 162 Y------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
Query: 917 ESPEIIFDNILNRKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
E+ +F L K P +P D +S A D +N +P+ R A E+ HP
Sbjct: 216 EAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR---ELLQHP 270
Query: 973 F 973
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 48/282 (17%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ K + GAFG V+ + A+K LK+ + IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 798
+P VV+ T + LY+VMEY+ GGDL S LRK ++ +++L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL--------------------- 152
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917
+ R + ++APE L + +D WS G++L+E T G P+
Sbjct: 153 --YDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
S E + + + N P + E DL+ + DP R
Sbjct: 208 SNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
G +V L T F +K L+K + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817
D+++LV+++ GG L+S + K + E+ + + AE+V+AL+ LH GIV RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 877
+L+ GHI+LT F E + +A +N
Sbjct: 116 ILLDDRGHIQLTYFS-------------RWSEVEDSCDGEA-------VENM-------- 147
Query: 878 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 937
Y APE+ +E A DWWS+G ILFE +TG I LN +P
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-------IP 198
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGAA--EVKAHPFF 974
+S EA+ L+ + L +P +RLGA A ++K+HPFF
Sbjct: 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ K + GAFG V+ A+K LK+ IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY-----IAELVLAL 800
+P +V+ T + L +VMEY+ GGDL LRK E ++ + IA +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---GM 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL----------------------- 153
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
+ + + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 154 YDDDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + P + E L+ + DP R
Sbjct: 211 AEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 693 KPISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + GAFG V+ + K A+K LK+ + + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNV 58
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---------AL 800
VR T + LYLV+EY+ GGDL LRK + + ++ L +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S VHRDL N L+ D +K++DFGLS+ ++ T G +P
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLP----- 170
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
R ++APE L +D WS G++L+E T G P+ S
Sbjct: 171 -------IR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E + + + P P E +L+ DP R
Sbjct: 214 EEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 74/321 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
++I+ I G F V A+ R TG +AIK +KK +E++ R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 746 NPFVVRF----FYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLAL 800
+P ++R F T R L LV E ++ +LY L++ + L E + Y+ +L+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+++H GI HRD+KP+N+LI D +KL DFG + I P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR------GIYSKPP-----------Y 155
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE-- 917
EY + T Y APE LL +G D W+VG + FE ++ P F
Sbjct: 156 TEY-----------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 918 --------------SPEIIFD----NILNRKIP------WPCVPSDMSFEAQDLINRFLI 953
E++ +N P + + S E DL+ + L
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA 264
Query: 954 HDPNQRLGANGAAEVKAHPFF 974
+DP++R+ A A HP+F
Sbjct: 265 YDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 101/347 (29%), Positives = 148/347 (42%), Gaps = 113/347 (32%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI------LAER 738
S+D++E + I G +G V+ AR + TG++ A LKKL K + E+ L E
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVA---LKKL----KMEKEKEGFPITSLREI 55
Query: 739 NILITVRNPFVVRFFYSFTCR--------DNLYLVMEYLNGGDLYSLLR---------KV 781
NIL+ +++P +V T + D +Y+VMEY+ DL SL+ +V
Sbjct: 56 NILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 782 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
CL + +L+ + +LH I+HRDLK NLL+ + G +K+ DFGL++
Sbjct: 109 KCL--------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------ 154
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 900
EY + V T Y APE+LLG E+ A D WSV
Sbjct: 155 --------------------EYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 901 GIILFEFITGIPPFTAESP----EIIFD-----------------------------NIL 927
G I E +T P F +S IF N L
Sbjct: 194 GCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+K P +S DL+NR L +DP +R+ A A + HP+F
Sbjct: 254 RKKFP----ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 96/328 (29%), Positives = 147/328 (44%), Gaps = 76/328 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE + + G G V R +G + A K L L+ I+ +I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARK-LIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L+K G + E++ +I IA ++ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 806 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S LI++ +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 157 --------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 922 IF---------------------------------DNILNRKIPWPCVPSD-MSFEAQDL 947
+F D I+N P P +PS S E QD
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQDF 266
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFK 975
+++ L +P +R E+ HPF K
Sbjct: 267 VDKCLKKNPKERA---DLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 90/293 (30%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +D F IK I G+ G V +A ++ TG A+K K+D+ ++ E + E I+
Sbjct: 21 REYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMR 74
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ VV + S+ D L++VME+L GG L ++ EE +A + ++ ++ AL Y
Sbjct: 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSY 133
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ G++HRD+K D++L+ DG IKL+DFG + +P
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA-------------QVSKEVP------- 173
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
R S VGTP ++APE++ +G D WS+GI++ E I G PP+ E P
Sbjct: 174 -------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I + P +S + ++ L+ +P+QR A E+ HPF K
Sbjct: 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 38/290 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILITVRNPFVVR 751
+ GAF + AR TG L A+K + + +E + E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 752 FFYSFTCRDNLY-LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
TC D+ + L +E++ GG + LL K G +E V Y +L+ L YLH I+H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 811 RDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
RD+K NLLI G +++ DFG + + +G E G +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAG-EFQGQL--------------- 168
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 925
+GT ++APE+L G ++G + D WSVG ++ E T PP+ AE +IF
Sbjct: 169 -----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-K 222
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I + P +P +S +D+ R L P R + E+ HP F+
Sbjct: 223 IASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 95/323 (29%), Positives = 147/323 (45%), Gaps = 77/323 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILIT 743
++ ++ I G +G V+ AR + TG++ A LKK IR + + E + + E ++L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPSTAIREISLLKE 54
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
+ +P +VR + LYLV E+L+ DL + L+ + + Y+ +L+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y HS ++HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--------------GV-------P 152
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 919
T H V T Y APEILLG+ Y D WS+G I E + P F +S
Sbjct: 153 VRTYT-----HEVV-TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDS- 204
Query: 920 EI-----IFDNILN--RKIPWPCVPSDMSF---------------------EAQDLINRF 951
EI IF L + WP V S + + DL+++
Sbjct: 205 EIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKM 263
Query: 952 LIHDPNQRLGANGAAEVKAHPFF 974
L++DP +R+ A A + HP+F
Sbjct: 264 LVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 86/333 (25%), Positives = 140/333 (42%), Gaps = 81/333 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRKNDIE 732
++ I+ I GA+G V A +G AIK L++L ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
I+A R+IL F ++Y+VM+ L DL+ ++ L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ +L+ L+Y+HS ++HRDLKP NLL+ D +++ DFG+++ GL ++ +
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKY----- 166
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI--- 908
EY V T Y APE+LL E+ A D WSVG I E +
Sbjct: 167 ------FMTEY-----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
Query: 909 ------------------TGIPP------FTAESPEIIFDNILNRK-IPWPCVPSDMSFE 943
G P ++ N+ ++ +PW + S E
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
A DL+++ L DP +R+ A + HPF
Sbjct: 270 ALDLLSQMLQFDPEERITVEQALQ---HPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTG-DLFAIK-------VLKKLDMIRKNDIERILAERNI 740
+ +++ + GAFG V+ RK+ G +L A+K K R I I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 741 LI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG---GDLYSLLRKVG--CLEEDVARIYIA 794
+ +R+P +VR++ +F D LY+VM+ + G G+ ++ L++ EE + I++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 795 ELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
++VLAL YLH IVHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
Q+ S VGT Y PEI+ +G AD W+ G IL++ T PP
Sbjct: 163 ----------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 959
F + + + I+ + +P M S + D+I L D R
Sbjct: 213 FYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-30
Identities = 84/287 (29%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG V+ T ++ AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+ R++ S+ L+++MEYL GG LL K G LEE + E++ L+YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926
+ R++ VGTP ++APE++ + + + AD WS+GI E G PP + P ++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--L 212
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ + P P + S ++ + L DP R A E+ H F
Sbjct: 213 IPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 90/300 (30%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 688 DFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ EI+K + G FG+V + + + T LF K++K + N IE V
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIE---------PMVH 62
Query: 746 -----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
NP ++ +YS T L+M+Y+ GDL+ LL+K G L E + I +LV AL
Sbjct: 63 QLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 801 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LH I+H D+K +N+L I L D+GL KI I T D
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IG---------TPSCY--D-- 167
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
GT DY +PE + G + + DWW+VG++ +E +TG PF +
Sbjct: 168 ----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 920 EII-FDNILNR---KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E + +++L R K+P ++S A D + L ++ N RL E+ HPF K
Sbjct: 212 EELDLESLLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 95/330 (28%), Positives = 139/330 (42%), Gaps = 79/330 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILI 742
S+ +FE + I G +G V+ AR T+G++ A LKK+ M + D I L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 743 TVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 799
+R+P +V + D+++LVMEY DL SLL + E + + +L+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L+YLH I+HRDLK NLL+ G +K+ DFGL++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------------------YG 159
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
P T V T Y APE+LLG T + A D W+VG IL E + P +S
Sbjct: 160 LPAKPMTPK------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 919 P----EIIFD-----------------------------NILNRKIPWPCVPSDMSFEAQ 945
++I N L K PW +S
Sbjct: 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW------LSEAGL 267
Query: 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
L+N L++DP +R A E +FK
Sbjct: 268 RLLNFLLMYDPKKRA---TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 96/330 (29%), Positives = 148/330 (44%), Gaps = 72/330 (21%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KK 722
S S SS S+ S+ S+ + E + I GA G V+ R TG L+A+KV+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 723 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
D +R+ +I E IL V +P VV+ F + +++E+++GG L +
Sbjct: 112 EDTVRR----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA 165
Query: 783 CLEE--DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
+ DVAR +++ + YLH IVHRD+KP NLLI ++K+ DFG+S+I +
Sbjct: 166 DEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LA 219
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 895
T+D P + S+VGT Y++PE + G GYA
Sbjct: 220 QTMD----------PCN---------------SSVGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW------------PCVPSDMSFE 943
D WS+G+ + EF G PF + R+ W P P+ S E
Sbjct: 255 DIWSLGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASRE 303
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ I+ L +P +R A ++ HPF
Sbjct: 304 FRHFISCCLQREPAKRWSAM---QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 83/233 (35%), Positives = 119/233 (51%), Gaps = 29/233 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 745
+ FE++ + GA+G V R + T ++ AIK K D ++ E L E +L T++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+V +F R LYLV EY+ L L + + R YI +L+ A+ + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IVHRD+KP+NLLI+H+ +KL DFG ++ +LS +G S+A+Y EY
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS----EG---SNANYTEY-- 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y +PE+LLG +G A D WSVG IL E G P F ES
Sbjct: 162 ---------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 87/293 (29%), Positives = 143/293 (48%), Gaps = 39/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +EII + GAFG+V+ A+ + TG L A KV+ D + ++E + E +IL + +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 805
P +V+ +F +NL++++E+ GG + +++ ++ L E R+ + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L DG IKL DFG+S NT +
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTI-------------------- 157
Query: 866 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ I + P PS S E +D + + L + + R ++ HPF
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV--LKKLDMIRKNDIERILAERNILITV 744
+D E I + G G V + TG + A KV + +RK +IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIMHEC 60
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
R+P++V F+ +F +N+ + ME+++ G L + +K G + ++ +V L YL+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+ I+HRD+KP N+L+ G IKL DFG+S LIN+ D
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 916
+ VGT Y++PE + G ++ +D WS+GI + E G PF
Sbjct: 161 ---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 917 -ESPEIIFD---NILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
+ P I D I+ P P +PS D + +D ++ L+ DP +R
Sbjct: 212 QDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER--PTPQQLCAMP 267
Query: 972 PF 973
PF
Sbjct: 268 PF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 37/286 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V +++ S+ L+++MEYL GG LLR G +E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI- 213
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
K P + + S ++ I+ L DP+ R A E+ H F
Sbjct: 214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 92/328 (28%), Positives = 142/328 (43%), Gaps = 74/328 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
D +E ++ I G +G+V+ AR + TG L A+K +L+M + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 746 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLL----RKVGC-LEEDVARIYIAE 795
+ ++VR + +LYLV EYL+ DL + R G L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L+ + + H G++HRDLKP NLL+ G +K+ D GL + +I +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----AFSIPVK-------- 166
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913
H V T Y APE+LLG+ H D WSVG I E P
Sbjct: 167 --------------SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 914 FTAESPEI-----IFDNI--LNRKIPWPCV-------------PSDMSF-------EAQD 946
F +S E+ IF + ++ WP V P D+S E D
Sbjct: 212 FPGDS-ELQQLLHIFKLLGTPTEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269
Query: 947 LINRFLIHDPNQRLGANGAAEVKAHPFF 974
L+ + L +DP +R+ A A HP+F
Sbjct: 270 LLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 39/288 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+E I+ + RGAFG V L R++ L IK + M + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
++ ++ +F L +VMEY GG L ++K L+ED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 807 GIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L+ H +K+ DFG+SKI LS S A
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSS-------KSKA------- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924
++ VGTP Y++PE+ G + +D W++G +L+E + F A + P ++
Sbjct: 159 ------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+ P + S + + LI L DP++R + ++ A P
Sbjct: 213 IMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLS---QIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 95/305 (31%), Positives = 138/305 (45%), Gaps = 51/305 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII+ I +G +G+V+ + G L A+K+L D I D E I AE NIL ++ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVD-EEIEAEYNILQSLPN 77
Query: 747 -PFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 796
P VV+F+ F D L+LV+E NGG + L L L+E + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+L L++LH+ I+HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 857 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEILLGTE---HGYAA--DWWSVGIILFEFITG 910
Q T R R+++VGTP ++APE++ + + Y A D WS+GI E G
Sbjct: 177 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
PP P I P P I++ LI D R E
Sbjct: 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE--- 286
Query: 971 HPFFK 975
HPF K
Sbjct: 287 HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EIIK I G+FG+++LA+ ++ + IK + M K E E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCL-EEDVARIYIAELVLALEYLHSL 806
+V FF SF L++VMEY +GGDL + R+ G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 807 GIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+K N+ ++ +G + KL DFG+++ +N++++L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
++ VGTP YL+PEI + D WS+G +L+E T PF + +
Sbjct: 160 ------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I P P + S + + LI++ P R
Sbjct: 214 ICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 77/286 (26%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER----ILAERNILITVRNPFVV 750
+ +GA+G V+ G L A+K ++ LD E+ + E ++L ++++ +V
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVE-LDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 751 RFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+ Y TC D+ + + ME++ GG + S+L + G L E V Y +++ + YLH+ +
Sbjct: 66 Q--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
VHRD+K +N+++ +G IKL DFG ++ + + L G ++ +
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG----LHGTHSNML-------------- 165
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
S GTP ++APE++ + +G +D WS+G +FE TG PP + I
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ P +P S A D + L D ++R A ++ H F
Sbjct: 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 33/234 (14%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +DFE+I+ I G +G V+ AR TG+L AIKV+K + D + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ +V +F S+ RD L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS G +HRD+K N+L+ +GH+KL DFG+S I TI
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI------------------- 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEI-LLGTEHGY--AADWWSVGIILFEFITGIPP 913
R S +GTP ++APE+ + + GY D W+VGI E PP
Sbjct: 161 ------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 95/317 (29%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F+ ++ I G +G V+ AR + TG++ A+K ++ LD + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V+ + LYLV E+L+ DL + + + + + Y+ +L+ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDLKP NLLI +G IKL DFGL++ G+ P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------------PVRTY 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI--- 921
T H V T Y APEILLG + + A D WS+G I E +T F +S EI
Sbjct: 158 T-----HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQL 210
Query: 922 --IFDNI-LNRKIPWPCV--------------PSDMSF-------EAQDLINRFLIHDPN 957
IF + ++ WP V D S + +DL+++ L +DPN
Sbjct: 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN 270
Query: 958 QRLGANGAAEVKAHPFF 974
+R+ A A AHPFF
Sbjct: 271 KRISAKAAL---AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 78/273 (28%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITVRNPFV 749
++ + +G++G V L R RT G + V+KKL++ + ER AE+ +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 750 VRFFYSFTCRDN-LYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 806
V + S+ D LY+VM + GGDLY L+ K L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLK N+ + IK+ D G++++ + N D++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------- 160
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ +GTP Y++PE+ + Y +D W++G ++E T F A+ + I
Sbjct: 161 ------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ K+ P +P D S E +LI L P +R
Sbjct: 215 IEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 48/289 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII+ I +G +G+VF + G A+K+L D I D E I AE NIL + +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDID-EEIEAEYNILKALSD 73
Query: 747 -PFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 796
P VV+F+ + +D L+LV+E NGG + L L++ +EE + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++ L++LH +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 857 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFITG 910
Q T R R+++VGTP ++APE++ L + + D WS+GI E G
Sbjct: 173 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PP P I P P S E D I + L D +R
Sbjct: 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ +++ + G+FGR L + + +A+K ++ + +E E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL--PKSSSAVEDSRKEAVLLAKMKHP 58
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 805
+V F SF +LY+VMEY +GGDL ++ + ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRD+K N+ + +G +KL DFG +++ L+ P Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP-----GAYACTY----- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
VGTP Y+ PEI + +D WS+G IL+E T PF A S + N
Sbjct: 161 ---------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKN 207
Query: 926 ILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
++ + + + +PS S+E + LI + +P R A
Sbjct: 208 LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 82/287 (28%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--L 212
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ + P P + + S ++ + L +P+ R A E+ H F
Sbjct: 213 IPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 51/303 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIERILAERNILITVR 745
D+ E++ + +G +G V+ R TG A+K ++ +LD + N +I+ E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGD---LYSLLRKVGCLEEDVARIYIAELVLALEY 802
+P++V F+ +F +Y+ MEY++ G LY+ + EDV R +V L++
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 803 L-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
L I+HRD+KP N+L+ +G +KL DFG+S + S +T+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN---------- 161
Query: 862 EYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYA-----ADWWSVGIILFEFITGIPPFT 915
+G Y+APE I G + +D WS+G+ + E G P+
Sbjct: 162 -------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 916 AESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
E+ IF + I P +PS S +AQD + + L PN+R A++ HP
Sbjct: 209 PETYANIFAQL--SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR---PTYAQLLEHP 263
Query: 973 FFK 975
+
Sbjct: 264 WLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 93/336 (27%), Positives = 144/336 (42%), Gaps = 92/336 (27%)
Query: 689 FEI------IKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRK 728
FE+ IKPI RGA+G V A+ T + AIK L+++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 729 NDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
D E ++A ++I+ R F +++Y+V E L DL+ ++R L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ ++ +L+ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------- 159
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 906
E M EY V T Y APE+LL +E+ A D WSVG I E
Sbjct: 160 -EKGDFM------TEY-----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 907 FITGIPPFTAE--------------SP-EIIFDNILN-------RKIP-WPCVP-----S 938
+ P F + SP E I N R +P P
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP 261
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ A DL+ + L+ DP++R+ A HP+
Sbjct: 262 HANPLAIDLLEKMLVFDPSKRITVEEALA---HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 89/310 (28%), Positives = 135/310 (43%), Gaps = 59/310 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
+ + + GA G V R + TG +FA+K + N ++IL E I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSC 56
Query: 745 RNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------YIAEL 796
++P++V+++ +F ++ + MEY GG L S+ +KV ++ RI IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 797 VL-ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
VL L YLHS I+HRD+KP N+L+ G +KL DFG+S L+N S T
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVN-----SLAGT----- 162
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
GT Y+APE + G + +D WS+G+ L E PF
Sbjct: 163 ------------------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 916 AESPEI-----IFDNILNRKIPW----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
E + I+N P P S E +D I + L DP +R
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR---PTPW 261
Query: 967 EVKAHPFFKG 976
++ HP+ K
Sbjct: 262 DMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 35/286 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 750
K + +GAFGRV+L TG A K ++ ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 751 RFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+++ R L + MEY+ GG + L+ G L E V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSG---TGI--------------- 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 927
S GTP +++PE++ G +G AD WS+G + E +T PP+ E+ IF +
Sbjct: 167 ---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--I 221
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ P +PS +S A+D + + + R A E+ HPF
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+F I K I RG F V+ A G A+K ++ D++ + E ++L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYL 803
V++++ SF + L +V+E + GDL +++ + E Y +L ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS ++HRD+KP N+ I G +KL D GL + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR---------------------------F 155
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY- 214
Query: 924 DNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 959
L +KI +P +PSD S E + L+N + DP +R
Sbjct: 215 --SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D+E+I+ + G +G V+ AR TG+L A+K++K + +D I E ++ ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V +F S+ R+ L++ MEY GG L + G L E E + L YLHS G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRD+K N+L+ +G +KL DFG++ I TI
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVA--AKITATI------------------------ 160
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 913
R S +GTP ++APE+ ++G D W+VGI E PP
Sbjct: 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI-LAERNILITVR 745
+ +E + I G++G VF R R TG + AIK K ++ I++I L E +L ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLK 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P +V F + L+LV EY + L L + + E + + I + + A+ + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRD+KP+N+LI G IKL DFG ++I L+GP D Y +Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDD--------YTDY-- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912
V T Y APE+L+G T++G D W++G + E +TG P
Sbjct: 161 ---------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 89/331 (26%), Positives = 135/331 (40%), Gaps = 64/331 (19%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI- 742
+ + D+EI+ + G FG V+ AR+ TG + A LKK+ M + D I A R I I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKIL 61
Query: 743 -TVRNPFVVRF---FYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+++P VV R ++Y+V Y++ DL LL L E + Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE-TD 851
+ +L+ + YLH I+HRD+K N+LI + G +K+ DFGL++ D P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP------YDGPPPNPKG 174
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910
G Y + V T Y PE+LLG + A D W +G + E T
Sbjct: 175 GGGGGTRKYT-----------NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 911 IPPFTAESP----EIIFD-----------------NILNRKIPWPCVPS-DMSFEAQ--- 945
P +S +IF + + F
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 946 --DLINRFLIHDPNQRLGANGAAEVKAHPFF 974
DL+++ L DP +RL A+ A HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 82/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G +G V+ AR +T AIK + + D ++ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 811
S + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 812 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
D+K DN+L+ + G +K++DFG SK GI P +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK-------------RLAGINPCTETF---------- 169
Query: 871 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 927
GT Y+APE++ GY AD WS+G + E TG PPF P+ +
Sbjct: 170 ----TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
KI P +P +S EA++ I R DP++R A+
Sbjct: 226 MFKIH-PEIPESLSAEAKNFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 92/323 (28%), Positives = 152/323 (47%), Gaps = 54/323 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR 745
DD E+I+ + RGA+G V R TG + A+K ++ + + +R+L + +I + +V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA--TVNSQEQKRLLMDLDISMRSVD 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 801
P+ V F+ + ++++ ME ++ L +KV + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 802 YLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YLHS L ++HRD+KP N+LI +G +KL DFG+S
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG------------------------- 152
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEIL--LGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
D+ + G Y+APE + + GY +D WS+GI + E TG P+
Sbjct: 153 ---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 917 ESPEIIFDNILN-RKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+S + F + + P P +P++ S E QD +N+ L + +R E+ HPFF
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP---ELLQHPFF 264
Query: 975 KGVNWDSLALQKMTQATSYHALV 997
L L K T S+ +L+
Sbjct: 265 ------ELHLSKNTDVASFVSLI 281
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 83/267 (31%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +GAFGRV+L TG A+K ++ D + + A + ++N R
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 753 FYSFTC-RD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ C RD L + ME++ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRD+K N+L G++KL DFG SK TI LSG G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSG---TGMK------------- 167
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNI 926
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF
Sbjct: 168 -----SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-- 220
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLI 953
+ + P +P +S +D + R +
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 90/336 (26%), Positives = 138/336 (41%), Gaps = 83/336 (24%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--T 743
+ +E + I +G FG VF AR + T + A LKK+ M + + I A R I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 744 VRNPFVVRFF---------YSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIY 792
+++ VV Y+ + + YLV E+ DL LL + V ++ ++
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV- 124
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS------------ 172
Query: 853 IMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
+ NR++ V T Y PE+LLG G D W G I+ E T
Sbjct: 173 ------------KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 911 IPPFTAES----------------PEI--------IFDNI-----LNRKIP---WPCVPS 938
P + PE+ +F + RK+ P V
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD 280
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
A DLI++ L+ DP +R+ A+ A H FF
Sbjct: 281 P---HALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 94/325 (28%), Positives = 146/325 (44%), Gaps = 78/325 (24%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILI 742
D+ I+ I G +G V+ R + TG + A +KK IR +++ E + + E ++L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVA---MKK---IRLESEEEGVPSTAIREISLLK 54
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLA 799
+++P +V LYL+ E+L+ DL L K ++ ++ + Y+ +++
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ + HS ++HRDLKP NLLI + G IKL DFGL++ GI P +
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------AFGI-PVRVY 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
E V T Y APE+LLG + D WS+G I E T P F +S
Sbjct: 159 THE------------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
Query: 919 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 949
EI IF IL + WP V S ++ + DL+
Sbjct: 207 -EIDQLFRIF-RILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFF 974
+ LI+DP +R+ A A HP+F
Sbjct: 264 KMLIYDPAKRISAKKALN---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 90/321 (28%), Positives = 137/321 (42%), Gaps = 80/321 (24%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK--------LDMIRKNDIERILAERNILIT 743
++P+ GAFG V AR + TG AIK + K R+ + + L NI I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+ + F+ + +++Y V E L G DL+ LL LE+ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS G+VHRDLKP N+LI + +K+ DFGL++I D Y
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-------------------QDPQMTGY 165
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
V T Y APEI+L ++ D WS G I E + G P F +
Sbjct: 166 -----------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
Query: 920 -EIIFD----------------NILN--------RKIPWPCVPSDMSFEAQDLINRFLIH 954
II D N L +P+ + A DL+ + L+
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 955 DPNQRLGANGAAEVKAHPFFK 975
DP +R+ AAE AHP+
Sbjct: 275 DPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D + + + G G V+ A T + A+KV+ LD I ++I++E IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LD-ITVELQKQIMSELEILYKCDSP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+++ F+ +F + + + E+++GG L + RK+ E + RI +A +V L YL SL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIP--EHVLGRIAVA-VVKGLTYLWSLK 115
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRD+KP N+L+ G +KL DFG+S Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST-----------------------------QLV 146
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
N + VGT Y+APE + G ++G +D WS+GI E G P+
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 93/327 (28%), Positives = 140/327 (42%), Gaps = 77/327 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
D ++ + P+ GA+G+V A TG AIK KL ++ I +R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 745 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ V+ FT +L YLV L G DL +++ K L +D + + +++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIV-KCQKLSDDHIQFLVYQILR 129
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS GI+HRDLKP N+ + D +K+ DFGL++ +D
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------------HTDD 170
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
Y V T Y APEI+L H Y D WSVG I+ E +TG F
Sbjct: 171 EMTGY-----------VATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPG 218
Query: 917 ESPEIIFDNILN----------RKIP----------WPCVP--------SDMSFEAQDLI 948
I+N +KI P +P S + A DL+
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLL 278
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ L+ DP++R+ AAE AHP+
Sbjct: 279 EKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 90/332 (27%), Positives = 146/332 (43%), Gaps = 82/332 (24%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAE-------- 737
D E +PI GAFG V+ G A LKK+ + +N +R+ E
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVA---LKKMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 738 -RNIL--ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
N+L + + P + F + +Y+V E + DL+ ++ L D ++++
Sbjct: 58 HDNVLSALDILQPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY 110
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+++ L+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------ 152
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913
+ ++++ V T Y APEIL+G+ H A D WSVG I E +
Sbjct: 153 --------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL 204
Query: 914 FTAESP----EIIFD-------------------NILNRKIPWPCVP------SDMSFEA 944
F A+SP ++I D +IL P +P S + EA
Sbjct: 205 FQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEA 264
Query: 945 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
L+ R L+ DP++R+ AA+ AHP+
Sbjct: 265 VHLLCRMLVFDPDKRI---SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 39/236 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVL---KKLDMIRKNDIERILAERNI--LIT 743
+E + + G++G V + + TG + AIK + M++K +A R I L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRMLKQ 56
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+R+ +V F + LYLV E+++ L L + L+E R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P Y +Y
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEV--------YTDY 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y APE+L+G T++G A D W+VG ++ E +TG P F +S
Sbjct: 161 -----------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ +F+I K I RG F V+ A A+K ++ +M+ + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 801
+P V+++ SF + L +V+E + GDL ++ ++ + E Y +L A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-------------------------- 154
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 155 -FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 922 IFDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 959
L +KI +P +P++ S + ++L++ + DP+QR
Sbjct: 214 F---SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 94/332 (28%), Positives = 143/332 (43%), Gaps = 74/332 (22%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERI 734
+ +D F+II I G +G+V+ AR + TG+L A+K ++ + IR+ I R
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 735 LAERNIL----ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVA 789
L RNI+ I + F + YLV EY++ DL LL + ED
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ ++ +L+ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFI 908
Y ++R + V T Y PE+LLG E +G A D WS G IL E
Sbjct: 166 -------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
Query: 909 TGIPPFTAES--------------------PEII----FDNILNRKIPWPCVPSDMSF-- 942
T P F A P++I F+ + +K + + SF
Sbjct: 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP 272
Query: 943 -EAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
A DL++ L DP++R A E P+
Sbjct: 273 TPALDLLDHMLTLDPSKRCTAE---EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 92/336 (27%), Positives = 145/336 (43%), Gaps = 84/336 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L+K G + E + ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 806 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
Query: 922 IF-----------------------------------------DNILNRKIPWPCVPSDM 940
+F D I+N P P +PS +
Sbjct: 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSGV 270
Query: 941 -SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E QD +N+ LI +P +R ++ H F K
Sbjct: 271 FGAEFQDFVNKCLIKNPAERADLK---QLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 41/289 (14%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFV 749
K + RGAFG V+L TG A+K + D ++ + E +L +R+ +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP-FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 750 VRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
V+++ RD L + +EY+ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCL--RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IVHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSG---TGI------------ 166
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFD 924
S GTP +++PE++ G +G AD WSV + E +T PP+ E+ IF
Sbjct: 167 ------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ + P +P +S +D + + + + + A + HPF
Sbjct: 221 --IATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPT----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 49/247 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 745
FE+++ + G +G+V+ R TG L AIKV+ + +++ E I E N+L R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 746 NPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 797
N + ++ +F + D L+LVME+ G + L++ L+ED E++
Sbjct: 74 N--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L +LH+ ++HRD+K N+L+ + +KL DFG+S
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 169
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIP 912
+ +T R R++ +GTP ++APE++ E + Y +D WS+GI E G P
Sbjct: 170 ----QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 913 PFTAESP 919
P P
Sbjct: 225 PLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 87/330 (26%), Positives = 147/330 (44%), Gaps = 83/330 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-------------VLKKLDMIRKNDIER 733
++ + I GA+G V A + TG AIK L+++ ++R+ E
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
I+ +I+ F SF +++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIR-------PPSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+++ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++I + D +G T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT--- 167
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGI 911
EY V T Y APEI+L GY A D WSVG IL E ++
Sbjct: 168 --------EY-----------VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 912 PPFTAE--------------SPEII-FDNILNRK-------------IPWPCVPSDMSFE 943
P F + +P + I++ + +PW + + +
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
A DL+++ L +P++R+ E AHP+
Sbjct: 268 ALDLLDKMLTFNPHKRITVE---EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRN 746
+E+IK + +GA+G V AR T + + + KK+ + I +R L E +L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 747 --------PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ F +F + LYL E L DL+ ++R L + + +I +++
Sbjct: 61 HKNITCLYDMDIVFPGNF---NELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS ++HRDLKP NLL+ D +K+ DFGL++ G N + +G
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG----------- 164
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917
EY V T Y APEI+L + A D WSVG IL E + P F +
Sbjct: 165 FMTEY-----------VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213
Query: 918 S-----PEIIF------DNILNR-----------------KIPWPCVPSDMSFEAQDLIN 949
+I+ + L+R K P+ + + + A DL+
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273
Query: 950 RFLIHDPNQRLGANGAAEVKAHPF 973
+ L DP +R+ A E HP+
Sbjct: 274 KLLAFDPTKRISVEEALE---HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 50/307 (16%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K ++D E + I G G+V+ R + TG + A+K +++ K + +RIL + ++
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDV 66
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL 798
++ + P++V+ + F ++++ ME L L LL+++ G + ED+ +V
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 799 ALEYL---HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
AL YL H G++HRD+KP N+L+ G++KL DFG+S G +
Sbjct: 126 ALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS-----------------GRL- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGI 911
D++ + + G Y+APE + ++ AD WS+GI L E TG
Sbjct: 166 ----------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 912 PPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEV 968
P+ E + IL P +P + F + ++ L D +R E+
Sbjct: 216 FPYKNCKTEFEVLTKILQE--EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR---EL 270
Query: 969 KAHPFFK 975
HPF +
Sbjct: 271 LQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 94/330 (28%), Positives = 152/330 (46%), Gaps = 76/330 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAERNILITVRN 746
++I + I +G++G V A TG+ AIK K++ + ++ D RIL E +L +R+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KINDVFEHVSDATRILREIKLLRLLRH 58
Query: 747 PFVV---RFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
P +V + R+ ++Y+V E L DL+ +++ L + + ++ +L+ AL+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+H+ + HRDLKP N+L D +K+ DFGL+++ N+T P+ +
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT------------PTAIFWT 164
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 917
+Y V T Y APE L G +++ A D WS+G I E +TG P F +
Sbjct: 165 DY-----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
Query: 918 ---------------SPEII----------FDNILNRKIPWPCVPSDMSFEAQD-----L 947
SPE I + + + +K P VP F D L
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP---VPFSQKFPNADPLALRL 269
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ R L DP R A E A P+FKG+
Sbjct: 270 LERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 89/326 (27%), Positives = 135/326 (41%), Gaps = 83/326 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--------MIRKNDIERILAERNI 740
F+ ++ + G + V+ R RTTG++ A+K + LD IR+ + + L NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHENI 60
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKV-GCLEEDVARIYIAELV 797
VR + L LV EY++ DL Y V G L+ + + + +L+
Sbjct: 61 ---------VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPS 856
+ + H ++HRDLKP NLLI G +KL DFGL++ G+ NT
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS------------ 158
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 915
+ V T Y AP++LLG+ + + D WSVG I+ E ITG P F
Sbjct: 159 ----------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
Query: 916 AESPE----IIFDNI----------------LNRKIPWPCVPSDMSF-------EAQDLI 948
+ E IF + P P D+ DL+
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPHADPLGIDLL 261
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
+R L +P R+ A+ A HP+F
Sbjct: 262 HRLLQLNPELRISAHDAL---QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 81/319 (25%), Positives = 135/319 (42%), Gaps = 69/319 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L +
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLLKEL 56
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 803
++ +VR + L LV EY + DL G ++ ++ + ++ +L+ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS ++HRDLKP NLLI +G +KL DFGL++ GI P + E
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR--------------AFGI-PVRCYSAE- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF--------------- 907
V T Y P++L G + + D WS G I E
Sbjct: 160 -----------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
Query: 908 -------ITGIP-----PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
+ G P P ++ P+ + V ++ +DL+ L+ +
Sbjct: 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268
Query: 956 PNQRLGANGAAEVKAHPFF 974
P QR+ A A + HP+F
Sbjct: 269 PVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-21
Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 53/301 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 749 VVRFFYSFTCR-------DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLA 799
+ +Y + D L+LVME+ G + L++ K L+E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L +LH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------------------------ 159
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPF 914
+ +T R R++ +GTP ++APE++ E + + +D WS+GI E G PP
Sbjct: 160 --QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
Query: 915 TAESP-EIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
P +F L + P P + S S + Q I L+ + +QR ++ HP
Sbjct: 217 CDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR---PTTEQLMKHP 270
Query: 973 F 973
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER---ILAERNILITVR 745
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNG--GDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+P + + + +LVMEY G D+ + +K E ++A I L L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQ-GLAYL 131
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS +HRD+K N+L+ G +KL DFG + + + P++
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL----------------VSPAN------ 169
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 97/325 (29%), Positives = 146/325 (44%), Gaps = 72/325 (22%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LIT 743
+D +E ++ I G +G V+ AR R T + A LKK+ + ++++ A R I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED--VARIYIAELVLALE 801
+++ +VR LYLV EYL+ DL + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y HS ++HRDLKP NLLI + +KL DFGL++ GI P
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------------AFGI-PVRTFT 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFTAES 918
E V T Y APEILLG+ H Y+ D WSVG I E + P F +S
Sbjct: 162 HE------------VVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
Query: 919 PEI-----IFDNILN--RKIPWPCVPSDMSFEAQ---------------------DLINR 950
EI IF IL + WP V S +++ DL+++
Sbjct: 209 -EIDELFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFK 975
L DP++R+ A A E H +FK
Sbjct: 267 MLRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 42/275 (15%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
GA G V A++ + G+ FA+KV+ ++ + + D R AE L+ +V+ F
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101
Query: 758 CRDN--------LYLVMEYLNGGDLYSLLR---KVG-CLEEDVARIYIAELVLALEYLHS 805
+D + LV++Y N GDL ++ K E A + +++LA+ ++HS
Sbjct: 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRD+K N+L+ +G +KL DFG SK + T+
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSK--MYAATV---------------------- 197
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924
+D+ R + GTP Y+APEI + AD +S+G++L+E +T PF E+ E++
Sbjct: 198 SDDVGR-TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ R P +P +S E Q+++ L DP +R
Sbjct: 257 TLAGRYDP---LPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 87/326 (26%), Positives = 137/326 (42%), Gaps = 75/326 (23%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNIL 741
++ ++ + + G++ V+ R + TG L A+K IR E + E ++L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLAL 800
+++ +V + L LV EYL+ DL + G L R+++ +L+ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y H ++HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------PSKTYS 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----- 914
E V T Y P++LLG TE+ + D W VG I +E TG P F
Sbjct: 162 NE------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 915 TAESPEIIFDNILNRKIP--WPCVPSDMSF------------------------EAQDLI 948
+ IF +L WP V S+ F ++L
Sbjct: 210 VEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELA 268
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
+FL ++P +R+ AAE HP+F
Sbjct: 269 LKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 53/294 (18%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + +G+FG V+ LA+ G+ AIK + + +R + L E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVM 63
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA----------RI 791
VVR + +VME + GDL S LR E +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKF 121
Query: 792 Y--IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
AE+ + YL + VHRDL N ++A D +K+ DFG+++ I T D
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET-DYYRKG 178
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
G++P ++APE L +D WS G++L+E T
Sbjct: 179 GKGLLPV----------------------RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 910 -GIPPFTAESPEIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRL 960
P+ S E + +++ P P + +L+ ++P R
Sbjct: 217 LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-20
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 37/242 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G V + + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L++ + E++ ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 806 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
Query: 922 IF 923
IF
Sbjct: 213 IF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-20
Identities = 85/274 (31%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILITVRNPFVV 750
+ R F+A T G KV+ K M+ ND ER A E + L + +V
Sbjct: 75 VGRNPTTAAFVA---TRGSDPKEKVVAKFVML--ND-ERQAAYARSELHCLAACDHFGIV 128
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+ F F D L L+MEY +GGDL L++ +E + ++VLAL+ +HS
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLK N+ + G IKL DFG SK + ++D++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS------------------- 229
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
S GTP YLAPE+ + AD WS+G+IL+E +T PF S I +
Sbjct: 230 ------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 927 LNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L K P+PC S + L++ L +P R
Sbjct: 284 LYGKYDPFPCPVSS---GMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-20
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE------RILAERNILI 742
++II+ I +G G V+LA A LKK IR++ E R L E I
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV---GCLEEDVA---------R 790
+ +P +V + + D +Y M Y+ G L SLL+ V L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG--LSKIGLINNTIDLSGP 848
I+ ++ +EY+HS G++HRDLKPDN+L+ G + + D+G + K + +D+
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
E I S P VGTPDY+APE LLG + D +++G+IL++ +
Sbjct: 177 ER-NICYSSMTIP----------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 909 TGIPPFTAES-PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
T P+ + +I + +++ I P+ +P +S + + L DP +R
Sbjct: 226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-20
Identities = 91/326 (27%), Positives = 141/326 (43%), Gaps = 75/326 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
D + +K + GA+G V A R TG AIK KL ++++ +R E +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 71
Query: 745 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ FT +L YLVM ++ G DL L+ K L ED + + +++
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-KHEKLSEDRIQFLVYQMLK 129
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------------------- 166
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
QTD+ V T Y APE++L H D WSVG I+ E +TG P F
Sbjct: 167 ------QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
Query: 918 --------------SPEIIFDNILN--------------RKIPWPCVPSDMSFEAQDLIN 949
+P F L RK + + + + A +++
Sbjct: 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFK 975
+ L+ D R+ AAE AHP+F+
Sbjct: 280 KMLVLDAESRI---TAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-20
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 63/264 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
+ ++++E+IK I G FG VFL + + T + F K + + ++ + +++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRE 68
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELV 797
+++ +VR+ F + N LY++ME+ + GDL ++K G +EE +L+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 798 LALEYLHSLG-------IVHRDLKPDNLL----IAHDGHI-------------KLTDFGL 833
AL Y H+L ++HRDLKP N+ I H G I K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 834 SK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
SK IG+ HS VGTP Y +PE+LL
Sbjct: 189 SKNIGI-----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219
Query: 893 Y--AADWWSVGIILFEFITGIPPF 914
Y +D W++G I++E +G PF
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 86/321 (26%), Positives = 133/321 (41%), Gaps = 60/321 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERI---------LAERNILIT 743
+ G +G+V A TG + AIK +K ++ D + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
+++ ++ + D + LVM+ + DL ++ RK+ E V I + +++ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI-LLQILNGLNV 134
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH +HRDL P N+ I G K+ DFGL++ SD +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR-------------RYGYPPYSDTLSKD 181
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 921
S V T Y APE+L+G E + +A D WSVG I E +TG P F E+ EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-EI 240
Query: 922 -----IFDNILNRKIP--WP---CVPSDMSF-----------------EAQDLINRFLIH 954
IF +L WP +P F +A DL+ L
Sbjct: 241 DQLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 955 DPNQRLGANGAAEVKAHPFFK 975
+P +R+ A A + H +FK
Sbjct: 300 NPLERISAKEALK---HEYFK 317
|
Length = 335 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVR 745
IK + G FG+V L R TG+ A+K L ++D ER E IL T+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFER---EIEILRTLD 64
Query: 746 NPFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +V++ +L L+MEYL G L L++ +I + L+L
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQI 118
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++YL S +HRDL N+L+ + +K++DFGL+K ++P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK-----------------VLPE 161
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
D Y S + + APE L ++ A+D WS G+ L+E T P +
Sbjct: 162 DKDY----YYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
Query: 917 ESPEI 921
E
Sbjct: 215 PPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 43/287 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRNPFVVRF 752
+ +G+FG V+L + + +KVLK++ + N E + A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE----LVLALEYLHSLGI 808
SF RD ++ EY G DL L ++ + ++ + E L+L + Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+ T
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSR--LLMGSCDLATTFT------------------ 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
GTP Y++PE L + +D WS+G IL+E F ++ F +++
Sbjct: 167 -------GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVL 215
Query: 929 RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
R + P P +P S + ++ L DP+ R AAE+ +PF
Sbjct: 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 79/326 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERILAERNI 740
+E + I GA+G V+ AR +G A+K ++ L +R E L +R
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR----EVALLKR-- 55
Query: 741 LITVRNPFVVRFF----YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYI 793
L +P +VR S T R+ + LV E+++ DL + L KV L + + +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+ + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++I +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT--------- 165
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 914 FTAESPE----IIFDNI-LNRKIPWP--------------------CVPSDMSFEAQDLI 948
F S IFD I L + WP VP ++ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
L +P++R+ A A + HPFF
Sbjct: 266 LEMLTFNPHKRISAFRALQ---HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 84/308 (27%), Positives = 139/308 (45%), Gaps = 59/308 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILI 742
+D + + I RGAFG V + +G + A+K IR E R+L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 743 TVRN-PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSL--LRKVGCLEEDV-ARIYIAEL 796
+ P++V+F+ + + ++ ME ++ Y + E++ +I +A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-T 116
Query: 797 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
V AL YL L I+HRD+KP N+L+ +G+IKL DFG+S G + ++I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI------------ 162
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIP 912
+T + G Y+APE I GY +D WS+GI L+E TG
Sbjct: 163 --------AKTRD------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208
Query: 913 PFTAESPEIIFDNILN-RKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAE 967
P+ + +FD + K P + + S + IN LI D ++R E
Sbjct: 209 PYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK---E 263
Query: 968 VKAHPFFK 975
+ HPF K
Sbjct: 264 LLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 84/332 (25%), Positives = 137/332 (41%), Gaps = 85/332 (25%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIK------------VLKKLDMIRKNDIERILAERN 739
++P+ G+ G VF A A+K L+++ +IR+ D + I+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 740 ILIT--VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+L V +++Y+V EY+ DL ++L + G L E+ AR+++ +L+
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLL 124
Query: 798 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
L+Y+HS ++HRDLKP N+ I D +K+ DFGL++I
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------V 165
Query: 857 DAHYPEYQQTDNRNRHSA-----VGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910
D HY H + T Y +P +LL + A D W+ G I E +TG
Sbjct: 166 DPHY----------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 911 IPPFTA----ESPEIIFDNI----------LNRKIPW--------PCVP-----SDMSFE 943
P F E ++I +++ L IP P P ++ E
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
A D + + L +P RL A A HP+
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEAL---MHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-19
Identities = 83/322 (25%), Positives = 136/322 (42%), Gaps = 69/322 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +E ++ + G++ V+ + + G L A+KV++ + + + E ++L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V ++ L LV EY++ + + G L + ++++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLKP NLLI+ G +KL DFGL++ + PS + E
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------PSHTYSNE---- 163
Query: 867 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA-----ESPE 920
V T Y P++LLG TE+ D W VG I E I G+ F + E
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215
Query: 921 IIFDNILNRKIP----WPCVPSDMSFE------------------------AQDLINRFL 952
IF L P WP V S F+ A+DL ++ L
Sbjct: 216 RIF---LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272
Query: 953 IHDPNQRLGANGAAEVKAHPFF 974
P RL A A +H +F
Sbjct: 273 QCFPKNRLSAQAAL---SHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 81/318 (25%), Positives = 133/318 (41%), Gaps = 71/318 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITVRNP 747
++ + G++ V+ R G L A+KV I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V ++ L V EY++ +++ G L R+++ +L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLKP NLLI++ G +KL DFGL++ I PS + E
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------PSQTYSSE----- 163
Query: 868 NRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF--TAESPEII-- 922
V T Y P++LLG T++ A D W G I E + G P F ++ E +
Sbjct: 164 -------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
Query: 923 ---------------FDNILNRKIPW--PCVPSDM---------SFEAQDLINRFLIHDP 956
+ N K W PC P + +A+DL ++ L+ P
Sbjct: 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 957 NQRLGANGAAEVKAHPFF 974
R+ A A HP+F
Sbjct: 277 KDRISAQDAL---LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I RG FG VF R R A+K + + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 807
T + +Y+VME + GGD + LR G R+ + EL+ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ +K++DFG+S+ E DG+ S +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR------------EEEDGVYASTGGMKQ----- 157
Query: 868 NRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDN 925
P + APE L + +D WS GI+L+E F G P+ S + +
Sbjct: 158 ---------IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I + + PC P L+ R +DP QR
Sbjct: 209 I-EQGVRLPC-PELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 43/242 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFA----IKVLKKLDMIRKNDIERILAERNILITV 744
+E + I GA+G+VF AR G F ++V + + + I + R+ L T
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 745 RNPFVVRFF----YSFTCRDN-LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAEL 796
+P VVR F S T R+ L LV E+++ DL + L KV G E + + + +L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------------- 159
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+Q S V T Y APE+LL + + D WSVG I E P F
Sbjct: 160 ----YSFQMALT----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211
Query: 917 ES 918
S
Sbjct: 212 SS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 88/316 (27%), Positives = 130/316 (41%), Gaps = 76/316 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITVRNP 747
+ G + VF R + T +L A+K ++ IR+ + + L NI +T+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHD- 70
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-DVARIYIAELVLALEYLHSL 806
++ T LV EYL+ DL L G L +I++ +L+ L Y H
Sbjct: 71 -IIHTERCLT------LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV---------------PTKTYSNE---- 163
Query: 867 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----TAESPEI 921
V T Y P++LLG TE+ D W VG IL+E TG P F E +
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 922 IFDNI-LNRKIPWPCVPSDMSFE--------AQDLINR--------------FLIHDPNQ 958
IF + + WP + S+ F AQ LIN L+++
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275
Query: 959 RLGANGAAEVKAHPFF 974
R+ A A H +F
Sbjct: 276 RISAEAALR---HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-17
Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 29/255 (11%)
Query: 711 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEYL 769
TG AIK+L+ ++ R E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 770 NGGDLYSLLRKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---H 825
G L +L G L + R+ + +++ AL H+ GIVHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
K+ DFG+ + + +GTP Y APE
Sbjct: 121 AKVLDFGIGTLL------------------PGVRDADVATLTRT--TEVLGTPTYCAPEQ 160
Query: 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEA 944
L G +D ++ G+I E +TG S EI++ + + P P
Sbjct: 161 LRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHPL 218
Query: 945 QDLINRFLIHDPNQR 959
++ + L DP QR
Sbjct: 219 GQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-17
Identities = 88/322 (27%), Positives = 136/322 (42%), Gaps = 80/322 (24%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 749
+K + GA+G V A + TG+ AIK KL +++I +R E +L +++ V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 750 VRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLE--EDVARIYIAELVLALE 801
+ FT + YLVM Y+ + L+K+ ED + + +++ L+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+HS GI+HRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEMT 172
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES-- 918
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 173 GY-----------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221
Query: 919 --------------PEII--FDNILNRKI--PWPCVPS--------DMSFEAQDLINRFL 952
PE + ++ + P P S +A DL+ + L
Sbjct: 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
Query: 953 IHDPNQRLGANGAAEVKAHPFF 974
D ++RL A A E HP+F
Sbjct: 282 ELDVDKRLTATEALE---HPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-17
Identities = 88/326 (26%), Positives = 137/326 (42%), Gaps = 77/326 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITV 744
+ ++ + P+ GA+G V A TG A+K L + +I +R E +L +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 73
Query: 745 RNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ FT +++YLV +L G DL +++ K L +D + I +++
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILR 131
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ TD M
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMT--- 175
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 176 --------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
Query: 918 SPEIIFDNILN----------RKIP----------WPCVPSDMSFE---------AQDLI 948
IL +KI +P M+F A DL+
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLL 280
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFF 974
+ L+ D ++R+ AA+ AH +F
Sbjct: 281 EKMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 55/248 (22%)
Query: 689 FEIIKPISRGAFGRVFLAR--KRTTGDLFAIKVLK--KLDM-------IRKNDIERILAE 737
+EI I RG +GRV+ A+ G +AIK K K R+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIY 792
N+ +++ F+ S +YL+ +Y DL+ +++ K + + +
Sbjct: 62 ENV-VSLVEVFLEHADKS------VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINNTIDLSGP 848
+ +++ + YLHS ++HRDLKP N+L+ +G +K+ D GL++ L N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFE 906
D + V T Y APE+LLG H Y A D W++G I E
Sbjct: 172 L-DPV---------------------VVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAE 208
Query: 907 FITGIPPF 914
+T P F
Sbjct: 209 LLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + +G FG V L R + TG++ A+K L+ D ER E IL ++++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHD 65
Query: 748 FVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEY 802
+V+ Y C R NL LVMEYL G L L+K L+ +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRDL N+L+ + +K+ DFGL+K+ +P D Y +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------LPQDKEYYK 166
Query: 863 YQQTDNRNRHSAVGTPDY-LAPEILLGTEHGYAADWWSVGIILFEFIT 909
++ +P + APE L ++ A+D WS G++L+E T
Sbjct: 167 VREPGE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ + +LVMEY G DL + +K E ++A + L L YLHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGAL-QGLAYLHSH 134
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG + I + P++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------MAPAN--------- 169
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +G FG V+ + ++ A+K + + + L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 807
+ +Y+VME + GG L + LRK R+ + +L+ +EYL S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ + +K++DFG+S+ E GI Y +D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------EEEGGI---------YTVSD 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
+ T APE L + +D WS GI+L+E F G P+
Sbjct: 153 GLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I G+FG V+ AR T ++ AIK + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+ + + +LVMEY G DL + +K E ++A I L L YLHS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSH 144
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L+ G +KL DFG + I P++
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI----------------ASPAN--------- 179
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 180 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+ + ++ I +G FG V L R G A+K LK + LAE +++ T+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEY 802
R+P +V+ + LY+V EY+ G L LR G + + ++ +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G+FG V+ A T ++ A+K + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 755 SFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+ +LVMEY G DL + +K E ++A I L L YLHS ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSHNMIHRD 146
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K N+L+ G +KL DFG + S P +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASK---------SSPA----------------------N 175
Query: 873 SAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 749
+KPI GA G V A TG AIK KL +N +R E ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 750 VRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALE 801
+ FT + +L YLVME ++ L +V ++ D R+ + +++ ++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+LHS GI+HRDLKP N+++ D +K+ DFGL++ M + Y
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTP--Y- 177
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 178 -------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 83/314 (26%), Positives = 129/314 (41%), Gaps = 72/314 (22%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILITVRNPFVV 750
+ G + V+ R + T +L A+K IR E + E ++L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIV 809
+L LV EYL+ DL L G + ++++ +L+ L Y H ++
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDLKP NLLI G +KL DFGL++ I P+ + E
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSI---------------PTKTYSNE------- 164
Query: 870 NRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFD 924
V T Y P+ILLG T++ D W VG I +E TG P F + E IF
Sbjct: 165 -----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF- 218
Query: 925 NILNRKI--PWPCVPSDMSF----------------------EAQDLINRFLIHDPNQRL 960
IL WP + S+ F + +L+++ L + +R+
Sbjct: 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278
Query: 961 GANGAAEVKAHPFF 974
A A + HP+F
Sbjct: 279 SAEEAMK---HPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++K + G FG V++ + AIK LK+ M E LAE N++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
P +VR Y+ ++ +Y++ EY+ G L L+ ++ + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ I + EY
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDN-------------------EYT 158
Query: 865 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEI 921
R A + APE I GT +D WS GI+L E +T IP +PE+
Sbjct: 159 A-----REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I + L R P P + E +L+ P +R
Sbjct: 213 IQN--LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 82/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A G A+K L + + +R E +L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKC 76
Query: 744 VRNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + ++YLVME ++ L +V +E D R+ + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQ 131
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ N
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------- 176
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT------ 909
+ T V T Y APE++LG + D WSVG I+ E +
Sbjct: 177 -------FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
Query: 910 ---------------GIPP--FTAESPEIIFDNILNRK----------IPWPCVPSD--- 939
G P F + + + NR P PS+
Sbjct: 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283
Query: 940 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ +A+DL+++ L+ DP++R+ + E HP+
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVD---EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
+K + G FG V L + R + AIK + + M ++ IE E +++ + +P +V+
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+ T + LY+V E++ G L + LR + G L +D+ ++ +EYL +H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RDL N L++ G +K++DFG+++ L + SG A +P
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG----------AKFP--------- 164
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 918
+ PE+ +++ +D WS G++++E F G PF +S
Sbjct: 165 -------VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 695 ISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
+ GAFG+VFLA L A+K LK+ + D +R E +L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLE--EDVA--------RIYIAE 795
VRF+ T L +V EY+ GDL LR G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 796 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ + + YL SL VHRDL N L+ +K+ DFG+S+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------- 170
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
D + +Y + R P PE +L + +D WS G++L+E T
Sbjct: 171 --DIYSTDYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 76/322 (23%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITV 744
++ + G + VF R + T +L A+K ++ IR+ + + L NI +T+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-VTL 69
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYL 803
+ +V S T LV EYL+ DL + G + +I++ +++ L Y
Sbjct: 70 HD--IVHTDKSLT------LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H ++HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---------------PTKTYSNE- 164
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 920
V T Y P++LLG +E+ D W VG I FE +G P F + E
Sbjct: 165 -----------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
Query: 921 --IIFDNI-LNRKIPWPCVPSDMSF----------------------EAQDLINRFLIHD 955
+IF + + WP + S+ F E +L+ +FL ++
Sbjct: 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE 273
Query: 956 PNQRLGANGAAEVKAHPFFKGV 977
+R+ A E H +F+ +
Sbjct: 274 SKKRISAE---EAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-14
Identities = 85/327 (25%), Positives = 134/327 (40%), Gaps = 83/327 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITVRN 746
++ + P+ GA+G V A A+K L + +I R E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKH 73
Query: 747 PFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
V+ FT ++ YLV L G DL +++ K L ++ + I +L+ L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGL 131
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+Y+HS GI+HRDLKP N+ + D +++ DFGL++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------- 166
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
Q D+ V T Y APEI+L H D WSVG I+ E + G F P
Sbjct: 167 ----QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF----P 217
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFE---------------------------AQDL 947
+ + L R + P P V +S E A DL
Sbjct: 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL 277
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + L+ D ++R+ A+E AHP+F
Sbjct: 278 LEKMLVLDSDKRI---SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 695 ISRGAFGR--VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
I + V LA+ + T L A+K + LD K D++ + E +++P ++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVH 810
SF LY+V + G LL+ L E + +++ AL+Y+HS G +H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 811 RDLKPDNLLIAHDGHIKLTDF----GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
R +K ++L++ DG + L+ + K G +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP------------------- 165
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFT 915
+ S P +L+PE+L GY D +SVGI E G PF
Sbjct: 166 ----KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 83/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 744 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + +L YLVME ++ L +V +E D R+ + +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQ 127
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T G
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------- 908
Y V T Y APE++LG + D WSVG I+ E +
Sbjct: 174 MMTPY--------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 909 ----------------TGIPPFTAESPEIIFDNILNRK----------IPWPCVPSD--- 939
T P F + + + + NR P P+D
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 940 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ +A+DL+++ L+ DP +R+ + A + HP+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQ---HPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR---TTGD--LFAIKVLKK--LDMIRKNDIERILAERN 739
D + + + GAFG+VFL D L A+K LK+ + RK D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK-DFER---EAE 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------CL 784
+L ++ +V+F+ T D +V EY+ GDL LR G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ +I + ++ + YL S VHRDL N L+ +D +K+ DFG+S+
Sbjct: 121 LSQLLQIAV-QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 77/299 (25%), Positives = 121/299 (40%), Gaps = 70/299 (23%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + G FG+V L TG++ A+K LK+ + ++N E NIL T+ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNT-SGWKKEINILKTLYHE 66
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+V+ Y C + L L+MEY+ G L L K ++ +A+L+L
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQI 116
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--------------------- 155
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
PE + R R + A E L + YA+D WS G+ L+E +T
Sbjct: 156 --AVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK-- 210
Query: 917 ESPEIIFD----------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+SP F+ +L R + PC P + E L+ + R
Sbjct: 211 QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ +IK ++ G+ GRVF+A K D +K+ +K L E +L V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118
Query: 749 VVR-----FFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
V+R + TC +V+ + + DLY+ L ++ L D A I +++ L Y
Sbjct: 119 VIRMKDTLVSGAITC-----MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ I+HRD+K +N+ I + + D G ++ + P G+
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGL--------- 216
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
GT + APE+L ++ AD WS GI+LFE +
Sbjct: 217 ------------AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 79/298 (26%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 688 DFEIIKPISRGAFGRVFLAR---KRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILI 742
D + + + GAFG+VFLA T D L A+K LK + + D +R E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 798
+++ +V+F+ D L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 799 A------------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
+ + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 171
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
D + +Y + H+ + ++ PE ++ + +D WS G+IL+E
Sbjct: 172 ----------DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 907 FIT-GIPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
T G P+ S + + I ++ P C P E D++ +P QRL
Sbjct: 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-PK----EVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 71/303 (23%)
Query: 693 KPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
K + G FG+V F + R A+K+LK+ +++ +L+E N+L V +P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--NASSSELRDLLSEFNLLKQVNHP 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGC-------------LEEDVARI 791
V++ + + + L L++EY G L S LR KVG L+ R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 792 YIAELVLA--------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
+++ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-------- 175
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGI 902
+ + D+ + S P ++A E L + +D WS G+
Sbjct: 176 ------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNI-----LNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
+L+E +T G P+ +PE +F+ + + R P + S E +L+ +P
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTCWKQEP 270
Query: 957 NQR 959
++R
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 698 GAFG----RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 753
G FG V+ RK+ AIKVLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 754 YSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALEYLHSLGI 808
C + L LVME +GG L L ++++ + EL+ + ++YL
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRDL N+L+ + + K++DFGLSK + D++Y
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK----------------ALGADDSYY-------- 152
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESPEII 922
+ R + + APE + + +D WS GI ++E F G P+ + PE++
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+F + + + G FG V+ + + AIK+LK D++++ D ++ E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-ALEYLHS 805
++ F + + +Y++ E + G L + LR VA I +A V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N+L+ D K+ DFGL+++ I + LS SD P Y+
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---------SDKKIP-YKW 170
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIP 912
T APE +D WS GI+L+E T +P
Sbjct: 171 T---------------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + G FG+V L R TG+ A+K LK N I + E IL + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
+V+ Y C ++ + L+ME+L G L L R + Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRDL N+L+ + +K+ DFGL+K + +D Y
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----------------IETDKEY-- 165
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y D+ + S V + APE L+ ++ A+D WS G+ L+E +T
Sbjct: 166 YTVKDDLD--SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 695 ISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
+ +G FG VF L K A+K K+ D+ ++ I + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV----AVKTCKE-DLPQELKI-KFLSEARILKQYDHPNIVK 56
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLG 807
T R +Y+VME + GGD S LRK ++++ + + L + YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ + +K++DFG+S+ E DGI S +Q
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSG----LKQIP 157
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
+ + APE L + +D WS GI+L+E F G+ P+
Sbjct: 158 IK----------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-13
Identities = 89/331 (26%), Positives = 138/331 (41%), Gaps = 77/331 (23%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERNIL 741
R+ +++ I G+FG V+ A T + AIK VL+ D KN I+ N +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLNHI 119
Query: 742 ITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGG-----DLYSLLRKVGCLEEDVARI 791
+ F+ ++Y+ + N L +VME++ Y+ R L + ++
Sbjct: 120 NII---FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKL 174
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPET 850
Y +L AL Y+HS I HRDLKP NLLI + H +KL DFG +K +L
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLA--- 223
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909
+ S + + Y APE++LG T + D WS+G I+ E I
Sbjct: 224 -----------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 910 GIPPFTAESP-------------------EIIFDNILNRKIP-------WPCVPSDMSFE 943
G P F+ +S + + N + K P P +
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
A + I++FL ++P +RL E A PFF
Sbjct: 327 AINFISQFLKYEPLKRL---NPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
G +G V+ + A+K LK+ M ++E L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEED-VARIYIA-ELVLALEYLHSLGIVHRDLKP 815
Y++ E++ G+L LR+ E + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 875
N L+ + +K+ DFGLS++ D H+
Sbjct: 133 RNCLVGENHLVKVADFGLSRL---------------------------MTGDTYTAHAGA 165
Query: 876 GTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D +K + G FG V + R D+ AIK++K+ M IE E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSL 806
+V+ + T + +Y+V EY++ G L + LR+ G + + + + V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
+HRDL N L+ G +K++DFGLS+ L D Y
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL------------------DDEYT----- 156
Query: 867 DNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+VG+ + PE+LL ++ +D W+ G++++E +
Sbjct: 157 ------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 744 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + +L Y+VME ++ L +V +E D R+ + +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQ 134
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T + P
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY------ 185
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 186 -------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+RTSI ++++ + G FG V+ T + A+K LK M D + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEE--DVARIYIAE 795
+R+P +++ + T + +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ + YL + +HRDL N+L+ + K+ DFGL+++ I
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----------------IKE 155
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y+ R A + APE L +D WS GI+L E +T
Sbjct: 156 D-----IYEA-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S D + KP+ G FG+V +A K A+K+LK D + D+ +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 738 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIY 792
++ + ++ ++ + T LY+++EY + G+L LR D+AR+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 793 IAELVL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
++ +EYL S +HRDL N+L+ + +K+ DFGL++ +N
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VN 188
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
N ID T+G +P ++APE L + + +D WS
Sbjct: 189 N-IDYYKKTTNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSF 225
Query: 901 GIILFEFIT-GIPPFTAESPEIIF 923
G++++E T G P+ E +F
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 54/238 (22%)
Query: 686 IDDFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
ID E+ +K + G FG V L + R D+ AIK++++ M + IE E +++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMK 55
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +P +V+ + T + +++V EY+ G L + LR+ E +L
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-------TEWLLDMCSD 108
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
A+EYL S G +HRDL N L+ D +K++DFGL++ L
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----------------- 151
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
D Y S+ GT + PE+ + +D WS G++++E +
Sbjct: 152 -DDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 45/229 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
++ + + G FG V++ T + A+K LK M E L E I+ +R+
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLALE 801
+V+ + + + +Y+V EY++ G L L+ ++ L + A+I AE +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AE---GMA 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL S +HRDL N+L+ + + K+ DFGL++ LI E D
Sbjct: 118 YLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR--LI---------EDD--------- 156
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
EY R A + APE +D WS GI+L E +T
Sbjct: 157 -EYTA-----REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 52/230 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F I++ + GA G F T + IK ++ E +IL + +P
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPS 144
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL------VL-ALE 801
+++ +FT L++ DLY C I I ++ VL A++
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKT-DLY-------CYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLH I+HRD+K +N+ I H G + L DFG + P D
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAA------------------CFPVDI--- 235
Query: 862 EYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
N N++ GT APE+L +G A D WS GI+LFE T
Sbjct: 236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G FG V + TG A+K +K D+ + L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDVT----AQAFLEETAVMTKLHHKNLVRLL- 65
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--LEYLHSLGIVHRD 812
+ LY+VME ++ G+L + LR G V ++ L +A +EYL S +VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
L N+L++ DG K++DFGL+++G +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVG------------------------------SMGVD 155
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
++ + APE L + +D WS G++L+E F G P+
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 47/281 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++IK + G FG V++ + A+K LK M E L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLA 799
+V+ Y+ + +Y+V EY++ G L L+ K+ L D+A A++
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV-DMA----AQVAAG 114
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + +HRDL+ N+L+ K+ DFGL++ LI +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDN----------------- 155
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
EY R A + APE L +D WS GI+L E +T G P+ +
Sbjct: 156 --EYTA-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + R PC P D +L+ + DP +R
Sbjct: 209 NREVLEQV-ERGYRMPC-PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 33/240 (13%)
Query: 693 KPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + G+FG V + G + A+K LK + + ++ L E I+ ++ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLG 807
+R Y L +V E G L LRK ++ + Y ++ + YL S
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N+L+A D +K+ DFGL + L N + H Y +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN---------------EDH---YVMEE 158
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNI 926
+ A + APE L +A+D W G+ L+E F G P+ S I I
Sbjct: 159 HLKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 741
D + KP+ GAFG+V A + A+K+LK D + D+ +++E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMM 69
Query: 742 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIAEL 796
+ ++ ++ T LY+V+EY G+L LR E D R L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 797 VL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844
+E+L S +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------- 180
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGII 903
D H+ +Y + R P ++APE L + + +D WS G++
Sbjct: 181 ------------DIHHIDYYRKTTNGR-----LPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 904 LFEFIT-GIPPFTAESPEIIFDNI 926
L+E T G P+ E +F +
Sbjct: 224 LWEIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 44/227 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILI 742
++ + ++++ I +G FG V L R G+ A+K +K ND + LAE +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-------NDATAQAFLAEASVMT 54
Query: 743 TVRNPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLA 799
+R+ +V+ + LY+V EY+ G L LR G L D + ++ A
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+EYL + VHRDL N+L++ D K++DFGL+K + S + G +P
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV--- 163
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
+ APE L + +D WS GI+L+E
Sbjct: 164 -------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
A+K LK+ + + L E +++ + +P +VR + L LVME G L
Sbjct: 27 AVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLL 83
Query: 776 SLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
L+K ++ + EL + YL S VHRDL N+L+ + K++DF
Sbjct: 84 KYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 832 GLSK 835
G+S+
Sbjct: 140 GMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 693 KPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ + GAFG+VFLA L A+K LK + D R E +L +++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR------------IYIAE 795
+V+F+ D L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 796 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ A + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------------- 168
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
D + +Y + H+ + ++ PE ++ + +D WS+G++L+E T
Sbjct: 169 --DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITV 744
E IK + GAFG V+ G+ AIKVL++ + K + IL E ++ +V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKA-NKEILDEAYVMASV 66
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLAL 800
+P VVR + L+ + + G L +R +G + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LDVDEK---------- 164
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIP 912
EY + P ++A E +L + + +D WS G+ ++E +T GIP
Sbjct: 165 -EYHAEGGK-------VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
Query: 913 PFTAESPEII 922
E P+++
Sbjct: 217 --AVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 81/316 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKK---LDMIRKNDIERILAER 738
++ E ++ I +GAFGRVF AR + A+K+LK+ DM + D +R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQR---EA 59
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------------KVGCLE 785
++ +P +V+ + L+ EY+ GDL LR +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 786 EDVARIYIAELVL---------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ + ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 837 GLINNTIDLSGPETDGI----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
I + E D I MP PE + +
Sbjct: 180 --IYSADYYKASENDAIPIRWMP---------------------------PESIFYNRYT 210
Query: 893 YAADWWSVGIILFE-FITGIPPFTAES-PEIIF----DNILNRKIPWPCVPSDMSFEAQD 946
+D W+ G++L+E F G+ P+ + E+I+ N+L+ C P + E +
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------C-PDNCPLELYN 263
Query: 947 LINRFLIHDPNQRLGA 962
L+ P+ R
Sbjct: 264 LMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++K + G FG V++ + + A+K LK M ++ L E N++ T+++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
+VR + T + +Y++ EY+ G L L+ + + ++ + A++ + Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ D Y
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARV------------------IEDNEYTA-- 160
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
R A + APE + +D WS GI+L+E +T G P+ S
Sbjct: 161 ------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 692 IKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
I + RG FG VFLA+ + + L +K L+K +N E ++ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDV--------ARIYIA-E 795
VVR CR+ Y+++EY + GDL LR +E + ++ + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ L +++L + VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
D + EY + N A+ +LAPE + + +D WS G++++E F G PF
Sbjct: 166 -DVYNSEYYKLRN-----ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
S E + + + K+ P VP L+ R +P R
Sbjct: 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 693 KPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDI---ERILAERNILITVRN 746
+ G FG V K++ + A+K+LK + ND + +L E N++ + N
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDN----NDPALKDELLREANVMQQLDN 55
Query: 747 PFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALE 801
P++VR C ++ LVME G L L+K + V I ELV + ++
Sbjct: 56 PYIVRMIG--ICEAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMK 109
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL VHRDL N+L+ + K++DFGLSK + +D +Y
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK-----------------ALGADENYY 152
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESP 919
+ + + APE + + +D WS G++++E F G P+ +
Sbjct: 153 KAKTHGK-------WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
E+ ++ C P E DL+ + ++R G
Sbjct: 206 EVT--QMIESGERMEC-PQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID-------DFEIIKP 694
EL D T + Y + +S+S + V + +S D + I+
Sbjct: 47 ELGDSDDVTHATDYDADE----ESLSPQTDVCQ---EPCETTSSSDPASVVRMQYNILSS 99
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
++ G+ G VF+ K GD KV+ K + R E +IL T+ + ++ +
Sbjct: 100 LTPGSEGEVFVCTKH--GDEQRKKVIVKA-VTGGKTPGR---EIDILKTISHRAIINLIH 153
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDL 813
++ + + +VM DL++ + + G L + A I I +L AL YLH GI+HRD+
Sbjct: 154 AYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDV 211
Query: 814 KPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
K +N+ + + L DFG + K+ +T P +
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDT------------PQC--------------Y 245
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
GT + +PE+L + D WS G++LFE
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 693 KPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V +A K A+K+LK D K D+ +++E ++ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEK-DLSDLISEMEMMKMIG 81
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------CLEED---VARIYIAE 795
++ ++ + T LY+++EY + G+L LR C ++ +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 796 LV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------------- 188
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
D H+ +Y + R ++APE L + + +D WS G++L+E
Sbjct: 189 --------DIHHIDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 909 T-GIPPFTAESPEIIF 923
T G P+ E +F
Sbjct: 237 TLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 46/243 (18%)
Query: 695 ISRGAFGRVFLARKRT-----TGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ GAFG V+ +G + A+K L+K ++ + L E +++ +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE------ 801
+V+ + Y++ME + GGDL S LR + + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
YL + +HRDL N L++ G+ +K+ DFGL++ + + D E +G++P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKS--DYYRKEGEGLLPV 177
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 915
++APE LL + +D WS G++++E +T G P+
Sbjct: 178 ----------------------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 916 AES 918
A +
Sbjct: 216 ALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVL-----------KKLD-MIRKNDIERILAERN 739
+K I RGA ++L GD IK + +LD IR+ ER E
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 740 ILIT-----VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
I+ V P V +N +VMEY+ G L L+ G E +++R
Sbjct: 52 IMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR---- 102
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
E+ + LHS GI+H DL N+++ G I L DFGL++
Sbjct: 103 EIGRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 692 IKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++ + AFG+++ G L AIK LK D+ E +++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVARI---------- 791
+V T + ++ EYLN GDL+ L VGC ++ +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 792 YIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR--------------- 172
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FIT 909
I +D + R + ++ ++ PE ++ + +D WS G++L+E F
Sbjct: 173 -EIYSADYY---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
Query: 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSD 939
G+ P+ S + + + + R++ PC D
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL-LPC-SED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 47/273 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V++ T + AIK LK M+ E L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLG 807
+ + +Y+V E++ G L L+ E D + + +LV + Y+ +
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQLVDMAAQIADGMAYIERMN 122
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL+ N+L+ + K+ DFGL++ LI + EY
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDN-------------------EYTA-- 159
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926
R A + APE L +D WS GI+L E +T G P+ + + +
Sbjct: 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
R PC P +L+ DP++R
Sbjct: 217 -ERGYRMPC-PQGCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V++ T + AIK LK M E L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 812
+ + +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
L+ N+L+ + K+ DFGL++ LI + EY R
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDN-------------------EYTA-----RQ 161
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 931
A + APE L +D WS GI+L E T G P+ + D + R
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PC P + DL+ + +P +R
Sbjct: 221 RMPC-PPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 70/265 (26%)
Query: 693 KPISRGAFGRVFLA------RKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V +A + + + A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK------------------------ 780
++ ++ + T LY+++EY + G+L LR
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 781 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839
V C + VAR +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 LVSCAYQ-VAR--------GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
D H +Y + R ++APE L + + +D WS
Sbjct: 183 -----------------DVHNIDYYKKTTNGRLPV----KWMAPEALFDRVYTHQSDVWS 221
Query: 900 VGIILFEFIT-GIPPFTAESPEIIF 923
G++L+E T G P+ E +F
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 55/262 (20%)
Query: 692 IKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------YIAELVLAL 800
+V R + LV + + G L +R E+ RI + ++ +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVR------ENKDRIGSQDLLNWCVQIAKGM 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL + +VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------------------ 164
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-- 916
EY + P ++A E +L + +D WS G+ ++E +T G P+
Sbjct: 165 -EYHADGGK-------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
Query: 917 --ESPEIIFDNILNRKIPWPCV 936
E P+++ ++P P +
Sbjct: 217 AREIPDLLEK---GERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 691 IIKPISRGAFGRVFLARKRTTGD---LFAIKVLKK--LDMIRKNDIERILAERNILITVR 745
I K I G FG V R + G AIK LK + R++ L+E +I+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD----FLSEASIMGQFD 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------L 798
+P ++ T + +V EY+ G L + LRK + + +LV
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIAS 117
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL +G VHRDL N+L+ + K++DFGLS++ + + + + G +P
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI-- 173
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ APE + + A+D WS GI+++E ++
Sbjct: 174 --------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 693 KPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 750
K + G FG V++A K T A+K +K M +E LAE N++ T+++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGI 808
+ ++ ++ +Y++ E++ G L L+ ++ + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDL+ N+L++ K+ DFGL+++ N G A +P
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----------AKFP------- 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-ESPEII 922
+ APE + +D WS GI+L E +T G P+ +PE+I
Sbjct: 167 ---------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 683 RTSIDDFEIIKPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIR-KNDIERILA 736
+ ++ + GAFG+V +R + AIK LK+ + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 790
E ++ +++P +V T ++ EYL GDL+ L VG D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 791 ---------IYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
++IA + A +EYL S VHRDL N L+ +K++DFGLS+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
S +Y R + ++ ++ PE +L + +D WS
Sbjct: 176 ---------------SADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 901 GIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 939
G++L+E F G+ P+ S + + + I +R++ PC P D
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC-PED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 35/151 (23%)
Query: 768 YLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-------ALEYLHSLGIVHRDLKPDNLL 819
Y+N G+L L++ E + + + +LV + YLH G++H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 878
I + +K+TD LS+ DL P D H DN NR P
Sbjct: 150 IDEELQVKITDNALSR--------DL--------FPMDYHC----LGDNENR------PV 183
Query: 879 DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
++A E L+ E+ A+D WS G++L+E +T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLA-RKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
+D + + I G FG V+ + A+K K + E+ L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQ 63
Query: 744 VRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALE 801
+P +V+ +N +++VME G+L S L+ L+ +Y +L AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
YL S VHRD+ N+L++ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERI--LAER 738
I K I G FG V R + G AIK LK +D +R+ L E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEA 56
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV- 797
+I+ +P ++R T + ++ EY+ G L LR+ + + ++
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLR 113
Query: 798 ---LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
++YL + VHRDL N+L+ + K++DFGLS+ +
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR----------------LE 157
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+A Y T + T APE + + A+D WS GI+++E ++
Sbjct: 158 DSEATY-----TTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILIT 743
+F+ IK + GAFG V+ G+ AIK L++ + N + IL E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI----AELVLA 799
V NP V R + L+ + + G L +R+ ++++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LGADEK--------- 164
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY + P ++A E +L + + +D WS G+ ++E +T G P+
Sbjct: 165 --EYHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 49/166 (29%), Positives = 66/166 (39%), Gaps = 53/166 (31%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LD-MIRKNDIERILAERNILI 742
I++GA ++L GD +K + K LD IR+ ER E +L
Sbjct: 2 IAKGAEAIIYL------GDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLS 52
Query: 743 TVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEEDVAR 790
R N VV DN +VMEY+ G L LLR++G V +
Sbjct: 53 RARKAGVNTPVVYDVD----PDNKTIVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK 105
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
LH GIVH DL N+++ D + L DFGL K
Sbjct: 106 ------------LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 56/258 (21%)
Query: 693 KPISRGAFGRVFLAR----KRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V A ++ D A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEMELMKLIG 75
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR------------------KVGCLEE 786
++ ++ T LY+++EY G+L LR + ++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 787 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
V+ Y ++ +EYL S +HRDL N+L+ D +K+ DFGL++ G+ + ID
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GV--HDIDYY 190
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
++G +P ++APE L + + +D WS GI+++E
Sbjct: 191 KKTSNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 907 FIT-GIPPFTAESPEIIF 923
T G P+ E +F
Sbjct: 229 IFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ + KN L E I+ +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 774 LYSLLR----KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAH 822
L L + + DV I + L+ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 882
+ IK+ DFG+S+ + + +Y + R AV +++
Sbjct: 166 NYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWMS 200
Query: 883 PE-ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
E ILLG + A+D W+ G+ L+E +T E P
Sbjct: 201 WESILLG-KFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-09
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 64/225 (28%)
Query: 672 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK------------- 718
V PL R S DDF++ + G FG F + D +
Sbjct: 130 VGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRV 189
Query: 719 VLKKLDMIR--------------KNDIERILAERNILITV-RNPFVVR-------FFYSF 756
VLK+++M R K E + E + + RNP +F S
Sbjct: 190 VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSN 249
Query: 757 TC-----RDNLYLVMEYLNGGDLYSLLR-KVG----CLEE-------------------D 787
T + + +LV ++ + L L K+G CLEE +
Sbjct: 250 TADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
V + + +++ L LH +GIVHRD+KP+NLL+ DG +K+ DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 61/254 (24%), Positives = 111/254 (43%), Gaps = 40/254 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ K + GAFG+V A K A+K+LK ++ E +++E I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--TAHSSEREALMSELKIM 92
Query: 742 ITVRNPF-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVL 798
+ N +V + T + ++ EY GDL + LR+ L + + ++
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+ +L S +HRDL N+L+ H +K+ DFGL++ IM +D+
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR----------------DIM-NDS 195
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 917
+Y + +A ++APE + + + +D WS GI+L+E F G P+
Sbjct: 196 NYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY--- 244
Query: 918 SPEIIFDNILNRKI 931
P + D+ + I
Sbjct: 245 -PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------------- 791
+P ++ + R LYL +EY G+L LRK LE D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 792 --YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ KN L E IL +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKILRP--DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 774 LYSLLRKVGCLEEDV------------------ARIYIA-ELVLALEYLHSLGIVHRDLK 814
L L +++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
N L+ + IK+ DFG+S+ + + +Y + R A
Sbjct: 166 TRNCLVGENLTIKIADFGMSR---------------------NLYAGDYYRIQGR----A 200
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDN 925
V ++A E +L + A+D W+ G+ L+E + P+ + E + +N
Sbjct: 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++ I G FG V+L AIK +++ M ++ IE E +++ + +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE----EAQVMMKLSH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 805
P +V+ + T R + LV E++ G L LR + G ++ ++ + YL S
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDL N L+ + +K++DFG+++ L D Y
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL------------------DDQYT---- 156
Query: 866 TDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 918
S+ GT + +PE+ +++ +D WS G++++E F G P+ S
Sbjct: 157 -------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 52/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 748
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA------ 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 799
+ + F S + R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 915 TAESPEIIFDN 925
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 56/293 (19%)
Query: 689 FEIIKPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
F + + + +G FG V L + + A+K+LK D+ +DIE L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 746 NPFVVRFF-YSFTCRDNLYL-----VMEYLNGGDLYS--LLRKVG----CLEEDVARIYI 793
+P V++ S R L ++ ++ GDL++ L+ ++G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
++ +EYL S +HRDL N ++ + + + DFGLSK I
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----------------KI 163
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911
D Y+Q A P +LA E L + +D W+ G+ ++E +T G
Sbjct: 164 YSGDY----YRQG------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
Query: 912 PPFTA-ESPEI----IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
P+ E+ EI I N L + P D + +L+ + +P R
Sbjct: 214 TPYAGVENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 70/255 (27%)
Query: 690 EIIKPISRGAFGRVFLA-----------------RKRTTGDLFAIKVLKK-LDMIRKNDI 731
++ + G FG V L L A+KVL+ + D
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDASDNAREDF 66
Query: 732 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------- 780
+ E IL + +P + R T L ++MEY+ GDL L+K
Sbjct: 67 LK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 781 -----VGCLEEDVARIYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
L +Y+A + + + YL SL VHRDL N L+ + IK+ DFG
Sbjct: 124 SKSLSFSTL------LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 894
M + + +Y + R A ++A E +L +
Sbjct: 176 -------------------MSRNLYSSDYYRVQGR----APLPIRWMAWESVLLGKFTTK 212
Query: 895 ADWWSVGIILFEFIT 909
+D W+ G+ L+E +T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 34/139 (24%)
Query: 773 DLYSLL----RKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827
DLY+ L R +G + VAR +L+ A++Y+H GI+HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887
L DFG + G + HY GT D APE+L
Sbjct: 301 LGDFGAACF-------------ARGSWSTPFHY------------GIAGTVDTNAPEVLA 335
Query: 888 GTEHGYAADWWSVGIILFE 906
G + + D WS G+++FE
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 690 EIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
E++ I RG V LAR + TG+ ++ + L+ + + E ++ +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 748 FVVRFFYSFTCRDNLYLV---MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYL 803
+V + +F + L++V M Y + DL G E +A YI + VL AL+Y+
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA--YILQGVLKALDYI 117
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H +G VHR +K ++LI+ DG + L+ GL S + +IN H
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------HGQR 157
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF 914
+ + ++S P +L+PE+L GY A D +SVGI E G PF
Sbjct: 158 LRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ + K L E I+ ++NP ++R D L ++ EY+ GD
Sbjct: 46 LVAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 774 LYSLL-----RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIA 821
L L ++ + IA L+ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 822 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 881
+ IK+ DFG+S+ + + +Y + R AV ++
Sbjct: 164 NHYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWM 198
Query: 882 APEILLGTEHGYAADWWSVGIILFEFITGIP--PFTAESPEIIFDN 925
A E +L + A+D W+ G+ L+E T P++ S E + +N
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 53/169 (31%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LDM-IRKNDIERILAERN 739
+ I +GA ++L D + + K LD +R+ ER E
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREAR 51
Query: 740 ILITVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEED 787
IL R +V DN +VMEY+ G L LLR+VG
Sbjct: 52 ILAKAREAGVPVPIVYDVDP----DNGLIVMEYIEGELLKDALEEARPDLLREVG---RL 104
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
V + LH GIVH DL N++++ G I DFGL +
Sbjct: 105 VGK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKV-LKKL-DMIRKNDIERILAERNILIT 743
D +++ + GAFG V+ R GD ++V +K L + + D L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 744 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE 801
+ +VR SF R ++++E + GGDL S LR+ E + + + +L+ A +
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 802 ------YLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDG 852
YL +HRD+ N L+ G K+ DFG+++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----------------- 167
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 911
D + Y + R A+ ++ PE L D WS G++L+E F G
Sbjct: 168 ----DIYRASYYRKGGR----AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
Query: 912 PPFT 915
P+
Sbjct: 220 MPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 703 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTCR 759
V+LAR TG L +++ D+ + E + A +N ++ R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRIT---DLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817
L+++ ++ G SLL+ + E + + + L YLH G +HR++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 818 LLIAHDGHIKLTDFGLSKI-GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
+LI+ DG + L+ GLS + L+ N G + + +P++ S
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRN-----GQKAKVVY----DFPQF---------STSV 171
Query: 877 TPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 914
P +L+PE+L +GY +D +SVGI E TG PF
Sbjct: 172 LP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V A + G AIK+LK + +ND E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 745 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 791
+P ++ + R LY+ +EY G+L LRK LE D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 792 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ +++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 7e-08
Identities = 47/160 (29%), Positives = 63/160 (39%), Gaps = 42/160 (26%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRN-- 746
I +GA + + +V K +LD +R ER AE +L R
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRT---ERTRAEARLLSEARRAG 397
Query: 747 ---PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-------SLLRKVGCLEEDVARIYIAEL 796
P + Y + +VMEY+ G DL L+RKVG E VA+
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVG---EIVAK------ 443
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
LH GIVH DL N ++ D + L DFGL K
Sbjct: 444 ------LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 52/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 748
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS------ 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 799
+ + F S R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 915 TAESPEIIFDN 925
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIRKNDIERILAERNILIT 743
S F+I+ + G FG+V A R + A+K+++ + R IE E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 744 VRNPF----VVRFFYSFTCRDNLYLVM-EYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ F + R+F + T ++ +VM +Y G L + K G ++A+++
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHR----HLAQIIF 238
Query: 799 ----ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
AL+Y H+ L ++H DLKP+N+L+ + +D P T+
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETS----------------DTVVD---PVTNRA 279
Query: 854 MPSDAHYPEYQQ----TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
+P D D R+ +A V T Y +PE++LG Y+ D WS+G I++E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 909 TG 910
TG
Sbjct: 340 TG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 71/260 (27%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDL---FAIKVLKKLDMIRKNDIERI--LAERN 739
+ +++ + +G+FG V+ AR G+ A+K + + +R ERI L E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEAS 61
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--------- 790
++ VVR + +VME + GDL S LR L +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR---SLRPEAENNPGRPPPTL 118
Query: 791 ----IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
AE+ + YL++ VHRDL N ++AHD +K+ DFG+++ D+
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIY 170
Query: 847 GPETD-------GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
ETD G++P ++APE L ++D WS
Sbjct: 171 --ETDYYRKGGKGLLPV----------------------RWMAPESLKDGVFTTSSDMWS 206
Query: 900 VGIILFEFITGIPPFTAESP 919
G++L+E + AE P
Sbjct: 207 FGVVLWEITS-----LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 695 ISRGAFGRVFLARKRTTG---DLFAIKVLKK--LDMIRKNDIERILAERNILITVRNPFV 749
I G FG V R + G AIK LK + R++ L+E +I+ +P +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFDHPNI 67
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEY 802
+ T + ++ E++ G L S LR ++ + + +LV ++Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L + VHRDL N+L+ + K++DFGLS+ L ++T D P
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSD----------------PT 164
Query: 863 YQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y S++G + APE + + A+D WS GI+++E ++
Sbjct: 165 YT--------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751
I G FG+V AR + G AIK +K + K+D E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----------------YIAE 795
+ R LYL +EY G+L LRK LE D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 51/276 (18%)
Query: 657 ENSRLILDSVSQSSGVSTPLHSSHKERTS--IDDFEIIKPISRGAFGRVFL-ARKRTTGD 713
+ S L D + PL + + + F +I + GAFG++F+ A + +T +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEE 175
Query: 714 LFAIKVLKKLDMIRKNDIERILA-------------ERNILITVR--NPFVVRFFYSFTC 758
A + + + K ER++A E IL R + +++
Sbjct: 176 AEARRGVNSTNQ-GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS 234
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLALEYLHSLGIVHRDL 813
N Y++ + + DLYS + +D R + +L+ A+EY+H ++HRD+
Sbjct: 235 EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K +N+ + DG I L DFG MP +++ +
Sbjct: 294 KLENIFLNCDGKIVLGDFGT-------------------AMP-------FEKEREAFDYG 327
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
VGT +PEIL G + D WS G+IL + ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 693 KPISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + G FG V L++ + A+K +K LD+ ++IE L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 750 VRFF-YSFTCRDNLYL-----VMEYLNGGDLYSLL--RKVGCLEEDVAR----IYIAELV 797
++ F + ++ ++ GDL+S L ++G L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 691 IIKPISRGAFGRVFLARKRTTGDLFAIKV----LKKLDMIRKNDIERILAERNILITVRN 746
IK + G RV+L T + + +K+ K D R+ I ++LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPV---- 55
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P V+ S YL+ME++ G L +V E++ +AEL+ L L L
Sbjct: 56 PKVL---ASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
+ H DL P N+L+ + + D+ + G
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 50/231 (21%)
Query: 693 KPISRGAFGRVFLARKRTTGD---LFAIKVLKK-LDMIRKNDIERILAERNILITVRNPF 748
K I G FG VF + G AIK LK ++ D L+E +I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF---LSEASIMGQFSHHN 67
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL----------YSLLRKVGCLEEDVARIYIAELVL 798
++R T ++ EY+ G L +S + VG L A
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA--------- 118
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL + VHRDL N+L+ + K++DFGLS++ + + + + + G +P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPI-- 174
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ APE + + A+D WS GI+++E ++
Sbjct: 175 --------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 692 IKPISRGAFGRVF----LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+K + GAFG V+ + T AIK+L + + N + E I+ ++ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEALIMASMDHP 69
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----YIAELVLALEYL 803
+VR + LV + + G LL V ++++ + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHG---CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+VHRDL N+L+ H+K+TDFGL+++ L G E EY
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------LEGDEK-----------EY 166
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIPPFTA 916
N ++A E + + + +D WS G+ ++E +T GIP T
Sbjct: 167 ------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TR 218
Query: 917 ESPEII 922
E P+++
Sbjct: 219 EIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-06
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 36/188 (19%)
Query: 675 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---I 731
PL + DDF + K + GAFG V+ + + K K + + + +
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVY----KASLVNKQSKKEGKYVLKKATEYGAV 175
Query: 732 ERILAERNILITVRNPFVVRFFYSFTC------RDNLYLVMEYLNGGDLYSL-------- 777
E + ER + N F Y F D +LV Y L L
Sbjct: 176 EIWMNER-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPY 233
Query: 778 ------LRKVGCL------EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DG 824
L KV L E + + + +++ AL+ LHS GIVHRD+KP N++ + G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 825 HIKLTDFG 832
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 64/263 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLF---------AIKVLKKLDMIRKNDIERILAERNILITVR 745
I +G FG V+ G L A+K L ++ + ++E+ L E I+
Sbjct: 3 IGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFS 54
Query: 746 NPFVVRFFYSFTCRDNLYLV-MEYLNGGDLYSLLRK----------VGCLEEDVARIYIA 794
+P V+ + LV + Y+ GDL + +R +G VA+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK---- 109
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+EYL S VHRDL N ++ +K+ DFGL++
Sbjct: 110 ----GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR------------------- 146
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D + EY N H+ P ++A E L + +D WS G++L+E +T G P
Sbjct: 147 --DIYDKEYYSVHN---HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
Query: 913 PFTAESPEIIFDNILN-RKIPWP 934
P+ I +L R++ P
Sbjct: 202 PYPDVDSFDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 45.9 bits (110), Expect = 2e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 764 LVMEYLNGGDLYS-LLRKVGCLEEDVARIY--IAELVLALEYLHSLGIVHRDLKPDNLLI 820
LVME++ G + + L+ V L ED +Y I EL+ L G+VH DL N+L+
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKL--YREAGLVHGDLSEYNILV 148
Query: 821 AHDGHIKLTDFG 832
DG + + D
Sbjct: 149 -DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 53/245 (21%)
Query: 693 KPISRGAFGRVF--LAR---KRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 745
+ + +G+FG V+ +A+ K AIK + + +R ERI L E +++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR----ERIEFLNEASVMKEFN 67
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA---------RIYIA-E 795
VVR + ++ME + GDL S LR + E+ I +A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ + YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------------------- 167
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +TD + P +++PE L +D WS G++L+E T
Sbjct: 168 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 216
Query: 915 TAESP 919
AE P
Sbjct: 217 LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL--DMIRKNDIERILAERNILITVRNPFV 749
+K + G FG V GD I V K D + + I + ++ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGI 808
VR +L LV + G L +R+ L+ + ++ + YL +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHR+L N+L+ D +++ DFG+ +D YP+ D
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGV----------------------ADLLYPD----DK 164
Query: 869 RNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ +S TP ++A E +L + + +D WS G+ ++E ++ G P+ P + D
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIK LK D E E + +++P +V T L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 776 SLL------RKVGCLEEDVARI----------YIAELVLALEYLHSLGIVHRDLKPDNLL 819
L VG ++D + ++ +E+L S +VH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ ++K++D GL + + L G + ++P
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMG---NSLLPI----------------------R 191
Query: 880 YLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPS 938
+++PE ++ + +D WS G++L+E F G+ P+ S + + + I NR++ PC P
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPC-PD 249
Query: 939 D 939
D
Sbjct: 250 D 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 72/298 (24%)
Query: 693 KPISRGAFGRVFL--ARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILIT 743
I G FG+V L A + + +K L+ +L +++ R L N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAEL 796
+ C ++ LV+E+ GDL + LR ++DV + E+
Sbjct: 61 LGQ-----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
L +LH +H DL N + D +K+ D+GL+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL--------------------- 148
Query: 857 DAHYPE-YQQTDNRNRHSAVGTPDYLAPEI-------LLGTEHGYAADWWSVGIILFE-F 907
YPE Y T + + +LAPE+ LL + ++ WS+G+ ++E F
Sbjct: 149 -EQYPEDYYITKDCH----AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
Query: 908 ITGIPPFTAESPEIIFDNIL---NRKIPWPCVP---SDMSFEAQDLINRFLIHDPNQR 959
P+ S E + ++ + K+P P + SD +E + +F DP R
Sbjct: 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIK----VLKKLDMIRKNDIERILAERNILITVRNPFVV 750
+ +G F ++F +R GD + +LK LD +N E +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 809
+ C D +V EY+ G L + L+K L ++ +A +L AL +L G+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 810 HRDLKPDNLLIAHDGH--------IKLTDFGLS 834
H ++ N+L+ + IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 30/134 (22%)
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+E+L S VHRDL N+L+A +K+ DFGL++ IM D+
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----------------DIM-HDS 291
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 917
+Y ++ S ++APE + + +D WS GI+L+E F G P+
Sbjct: 292 NYV--------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY--- 340
Query: 918 SPEIIFDNILNRKI 931
P +I D+ KI
Sbjct: 341 -PGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
R +Y F + L + + +++ C + + + + +++ LEY+H GI H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 26/124 (20%)
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
Y ++ +E+L S +HRDL N+L++ + +K+ DFGL++ D+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DI------ 224
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITG 910
Y+ D + SA ++APE + + +D WS G++L+E F G
Sbjct: 225 -----------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 911 IPPF 914
P+
Sbjct: 274 ASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 1/37 (2%)
Query: 799 ALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLS 834
AL LH GI H DL KP N L+ DG + DF L+
Sbjct: 123 ALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159
|
Length = 365 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
DLY +KV LE+ + Y ++ +E+L S +HRDL N+L++ + +K+ DFG
Sbjct: 170 DLY---KKVLTLEDLIC--YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
L++ D+ + D + DA P ++APE + +
Sbjct: 225 LAR--------DIY-KDPDYVRKGDARLPL----------------KWMAPETIFDRVYT 259
Query: 893 YAADWWSVGIILFE-FITGIPPF 914
+D WS G++L+E F G P+
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+E+L S VHRDL N+LI +K+ DFGL++ IM D++
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----------------DIM-RDSN 294
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
Y ++ S ++APE + + +D WS GI+L+E T G P+
Sbjct: 295 YI--------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 919 PEIIFDNILNR--KIPWPCVPSDMSFE 943
F N + R ++ P SD +E
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 40/187 (21%), Positives = 61/187 (32%), Gaps = 47/187 (25%)
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
A + L L L HR K N+L+ DG +KL G PE
Sbjct: 21 AVCLQCLGALREL---HRQAKSGNILLTWDGLLKL--DGSVAF---------KTPEQSR- 65
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 914 FTAESP-----EIIFDNILNRKIPWPCVPSDMS--FEAQDLINRFLIHDPNQRLGANGAA 966
+ E EI+ + + +S +D + P +R AN
Sbjct: 104 YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN--- 160
Query: 967 EVKAHPF 973
AH
Sbjct: 161 HYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 5e-04
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 40/169 (23%)
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNI--------LI 742
IS G V+ AR G+ A+K+ K + K+ + I + R+ L+
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLV 62
Query: 743 TV------RN-----------PFVVRFFYSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCL 784
RN P + + N+ LVME++ + G L+ V
Sbjct: 63 FAWAEKEFRNLKRLYEAGVPVPEPI------LLKKNV-LVMEFIGDDGSPAPRLKDVPLE 115
Query: 785 EEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
EE+ +Y ++V + L G+VH DL N+L HDG + D
Sbjct: 116 EEEAEELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYI 793
LAE L + +VR T + + +V EY++ G L S LRK G L +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
L ++YL +G VH+ L +L+ D K++ F E
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------------RLQEDK-- 158
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+A Y T + + APE + A+D WS GI+++E ++
Sbjct: 159 --SEAIY-----TTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
ISRG G + + G F +K + ++ I ++I + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKLQHPNIVKLIG 750
Query: 755 SFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIV 809
CR YL+ EY+ G +L +LR + I IA+ AL +LH S +V
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
+L P+ ++I DG D ++ L P TD +
Sbjct: 806 VGNLSPEKIII--DG----KDEPHLRLSL----------------------PGLLCTDTK 837
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
S+ Y+APE + +D + G+IL E +TG P AE
Sbjct: 838 CFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824
VMEY++G +LY + R + ED + E++ + + GI+H DL N+L+ D
Sbjct: 109 VMEYIDGVELYRV-RVL----EDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 825 HIKLTDF 831
I + D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ +L S +HRDL N+L+ H K+ DFGL++ I N +++ ++ +A
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRN-------DSNYVVKGNAR 277
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
P ++APE + + + +D WS GI+L+E F G P+
Sbjct: 278 LP----------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKV-LKKLDMIRKNDIERILAERNILITVRNPFVVR 751
K + G FG V + + + V K+ + ++++E L+E + +P V+R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 752 FFYSFTCRDNL--------YLVMEYLNGGDLYSLL--RKVG----CLEEDVARIYIAELV 797
C + +++ ++ GDL+S L ++G L + ++ ++
Sbjct: 65 LIG--VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818
L + L LL ++ L E + + L+ AL L +VH DL P NL
Sbjct: 123 LKLLRQLAAALRRLVAAELLDRLAELWERLLA-ALLALLPALP----LVLVHGDLHPGNL 177
Query: 819 LIAHDGHIK-LTDFGLSKIG 837
L+ G + + DF + +G
Sbjct: 178 LVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDLKPDNLLIAH 822
+VMEY+ G +LY L V +E I + +L + + GIVH DL N+L+
Sbjct: 184 VVMEYIEGVELYRLRLDVENPDE------ILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237
Query: 823 DGHIKLTDF 831
DG I + D+
Sbjct: 238 DGDIVVIDW 246
|
Length = 304 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1044 | |||
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.18 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.03 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.71 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.54 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.52 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.35 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.97 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.82 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.56 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.52 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.61 | |
| PLN02236 | 344 | choline kinase | 95.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.39 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.32 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.79 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.73 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.58 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 90.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.6 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.75 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.36 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.36 | |
| PTZ00296 | 442 | choline kinase; Provisional | 87.36 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 83.2 |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-65 Score=613.19 Aligned_cols=943 Identities=34% Similarity=0.421 Sum_probs=724.4
Q ss_pred CCCcccccccccCCCC-CCccccccccccCCCCCc---ccccccccccchhcc-cchH-HHHHhhchH--HHHHH-----
Q 001614 12 GIPSGLNRIKTRGGVS-KPDELTESRSYGVSRPPQ---KHKQKTVAQGHVKLA-NSFT-EEVRKGKKI--AQWFT----- 78 (1044)
Q Consensus 12 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~--~~~~~----- 78 (1044)
-+++|+|+|||+-.-. -+-.|..- -+.|+|- -.||+-|..|+...| |.|. -.-+++-|+ .+|..
T Consensus 80 p~e~df~~IklisngAygavylvrh---~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~ 156 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRH---KETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAV 156 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeec---cccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHh
Confidence 4678999999974221 11111100 1223332 257888888877665 5554 223444444 34443
Q ss_pred hhhccccccCCCCCCCCCCCCCCCcCCccccccccccccchhhhHHHHhhhcccccCCccccccccCCCCCCCCCCccCC
Q 001614 79 SYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAH 158 (1044)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (1044)
.|.-.+.||-+.--+.+.+-+-+ -+.||-..| ..|..|.-..- -+.+-++++|+||++.||.-.--+.+++
T Consensus 157 Eylh~ygivhrdlkpdnllIT~m-----GhiKlTDfg---Lsk~GLms~at-nl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 157 EYLHSYGIVHRDLKPDNLLITSM-----GHIKLTDFG---LSKKGLMSLAT-NLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred HhhccCCeecCCCCCCcceeeec-----ccccccchh---hhhhhhhhccc-hhhhcchHHHHHHhhhccccCCccccCh
Confidence 37777889988777666554433 234444443 56777765554 6778899999999999998888889999
Q ss_pred CcCCHH--------HHHHHHHHHHHHHHHhhhhh-----HhhhHHHHHHHHhhcCCCCchhhhhHHHHHHHHHHhhhhhc
Q 001614 159 SYNDLK--------ELLDTLHSRFDAAKEVVNSE-----LATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTS 225 (1044)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (1044)
.|+..+ +.+|.|+.+|+-.++-|..+ +|+|+.|.+...|+++-.-.|-++++++||..+-+|..||.
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 999999 99999999999999999999 99999999999999998899999999999999999999999
Q ss_pred chhhhhhhHHHHhhHHh---HhcccchHHHHhhhhHHHHHHhhhHHhhccccccchhcc--chhhHhhhcccCCcccccc
Q 001614 226 CLFRANCETIVQDLTEK---RQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEK--SLHKFKKCLESVPAVETSW 300 (1044)
Q Consensus 226 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 300 (1044)
=-||+-||-|+|.||.+ ||+|+-+.++|...+|+||+|||+|+-+|.+|...+++- ..++|.-|.+-..++..+|
T Consensus 308 ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss~ 387 (1205)
T KOG0606|consen 308 GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSSW 387 (1205)
T ss_pred hhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCccccccccccccccccccccccccch
Confidence 99999999999999999 999999999999999999999999999999999999888 6789999999999999999
Q ss_pred cC-------CCCccccchhhHHHHhhhccccccccc--cccccccccccCCcCccccccccccceeccCCCCccccchhh
Q 001614 301 VP-------SPGTAESDLDYASYQKANAKKKISGQQ--KVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSR 371 (1044)
Q Consensus 301 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (1044)
-- .+-.-++...+-.++- +-.++. +...-|++..-.-+..+++..+| -.--|.|.+-++-
T Consensus 388 ~~l~~~~t~~~~~~~~~~~~~~~~~-----~~~g~k~~~~~~sp~~~kl~~st~~ss~s~~------~~~s~~~~~~~~~ 456 (1205)
T KOG0606|consen 388 ESLAQLETATPREKSSQSSQGEVSP-----SSAGQKDSWKSNSPESSKLELSTALSSVSPN------HPGSPSKSLTSAA 456 (1205)
T ss_pred hhhhccccccccccccccccccccC-----CccccccccccCChhhhhccccchhhhcccc------cCCCccccccchh
Confidence 65 1111111111111111 111111 12222322222222122222222 0122223322221
Q ss_pred h----hh------hhcccccce------EEEeeecC-------C--------------CCCCcCCCCCCCCCceeeeccc
Q 001614 372 M----QE------QQSHIVEGR------IVEVTKSN-------C--------------GSPHEQGQSLDGSDSVICRICE 414 (1044)
Q Consensus 372 ~----~~------~~~~~~~~~------~~~~~~~~-------~--------------~~~~~~~~~~~~~~~~~~~~~~ 414 (1044)
- +. -.+++..+| ++.-++.. | ...|..-+.+..+|+.||||||
T Consensus 457 s~~~~~~~~s~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~d~~i~~~~e 536 (1205)
T KOG0606|consen 457 STLRTALRTSSPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTSDSGICRICE 536 (1205)
T ss_pred hhhccccccCCCCCCccccccCCCCCccccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccCCcccccccc
Confidence 1 11 112333333 22111100 1 1345666889999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhHHhHHHHHHHHHhhcc--CCCCCCCCCCcccccccCccceeccCCCccc
Q 001614 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCN--SSSHPILGSPENSRTQSMNSAITYDGYSPKI 492 (1044)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (1044)
.++|..|.|.|++||+++++|+.+|++++.|+.|+.+.++++..|.. ++.+| -|+|..+..+ +...-++..| +.
T Consensus 537 ~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~-~~~~l~s~lS--~~~~sS~p~S-rd 612 (1205)
T KOG0606|consen 537 AEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP-TGGPLCSPLS--PRSLSSNPSS-RD 612 (1205)
T ss_pred cccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC-cccccccccC--CCCCCCCccc-Cc
Confidence 99999999999999999999999999999999999999999877654 33444 4667776663 5556677777 99
Q ss_pred hhhhccCcchhhhccccccccccccCCCc--ceeecccccccccCCCCCCCCCCccccCCCCCCCCCCccccccccCCch
Q 001614 493 SEWRNKGVEGMFEDIHEMDTACIDDSHLG--SLNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPA 570 (1044)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~s~~~~~~~~~p~~~h~~~~~~~~~~~~ 570 (1044)
+.|+|+++++|+++.+.++.. +++..+| .+.++-..|-+. .|.-.++.++-+..||..+|...|.|.+|..+|+.-
T Consensus 613 sspsrd~s~~~~~~~ppI~i~-~~~~~yGft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v 690 (1205)
T KOG0606|consen 613 SSPSRDSSAAMLSLRPPITIH-FSGKKYGFTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPV 690 (1205)
T ss_pred cccccccchhhcCcCCceeee-ccccccCceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCccc
Confidence 999999999999999987654 4555677 667778889888 888899999999999999999999999999999999
Q ss_pred hhHHHhhchHHHH--HHHhhccccccccCh-HhHHHhhchhHHHhhhcccccccccchh-hHHHHHhhhhHHHHhhhhcc
Q 001614 571 ELEDVQQMIELAD--IARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFG-SRIEKLLREKYILACELLDE 646 (1044)
Q Consensus 571 ~~~d~~~~~~l~~--~a~~~~~t~l~k~~~-~~l~~~l~~l~~~~~~~~~~~~~id~fG-~ri~kllr~~~~l~~~lL~~ 646 (1044)
.-++..++.+|.. +++....|---+... -.-.++..++.-+|.+.+.+..++++|+ .|+.++++..+.-.|+++..
T Consensus 691 ~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~ 770 (1205)
T KOG0606|consen 691 HGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHT 770 (1205)
T ss_pred chhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcc
Confidence 9999999999999 777777665555545 4455888999999999999999999999 88999999998887877655
Q ss_pred CCCCccccccccchhhhcccccCCC---CCCCCCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecc
Q 001614 647 KSPTSFSKYKENSRLILDSVSQSSG---VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723 (1044)
Q Consensus 647 ksp~sfS~~~ens~llldsls~~s~---~~~p~~ss~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~ 723 (1044)
...-..+ . +++..... ...|..... .+...+++.+.+.+-.|+++.++.+....+|...+.|+..+.
T Consensus 771 ~~s~~ss----~-----eS~pgdp~~sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~a 840 (1205)
T KOG0606|consen 771 SRSFLSS----S-----ESLPGDPTRSLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLA 840 (1205)
T ss_pred ccccccc----c-----ccCCCCcccccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccchhhhccc
Confidence 4321000 0 01111100 111222222 457889999999999999999999998888888888887776
Q ss_pred cccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 001614 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803 (1044)
Q Consensus 724 ~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYL 803 (1044)
..+.....+....+-.++....+|.++..+..+....+.+|+++|..|++|...++..++.+.+-++.++..+..+.+||
T Consensus 841 p~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L 920 (1205)
T KOG0606|consen 841 PKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESL 920 (1205)
T ss_pred hhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcc
Confidence 66666667777788788777888999988888888889999999999999999999999999999999999999999999
Q ss_pred HhcCeeeccCCCCceeecCCCcEEEeecC-CcccccccCcccCCCCCCCCCCCC---CCCCCcccccCcCCccCccCCCC
Q 001614 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFG-LSKIGLINNTIDLSGPETDGIMPS---DAHYPEYQQTDNRNRHSAVGTPD 879 (1044)
Q Consensus 804 Hs~GIIHRDLKPeNILLdedg~VKLsDFG-LAki~~~~~t~dls~p~t~~~~~s---~s~~~e~~~~~~~~~~s~vGTp~ 879 (1044)
|...+.|||++|.|+|+..+|+.++.||| +..+...+.+.+.+|+...+..-+ ..........+........||+.
T Consensus 921 ~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~ 1000 (1205)
T KOG0606|consen 921 HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPD 1000 (1205)
T ss_pred ccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCc
Confidence 99999999999999999999999999999 556655666666655444332211 12222222223345667889999
Q ss_pred CCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCC
Q 001614 880 YLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 880 YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskR 959 (1044)
|.+||.+.+...+..+|+|++|+++++.++|.+||....++.++++|..+..+|+..+...++++++++..+|..+|.+|
T Consensus 1001 ~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1001 YLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred ccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CChhhHHHHHcCCCCCCCCcchhHhhhccccchh
Q 001614 960 LGANGAAEVKAHPFFKGVNWDSLALQKMTQATSY 993 (1044)
Q Consensus 960 PSadeA~EIL~HPwFk~id~d~L~~qk~~~~~s~ 993 (1044)
.++..+.+...||||++++|+.+..++..+.+..
T Consensus 1081 ~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1081 LGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred cCcccccccccCCccCCCCccccccccCccCCCC
Confidence 9988888999999999999999988876555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-55 Score=481.51 Aligned_cols=277 Identities=52% Similarity=0.961 Sum_probs=256.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
....++|++++.||+|+||+||.++.+.|++.||+|+++|.......+.+...+|..||..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35678999999999999999999999999999999999998888888899999999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|||+||+.||.|+.+|++.+.+++..++.|+.+|+.||.|||+.|||||||||+|||+|.+|+++|+||||++...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~---- 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL---- 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
.......+.|||+.|||||++.+..|+..+||||||+++|||++|.+||.+.+..++
T Consensus 177 -----------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 177 -----------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred -----------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 122344568999999999999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC-hhhHHHHHcCCCCCCCCcchhHhhhcc
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQKMT 988 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS-adeA~EIL~HPwFk~id~d~L~~qk~~ 988 (1044)
+++|..+..+.+ |..++.++++||+++|++||.+|.. ..++.++.+||||++++|+.+...+..
T Consensus 234 ~~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 234 YDKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred HHHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCC
Confidence 999999885433 4569999999999999999999985 346889999999999999999877554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=490.24 Aligned_cols=308 Identities=49% Similarity=0.860 Sum_probs=263.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
+...++|+++..||+|+||.||+|+.+.||..||+|+++|..+........++.|..+|...++|+||++|..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||||||++||++..+|.+.+.+++..+++|+.+++.||.-||+.|+|||||||+|+|||..|++||+||||+......+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999964333222
Q ss_pred ccCCC------CCCCCCCCCCCC--------------CCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHH
Q 001614 843 IDLSG------PETDGIMPSDAH--------------YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (1044)
Q Consensus 843 ~dls~------p~t~~~~~s~s~--------------~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGV 902 (1044)
.+... .......+.+.. +..+..+......+.+|||.|||||+|.+..|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 22100 000000111100 0111122333445689999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHhhhccC--CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 903 ILFEFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 903 ILYELLTGr~PF~g~s~~ei~qkIl~g~--i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
|+||||.|.+||.+.++++++++|++.. +.+|. ...+++++++||.+||. ||.+|....++.||..||||++++|+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999999999876 44443 24678999999999999 99999999999999999999999999
Q ss_pred hhHhhhccccch
Q 001614 981 SLALQKMTQATS 992 (1044)
Q Consensus 981 ~L~~qk~~~~~s 992 (1044)
.+....+++.+.
T Consensus 455 ~l~~~~apfvP~ 466 (550)
T KOG0605|consen 455 HLREMPAPFVPQ 466 (550)
T ss_pred hhhcCCCCCCCC
Confidence 997666665554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=454.68 Aligned_cols=271 Identities=44% Similarity=0.875 Sum_probs=255.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|+++++||.|+||.|.+++.+.+|..||+|++.+....+-...+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45789999999999999999999999999999999999988888888899999999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
+||||++||.|+.++++.+++++..+++|+.||+.||+|||+++|++|||||+|||+|.+|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999842
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.....+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||.+.++..++
T Consensus 195 ------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 195 ------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred ------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 12356789999999999999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC--hhhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS--adeA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
++|+.+.+.|| ..+++++++||+++|+.|-.+|.. -++..++..||||++++|+.+..++.
T Consensus 251 ~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 251 EKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred HHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 99999999877 688999999999999999999966 34688999999999999999887644
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=473.46 Aligned_cols=296 Identities=38% Similarity=0.733 Sum_probs=266.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCe
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~ 761 (1044)
....+||.+++.||.|+|++|++|+.+.+++.||||++.|..+.++.....+..|..+|.+| .||.|++||..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56788999999999999999999999999999999999998888888888999999999999 79999999999999999
Q ss_pred eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+|+|+||+++|+|.++|++.+.|++..+++|+.||+.||+|||++|||||||||+|||+|.+|++||+|||-|+++....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998753222
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
... .+ +...........+++||..|.+||+|..+..++.+|||+||||||+|+.|.+||.+.++-.
T Consensus 229 ~~~-------------~~-~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 229 KSQ-------------EN-PVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred ccc-------------cC-ccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 110 00 0111111222467899999999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhccccchhhhhhh
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSYHALVK 998 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~~~~s~~~l~k 998 (1044)
++++|+.-.+.|| .++++.+++||+++|..||.+|+| +.+|.+||||.+++|+.+..+.++....+.+..+
T Consensus 295 iFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~ 365 (604)
T KOG0592|consen 295 IFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQTPPKLQPYKPATS 365 (604)
T ss_pred HHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcCCCcccCCCCccc
Confidence 9999999998877 788999999999999999999999 7899999999999999999888887777655444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=472.45 Aligned_cols=263 Identities=34% Similarity=0.642 Sum_probs=246.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|...+.||+|||+.||.+++..+|+.||+|++.+..+.+....+.+.+|++|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|+|+.|+|..++++.+.++|.+++.|++||+.||.|||+++|||||||..|+|++++.+|||+|||||...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l--------- 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL--------- 168 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999742
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
..+..+..+.||||.|.|||++....++..+||||+||+||.||.|++||...+..+++.+|
T Consensus 169 ------------------e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 169 ------------------EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred ------------------cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 12334667899999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC-CCCCcchh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF-KGVNWDSL 982 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF-k~id~d~L 982 (1044)
....+.+| ..+|.++++||.+||+.||.+||| +.++|.|+|| +++-...+
T Consensus 231 k~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 231 KLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred HhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhhCCCcCCCC
Confidence 99998876 589999999999999999999999 8899999999 55433333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=460.14 Aligned_cols=264 Identities=36% Similarity=0.605 Sum_probs=234.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccC----hhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----KNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~----~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+..... ......+.+|+++|++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999999999999999998765443 123345689999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC---CcEEEeecCCcccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIG 837 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded---g~VKLsDFGLAki~ 837 (1044)
..||||||++||+|++.+-..+.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|++.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 57999999999962
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCC---CchhhhHHHHHHHHHHHhCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y---s~KSDIWSLGVILYELLTGr~PF 914 (1044)
. ....+.+.||||.|.|||++.+..+ ..++||||+||+||-+|+|.+||
T Consensus 330 g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF 381 (475)
T KOG0615|consen 330 G----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF 381 (475)
T ss_pred c----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence 1 1234568899999999999987553 44889999999999999999999
Q ss_pred CCCChHH-HHHhhhccCCCCC-CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCc
Q 001614 915 TAESPEI-IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1044)
Q Consensus 915 ~g~s~~e-i~qkIl~g~i~~p-~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~ 979 (1044)
.+..... +.++|..+.+.+- ..+..+++++.+||++||..||++||| +.++|+||||+..+.
T Consensus 382 S~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 382 SEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAPC 445 (475)
T ss_pred ccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhcccc
Confidence 8876665 8899999988764 456789999999999999999999999 778899999997653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=467.23 Aligned_cols=275 Identities=39% Similarity=0.811 Sum_probs=253.3
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCC
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~ 760 (1044)
.....++|.++++||+|+||+|+++..+.+++.||||+++|..+...++.+..+.|.+|+.... ||++++++.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4678899999999999999999999999999999999999999999999999999999998886 999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
++|+||||+.||++..+ +..+.+++..+++|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++-..
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-- 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-- 519 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence 99999999999995444 445679999999999999999999999999999999999999999999999999998421
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.......+.||||.|||||++.++.|+.++|||||||+|||||.|..||.+.+.+
T Consensus 520 -------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 520 -------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred -------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 1123556899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
++++.|+...+.+| ..+|.++.++|+++|.+||++|+.+ .++.++..||||+.++|+.|..++.
T Consensus 575 e~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i 640 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRI 640 (694)
T ss_pred HHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccC
Confidence 99999999987655 7899999999999999999999996 5688999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=430.89 Aligned_cols=261 Identities=32% Similarity=0.563 Sum_probs=235.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe-
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 761 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~- 761 (1044)
.+..++++.+..||+|..|+||+++++.|++.+|+|++.. ...+...+++.+|+++++.++|||||.+|++|.....
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3556788899999999999999999999999999999943 3456678899999999999999999999999999995
Q ss_pred eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
++|+||||++|+|.+++...+.+++.....++.+|++||.|||+ ++||||||||+|||++..|.|||||||.++...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999999999999999999999999999995 999999999999999999999999999987421
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~--- 917 (1044)
+....+.+||..|||||-+.+..|+.++||||||+.++|+++|+.||...
T Consensus 231 ---------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 231 ---------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred ---------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 11345789999999999999999999999999999999999999999764
Q ss_pred --ChHHHHHhhhccCCCCCCCCCC-CCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCc
Q 001614 918 --SPEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1044)
Q Consensus 918 --s~~ei~qkIl~g~i~~p~ip~~-iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~ 979 (1044)
+.-+.+..|..+.. |..|.. +|+++++||..||++||.+||+ +.|+++|||++....
T Consensus 284 ~~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKFED 343 (364)
T ss_pred CCCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhccc
Confidence 56778888887654 456676 9999999999999999999999 889999999987543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=430.45 Aligned_cols=309 Identities=40% Similarity=0.725 Sum_probs=263.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
....+.|++++.||.|.-|+||+++.+.++..+|+|++.+..+.......+...|.+||+.++||+++.||..|+.++.+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 35567899999999999999999999999999999999998888788889999999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 763 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
|+|||||+||+|+.+++++ +.+++..+++|+.+++.||+|||-.|||+|||||+||||-++|+|.|+||.|+......
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999875 46999999999999999999999999999999999999999999999999998643222
Q ss_pred CcccCC-CCCCC------------CCCCC---CCC------------CCcc-cccCcCCccCccCCCCCCCcccccCCCC
Q 001614 841 NTIDLS-GPETD------------GIMPS---DAH------------YPEY-QQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (1044)
Q Consensus 841 ~t~dls-~p~t~------------~~~~s---~s~------------~~e~-~~~~~~~~~s~vGTp~YmAPEvL~g~~y 891 (1044)
-+.-.+ .+... ...+. ... .++. ........++.+||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 111110 00000 00000 000 0000 1223356678899999999999999999
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC-hhhHHHHHc
Q 001614 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKA 970 (1044)
Q Consensus 892 s~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS-adeA~EIL~ 970 (1044)
+.++|||+|||++||||.|..||.+.+..+.+.+|+.....||..+ .++..++|||+++|.+||.+|+. ..+|.+|.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999999999999999999999999999999999999988765 78899999999999999999998 567999999
Q ss_pred CCCCCCCCcchhHhhhccccch
Q 001614 971 HPFFKGVNWDSLALQKMTQATS 992 (1044)
Q Consensus 971 HPwFk~id~d~L~~qk~~~~~s 992 (1044)
||||++++|.-+-..+++..+.
T Consensus 392 HpFF~gVnWaLir~~~PP~iP~ 413 (459)
T KOG0610|consen 392 HPFFEGVNWALIRCARPPEIPK 413 (459)
T ss_pred CccccCCChhheeccCCCcCCC
Confidence 9999999999766666666544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=428.65 Aligned_cols=261 Identities=34% Similarity=0.640 Sum_probs=238.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
...+|.+.+.||.|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.++|||||.+++++.+++.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999987543 45567788999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC------CcEEEeecCCccccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD------GHIKLTDFGLSKIGL 838 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded------g~VKLsDFGLAki~~ 838 (1044)
|||||+||+|.+||++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 458999999998532
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
+.....+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|+.||...+
T Consensus 167 ----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 ----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2233457899999999999999999999999999999999999999999999
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
..+.+..+..+....+.++..+++...+|+...|+.+|..|.+ ..+.+.|+++..-
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAAN 274 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhcccC
Confidence 9999999988887777778888889999999999999999999 5567889988754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=417.64 Aligned_cols=270 Identities=42% Similarity=0.852 Sum_probs=241.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
....++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+++.++||||+++++++...+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34578999999999999999999999999999999999865444444567789999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~---- 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---- 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC----
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999986310
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 170 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 170 --------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred --------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 011235799999999999998899999999999999999999999999998888
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
+..+..+...+| ..++..+++||.+||+.||.+||+. ..+.+++.||||++.+|+.+...
T Consensus 224 ~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~ 285 (329)
T PTZ00263 224 YEKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR 285 (329)
T ss_pred HHHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence 888887765543 5689999999999999999999984 34789999999999999987543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=429.20 Aligned_cols=260 Identities=39% Similarity=0.681 Sum_probs=234.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccCh--hHHHHHHHHHHHHHhcC-CCceEEEeeeeecCC
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~--~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~ 760 (1044)
...+.|.+.+.||+|+||+|+.|.+..+|..||+|++.+...... .....+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999999999999999998876422211 23456678999999999 999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC-CcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded-g~VKLsDFGLAki~~~ 839 (1044)
.+|+|||||.||+|++++.+.+++.+..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999987421
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC-CC-chhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HG-YAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys-~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.......+.||||.|+|||++.+.. |+ .++||||+||+||.|++|..||.+.
T Consensus 173 --------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 173 --------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred --------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 1123456789999999999999977 84 7999999999999999999999999
Q ss_pred ChHHHHHhhhccCCCCCCCCCCC-CHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~i-S~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
+...++.+|..+.+.+| ..+ |+++++||.+||..||.+|++ +.+++.||||+.
T Consensus 227 ~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 227 NVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQK 280 (370)
T ss_pred cHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhcc
Confidence 99999999999988766 555 999999999999999999999 889999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=441.58 Aligned_cols=262 Identities=34% Similarity=0.617 Sum_probs=242.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
.++-|++++.||.|+.|.|.+|++..||+.+|||++.+...........+.+|+-||+.+.||||+++|++++...++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35679999999999999999999999999999999988655555556788999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|.||++||.|++++.+.|++++.+++++++||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.+-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------- 162 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------- 162 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999752
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCC-CchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.+.....+.||+|.|.|||++.|.+| +.++||||+|||||.||||++||.+.+...++
T Consensus 163 ---------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 163 ---------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred ---------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 12334567899999999999999988 67999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
.++..|.+.+| ..+|+++++||.+||..||.+|+| ..+|++|||+.+..--
T Consensus 222 lKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 222 LKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYTSL 272 (786)
T ss_pred HHHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCCCC
Confidence 99999998876 789999999999999999999999 8899999999986543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=406.67 Aligned_cols=266 Identities=42% Similarity=0.820 Sum_probs=236.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997644333345667889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 153 ----------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred ----------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0112357999999999999988999999999999999999999999999998888888
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
..+...++ ..+++.+++||++||+.||.+||+. ..+.+++.||||+.++|..+...
T Consensus 211 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~ 268 (291)
T cd05612 211 LAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQR 268 (291)
T ss_pred HhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcC
Confidence 88776544 5679999999999999999999952 23789999999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=411.77 Aligned_cols=263 Identities=43% Similarity=0.794 Sum_probs=232.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
+.||+|+||.||+++++.+|+.||+|++++...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998654444556677889999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCC
Q 001614 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1044)
Q Consensus 773 SL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~ 852 (1044)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------- 147 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-------------
Confidence 9999999888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCC
Q 001614 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (1044)
Q Consensus 853 ~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~ 932 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+...
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05571 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213 (323)
T ss_pred --------------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 011123457999999999999989999999999999999999999999998888888888776654
Q ss_pred CCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 933 ~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
+ |..+++++.+||.+||+.||.+||+. ..+.++++||||.+++|..+...
T Consensus 214 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~ 265 (323)
T cd05571 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQK 265 (323)
T ss_pred C---CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 4 46789999999999999999999942 13889999999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=408.36 Aligned_cols=261 Identities=41% Similarity=0.851 Sum_probs=232.7
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||+|+||.||+|++..+++.||+|++++...........+.+|+.++.+++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765444455667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCC
Q 001614 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1044)
Q Consensus 775 ~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~ 854 (1044)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--------------- 145 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--------------- 145 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---------------
Confidence 99998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCC
Q 001614 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (1044)
Q Consensus 855 ~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p 934 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 146 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~- 212 (312)
T cd05585 146 ------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF- 212 (312)
T ss_pred ------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC-
Confidence 0011234579999999999999899999999999999999999999999998888888888776554
Q ss_pred CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 935 ~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
+..+++++++||.+||+.||.+||++..+.++|.||||+..+|..+...
T Consensus 213 --~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~ 261 (312)
T cd05585 213 --PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMK 261 (312)
T ss_pred --CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 4678999999999999999999998878999999999999988776443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=412.90 Aligned_cols=297 Identities=43% Similarity=0.785 Sum_probs=237.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+|++..+|+.||||++++...........+.+|+.+|..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654444445667889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCC-----------CCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 847 GPETDGIMP-----------SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 847 ~p~t~~~~~-----------s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
......... .......+...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 000000000 000000000000111224579999999999999899999999999999999999999999
Q ss_pred CCChHHHHHhhhccCCCCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHh
Q 001614 916 AESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984 (1044)
Q Consensus 916 g~s~~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~ 984 (1044)
+.+..+....+......+.. ....+++++++||.+||. +|.+|++...+.+++.||||++++|+.+..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~ 309 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRE 309 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 99888888777765433221 112578999999999997 999999877789999999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=413.01 Aligned_cols=272 Identities=40% Similarity=0.794 Sum_probs=239.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCC-cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~tG-k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
.....++|++.+.||+|+||.||+|.+..++ ..||+|.+.+...........+.+|+.++..++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4467789999999999999999999976655 689999997654444555678899999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~-- 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999986310
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
......+||+.|||||++.+..++.++|||||||++|+|++|..||.+.++.
T Consensus 183 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 234 (340)
T PTZ00426 183 ----------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234 (340)
T ss_pred ----------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH
Confidence 0112357999999999999888999999999999999999999999999988
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhhh
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~qk 986 (1044)
..+..+..+...+ |..+++.+++||++||+.||.+|++. ..+.++++||||++++|..+..+.
T Consensus 235 ~~~~~i~~~~~~~---p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~ 299 (340)
T PTZ00426 235 LIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKN 299 (340)
T ss_pred HHHHHHhcCCCCC---CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 8888888776554 46789999999999999999999731 128899999999999998766443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=406.85 Aligned_cols=296 Identities=30% Similarity=0.507 Sum_probs=263.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..+.|++.+.||+|.|+.||++.+..||+.+|+|++... ..+....+.+.+|++|.+.|+||||+++.+.+......|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~-k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhh-hhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 456799999999999999999999999999999998653 3445577899999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC---CcEEEeecCCcccccccC
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded---g~VKLsDFGLAki~~~~~ 841 (1044)
|+|+|.||+|..-|-..-.+++..+..+++||++||.|+|.+||||||+||+|+|+... ..+||+|||+|.-..
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 99999999998777666778999999999999999999999999999999999999643 359999999997321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
........+|||+|||||++...+|+..+|||+.|||||-||.|.+||++.+...
T Consensus 165 -------------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 165 -------------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred -------------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 1223456789999999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhccccchhhhhhhhh
Q 001614 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSYHALVKFQ 1000 (1044)
Q Consensus 922 i~qkIl~g~i~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~~~~s~~~l~kfq 1000 (1044)
+++.|..+.+.++. .++.+++++++||++||..||.+|+| +.+.|+|||+++- .-....+.......++++|+
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r---~~~As~~H~~dtvd~lrkfN 293 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR---ERVASAIHRQDTVDCLKKFN 293 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch---HHHHHHhhhHHHHHHHHHhh
Confidence 99999999998887 66889999999999999999999999 7788999999863 23344566677889999999
Q ss_pred hhhHHHHHHHHHHHH
Q 001614 1001 VDCRMIRMVATLMLT 1015 (1044)
Q Consensus 1001 ~~~~l~~~il~lm~~ 1015 (1044)
...+++..+++-+..
T Consensus 294 arRKLKgavLtav~s 308 (355)
T KOG0033|consen 294 ARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999998865
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=410.24 Aligned_cols=296 Identities=42% Similarity=0.804 Sum_probs=234.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||+||+|.++.+++.||+|++++...........+.+|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445677889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998743211100000
Q ss_pred CCCCCCCCCCCCCCCc---------ccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 847 GPETDGIMPSDAHYPE---------YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e---------~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
..... ..+.+..+.. +...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNH-SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccc-cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 00000 0000000000 0000111123568999999999999989999999999999999999999999999
Q ss_pred ChHHHHHhhhccC--CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 918 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 918 s~~ei~qkIl~g~--i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
+..+.+.++.... ..+|. ...+++++++||.+|+. +|.+|++...+.++++||||++++|+.+...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred CHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhC
Confidence 9988888887643 33332 12478999999999875 5665533222889999999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=394.05 Aligned_cols=267 Identities=33% Similarity=0.591 Sum_probs=226.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.++..++||||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47889999999999999999999999999999876443333445568899999999999999999999999999999999
Q ss_pred eccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999999888643 3589999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH----H
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE----I 921 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~----e 921 (1044)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. .
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 155 ----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred ----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 01112357999999999999999999999999999999999999999876542 2
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhh
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~q 985 (1044)
+...+..... ..+..+++++.+||++||+.||.+||++. .+.++++||||.+++|+.+...
T Consensus 213 ~~~~~~~~~~---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 213 VDRRVKEDQE---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred HHHHhhcccc---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 2222322222 24467899999999999999999999852 4889999999999999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=408.56 Aligned_cols=296 Identities=44% Similarity=0.823 Sum_probs=238.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++.++.+|+.||+|++++...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444555678889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++............
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCCCCCCC---------CcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 847 GPETDGIMPSDAHY---------PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~---------~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
..... ..+....+ ..+...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTH-NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccc-CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 00000 00000000 000001111223468999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhccC--CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 918 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 918 s~~ei~qkIl~g~--i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
++...+.++.... ..+|. ...+++++++||.+|+. ||.+|++...+.++++||||++++|..+...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred CHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcC
Confidence 9888888877643 22221 12478999999999874 9999998777999999999999999987544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=399.69 Aligned_cols=268 Identities=38% Similarity=0.794 Sum_probs=234.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC-ceEEEeeeeecCCeeEEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP-NIVkL~gvfed~~~LyLVm 766 (1044)
+|++.+.||+|+||.||+|++..+++.||+|++++...........+..|..++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999865444445667788999999999765 6888999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999762100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 154 --------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred --------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001123457999999999999989999999999999999999999999999988888888
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
......+ +..++.++.+||.+||..||.+|++. ....++++||||+.++|..+...
T Consensus 214 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~ 271 (324)
T cd05587 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERR 271 (324)
T ss_pred HcCCCCC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 7766543 46789999999999999999999984 23578999999999999887644
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=402.13 Aligned_cols=269 Identities=42% Similarity=0.797 Sum_probs=234.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+|++..+|+.||+|++++...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654333445677899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999986311
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 153 ----------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred ----------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 0123457999999999999989999999999999999999999999998888877766
Q ss_pred hccCC--CCCCCC---CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhcc
Q 001614 927 LNRKI--PWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMT 988 (1044)
Q Consensus 927 l~g~i--~~p~ip---~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~ 988 (1044)
..... ..+... ..+++++.+||.+||..+|.+||+ +.+++.||||++++|..+....++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~~ 274 (333)
T cd05600 211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKPP 274 (333)
T ss_pred HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCCC
Confidence 54322 112111 256899999999999999999999 889999999999999877643333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=410.04 Aligned_cols=297 Identities=42% Similarity=0.785 Sum_probs=233.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||++.+..+|+.||||++.+...........+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997654444555678899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC-
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL- 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl- 845 (1044)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863211100000
Q ss_pred ----C-CCCCCC------CCC--------CCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHH
Q 001614 846 ----S-GPETDG------IMP--------SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1044)
Q Consensus 846 ----s-~p~t~~------~~~--------s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYE 906 (1044)
. ...... ... .......+...........+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 000000 000 000000000000001123579999999999999899999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHh
Q 001614 907 FITGIPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984 (1044)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~ 984 (1044)
|++|..||.+.+..+.+..+..... .++. ...++.++++||.+||. +|.+|++...+.+++.||||++++|+.+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 9999999999888888877765432 2221 12578999999999997 788776323388999999999999987743
Q ss_pred h
Q 001614 985 Q 985 (1044)
Q Consensus 985 q 985 (1044)
.
T Consensus 319 ~ 319 (377)
T cd05629 319 I 319 (377)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=399.10 Aligned_cols=269 Identities=38% Similarity=0.782 Sum_probs=236.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVm 766 (1044)
+|++.+.||+|+||.||+|++..+++.||+|++++...........+..|..++..+ +||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999875443444556678888888877 5899999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 154 --------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred --------------------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123457999999999999999999999999999999999999999999998888888
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhhh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~qk 986 (1044)
......+| ..++.++.+||.+||+.||.+|++. ....+++.||||+.++|+.+....
T Consensus 214 ~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~ 272 (323)
T cd05616 214 MEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 272 (323)
T ss_pred HhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 87765544 6789999999999999999999985 346789999999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=401.49 Aligned_cols=263 Identities=42% Similarity=0.787 Sum_probs=231.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
+.||+|+||.||++++..+|..||+|++++...........+.+|+.+++.++||||++++++|...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998654444556677889999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCC
Q 001614 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1044)
Q Consensus 773 SL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~ 852 (1044)
+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------- 147 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCC
Q 001614 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (1044)
Q Consensus 853 ~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~ 932 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05595 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213 (323)
T ss_pred --------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 001122457999999999999889999999999999999999999999998888888887776655
Q ss_pred CCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 933 ~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
+ |..+++++.+||.+||+.||.+||+. ..+.++++||||.+++|..+...
T Consensus 214 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~ 265 (323)
T cd05595 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 265 (323)
T ss_pred C---CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 4 46789999999999999999999942 23889999999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=402.95 Aligned_cols=263 Identities=43% Similarity=0.816 Sum_probs=231.1
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998754445556678899999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCC
Q 001614 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1044)
Q Consensus 773 SL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~ 852 (1044)
+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------------- 147 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------------- 147 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCC
Q 001614 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (1044)
Q Consensus 853 ~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~ 932 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 213 (328)
T cd05593 148 --------------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213 (328)
T ss_pred --------------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc
Confidence 001122457999999999999889999999999999999999999999988888888777766654
Q ss_pred CCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 933 ~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
+ |..+++++.+||.+||+.||.+|++. ..+.++++||||.+.+|..+...
T Consensus 214 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~ 265 (328)
T cd05593 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDK 265 (328)
T ss_pred C---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 4 46789999999999999999999841 23889999999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=425.01 Aligned_cols=374 Identities=33% Similarity=0.558 Sum_probs=299.0
Q ss_pred CCCCCCccccccccCCchhhH-HHhhchHHHHHHHhhccccccccChHhHHHhhchhH--HHhhhc---ccccccccchh
Q 001614 553 TPKAGHFDPFWLERNHPAELE-DVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQ--DVLQHS---KLKALVIDTFG 626 (1044)
Q Consensus 553 ~p~~~h~~~~~~~~~~~~~~~-d~~~~~~l~~~a~~~~~t~l~k~~~~~l~~~l~~l~--~~~~~~---~~~~~~id~fG 626 (1044)
-|+.--+..|| .++.| ++.......+.++.|++.+||++ +.+++++.+ +.+.+. ....+..+.|.
T Consensus 74 ~~~~~~~i~Fl-----~~v~eYE~~~~~~r~~~~~~i~~~~l~~~----~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~ 144 (591)
T KOG0986|consen 74 RPELRPAIEFL-----EEVKEYEKADDDERKDKARQILDAYLMKE----LLACLPQFSSKDLVTHVQEHLLEKPPKDLFQ 144 (591)
T ss_pred CchhhhHHHHH-----HHHHHHhcCCcccchhhHHHHHHHHhhcc----ccccCCCcchhhhhHHHhhhccccCchhhhH
Confidence 35555567788 22322 23337888999999999999999 778887774 222222 33446777777
Q ss_pred hHHHHHhhhhHHHHhhhhccCCCCccccccccchhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEE
Q 001614 627 SRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706 (1044)
Q Consensus 627 ~ri~kllr~~~~l~~~lL~~ksp~sfS~~~ens~llldsls~~s~~~~p~~ss~~~~~si~dY~Ilk~LG~GgFG~VYka 706 (1044)
..+... |..+.. ..|..|.... ..++..++... +......+.|+..++||+||||.||-+
T Consensus 145 ~~~~~~--------~~~L~~---~pF~~f~~S~--yf~rFlQWK~l-------E~qpvt~n~F~~~RvlGkGGFGEV~ac 204 (591)
T KOG0986|consen 145 PLARAI--------CAYLRG---DPFQEFLESD--YFTRFLQWKWL-------ELQPVTKNTFRVYRVLGKGGFGEVCAC 204 (591)
T ss_pred HHHHHH--------HHHhcc---chHhHhHHHH--HHHHHHHHHHH-------HhhhccccceeeeEEEecccccceeEE
Confidence 666554 232222 1222222211 11333333221 123355678999999999999999999
Q ss_pred EECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHHHhcC--CC
Q 001614 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CL 784 (1044)
Q Consensus 707 ~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g--~L 784 (1044)
+.+.||+.||+|.+.|.+..........++|..||.+++.|+||.+-++|++.+.+++||..|+||+|.-+|.+.+ .+
T Consensus 205 qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF 284 (591)
T KOG0986|consen 205 QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGF 284 (591)
T ss_pred EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCC
Confidence 9999999999999988777677777889999999999999999999999999999999999999999999987766 79
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCccc
Q 001614 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864 (1044)
Q Consensus 785 see~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~ 864 (1044)
++..+++|+.+|+.||++||..+|++|||||+|||+|+.|+++|+|+|||.-+..
T Consensus 285 ~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~------------------------- 339 (591)
T KOG0986|consen 285 DEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE------------------------- 339 (591)
T ss_pred chHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC-------------------------
Confidence 9999999999999999999999999999999999999999999999999974322
Q ss_pred ccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----hHHHHHhhhccCCCCCCCCCCC
Q 001614 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----PEIIFDNILNRKIPWPCVPSDM 940 (1044)
Q Consensus 865 ~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s----~~ei~qkIl~g~i~~p~ip~~i 940 (1044)
.......+||.+|||||++.+..|+...|+|||||+||||+.|+.||.... .+++-+.++.....++ ...
T Consensus 340 ---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---~kF 413 (591)
T KOG0986|consen 340 ---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---DKF 413 (591)
T ss_pred ---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc---ccc
Confidence 223345689999999999999999999999999999999999999997643 3466677776665544 789
Q ss_pred CHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhhh
Q 001614 941 SFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 941 S~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~qk 986 (1044)
|+++++|.+.+|++||.+|... +.+.++.+||||+++||..+.+..
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagm 461 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGM 461 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccC
Confidence 9999999999999999999984 468899999999999999998774
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=409.61 Aligned_cols=280 Identities=42% Similarity=0.777 Sum_probs=261.3
Q ss_pred CCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001614 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1044)
Q Consensus 678 ss~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfe 757 (1044)
...+....+++|..++.||+|.||+|.+++.+.+|+.||+|++++.-.+...+....+.|-++|+..+||++..+...|+
T Consensus 159 ~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 159 AKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred ccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34555678999999999999999999999999999999999999988888888999999999999999999999999999
Q ss_pred cCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
..+.+|+||||..||.|+-+|.+...+++..+++|-.+|+.||.|||+++||+||||.+|.|+|.+|++||.|||+++-.
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999831
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
........+.||||.|+|||++....|+.++|+|.+||++|||++|+.||+..
T Consensus 319 ---------------------------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 319 ---------------------------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ---------------------------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 12234567899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC--hhhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS--adeA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
+...++.-|+.+.+.|| ..++++++.|+..+|.+||.+|.. .++|.++..|+||.+++|+....++.
T Consensus 372 dh~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki 440 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI 440 (516)
T ss_pred chhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence 99999999999998876 789999999999999999999998 67899999999999999999877654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=406.66 Aligned_cols=295 Identities=45% Similarity=0.751 Sum_probs=234.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999986544445566788999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999975321100000000
Q ss_pred C------CCCCCC-----CCCCCC---------CcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHH
Q 001614 848 P------ETDGIM-----PSDAHY---------PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1044)
Q Consensus 848 p------~t~~~~-----~s~s~~---------~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYEL 907 (1044)
. ...... +..... ..............+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 0 000000 000000 00000011112346899999999999998999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHhhhccCCCCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhH
Q 001614 908 ITGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1044)
Q Consensus 908 LTGr~PF~g~s~~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~ 983 (1044)
++|+.||.+.++.+....+......... ....+++++.+||.+|+ .+|.+|++...+.+++.||||++++|....
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~ 317 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSSDL 317 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHHHH
Confidence 9999999998888777777654332211 12468999999999987 599999986678899999999999988643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=399.66 Aligned_cols=263 Identities=40% Similarity=0.811 Sum_probs=230.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999864433445567788899988876 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~------------ 148 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF------------ 148 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+..+..
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 149 ---------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred ---------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112345799999999999988999999999999999999999999999999988888887765
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChh---hHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad---eA~EIL~HPwFk~id~d~L~~q 985 (1044)
.+ +..+++++.+||.+||+.||.+||++. ...+++.||||++++|+.+...
T Consensus 214 ~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 267 (320)
T cd05590 214 VY---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRR 267 (320)
T ss_pred CC---CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 43 467899999999999999999999952 2488999999999999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=397.53 Aligned_cols=263 Identities=40% Similarity=0.804 Sum_probs=230.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999875444455567788899998866 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~------------ 148 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL------------ 148 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+..+..
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 149 ---------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred ---------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01112345799999999999988999999999999999999999999999999999998888765
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChh----hHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN----GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad----eA~EIL~HPwFk~id~d~L~~q 985 (1044)
.+| ..++.++.+||.+||+.||.+||+.. .+.++++||||..++|..+...
T Consensus 214 ~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~ 268 (321)
T cd05591 214 LYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQR 268 (321)
T ss_pred CCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence 443 56899999999999999999999432 3889999999999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=399.35 Aligned_cols=297 Identities=46% Similarity=0.835 Sum_probs=237.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+|++..+|+.||+|++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998754444456678899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC-
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL- 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl- 845 (1044)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874321110000
Q ss_pred -CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 -SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 -s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
.........+....................||+.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 0000000000000000000011122345679999999999999999999999999999999999999999998888888
Q ss_pred hhhc--cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 925 NILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 925 kIl~--g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
++.. ....++.. ..+++++.+||.+||. ||.+||+ .+.++++||||++++|+......+
T Consensus 241 ~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~ 301 (350)
T cd05573 241 KIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLG--SFEEIKSHPFFKGIDWENLRETKP 301 (350)
T ss_pred HHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCC
Confidence 7776 33333322 2379999999999997 9999998 245779999999999987764443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=398.16 Aligned_cols=262 Identities=42% Similarity=0.793 Sum_probs=229.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
+.||+|+||.||++.+..+|+.||+|++++...........+.+|+.++..++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998754444455677889999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 773 SL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
+|.+++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~------------ 148 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK------------ 148 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC------------
Confidence 999999888889999999999999999999997 7999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 149 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred ---------------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 00112245799999999999988999999999999999999999999999888888887776665
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 984 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~ 984 (1044)
.+ +..+++++.+||.+||+.||.+|++. ..+.++++||||.++.|.....
T Consensus 214 ~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~ 265 (325)
T cd05594 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYE 265 (325)
T ss_pred CC---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 54 46789999999999999999999831 1288999999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=395.98 Aligned_cols=263 Identities=42% Similarity=0.831 Sum_probs=227.9
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHH-HHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~-ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999999999999999997644333444456666665 45789999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE------------ 148 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 149 ---------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred ---------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01112345799999999999998999999999999999999999999999988888888877654
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCCh-hhHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa-deA~EIL~HPwFk~id~d~L~~q 985 (1044)
.. +..+++.+.+||.+||+.||.+||++ ..+.+++.||||..++|..+...
T Consensus 214 ~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~ 265 (323)
T cd05575 214 RL---KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNK 265 (323)
T ss_pred CC---CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhc
Confidence 43 35789999999999999999999995 35679999999999999887544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=402.67 Aligned_cols=296 Identities=46% Similarity=0.767 Sum_probs=232.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++++.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++.|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997644433445567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999997532100000000
Q ss_pred CC----CCCCCCCCCCC------------CCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhC
Q 001614 847 GP----ETDGIMPSDAH------------YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1044)
Q Consensus 847 ~p----~t~~~~~s~s~------------~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTG 910 (1044)
.. ......+.... ...............+||+.|||||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 00000000000 000000001112346899999999999998999999999999999999999
Q ss_pred CCCCCCCChHHHHHhhhccCCCCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhH
Q 001614 911 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~ 983 (1044)
+.||.+.++.+....+......... ....+++++.+||.+|+ .+|.+|++...+.++++||||++++|..+.
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 9999998887776666544322211 12468999999999987 599999944348899999999999988764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=401.23 Aligned_cols=292 Identities=44% Similarity=0.736 Sum_probs=230.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|++++.||+|+||+||+|++..+++.||+|++++...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987555555566789999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC--
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL-- 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl-- 845 (1044)
|++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999863211100000
Q ss_pred CCC--CCCCCCCCC-----C------CC-----CcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHH
Q 001614 846 SGP--ETDGIMPSD-----A------HY-----PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1044)
Q Consensus 846 s~p--~t~~~~~s~-----s------~~-----~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYEL 907 (1044)
.+. ......+.. . .. ..............+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 000 000000000 0 00 00000001112346899999999999988899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHhhhccC--CCCCCCCCCCCHHHHHHHHhHcc--CCcCCCCChhhHHHHHcCCCCCCCCcchhH
Q 001614 908 ITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLI--HDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1044)
Q Consensus 908 LTGr~PF~g~s~~ei~qkIl~g~--i~~p~ip~~iS~eLkdLIkkcLq--kDPskRPSadeA~EIL~HPwFk~id~d~L~ 983 (1044)
++|..||...+..+....+.... ..++ ....+++++.+||.+|+. .+|..|++ +.+++.||||.+++|....
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~~~ 317 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSSDI 317 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhHHh
Confidence 99999999888777666665432 2222 123589999999999664 45555999 8899999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=393.76 Aligned_cols=266 Identities=41% Similarity=0.778 Sum_probs=230.0
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHH---HhcCCCceEEEeeeeecCCeeEEE
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL---ITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~IL---s~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
|++.+.||+|+||.||+|.+..+|+.||+|++++.........+.+.+|..++ ..++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865443444556777777765 466799999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||++||+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~------ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG------ 153 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC------
Confidence 999999999988864 5699999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 154 ---------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~ 212 (324)
T cd05589 154 ---------------------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212 (324)
T ss_pred ---------------------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01112346799999999999998999999999999999999999999999988888888
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhh
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~q 985 (1044)
+......+ |..+++.+.+||.+||+.||.+||++. .+.++++||||++++|..+...
T Consensus 213 i~~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~ 271 (324)
T cd05589 213 IVNDEVRY---PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLAR 271 (324)
T ss_pred HHhCCCCC---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhC
Confidence 87776543 467899999999999999999999642 3889999999999998876543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=421.97 Aligned_cols=256 Identities=36% Similarity=0.631 Sum_probs=236.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.|... .+.+...+.+|++|++.++|||||.++++|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3679999999999999999999999999999999987543 345678899999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
+|||.| +|+.+|...+.++++.++.++.|++.||.|||+++|+|||+||.|||++..|.+|+||||+|+....+
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~----- 153 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN----- 153 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-----
Confidence 999987 99999999999999999999999999999999999999999999999999999999999999853221
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
......+.|||.|||||++.+++|+..+|+||||||+|||++|++||...+.-+....
T Consensus 154 ----------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~ 211 (808)
T KOG0597|consen 154 ----------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS 211 (808)
T ss_pred ----------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence 2234567899999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
|+.....|| ...+..+.+|++.+|.+||.+|++ ..+++.|||.++
T Consensus 212 I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 212 ILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred HhcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 999988776 589999999999999999999999 889999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=406.53 Aligned_cols=261 Identities=40% Similarity=0.669 Sum_probs=237.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~Ly 763 (1044)
....|++.+.||.|.||.||+++.+.||+.||+|++.+...........+.+|+.+|+++. |||||.++++|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567999999999999999999999999999999999877665556788999999999999 999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC----CcEEEeecCCcccccc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded----g~VKLsDFGLAki~~~ 839 (1044)
+|||+|.||.|++.+... .+++..+..++.||+.|++|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~- 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK- 190 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc-
Confidence 999999999999999876 49999999999999999999999999999999999999643 479999999998521
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
........+|||.|+|||++....|+..+||||+||++|.|++|.+||.+.+.
T Consensus 191 ---------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 191 ---------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ---------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 12345678999999999999989999999999999999999999999999999
Q ss_pred HHHHHhhhccCCCCCCC-CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 920 EIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~i-p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
...+.+|..+.+.++.. ++.++..+++||.+||..||.+|+| +.++|+|||+++.
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 99999999998877653 4578999999999999999999999 8888999999875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=394.12 Aligned_cols=268 Identities=38% Similarity=0.787 Sum_probs=234.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLVm 766 (1044)
+|++.+.||+|+||.||+|.++.+|+.||+|++++...........+..|..++..+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998654434445667888999998886 577888999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-------
Confidence 9999999999999888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 154 --------------------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred --------------------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001123457999999999999889999999999999999999999999999988888888
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~q 985 (1044)
......+ |..++.++.+|+.+||+.||.+|++.. ...++++||||+.++|..+...
T Consensus 214 ~~~~~~~---p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~ 271 (323)
T cd05615 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENR 271 (323)
T ss_pred HhCCCCC---CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence 8776544 467899999999999999999999853 3679999999999999887654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=406.43 Aligned_cols=258 Identities=31% Similarity=0.504 Sum_probs=224.0
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcE-EEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~-VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
..+...++.+.+.||.|+||+||+|.|. |.. ||+|++......... ...|.+|+.+|.+++|||||+++|++..+.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3455667778888999999999999998 777 999999764433333 779999999999999999999999999988
Q ss_pred -eeEEEEeeccccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-eeeccCCCCceeecCCC-cEEEeecCCcc
Q 001614 761 -NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAHDG-HIKLTDFGLSK 835 (1044)
Q Consensus 761 -~LyLVmEY~~GGSL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~G-IIHRDLKPeNILLdedg-~VKLsDFGLAk 835 (1044)
.+++|||||++|+|.++++. ...++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 578999999999999999999999999 99999999999999998 99999999997
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc--CCCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~--g~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
...... .......||+.|||||++. ...|+.++||||||+++|||+||+.|
T Consensus 193 ~~~~~~---------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 193 EKVISK---------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred eecccc---------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 521100 1222368999999999999 56899999999999999999999999
Q ss_pred CCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|.+..+..+...+..+..+ |.+|..+++.+..||..||..||.+||++.++...|.
T Consensus 246 f~~~~~~~~~~~v~~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 9999987766666655544 6677789999999999999999999999888777765
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=394.80 Aligned_cols=263 Identities=38% Similarity=0.795 Sum_probs=224.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||++++..+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875444444567788999999988 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~------------- 147 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI------------- 147 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986210
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---------ChHHH
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 922 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~---------s~~ei 922 (1044)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 148 --------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred --------------cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 0011223457999999999999989999999999999999999999999632 12234
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh---hHHHHHcCCCCCCCCcchhHhh
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad---eA~EIL~HPwFk~id~d~L~~q 985 (1044)
...+...... +|..++..+.+||.+||+.||.+|+++. .+.++++||||+.++|..+...
T Consensus 214 ~~~~~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~ 276 (329)
T cd05588 214 FQVILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQK 276 (329)
T ss_pred HHHHHcCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhC
Confidence 4455555443 4467899999999999999999999853 3789999999999999877543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=391.84 Aligned_cols=261 Identities=41% Similarity=0.818 Sum_probs=225.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHh-cCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~-L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|++..+++.||+|++++...........+..|..++.. .+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999986443334445566777777765 4899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~------------ 148 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 149 ---------------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 00122345799999999999988899999999999999999999999999988888887766543
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
.++..++.++.+||.+||..||.+||++ ..+++.||||+.++|..+...
T Consensus 214 ---~~~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~ 262 (316)
T cd05592 214 ---HFPRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKR 262 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhC
Confidence 3456789999999999999999999983 247889999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=394.18 Aligned_cols=268 Identities=41% Similarity=0.756 Sum_probs=230.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++.++.+|+.||+|++++...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998754434445677889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---- 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK---- 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC----
Confidence 999999999999876 679999999999999999999999999999999999999999999999999986421100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~------g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
........||+.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 157 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 157 ----------------------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ----------------------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 00112347999999999986 45678899999999999999999999998888
Q ss_pred HHHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 920 EIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 920 ~ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
...+.++..... .++. ...+++++.+||.+||+ +|.+||+ +.+++.||||..++|..+...
T Consensus 215 ~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~~~~ 277 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNIRNS 277 (330)
T ss_pred HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHHhhC
Confidence 888777765432 2222 23578999999999998 9999999 778999999999999877543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=391.00 Aligned_cols=263 Identities=40% Similarity=0.836 Sum_probs=229.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||+||+|.+..+++.||+|++++...........+.+|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999875444445567788899999888 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------------ 148 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL------------ 148 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc------------
Confidence 99999998888899999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 149 ---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 149 ---------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred ---------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 00112235799999999999999999999999999999999999999999888888888777665
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
.+ +..++..+.+||.+||..||.+||++ ..+.+++.||||+..+|......
T Consensus 214 ~~---~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~ 266 (318)
T cd05570 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERK 266 (318)
T ss_pred CC---CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 43 46789999999999999999999993 12289999999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=396.12 Aligned_cols=339 Identities=20% Similarity=0.275 Sum_probs=299.4
Q ss_pred cCCCCCCCCCCccccccccCCchhhHHHhhchHHHHHHHhhccccccccChHhHHHhhchhHHHhhhcccccccccchhh
Q 001614 548 VSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGS 627 (1044)
Q Consensus 548 ~~~~~~p~~~h~~~~~~~~~~~~~~~d~~~~~~l~~~a~~~~~t~l~k~~~~~l~~~l~~l~~~~~~~~~~~~~id~fG~ 627 (1044)
--+-||| -|||||| ||+++||||+..||+|.||||+|.|||+|+ ++.|...|.++++.+||+..++.++|
T Consensus 97 nehgntp--lhyacfw---gydqiaedli~~ga~v~icnk~g~tpldka-kp~l~~~l~e~aek~gq~~nripfkd---- 166 (448)
T KOG0195|consen 97 NEHGNTP--LHYACFW---GYDQIAEDLISCGAAVNICNKKGMTPLDKA-KPMLKNTLLEIAEKHGQSPNRIPFKD---- 166 (448)
T ss_pred hccCCCc--hhhhhhh---cHHHHHHHHHhccceeeecccCCCCchhhh-chHHHHHHHHHHHHhCCCCCcccccc----
Confidence 3445666 6999999 999999999999999999999999999999 99999999999999999999999999
Q ss_pred HHHHHhhhhHHHHhhhhccCCCCccccccccchhhhcccccCCCCCCCCCCCccccccCCCeEEEEeeccCCceEEEEEE
Q 001614 628 RIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 707 (1044)
Q Consensus 628 ri~kllr~~~~l~~~lL~~ksp~sfS~~~ens~llldsls~~s~~~~p~~ss~~~~~si~dY~Ilk~LG~GgFG~VYka~ 707 (1044)
..|.+.+++++....+...++...+..++.+|.+...|+.|+|+
T Consensus 167 ------------------------------------t~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgr 210 (448)
T KOG0195|consen 167 ------------------------------------TTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGR 210 (448)
T ss_pred ------------------------------------cccccccccccccccccccCcchhhhhhhhhhccCCCccccccc
Confidence 56777777778777778888889999999999999999999999
Q ss_pred ECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHHHhcCC--CC
Q 001614 708 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LE 785 (1044)
Q Consensus 708 ~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~--Ls 785 (1044)
|+ |..+++|++.- +.......+.|..|+..|+.+.||||+++++.|..+.++.+|..||+.|+|++++++... ++
T Consensus 211 wq--gndivakil~v-r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd 287 (448)
T KOG0195|consen 211 WQ--GNDIVAKILNV-REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVD 287 (448)
T ss_pred cc--Ccchhhhhhhh-hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEe
Confidence 98 77888898853 445566678899999999999999999999999999999999999999999999987654 68
Q ss_pred HHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceeecCCCcEEEe--ecCCcccccccCcccCCCCCCCCCCCCCCCCC
Q 001614 786 EDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLT--DFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861 (1044)
Q Consensus 786 ee~ar~Ia~QIL~ALaYLHs~G--IIHRDLKPeNILLdedg~VKLs--DFGLAki~~~~~t~dls~p~t~~~~~s~s~~~ 861 (1044)
..++..++.+|++|++|||+.. |...-|....++||++.+.+|+ |-.++.
T Consensus 288 ~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-------------------------- 341 (448)
T KOG0195|consen 288 HSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------------------------- 341 (448)
T ss_pred cchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------------------------
Confidence 8899999999999999999975 5566799999999999887765 444432
Q ss_pred cccccCcCCccCccCCCCCCCcccccCCCCC---chhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCC
Q 001614 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPS 938 (1044)
Q Consensus 862 e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys---~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~ 938 (1044)
+.......|.||+||.+...+-+ .++|+|||++++|||.|...||.+.+++++..+|...+++ +.+|+
T Consensus 342 --------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr-v~ipp 412 (448)
T KOG0195|consen 342 --------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR-VHIPP 412 (448)
T ss_pred --------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc-ccCCC
Confidence 12234578999999999876543 4899999999999999999999999999999999988877 66889
Q ss_pred CCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 939 ~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+++.++..||+.|++.||.+||.++++..||+
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 99999999999999999999999999888775
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=390.21 Aligned_cols=270 Identities=46% Similarity=0.849 Sum_probs=225.8
Q ss_pred CeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-ChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCee
Q 001614 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k---~tGk~VAVKiIkK~~~~-~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~L 762 (1044)
+|++.+.||+|+||.||++++. .+|+.||+|++.+.... .......+.+|+.++..+. ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999764322 2234567889999999994 89999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-- 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-- 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCC----
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---- 917 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~---- 917 (1044)
........+||+.|||||++.+. .++.++|||||||++|+|++|..||...
T Consensus 159 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 159 ------------------------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred ------------------------CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 01112245799999999999865 4788999999999999999999999643
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhhh
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~qk 986 (1044)
....+...+..... .++..+++.+.+||.+||+.||.+||++. .+.++++||||++.+|..+...+
T Consensus 215 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~ 282 (332)
T cd05614 215 TQSEVSRRILKCDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRK 282 (332)
T ss_pred CHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 23344444544433 34467899999999999999999999654 58999999999999998876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=390.97 Aligned_cols=261 Identities=38% Similarity=0.778 Sum_probs=224.6
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999864333334456677888888754 899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999998762100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 149 ---------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred ---------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 00112345799999999999998999999999999999999999999999888888887766543
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
. .+..++.++++||.+||..||.+||++. .++++||||+.++|..+...
T Consensus 214 ~---~~~~~~~~~~~li~~~l~~dP~~R~~~~--~~~~~h~~f~~~~~~~~~~~ 262 (316)
T cd05620 214 H---YPRWITKESKDILEKLFERDPTRRLGVV--GNIRGHPFFKTINWTALEKR 262 (316)
T ss_pred C---CCCCCCHHHHHHHHHHccCCHHHcCCCh--HHHHcCCCcCCCCHHHHHhC
Confidence 3 4467899999999999999999999931 36889999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=393.00 Aligned_cols=264 Identities=39% Similarity=0.792 Sum_probs=228.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHH-HHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~-ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||+||+|.++.+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999999999999999997644333444556666665 46779999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~------------ 148 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA------------ 148 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++++.+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 149 ---------------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred ---------------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 01112345799999999999998999999999999999999999999999988888888877654
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChh-hHHHHHcCCCCCCCCcchhHhhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad-eA~EIL~HPwFk~id~d~L~~qk 986 (1044)
.+ +...+..+.++|.+||+.||.+||++. .+.+++.||||++.+|..+...+
T Consensus 214 ~~---~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 266 (325)
T cd05604 214 VL---RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKK 266 (325)
T ss_pred cC---CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 43 356889999999999999999999953 57799999999999998776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=390.60 Aligned_cols=263 Identities=46% Similarity=0.876 Sum_probs=226.7
Q ss_pred EeeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-ChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 693 KPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k---~tGk~VAVKiIkK~~~~-~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
+.||+|+||.||++++. .+++.||+|++++.... .......+.+|+.+|+.++||||++++++|...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999874 46889999999764322 123345678999999999999999999999999999999999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCC
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p 848 (1044)
+++|+|.+++...+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--------- 152 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--------- 152 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc---------
Confidence 99999999999888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhc
Q 001614 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928 (1044)
Q Consensus 849 ~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~ 928 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 153 ------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred ------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 01112345799999999999988899999999999999999999999999988888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC--hhhHHHHHcCCCCCCCCcchhHhh
Q 001614 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 929 g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS--adeA~EIL~HPwFk~id~d~L~~q 985 (1044)
+...+ +..+++++.+||.+||+.||.+||+ ...+.+++.||||+..+|..+...
T Consensus 215 ~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~ 270 (323)
T cd05584 215 GKLNL---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270 (323)
T ss_pred CCCCC---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcC
Confidence 76543 4678999999999999999999993 122889999999999999877543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=377.74 Aligned_cols=258 Identities=34% Similarity=0.490 Sum_probs=214.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+|+++.+++.||+|+++... ........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999999999999999987543 22334567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++++.|..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------ 153 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG------ 153 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc------
Confidence 99999877766655567999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
.........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 154 --------------------SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred --------------------ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001112356899999999999888999999999999999999999999887654433322
Q ss_pred hccC-------------------CCCCC----------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 927 LNRK-------------------IPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 927 l~g~-------------------i~~p~----------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.... ..++. ....+|.++.+||++||+.||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 2110 01110 01236888999999999999999999 7889999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=392.61 Aligned_cols=263 Identities=40% Similarity=0.806 Sum_probs=223.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|++..+++.||+|++++...........+.+|..++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875444445566788899988776 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~------------ 148 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR------------ 148 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---------ChHHH
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 922 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~---------s~~ei 922 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||... .....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 149 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 011123457999999999999999999999999999999999999999521 12234
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh---hHHHHHcCCCCCCCCcchhHhh
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad---eA~EIL~HPwFk~id~d~L~~q 985 (1044)
...+...... +|..++..+.+||.+||+.||.+||++. .+.++++||||++++|+.+...
T Consensus 214 ~~~i~~~~~~---~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~ 276 (329)
T cd05618 214 FQVILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQK 276 (329)
T ss_pred HHHHhcCCCC---CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcC
Confidence 4555555443 4467899999999999999999999842 3578999999999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=392.24 Aligned_cols=262 Identities=44% Similarity=0.801 Sum_probs=229.3
Q ss_pred EeeccCCceEEEEEEE---CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeec
Q 001614 693 KPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~---k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~ 769 (1044)
+.||+|+||.||++++ ..+|+.||+|++++... .......+.+|+.+|++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999886 35789999999976432 2234456788999999999999999999999999999999999
Q ss_pred cccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCC
Q 001614 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1044)
Q Consensus 770 ~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~ 849 (1044)
++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---------- 150 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID---------- 150 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC----------
Confidence 9999999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhcc
Q 001614 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (1044)
Q Consensus 850 t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g 929 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 151 -----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 151 -----------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred -----------------CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 001123457999999999999888999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhh--HHHHHcCCCCCCCCcchhHhh
Q 001614 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 930 ~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSade--A~EIL~HPwFk~id~d~L~~q 985 (1044)
...+ |..+++++.+||.+||+.||.+||++.+ +.+++.||||..++|..+...
T Consensus 214 ~~~~---p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T cd05582 214 KLGM---PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR 268 (318)
T ss_pred CCCC---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhc
Confidence 6543 4678999999999999999999999877 899999999999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=393.82 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=218.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
++.|+.+.++|+|+||+||+|+++.||+.||||.+... ..++...+-.++|+++|++++|||+|.++++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 35688899999999999999999999999999999653 33455556789999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
+|||+..-|..+-+-...++.+.++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~------ 153 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA------ 153 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC------
Confidence 99998844444433445699999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
+.......+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+.+.-+.+-
T Consensus 154 ---------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 154 ---------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred ---------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 1223345678999999999998 789999999999999999999999999988755544
Q ss_pred hhhc--------------c-----CCCCCCC---------CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 925 NILN--------------R-----KIPWPCV---------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 925 kIl~--------------g-----~i~~p~i---------p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
.|.. . ++.+|.. .+.++.-+.+|+++||..||.+|++ ..++|.||||.+
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~yFd~ 289 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcChHHHH
Confidence 4332 1 1112221 1356778899999999999999999 889999999965
Q ss_pred C
Q 001614 977 V 977 (1044)
Q Consensus 977 i 977 (1044)
+
T Consensus 290 ~ 290 (396)
T KOG0593|consen 290 F 290 (396)
T ss_pred H
Confidence 4
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=390.45 Aligned_cols=263 Identities=42% Similarity=0.815 Sum_probs=226.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHH-HHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~-ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999997644333333445555554 56789999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~------------ 148 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE------------ 148 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05602 149 ---------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213 (325)
T ss_pred ---------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc
Confidence 01112345799999999999998999999999999999999999999999988888888876654
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChh-hHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad-eA~EIL~HPwFk~id~d~L~~q 985 (1044)
.+ +..+++.+.+||.+||+.||.+||++. ...++++|+||..++|+.+...
T Consensus 214 ~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~ 265 (325)
T cd05602 214 QL---KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINK 265 (325)
T ss_pred CC---CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhC
Confidence 43 357899999999999999999999954 5679999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=388.85 Aligned_cols=263 Identities=41% Similarity=0.824 Sum_probs=227.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHH-HHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~-ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999997644333444555666665 57889999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE------------ 148 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999998863100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 149 ---------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred ---------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 00112345799999999999988899999999999999999999999999988888888877654
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCCh-hhHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa-deA~EIL~HPwFk~id~d~L~~q 985 (1044)
. .+...+..+.++|.+||+.||.+||++ .++.++++||||..++|..+...
T Consensus 214 ~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T cd05603 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHK 265 (321)
T ss_pred C---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcC
Confidence 4 346788999999999999999999985 45789999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=398.28 Aligned_cols=270 Identities=41% Similarity=0.746 Sum_probs=230.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45679999999999999999999999999999999997644434445566889999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~--- 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN--- 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC---
Confidence 999999999999998654 5889999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 196 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 196 -----------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred -----------------------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 00112345799999999998753 378899999999999999999999999988
Q ss_pred HHHHHhhhccCCC--CCCCCCCCCHHHHHHHHhHccCCcCC--CCChhhHHHHHcCCCCCCCCcchhHh
Q 001614 920 EIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLAL 984 (1044)
Q Consensus 920 ~ei~qkIl~g~i~--~p~ip~~iS~eLkdLIkkcLqkDPsk--RPSadeA~EIL~HPwFk~id~d~L~~ 984 (1044)
...+.++...... ++. ...+|.++++||.+||+.+|.+ |++ +.++++||||++.+|.....
T Consensus 253 ~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~~~~ 317 (370)
T cd05596 253 VGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTFDNI 317 (370)
T ss_pred HHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhhHHh
Confidence 8888888765432 232 2357999999999999999988 999 88999999999988875443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=444.70 Aligned_cols=285 Identities=42% Similarity=0.773 Sum_probs=254.7
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
..+...++|.+++.||+|+||.|.+++++.|++.||+|++.|-.+....+..-|..|..+|..-+.+.|++++.+|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34567789999999999999999999999999999999999877776777788999999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
++|+|||||+||+|-.++.+...+++..+++|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+..+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999987532211
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
. .......+|||.|++||+|.. +.|+..+||||+||++|||+.|..||+
T Consensus 229 G--------------------------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 229 G--------------------------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred C--------------------------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 1 223456799999999999952 568999999999999999999999999
Q ss_pred CCChHHHHHhhhcc--CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhccccchh
Q 001614 916 AESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSY 993 (1044)
Q Consensus 916 g~s~~ei~qkIl~g--~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~~~~s~ 993 (1044)
..+..+.+.+|+.. .+.||. ...+|.++++||.+++. +|..|.+-+++.++..||||.+++|+.+--..+|..+.+
T Consensus 283 adslveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 99999999999987 455662 24699999999999886 699999999999999999999999998876666655543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=389.09 Aligned_cols=261 Identities=39% Similarity=0.779 Sum_probs=224.3
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHh-cCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~-L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||+||+|++..+++.||+|++++...........+..|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999976433223345667778888876 4899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC------------
Confidence 99999998878899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 149 ---------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred ---------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 00112345799999999999998999999999999999999999999999888888877765543
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
. .+..++.++++||.+||+.||.+||++. .+++.||||+.++|..+...
T Consensus 214 ~---~~~~~~~~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~ 262 (316)
T cd05619 214 C---YPRWLTREAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWSALEER 262 (316)
T ss_pred C---CCccCCHHHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHHHHHhC
Confidence 3 3456899999999999999999999932 37899999999999876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=389.14 Aligned_cols=270 Identities=41% Similarity=0.773 Sum_probs=229.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997644334444566889999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~---- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.......+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..
T Consensus 157 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 157 ----------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ----------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 01112357999999999986 346788999999999999999999999999988
Q ss_pred HHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCC--CCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 921 IIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 921 ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPsk--RPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
+.+.++..... ++|.....+++++++||.+||..++.+ |++ +.++++||||.+++|+.+...
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~---~~~~~~h~~f~~~~~~~~~~~ 280 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG---IEDFKQHPFFTGIDWDNIRNC 280 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCC---HHHHhCCCCcCCCCHHHHhhC
Confidence 88888876543 344444578999999999999765544 466 889999999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=389.97 Aligned_cols=264 Identities=39% Similarity=0.789 Sum_probs=225.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||+|+||.||+|++..+++.||+|++++...........+.+|..++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875444445567788999999888 599999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------ 148 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG------------ 148 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-------ChHHHHH
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEIIFD 924 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~-------s~~ei~q 924 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||... .......
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 149 ---------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred ---------------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 011123457999999999999999999999999999999999999999532 2234445
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh---hHHHHHcCCCCCCCCcchhHhhh
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad---eA~EIL~HPwFk~id~d~L~~qk 986 (1044)
.+.....+ +|..++..+.++|.+||+.||.+|+++. .+.+++.||||++++|+.+....
T Consensus 214 ~~~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 275 (327)
T cd05617 214 VILEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQ 275 (327)
T ss_pred HHHhCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCC
Confidence 55444433 4467899999999999999999999852 46799999999999999876443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.96 Aligned_cols=270 Identities=43% Similarity=0.805 Sum_probs=227.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998644444455677889999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986321100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.......+||+.|||||++.. ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 157 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 157 ----------------------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ----------------------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 001123469999999999863 45788999999999999999999999998888
Q ss_pred HHHHhhhccC--CCCCCCCCCCCHHHHHHHHhHccCCcCC--CCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 921 ei~qkIl~g~--i~~p~ip~~iS~eLkdLIkkcLqkDPsk--RPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
+.+..+.... ..++.....+++++++||.+||..++.+ |++ +.++++||||.+.+|..+...
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~---~~~~l~hp~~~~~~~~~~~~~ 280 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG---LQDFKDHPFFEGIDWDNIRNS 280 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCCCCCCCCHHHHhhC
Confidence 8777776543 2333334568999999999999753333 556 889999999999999887543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.04 Aligned_cols=263 Identities=32% Similarity=0.615 Sum_probs=220.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||+|+||+||++.++.+|+.||+|.+.+...........+..|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998764433334456788999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCC
Q 001614 775 YSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1044)
Q Consensus 775 ~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t 850 (1044)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 988743 346899999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHhh
Q 001614 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNI 926 (1044)
Q Consensus 851 ~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~----~ei~qkI 926 (1044)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. ......+
T Consensus 151 -----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 151 -----------------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred -----------------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 0112235789999999999999999999999999999999999999976543 2333344
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhhhc
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
..... ..+..+++++.+|+.+||+.||.+||++. .+.++++||||++++|..+.....
T Consensus 214 ~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~ 273 (280)
T cd05608 214 LNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGML 273 (280)
T ss_pred cccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccC
Confidence 33332 23467899999999999999999999643 388999999999999998755433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=397.27 Aligned_cols=261 Identities=35% Similarity=0.600 Sum_probs=221.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC--eeE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NLY 763 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--~Ly 763 (1044)
..+|...+.||+|+||.||++.+..+|..+|||.+.... ....+.+.+|+.+|.+++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999999999999886531 122677899999999999999999999865555 599
Q ss_pred EEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLAki~~~~~ 841 (1044)
++|||+++|+|.+++.+.+ .+++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999877 7999999999999999999999999999999999999999 79999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCC-CCh
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA-ESP 919 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g-~s~ 919 (1044)
............|||.|||||++.++ ....++|||||||++.||+||..||.. ...
T Consensus 171 ----------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 171 ----------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred ----------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 00011223457899999999999863 234599999999999999999999988 455
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
....-.+.... ..|.+|..+|+++++||.+|+.+||.+||| |.++|.|||.+..
T Consensus 229 ~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 229 AEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 55455555444 346788999999999999999999999999 8899999999763
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=390.94 Aligned_cols=262 Identities=44% Similarity=0.807 Sum_probs=226.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc---CCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L---~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
||+|+||+||+|++..+|+.||+|++.+...........+..|..++..+ .||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999764444444555667788887765 699999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~------------ 148 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT------------ 148 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC------------
Confidence 99999999888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~ 930 (1044)
........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+..+.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 149 ---------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred ---------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 01112345799999999999764 48899999999999999999999999998888888887776
Q ss_pred CCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh-hhHHHHHcCCCCCCCCcchhHhh
Q 001614 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 931 i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa-deA~EIL~HPwFk~id~d~L~~q 985 (1044)
..++. ..+++++.+||.+||+.||.+||++ ..+.++++||||...+|+.+...
T Consensus 214 ~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~ 267 (330)
T cd05586 214 VRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKK 267 (330)
T ss_pred CCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhC
Confidence 65542 3578999999999999999999964 35889999999999999876543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=376.29 Aligned_cols=267 Identities=34% Similarity=0.607 Sum_probs=224.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999976433333344567889999999999999999999999999999999
Q ss_pred eccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999988654 4589999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD- 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q- 924 (1044)
.......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 155 ----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 001123478999999999998889999999999999999999999998766543322
Q ss_pred ---hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhh
Q 001614 925 ---NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 925 ---kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~q 985 (1044)
.+.... ...+..+++.+.+||.+||..||.+||+.. .+.+++.||||...+|+.+...
T Consensus 213 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 275 (285)
T cd05605 213 VERRVKEDQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAG 275 (285)
T ss_pred HHHHhhhcc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhC
Confidence 222222 223456899999999999999999999433 3889999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=387.52 Aligned_cols=272 Identities=42% Similarity=0.768 Sum_probs=229.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|..++..++||||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997644334445566889999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---- 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC----
Confidence 99999999999987 4679999999999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.......+||+.|+|||++.+ +.++.++|||||||++|+|++|+.||...+..
T Consensus 157 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 157 ----------------------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ----------------------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 001123579999999999875 46788999999999999999999999998888
Q ss_pred HHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 921 IIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 921 ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
+.+..+..... +++.....++.++++||.+||..++ +|+....+.++++||||++++|+.+...
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 280 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKHAFFEGIDWENIRNL 280 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcCCCcCCCCHHHHhhC
Confidence 88888776543 3344445679999999999998655 4543334889999999999999887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=395.92 Aligned_cols=269 Identities=40% Similarity=0.740 Sum_probs=227.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997644444445567889999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~--- 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET--- 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC---
Confidence 999999999999999654 5899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC----CCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
........+||+.|||||++.+.. ++.++|||||||++|+|++|..||.+.+.
T Consensus 196 -----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 196 -----------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred -----------------------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 001123567999999999997643 78899999999999999999999999988
Q ss_pred HHHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCC--CCChhhHHHHHcCCCCCCCCcchhH
Q 001614 920 EIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSLA 983 (1044)
Q Consensus 920 ~ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPsk--RPSadeA~EIL~HPwFk~id~d~L~ 983 (1044)
...+..+..... .+|. ...++..+++||.+||..+|.+ |++ +.++++||||+...|+...
T Consensus 253 ~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~---~~e~l~hp~~~~~~~~~~~ 316 (370)
T cd05621 253 VGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNG---VEEIKQHPFFKNDQWNWDN 316 (370)
T ss_pred HHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCC---HHHHhcCcccCCCCcChHh
Confidence 888888876543 2221 1357999999999999855543 778 8899999999987765443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=402.58 Aligned_cols=270 Identities=37% Similarity=0.667 Sum_probs=229.5
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccC-----------hhHHHHHHHHHHHHHhcCCCc
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------KNDIERILAERNILITVRNPF 748 (1044)
Q Consensus 680 ~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~-----------~~~~e~flrEi~ILs~L~HPN 748 (1044)
...+..+++|++.+.||+|.||.|-+|++..+++.||||++.+..... ...++...+|+.||++|+|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 345577899999999999999999999999999999999998643221 123468999999999999999
Q ss_pred eEEEeeeeecC--CeeEEEEeeccccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCc
Q 001614 749 VVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (1044)
Q Consensus 749 IVkL~gvfed~--~~LyLVmEY~~GGSL~dlLkk~g~-Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~ 825 (1044)
||+|+++..++ +.+|||+|||..|.+...- .... +++.+++.|+++++.||+|||.+|||||||||+|+||+++|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999999886 4699999999999875432 2333 899999999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC----CCchhhhHHHH
Q 001614 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVG 901 (1044)
Q Consensus 826 VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~KSDIWSLG 901 (1044)
|||+|||.+..+..+. ...........+|||.|||||.+.++. .+.+.||||+|
T Consensus 249 VKIsDFGVs~~~~~~~----------------------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGS----------------------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred EEeeccceeeecccCC----------------------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 9999999886432110 001111223378999999999997732 36689999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 902 VILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
|+||.|+.|+.||-+....+++.+|.+..+.+|..+ .+.+++++||.+||.+||.+|++ +.++..|||...
T Consensus 307 VTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVTR 377 (576)
T ss_pred hhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheee---hhhheecceecc
Confidence 999999999999999999999999999998888654 68899999999999999999999 889999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=375.39 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=212.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+++|++.+.||.|+||.||+|.++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5789999999999999999999999999999999865321 22345678999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~----- 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV----- 155 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC-----
Confidence 999975 9999887654 478999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 156 ----------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred ----------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0011223468999999999875 56899999999999999999999999888766555
Q ss_pred HhhhccCC-------------------CCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNRKI-------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g~i-------------------~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+..... .++. ....+++++.+||.+||+.||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~f 288 (288)
T cd07871 214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSYF 288 (288)
T ss_pred HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCCC
Confidence 44432100 0110 11356889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=411.18 Aligned_cols=256 Identities=35% Similarity=0.583 Sum_probs=231.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|....+||+|+.|.||.+....+++.||||.+.... ....+-+++|+.+|+..+|+|||++++.|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45778889999999999999999999999999987643 233467899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|||+||+|.|++... .++|.+++.+++++++||+|||.+||||||||.+|||++.+|.+||+||||+..+.
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~-------- 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS-------- 420 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc--------
Confidence 999999999998654 49999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
....+..+.+|||+|||||++....|++++||||||++++||+-|.+||-..++-..+..|
T Consensus 421 -------------------~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 421 -------------------EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred -------------------cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 1122556789999999999999999999999999999999999999999999998888888
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
...+.+-...+..+|+.+++|+.+||+.||.+|++ |.++|.||||+.
T Consensus 482 a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 482 ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLKM 528 (550)
T ss_pred hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhhh
Confidence 88877766677899999999999999999999999 889999999953
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=380.26 Aligned_cols=263 Identities=30% Similarity=0.487 Sum_probs=212.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-----Cee
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----DNL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~-----~~L 762 (1044)
+|++.+.||+|+||.||+|.+..+|..||+|.++... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999986422 2233456788999999999999999999987543 258
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987321000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 158 -----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 158 -----------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred -----------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 00011134579999999999876 57899999999999999999999999876543
Q ss_pred HHHHhhhc--------------------------cC--CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 921 IIFDNILN--------------------------RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 921 ei~qkIl~--------------------------g~--i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
.....+.. .. .++....+.+++.+.+||.+||+.||.+||| +.++|+||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l~hp 291 (338)
T cd07859 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEALADP 291 (338)
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHhcCc
Confidence 32211110 00 0111112356788999999999999999999 88999999
Q ss_pred CCCCCCc
Q 001614 973 FFKGVNW 979 (1044)
Q Consensus 973 wFk~id~ 979 (1044)
||+++..
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9988654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=392.00 Aligned_cols=249 Identities=30% Similarity=0.548 Sum_probs=222.4
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEee-eeecCCe
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRDN 761 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~g-vfed~~~ 761 (1044)
.....+|+++++||+|+||+||++.+..+|..+|.|.+. -...+.........|+.+|++|+|||||++++ .|.....
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 345678999999999999999999999999999999987 45667778889999999999999999999998 5655555
Q ss_pred -eEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--eeeccCCCCceeecCCCcEEEeecC
Q 001614 762 -LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS--LG--IVHRDLKPDNLLIAHDGHIKLTDFG 832 (1044)
Q Consensus 762 -LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs--~G--IIHRDLKPeNILLdedg~VKLsDFG 832 (1044)
++||||||.+|+|...++. ...+++..++.++.|++.||.+||+ .. |+||||||.||+++.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999863 3569999999999999999999999 45 9999999999999999999999999
Q ss_pred CcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCC
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1044)
Q Consensus 833 LAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~ 912 (1044)
|++++... .....+.+|||.||+||.+...+|+.++||||+||++|||+.-.+
T Consensus 174 L~r~l~s~---------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 174 LGRFLSSK---------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred hHhHhcch---------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 99864211 123356799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHhhhccCCCCCCCC-CCCCHHHHHHHHhHccCCcCCCCC
Q 001614 913 PFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLG 961 (1044)
Q Consensus 913 PF~g~s~~ei~qkIl~g~i~~p~ip-~~iS~eLkdLIkkcLqkDPskRPS 961 (1044)
||.+.+-.....+|..+.+ |.+| ...|.++..||..|+..||..||+
T Consensus 227 PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 227 PFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 9999999999999998865 4455 678999999999999999999998
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=392.52 Aligned_cols=271 Identities=44% Similarity=0.774 Sum_probs=228.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
....++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999764444444556788999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-- 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-- 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC--
Confidence 9999999999999998754 5899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC----CCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
........+||+.|||||++.+. .++.++|||||||++|+|++|..||.+.+
T Consensus 196 ------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 196 ------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred ------------------------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 00112346799999999999753 37889999999999999999999999999
Q ss_pred hHHHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchh
Q 001614 919 PEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1044)
Q Consensus 919 ~~ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L 982 (1044)
....+.+|..... .++. +..++..+++||..||. +|..|++...+.++++||||++..|...
T Consensus 252 ~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~ 315 (371)
T cd05622 252 LVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWE 315 (371)
T ss_pred HHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHH
Confidence 8888888876542 3332 34689999999999998 5665543334889999999998766543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=376.47 Aligned_cols=261 Identities=29% Similarity=0.518 Sum_probs=210.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||.|+||.||+|+++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875322 22234678899999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 99996 5888877654 5689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~-~ei 922 (1044)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 156 ----------------------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred ----------------------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 0011123568999999999875 4578899999999999999999999987543 222
Q ss_pred HHhhhc--cC---CCCCC------------------------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 923 FDNILN--RK---IPWPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 923 ~qkIl~--g~---i~~p~------------------------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
...+.. +. ..++. .....++++++||.+||+.||.+||| +.++|+|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~h~~ 290 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALSHEY 290 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhcCcc
Confidence 222211 00 00000 00124578999999999999999999 889999999
Q ss_pred CCCCCc
Q 001614 974 FKGVNW 979 (1044)
Q Consensus 974 Fk~id~ 979 (1044)
|+.+.+
T Consensus 291 f~~~~~ 296 (303)
T cd07869 291 FSDLPP 296 (303)
T ss_pred cccCCh
Confidence 998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=372.40 Aligned_cols=287 Identities=49% Similarity=0.882 Sum_probs=241.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987644333445667889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~- 159 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL- 159 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc-
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874221111000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
..... . ............|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+
T Consensus 160 -------~~~~~--~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 160 -------YEGHI--E--KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred -------ccccc--c--cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 00000 0 000001112346889999999998888999999999999999999999999998888888888
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
..+...++..+..++.++.+||.+||+.||.+||++..+.++|+||||.+.+|......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~ 287 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQ 287 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhc
Confidence 77766666555578999999999999999999999888999999999999999876544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=378.49 Aligned_cols=262 Identities=35% Similarity=0.664 Sum_probs=243.8
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 680 ~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
......+++|++++.||+|.||.||+|+.+.++-.||+|++.+...........+.+|++|-+.|+||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 44567889999999999999999999999999999999999998877777778899999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLk--k~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
..+||++||.++|+|+..|. ....+++..+..|++|++.|+.|+|..+||||||||+|+|++..|.+||+|||-+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999998 6678999999999999999999999999999999999999999999999999987631
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
+..+..+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...
T Consensus 175 -----------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 175 -----------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred -----------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 133556789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
+..+.+++|....+.+| ..++.++++||.+||.++|.+|++ ..+++.|||+..
T Consensus 226 ~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 99999999999887766 789999999999999999999999 889999999864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=370.45 Aligned_cols=263 Identities=32% Similarity=0.585 Sum_probs=217.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||+|+||.||++..+.+|+.||+|.+.+...........+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998754333333345567799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCC
Q 001614 775 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1044)
Q Consensus 775 ~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~ 852 (1044)
.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 99886543 488899999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHhhhc
Q 001614 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 928 (1044)
Q Consensus 853 ~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~----~ei~qkIl~ 928 (1044)
........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 148 ---------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ---------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 0011234689999999999988899999999999999999999999976432 334444443
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhh-HHHHHcCCCCCCCCcchhHhhhc
Q 001614 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG-AAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 929 g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSade-A~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
..... ....+++++++||.+||+.||.+||++.+ ..+++.||||++++|..+.....
T Consensus 213 ~~~~~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~ 270 (277)
T cd05607 213 DEVKF--EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLI 270 (277)
T ss_pred ccccc--ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcC
Confidence 33332 22468999999999999999999999643 46889999999999988765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.84 Aligned_cols=267 Identities=48% Similarity=0.888 Sum_probs=235.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++.+..+++.||+|++++...........+.+|+.++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997654444455678999999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++|+|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~------- 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------- 153 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-------
Confidence 9999999999999888899999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+
T Consensus 154 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 154 -----------------------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred -----------------------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 012346899999999998888899999999999999999999999988877777777
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhhh
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~qk 986 (1044)
..+... ++..++..++++|.+||..||.+|++. ..+.++++||||+..+|..+....
T Consensus 211 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 269 (290)
T cd05580 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRK 269 (290)
T ss_pred hcCCcc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhcc
Confidence 766544 346779999999999999999999942 248899999999999998876443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=396.63 Aligned_cols=279 Identities=38% Similarity=0.794 Sum_probs=253.8
Q ss_pred CccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeee
Q 001614 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT 757 (1044)
Q Consensus 679 s~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfe 757 (1044)
+....+...+|.++.+||+|+||+|.++..+.+.+.||||++++.-.+..++.+--+.|-++|.... -|++++++.+|+
T Consensus 341 ~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 341 SKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred CcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 3444677889999999999999999999999999999999999977777777777888999988774 689999999999
Q ss_pred cCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
+.+.+|+||||+.||+|..+|+..+.+.+..+.+|+.+|+-||-+||++|||+||||.+|||+|.+|++||+|||+++-.
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999731
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
. .......+.||||.|+|||++..++|+..+||||+||+|||||.|.+||.+.
T Consensus 501 i---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 I---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred c---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 1 1233456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC--hhhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS--adeA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
+..++++.|+.....+| ..+|.++..+++.+|.+.|.+|+. .+.-.++..||||+.++|+.+....+
T Consensus 554 DE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~ei 622 (683)
T KOG0696|consen 554 DEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREI 622 (683)
T ss_pred CHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccC
Confidence 99999999999887765 789999999999999999999988 34567899999999999999987643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.51 Aligned_cols=298 Identities=28% Similarity=0.466 Sum_probs=248.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-----cChhHHHHHHHHHHHHHhcC-CCceEEEeeeee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVR-NPFVVRFFYSFT 757 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~-----~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfe 757 (1044)
...+.|...+.||.|..+.|.++.++.+|+.+|+|++.-... .-..-.+...+|+.||+++. ||+|+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 345678888899999999999999999999999999864221 11223455678999999985 999999999999
Q ss_pred cCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
++..+++|+|.|+.|.|+|+|...-.+++..++.+++|++.|+.|||.++|+||||||+|||++++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999889999999999999999999999999999999999999999999999999999742
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC------CCCCchhhhHHHHHHHHHHHhCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g------~~ys~KSDIWSLGVILYELLTGr 911 (1044)
.+..+....||||+|+|||.+.. ..|+..+|+|++|||+|.||.|.
T Consensus 174 ----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 ----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred ----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 23445667899999999999853 46888999999999999999999
Q ss_pred CCCCCCChHHHHHhhhccCCCCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchh-------H
Q 001614 912 PPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL-------A 983 (1044)
Q Consensus 912 ~PF~g~s~~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L-------~ 983 (1044)
+||+......+++.|+.|++.|.. .+.++|..+++||.+||+.||.+|+| +.++|.||||.++-..+. .
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~~~~~~r~msP~~~ 302 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQIAQQQARQMSPVVE 302 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHHHHhcccccCCCcc
Confidence 999999999999999999988764 34689999999999999999999999 888999999965422111 1
Q ss_pred hhhccccchhhhhhhhhhhhHHHHHHHHH
Q 001614 984 LQKMTQATSYHALVKFQVDCRMIRMVATL 1012 (1044)
Q Consensus 984 ~qk~~~~~s~~~l~kfq~~~~l~~~il~l 1012 (1044)
........+.+..++|+......+++..+
T Consensus 303 ~~~~k~qt~~~aRkrFk~ail~vra~~Ri 331 (411)
T KOG0599|consen 303 VELVKDQTSERARKRFKVAILTVRAFQRI 331 (411)
T ss_pred hhhhhhhhhHHhhhheeeeeehHHHHHHH
Confidence 11122334556666777655555554443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=390.13 Aligned_cols=269 Identities=31% Similarity=0.518 Sum_probs=231.9
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~ 761 (1044)
.....++|++...||.|..++||+|+...++..||||++.-... ..+.+.+.+|+..|+.++||||++++.+|..+..
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 34567899999999999999999999999999999999975432 2347889999999999999999999999999999
Q ss_pred eEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
+|+||.||.+|++.++++.. ..++|..+..++++++.||.|||.+|-||||||+.||||+.+|.|||+|||.+..+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999999999999864 3499999999999999999999999999999999999999999999999998753211
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
+.. .......+.+|||.|||||+++. ..|+.|+||||||++..||.+|..||...
T Consensus 179 ~G~-----------------------R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 179 SGD-----------------------RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred cCc-----------------------eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 100 00111157799999999999754 57999999999999999999999999999
Q ss_pred ChHHHHHhhhccCCCCCCC-------CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 918 SPEIIFDNILNRKIPWPCV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~i-------p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
.+++++...+++..+.+.. ....+..++.+|..||++||.+||| |.++|+|+||+...
T Consensus 236 pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 236 PPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAK 300 (516)
T ss_pred ChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhcc
Confidence 9999988888887664321 1235667899999999999999999 88999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=376.86 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=219.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||+|+||.||++++..+|..||+|++... ........+.+|+.+|+.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 357899999999999999999999999999999998652 234455789999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999999888899999999999999999999986 699999999999999999999999998863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++.
T Consensus 157 -------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 157 -------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred -------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112346999999999999988999999999999999999999999766554432
Q ss_pred HhhhccC--------------------------------------------CCCCCC-CCCCCHHHHHHHHhHccCCcCC
Q 001614 924 DNILNRK--------------------------------------------IPWPCV-PSDMSFEAQDLINRFLIHDPNQ 958 (1044)
Q Consensus 924 qkIl~g~--------------------------------------------i~~p~i-p~~iS~eLkdLIkkcLqkDPsk 958 (1044)
..+.... ...+.. ...+++++++||.+||+.||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCccc
Confidence 2111000 000111 1246889999999999999999
Q ss_pred CCChhhHHHHHcCCCCCCCCcc
Q 001614 959 RLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 959 RPSadeA~EIL~HPwFk~id~d 980 (1044)
||| +.++++||||+.....
T Consensus 292 Rpt---~~ell~h~~~~~~~~~ 310 (331)
T cd06649 292 RAD---LKMLMNHTFIKRSEVE 310 (331)
T ss_pred CCC---HHHHhcChHHhhcccc
Confidence 999 8889999999865433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=395.36 Aligned_cols=318 Identities=32% Similarity=0.494 Sum_probs=264.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
.+..-|.+.+.||+|.|++|-++++.-||.+||||++.|..+. ......+++|++.|+.++|||||++|++..+...+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 4456799999999999999999999999999999999986543 445678999999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeec-CCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLd-edg~VKLsDFGLAki~~~~~ 841 (1044)
||+|+=++|+|+|||.++ ..+.+..++.|+.||+.||.|+|+..++||||||+|+.+. +-|-|||.||||+..+
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf---- 169 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF---- 169 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC----
Confidence 999999999999999765 4699999999999999999999999999999999998876 5688999999997532
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCC-chhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys-~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.+..+..+.||+..|-|||+|.|..|+ +++||||||||||.|++|++||...+..
T Consensus 170 ------------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 170 ------------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred ------------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 234567789999999999999999986 5899999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhccccchhhhhhhhh
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSYHALVKFQ 1000 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~~~~s~~~l~kfq 1000 (1044)
+.+-+|+..++..| ..++.++++||..||..||.+|.+ +++|..|+|++.++...-. . ....+.+.+..-.
T Consensus 226 ETLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~~sT--~-iPLvsr~~L~ee~ 296 (864)
T KOG4717|consen 226 ETLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRGLST--A-IPLVSRHHLPEEA 296 (864)
T ss_pred hhhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCCccc--c-CceeehhhCChHH
Confidence 99999999988755 789999999999999999999999 8899999999998754321 1 2233445555545
Q ss_pred hhhHHHHHHHHHHHHhhcHHHHHHHhhccHHHHHHHHHH
Q 001614 1001 VDCRMIRMVATLMLTLVTHLQILELRWMNAETLQSLVLV 1039 (1044)
Q Consensus 1001 ~~~~l~~~il~lm~~~~~~~qi~eLr~~~~e~l~~~~~~ 1039 (1044)
-...+++|++--|+..-+-.+..+-.+-|-.|-+++||.
T Consensus 297 Ha~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTATYfLLA 335 (864)
T KOG4717|consen 297 HATIIQQMVAGAIASEEDILRALENNEYNHITATYFLLA 335 (864)
T ss_pred HHHHHHHHhcccccCHHHHHHHHhccccchhhhHHHHHH
Confidence 556666666554443222222233333455777777664
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=391.79 Aligned_cols=255 Identities=31% Similarity=0.582 Sum_probs=236.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
-.+|++.++||+|.||+|-+++....|+.||||.|++..+.++++.-.+.+|++||+.|+||||+.+|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999999999999999999998888888999999999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||..+|.|+||+.+.+.+++..++.|++||+.|+.|+|.++++|||||.+|||+|.++++||+||||+.++.
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~------- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA------- 204 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999986431
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCC-CchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
......++||+|.|.+||+++|.+| ++.+|-|||||+||.|+.|..||.+.+-..+.+
T Consensus 205 ---------------------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 205 ---------------------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred ---------------------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 1233457899999999999999988 689999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
+|..+.+.-|. .+.++.-||+.||..||.+|.| +.++-.|=|.+
T Consensus 264 QIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWvN 307 (668)
T KOG0611|consen 264 QISRGAYREPE----TPSDASGLIRWMLMVNPERRAT---IEDIASHWWVN 307 (668)
T ss_pred HhhcccccCCC----CCchHHHHHHHHHhcCcccchh---HHHHhhhheee
Confidence 99999887554 4556889999999999999999 78888898875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=367.84 Aligned_cols=303 Identities=43% Similarity=0.785 Sum_probs=241.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|....+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999997654443346678999999999999999999999999999999999
Q ss_pred eeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 767 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||+.+++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999754 468999999999999999999999999999999999999999999999999986422111000
Q ss_pred CCCCCCCCCCC--CCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 845 LSGPETDGIMP--SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 845 ls~p~t~~~~~--s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
........... ....................||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000001111223346799999999999988899999999999999999999999998888887
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC-hhhHHHHHcCCCCCCCCcchhHhhhcccc
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQKMTQA 990 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS-adeA~EIL~HPwFk~id~d~L~~qk~~~~ 990 (1044)
+..+......++.. ..++..+.+||.+||..||.+||+ ...+.++|.||||++.+|..+....++..
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~ 308 (316)
T cd05574 241 FSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPII 308 (316)
T ss_pred HHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCC
Confidence 77777665554432 237899999999999999999999 45577899999999999998877655544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=368.15 Aligned_cols=267 Identities=35% Similarity=0.627 Sum_probs=223.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544334445667899999999999999999999999999999999
Q ss_pred eccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 999999999986443 589999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH---HH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---II 922 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~---ei 922 (1044)
........||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 155 ----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 00112347999999999999888999999999999999999999999865432 22
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHh
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLAL 984 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~ 984 (1044)
...+.... . ...+..+++++.+||.+||+.||.+|||++ .+.++++||||++++|..+..
T Consensus 213 ~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05630 213 VERLVKEV-Q-EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274 (285)
T ss_pred HHhhhhhh-h-hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhc
Confidence 22222111 1 123467889999999999999999999954 478999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=399.06 Aligned_cols=262 Identities=32% Similarity=0.513 Sum_probs=224.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--Ce
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 761 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~ 761 (1044)
...+.|+.+++||+|.||.||++++..||+.||+|.++... ..+.......+|+.||++|+||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 45678999999999999999999999999999999987532 3344566778999999999999999999988877 68
Q ss_pred eEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
+|||+|||+. +|.-++... -.|++.+++.|++||+.||+|||++||+|||||.+|||||++|.+||+|||||+++..
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~- 270 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP- 270 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC-
Confidence 9999999987 999998764 3699999999999999999999999999999999999999999999999999986321
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
.........+.|.+|.|||+|.| ..|+.++|+||.||||.||++|++.|.+.+.
T Consensus 271 -------------------------~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 271 -------------------------SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred -------------------------CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 11223556789999999999998 5799999999999999999999999999998
Q ss_pred HHHHHhhhccC-C----CCC--C-------------------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 920 EIIFDNILNRK-I----PWP--C-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 920 ~ei~qkIl~g~-i----~~p--~-------------------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
.+.+.+|..-- . .|+ . ....++..+.+|+..||..||.+|.| |.++|.|+|
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL~sey 402 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSALQSEY 402 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHhcCcc
Confidence 88887776410 0 011 1 11357888999999999999999999 888899999
Q ss_pred CCC
Q 001614 974 FKG 976 (1044)
Q Consensus 974 Fk~ 976 (1044)
|..
T Consensus 403 F~t 405 (560)
T KOG0600|consen 403 FTT 405 (560)
T ss_pred ccc
Confidence 953
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=364.26 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=207.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccccChhHHHHHHHHHHHHHhc---CCCceEEEeeeee-----
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT----- 757 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~-tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L---~HPNIVkL~gvfe----- 757 (1044)
++|++.+.||+|+||.||+|++.. +|+.||+|.++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 468899999865322 222234566777777665 6999999999875
Q ss_pred cCCeeEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
....+++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5999998753 358999999999999999999999999999999999999999999999999986
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 159 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccC----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 4210 011234568999999999988889999999999999999999999999
Q ss_pred CCChHHHHHhhhccCC-----CCC-------------------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 916 AESPEIIFDNILNRKI-----PWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 916 g~s~~ei~qkIl~g~i-----~~p-------------------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
+.+..+.+..+..... .++ .....+++.+++||.+||+.||.+||| +.++|+|
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~l~h 287 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 287 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHHhcC
Confidence 8887776666653211 010 012357888999999999999999999 8899999
Q ss_pred CCC
Q 001614 972 PFF 974 (1044)
Q Consensus 972 PwF 974 (1044)
|||
T Consensus 288 p~f 290 (290)
T cd07862 288 PYF 290 (290)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=357.31 Aligned_cols=257 Identities=60% Similarity=1.054 Sum_probs=221.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHH-HhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~IL-s~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
+.||.|+||.||+|.+..+|+.||+|++++...........+..|..++ ...+||||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999999999999999998764433333334455665554 455899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
++|.+++...+.+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....+..+..+..
T Consensus 149 ------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 149 ------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred ------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 01234588999999999888889999999999999999999999998888888877766655
Q ss_pred CCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 932 PWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 932 ~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
.++. .+..++.++.++|.+||+.||.+||++.++.+++.||||+.++|+
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 4432 334689999999999999999999998889999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=352.44 Aligned_cols=260 Identities=31% Similarity=0.503 Sum_probs=222.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc--ChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~--~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
++|.+.+.||.|++|.||++.+..+++.||+|.+...... .......+.+|+.++++++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754321 12234678899999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
..........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+......
T Consensus 159 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 159 ---------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ---------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 00001123468899999999999889999999999999999999999998877766655
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+...... +..+..++..+.+||.+||..+|.+||| +.++++||||
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 55444333 3456788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=398.00 Aligned_cols=259 Identities=32% Similarity=0.499 Sum_probs=220.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCC-e
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-N 761 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~-~ 761 (1044)
...++|.++++||.|+||.||+|+.+.+|..||||.+++. ....+ .-.-++|+..|++++ |||||++++++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K-f~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK-FYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh-hccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4567899999999999999999999999999999998763 33332 234478999999999 999999999999988 9
Q ss_pred eEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
+|+|||||+- +|+++++.+ ..|++..++.|+.||++||+|+|.+|+.||||||+|||+..+..+||+|||+|+-..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence 9999999965 999999755 569999999999999999999999999999999999999988999999999998321
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
........+-|.+|+|||+|.. +.|+.+.|||++|||++|+.+-++.|.|.+.
T Consensus 162 --------------------------SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 162 --------------------------SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred --------------------------cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 1122344578999999999875 6789999999999999999999999999988
Q ss_pred HHHHHhhhc-------------------cCCCCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 920 EIIFDNILN-------------------RKIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 920 ~ei~qkIl~-------------------g~i~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
.+.+.+|.. -.+.+|. +.+..+.++.+||.+||++||.+||| |.++|+||
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al~~p 292 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQALQHP 292 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHhcCc
Confidence 776666643 1223332 22458999999999999999999999 77889999
Q ss_pred CCCC
Q 001614 973 FFKG 976 (1044)
Q Consensus 973 wFk~ 976 (1044)
||..
T Consensus 293 ffq~ 296 (538)
T KOG0661|consen 293 FFQV 296 (538)
T ss_pred cccc
Confidence 9974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=372.90 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=208.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvf 756 (1044)
.+..++|++.+.||.|+||.||+|.+. .+++.||+|+++.. ........+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 345678999999999999999999852 34578999998642 2234456789999999999 899999999988
Q ss_pred ecCC-eeEEEEeeccccchHHHHHhc------------------------------------------------------
Q 001614 757 TCRD-NLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 781 (1044)
Q Consensus 757 ed~~-~LyLVmEY~~GGSL~dlLkk~------------------------------------------------------ 781 (1044)
...+ .+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7654 589999999999999999742
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCC
Q 001614 782 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853 (1044)
Q Consensus 782 --------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~ 853 (1044)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------ 228 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 228 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc------------
Confidence 236778888999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCC
Q 001614 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 932 (1044)
Q Consensus 854 ~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~ 932 (1044)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.........
T Consensus 229 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 229 -------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred -------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 0011123456789999999998899999999999999999997 99999876544333333333222
Q ss_pred CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 933 ~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+..+..+++.+.+||.+||+.||.+|||+.++.+.|+
T Consensus 296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2345678999999999999999999999887777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.87 Aligned_cols=271 Identities=34% Similarity=0.593 Sum_probs=225.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|+..+.||.|+||+||++.+..+++.||+|.+.+...........+.+|+.+|+.++|+||+.+++++...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876443333445667899999999999999999999999999999999
Q ss_pred eccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 99999999888653 3699999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........
T Consensus 155 ----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 155 ----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred ----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011234699999999999988899999999999999999999999987765443333
Q ss_pred hhccCCC-CCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhhh
Q 001614 926 ILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 926 Il~g~i~-~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~qk 986 (1044)
+...... ....+..++.++.+|+.+||+.||.+||++. .+.+++.|+||+.++|+.+...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCc
Confidence 3221111 1223467889999999999999999999943 26799999999999998765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=398.66 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=221.8
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
.+.+....+++++.||+|.||+||.|.|.. ...||+|.++...+ ..+.|++|+.+|++|+|+|||+++++|..++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 344455567788999999999999999973 34899999976432 3467889999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
.+|||||||+.|+|.++|+. ...+...+...++.|||+||+||+++++|||||...||||++++.+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999986 4568999999999999999999999999999999999999999999999999999432
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~ 917 (1044)
.+.+.. . ....-...|+|||++..+.++.+||||||||+||||+| |+.||.+.
T Consensus 355 d~~Y~~---------------------~-----~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 355 DDEYTA---------------------S-----EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred CCceee---------------------c-----CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 222211 0 11123467999999999999999999999999999999 99999999
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
+..+..+.+..|. ++| .|..+|+++.++|..||..+|++||||+.....+...|
T Consensus 409 sn~ev~~~le~Gy-Rlp-~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 409 SNEEVLELLERGY-RLP-RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CHHHHHHHHhccC-cCC-CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 9999998876654 444 46889999999999999999999999887766665443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.33 Aligned_cols=265 Identities=62% Similarity=1.126 Sum_probs=227.7
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||.|+||.||++.+..+|+.||+|++.............+.+|+.++++++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999765444445667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCC
Q 001614 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1044)
Q Consensus 775 ~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~ 854 (1044)
.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998878899999999999999999999999999999999999999999999999999874211110000
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCC
Q 001614 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (1044)
Q Consensus 855 ~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p 934 (1044)
...........+++.|+|||.+....++.++||||||+++|+|++|..||........+..+..+...++
T Consensus 152 ----------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 152 ----------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred ----------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 0001122345688999999999888889999999999999999999999999888888888877666554
Q ss_pred CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCc
Q 001614 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1044)
Q Consensus 935 ~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~ 979 (1044)
.. ..++..+.+||.+||+.+|.+|||+..+.++|+||||++++|
T Consensus 222 ~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 32 235899999999999999999999877799999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.56 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=205.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc---CCCceEEEeeeeecC-----
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L---~HPNIVkL~gvfed~----- 759 (1044)
+|++.+.||+|+||.||+|.++.+|+.||+|.++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48999999999999999999999999999999865321 112223455677776655 799999999988653
Q ss_pred CeeEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
..+++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 899988764 34899999999999999999999999999999999999999999999999998642
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 159 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SC----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cC----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 10 00112346899999999999888999999999999999999999999887
Q ss_pred ChHHHHHhhhccC-----CCCC-------------------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 918 SPEIIFDNILNRK-----IPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 918 s~~ei~qkIl~g~-----i~~p-------------------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
+......++.... ..++ ...+.++..+.+||.+||+.||.+||| +.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~hp~ 287 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQHPF 287 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhcCCC
Confidence 7665554443210 0000 112357788999999999999999999 889999999
Q ss_pred C
Q 001614 974 F 974 (1044)
Q Consensus 974 F 974 (1044)
|
T Consensus 288 f 288 (288)
T cd07863 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=369.86 Aligned_cols=257 Identities=31% Similarity=0.513 Sum_probs=216.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||.|+||.||++.+..+|..+|+|++... ........+.+|+++++.++||||++++++|...+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 357899999999999999999999999999999988652 233455678999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999999888899999999999999999999985 799999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 157 -------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred -------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 0112346899999999999888999999999999999999999999765443322
Q ss_pred Hhh--------------------------------------------hccCCCCCCCC-CCCCHHHHHHHHhHccCCcCC
Q 001614 924 DNI--------------------------------------------LNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQ 958 (1044)
Q Consensus 924 qkI--------------------------------------------l~g~i~~p~ip-~~iS~eLkdLIkkcLqkDPsk 958 (1044)
..+ ..... +..+ ...+.++++||.+||++||.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCccc
Confidence 111 11110 1111 236788999999999999999
Q ss_pred CCChhhHHHHHcCCCCCCC
Q 001614 959 RLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 959 RPSadeA~EIL~HPwFk~i 977 (1044)
||| +.+++.||||+..
T Consensus 290 Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 290 RAD---LKQLMVHAFIKRS 305 (333)
T ss_pred CcC---HHHHhhCHHHhcC
Confidence 999 8889999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.34 Aligned_cols=259 Identities=32% Similarity=0.541 Sum_probs=220.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
.+|...++||+|.||.||+|++..||+.||||.++... .........++|+..|+.++||||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~-~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN-AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc-cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888899999999999999999999999999997643 22233456889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||+. +|..+++.. ..++...++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~------ 153 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS------ 153 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC------
Confidence 99976 999999754 4689999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|.|.+.-+.+.
T Consensus 154 ---------------------p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 154 ---------------------PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred ---------------------CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 1112223378999999999987 579999999999999999999999999998877777
Q ss_pred hhhccC-----CCCCC--------------------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 925 NILNRK-----IPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 925 kIl~g~-----i~~p~--------------------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.|..-- ..||. +....+.++.+|+.+||.+||.+|++ |.|+|+|+||+..
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKSL 287 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhcC
Confidence 665410 01111 22346788899999999999999999 8889999999964
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=363.84 Aligned_cols=260 Identities=27% Similarity=0.497 Sum_probs=213.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
.+++|.+.+.||+|+||.||+|+++.+++.||+|.++.... ......+.+|+.++++++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875322 2233467789999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 156 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---- 156 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC----
Confidence 9999975 888888654 4588999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 157 -----------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred -----------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 0011123467999999999865 4688999999999999999999999988776554
Q ss_pred HHhhhccC-------------------CCCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 923 FDNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 923 ~qkIl~g~-------------------i~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
...+.... ..++. ....+++++++||.+||+.||.+||| +.++|.||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~ 290 (309)
T cd07872 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHAYFR 290 (309)
T ss_pred HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcChhhh
Confidence 44332210 00110 11357889999999999999999999 88999999998
Q ss_pred CC
Q 001614 976 GV 977 (1044)
Q Consensus 976 ~i 977 (1044)
..
T Consensus 291 ~~ 292 (309)
T cd07872 291 SL 292 (309)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=373.47 Aligned_cols=257 Identities=31% Similarity=0.495 Sum_probs=210.5
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
....++|+..+.||+|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999986432 234456789999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+++|+|.+. ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~--- 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ--- 220 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc---
Confidence 999999999998653 3356778889999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.........||+.|+|||++.. ...+.++|||||||++|+|++|+.||...
T Consensus 221 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 221 ------------------------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ------------------------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 0011224579999999999843 23456899999999999999999999743
Q ss_pred ChH---HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 918 SPE---IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 918 s~~---ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
... .....+.... .+..+..++.++++||.+||+.||.+||+ +.++++||||.+-
T Consensus 277 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 277 RQGDWASLMCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred CCccHHHHHHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 322 2222222221 13345678999999999999999999999 8899999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=375.17 Aligned_cols=260 Identities=31% Similarity=0.511 Sum_probs=215.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----ee
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~-----~L 762 (1044)
+|++.+.||+|+||.||++.+..+|+.||+|.+... .........+.+|+.+++.++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 578899999999999999999999999999988642 223344567899999999999999999999998876 78
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999996 5899998887889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.++..
T Consensus 158 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 158 -------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred -------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 0111234689999999999874 57899999999999999999999998887765
Q ss_pred HHHhhhc-----------------------cCCCCC------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 922 IFDNILN-----------------------RKIPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 922 i~qkIl~-----------------------g~i~~p------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
....+.. .....+ ......++++.+||.+||+.||.+||| +.++|.||
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l~hp 289 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADALAHP 289 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHhcCH
Confidence 5544432 111111 122456889999999999999999999 78899999
Q ss_pred CCCCCC
Q 001614 973 FFKGVN 978 (1044)
Q Consensus 973 wFk~id 978 (1044)
||.+..
T Consensus 290 ~~~~~~ 295 (372)
T cd07853 290 YLDEGR 295 (372)
T ss_pred hhCCCc
Confidence 998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=350.78 Aligned_cols=258 Identities=39% Similarity=0.784 Sum_probs=223.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||.|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999865544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCC
Q 001614 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1044)
Q Consensus 775 ~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~ 854 (1044)
.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~--------------- 145 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--------------- 145 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc---------------
Confidence 99998888899999999999999999999999999999999999999999999999998864210
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHhhhccCCC
Q 001614 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PEIIFDNILNRKIP 932 (1044)
Q Consensus 855 ~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s--~~ei~qkIl~g~i~ 932 (1044)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+..+...
T Consensus 146 -------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 212 (262)
T cd05572 146 -------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212 (262)
T ss_pred -------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC
Confidence 001123468899999999988889999999999999999999999998776 66666666643322
Q ss_pred CCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcch
Q 001614 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDS 981 (1044)
Q Consensus 933 ~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~ 981 (1044)
+..|...++++.++|.+||+.||.+||+. ..+.++++||||++++|+.
T Consensus 213 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 262 (262)
T cd05572 213 -LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262 (262)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCCC
Confidence 33455668999999999999999999992 3367899999999999873
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=356.27 Aligned_cols=264 Identities=34% Similarity=0.584 Sum_probs=225.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.+.|++.+.||.|+||.||+|++..++..||+|.+... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 45799999999999999999999999999999998642 344567789999999999999999999999999999999
Q ss_pred EeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~----- 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----- 162 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc-----
Confidence 999999999988764 45689999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
.........+++.|+|||++. ...++.++|||||||++|+|++|..||...+.
T Consensus 163 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 163 ----------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred ----------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 001122346889999999985 34567899999999999999999999988877
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchh
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L 982 (1044)
.....++.....+....+..++.++.+||.+||..||.+||+ +.++++||||..++|...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 221 MRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchh
Confidence 776666655443333345678899999999999999999999 789999999999887763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.29 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=222.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||+|+||.||+|.++.+|+.|++|.+.... ........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh-CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5889999999999999999999999999999986532 234566789999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 99999999999764 56889999999999999999999999999999999999999999999999988642100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 155 ----------------------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ----------------------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0111234688999999999988899999999999999999999999998888777777
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+..+.. +..+..++.++.++|.+||+.+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHcCCC--CCCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 766543 3344578899999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=386.76 Aligned_cols=256 Identities=30% Similarity=0.417 Sum_probs=207.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~----- 759 (1044)
...+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4568999999999999999999999999999999885421 2345799999999999999998876432
Q ss_pred ---CeeEEEEeeccccchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeec
Q 001614 760 ---DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDF 831 (1044)
Q Consensus 760 ---~~LyLVmEY~~GGSL~dlLk----k~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDF 831 (1044)
..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 247799999975 7777664 345689999999999999999999999999999999999999665 6999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhC
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTG 910 (1044)
|+|+.... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 216 Gla~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 267 (440)
T PTZ00036 216 GSAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267 (440)
T ss_pred ccchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99873210 011223578999999999876 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 911 IPPFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g-----------------~i~~p~---------ip~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
.+||.+.+..+.+..+... ...++. +|...++++.+||.+||++||.+|||
T Consensus 268 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t--- 344 (440)
T PTZ00036 268 YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN--- 344 (440)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC---
Confidence 9999988766555444321 011111 23457889999999999999999999
Q ss_pred HHHHHcCCCCCCCCc
Q 001614 965 AAEVKAHPFFKGVNW 979 (1044)
Q Consensus 965 A~EIL~HPwFk~id~ 979 (1044)
+.++|.||||..+..
T Consensus 345 a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 PIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhCChhHHhhhc
Confidence 889999999987654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=380.69 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=208.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
....+|++.+.||+|+||.||++.+..+++.||+|.... ..+.+|+.+|++++||||++++++|......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 445689999999999999999999999999999996432 34678999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
+|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--- 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--- 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc---
Confidence 9999995 699999988788999999999999999999999999999999999999999999999999998631100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s----- 918 (1044)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 236 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~ 292 (391)
T PHA03212 236 -----------------------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292 (391)
T ss_pred -----------------------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence 0011224579999999999999899999999999999999999998874321
Q ss_pred --hHHHHHhhhc--------------------------cCCCCCC-C-----CCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 919 --PEIIFDNILN--------------------------RKIPWPC-V-----PSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 919 --~~ei~qkIl~--------------------------g~i~~p~-i-----p~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
....+..+.. .....+. . ...++.++.+||.+||+.||.+|||
T Consensus 293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt--- 369 (391)
T PHA03212 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS--- 369 (391)
T ss_pred CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC---
Confidence 1111111111 0000000 0 0135678999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 001614 965 AAEVKAHPFFKGV 977 (1044)
Q Consensus 965 A~EIL~HPwFk~i 977 (1044)
+.++|+||||+.+
T Consensus 370 a~elL~hp~f~~~ 382 (391)
T PHA03212 370 AEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcChhhccC
Confidence 8899999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=360.37 Aligned_cols=245 Identities=20% Similarity=0.216 Sum_probs=211.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec----CCeeEEEEee
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYLVMEY 768 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed----~~~LyLVmEY 768 (1044)
..||+|++|.||+|.+ +|+.||||.+++.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 489999999976543333345778899999999999999999999876 3578999999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
+++|+|.+++.+...+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-------- 175 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-------- 175 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc--------
Confidence 99999999999888899999999999999999999984 999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+++..
T Consensus 176 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 176 ----------------------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred ----------------------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0113468899999999976 6789999999999999999999999999988888888
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+.....++ ..+..+++++++||.+||+.||.+|||++++.+.|+
T Consensus 234 i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 234 IINKNNSL-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred HHhcCCCC-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 76665543 345578999999999999999999999877766553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=372.58 Aligned_cols=265 Identities=33% Similarity=0.501 Sum_probs=223.2
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 759 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~- 759 (1044)
....++++|+.+..|++|+||.||+|+++.|++.||+|.++... ......-.-++|+.+|.+++|||||.+-++....
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 44567889999999999999999999999999999999987533 2222223468999999999999999998776543
Q ss_pred -CeeEEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 760 -DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 -~~LyLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
+.+|+|||||+. +|..++.+.+ +|...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 579999999987 9999998776 7999999999999999999999999999999999999999999999999999842
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
. .+.......+-|.+|.|||+|.+ ..|+...||||+|||+.||+++++.|.+
T Consensus 228 g---------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 228 G---------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred c---------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 1 11233455788999999999988 5689999999999999999999999999
Q ss_pred CChHHHHHhhhcc-------------------CCCCCCCC---------C-CCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 917 ESPEIIFDNILNR-------------------KIPWPCVP---------S-DMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 917 ~s~~ei~qkIl~g-------------------~i~~p~ip---------~-~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
.+..+.+.+|..- ...++..| . .+++...+|+..+|.+||.+|.| |.+
T Consensus 281 ~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t---A~~ 357 (419)
T KOG0663|consen 281 KSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT---AED 357 (419)
T ss_pred CchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---HHH
Confidence 9988887777641 01111111 1 25688899999999999999999 778
Q ss_pred HHcCCCCCCC
Q 001614 968 VKAHPFFKGV 977 (1044)
Q Consensus 968 IL~HPwFk~i 977 (1044)
.|+|.||...
T Consensus 358 ~L~h~~F~e~ 367 (419)
T KOG0663|consen 358 GLKHEYFRET 367 (419)
T ss_pred hhcccccccC
Confidence 8999999873
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=369.49 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=209.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--- 760 (1044)
...++|++.+.||+|+||.||++.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 34689999999999999999999999999999999986532 23345567889999999999999999999986543
Q ss_pred ---eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 761 ---~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999975 6666664 34888999999999999999999999999999999999999999999999998631
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 174 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CT----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cc----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 10 01112357899999999999989999999999999999999999999877
Q ss_pred ChHHHHHhhhc----------------------cCCCCCC-----------------CCCCCCHHHHHHHHhHccCCcCC
Q 001614 918 SPEIIFDNILN----------------------RKIPWPC-----------------VPSDMSFEAQDLINRFLIHDPNQ 958 (1044)
Q Consensus 918 s~~ei~qkIl~----------------------g~i~~p~-----------------ip~~iS~eLkdLIkkcLqkDPsk 958 (1044)
+....+..+.. ....++. .....++++++||.+||+.||.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65433222211 1000000 11224678999999999999999
Q ss_pred CCChhhHHHHHcCCCCCC
Q 001614 959 RLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 959 RPSadeA~EIL~HPwFk~ 976 (1044)
||| +.++|.||||..
T Consensus 306 R~t---~~e~l~hp~~~~ 320 (359)
T cd07876 306 RIS---VDEALRHPYITV 320 (359)
T ss_pred CCC---HHHHhcCchhhh
Confidence 999 889999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=392.32 Aligned_cols=303 Identities=45% Similarity=0.748 Sum_probs=249.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
+...-|..++.||-|+||+|.+++..+|...||+|.++|...+.......+..|..||...+++.||+||..|++.+++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 44456889999999999999999999999999999999988888888999999999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
+||+|++||++..+|.+.+.|.|..+++|+.++..|+++.|..|+|||||||+|||||.+|++||.||||+.-+...+..
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998743322221
Q ss_pred cCCCCCCCCCCCCCCCCCccc---------------ccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQ---------------QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~---------------~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELL 908 (1044)
.......+..-.+-....++. ....-.....+||+.|+|||+|....|+..+||||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 111111111000000111111 11112234678999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhh
Q 001614 909 TGIPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk 986 (1044)
.|++||-..++.+...++.+-.- .++ ....+|.++.++|.++. .+++.|+.-..+.++..||||++|||..+-.++
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~-~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ 943 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIP-YQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQR 943 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccc-cccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhhhcc
Confidence 99999998888777666654322 222 23578999999999966 479999998889999999999999999876554
Q ss_pred cc
Q 001614 987 MT 988 (1044)
Q Consensus 987 ~~ 988 (1044)
.+
T Consensus 944 Ap 945 (1034)
T KOG0608|consen 944 AP 945 (1034)
T ss_pred CC
Confidence 43
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=356.84 Aligned_cols=263 Identities=38% Similarity=0.650 Sum_probs=212.3
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHH---hcCCCceEEEeeeeecCCeeEEEEeecc
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs---~L~HPNIVkL~gvfed~~~LyLVmEY~~ 770 (1044)
.||+|+||.||++.+..+|+.||+|++.+...........+.+|..+++ ..+||||+.+++++...+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997644333333334455554444 3479999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCC
Q 001614 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1044)
Q Consensus 771 GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t 850 (1044)
+|+|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~------------ 148 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh---HHHHHhh
Q 001614 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNI 926 (1044)
Q Consensus 851 ~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~---~ei~qkI 926 (1044)
........||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .......
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 211 (279)
T cd05633 149 -----------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (279)
T ss_pred -----------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh
Confidence 001123468999999999864 5688999999999999999999999975432 2222211
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC--hhhHHHHHcCCCCCCCCcchhHhhhcc
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQKMT 988 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS--adeA~EIL~HPwFk~id~d~L~~qk~~ 988 (1044)
.... ...+..+++++.+||.+||..||.+||+ ...+.++++||||++++|.....++.+
T Consensus 212 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~ 272 (279)
T cd05633 212 LTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYP 272 (279)
T ss_pred hcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCC
Confidence 1111 2345678999999999999999999994 123789999999999999887665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=396.29 Aligned_cols=275 Identities=36% Similarity=0.724 Sum_probs=255.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
..+.+++.+..||-||||.|-++..+.....+|+|+++|.........+++..|.+||..++.|+||++|..|.+...+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 45678888999999999999999887655669999999988888888999999999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
++||-|-||.|+..++..+.|++..+++|+..+++|++|||++|||+|||||+|.|++.+|.+||.|||+|+..
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki------ 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI------ 570 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999852
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
....+.+++||||.|.|||++.+...+.++|.||||+++||||+|.+||.+.+++.++
T Consensus 571 ----------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 571 ----------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY 628 (732)
T ss_pred ----------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 2345778999999999999999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCC--hhhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPS--adeA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
..|+++.-. ..+|..++..+.+||+++...+|.+|.. ..++.+|..|.||.++||+.+.....
T Consensus 629 n~ILkGid~-i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L 693 (732)
T KOG0614|consen 629 NLILKGIDK-IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTL 693 (732)
T ss_pred HHHHhhhhh-hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccC
Confidence 999987543 3356889999999999999999999999 78899999999999999999977643
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=342.58 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=218.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-CeeEEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVM 766 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~-~~LyLVm 766 (1044)
+|++.+.||.|++|.||++.++.+++.||+|.+.... ........+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986532 2344566788999999999999999999887644 4689999
Q ss_pred eeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 767 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||+++++|.+++... ..+++..+..++.|++.|++|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 999999999999753 45899999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+......
T Consensus 156 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 156 -----------------------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred -----------------------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 011223468999999999998889999999999999999999999998887776666
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+..+.. +..+..+++++.+||.+||+.||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 6655543 3345678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.61 Aligned_cols=255 Identities=38% Similarity=0.664 Sum_probs=213.3
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|++.+.||+|+||.||++.+..+++.||+|++...... ........+|+.++++++||||+++++++.....+++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999864322 22233445699999999999999999999999999999999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCC
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p 848 (1044)
+++++|.+++.....++...+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---------- 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 9999999999988889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---hHHHHH
Q 001614 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAES---PEIIFD 924 (1044)
Q Consensus 849 ~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~KSDIWSLGVILYELLTGr~PF~g~s---~~ei~q 924 (1044)
..........+++.|+|||++. +..++.++||||||+++|+|++|..||...+ ......
T Consensus 150 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 150 -----------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp -----------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 1112334567899999999998 7788999999999999999999999999873 333333
Q ss_pred hhhccCCCCCC-CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~-ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+.......... .....+..+.+||.+||+.||.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 33322211110 01123489999999999999999999 8899999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=391.52 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=230.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|+..+.||+|+||.||+|.+..+++.||+|++.-. ....+++.+.+|+.+|..+++|||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh--hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4577889999999999999999999999999999753 34567889999999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|||.||++.++++....+.+..+..++++++.|+.|||..+.+|||||+.|||+..+|.+||+|||.+....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~-------- 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT-------- 162 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee--------
Confidence 999999999999988888999999999999999999999999999999999999999999999999886321
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
.......+.+|||.|||||++.+..|+.++||||||++.|||++|.+||....++..+..|
T Consensus 163 -------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 163 -------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred -------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 1122347889999999999999989999999999999999999999999999997766655
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
-+... |.+...+|+.+++||..||++||+.||+ |.++|+|+|++.
T Consensus 224 pk~~P--P~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 PKSAP--PRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKR 268 (467)
T ss_pred cCCCC--CccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHh
Confidence 55443 4455689999999999999999999999 889999999986
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.29 Aligned_cols=259 Identities=33% Similarity=0.577 Sum_probs=223.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||.|+||.||++.+..++..||+|+++.. .......+.+|+.++++++||||+++++.+.....+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998642 344567889999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++|+|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~----- 155 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS----- 155 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----
Confidence 9999999999998764 5699999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
.........|++.|+|||++. ...++.++||||||+++|+|++|..||...+.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 156 ----------------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ----------------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 011122356899999999985 34467899999999999999999999998888
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.....++..+..+....+..++.++.+||.+||+.+|.+||+ +.++++||||...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhccc
Confidence 777777766554433345678999999999999999999999 7899999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.75 Aligned_cols=262 Identities=27% Similarity=0.464 Sum_probs=219.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc---cChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM---IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~---~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
+|++.+.||.|+||.||+|.. .+|+.+|+|.++.... ........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999987 4788999998864321 123345678899999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||||+++|+|.+++.+.+.+++..+..++.|++.||+|||+.+|+|+||+|+||++++++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-- 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc--
Confidence 999999999999998878899999999999999999999999999999999999999999999999998864211000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
............|++.|+|||++.+..++.++||||||+++|+|++|..||...+......
T Consensus 158 -------------------~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 218 (265)
T cd06631 158 -------------------HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218 (265)
T ss_pred -------------------cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence 0000111223468999999999998889999999999999999999999998776655554
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+.......+..+..++.++.+||.+||..+|.+||+ +.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 4444433445566789999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=384.20 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=204.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC------CceEEEeeeeec
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFTC 758 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H------PNIVkL~gvfed 758 (1044)
..++|++.+.||+|+||+||+|.+..+++.||||+++... .....+..|+.++..+.| ++|+.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999999999999999996422 223445667777776654 568999988876
Q ss_pred C-CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCC------------
Q 001614 759 R-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG------------ 824 (1044)
Q Consensus 759 ~-~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg------------ 824 (1044)
. ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 4689999988 77999999888889999999999999999999998 5999999999999998765
Q ss_pred ----cEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHH
Q 001614 825 ----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900 (1044)
Q Consensus 825 ----~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSL 900 (1044)
.+||+|||++... .......+||+.|||||++.+..|+.++|||||
T Consensus 282 ~~~~~vkl~DfG~~~~~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 331 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331 (467)
T ss_pred CCCceEEECCCCccccC------------------------------ccccccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence 4999999987521 011234679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCC------------------------CC-C--------------CCCC
Q 001614 901 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWP------------------------CV-P--------------SDMS 941 (1044)
Q Consensus 901 GVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p------------------------~i-p--------------~~iS 941 (1044)
||++|||++|++||.+.+..+....+......+| .. + ...+
T Consensus 332 Gvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (467)
T PTZ00284 332 GCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD 411 (467)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhch
Confidence 9999999999999988776544333221100000 00 0 0124
Q ss_pred HHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 942 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 942 ~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.+.+||.+||++||.+||| +.|+|+||||...
T Consensus 412 ~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLKY 444 (467)
T ss_pred HHHHHHHHHhCCcChhhCCC---HHHHhcCcccccc
Confidence 56789999999999999999 8899999999875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.72 Aligned_cols=261 Identities=31% Similarity=0.524 Sum_probs=219.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccC------hhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~------~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~ 761 (1044)
.|.+...||.|+||.||+|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3678889999999999999999889999999886543221 1234678899999999999999999999999999
Q ss_pred eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987421110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
. ............|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+...
T Consensus 161 ~---------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 161 L---------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred c---------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 0 0001112233568999999999988889999999999999999999999998876655
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
....+... ..+..+..++..+.++|.+||+.||.+||+ +.++++||||
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 55544442 224456778999999999999999999999 7899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=365.57 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=210.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~----- 759 (1044)
..++|++.+.||+|+||.||++.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4678999999999999999999999999999999986532 2334456788999999999999999999887654
Q ss_pred -CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 -~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
..+|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999975 77777753 48889999999999999999999999999999999999999999999999986311
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 178 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 178 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred C----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0 001123568999999999999999999999999999999999999999887
Q ss_pred hHHHHHhhhccCCC----------------------C--------------C---CCCCCCCHHHHHHHHhHccCCcCCC
Q 001614 919 PEIIFDNILNRKIP----------------------W--------------P---CVPSDMSFEAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~----------------------~--------------p---~ip~~iS~eLkdLIkkcLqkDPskR 959 (1044)
..+.+.++...... + + ......+.++++||.+||+.||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 76655554321000 0 0 0011235678999999999999999
Q ss_pred CChhhHHHHHcCCCCCC
Q 001614 960 LGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 960 PSadeA~EIL~HPwFk~ 976 (1044)
|| +.++|+||||..
T Consensus 310 ~t---~~e~L~hp~~~~ 323 (364)
T cd07875 310 IS---VDEALQHPYINV 323 (364)
T ss_pred CC---HHHHhcCccccc
Confidence 99 888999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.30 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=219.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||+||+|.+..++..+|+|++..... ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 479999999999999999999998999999999865332 225678999999999999999999999999999999999
Q ss_pred eeccccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 767 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~---g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||+++++|.+++... ..+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999864211100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
..........|++.|+|||++... .++.++|+|||||++|+|++|..||...+....
T Consensus 158 ----------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 158 ----------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred ----------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 000112345689999999999876 788999999999999999999999988877766
Q ss_pred HHhhhccCCC-CCCC--CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 923 FDNILNRKIP-WPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 923 ~qkIl~g~i~-~p~i--p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+.++.....+ ++.. ...+++.+.+||.+||..||.+||+ +.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 6666554322 1111 1367899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.22 Aligned_cols=258 Identities=27% Similarity=0.444 Sum_probs=209.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--- 760 (1044)
...++|++.+.||+|+||.||++.+..+++.||+|.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 34679999999999999999999999999999999986532 23345567889999999999999999999886543
Q ss_pred ---eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 761 ---~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 57999999975 67777653 4888999999999999999999999999999999999999999999999998631
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 170 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CC----------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 10 01112357899999999999989999999999999999999999999887
Q ss_pred ChHHHHHhhhcc----------------------CC-----CCC------------CCCCCCCHHHHHHHHhHccCCcCC
Q 001614 918 SPEIIFDNILNR----------------------KI-----PWP------------CVPSDMSFEAQDLINRFLIHDPNQ 958 (1044)
Q Consensus 918 s~~ei~qkIl~g----------------------~i-----~~p------------~ip~~iS~eLkdLIkkcLqkDPsk 958 (1044)
+....+..+... .. .++ ..+...+.++++||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 654433322110 00 000 011234567899999999999999
Q ss_pred CCChhhHHHHHcCCCCCC
Q 001614 959 RLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 959 RPSadeA~EIL~HPwFk~ 976 (1044)
||| +.++|+||||..
T Consensus 302 Rps---~~ell~hp~~~~ 316 (355)
T cd07874 302 RIS---VDEALQHPYINV 316 (355)
T ss_pred cCC---HHHHhcCcchhc
Confidence 999 889999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.51 Aligned_cols=260 Identities=36% Similarity=0.647 Sum_probs=217.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||+|+||+||++.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999764433333456678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCC
Q 001614 775 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1044)
Q Consensus 775 ~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~ 852 (1044)
.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99997765 689999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHhhhc
Q 001614 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 928 (1044)
Q Consensus 853 ~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~----~ei~qkIl~ 928 (1044)
........+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 148 ---------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ---------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 0111234578899999999888899999999999999999999999976543 233333322
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhh
Q 001614 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 929 g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~q 985 (1044)
.. ...+..+++++.++|.+||+.||.+||++. .+.+++.||||+.++|..+...
T Consensus 213 ~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~ 268 (277)
T cd05577 213 MA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAG 268 (277)
T ss_pred cc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcC
Confidence 22 223466899999999999999999999432 2888999999999999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=351.10 Aligned_cols=256 Identities=33% Similarity=0.556 Sum_probs=218.6
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|++.+.||.|+||.||+|.+..++..+++|.+... .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 67889999999999999999999999999988542 234567789999999999999999999999999999999999
Q ss_pred ccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-------- 155 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-------- 155 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--------
Confidence 999999998865 45689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
.........|++.|+|||++. +..++.++|||||||++|+|++|.+||...+....
T Consensus 156 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 156 -------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred -------------------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 001122346899999999984 34577899999999999999999999998887776
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
...+.....+....+..++.++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 666655543333345678999999999999999999999 7789999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.54 Aligned_cols=262 Identities=33% Similarity=0.531 Sum_probs=219.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec-----CC
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----RD 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed-----~~ 760 (1044)
...|...+.||.|+||.|+.+.++.+|+.||+|.+.. ........++.++|+.+|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456668999999999999999999999999998753 24455677899999999999999999999998876 34
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+|+|+|+| +-+|...++....+++..+..+++||++||+|+|+.||+||||||.|+|++.+..+||+|||+|+.....
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 699999999 5599999998888999999999999999999999999999999999999999999999999999853110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
.........+.|.+|.|||++.. ..|+.+.||||+|||+.|||+|++-|.|.+.
T Consensus 179 -------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 179 -------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred -------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 01122344578999999999865 6899999999999999999999999998765
Q ss_pred HHHHHhhhc----------------------------cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 920 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~----------------------------g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
-..+..|+. ...+|..+.++.++.+.+|+.+||..||.+|+| |.++|.|
T Consensus 234 v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL~h 310 (359)
T KOG0660|consen 234 VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEALAH 310 (359)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHhcC
Confidence 443333321 111222344689999999999999999999999 8888999
Q ss_pred CCCCCC
Q 001614 972 PFFKGV 977 (1044)
Q Consensus 972 PwFk~i 977 (1044)
||+.+.
T Consensus 311 PYl~~~ 316 (359)
T KOG0660|consen 311 PYLAPY 316 (359)
T ss_pred hhhhhh
Confidence 999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=385.60 Aligned_cols=263 Identities=29% Similarity=0.471 Sum_probs=225.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--- 760 (1044)
...++|++.+.||+|+||.||++++..+|+.||||++.... ........+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc-CCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 44579999999999999999999999999999999987543 34556678899999999999999999987765432
Q ss_pred -----eeEEEEeeccccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeec
Q 001614 761 -----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 761 -----~LyLVmEY~~GGSL~dlLkk~----g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDF 831 (1044)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 378999999999999998643 46899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCC
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr 911 (1044)
|+++...... ........+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 188 Gls~~~~~~~-------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 188 GFSKMYAATV-------------------------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ccCeeccccc-------------------------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9987421000 001123467999999999999989999999999999999999999
Q ss_pred CCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 912 ~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.||.+.+..+++..+..+... ..+..+++++.+||.+||+.||.+||+ +.+++.|||++..
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 999999888888887766543 356789999999999999999999999 7789999998754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.05 Aligned_cols=256 Identities=32% Similarity=0.502 Sum_probs=215.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986432 2344567899999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA----- 158 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
.........|++.|+|||++. ...++.++|+|||||++|+|++|..||....+..
T Consensus 159 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~ 216 (267)
T cd06645 159 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred ----------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh
Confidence 001122356899999999984 4568889999999999999999999997766544
Q ss_pred HHHhhhccCCCCCCC--CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 922 IFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 922 i~qkIl~g~i~~p~i--p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
....+.......+.. ...++..+.+||.+||+.||.+||+ +.+++.|||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 217 ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 433333333222221 1257789999999999999999999 788999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=354.08 Aligned_cols=260 Identities=27% Similarity=0.502 Sum_probs=213.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||.|+||.||+|.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999865321 2233467789999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---- 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 156 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC----
Confidence 999997 5898888754 4689999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 157 -----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -----------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0011123457899999999876 4578899999999999999999999988776554
Q ss_pred HHhhhccC-------------------CCCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 923 FDNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 923 ~qkIl~g~-------------------i~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
...+.... ..++. ....+++.+++||.+||+.||.+||| +.++|+||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~~f~ 290 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHPYFH 290 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCcccc
Confidence 43332110 00111 11357889999999999999999999 88999999998
Q ss_pred CC
Q 001614 976 GV 977 (1044)
Q Consensus 976 ~i 977 (1044)
.+
T Consensus 291 ~~ 292 (301)
T cd07873 291 CL 292 (301)
T ss_pred cc
Confidence 65
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=382.72 Aligned_cols=258 Identities=28% Similarity=0.401 Sum_probs=222.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC-CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~t-Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
...|.+.+.||+|+||.||++....+ +..||+|.+.. ........+.+|+.+|+.++|||||+++++|...+.+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML---NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 78899997643 233445677889999999999999999999999999999
Q ss_pred EEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 765 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999998742110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 223 ~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 V-------------------------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred c-------------------------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0 001123467999999999999989999999999999999999999999998888
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
+++..+..+... ..+..+++++.+||.+||..||.+||+ +.+++.|||++.
T Consensus 278 ~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~ 328 (478)
T PTZ00267 278 EIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHH
Confidence 888888776543 345678999999999999999999999 778899999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=341.94 Aligned_cols=254 Identities=31% Similarity=0.569 Sum_probs=217.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||.|+||.||+|.+..++..|++|.++... ....+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999889999999986421 267899999999999999999999999999999999
Q ss_pred EeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+|+|+||+|.||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 999999999999975 456899999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........|++.|+|||++.+..++.++||||||+++|+|++|..||...++.....
T Consensus 153 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 153 -----------------------MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred -----------------------ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 001223458899999999998889999999999999999999999998776655544
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+..........+..++.++.+||.+||+.||.+||| +.++|.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 4433322222234567889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=350.62 Aligned_cols=263 Identities=38% Similarity=0.642 Sum_probs=213.3
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHH---HHHhcCCCceEEEeeeeecCCeeEEEEeecc
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN---ILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~---ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~ 770 (1044)
.||+|+||.||++.+..+|+.||+|++.+...........+..|.. +++...||||+.+++++...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987643322222233444444 3444679999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCC
Q 001614 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1044)
Q Consensus 771 GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t 850 (1044)
||+|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----------- 149 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----------- 149 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCC---ChHHHHHhh
Q 001614 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNI 926 (1044)
Q Consensus 851 ~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~---s~~ei~qkI 926 (1044)
.......|++.|+|||++.++ .++.++||||+|+++|+|++|..||.+. ........+
T Consensus 150 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 211 (278)
T cd05606 150 ------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (278)
T ss_pred ------------------cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh
Confidence 011234689999999999754 6889999999999999999999999776 333333333
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh--hHHHHHcCCCCCCCCcchhHhhhcc
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQKMT 988 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad--eA~EIL~HPwFk~id~d~L~~qk~~ 988 (1044)
..... ..+..++.++.++|.+||..+|.+||... .+.++++||||++++|..+..++.+
T Consensus 212 ~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~ 272 (278)
T cd05606 212 LTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYP 272 (278)
T ss_pred hccCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccC
Confidence 32222 24456799999999999999999999211 2888999999999999988765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.62 Aligned_cols=255 Identities=40% Similarity=0.733 Sum_probs=220.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999986554444567889999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~-------- 152 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-------- 152 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC--------
Confidence 999999999998877899999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh---HHHHH
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFD 924 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~---~ei~q 924 (1044)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. .....
T Consensus 153 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 153 --------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred --------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 0012234688899999999888899999999999999999999999987763 33333
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.... ..+..+..++..+.++|.+||+.||.+||++. +.++++||||
T Consensus 213 ~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 213 KQET---ADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred Hhcc---ccccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 3222 22345567889999999999999999999943 4899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=349.53 Aligned_cols=267 Identities=23% Similarity=0.357 Sum_probs=220.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~-----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed 758 (1044)
+..++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999997652 34589999876432 22334568899999999999999999999999
Q ss_pred CCeeEEEEeeccccchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEE
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk~g----------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKL 828 (1044)
....|+||||+++|+|.+++.... .++...+..++.|++.||.|||+++|+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999997532 2456778889999999999999999999999999999999999999
Q ss_pred eecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHH
Q 001614 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 829 sDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELL 908 (1044)
+|||+++....... ........++..|+|||.+.++.++.++|||||||++|+|+
T Consensus 161 ~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~ 215 (288)
T cd05061 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215 (288)
T ss_pred CcCCcccccccccc-------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHH
Confidence 99999863210000 00111234577899999999888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc---CCCCCCCCc
Q 001614 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGVNW 979 (1044)
Q Consensus 909 T-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~---HPwFk~id~ 979 (1044)
+ |..||.+.+..+....+..+.. +..+..+++.+.++|.+||+.||.+|||+.++.+.+. ||||++++|
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 216 SLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 8 7999998888887777665543 2334677899999999999999999999877776655 899999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=342.24 Aligned_cols=260 Identities=29% Similarity=0.482 Sum_probs=217.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc--ccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--Cee
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~--~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~L 762 (1044)
.+|++.+.||+|+||.||+|.+..+|..||+|.+.... .........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886422 11223457888999999999999999999998764 468
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+++|+|.+++.+.+.+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~- 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC- 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-
Confidence 8999999999999999887889999999999999999999999999999999999999999999999999886321000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
..........|+..|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 161 -----------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred -----------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 000112234689999999999888899999999999999999999999988766655
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
...+..... .+..|..++..+.++|.+||. +|.+||+ +.+++.|||++
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQPT-NPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHhcCCC-CCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 555443322 244566788899999999995 8999999 88999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=346.84 Aligned_cols=255 Identities=30% Similarity=0.499 Sum_probs=207.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.+..+|..||+|.++... ........+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986432 223334678899999999999999999999999999999999
Q ss_pred eccccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 768 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~---g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|++ ++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 997 5898888643 4689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.....
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 154 ----------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ----------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0011123367899999999875 45788999999999999999999999876543322
Q ss_pred HhhhccC--------------------------CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g~--------------------------i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+.... .........+++++.+||.+||+.||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 2211100 0000112357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.08 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=216.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--cChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--Cee
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~--~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~L 762 (1044)
.+|++.+.||+|+||.||++.+..+|..||+|.++.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998865321 1223456788999999999999999999988753 578
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
+++|||+++++|.+++...+.+++.....++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999986321000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
..........|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 161 -----------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred -----------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 000111234588999999999988899999999999999999999999987766555
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
...+..... .+.++..+++.+++|| .||..+|.+||+ +.+++.||||+
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQPT-NPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCCC-CCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 544433322 2445667889999999 577789999999 88999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=345.27 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=212.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999865321 2223456789999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++++|..++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------ 153 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP------ 153 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC------
Confidence 99999999888877777999999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........++..|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 154 ---------------------GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred ---------------------cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 001123457889999999876 4578899999999999999999999987765443333
Q ss_pred hhccC-------------------CCCCC---------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNRK-------------------IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~-------------------i~~p~---------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+.... ...+. ....++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 22100 00000 01356888999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.47 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=210.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~----- 759 (1044)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3578999999999999999999999999999999986532 2223456678999999999999999999888643
Q ss_pred -CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 -~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
..+|++|+++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3479999998 7799888754 569999999999999999999999999999999999999999999999999986311
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 170 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ------------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 01123468999999999977 56889999999999999999999999876
Q ss_pred ChHHHHHhhhccCC--------------------CCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 918 SPEIIFDNILNRKI--------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i--------------------~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+.......+..... .++. .....++.+.+||.+||..||.+||| +.++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~ell 296 (343)
T cd07878 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASEAL 296 (343)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 65444433321100 0010 11246778899999999999999999 88999
Q ss_pred cCCCCCCCC
Q 001614 970 AHPFFKGVN 978 (1044)
Q Consensus 970 ~HPwFk~id 978 (1044)
.||||....
T Consensus 297 ~hp~~~~~~ 305 (343)
T cd07878 297 AHPYFSQYH 305 (343)
T ss_pred cCcchhccC
Confidence 999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=354.13 Aligned_cols=257 Identities=31% Similarity=0.512 Sum_probs=215.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++.+..+|..||+|.+... ........+.+|++++++++||||++++++|...+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 4799999999999999999999999999999988642 23344567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+++|+|.+++.+.+.+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999988889999999999999999999998 589999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 209 (308)
T cd06615 152 ----------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209 (308)
T ss_pred ----------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence 0011235789999999999888899999999999999999999999976554333221
Q ss_pred hhccCC----------------------------------CCCCCC-CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 926 ILNRKI----------------------------------PWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 926 Il~g~i----------------------------------~~p~ip-~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+..... ..+..+ ..++.++++||.+||..||.+||+ +.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~ 286 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKELTK 286 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHHHhc
Confidence 111000 001111 236788999999999999999999 889999
Q ss_pred CCCCCCC
Q 001614 971 HPFFKGV 977 (1044)
Q Consensus 971 HPwFk~i 977 (1044)
||||.+.
T Consensus 287 ~~~~~~~ 293 (308)
T cd06615 287 HPFIKRA 293 (308)
T ss_pred Chhhhhc
Confidence 9999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.55 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=211.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999986532 3344567899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-------- 146 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------- 146 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc--------
Confidence 99999999655 357888999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh-------
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------- 919 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~------- 919 (1044)
.......+||+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 147 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 147 ---------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred ---------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 0011235789999999999988899999999999999999999999965321
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCc
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~ 979 (1044)
......+.....+ .......++++.+||.+||+.||.+||+ +.+++.||||...+-
T Consensus 206 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~~ 261 (279)
T cd06619 206 LQLLQCIVDEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYND 261 (279)
T ss_pred HHHHHHHhccCCC-CCCCCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCcccccccC
Confidence 2222222222211 1112457889999999999999999999 788999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=345.13 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=211.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecC-----
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~----- 759 (1044)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456888999999999999999999999999999986532 2345788999999998 699999999998753
Q ss_pred -CeeEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 760 -DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 760 -~~LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+|+||||+||++++++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4589999999999999999763 3589999999999999999999999999999999999999999999999999863
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr 911 (1044)
... .........|++.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 161 ~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 161 LDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred ccc---------------------------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 210 001123456899999999986 335788999999999999999999
Q ss_pred CCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 912 ~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.||....+......+.....+ ...+..++.++.+||.+||..||.+||| +.+++.||||
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 214 PPLCDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCccccCHHHHHHHHhcCCCC-CCCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 999877665554444333222 1223467899999999999999999999 7899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=344.65 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=214.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3568999999999999999999999999999999986432 2334567899999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA----- 158 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
.........|++.|+|||.+. ...++.++|||||||++|+|++|..||...++..
T Consensus 159 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 159 ----------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred ----------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 001112346889999999985 3457889999999999999999999997666554
Q ss_pred HHHhhhccCCCCCC--CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 922 IFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 922 i~qkIl~g~i~~p~--ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
....+.......+. ....++..+.+||.+||+.||.+||+ +.++|+|+|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 43333333322221 12357889999999999999999999 778899987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=351.55 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC----------------CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCce
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~----------------tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNI 749 (1044)
.++|++.++||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+|.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998642 34479999986532 34456779999999999999999
Q ss_pred EEEeeeeecCCeeEEEEeeccccchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCeee
Q 001614 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-------------------CLEEDVARIYIAELVLALEYLHSLGIVH 810 (1044)
Q Consensus 750 VkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g-------------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIH 810 (1044)
+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986432 3567788899999999999999999999
Q ss_pred ccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC
Q 001614 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (1044)
Q Consensus 811 RDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 890 (1044)
|||||+|||++.++.+||+|||++........ ........+++.|||||++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-------------------------YRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce-------------------------eEecCcCCCCccccCHHHHhcCC
Confidence 99999999999999999999999863211000 00112345678999999998888
Q ss_pred CCchhhhHHHHHHHHHHHh--CCCCCCCCChHHHHHhhhc---c--CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChh
Q 001614 891 HGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDNILN---R--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1044)
Q Consensus 891 ys~KSDIWSLGVILYELLT--Gr~PF~g~s~~ei~qkIl~---g--~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSad 963 (1044)
++.++||||||+++|+|++ +..||.+.+..+....+.. . ...+...+..++..+.+||.+||+.||.+|||+.
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 9999999999999999987 6788988776665544321 1 1112233467889999999999999999999988
Q ss_pred hHHHHHc
Q 001614 964 GAAEVKA 970 (1044)
Q Consensus 964 eA~EIL~ 970 (1044)
++.+.|+
T Consensus 297 ~i~~~l~ 303 (304)
T cd05096 297 DIHAFLT 303 (304)
T ss_pred HHHHHHh
Confidence 7766553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.54 Aligned_cols=255 Identities=35% Similarity=0.548 Sum_probs=218.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.++++++||||+++++++.....+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999899999999987532 23567889999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~----- 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----- 153 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh-----
Confidence 9999999999999776 7899999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC---CCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
.........|++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.++..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 154 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ----------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112235688999999999776 78899999999999999999999998887666
Q ss_pred HHHhhhccCCCCC--CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 922 IFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 922 i~qkIl~g~i~~p--~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
....+.......+ ..+..++.++.+||.+||..+|.+||| +.+++.|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 5555544433222 123456788999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.49 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=216.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tG-----k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
..++|++.+.||+|+||.||+|.....+ ..||+|.++... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999986555 689999886422 334456789999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded 823 (1044)
...|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 447888899999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHH
Q 001614 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1044)
Q Consensus 824 g~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (1044)
+.++|+|||++....... .........+++.|+|||.+.+..++.++|||||||+
T Consensus 161 ~~~~L~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~i 215 (283)
T cd05048 161 LTVKISDFGLSRDIYSAD-------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215 (283)
T ss_pred CcEEECCCcceeeccccc-------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHH
Confidence 999999999986321000 0011123456889999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 904 LYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+|||++ |..||.+.+..++...+..+.. +..+..+++++.+|+.+||+.||.+||++.++.+.|
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 216 LWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999998 9999999888888877766543 234678999999999999999999999977776655
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=345.34 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=214.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k---~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~ 761 (1044)
..++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4568999999999999999999875 345689999987532 23445678999999999999999999999999999
Q ss_pred eEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999764 56899999999999999999999999999999999999999999999999976521000
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 161 --------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred --------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 0001112345678999999998899999999999999999775 9999999888
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
......+..+. .. ..+..++..+.+++.+||+.+|.+||+++++.++|.
T Consensus 215 ~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 215 QDVIKAVEDGF-RL-PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred HHHHHHHHCCC-CC-CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 87777665443 22 245778999999999999999999999887777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.54 Aligned_cols=259 Identities=34% Similarity=0.539 Sum_probs=219.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
...+|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.....+|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999886533 2234678899999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---- 169 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc----
Confidence 9999999999999865 45889999999999999999999999999999999999999999999999987631100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||...++.....
T Consensus 170 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 170 -----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred -----------------------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 001123468999999999988888999999999999999999999998877654443
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.+.....+....+..++..+.+||.+||..||.+||+ +.+++.||||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~ 276 (296)
T cd06654 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKIA 276 (296)
T ss_pred HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhcc
Confidence 3333332222335678899999999999999999999 8889999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.21 Aligned_cols=254 Identities=29% Similarity=0.536 Sum_probs=221.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||++....+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999865322 33455688999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999999997543 5789999999999999999999999999999999999999999999999988632100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....
T Consensus 155 ----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 155 ----------------------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ----------------------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 0011234588999999999988889999999999999999999999998888888877
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+..+..+ ..+..++.++.++|.+||+.+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYP--PVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HhcCCCC--CCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 7766543 345678999999999999999999999 8889999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=340.66 Aligned_cols=256 Identities=32% Similarity=0.530 Sum_probs=214.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCC---
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~--- 760 (1044)
..++|++.+.||.|+||.||+|.++.+++.|++|++.... .....+.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4578999999999999999999999899999999986532 2446789999999999 6999999999997644
Q ss_pred ---eeEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 761 ---NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 761 ---~LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999865 35789999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHH
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELL 908 (1044)
+..... .........|++.|+|||++.. ..++.++|||||||++|+|+
T Consensus 160 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 160 SAQLDS---------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ceeccc---------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 863210 0011223568999999999853 34678999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+|..||...+.......+.....+....+..++..+++||.+||..||.+||| +.+++.|||+
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred hCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 99999987776666656555433222223347889999999999999999999 8899999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=342.01 Aligned_cols=261 Identities=29% Similarity=0.506 Sum_probs=215.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc---ChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~---~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
+|+..+.||+|+||.||++....+++.||+|++...... .......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998753311 12245788999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998888899999999999999999999999999999999999998776 59999999986421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH---
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE--- 920 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~--- 920 (1044)
...........|+..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 159 ---------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 159 ---------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred ---------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 00001122346899999999998888999999999999999999999999754432
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
.....+..... .+..+..+++++.++|.+||..+|.+||+ +.++++||||+
T Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 218 ALIFKIASATT-APSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred HHHHHHhccCC-CCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 22222222222 24455678899999999999999999999 88999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=344.63 Aligned_cols=257 Identities=33% Similarity=0.580 Sum_probs=221.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999986532 2334567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++++|.+++... .+++..+..++.|++.||.|||+.+|+|+||+|+||++++++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~------ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST------ 151 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc------
Confidence 999999999999765 7899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
........|++.|+|||++.+..++.++||||||+++|+|++|..||...++......+
T Consensus 152 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 152 ---------------------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred ---------------------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 01123356889999999999888999999999999999999999999887776666655
Q ss_pred hccCCCCCCCCCC-CCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 927 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 927 l~g~i~~p~ip~~-iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
.....+ ..+.. ++..+.++|.+||..||.+||| +.+++.||||....
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~ 258 (274)
T cd06609 211 PKNNPP--SLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAK 258 (274)
T ss_pred hhcCCC--CCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCC
Confidence 554332 22333 7899999999999999999999 88899999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.34 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=213.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|++..+++.||+|.++............+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999887644445555677899999999999999999999999999999999
Q ss_pred eeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 767 EY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-- 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch--
Confidence 99999999998853 345889999999999999999999999999999999999999999999999988642100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--hH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 920 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s--~~ 920 (1044)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..
T Consensus 160 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred -------------------------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 011123468899999999998889999999999999999999999996553 23
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
.....+.....+ +..+...+..+.+||.+||+.+|.+||++.++.+.+
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 215 SLCQKIEQCDYP-PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHhcCCCC-CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 444444433322 222346788999999999999999999977776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.57 Aligned_cols=257 Identities=32% Similarity=0.508 Sum_probs=210.9
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeee-----
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT----- 757 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfe----- 757 (1044)
...++|++.+.||+|+||.||++.+..+++.||+|+++... .....+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45679999999999999999999999999999999876422 2235677899999999 6999999999873
Q ss_pred cCCeeEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
..+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 44578999999999999998753 34688899999999999999999999999999999999999999999999999
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHH
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELL 908 (1044)
+...... ........|++.|+|||++.. ..++.++|||||||++|+|+
T Consensus 171 ~~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~ 223 (286)
T cd06638 171 SAQLTST---------------------------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223 (286)
T ss_pred eeecccC---------------------------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence 8632100 011223468999999999853 45788999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+|..||...+.......+..........+..++..+.+||.+||+.||.+||| +.++++|+||
T Consensus 224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 224 DGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred cCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 99999988776554444333322212234556889999999999999999999 8889999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.39 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=222.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||.++...+++.+++|.+.... ........+.+|+.++++++||||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc-cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 5899999999999999999999999999999986533 234456778999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 99999999999764 468999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus 156 -----------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 156 -----------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred -----------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 012235689999999999888889999999999999999999999999888888877
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+..+... ..+..++.++.++|.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 7766543 334678999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=346.24 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=206.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.+..+|+.||+|.++... ........+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4889999999999999999999999999999986532 222233567889999999999999999999999999999999
Q ss_pred eccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 768 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 768 Y~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------- 151 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------- 151 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC-------
Confidence 9974 78887764 56799999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHH
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF-TAESPEIIFD 924 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF-~g~s~~ei~q 924 (1044)
.........+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+.
T Consensus 152 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 152 --------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred --------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 00111234578999999998764 4789999999999999999998885 4444444433
Q ss_pred hhhccC-----------------CCC---------CCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRK-----------------IPW---------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~-----------------i~~---------p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+.... ..+ ....+.+++++.+||.+||+.||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 332110 000 1112357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=347.45 Aligned_cols=255 Identities=30% Similarity=0.550 Sum_probs=215.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||+|+||.||++.+..+|..||+|.++.. ........+.+|+.++++++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4689999999999999999999999999999988642 23444578899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 767 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~---g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||+++++|..++... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999998763 368999999999999999999997 599999999999999999999999999886310
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC------CCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~------~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
........|++.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 155 -------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0011234588899999998553 357899999999999999999999977
Q ss_pred CChHHHHHh---hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 917 ESPEIIFDN---ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 917 ~s~~ei~qk---Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
......... +..+ ..+..+..++.++.+||.+||+.+|.+||+ +.+++.||||...
T Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 210 ETYANIFAQLSAIVDG--DPPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred cchhhHHHHHHHHhhc--CCCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 655444333 2222 223455678999999999999999999999 7789999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.72 Aligned_cols=258 Identities=32% Similarity=0.521 Sum_probs=213.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--- 759 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~--- 759 (1044)
...++|++.+.||.|+||.||++....+++.+|+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999986532 2235677899999998 799999999998754
Q ss_pred --CeeEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 760 --DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 760 --~~LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
..+|+||||+++|+|.++++. ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 35689999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-----CCCchhhhHHHHHHHHHHH
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-----~ys~KSDIWSLGVILYELL 908 (1044)
+...... ........|++.|+|||++... .++.++|||||||++|+|+
T Consensus 175 ~~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 175 SAQLTST---------------------------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred chhcccc---------------------------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 8632100 0011234688999999998643 3678999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
+|+.||...........+.....+....+...+..+.+||.+||+.+|.+||+ +.++++||||+
T Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 99999988777666555554433222234567788999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.81 Aligned_cols=258 Identities=34% Similarity=0.551 Sum_probs=218.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
..+|++.+.||.|+||.||++.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 468999999999999999999999999999999986432 22346788999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~----- 168 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 168 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-----
Confidence 999999999999865 45889999999999999999999999999999999999999999999999988631100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.++......
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 169 ----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred ----------------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 0011234688999999999988899999999999999999999999987765444333
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.....+....+..++..+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 333333222345678899999999999999999999 8899999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.85 Aligned_cols=253 Identities=29% Similarity=0.499 Sum_probs=219.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ........+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc-cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5899999999999999999999999999999987543 234456789999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeecCCcccccccCccc
Q 001614 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDFGLAki~~~~~t~d 844 (1044)
|+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 3589999999999999999999999999999999999998654 689999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 155 -----------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred -----------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 011123468999999999998888999999999999999999999999888777776
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+..... ...+..++.++.++|.+||..||.+||| +.+++.||||
T Consensus 212 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 6665443 2345678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.36 Aligned_cols=255 Identities=34% Similarity=0.573 Sum_probs=218.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--cChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~--~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36778899999999999999998999999999865331 2234567889999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||+++++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998888899999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC-CCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........|++.|+|||.+.... ++.++|+||||+++|+|++|..||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 155 ----------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred ----------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 00122456899999999987766 8999999999999999999999998776555544
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+.... ..+.++..+++.+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRSK-ELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHhcc-cCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 443322 334556778999999999999999999999 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=349.13 Aligned_cols=258 Identities=35% Similarity=0.559 Sum_probs=220.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 357999999999999999999999999999999886432 23456788999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||+++|+|..++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~----- 168 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE----- 168 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-----
Confidence 9999999999988654 5899999999999999999999999999999999999999999999999987631100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.++......
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 169 ----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred ----------------------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011234689999999999888899999999999999999999999988877655544
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.....+....+..+++.+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 444433333345678999999999999999999999 7899999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=355.80 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=207.7
Q ss_pred EEEeeccC--CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 691 IIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 691 Ilk~LG~G--gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
++++||+| +|++||++.++.+|+.||+|.++... ........+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA-CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh-ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 78899999999999999999986532 2233456677899999999999999999999999999999999
Q ss_pred ccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 769 LNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 769 ~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~-~~---- 155 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN-HG---- 155 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccc-cc----
Confidence 9999999999653 4589999999999999999999999999999999999999999999999986542100 00
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
.. . ...........++..|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 156 ------~~-----~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 156 ------QR-----L----RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred ------cc-----c----cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 00 0 000001122357788999999976 468999999999999999999999998765544333
Q ss_pred hhhccCCCC-------------------------------------------CCCCCCCCHHHHHHHHhHccCCcCCCCC
Q 001614 925 NILNRKIPW-------------------------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1044)
Q Consensus 925 kIl~g~i~~-------------------------------------------p~ip~~iS~eLkdLIkkcLqkDPskRPS 961 (1044)
....+..+. ......+++++.+||.+||+.||.+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 332221110 0011235778999999999999999999
Q ss_pred hhhHHHHHcCCCCCCC
Q 001614 962 ANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 962 adeA~EIL~HPwFk~i 977 (1044)
+.++++||||+.+
T Consensus 301 ---~~ell~~p~f~~~ 313 (327)
T cd08227 301 ---ASTLLNHSFFKQI 313 (327)
T ss_pred ---HHHHhcChhhhhc
Confidence 7899999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=353.38 Aligned_cols=250 Identities=25% Similarity=0.444 Sum_probs=192.0
Q ss_pred EEeeccCCceEEEEEEEC--CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec--CCeeEEEEe
Q 001614 692 IKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 767 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k--~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed--~~~LyLVmE 767 (1044)
.++||+|+||.||+|+++ .+++.||+|.+.... ....+.+|+.+|++++||||+++++++.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 458999999999999976 367899999886432 22457789999999999999999998854 456899999
Q ss_pred eccccchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceee----cCCCcEEEeecCCc
Q 001614 768 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 834 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~---------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILL----dedg~VKLsDFGLA 834 (1044)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 996 5888887532 248899999999999999999999999999999999999 45678999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
....... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCC------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 7421000 00112234678999999999977 4589999999999999999999999
Q ss_pred CCCCCh---------HHHHHhhhcc-CCC----------CC------------------------CCCCCCCHHHHHHHH
Q 001614 914 FTAESP---------EIIFDNILNR-KIP----------WP------------------------CVPSDMSFEAQDLIN 949 (1044)
Q Consensus 914 F~g~s~---------~ei~qkIl~g-~i~----------~p------------------------~ip~~iS~eLkdLIk 949 (1044)
|..... ......+... ..+ ++ ......+.++.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 965432 1111111110 000 00 001123567899999
Q ss_pred hHccCCcCCCCChhhHHHHHcCCCC
Q 001614 950 RFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 950 kcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+||+.||.+||| +.++|+||||
T Consensus 296 ~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC---HHHHhcCCCC
Confidence 999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.31 Aligned_cols=254 Identities=32% Similarity=0.568 Sum_probs=218.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec--CCeeEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLV 765 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed--~~~LyLV 765 (1044)
+|++.+.||.|+||.||++.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc-CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5889999999999999999999999999999986533 234556788999999999999999999987754 4568999
Q ss_pred EeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLH-----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLH-----s~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
|||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 356899999999999999999999 89999999999999999999999999999874
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
.... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~~---------------------------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGHD---------------------------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccCC---------------------------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 2100 0011234689999999999888899999999999999999999999998
Q ss_pred CChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 917 ~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+.......+..+.. +..+...+..+.+|+.+||+.+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 887777776665543 4456788999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.96 Aligned_cols=275 Identities=39% Similarity=0.745 Sum_probs=227.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLV 765 (1044)
++|.+.+.||.|+||.||++....+|..||+|++.+...........+.+|+.+++++. ||||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999997654444555678899999999999 99999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~- 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE- 159 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987432111000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
..+ . ... .................|++.|+|||++....++.++|+||||+++|+|++|..||...+....+..
T Consensus 160 ~~~-~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 160 SNK-G-DAT----NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cCC-C-CCc----cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 000 0 000 0000000111233455789999999999888889999999999999999999999998887777777
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhH----HHHHcCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA----AEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA----~EIL~HPwF 974 (1044)
+...... .+..+++.+.+||.+||+.||.+||+ + .++++||||
T Consensus 234 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYS---FPPNFPPDAKDLIEKLLVLDPQDRLG---VNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCC---CCCccCHHHHHHHHHHhcCCHhhCCC---cccCHHHHhcCCCC
Confidence 6654443 34677999999999999999999999 6 799999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.78 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=219.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCc-eEEEeeeeecCC----
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRD---- 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPN-IVkL~gvfed~~---- 760 (1044)
...|..+++||+|+||+||+|+.+.+|+.||+|.++-.... +.......+|+.+|+.++|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888999999999999999999999999998753321 223456789999999999999 999999999888
Q ss_pred --eeEEEEeeccccchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 761 --NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 761 --~LyLVmEY~~GGSL~dlLkk~g----~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
.+|+||||++. +|..++...+ .++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 9999998655 5788899999999999999999999999999999999999999999999999
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
+.... +.......++|.+|.|||++.+. .|+...||||+|||++||+++++-
T Consensus 168 ra~~i---------------------------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFSI---------------------------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhcC---------------------------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 84210 11224456899999999999986 789999999999999999999999
Q ss_pred CCCCChHHHHHhhhcc-----CCCCCC-------------C---------CCCCCHHHHHHHHhHccCCcCCCCChhhHH
Q 001614 914 FTAESPEIIFDNILNR-----KIPWPC-------------V---------PSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g-----~i~~p~-------------i---------p~~iS~eLkdLIkkcLqkDPskRPSadeA~ 966 (1044)
|.+.+..+....|..- ...||. . .+..+++..+|+.+||+++|.+|.| +.
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S---a~ 297 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS---AK 297 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC---HH
Confidence 9999887776666531 111221 1 1233458899999999999999999 77
Q ss_pred HHHcCCCCCCCC
Q 001614 967 EVKAHPFFKGVN 978 (1044)
Q Consensus 967 EIL~HPwFk~id 978 (1044)
.+|.||||....
T Consensus 298 ~al~h~yf~~~~ 309 (323)
T KOG0594|consen 298 GALTHPYFSELP 309 (323)
T ss_pred HHhcChhhcccc
Confidence 889999999763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.21 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=217.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
+...+|.+.+.||.|+||.||+|.++.+++.||+|++... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4456799999999999999999999999999999998642 234567899999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999999753 358899999999999999999999999999999999999999999999999986421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 159 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 --------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred --------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 001112234678999999998889999999999999999998 99999988887
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
+....+.... . +..+..++.++.++|.+||+.||.+||++.++.+.|+.
T Consensus 213 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 213 QVYELLEKGY-R-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HHHHHHHCCC-C-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 7777765432 2 23457789999999999999999999998888777653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=389.39 Aligned_cols=151 Identities=57% Similarity=1.009 Sum_probs=141.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+++|.+.+.||.|+||.||+|.+..+++.||||++++...........+..|+.++..++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999875555555667899999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
|||+.||+|.+++...+.+++..++.++.||+.||.|||.+||+||||||+|||++.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=365.62 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=212.6
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tG-----k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~g 754 (1044)
.+....++|++.+.||+|+||.||+|++..+| ..||+|+++... .......+.+|+.+++.+ +||||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 33455678999999999999999999875443 579999986532 233456789999999999 8999999999
Q ss_pred eeecCCeeEEEEeeccccchHHHHHhc-----------------------------------------------------
Q 001614 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 781 (1044)
Q Consensus 755 vfed~~~LyLVmEY~~GGSL~dlLkk~----------------------------------------------------- 781 (1044)
+|...+.+|+|||||++|+|.+++...
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 999999999999999999999998642
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 782 -----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 782 -----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
..+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~--- 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--- 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc---
Confidence 136778889999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~ 923 (1044)
.........+++.|||||++.+..++.++|||||||++|+|++ |..||........+
T Consensus 267 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 267 ----------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred ----------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 0001112345678999999988899999999999999999997 99999877655444
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
..+...... +..+..+++++.++|.+||+.||.+||++.++.++|+
T Consensus 325 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 325 YKMVKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred HHHHHcccC-ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 444444333 2244567899999999999999999999888777654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.72 Aligned_cols=269 Identities=45% Similarity=0.837 Sum_probs=223.7
Q ss_pred CeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccC-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCee
Q 001614 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k---~tGk~VAVKiIkK~~~~~-~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~L 762 (1044)
+|++.+.||+|+||.||++++. .+++.||+|++++..... ......+.+|+.++.++ +||||+++++++.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999987543222 23446788999999999 599999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++|+||||.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999886421100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC--CCchhhhHHHHHHHHHHHhCCCCCCCCC--
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES-- 918 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~KSDIWSLGVILYELLTGr~PF~g~s-- 918 (1044)
........|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 160 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 160 -------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred -------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 01112346899999999987654 6889999999999999999999996432
Q ss_pred --hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhh
Q 001614 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 919 --~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~q 985 (1044)
..++...+..... ..+..++..+.++|.+||+.||++|||+.++.++|+||||+.++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~ 280 (288)
T cd05583 215 NSQSEISRRILKSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280 (288)
T ss_pred chHHHHHHHHHccCC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence 2333344444332 234668899999999999999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.50 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=212.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999998999999998865332 2234567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++++|..+......+++..+..++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------ 153 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC------
Confidence 99999999988877667999999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........+++.|+|||++.+ ..++.++||||||+++|+|++|.+||...+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 154 ---------------------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred ---------------------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 011123468899999999875 4578899999999999999999999987665433322
Q ss_pred hhcc-------------------CCCCCC---------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g-------------------~i~~p~---------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+... ....+. ..+.++..+.+||.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 2210 000010 12467889999999999999999999 7789999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.63 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=210.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~-----k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gv 755 (1044)
.....++|++.+.||+|+||.||+|++ ..++..||+|+++... .......+.+|+.+|..+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 344566899999999999999999975 3456789999986432 233456789999999999 89999999999
Q ss_pred eecCCeeEEEEeeccccchHHHHHhcC-----------------------------------------------------
Q 001614 756 FTCRDNLYLVMEYLNGGDLYSLLRKVG----------------------------------------------------- 782 (1044)
Q Consensus 756 fed~~~LyLVmEY~~GGSL~dlLkk~g----------------------------------------------------- 782 (1044)
+...+..|+|||||+||+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986421
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 783 ----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 783 ----------------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 3677888999999999999999999999999999999999999999999998742110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
.. ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 268 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~ 322 (375)
T cd05104 268 SN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322 (375)
T ss_pred cc-------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence 00 001112345678999999999899999999999999999998 8999987655
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+....... +..+...+.++.+||.+||+.||.+||++.++.+.|+
T Consensus 323 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 323 DSKFYKMIKEGYR-MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred hHHHHHHHHhCcc-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 4443333433332 2234567889999999999999999999887777664
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=363.20 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=212.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC--CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k--~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
...+|.+.+.||.|+||.||++... .++..||+|.+... ....+|+.+|+.++||||++++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999764 34678999987542 2346899999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+|||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~- 239 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP- 239 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc-
Confidence 99999995 6899999777889999999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh---
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~--- 919 (1044)
.........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+...
T Consensus 240 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 295 (392)
T PHA03207 240 ------------------------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295 (392)
T ss_pred ------------------------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence 01112245799999999999998999999999999999999999999976532
Q ss_pred HHHHHhhhcc----CC-------------------------CCCC--CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 920 EIIFDNILNR----KI-------------------------PWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 920 ~ei~qkIl~g----~i-------------------------~~p~--ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
...+..+... .. ..+. ....++.++++||.+||..||.+||| +.++
T Consensus 296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps---a~e~ 372 (392)
T PHA03207 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS---AQDI 372 (392)
T ss_pred HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---HHHH
Confidence 1111111110 00 0000 01245678999999999999999999 8899
Q ss_pred HcCCCCCCCCcchhH
Q 001614 969 KAHPFFKGVNWDSLA 983 (1044)
Q Consensus 969 L~HPwFk~id~d~L~ 983 (1044)
|.||||....|+.+.
T Consensus 373 l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 373 LSLPLFTKEPINLLN 387 (392)
T ss_pred hhCchhhccchhhhc
Confidence 999999988887653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=377.16 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=233.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe-eEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYL 764 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~-LyL 764 (1044)
.++|..++++|+|+||.+++++++.++..|++|.+.-.. ......+...+|+.+++++.|||||.+++.|...+. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~-~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK-LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc-cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 578999999999999999999999999999999997544 344456688999999999999999999999999998 999
Q ss_pred EEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||+||+||+|.+.|.+. ..++++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--- 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--- 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC---
Confidence 99999999999999754 4699999999999999999999999999999999999999999999999999996321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
......+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|...+....
T Consensus 159 ------------------------~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 159 ------------------------EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred ------------------------chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 11133467999999999999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
..+|..+.+ ..+|...+.+++.||+.||..+|..||+ +.++|.+|.+..
T Consensus 215 i~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 215 ILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLLR 263 (426)
T ss_pred HHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhhh
Confidence 999998873 4467889999999999999999999999 889999998863
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=337.93 Aligned_cols=259 Identities=32% Similarity=0.523 Sum_probs=213.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-------ChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~-------~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
+|.+.+.||.|+||.||+|....+|+.||+|.++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999989999999988642111 1112456888999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~- 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD- 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc-
Confidence 9999999999999999999888899999999999999999999999999999999999999999999999999863110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC--CCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
. ..........|+..|+|||++.... ++.++|+||||+++|+|++|..||....
T Consensus 161 -~-----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 161 -I-----------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred -c-----------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 0 0001122346889999999987654 7889999999999999999999997666
Q ss_pred hHHHHHhhhccCCC--CC-CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 919 PEIIFDNILNRKIP--WP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~--~p-~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.......+...... ++ .....++.++.+||.+||..+|.+||+ +.++|+||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 55444333322211 11 122356899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.53 Aligned_cols=258 Identities=35% Similarity=0.599 Sum_probs=221.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|++|.||++.+..+|+.||+|.+..... ......+.+|+.++.+++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 478999999999999999999999999999999865322 145678999999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~----- 153 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT----- 153 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC-----
Confidence 999999999999887889999999999999999999999 99999999999999999999999999988642100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---ChHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEII 922 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~---s~~ei 922 (1044)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+.
T Consensus 154 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 154 ----------------------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred ----------------------CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 00112346889999999999888999999999999999999999999777 34455
Q ss_pred HHhhhccCCCCCCCCCC-CCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~-iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
...+..... +..+.. ++..+.++|.+||..+|.+||+ +.++++||||+.++
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 212 MQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 555543322 233445 8899999999999999999999 88999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=336.79 Aligned_cols=256 Identities=30% Similarity=0.452 Sum_probs=208.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..+++.....||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344555567899999999999999989999999988643 23456788999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCccccccc
Q 001614 765 VMEYLNGGDLYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~-g~L--see~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLAki~~~~ 840 (1044)
||||+++++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999999764 445 78888899999999999999999999999999999986 679999999987632100
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
........|++.|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus 163 ---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 163 ---------------------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ---------------------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 0011223588999999998664 37889999999999999999999997654
Q ss_pred hHH-HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 919 PEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 919 ~~e-i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
... ....+.... ..+.++..+++++++||.+||+.+|.+||| +.+++.||||
T Consensus 216 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 216 EPQAAMFKVGMFK-IHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred ChhhhHhhhhhhc-cCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 322 111111111 123456778999999999999999999999 8889999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.84 Aligned_cols=257 Identities=36% Similarity=0.578 Sum_probs=213.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999876432 23345678999999999999999999999999999999999
Q ss_pred eccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 768 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 768 Y~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|+ +++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE----- 153 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-----
Confidence 99 9999999865 3568999999999999999999999999999999999999999999999999886421000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+....+..
T Consensus 154 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 154 ---------------------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred ---------------------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 0112234689999999998754 468899999999999999999999987776555444
Q ss_pred hhccC-------------------CCCC--------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 926 ILNRK-------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 926 Il~g~-------------------i~~p--------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
+.... ..++ ......+..+.+||.+||+.||.+||+ +.+++.||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 33210 0011 112356789999999999999999999 88999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.91 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=210.9
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeec----
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC---- 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed---- 758 (1044)
...+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.++.++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3457899999999999999999999999999999988642 23446688899999998 69999999999853
Q ss_pred --CCeeEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 759 --RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 759 --~~~LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
...+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45789999999999999999753 45888889999999999999999999999999999999999999999999987
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHh
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 909 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLT 909 (1044)
..... .........|++.|+|||++. +..++.++|||||||++|+|++
T Consensus 169 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 169 AQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred hhhhc---------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 63110 001123456899999999986 3467889999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
|..||....+......+...... ......++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 222 g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 222 GAPPLCDMHPMRALFLIPRNPPP-KLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred CCCCccccCHHhhhhhHhhCCCC-CCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 99999877655444433332211 2223468899999999999999999999 7899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.67 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=215.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~-----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4578999999999999999998753 35789999986532 2334578999999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcE
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g--------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~V 826 (1044)
.+|+||||+++|+|.+++...+ .+++..+..++.||+.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997543 37888899999999999999999999999999999999999999
Q ss_pred EEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHH
Q 001614 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1044)
Q Consensus 827 KLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYE 906 (1044)
||+|||++........ ........+++.|+|||++.+..++.++|||||||++|+
T Consensus 162 kl~d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216 (280)
T ss_pred EECCcccceecccCcc-------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHH
Confidence 9999999863210000 001123346789999999999899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 907 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 907 LLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|++ |..||.+.+.......+..+... ..+..++..+.+||.+||+.||.+||+++++.+.|
T Consensus 217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 217 IFTYGKQPWYGLSNEEVIECITQGRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 998 99999988888887777765543 23467899999999999999999999977776665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=332.29 Aligned_cols=258 Identities=37% Similarity=0.628 Sum_probs=215.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++||||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999998999999999876432 24567889999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~----- 154 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT----- 154 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC-----
Confidence 999999999998877799999999999999999999999999999999999999999999999999874211110
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC---CCchhhhHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 923 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~---ys~KSDIWSLGVILYELLTGr~PF~g~s~-~ei~ 923 (1044)
..........+++.|+|||++.+.. ++.++||||||+++|+|++|..||..... ....
T Consensus 155 ------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~ 216 (264)
T cd06626 155 ------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216 (264)
T ss_pred ------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH
Confidence 0000012356889999999998765 78899999999999999999999976533 3333
Q ss_pred HhhhccCCCCCCCCC--CCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNRKIPWPCVPS--DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~--~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+..+. .+.+|. .+++.+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 217 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGAGH--KPPIPDSLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHhcCC--CCCCCcccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 2333222 122333 35899999999999999999999 8899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.80 Aligned_cols=258 Identities=30% Similarity=0.509 Sum_probs=207.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHH-HHhcCCCceEEEeeeeecCCeeEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~I-Ls~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
++|++.+.||+|+||.||++.++.+|+.||+|.++... . ......+..|+.+ ++.++||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~-~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV-N-SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC-C-cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987532 1 2233455666665 6677899999999999999999999
Q ss_pred EeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
|||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99996 588887754 24689999999999999999999997 999999999999999999999999999863110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC----CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g----~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
........|++.|+|||++.+ ..++.++|+|||||++|+|++|..||..
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 ---------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ---------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 001122468899999999864 4568899999999999999999999975
Q ss_pred C-ChHHHHHhhhccCCCCCCC-CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 917 E-SPEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 917 ~-s~~ei~qkIl~g~i~~p~i-p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
. ...+....+..+.. +.. ...+|.++.+||.+||..+|.+||+ +.+++.||||....++
T Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPS--PQLPAEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCC--CCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 3 22233333333221 222 2457899999999999999999999 7889999999876544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=335.18 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=211.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||+|+||.||++.++. +..+|+|.+.+.. .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4679999999999999999998864 5689999876432 2245788999999999999999999999999999999
Q ss_pred EeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc---
Confidence 999999999999975 3568999999999999999999999999999999999999999999999999886321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~ 923 (1044)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+..
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05114 155 -----------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV 211 (256)
T ss_pred -----------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 001112245678999999988889999999999999999999 99999998888888
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
..+..+... ..+...+..+.+|+.+||+.||.+||+++++.+.|
T Consensus 212 ~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 212 EMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 777765432 23456788999999999999999999977766554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=339.51 Aligned_cols=258 Identities=33% Similarity=0.543 Sum_probs=213.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|.+..+++.||+|.++... ........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999886532 23334577899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++++.|..++.+...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~----- 154 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP----- 154 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc-----
Confidence 999998887777766779999999999999999999999999999999999999999999999999986421000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........+++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+....
T Consensus 155 ---------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 155 ---------------------ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred ---------------------cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112234688999999999887 789999999999999999999999987665443322
Q ss_pred hhccC-------------------CCCC----------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNRK-------------------IPWP----------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~-------------------i~~p----------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+.... ..++ ..+..++.++.+||++||..+|.+||+ +.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~f 288 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPYF 288 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCCC
Confidence 21100 0000 012335889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=341.95 Aligned_cols=269 Identities=43% Similarity=0.810 Sum_probs=221.6
Q ss_pred CeEEEEeeccCCceEEEEEEEC---CCCcEEEEEEeecccccC-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCee
Q 001614 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k---~tGk~VAVKiIkK~~~~~-~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~L 762 (1044)
+|++.+.||.|+||.||++.+. .+|..||+|+++...... ....+.+.+|+.++..+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478999999987533221 22346778899999999 589999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999886321100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCC--
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-- 918 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~s-- 918 (1044)
........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+
T Consensus 160 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 160 -------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred -------------------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 011123568999999999875 346789999999999999999999996433
Q ss_pred --hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhh
Q 001614 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 985 (1044)
Q Consensus 919 --~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~q 985 (1044)
...+...+.....+ .+..+++.+.+|+.+||+.||.+||+. ..+.+++.||||..++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 215 NSQAEISRRILKSEPP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred ccHHHHHHHhhccCCC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 23344444443333 346788999999999999999999852 34889999999999999887543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=383.17 Aligned_cols=258 Identities=33% Similarity=0.588 Sum_probs=232.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
-|.++..||.|+||+||++..+.++-..|.|+|.. ....+.+.++-|++||..++||+||++++.|..++.++|+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 46788899999999999999999999999998853 456788999999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||.||-+..++-.- ..+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+...
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--------- 180 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--------- 180 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc---------
Confidence 99999998887654 46999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
.....+..+++|||+|||||+.. ..+|++++||||||++|.||.-+.+|-...+++.
T Consensus 181 ------------------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR 242 (1187)
T KOG0579|consen 181 ------------------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 242 (1187)
T ss_pred ------------------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH
Confidence 11233556789999999999975 4689999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
++-+|.+...+-...|..++..+.+|+++||.+||..||+ +.++|+||||.+++
T Consensus 243 VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 243 VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCC
Confidence 9999998887766678899999999999999999999999 88999999998753
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.38 Aligned_cols=255 Identities=34% Similarity=0.576 Sum_probs=217.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||++.++.+++.+|+|.+.... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 46888899999999999999999999999999987532 2345577899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~----- 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----- 153 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH-----
Confidence 999999999999876 779999999999999999999999 9999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-----Ch
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-----SP 919 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~-----s~ 919 (1044)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||... ..
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred ------------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 0011156889999999999889999999999999999999999999754 23
Q ss_pred HHHHHhhhccCCCCCCCCCC-CCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 920 EIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~-iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
......+..... +..+.. ++.++.+||.+||..||.+||| +.+++.||||+..
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~~ 263 (265)
T cd06605 210 FELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhcc
Confidence 334444443322 233333 8899999999999999999999 8889999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=359.88 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=201.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
...+|++.+.||+|+||.||+|.+..+++.||+|+..+. ....|+.++++++||||+++++++......|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999999999999999975431 23568999999999999999999999999999
Q ss_pred EEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 209 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---- 209 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc----
Confidence 999995 588888865 45689999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCC-CCCCCh---
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAESP--- 919 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~P-F~g~s~--- 919 (1044)
........||+.|+|||++.+..++.++|||||||++|+|+++..| |.....
T Consensus 210 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~ 265 (357)
T PHA03209 210 ------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265 (357)
T ss_pred ------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHH
Confidence 0111235699999999999998999999999999999999986544 433211
Q ss_pred ------HHHHHhhhcc-C---CCCC-----------------------C----CCCCCCHHHHHHHHhHccCCcCCCCCh
Q 001614 920 ------EIIFDNILNR-K---IPWP-----------------------C----VPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1044)
Q Consensus 920 ------~ei~qkIl~g-~---i~~p-----------------------~----ip~~iS~eLkdLIkkcLqkDPskRPSa 962 (1044)
...+..+... . ..++ . ....++.++.+||.+||+.||.+|||
T Consensus 266 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt- 344 (357)
T PHA03209 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS- 344 (357)
T ss_pred HHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC-
Confidence 0111111110 0 0011 0 01245677888999999999999999
Q ss_pred hhHHHHHcCCCCCCC
Q 001614 963 NGAAEVKAHPFFKGV 977 (1044)
Q Consensus 963 deA~EIL~HPwFk~i 977 (1044)
+.++|+||||+.+
T Consensus 345 --a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 --AEEILNYPMFAQL 357 (357)
T ss_pred --HHHHhcCchhccC
Confidence 8899999999853
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.36 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=213.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||++.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++...+.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999887654444555678899999999999999999999999999999999
Q ss_pred eeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 767 EY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999999863 345899999999999999999999999999999999999999999999999987642100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh--H
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--E 920 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~--~ 920 (1044)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+... .
T Consensus 160 -------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 0111234689999999999888899999999999999999999999976543 3
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
.....+.....+ +..+..+++.+++||.+||..||.+|||+.++.+.+
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 215 SLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 334444333222 222346888999999999999999999987776655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=332.92 Aligned_cols=249 Identities=28% Similarity=0.520 Sum_probs=213.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||++.+..+++.||+|.++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986532 23355778899999999999999999999999999999999
Q ss_pred eccccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~------ 152 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS------ 152 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc------
Confidence 9999999999864 34588999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 153 ---------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ---------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 00111234689999999999888899999999999999999999999998887777777
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+..+... ..+..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 212 VCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred HhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 6655433 345678899999999999999999999 545553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.91 Aligned_cols=255 Identities=30% Similarity=0.503 Sum_probs=214.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
++|++.+.||.|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999987544444455678999999999999999999999999999999999
Q ss_pred eeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 767 EY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999999864 245889999999999999999999999999999999999999999999999987632100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--hH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 920 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s--~~ 920 (1044)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||.... ..
T Consensus 160 -------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 011123468899999999998889999999999999999999999996543 33
Q ss_pred HHHHhhhccCCCCCCCCC-CCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~-~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+..+.. +..+. .++..+.++|.+||..+|.+|||+.++.+.++
T Consensus 215 ~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 215 SLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred HHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 44444444332 22333 67889999999999999999999887777664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=358.08 Aligned_cols=268 Identities=30% Similarity=0.534 Sum_probs=229.1
Q ss_pred CCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEE
Q 001614 687 DDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 687 ~dY~Il-k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyL 764 (1044)
+-|++. +.||+|+|+.|..+....+|..||||++.|. ......++++|++++..++ |+||++++++|+++.++||
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 345553 5799999999999999999999999999874 2445678999999999996 9999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC---cEEEeecCCcccccccC
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg---~VKLsDFGLAki~~~~~ 841 (1044)
|||-|.||+|..+|++...|++.++..+.++|+.||.|||.+||.||||||+|||..... -||||||.|..-...++
T Consensus 154 VfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred EEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999997665 48999999875322222
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
.. + | .......+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+
T Consensus 234 ~~--s-p-----------------astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 234 DC--S-P-----------------ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CC--C-C-----------------CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 11 1 0 1122345679999999999863 24689999999999999999999999965
Q ss_pred CC---------------hHHHHHhhhccCCCCCCC-CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 917 ES---------------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 917 ~s---------------~~ei~qkIl~g~i~~p~i-p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
.- ...++..|..+.+.||.- +..+|.++++||+.+|.+|+.+|.+ +.++++|||++....+
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPE 370 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchh
Confidence 31 367888999999998864 4579999999999999999999999 8899999999986444
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=342.72 Aligned_cols=259 Identities=33% Similarity=0.503 Sum_probs=213.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc--ChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~--~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+|++.+.||.|+||.||+|.+..+|+.||+|.++..... .......+..|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999764322 122345677899999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----- 154 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC-----
Confidence 9999 899999998766 799999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.........+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 155 ----------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred ----------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 0011123356889999999865 45788999999999999999999889877765544
Q ss_pred HhhhccCC-------------------------CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 924 DNILNRKI-------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 924 qkIl~g~i-------------------------~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.++..... +........+..+.+||.+||+.||.+||| +.+++.||||.+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~~~ 288 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFSND 288 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCccccCC
Confidence 44432100 000012346788999999999999999999 8889999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.66 Aligned_cols=257 Identities=38% Similarity=0.614 Sum_probs=219.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--CeeEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLV 765 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~LyLV 765 (1044)
+|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.++++++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 48889999999999999999998999999999875432 245578899999999999999999999999988 889999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998887899999999999999999999999999999999999999999999999999874221110
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-hHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s-~~ei~q 924 (1044)
........++..|+|||.+.+..++.++||||||+++|+|++|..||.... ......
T Consensus 157 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (260)
T cd06606 157 ----------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214 (260)
T ss_pred ----------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 001223568899999999988889999999999999999999999998765 333333
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+.. ....+.++..++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 215 ~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 215 KIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred hccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 3332 22334566778999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=337.78 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=211.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed 758 (1044)
...++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34578999999999999999999864 235689999885422 22345678899999999999999999999999
Q ss_pred CCeeEEEEeeccccchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEE
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk~g----------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKL 828 (1044)
....++||||+++|+|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999997532 2567788889999999999999999999999999999999999999
Q ss_pred eecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHH
Q 001614 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 829 sDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELL 908 (1044)
+|||++........ ........+++.|||||++.+..++.++|||||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999863211000 00111235678899999999888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 909 T-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+ |..||.+.+.......+..... +..+..++..+.+||.+||+.||.+|||+.++.+.+
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 9 7999998888777776665543 334567889999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.91 Aligned_cols=254 Identities=35% Similarity=0.656 Sum_probs=222.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||++.+..++..||+|++.... ........+.+|+++++.++|||++++++.+.....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc-CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 5889999999999999999999999999999986532 234566788999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 768 YLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~----g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--- 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--- 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC---
Confidence 99999999999764 67999999999999999999999999999999999999999999999999988642100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
........|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 157 ------------------------VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred ------------------------cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 01122346899999999998888999999999999999999999999888877777
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+.... .+..+..++..+.++|.+||..+|.+||+ +.++|.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 7766554 34456688999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.38 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=215.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tG-----k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed 758 (1044)
+..++|++.+.||.|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 45678999999999999999999986443 789999976432 23345678899999999999999999999999
Q ss_pred CCeeEEEEeeccccchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEE
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk~g----------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKL 828 (1044)
....|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999996432 3677889999999999999999999999999999999999999999
Q ss_pred eecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHH
Q 001614 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 829 sDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELL 908 (1044)
+|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred CCcccchhhccCcc-------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence 99999864211000 01112345678999999998888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 909 T-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+ |..||.+.+.......+..+.. +..|..++.++.+||.+||+.+|.+|||+.++.+.|+
T Consensus 216 t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 216 TLAEQPYQGLSNEEVLKFVIDGGH--LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ccCCCCCccCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 8 9999998888887777764432 3345678999999999999999999999777766553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=338.76 Aligned_cols=255 Identities=33% Similarity=0.540 Sum_probs=208.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.+..+|+.||+|.++... ........+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999886432 222334578899999999999999999999999999999999
Q ss_pred eccccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 996 589988865 356899999999999999999999999999999999999999999999999987631100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC-CCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........+++.|+|||++.+.. ++.++||||||+++|+|+||+.||.+.+......
T Consensus 154 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 154 ----------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ----------------------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 00112235788999999987644 6889999999999999999999998776544333
Q ss_pred hhhccC-C-----------------CCC--------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRK-I-----------------PWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~-i-----------------~~p--------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
++.... . .++ .....+++++++||.+||+.||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 322110 0 000 012357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.06 Aligned_cols=257 Identities=22% Similarity=0.371 Sum_probs=213.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
..++|++.+.||+|+||.||+|.+. .++..||+|.++.. ........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3578999999999999999999863 35578999988642 23345567889999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~-----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded 823 (1044)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 236788889999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHH
Q 001614 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1044)
Q Consensus 824 g~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (1044)
+.+||+|||+++....... ........++..|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 9999999999874211100 001123346778999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 904 LYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+|+|++ |..||.+.+...+...+..... +..+..+++.+.++|.+||+.||.+||+++++.+.|.
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 999998 9999988887776666654432 2345678999999999999999999999877766553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.31 Aligned_cols=257 Identities=32% Similarity=0.515 Sum_probs=207.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCe----
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN---- 761 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~---- 761 (1044)
++|++.+.||.|+||.||+|.+..+|+.||+|.++... ........+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999876532 22223457888999999995 6999999999987766
Q ss_pred -eEEEEeeccccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCc
Q 001614 762 -LYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLS 834 (1044)
Q Consensus 762 -LyLVmEY~~GGSL~dlLkk~-----g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLA 834 (1044)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 898888642 35799999999999999999999999999999999999998 889999999988
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
..... .........+++.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 159 ~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCC---------------------------CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 63210 0001122357889999999865 4578999999999999999999999
Q ss_pred CCCCChHHHHHhhhccCC-----CC------------CC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 914 FTAESPEIIFDNILNRKI-----PW------------PC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i-----~~------------p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
|.+.+.......+..... .+ +. ..+.++.++.+||.+||..||.+||+ +.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~~ei 288 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---AKAA 288 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---HHHH
Confidence 988776554444332100 00 00 11357889999999999999999999 7899
Q ss_pred HcCCCCC
Q 001614 969 KAHPFFK 975 (1044)
Q Consensus 969 L~HPwFk 975 (1044)
+.||||+
T Consensus 289 l~~~~~~ 295 (295)
T cd07837 289 LTHPYFD 295 (295)
T ss_pred hcCCCcC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.88 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=214.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
+..++|++.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999875 5678999987642 223567899999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+||||+++|+|.+++... ..++...+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999753 457888899999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 158 --------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred --------------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 001112346778999999988889999999999999999998 99999988877
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+... ..++ .+..++.++.+||.+||..+|.+||+++++.++|+
T Consensus 212 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 212 DVMSALQRG-YRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 777666544 2323 33568899999999999999999999888887764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.72 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=216.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||+|+||.||++.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3468999999999999999999999999999999886432 23446788999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+++|+|.+++.+.+.+++..+..++.+++.||.|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999888889999999999999999999997 5899999999999999999999999998753100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH---
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE--- 920 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~--- 920 (1044)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 157 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~ 211 (284)
T cd06620 157 -------------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211 (284)
T ss_pred -------------------------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh
Confidence 0112346899999999998888999999999999999999999999865542
Q ss_pred --------HHHHhhhccCCCCCCCCC-CCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 921 --------IIFDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 921 --------ei~qkIl~g~i~~p~ip~-~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
.....+..... +.++. .++.++.+||.+||+.||.+||| +.++++||||..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 212 QDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 22333332221 11222 37889999999999999999999 788999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.19 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=217.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc--ccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--Cee
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~--~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~L 762 (1044)
.+|++.+.||+|+||.||++.+..+|+.||+|.+.... .........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875321 12234567889999999999999999999998764 468
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
+++|||+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
. ..........|++.|+|||++.+..++.++|+|||||++|+|++|+.||........
T Consensus 160 -----------~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 160 -----------C-----------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred -----------c-----------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 0 000111234689999999999988889999999999999999999999988776666
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..++.....+ +.+|..+++.+.++|.+||+ +|.+||+ +.+++.|||.
T Consensus 218 ~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 6555443322 45678899999999999999 5799999 7799999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=361.86 Aligned_cols=255 Identities=33% Similarity=0.541 Sum_probs=211.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----e
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 761 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~-----~ 761 (1044)
-.|.-.+.+|.|+||.||+|....+++.||||.+-... +.-.+|+.+|+.++|||||++..+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 35888899999999999999999999999999775422 23357999999999999999998886532 3
Q ss_pred eEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC-CcEEEeecCCccc
Q 001614 762 LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKI 836 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded-g~VKLsDFGLAki 836 (1044)
+.+|||||+. +|+.+++. ...++.-.++.|..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 5689999986 99999874 4668889999999999999999999999999999999999976 8999999999986
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
...++ ...+...|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.
T Consensus 176 L~~~e----------------------------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 176 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred eccCC----------------------------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 42211 2234567899999999987 679999999999999999999999999
Q ss_pred CCChHHHHHhhhcc-----------------CCCCCC---------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 916 AESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 916 g~s~~ei~qkIl~g-----------------~i~~p~---------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|.+....+..|.+- ...+|. .....++++.+|+.++|+++|.+|.+ +.++|
T Consensus 228 G~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~~~l 304 (364)
T KOG0658|consen 228 GDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---ALEAL 304 (364)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HHHHh
Confidence 98876665555431 111111 23568999999999999999999999 88999
Q ss_pred cCCCCCCCCcc
Q 001614 970 AHPFFKGVNWD 980 (1044)
Q Consensus 970 ~HPwFk~id~d 980 (1044)
.||||....-.
T Consensus 305 ~h~fFdelr~~ 315 (364)
T KOG0658|consen 305 AHPFFDELRDP 315 (364)
T ss_pred cchhhHHhhCc
Confidence 99999876444
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.88 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=215.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
..++|.+.+.||.|+||.||++... .++..||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3468999999999999999999853 34567999988642 234567799999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcE
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g-------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~V 826 (1044)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997543 38999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHH
Q 001614 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (1044)
Q Consensus 827 KLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYE 906 (1044)
||+|||++........ ........+++.|+|||++.+..++.++|||||||++|+
T Consensus 160 kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 160 KIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred EeccCCccccccCCce-------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 9999999863210000 001122346789999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 907 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 907 LLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|++ |..||...+.......+..+... ..+..++.++.+|+.+||+.||.+|||+.++...|+
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 998 99999988888888887766532 234568899999999999999999999887766664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.43 Aligned_cols=254 Identities=29% Similarity=0.517 Sum_probs=217.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||+|.++.+|..||+|.+.... ......+.+.+|+.+++.++||||+++++.+.....+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh-ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5889999999999999999999999999999986532 223345678899999999999999999999999999999999
Q ss_pred eccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeecCCcccccccCccc
Q 001614 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDFGLAki~~~~~t~d 844 (1044)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||++++++ .+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----- 154 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC-----
Confidence 999999999997643 478999999999999999999999999999999999999886 469999998863210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 155 ----------------------SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ----------------------CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0001123458999999999988889999999999999999999999998887777666
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+..... +..+..++.++.++|.+||..+|.+||| +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 6655443 3344678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.01 Aligned_cols=256 Identities=31% Similarity=0.551 Sum_probs=219.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|...+.||.|++|.||++.+..+++.+|+|.+... .......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 355567999999999999999989999999987532 23345668899999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|++|++|.+++.. +.+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-------- 167 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------- 167 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--------
Confidence 9999999999987 6789999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl 927 (1044)
.........|++.|+|||.+.+..++.++||||||+++|+|++|..||...++......+.
T Consensus 168 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 168 -------------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred -------------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 0011123568999999999988889999999999999999999999998888777777666
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 928 ~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
....+....+..++..+.+||.+||+.+|.+||+ +.+++.||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 229 DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred hcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 5543333333457899999999999999999999 8899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.85 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=206.9
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
+.||+|+||.||+|.++.+|+.||+|.+... ........+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3699999999999999999999999987642 23445577999999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 773 SL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~~--------- 148 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-GV--------- 148 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-cc---------
Confidence 999999764 4589999999999999999999999999999999999999999999999999763110 00
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~ 930 (1044)
. ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+....
T Consensus 149 --~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 149 --Y-------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred --c-------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 0 000011123567999999998889999999999999999998 999998877766655554432
Q ss_pred CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 931 i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+ ...+..++..+.+|+.+||+.||.+|||++++.+.|+
T Consensus 214 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 -R-LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -C-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2 2345678899999999999999999999888777653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.62 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=209.7
Q ss_pred eeccCCceEEEEEEE--CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 694 PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~--k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
.||+|+||.||+|.+ ..++..+|+|+++.. .......+.+.+|+.+++.++||||+++++++. .+.+++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999975 456789999998643 233445678999999999999999999999875 4567999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 772 GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~--------- 150 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN--------- 150 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC---------
Confidence 99999998878899999999999999999999999999999999999999999999999999864210000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~ 930 (1044)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||...+.......+..+.
T Consensus 151 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~ 215 (257)
T cd05116 151 ---------------YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215 (257)
T ss_pred ---------------eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 0001112245689999999988889999999999999999998 999999888887777776554
Q ss_pred CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 931 i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
. +..|..+++++++||.+||+.||.+||+++++.+.|+.=
T Consensus 216 ~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 R--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2 335677999999999999999999999988888777643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.59 Aligned_cols=263 Identities=34% Similarity=0.570 Sum_probs=224.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..+.|++...||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++||||+++++++.....+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34568889999999999999999998899999999875321 45678899999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 999999999999998876 7999999999999999999999999999999999999999999999999987531100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
........+++.|+|||++.+..++.++|+||||+++|+|++|..||...++....
T Consensus 170 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 170 ------------------------KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred ------------------------hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 00112345789999999998888999999999999999999999999888776665
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcch
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~ 981 (1044)
..+.....+....+..++..+++||.+||+.+|.+||+ +.+++.||||+...|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCchH
Confidence 55554443322223448899999999999999999999 78899999999866553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=372.77 Aligned_cols=261 Identities=33% Similarity=0.576 Sum_probs=236.8
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~ 761 (1044)
.......|.+..+||+|.|++|.++++..+|..||||++.+.... ......+.+|+++|+.++|||||+++.+...+..
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 345678899999999999999999999999999999999886544 3344568999999999999999999999999999
Q ss_pred eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+|+||||+.+|.+++++.+.+.+.+..++.++.|+++|++|||+++|+|||||.+|||++.+.++||+|||++.++.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCC-CchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
......+.||+|.|.|||++.+..| ++.+|+||+|++||-|+.|.+||.+.+..
T Consensus 207 -------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 207 -------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred -------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 1224457899999999999999777 67999999999999999999999999988
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.....+.+.++.| ..++.++++||+++|..+|.+|++ +.++.+|.|.+..
T Consensus 262 ~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 262 ELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRNDL 312 (596)
T ss_pred cccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccchh
Confidence 88888888887754 678899999999999999999999 8889999999753
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.81 Aligned_cols=256 Identities=30% Similarity=0.566 Sum_probs=215.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC---CCceEEEeeeeecCCeeEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~---HPNIVkL~gvfed~~~LyL 764 (1044)
.|++.+.||.|+||.||+|.+..+|+.||+|.++... .......+.+|+.+++.+. ||||+++++++.....+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999986422 2344567889999999996 9999999999999999999
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
||||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....+
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN---- 154 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC----
Confidence 9999999999999866 47899999999999999999999999999999999999999999999999988642110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 155 -----------------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred -----------------------ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 011223468999999999875 45688999999999999999999999887765555
Q ss_pred HhhhccCCCCCCCCC-CCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 924 DNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~-~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
..+.... .+..+. .++.++.++|.+||+.||.+||+ +.+++.||||+...
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 212 MLIPKSK--PPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred hccccCC--CCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 4433322 223333 37889999999999999999999 88889999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.50 Aligned_cols=250 Identities=52% Similarity=0.955 Sum_probs=219.6
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||.|+||.||++.+..+++.||+|++++...........+..|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999999876554455677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCC
Q 001614 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1044)
Q Consensus 775 ~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~ 854 (1044)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-------------- 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-------------- 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--------------
Confidence 999988878999999999999999999999999999999999999999999999999988642100
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCC
Q 001614 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (1044)
Q Consensus 855 ~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p 934 (1044)
........|+..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+.....+
T Consensus 147 -------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 211 (250)
T cd05123 147 -------------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR-- 211 (250)
T ss_pred -------------CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--
Confidence 01223456889999999998888899999999999999999999999888777777777664443
Q ss_pred CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 935 ~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+..++..+.+||++||..||.+||++..+.++++||||
T Consensus 212 -~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 -FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 446678999999999999999999995445899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.47 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=190.9
Q ss_pred EEeeccCCceEEEEEEECC--CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec--CCeeEEEEe
Q 001614 692 IKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 767 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~--tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed--~~~LyLVmE 767 (1044)
..+||+|+||.||+|+++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3589999999999999764 56799999886432 22457789999999999999999998854 557899999
Q ss_pred eccccchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceee----cCCCcEEEeecCCc
Q 001614 768 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 834 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~---------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILL----dedg~VKLsDFGLA 834 (1044)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9865 888887521 247889999999999999999999999999999999999 45678999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
+...... ..........||+.|+|||++.+ ..++.++|||||||++|+|+||.+|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~ 215 (317)
T cd07867 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCc------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence 7421000 00112234578999999999976 4578999999999999999999999
Q ss_pred CCCCChH---------HHHHhhhcc----------------------------CCC-------CCCCCCCCCHHHHHHHH
Q 001614 914 FTAESPE---------IIFDNILNR----------------------------KIP-------WPCVPSDMSFEAQDLIN 949 (1044)
Q Consensus 914 F~g~s~~---------ei~qkIl~g----------------------------~i~-------~p~ip~~iS~eLkdLIk 949 (1044)
|...... .....+... ... ........+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 295 (317)
T cd07867 216 FHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295 (317)
T ss_pred cccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHH
Confidence 9654321 001110000 000 00011224567889999
Q ss_pred hHccCCcCCCCChhhHHHHHcCCCC
Q 001614 950 RFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 950 kcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+||+.||.+||| +.|+|+||||
T Consensus 296 ~~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 296 KLLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HHhccCcccccC---HHHHhcCCCC
Confidence 999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.25 Aligned_cols=252 Identities=38% Similarity=0.641 Sum_probs=214.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999875332 356788999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|+++++|.+++... ..+++..+..++.|++.||+|||..|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------ 151 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT------ 151 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc------
Confidence 99999999999776 57999999999999999999999999999999999999999999999999988632100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+
T Consensus 152 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 152 ----------------------KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ----------------------ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 0023456889999999998888899999999999999999999999887655544444
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
.....+....+..++..+.++|.+||+.||.+||| +.+++.|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 210 ATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 33222211112234889999999999999999999 889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=337.88 Aligned_cols=256 Identities=31% Similarity=0.536 Sum_probs=218.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|+..+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.+.||||+++++++.+...+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999999899999999987532 2345678899999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||++||+|.+++.. +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------ 154 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC------
Confidence 99999999999865 56899999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
........++..|+|||++.+..++.++|+|||||++|+|++|..||...++......+
T Consensus 155 ---------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 155 ---------------------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred ---------------------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 00112346888999999998888999999999999999999999999887776665544
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.... .+..+..++..+.+||.+||+.+|.+||+ +.+++.||||...
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 259 (277)
T cd06640 214 PKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKN 259 (277)
T ss_pred hcCC--CCCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhc
Confidence 3332 23445567889999999999999999999 7889999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.41 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=205.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999998999999999865321 1123456789999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 155 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---- 155 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC----
Confidence 9999975 999988754 4689999999999999999999999999999999999999999999999998763100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCC-hHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES-PEI 921 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s-~~e 921 (1044)
.........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.. ..+
T Consensus 156 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 156 -----------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -----------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 0001112346889999999876 458899999999999999999999997655 222
Q ss_pred HHHhhhcc-------------------CCCCC--------CCCCCCC--HHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 922 IFDNILNR-------------------KIPWP--------CVPSDMS--FEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 922 i~qkIl~g-------------------~i~~p--------~ip~~iS--~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
....+... ...++ .....++ .++.++|.+||+.||.+||| +.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~~~ 289 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMKHP 289 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhcCC
Confidence 22211110 00000 0011234 78899999999999999999 77899999
Q ss_pred CC
Q 001614 973 FF 974 (1044)
Q Consensus 973 wF 974 (1044)
||
T Consensus 290 ~f 291 (291)
T cd07844 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.11 Aligned_cols=261 Identities=33% Similarity=0.482 Sum_probs=212.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--Cee
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~L 762 (1044)
..++|++.+.||.|+||.||+|.++.+|+.||+|.++.... .......+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 56889999999999999999999999999999999864322 222233567899999999999999999998765 568
Q ss_pred EEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 999999965 88888875 356899999999999999999999999999999999999999999999999998642100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 162 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 162 --------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred --------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 001122346889999999875 45789999999999999999999999988877
Q ss_pred HHHHhhhccC-------------------CCCCCC--------CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 921 IIFDNILNRK-------------------IPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 921 ei~qkIl~g~-------------------i~~p~i--------p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
+.+..+.... ...+.. ....++++.+||.+||+.||.+||| +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~h~~ 292 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhcChh
Confidence 7666554311 000000 1235888999999999999999999 889999999
Q ss_pred CCCC
Q 001614 974 FKGV 977 (1044)
Q Consensus 974 Fk~i 977 (1044)
|++.
T Consensus 293 f~~~ 296 (309)
T cd07845 293 FKEK 296 (309)
T ss_pred hccC
Confidence 9853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=324.15 Aligned_cols=254 Identities=31% Similarity=0.612 Sum_probs=220.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|++++++++|||++++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999998999999999976432 23466789999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------- 152 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------- 152 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC-------
Confidence 9999999999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl 927 (1044)
........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 153 --------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 153 --------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred --------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 001223468899999999988788999999999999999999999998776655544444
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 928 ~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
... .+..+..++..+.++|.+||..+|++||+ +.+++.||||
T Consensus 213 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 213 QDD--HPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred ccC--CCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 322 34456788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.80 Aligned_cols=260 Identities=31% Similarity=0.488 Sum_probs=210.0
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+++|++.+.||.|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999998865322 223345688999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCcccccccCc
Q 001614 766 MEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~--Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLAki~~~~~t 842 (1044)
|||++ ++|.+++..... +++..+..++.||+.||+|||+++|+|+||+|+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--- 155 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--- 155 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC---
Confidence 99996 588888765433 578888999999999999999999999999999999985 55799999999863110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 156 ------------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred ------------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0001123467899999999876 457889999999999999999999998876655
Q ss_pred HHHhhhccC-C--------------------CCCC-----CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 922 IFDNILNRK-I--------------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 922 i~qkIl~g~-i--------------------~~p~-----ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
...++.... . .++. ....+++++.++|.+||+.+|.+||+ +.+++.||||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~~~~ 288 (294)
T PLN00009 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCchHh
Confidence 544432210 0 0000 12357889999999999999999999 78889999998
Q ss_pred CC
Q 001614 976 GV 977 (1044)
Q Consensus 976 ~i 977 (1044)
+.
T Consensus 289 ~~ 290 (294)
T PLN00009 289 DL 290 (294)
T ss_pred HH
Confidence 65
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.00 Aligned_cols=257 Identities=32% Similarity=0.520 Sum_probs=223.0
Q ss_pred ccccCCCeEEE-EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeec-
Q 001614 682 ERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC- 758 (1044)
Q Consensus 682 ~~~si~dY~Il-k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed- 758 (1044)
+...+++|++. ++||-|-.|+|..+.++.||+.+|+|++.. .....+|+++.... .|||||.++++|+.
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 34467788886 579999999999999999999999998742 34567899887766 49999999998865
Q ss_pred ---CCeeEEEEeeccccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC---CCcEEEee
Q 001614 759 ---RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTD 830 (1044)
Q Consensus 759 ---~~~LyLVmEY~~GGSL~dlLkk~g~--Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde---dg~VKLsD 830 (1044)
...+.+|||.|+||.|++.++.++. +++.++..|++||+.|+.|||+.+|.||||||+|+|... |..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 3568999999999999999987765 999999999999999999999999999999999999975 44799999
Q ss_pred cCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhC
Q 001614 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (1044)
Q Consensus 831 FGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTG 910 (1044)
||+|+.... .....+.|.||+|.|||++....|+..+|+||+||++|-||+|
T Consensus 208 fGFAK~t~~----------------------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 208 FGFAKETQE----------------------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred cccccccCC----------------------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 999984210 1234567899999999999989999999999999999999999
Q ss_pred CCCCCCCC----hHHHHHhhhccCCCCCCC-CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 911 IPPFTAES----PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 911 r~PF~g~s----~~ei~qkIl~g~i~~p~i-p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.+||+... ...+..+|..+.+.||.. +..+|.+++++|+++|..+|.+|+| +.++++|||+.+.
T Consensus 260 yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 260 YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQY 328 (400)
T ss_pred CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhccc
Confidence 99997654 356788999999998863 4578999999999999999999999 8899999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.60 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=209.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|++|.||+|++..+|..||+|.++.... ......+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875322 2234567889999999999999999999999999999999
Q ss_pred eccccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 768 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~---g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|+++ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++.....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~----- 152 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI----- 152 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC-----
Confidence 9985 898888654 3589999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 153 ----------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ----------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 0001123457899999999876 45688999999999999999999999887766555
Q ss_pred HhhhccC------------------CCCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g~------------------i~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+.... ..++. ..+.+++.+.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5443210 00000 11346788999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.10 Aligned_cols=257 Identities=31% Similarity=0.537 Sum_probs=216.2
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
+.|.....||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 4556667899999999999999999999999988642 2334567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||++++++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~------- 170 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK------- 170 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc-------
Confidence 99999999998854 4689999999999999999999999999999999999999999999999998763110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
.........|++.|+|||++.+..++.++||||||+++|+|++|..||...+....+..+
T Consensus 171 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 171 --------------------EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred --------------------ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001112356899999999998888999999999999999999999999888776665554
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
..............+..+.+||.+||..||.+||| +.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 43322211222357889999999999999999999 7899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.93 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=214.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|++.+.||.|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45899999999999999999999899999999987544444455677899999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 9997 577777653 4568999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
......|++.|+|||++. ...++.++||||||+++|+|++|..||.+.+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred ------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 011245788999999984 35678899999999999999999999988776665
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
...+.....+ ...+..++..+.+||.+||+.||.+||+ +.+++.||||..
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 223 LYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 5544433222 1123457889999999999999999999 888899999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.87 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=209.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEE--EEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCC
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~V--AVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~ 760 (1044)
..+++|++.+.||+|+||.||+|.++.++..+ |+|.++. .........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 45689999999999999999999998877654 6665542 22344556788999999999 8999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg 824 (1044)
.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997542 478899999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHH
Q 001614 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1044)
Q Consensus 825 ~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (1044)
.+||+|||++.... . ........+++.|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~--~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQE--V--------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccc--h--------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 99999999875210 0 0001112346789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 905 YELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|+|+| |..||.+.+..+....+..+. . +..+..+++++.+||.+||+.+|.+||+++++.+.+
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcCC-c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998 999998888777776654331 2 223456789999999999999999999966655544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.31 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=203.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865321 22234677899999999999999999999999999999
Q ss_pred EeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP---- 156 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC----
Confidence 99996 677776654 356788889999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChH-HH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPE-II 922 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~-ei 922 (1044)
........+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. +.
T Consensus 157 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 157 -----------------------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred -----------------------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 0011234578999999998763 5788999999999999999999999765432 22
Q ss_pred HHhhhcc-CCC------------------CCC--------C--CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 923 FDNILNR-KIP------------------WPC--------V--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 923 ~qkIl~g-~i~------------------~p~--------i--p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
...+... ..+ ++. . ....++++.+|+.+||..||.+||| +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~h~~ 290 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALLHPY 290 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhcCCC
Confidence 2211100 000 000 0 0123678899999999999999999 889999999
Q ss_pred C
Q 001614 974 F 974 (1044)
Q Consensus 974 F 974 (1044)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.64 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=212.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCC----------------cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCc
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTG----------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tG----------------k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPN 748 (1044)
...+|++.+.||+|+||.||++.+..++ ..||+|.+.... .......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3468999999999999999999876544 468999886532 2345678899999999999999
Q ss_pred eEEEeeeeecCCeeEEEEeeccccchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 001614 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1044)
Q Consensus 749 IVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g-----------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeN 817 (1044)
|+++++++...+.+++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997765 68999999999999999999999999999999999
Q ss_pred eeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhh
Q 001614 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1044)
Q Consensus 818 ILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDI 897 (1044)
|+++.++.++|+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-------------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------eeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 9999999999999999864211100 011123456789999999988889999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCChHHHHHhhhcc-----CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 898 WSVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 898 WSLGVILYELLT--Gr~PF~g~s~~ei~qkIl~g-----~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|||||++|+|++ |..||...+....+..+... .......+..++.++.+||.+||+.||.+|||+.++.+.|+
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 999999999998 78899887777766655432 11112234567899999999999999999999777666553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.03 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=209.7
Q ss_pred eEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe----
Q 001614 689 FEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 761 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~t---Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~---- 761 (1044)
|++.+.||+|+||.||+|....+ +..||+|.++.. .........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56788999999999999998653 478999998642 2334456789999999999999999999998766554
Q ss_pred --eEEEEeeccccchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 762 --LYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 762 --LyLVmEY~~GGSL~dlLkk~------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998542 3588999999999999999999999999999999999999999999999999
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCC
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~ 912 (1044)
++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 874211100 001112235678999999988889999999999999999999 999
Q ss_pred CCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 913 PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||.+.+..+.++.+..+.. +..+..++..+.++|.+||+.||.+||++.++...|+
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred CCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9998888888777665532 3356788999999999999999999999777766553
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.60 Aligned_cols=250 Identities=33% Similarity=0.548 Sum_probs=202.0
Q ss_pred CCCeEEEEee--ccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHh-cCCCceEEEeeeeecCCee
Q 001614 686 IDDFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 686 i~dY~Ilk~L--G~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~-L~HPNIVkL~gvfed~~~L 762 (1044)
.++|++.+.+ |.|+||.||++..+.++..+|+|++.+.... . .|+..... .+||||++++++|...+.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-A-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-h-------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3466666665 9999999999999999999999998753211 1 12222222 2799999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDFGLAki~~~~~ 841 (1044)
|+||||+++|+|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~--- 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--- 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC---
Confidence 99999999999999998877899999999999999999999999999999999999999998 99999999876310
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 162 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 162 ----------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ----------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 0112358899999999998889999999999999999999999998654332
Q ss_pred HH-HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 922 IF-DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 922 i~-qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
+. ..+..........+..+++.+.+||.+||+.||.+||+. +.++|+||||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 21 111111111122345789999999999999999999961 478999999973
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.75 Aligned_cols=256 Identities=31% Similarity=0.543 Sum_probs=216.8
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|+..+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4667788999999999999999899999999986432 23345678999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+++++|.+++.. ..+++..+..++.||+.|+.|||++|++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~------- 154 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------- 154 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-------
Confidence 9999999999865 56899999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl 927 (1044)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||....+......+.
T Consensus 155 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 214 (277)
T cd06642 155 --------------------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 214 (277)
T ss_pred --------------------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh
Confidence 001123468899999999998889999999999999999999999998776666555443
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 928 ~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
... .+..+..++.++.++|.+||+.+|.+||+ +.+++.||||....
T Consensus 215 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~ 260 (277)
T cd06642 215 KNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYT 260 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHh
Confidence 332 23344567889999999999999999999 77889999997643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.86 Aligned_cols=247 Identities=29% Similarity=0.428 Sum_probs=210.9
Q ss_pred EeeccCCceEEEEEEECCC---CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeec
Q 001614 693 KPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~t---Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~ 769 (1044)
+.||+|+||.||+|.+... +..||+|.++.... ......+.+|+.++..++||||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3699999999999999866 88999999875432 224678999999999999999999999999999999999999
Q ss_pred cccchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 770 NGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 770 ~GGSL~dlLkk~---------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
++|+|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998742111
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 011233457889999999988889999999999999999999 6999999988
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
.+....+..+.. ...+..++.++.+++.+||+.||.+|||+.++...
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKGYR--LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHcCCC--CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 888887776432 33456789999999999999999999995555443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.81 Aligned_cols=263 Identities=30% Similarity=0.450 Sum_probs=206.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--- 760 (1044)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 346789999999999999999999999999999998864321 2222345678999999999999999999887654
Q ss_pred -----eeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 761 -----NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 761 -----~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999964 888887654 36899999999999999999999999999999999999999999999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
........ ..........+++.|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 167 ~~~~~~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 167 RAFSLSKN-----------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred ccccCCcc-----------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 74211000 000111234678999999998764 478899999999999999999999
Q ss_pred CCCCChHHHHHhhhc--cCCC-----------------CCC----------CCCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 914 FTAESPEIIFDNILN--RKIP-----------------WPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~--g~i~-----------------~p~----------ip~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
|.+.+.......+.. +..+ ++. .+...+..+.+||.+||..||.+|||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t--- 300 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID--- 300 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC---
Confidence 988776544332222 1000 000 01123567889999999999999999
Q ss_pred HHHHHcCCCC
Q 001614 965 AAEVKAHPFF 974 (1044)
Q Consensus 965 A~EIL~HPwF 974 (1044)
+.++|+||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.91 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=207.9
Q ss_pred eEEEEeeccCCceEEEEEEECCCCc--EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC------C
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------D 760 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk--~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~------~ 760 (1044)
|.+.+.||+|+||.||+|++..++. .+|+|.++.. .........+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999987775 6999988653 23455677899999999999999999999876432 2
Q ss_pred eeEEEEeeccccchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 761 NLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk------~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 47899999999999998742 234789999999999999999999999999999999999999999999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~P 913 (1044)
+....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 74211000 001122346778999999998889999999999999999999 8999
Q ss_pred CCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|.+.....+...+..+.. +..+..++..+.++|.+||+.||.+|||++++.+.|+
T Consensus 215 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 215 YPGVENSEIYDYLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred CCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 998888777777766543 2234678899999999999999999999777766654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=344.03 Aligned_cols=256 Identities=31% Similarity=0.545 Sum_probs=217.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.|.....||.|+||.||++.+..+++.||+|++.... ......+.+|+.++..++||||+++++++...+.+|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3445557999999999999999899999999986432 2234668899999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-------- 169 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 169 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--------
Confidence 9999999998754 5689999999999999999999999999999999999999999999999998763110
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl 927 (1044)
.........|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.
T Consensus 170 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 170 -------------------DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred -------------------ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0011223568999999999998889999999999999999999999998877766666655
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 928 ~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.........+..++..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 4443333344568899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.78 Aligned_cols=257 Identities=33% Similarity=0.507 Sum_probs=210.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--CeeE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 763 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~Ly 763 (1044)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++.... .......+.+|+.++.+++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc-cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 4689999999999999999999999999999999875332 222334577899999999999999999998877 8899
Q ss_pred EEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
+||||+++ +|.+++.... .+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999975 9999987644 5899999999999999999999999999999999999999999999999988632100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
........+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+...
T Consensus 160 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 160 -------------------------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred -------------------------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 0111234578999999998764 46889999999999999999999998877766
Q ss_pred HHHhhhccCC-------------------CC---------CCCCCC-CCHHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 922 IFDNILNRKI-------------------PW---------PCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 922 i~qkIl~g~i-------------------~~---------p~ip~~-iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
...++..... .+ ..++.. +++.+.+||.+||+.||++||| +.++|.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell~~~ 291 (293)
T cd07843 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDALKHP 291 (293)
T ss_pred HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHhcCC
Confidence 5554432100 00 011222 5888999999999999999999 88999999
Q ss_pred CC
Q 001614 973 FF 974 (1044)
Q Consensus 973 wF 974 (1044)
||
T Consensus 292 ~f 293 (293)
T cd07843 292 YF 293 (293)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.35 Aligned_cols=258 Identities=31% Similarity=0.499 Sum_probs=211.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--CeeEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYL 764 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~LyL 764 (1044)
++|...+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|++++++++||||++++++|... ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 47899999999999999999999999999999987532 224557789999999999999999999988654 46899
Q ss_pred EEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 765 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34588999999999999999999999999999999999999999999999998763110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~--- 917 (1044)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 158 ----------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 158 ----------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred ----------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 0011235788999999999889999999999999999999999999765
Q ss_pred --ChHHHHHhhhccCCC-CCCCC---CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 918 --SPEIIFDNILNRKIP-WPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 918 --s~~ei~qkIl~g~i~-~p~ip---~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
...+....+.....+ ++..+ ...++.+.+||.+||..||.+||| +.+++.||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~ 273 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQM 273 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccccc
Confidence 223333333332111 11111 234678999999999999999999 78999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.85 Aligned_cols=273 Identities=39% Similarity=0.801 Sum_probs=242.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~L 762 (1044)
...++|.++++||+|+|++|.+++.+.|.+.||+|++++.-....+++.-...|-.+.... +||++|.++.+|+++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4578999999999999999999999999999999999987666666777888888887766 699999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
++|.||++||+|.-+++++..++++.+++|..+|+.||.|||++|||+||||.+|+|+|..|++||.|+|+++-..
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l---- 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL---- 402 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCC------
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------ 916 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g------ 916 (1044)
.+.....+.||||.|.|||++.+..|+..+|+|+|||+++||+.|+.||.-
T Consensus 403 -----------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 403 -----------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred -----------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 223345678999999999999999999999999999999999999999942
Q ss_pred --CChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh---hhHHHHHcCCCCCCCCcchhHhhh
Q 001614 917 --ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 917 --~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa---deA~EIL~HPwFk~id~d~L~~qk 986 (1044)
.+.+.+++-|+..+++.| ..+|-.+..+++..|++||.+|... -...++..||||+.++|+.+..+.
T Consensus 460 d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~ 531 (593)
T KOG0695|consen 460 DMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQ 531 (593)
T ss_pred ccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcc
Confidence 234567788888887754 6788888999999999999999762 357899999999999999887654
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.53 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=209.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeee-ecCCee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDNL 762 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvf-ed~~~L 762 (1044)
...++|++.+.||+|+||.||++... |..||+|.++.. .....+.+|+.++++++||||+++++++ ...+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999875 889999988542 2346788999999999999999999875 455678
Q ss_pred EEEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 763 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997643 478899999999999999999999999999999999999999999999998763110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 155 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 155 -----------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0112234568999999988889999999999999999998 9999988877
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
......+..+. . +..+..+++.+.+||.+||+.+|.+|||+.++.+.|++
T Consensus 206 ~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 206 KDVVPRVEKGY-K-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 77766665442 2 23456789999999999999999999998887776653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.02 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=208.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcE----EEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~----VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
...+|++.+.||+|+||.||+|.+..+|.. ||+|.++.. ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 456899999999999999999998766654 899988642 2234556789999999999999999999998765
Q ss_pred eeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999999864 4588899999999999999999999999999999999999999999999999874211
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s 918 (1044)
... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 162 ~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 162 DEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCc-------------------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 000 001112335678999999999899999999999999999998 999998887
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
..++...+ .....++ .+..++.++.++|.+||..||.+||++.++...+.
T Consensus 217 ~~~~~~~~-~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 217 ASEISSIL-EKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred HHHHHHHH-hCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 76655433 3333322 34567889999999999999999999766655443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.48 Aligned_cols=258 Identities=34% Similarity=0.550 Sum_probs=216.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|.+.+.||.|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 46899999999999999999999888999999988542 223456789999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
+||+++|+|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~----- 168 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 168 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-----
Confidence 9999999999998754 4788899999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 169 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 169 ----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred ----------------------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 0111234688999999999888899999999999999999999999987766544333
Q ss_pred hhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 926 Il~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.....+....+..++..+.+||.+||..+|.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~ 275 (293)
T cd06647 227 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIA 275 (293)
T ss_pred hhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcC
Confidence 332222212234467889999999999999999999 7789999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.87 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=210.3
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLV 765 (1044)
++|...+.||+|+||.||++.+..+|+.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 567778899999999999999999999999999875322 245667899999999996 99999999999999999999
Q ss_pred EeeccccchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 766 MEYLNGGDLYSLL---R--KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 766 mEY~~GGSL~dlL---k--k~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
|||+.. +|.++. . ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 554433 2 235699999999999999999999975 999999999999999999999999999863110
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC---CCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
........|++.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 161 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 161 ----------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred ----------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 0011233688999999999765 688999999999999999999999976
Q ss_pred CCh-HHHHHhhhccCCCC--CCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchh
Q 001614 917 ESP-EIIFDNILNRKIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1044)
Q Consensus 917 ~s~-~ei~qkIl~g~i~~--p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L 982 (1044)
.+. .+....+..+..+. ...+..++.++.+||.+||+.||.+||| +.+++.||||+...+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 213 WNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNV 278 (288)
T ss_pred cchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcch
Confidence 542 22223332222211 1122357899999999999999999999 789999999998766554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.63 Aligned_cols=251 Identities=31% Similarity=0.499 Sum_probs=203.5
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecC--CeeEEE
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DNLYLV 765 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~--~~LyLV 765 (1044)
|++.+.||+|+||.||+|.+..+++.||+|.+++... ........+|+.++.++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999865321 222234567888898885 99999999999988 889999
Q ss_pred EeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||++ |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++. +.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 99997 588888765 357899999999999999999999999999999999999999 9999999999863210
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
........+++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 152 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 152 -----------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred -----------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 001112357899999998754 45688999999999999999999999887765544
Q ss_pred Hhhhcc------------------CCCCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g------------------~i~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+... ...++. ....++.++.+||.+||++||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 443221 011111 11356899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.10 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=213.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|++.+.||.|+||.||+|.+. +++.||+|.++... .....+.+|+.++++++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34567999999999999999999875 45789999986532 23456889999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997654 68999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 158 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 --------------------------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred --------------------------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 000111223468999999998889999999999999999999 99999988887
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+.... .. ..+..++..+.+++.+||+.+|.+||+++++.+.|+
T Consensus 212 ~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 212 EVLQQVDQGY-RM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 7776665442 22 234678899999999999999999999888877664
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.73 Aligned_cols=254 Identities=31% Similarity=0.525 Sum_probs=209.1
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|++.+.||.|++|.||+|.+..+|..||+|++.... ........+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987532 2233345688999999999999999999999999999999999
Q ss_pred ccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 769 LNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
++ ++|.+++.... .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 95 69999997765 6899999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
........+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+......+
T Consensus 153 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 153 ---------------------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ---------------------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011223578999999988764 578899999999999999999999987766444333
Q ss_pred hhccCC--------------------------CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 926 ILNRKI--------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 926 Il~g~i--------------------------~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+..... ........++.++.++|.+||+.||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 322100 001123467789999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=337.29 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=209.1
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCc--EEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk--~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~Ly 763 (1044)
++|++.+.||+|+||.||+|..+.++. .+++|.++. .........+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999987765 468887753 22334456789999999999 7999999999999999999
Q ss_pred EEEeeccccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEE
Q 001614 764 LVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VK 827 (1044)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 478889999999999999999999999999999999999999999
Q ss_pred EeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHH
Q 001614 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (1044)
Q Consensus 828 LsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYEL 907 (1044)
|+|||++.... . .........+..|+|||++.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~--~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEE--V--------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCcccc--c--------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 99999875210 0 0001112235679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
++ |..||.+.+.......+..+. . +..+..++..+.+||.+||+.+|.+||+++++.+.|
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 97 999999988888777765542 2 234567899999999999999999999977765544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.08 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=209.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~-----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45689999999999999999999987 6789999987542 2233456789999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC---cEEEe
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLT 829 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g-------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg---~VKLs 829 (1044)
...|+||||++||+|.+++.... .+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997653 488899999999999999999999999999999999998765 59999
Q ss_pred ecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh
Q 001614 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (1044)
Q Consensus 830 DFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT 909 (1044)
|||+++....... ........+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 162 dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASY-------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccc-------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999874210000 000112234568999999998889999999999999999997
Q ss_pred -CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 910 -GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 910 -Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
|..||.+.+.......+..... +..+..++..+.+||.+||+.+|.+||++.++.+.
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999998887777666554322 23456789999999999999999999995555443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=324.37 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=220.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+|++.+.||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999875332 33456778899999999999999999999999999999999
Q ss_pred eccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 768 YLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 768 Y~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999866 356899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~ 923 (1044)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 112245789999999999888999999999999999999999999988887777
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+..+.. +..+...+.++.++|.+||+.+|.+||+ +.++++||++
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGKY--PPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHhcCCC--CCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 66655543 3445678999999999999999999999 8899999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=333.18 Aligned_cols=255 Identities=31% Similarity=0.538 Sum_probs=218.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
-|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.++.+++||||+++++++...+.+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3778889999999999999999899999999886432 23345678899999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+++|+|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||||.||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~------- 154 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------- 154 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-------
Confidence 9999999999865 46899999999999999999999999999999999999999999999999987632100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl 927 (1044)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 155 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 155 --------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred --------------------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 001123468899999999988888999999999999999999999998877766666654
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 928 ~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.... +..+..++.++.++|.+||..+|.+||+ +.+++.||||...
T Consensus 215 ~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~ 259 (277)
T cd06641 215 KNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRF 259 (277)
T ss_pred cCCC--CCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhh
Confidence 4432 3345678899999999999999999999 7889999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.36 Aligned_cols=256 Identities=21% Similarity=0.313 Sum_probs=213.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~t-----Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
...+|++.+.||.|+||.||+|.+..+ +..||+|+++... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345688899999999999999987543 5789999986432 233456788999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded 823 (1044)
..+++++||+++++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247788889999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHH
Q 001614 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1044)
Q Consensus 824 g~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (1044)
+.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 215 (283)
T cd05091 161 LNVKISDLGLFREVYAADY-------------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215 (283)
T ss_pred CceEecccccccccccchh-------------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHH
Confidence 9999999999874211000 011123456789999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 904 LYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+|||++ |..||.+.+..+....+...... ..+..++..+.+|+..||+.+|.+||+++++...|
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 999998 89999998888888887776543 34578999999999999999999999977766554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=329.69 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=208.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
..+|++.+.||+|+||.||++.++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 357899999999999999999886 467899998864321 235688899999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++++|.+++... +.+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 9999999999999753 468999999999999999999999999999999999999999999999999886321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~ 923 (1044)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 155 -----------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 000111224568999999998899999999999999999999 89999888877777
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
..+.... . +..+...+.++.+|+.+||+.+|.+|||+.++.+.|
T Consensus 212 ~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 ESVSAGY-R-LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHcCC-c-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 6665442 2 233466899999999999999999999966655443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.41 Aligned_cols=264 Identities=29% Similarity=0.440 Sum_probs=212.9
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec----CCee
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNL 762 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed----~~~L 762 (1044)
++|++.+.||.|+||.||+|.++.+|..||+|.+.... ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999999999999999987532 223345678889999999999999999988763 3468
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 69999998778899999999999999999999999999999999999999999999999999864211000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
..........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 163 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 163 -----------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred -----------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 00111123478999999999865 468899999999999999999999998765433
Q ss_pred HHHhhhcc----------------------------CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 922 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 922 i~qkIl~g----------------------------~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
....+... ..++.......++++.++|.+||+.+|.+||+ +.+++.|||
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~ 296 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQHPF 296 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHhChh
Confidence 32221110 00111112457899999999999999999999 778999999
Q ss_pred CCCCC
Q 001614 974 FKGVN 978 (1044)
Q Consensus 974 Fk~id 978 (1044)
|.+..
T Consensus 297 ~~~~~ 301 (334)
T cd07855 297 LAQYH 301 (334)
T ss_pred hhhcc
Confidence 98754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.58 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=213.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~t---Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
.++|++.+.||+|+||.||+|.++.+ ...||+|.++... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998754 4589999886432 334456789999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
++||||+++|+|.+++... +.+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 161 -------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 161 -------------------------ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred -------------------------cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 0000112235678999999998889999999999999999998 99999888877
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+...... ..+..++..+.+|+.+||+.+|.+||++.++.+.|.
T Consensus 216 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 216 DVIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 777766554221 234578999999999999999999999777776654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=365.91 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=204.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
....|.+.+.||+|+||.||++.+..+++.||+|... ...+.+|+.+|++++|||||++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 3457999999999999999999999999999999532 1345789999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 999995 6898888654 469999999999999999999999999999999999999999999999999987421100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s----- 918 (1044)
........+||+.|+|||++.+..++.++|||||||+||||++|..|+....
T Consensus 315 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~ 371 (461)
T PHA03211 315 -----------------------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371 (461)
T ss_pred -----------------------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccccc
Confidence 0001123579999999999999899999999999999999999876553221
Q ss_pred ---hHHHHHhhhccCCC---CCC----------------------------CCCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 919 ---PEIIFDNILNRKIP---WPC----------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 919 ---~~ei~qkIl~g~i~---~p~----------------------------ip~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
...+.+.+...... ++. ....++.++.+||.+||+.||.+|||
T Consensus 372 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs--- 448 (461)
T PHA03211 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS--- 448 (461)
T ss_pred CCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC---
Confidence 22233222221111 110 00135668999999999999999999
Q ss_pred HHHHHcCCCCCC
Q 001614 965 AAEVKAHPFFKG 976 (1044)
Q Consensus 965 A~EIL~HPwFk~ 976 (1044)
+.|+|+||||+.
T Consensus 449 a~elL~hp~f~~ 460 (461)
T PHA03211 449 AAELLRLPLFQS 460 (461)
T ss_pred HHHHhhCcccCC
Confidence 889999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.24 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=209.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~---- 760 (1044)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.++++++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4578999999999999999999999999999999986432 23334567789999999999999999999886543
Q ss_pred --eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 --~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
.+|+||||+. ++|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 5799999996 4888888654 8999999999999999999999999999999999999999999999999986421
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred C----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 0 001123468899999999999999999999999999999999999998776
Q ss_pred hHHHHHhhhccC----------------------C-----C---------CCC----CCCCCCHHHHHHHHhHccCCcCC
Q 001614 919 PEIIFDNILNRK----------------------I-----P---------WPC----VPSDMSFEAQDLINRFLIHDPNQ 958 (1044)
Q Consensus 919 ~~ei~qkIl~g~----------------------i-----~---------~p~----ip~~iS~eLkdLIkkcLqkDPsk 958 (1044)
....+.++.... . + ++. .+...++.+.+||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 544433332100 0 0 000 01234667899999999999999
Q ss_pred CCChhhHHHHHcCCCCCC
Q 001614 959 RLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 959 RPSadeA~EIL~HPwFk~ 976 (1044)
||| +.++|.||||+.
T Consensus 302 R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 302 RIS---VDDALQHPYINV 316 (353)
T ss_pred CcC---HHHHhcChhHhh
Confidence 999 888999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=331.35 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=209.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
...++|++.+.||.|+||.||+|.+..+|. .||+|+++.. ........+.+|+.++..++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345789999999999999999999887776 4899988642 2344567789999999999999999999998754
Q ss_pred CeeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
..+++|||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++...
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 578999999999999999764 568999999999999999999999999999999999999999999999999987421
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~ 917 (1044)
.... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 161 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 161 IDET-------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccc-------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1000 000112235678999999998889999999999999999998 99999887
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
........+..+.. +..+..++.++.++|.+||+.||.+||++.++.+.+
T Consensus 216 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 216 PAREIPDLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred CHHHHHHHHHCCCc--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 77666655544332 223467899999999999999999999966665443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=388.38 Aligned_cols=261 Identities=31% Similarity=0.531 Sum_probs=215.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--C
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~ 760 (1044)
....++|++++.||.|+||.||+|++..++..||+|++.... ........+..|+.+|..++|||||+++++|... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 456789999999999999999999999999999999987533 3445567899999999999999999999988553 5
Q ss_pred eeEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CeeeccCCCCceeecC-------
Q 001614 761 NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-------GIVHRDLKPDNLLIAH------- 822 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~-------GIIHRDLKPeNILLde------- 822 (1044)
.+||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 68999999999999999975 25699999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CC
Q 001614 823 ----------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TE 890 (1044)
Q Consensus 823 ----------dg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ 890 (1044)
.+.+||+|||++..... .......+||+.|+|||++.+ ..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~----------------------------~s~~~s~vGTp~YmAPEvL~ge~~~ 219 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGI----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccc----------------------------cccccccCCCccccCHHHHhccCCC
Confidence 23589999999863210 001124579999999999864 45
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 891 ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
++.++||||||||||+|++|..||...+....+...+.....++ ....+.++.+||..||..+|.+||+ +.++|.
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPS---a~QlL~ 294 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPS---ALQCLG 294 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcC---HHHHhc
Confidence 88999999999999999999999976655443333333332222 2457899999999999999999999 889999
Q ss_pred CCCCCCC
Q 001614 971 HPFFKGV 977 (1044)
Q Consensus 971 HPwFk~i 977 (1044)
||||+.+
T Consensus 295 h~~ik~i 301 (1021)
T PTZ00266 295 YQIIKNV 301 (1021)
T ss_pred cHHHhhc
Confidence 9999755
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.30 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=206.0
Q ss_pred EEEEeeccCCceEEEEEEEC----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 690 EIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 690 ~Ilk~LG~GgFG~VYka~~k----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.+.+.||.|.||.||+|.+. ..+..|+||.++. .........+.+|++++++++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999998 4456899999854 23444578999999999999999999999999988889999
Q ss_pred EeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 766 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||++.||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~-- 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS-- 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 9999999999999876 679999999999999999999999999999999999999999999999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei 922 (1044)
.........+...|+|||++.+..++.++||||||+++|||++ |..||.+.+..++
T Consensus 158 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 158 -----------------------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp -----------------------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred -----------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0011223456788999999988889999999999999999999 7899999988888
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
...+..+.. +..+..++..+.++|..||..||.+||++.++.+.|
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 IEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 888755543 234577899999999999999999999977665543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=328.61 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=208.2
Q ss_pred eeccCCceEEEEEEEC--CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 694 PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k--~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
.||+|+||.||+|.++ .++..||+|++... ......+.+.+|+.++++++||||+++++++.. +.+++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999875 44567999988643 234445678999999999999999999998864 578999999999
Q ss_pred cchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCC
Q 001614 772 GDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1044)
Q Consensus 772 GSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t 850 (1044)
|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 150 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-------- 150 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc--------
Confidence 999999974 45689999999999999999999999999999999999999999999999999863211000
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhcc
Q 001614 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 929 (1044)
Q Consensus 851 ~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g 929 (1044)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..+
T Consensus 151 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 151 ----------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred ----------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 0000111234678999999988889999999999999999996 99999988887777666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 930 ~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.. +..+...++++.+||.+||..||.+||+++++.+.|+.-||
T Consensus 215 ~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 215 KR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 32 23456789999999999999999999999999988887765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.12 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=215.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
..+|++.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999987 8999999986532 22456788999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 766 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--- 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--- 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc---
Confidence 9999999999999753 45899999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei 922 (1044)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus 158 ------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~ 213 (261)
T cd05148 158 ------------------------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213 (261)
T ss_pred ------------------------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 001112345778999999988889999999999999999998 8999998888888
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+..+..+. . +..+..+++.+.++|.+||+.||.+|||+.++.+.|+
T Consensus 214 ~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 214 YDQITAGY-R-MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHHHHhCC-c-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 77776442 2 2345678999999999999999999999888877764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.61 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=208.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|++.+.||+|+||.||++.+.. +..+|+|.++.... ....+.+|+.++++++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998764 45699998864321 235689999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||||.||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc---
Confidence 9999999999999764 468999999999999999999999999999999999999999999999999876321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~ 923 (1044)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+.....
T Consensus 155 -----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05113 155 -----------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211 (256)
T ss_pred -----------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 001112345678999999988889999999999999999998 99999988887777
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
..+..+... ..+...+..+.+++.+||+.||.+||++.++..
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 212 EKVSQGLRL--YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253 (256)
T ss_pred HHHhcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 777665433 234567899999999999999999999555443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.22 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=213.5
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~tG-----k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gv 755 (1044)
.....++|++.+.||+|+||.||++.+...+ ..+|+|.+... ........+.+|+.++.++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456678999999999999999999986433 68999988643 2334556789999999999 79999999999
Q ss_pred eecCCeeEEEEeeccccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCcee
Q 001614 756 FTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1044)
Q Consensus 756 fed~~~LyLVmEY~~GGSL~dlLkk~----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNIL 819 (1044)
+...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999999642 35788999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHH
Q 001614 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1044)
Q Consensus 820 Ldedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (1044)
++.++.+||+|||+++....... ........+++.|+|||++.+..++.++||||
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred EcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCcccceee
Confidence 99999999999999874211000 00111123567899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 900 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 900 LGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|||++|+|++ |..||.+....+.+..+..+.. +..+...+..+.+|+.+||..||.+|||+.++.+.|
T Consensus 220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 9999999998 9999998888877776655432 234567889999999999999999999966555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.33 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=213.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
+..++|++.+.||.|+||.||+|... |+.||+|.++... .....+.+|+.+++.++||||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 34678999999999999999999875 8999999986532 14678999999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~-- 154 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-- 154 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc--
Confidence 9999999999999998765 689999999999999999999999999999999999999999999999999863100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 155 ----------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 155 ----------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred ----------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0012234567999999988889999999999999999997 99999888877
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+..+. . +..+..+++.+.+||.+||+.+|.+||+++++.+.|+
T Consensus 207 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 207 DVVPHVEKGY-R-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred HHHHHHhcCC-C-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 7666554432 2 2345678999999999999999999999887777664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=357.13 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=211.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF 756 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~t-----Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvf 756 (1044)
....++|.+.+.||+|+||.||+|.+... +..||+|+++.. ......+.+++|+.+|.++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34567899999999999999999987533 347999998653 23344568999999999996 99999999999
Q ss_pred ecCCeeEEEEeeccccchHHHHHhc-------------------------------------------------------
Q 001614 757 TCRDNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------- 781 (1044)
Q Consensus 757 ed~~~LyLVmEY~~GGSL~dlLkk~------------------------------------------------------- 781 (1044)
.....+|+|||||++|+|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999998642
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceee
Q 001614 782 -----------------------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820 (1044)
Q Consensus 782 -----------------------------------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILL 820 (1044)
..+++..+..++.||+.||+|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136777888999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHH
Q 001614 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900 (1044)
Q Consensus 821 dedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSL 900 (1044)
+.++.+||+|||+++...... .........+++.|+|||++.+..++.++|||||
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDS-------------------------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred eCCCEEEEEeCCcceeccccc-------------------------cccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 999999999999987421100 0011223457889999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 901 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 901 GVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||++|+|++ |..||........+.........+ ..+..++.++.+||.+||+.||.+||++.++.++|.
T Consensus 326 Gvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 999999997 999998765544333333333332 245678999999999999999999999888888775
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=327.51 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=210.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|++.+.||+|+||.||+|.+. ++..+|+|.++.... ....+.+|+.++++++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 44578999999999999999999876 567799999865322 2356889999999999999999999875 45689
Q ss_pred EEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
++|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999753 358999999999999999999999999999999999999999999999999986421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred --------------------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001112235678999999988889999999999999999999 99999988887
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+....+..+. . +..+...+..+.+|+.+||..||.+|||++++.+.|+
T Consensus 211 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 211 EVLEQVERGY-R-MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred HHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 7777765542 2 2245678899999999999999999999887776654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=332.82 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=214.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
..++|++.+.||.|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4578999999999999999999874 357899999886422 234456788999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVG----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g----------------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeN 817 (1044)
..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36778889999999999999999999999999999
Q ss_pred eeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhh
Q 001614 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1044)
Q Consensus 818 ILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDI 897 (1044)
|+++.++.++|+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------------YKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------------ccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999999999998763210000 001112234678999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 898 WSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
|||||++|+|++ |..||.+.+..+....+..+... ..+..++.++.+||.+||+.||.+|||+.++.+.|++
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 999999999998 88999988888887777655432 2346788999999999999999999998888887753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.41 Aligned_cols=261 Identities=30% Similarity=0.499 Sum_probs=207.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-----C
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~-----~ 760 (1044)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46899999999999999999999999999999998642 2233456788999999999999999999876544 3
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+|+||||+.+ +|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999965 88888754 56999999999999999999999999999999999999999999999999998642100
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 160 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred c------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 00011223578999999998765 5688999999999999999999999977654
Q ss_pred HHHHHhhh---------------ccC-------C------CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 920 EIIFDNIL---------------NRK-------I------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl---------------~g~-------i------~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
......+. ... . ++....+..++++.+||.+||+.||.+||| +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHhcC
Confidence 32221111 000 0 000112356788999999999999999999 8899999
Q ss_pred CCCCCC
Q 001614 972 PFFKGV 977 (1044)
Q Consensus 972 PwFk~i 977 (1044)
|||+..
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.76 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=209.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCC--------------cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTG--------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tG--------------k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVk 751 (1044)
.++|++.+.||+|+||.||++++..++ ..||+|.++.. ........+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 35899988642 23445567999999999999999999
Q ss_pred EeeeeecCCeeEEEEeeccccchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCcee
Q 001614 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1044)
Q Consensus 752 L~gvfed~~~LyLVmEY~~GGSL~dlLkk~g------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNIL 819 (1044)
+++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986432 3678888999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHH
Q 001614 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1044)
Q Consensus 820 Ldedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (1044)
++.++.+||+|||++........ ........+++.|+|||++.+..++.++||||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EcCCCcEEecccccccccccCcc-------------------------eeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 99999999999999863211000 01112334678999999999888999999999
Q ss_pred HHHHHHHHHh--CCCCCCCCChHHHHHhhhc-----cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 900 VGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 900 LGVILYELLT--Gr~PF~g~s~~ei~qkIl~-----g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|||++|+|++ |..||...+..+....+.. ....+...+..+++.+.+||.+||+.||.+||+++++.+.|+
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 9999999988 6789988777666554422 111223345568899999999999999999999888877664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=333.97 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=214.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 3467999999999999999999864 24557888887542 233446788999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded 823 (1044)
+.+++||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 37889999999999999999999999999999999999999
Q ss_pred CcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHH
Q 001614 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1044)
Q Consensus 824 g~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (1044)
+.++|+|||++....... .........|++.|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCc-------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 999999999986321100 0011123457889999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 904 LYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
+|+|++ |..||...+.......+..+... ..+...+..+.+|+.+||+.||.+||++.++.+.|..
T Consensus 215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 999999 99999888887777766555432 3346678999999999999999999998877776643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.12 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=213.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk---~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~ 761 (1044)
..++|+..+.||+|+||.||+|....++. .+|+|.++... .......+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45689999999999999999999876665 79999886422 23345678999999999999999999999999999
Q ss_pred eEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999754 57899999999999999999999999999999999999999999999999998642100
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
.. ..........++.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ~~------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 161 PE------------------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cc------------------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 00 0000111223567999999988889999999999999999997 9999988888
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
......+.... ..+ .+..++.++.+|+.+||+.+|.+||++.++.+.|.
T Consensus 217 ~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 217 HEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred HHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 77777776542 222 23567899999999999999999999877766653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.45 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=208.8
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~-----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvf 756 (1044)
.+..++|++.+.||.|+||.||+|.+.. +++.||+|+++... .......+..|+.++.++ +||||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3455689999999999999999997543 45789999886422 233456788999999999 799999999987
Q ss_pred ecC-CeeEEEEeeccccchHHHHHhc------------------------------------------------------
Q 001614 757 TCR-DNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 781 (1044)
Q Consensus 757 ed~-~~LyLVmEY~~GGSL~dlLkk~------------------------------------------------------ 781 (1044)
... ..++++|||+++|+|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 5689999999999999998542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCC
Q 001614 782 -------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (1044)
Q Consensus 782 -------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~ 854 (1044)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------- 227 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------- 227 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-------------
Confidence 257888999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCC
Q 001614 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPW 933 (1044)
Q Consensus 855 ~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~ 933 (1044)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+.........
T Consensus 228 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~- 294 (337)
T cd05054 228 ------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR- 294 (337)
T ss_pred ------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-
Confidence 0011123456778999999999999999999999999999998 99999876554444333333322
Q ss_pred CCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 934 p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+..+...++++.+++.+||+.+|.+||+++++.+.|.
T Consensus 295 ~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2345678899999999999999999999777766654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.49 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=207.1
Q ss_pred EeeccCCceEEEEEEECCCC---cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeec
Q 001614 693 KPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tG---k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~ 769 (1044)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.++||||+++++++. .+.+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876555 78999998754322 35567899999999999999999999876 45689999999
Q ss_pred cccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCC
Q 001614 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1044)
Q Consensus 770 ~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~ 849 (1044)
++|+|.+++.....+++..+..++.|++.||+|||+.+++|+||||+|||++.++.+||+|||++.....+..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------- 150 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------- 150 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhc
Q 001614 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928 (1044)
Q Consensus 850 t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~ 928 (1044)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 151 -----------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred -----------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 0000111224568999999998889999999999999999998 9999988887777666655
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 929 g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
... ...+..++..+++||.+||..+|.+||++.++.++|.
T Consensus 214 ~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 214 GER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred CCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 432 2345678899999999999999999999888877765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.65 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=212.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~---- 760 (1044)
..++|++.+.||+|+||.||++.+..+|..||+|.+.+. .........+.+|+.+|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 456899999999999999999999999999999998642 223334567889999999999999999999987654
Q ss_pred --eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 --~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 358999999 7799888864 569999999999999999999999999999999999999999999999999886310
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 ------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01123457899999999876 45788999999999999999999999877
Q ss_pred ChHHHHHhhhccCCC----------------------------CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~----------------------------~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+....+..+...... +......+++.+.++|.+||+.||.+||| +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~~l 296 (343)
T cd07880 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAEAL 296 (343)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 655444443321110 01122467888999999999999999999 78899
Q ss_pred cCCCCCCCC
Q 001614 970 AHPFFKGVN 978 (1044)
Q Consensus 970 ~HPwFk~id 978 (1044)
.||||+...
T Consensus 297 ~~~~~~~~~ 305 (343)
T cd07880 297 AHPYFEEFH 305 (343)
T ss_pred cCccHhhhc
Confidence 999998764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=331.88 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=213.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
...+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467899999999999999999753 34668999987642 344567899999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVG---------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g---------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg 824 (1044)
..+++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997643 478899999999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHH
Q 001614 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1044)
Q Consensus 825 ~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (1044)
.+||+|||++........ ........+++.|+|||++.+..++.++|||||||++
T Consensus 160 ~~kL~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred CEEECCCCceeEcCCCce-------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 999999999863211000 0011223467899999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 905 YELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|+|++ |.+||...........+..+.. +..+..+++.+.+||.+||+.||.+||+++++.+.|+
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 99998 9999988887777776655532 2234678999999999999999999999877766654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.78 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=213.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~-----k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvf 756 (1044)
....++|.+.+.||+|+||.||++.+ ..++..||+|.++... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45567899999999999999999985 2345689999886532 234456789999999999 799999999999
Q ss_pred ecCCeeEEEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 757 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 757 ed~~~LyLVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997543 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~P 913 (1044)
........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 189 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 189 RDIMNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred ccccCCCc-------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 63211000 001112346788999999998889999999999999999998 9999
Q ss_pred CCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|........+.......... ..+...++++.+||.+||..+|.+|||+.++.+.|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 244 YPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred cCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 98877665554444443332 234567899999999999999999999777766553
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.03 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=211.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
.+.++...-++-||.|+-|.||+|+.+ ++.||||.++. .+ ..++.-|++|+||||+.+.|+|.....+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e---lk-------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---LK-------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh---hh-------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 344455566778999999999999987 89999997643 11 2356778999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|||||||..|.|+.+|+....++......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++..
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~----- 262 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL----- 262 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987631
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
.......+++||..|||||++.+.+.+.|+|||||||+|||||||..||.+.+...+
T Consensus 263 -----------------------~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 263 -----------------------SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred -----------------------hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 122345678999999999999999999999999999999999999999998877666
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
+--+-...+..| .|..+++.++-||+.||+-.|.+||+| .+||.|
T Consensus 320 IwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPSF---rqil~H 364 (904)
T KOG4721|consen 320 IWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPSF---RQILLH 364 (904)
T ss_pred EEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCccH---HHHHHH
Confidence 544434444333 568899999999999999999999995 455666
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.87 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=214.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|...+.||+|+||.||+|++..+|..||+|.+.............+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999999999999999998765444445567788999999999999999999999999999999999
Q ss_pred ccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
+. |+|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---------- 171 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---------- 171 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc----------
Confidence 96 578887764 456899999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
.......|++.|+|||++. +..++.++|||||||++|+|++|..||...+......
T Consensus 172 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 172 ---------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred ---------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 0112346889999999984 3567889999999999999999999998877666555
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
.+.....+. .....++..+++||.+||+.+|.+||+ +.+++.||||+..+
T Consensus 231 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 231 HIAQNDSPT-LQSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCCCC-CCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 554443321 123457788999999999999999999 88999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=334.08 Aligned_cols=259 Identities=28% Similarity=0.476 Sum_probs=204.0
Q ss_pred CeEEEEeeccCCceEEEEEEECC--CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--CeeE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 763 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~--tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~Ly 763 (1044)
.|++.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999998763322233346678899999999999999999999988 7899
Q ss_pred EEEeeccccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC----CCcEEEeecCCc
Q 001614 764 LVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLS 834 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~-----g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde----dg~VKLsDFGLA 834 (1044)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777776432 36889999999999999999999999999999999999999 899999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
....... ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPL------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCc------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 7421100 00112234568999999998876 4578999999999999999999999
Q ss_pred CCCCChHH---------HHHhhhc--------------------------cCCCCCC--------CCCCCCHHHHHHHHh
Q 001614 914 FTAESPEI---------IFDNILN--------------------------RKIPWPC--------VPSDMSFEAQDLINR 950 (1044)
Q Consensus 914 F~g~s~~e---------i~qkIl~--------------------------g~i~~p~--------ip~~iS~eLkdLIkk 950 (1044)
|.+..... ....+.. ....++. .....+.++.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97654321 0111000 0000010 001567789999999
Q ss_pred HccCCcCCCCChhhHHHHHcCCCC
Q 001614 951 FLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 951 cLqkDPskRPSadeA~EIL~HPwF 974 (1044)
||+.||.+||| +.+++.||||
T Consensus 296 ~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.16 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=213.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|++.+.||.|+||.||++.+. ++..||+|.+.... .....+.+|+.+++.++||||+++++++.....++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45678999999999999999999976 45789999886532 23467899999999999999999999999989999
Q ss_pred EEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+||||+++++|.+++.... .++...+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997643 68999999999999999999999999999999999999999999999999986421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 158 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 158 --------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred --------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 000112234678999999998889999999999999999998 99999988887
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+..+. . ...+...+.++.+++.+||+.+|.+||+++++.+.|+
T Consensus 212 ~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 212 EVLEQVERGY-R-MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 7777765542 2 2234567899999999999999999999888877664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.61 Aligned_cols=253 Identities=33% Similarity=0.525 Sum_probs=207.3
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc---CCCceEEEeeeeecCCe----
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDN---- 761 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L---~HPNIVkL~gvfed~~~---- 761 (1044)
|++.+.||.|+||.||+|.++.+++.||+|.++.... .......+.+|+.+++++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999998899999999864322 222334566788877666 59999999999998877
Q ss_pred -eEEEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 762 -LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 762 -LyLVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
++++|||+++ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 48999999999999999999999999999999999999999999999999886421
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+
T Consensus 159 ~~----------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 FE----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred CC----------------------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 00 01122357899999999998889999999999999999999999999888
Q ss_pred hHHHHHhhhccC-----CCCC-------------------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 919 PEIIFDNILNRK-----IPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 919 ~~ei~qkIl~g~-----i~~p-------------------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..+...++.... ..++ .....+++.+.+||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcCcCC
Confidence 776666554311 0000 011245678899999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.29 Aligned_cols=255 Identities=19% Similarity=0.294 Sum_probs=206.6
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcE----EEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~----VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
..++|++.+.||+|+||+||+|.+..+|.. +++|.+... ........+..|+.++..+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 346899999999999999999999877774 666665421 123345677888889999999999999998764 5
Q ss_pred eeEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
..++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999999999999975 45689999999999999999999999999999999999999999999999999874211
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s 918 (1044)
.. .........++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 162 ~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 162 DD-------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CC-------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 00 0001123457788999999998889999999999999999998 999999887
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+....+.+..+.. +..+..++.++.+++.+||..||.+|||+.++.+.+
T Consensus 217 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 217 PHEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred HHHHHHHHHCCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 7766555544432 223456788999999999999999999977665543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.87 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=212.7
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk---~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
..+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4679999999999999999999865543 79999886422 233456889999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
|+||||+++|+|.+++... +.++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
. .........+++.|+|||++.+..++.++|+||||+++|++++ |..||.+.+..
T Consensus 161 ~------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 161 E------------------------AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred c------------------------eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 0 0001111234578999999998889999999999999999886 99999888877
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+....+..+. .. ..+..+++.+.+++.+||+.+|.+||++.++.+.|.
T Consensus 217 ~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 217 DVIKAIEEGY-RL-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred HHHHHHhCCC-cC-CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 7776665542 22 234578899999999999999999999888777664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.52 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=211.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~-------tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gv 755 (1044)
...++|.+.+.||+|+||.||++.+.. ++..+|+|.++.. ........+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 445789999999999999999998743 2357999998653 2334556788999999999 79999999999
Q ss_pred eecCCeeEEEEeeccccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCcee
Q 001614 756 FTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1044)
Q Consensus 756 fed~~~LyLVmEY~~GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNIL 819 (1044)
+...+.+|+||||+++|+|.+++.... .++...+..++.||+.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997542 3788889999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHH
Q 001614 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1044)
Q Consensus 820 Ldedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (1044)
++.++.+||+|||++........ ........+++.|+|||++.+..++.++||||
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 227 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227 (307)
T ss_pred EcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHHH
Confidence 99999999999999863210000 00011123457899999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 900 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 900 LGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|||++|+|++ |..||.+....++...+..... +..+..++.++.+||.+||..+|.+||++.++.+.|
T Consensus 228 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 228 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9999999998 8999988887777766654432 234567899999999999999999999977765554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.28 Aligned_cols=262 Identities=31% Similarity=0.471 Sum_probs=218.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----ee
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~-----~L 762 (1044)
+|++.+.||.|+||.||+|++..+|+.||+|.+.+.. ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999899999999987532 22345577899999999999999999999988875 78
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||++ ++|.+++.....+++..+..++.||+.||+|||+.||+|+||||.|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~- 157 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc-
Confidence 99999997 5899999887789999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
..........+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+
T Consensus 158 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 158 -----------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred -----------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 000112334689999999999887 78999999999999999999999999888766
Q ss_pred HHHhhhccCCC----------------------------CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCC
Q 001614 922 IFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 922 i~qkIl~g~i~----------------------------~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPw 973 (1044)
.+..+...... +......++.++.+||.+||+.+|.+||+ +.+++.|||
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~~~ 291 (330)
T cd07834 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALAHPY 291 (330)
T ss_pred HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCcc
Confidence 65555432110 11112347889999999999999999999 889999999
Q ss_pred CCCCC
Q 001614 974 FKGVN 978 (1044)
Q Consensus 974 Fk~id 978 (1044)
|+++.
T Consensus 292 ~~~~~ 296 (330)
T cd07834 292 LAQLH 296 (330)
T ss_pred HHhhc
Confidence 98754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.60 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=216.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|...+.||+|+||.||++++..+|..||+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888899999999999999999999999999987654444455678899999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||++| +|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 99975 78777754 4568999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
......|++.|+|||++. .+.++.++|||||||++|+|++|..||...+....
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 012346889999999984 35688899999999999999999999988777666
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
...+.....+. .....+++.+.+||.+||+.+|.+||+ +.+++.|+|+...
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 283 (317)
T cd06635 233 LYHIAQNESPT-LQSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLRE 283 (317)
T ss_pred HHHHHhccCCC-CCCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhcc
Confidence 66666554332 223567889999999999999999999 8899999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.30 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=209.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.++||+|+||.||+|.+..+ ..||+|++++... ....+.+|+.+++.++||||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 346799999999999999999988755 4699999875221 23568899999999999999999988754 56899
Q ss_pred EEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 99999999999999753 357889999999999999999999999999999999999999999999999986421100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~e 921 (1044)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 157 -------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~ 211 (262)
T cd05071 157 -------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211 (262)
T ss_pred -------------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence 001112346778999999988889999999999999999999 899999888777
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
....+..+. ..+ .+..++..+.+||.+||+.||.+||++.++.+.|+
T Consensus 212 ~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 212 VLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred HHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 777665442 222 34578899999999999999999999888877664
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.44 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=210.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
+..++|++.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 44578999999999999999999865 57889999886532 23467889999999999999999998874 45689
Q ss_pred EEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
++|||+++|+|.+++... ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 358889999999999999999999999999999999999999999999999886321000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 157 --------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred --------------------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 001112346788999999988889999999999999999999 99999988877
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+..+. . +..+...+.++.+||.+||+.+|.+||+++++..+|+
T Consensus 211 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 211 EVIQNLERGY-R-MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 7766654432 2 2345678899999999999999999999888777664
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=343.41 Aligned_cols=260 Identities=30% Similarity=0.463 Sum_probs=211.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~----- 760 (1044)
.++|.+.+.||.|+||.||++.+..+|+.||+|.++... ........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 457999999999999999999999999999999986532 22334567789999999999999999999876543
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 4899999996 689999988888999999999999999999999999999999999999999999999999998732100
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
........|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 162 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 162 ---------------------------GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred ---------------------------cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 011123467899999998865 4688999999999999999999999987654
Q ss_pred HHHHHhhhcc----------------------------CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~g----------------------------~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
......+... ...+....+.+++++.+||.+||+.||.+||| +.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell~h 291 (337)
T cd07858 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEALAH 291 (337)
T ss_pred HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHHcC
Confidence 3322221110 00011123468899999999999999999999 8899999
Q ss_pred CCCCCC
Q 001614 972 PFFKGV 977 (1044)
Q Consensus 972 PwFk~i 977 (1044)
|||+.+
T Consensus 292 ~~~~~~ 297 (337)
T cd07858 292 PYLASL 297 (337)
T ss_pred cchhhh
Confidence 999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.89 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=209.2
Q ss_pred CeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 688 DFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~-----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23578898876422 234457789999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCce
Q 001614 763 YLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~------------------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNI 818 (1044)
|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2367888999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhH
Q 001614 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1044)
Q Consensus 819 LLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIW 898 (1044)
|+++++.+||+|||++........ ........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-------------------------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCccc-------------------------hhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 999999999999999864211000 0011223457789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 899 SLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|||+++|+|++ |..||.+..+..+...+... ..+ ..+..++.++.+||..||+.+|.+||++.++.+.|+
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 99999999998 99999988887776655433 222 245678999999999999999999999887766554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.33 Aligned_cols=269 Identities=30% Similarity=0.451 Sum_probs=208.5
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~---- 760 (1044)
.+++|++.+.||.|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999999865322 2222345678999999999999999998875433
Q ss_pred ----eeEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 761 ----NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 761 ----~LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
.+|+||||+.+ +|...+.. ...+++..+..++.||++||.|||++||+|+||||+||++++++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 46999999975 67776654 4579999999999999999999999999999999999999999999999999987
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF 914 (1044)
........ ... . ............|++.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 164 ~~~~~~~~--------~~~---~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPN--------PKG---G-----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcc--------ccc---C-----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 42111100 000 0 0001112234578999999998865 45789999999999999999999999
Q ss_pred CCCChHHHHHhhhccCCC-----C---------------CCC-------CCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 915 TAESPEIIFDNILNRKIP-----W---------------PCV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~i~-----~---------------p~i-------p~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
.+.+.......+...... + ... ....++.+.+||.+||+.||.+||| +.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~e 304 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---ASD 304 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---HHH
Confidence 887776555444321000 0 000 1234567889999999999999999 889
Q ss_pred HHcCCCC
Q 001614 968 VKAHPFF 974 (1044)
Q Consensus 968 IL~HPwF 974 (1044)
++.||||
T Consensus 305 ll~~~~f 311 (311)
T cd07866 305 ALEHPYF 311 (311)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=365.77 Aligned_cols=251 Identities=33% Similarity=0.535 Sum_probs=210.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-C-----CceEEEeeeeecCCe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N-----PFVVRFFYSFTCRDN 761 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-H-----PNIVkL~gvfed~~~ 761 (1044)
+|.+.+.||+|+||+|.+|.+..|++.||||++++. .....+...|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 799999999999999999999999999999999863 455677889999999997 3 489999999999999
Q ss_pred eEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC--cEEEeecCCcccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIG 837 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg--~VKLsDFGLAki~ 837 (1044)
+|||+|++.. +|+++|+.+ ..++...++.++.||+.||.+||+.||||.||||+||||.+.+ .|||+|||.|+..
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999955 999999865 3589999999999999999999999999999999999997654 6999999999742
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
. ....+.+-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.|.
T Consensus 342 ~------------------------------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 S------------------------------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred C------------------------------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 1 1111345677899999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhccC---------------------CCCC----------------------------CCC-----------
Q 001614 918 SPEIIFDNILNRK---------------------IPWP----------------------------CVP----------- 937 (1044)
Q Consensus 918 s~~ei~qkIl~g~---------------------i~~p----------------------------~ip----------- 937 (1044)
+..+.+..|..-. ..++ ..|
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 8877666554200 0000 011
Q ss_pred CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 938 ~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
..-...+.+||++||..||.+|+| ..++|+||||.+
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~ 507 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTG 507 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC---HHHHhcCccccc
Confidence 011234679999999999999999 778899999985
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.04 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=207.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.++|.+...||.|+||.||++.+..+ ..+|+|.+.... .....+.+|+.+++.++||||+++++++. .+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999988654 469999876432 23456889999999999999999998875 4568999
Q ss_pred EeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 766 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++.++|+|||++.....+.
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-- 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-- 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc--
Confidence 9999999999999754 347889999999999999999999999999999999999999999999999986421100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei 922 (1044)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+......
T Consensus 157 ------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 212 (260)
T cd05069 157 ------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212 (260)
T ss_pred ------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 001112346778999999988889999999999999999999 9999998888777
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
...+..+. . +..+...+..+.+||.+||+.||.+||+++++.+.|+
T Consensus 213 ~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 213 LEQVERGY-R-MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HHHHHcCC-C-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 77665442 2 2244678899999999999999999999887777654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.85 Aligned_cols=255 Identities=35% Similarity=0.574 Sum_probs=209.6
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--CeeEEEE
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLVM 766 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~LyLVm 766 (1044)
|++.+.||.|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++... +.+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999997643 2333446788999999999999999999999988 7899999
Q ss_pred eeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+++ +|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99975 899888765 579999999999999999999999999999999999999999999999999986421100
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 155 ----------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred ----------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 001122457889999998765 457899999999999999999999998887766555
Q ss_pred hhhccCC-----CCCC----------------------CCCC-CCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKI-----PWPC----------------------VPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i-----~~p~----------------------ip~~-iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
.+..... .++. .... .+..+.++|.+||+.+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~~ 287 (287)
T cd07840 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEYF 287 (287)
T ss_pred HHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcCC
Confidence 4433110 0000 0012 3888999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.27 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=213.0
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC-------CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k-------~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~g 754 (1044)
....++|.+.+.||+|+||.||++++. .++..||+|.+... ........+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 355678999999999999999999753 23457999988642 2344567889999999999 7999999999
Q ss_pred eeecCCeeEEEEeeccccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCce
Q 001614 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1044)
Q Consensus 755 vfed~~~LyLVmEY~~GGSL~dlLkk~----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNI 818 (1044)
++.....+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999753 2367778889999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhH
Q 001614 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1044)
Q Consensus 819 LLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIW 898 (1044)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-------------------------cccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 999999999999999874211000 0011123467789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 899 SLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|||+++|+|++ |..||.+.+..++...+..+.. ...+..++.++.+||.+||..+|.+||++.++.+.|
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 99999999998 8999998888888777655432 234567899999999999999999999977766654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.77 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=208.0
Q ss_pred EeeccCCceEEEEEEECC-CCc--EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeec
Q 001614 693 KPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~-tGk--~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~ 769 (1044)
+.||+|++|.||+|.+.. .++ .||+|.+...... .....+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999998764322 566789999999999999999999999988 8899999999
Q ss_pred cccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 770 NGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 770 ~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
++|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 152 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----- 152 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc-----
Confidence 9999999997654 689999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkI 926 (1044)
. ........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 153 -----------~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 153 -----------H--------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred -----------c--------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0 001113457889999999998889999999999999999998 99999888887777766
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
...... ...+...+..+.+++.+||+.+|.+||++.++.+.|.
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 214 DKEGER-LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HhcCCc-CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 643333 2245678899999999999999999999777766553
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.25 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=213.6
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCC-----CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~t-----Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
.++|++.+.||.|+||.||+|+++.+ .+.|++|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 36799999999999999999997643 4679999875422 2234577999999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeec
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g---------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDF 831 (1044)
..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-C
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-G 910 (1044)
|++...... .........+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 987631100 0011223356788999999988888999999999999999999 8
Q ss_pred CCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
..||...........+..+...++ .+..++..+.++|.+||+.||.+||++.++...|
T Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 216 ELPFYGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred CCCccccchHHHHHHHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 899988877777777766665554 3456889999999999999999999966655543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.67 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=212.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC-------CCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~-------tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gv 755 (1044)
...++|.+.+.||+|+||.||+|++.. .+..+|+|.++.. ........+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 445789999999999999999998632 3457999988642 2234567789999999999 59999999999
Q ss_pred eecCCeeEEEEeeccccchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCcee
Q 001614 756 FTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (1044)
Q Consensus 756 fed~~~LyLVmEY~~GGSL~dlLkk~----------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNIL 819 (1044)
+.....+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999653 24788889999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHH
Q 001614 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (1044)
Q Consensus 820 Ldedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (1044)
++.++.+||+|||+++....... ........+++.|||||++.+..++.++||||
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 221 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221 (314)
T ss_pred EcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchhhH
Confidence 99999999999999873210000 00011123456899999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 900 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 900 LGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||+++|+|++ |..||.+.+..+.+..+..+.. ...+..++.++.+||.+||+.||.+||++.++.+.|.
T Consensus 222 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 222 FGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9999999999 8999998888888777665432 2345678899999999999999999999877776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.97 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=198.5
Q ss_pred eeccCCceEEEEEEECC--CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 694 PISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~--tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 69999999999997543 3457888876532 2334456788999999999999999999999999999999999999
Q ss_pred cchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 772 GDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 772 GSL~dlLkk~g-----~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY---- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh----
Confidence 99999997643 246778889999999999999999999999999999999999999999998863110000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s 918 (1044)
........+++.|+|||++.. ..++.++|||||||++|+|++ |..||....
T Consensus 156 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 156 ---------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ---------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 001123356788999999743 356789999999999999999 889998877
Q ss_pred hHHHHHhhhccC-CC--CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 919 PEIIFDNILNRK-IP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 919 ~~ei~qkIl~g~-i~--~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
+.+....+.... .+ .+..+..++..+.+++..|+ .||.+|||++++.++|.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 215 DEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLTY 269 (269)
T ss_pred HHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhcC
Confidence 766655544332 22 23345578899999999998 599999999988888765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.09 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=211.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk---~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
..+|++.+.||+|+||.||+|.++.+++ .||+|++... ........+..|+.+++.++||||+++++++.....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999987665 6999998642 2344567899999999999999999999999999999
Q ss_pred EEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999975 3568999999999999999999999999999999999999999999999999886421100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
. ... ........++..|+|||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 161 ~-----------------~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 161 S-----------------DPT-----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred c-----------------ccc-----cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 0 000 000011112467999999998899999999999999999886 99999988887
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
.....+... .+.+ .+..++..+.+++.+||+.+|.+||+++++...|
T Consensus 219 ~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 219 DVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred HHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 777766433 2222 3457889999999999999999999977665544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.14 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=209.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
..+|++.+.||.|+||.||++.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999886 477899998864321 235688999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|||+++|+|.+++... +.+++..+..++.|++.|++|||+.+++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence 9999999999999754 568999999999999999999999999999999999999999999999999886321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~ 923 (1044)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 155 -----------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05112 155 -----------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 001112335678999999998889999999999999999998 99999988877777
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
..+..+... ..+...+..+.+|+.+||+.+|.+||+++++.+.|
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 212 ETINAGFRL--YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHhCCCCC--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 776554322 22455789999999999999999999966665543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.78 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=207.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC----------------CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCce
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~----------------tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNI 749 (1044)
.++|++.+.||+|+||.||++.+.. ++..||+|.++.. ........+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986542 3447999988643 233445788999999999999999
Q ss_pred EEEeeeeecCCeeEEEEeeccccchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCce
Q 001614 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (1044)
Q Consensus 750 VkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g-----------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNI 818 (1044)
+++++++...+..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997542 366778999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhH
Q 001614 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (1044)
Q Consensus 819 LLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIW 898 (1044)
|++.++.++|+|||++........ ........+++.|+|||+..+..++.++|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999863210000 0011123456789999998888899999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCChHHHHHhhhc-----cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 899 SVGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 899 SLGVILYELLT--Gr~PF~g~s~~ei~qkIl~-----g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||||++|||++ |..||...+..+....... ........+..+++.+.+||..||+.||.+||++.++.++|+
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99999999998 7899988776665443311 111112234567899999999999999999999888877664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=317.38 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=204.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
+.||.|+||.||+|... ++..||+|.++... .......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999886432 2334457889999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 773 SL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
+|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....+.
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---------- 147 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc----------
Confidence 999998753 457899999999999999999999999999999999999999999999999886311000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~ 930 (1044)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..+.
T Consensus 148 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 148 ----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred ----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 001112234678999999988889999999999999999998 999999887777666665432
Q ss_pred CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 931 i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
. ...+..++..+.+|+.+||+.+|.+||++.++.+.|
T Consensus 212 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 212 -R-MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred -C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 1 234567899999999999999999999977766544
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.92 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=201.7
Q ss_pred eeccCCceEEEEEEECCCCc--EEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeEEEEeecc
Q 001614 694 PISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk--~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~LyLVmEY~~ 770 (1044)
.||+|+||.||+|+++.++. .+|+|.++.. ........+.+|+.++.++ +||||+++++++...+.+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 68999999999999988776 4688877532 2334556788999999999 79999999999999999999999999
Q ss_pred ccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 771 GGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 771 GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
+|+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997542 3788899999999999999999999999999999999999999999999987
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~P 913 (1044)
.... . ........+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~--~--------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 160 RGQE--V--------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccc--h--------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 5210 0 000111234668999999988889999999999999999997 9999
Q ss_pred CCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|.+.+....+..+..+. . ...+..++.++.+|+.+||..||.+|||+.++...|
T Consensus 212 f~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 212 YCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred ccccCHHHHHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 98887777776665432 2 223456789999999999999999999977666554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.75 Aligned_cols=260 Identities=33% Similarity=0.511 Sum_probs=209.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--- 760 (1044)
...++|++.+.||.|+||.||+|.++.+|+.||+|.++... ........+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecc-cccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999999999999999986532 12223456778999999999999999999987755
Q ss_pred -------eeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecC
Q 001614 761 -------NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1044)
Q Consensus 761 -------~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFG 832 (1044)
.+|+||||+++ +|.+++... ..+++..+..++.||+.||+|||+.||+|+||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999986 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCC
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 833 LAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr 911 (1044)
++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEE--------------------------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCc--------------------------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 986421100 001112346788999998865 35788999999999999999999
Q ss_pred CCCCCCChHHHHHhhhcc---CCC--CC----------------------CCCCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 912 PPFTAESPEIIFDNILNR---KIP--WP----------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 912 ~PF~g~s~~ei~qkIl~g---~i~--~p----------------------~ip~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
+||...+.......+... ..+ ++ .....++..+.+||..||+.||.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 999877665544333321 100 00 012346889999999999999999999
Q ss_pred HHHHHcCCCC
Q 001614 965 AAEVKAHPFF 974 (1044)
Q Consensus 965 A~EIL~HPwF 974 (1044)
+.+++.||||
T Consensus 293 ~~~il~~~~~ 302 (302)
T cd07864 293 AEEALNSPWL 302 (302)
T ss_pred HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.25 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=210.3
Q ss_pred eEEEEeeccCCceEEEEEEECCCC----cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tG----k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
+++.+.||.|+||.||++.+..++ ..||+|.++... .......+.+|+.++..++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 456789999999999999998766 899999986532 22256789999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 765 VMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~--Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
+|||+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 89999999999999999999999999999999999999999999999999874211100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~e 921 (1044)
+ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+...
T Consensus 159 --------------------~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 --------------------Y------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred --------------------c------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0 0001227889999999988889999999999999999998 899999888888
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
....+...... ..+..++.++.+++.+||..||.+|||+.++.+
T Consensus 213 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 88777665432 345668999999999999999999999555443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=362.07 Aligned_cols=263 Identities=29% Similarity=0.448 Sum_probs=227.2
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCc---E-EEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---L-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 756 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk---~-VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvf 756 (1044)
.+....++..+.++||+|+||+||+|..+..+. . ||+|..+.........+.++++|+++|++++|||||++||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345667788888999999999999999876433 3 899988754445677889999999999999999999999999
Q ss_pred ecCCeeEEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 757 TCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 757 ed~~~LyLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
....++|+|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999999877 49999999999999999999999999999999999999999999999999987
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF 914 (1044)
... .|... .....-...|+|||.+....|+.++|||||||++||+++ |..||
T Consensus 311 ~~~-----------------------~~~~~----~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 311 AGS-----------------------QYVMK----KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred CCc-----------------------ceeec----cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence 421 01111 111134578999999999999999999999999999999 88999
Q ss_pred CCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
.+.+..++..+|....++.+ .|...+.++..++.+|+..||++||++.++.+.++-
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred CCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 99999999999977777654 456788999999999999999999998887766543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=375.57 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=226.8
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECC-----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEee
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (1044)
Q Consensus 680 ~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~-----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~g 754 (1044)
....+...+..+.+.||+|.||+||+|+... ....||||.++... ..+...+|.+|+++|..++|||||+++|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3445667788889999999999999998642 23589999997533 3447789999999999999999999999
Q ss_pred eeecCCeeEEEEeeccccchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceee
Q 001614 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820 (1044)
Q Consensus 755 vfed~~~LyLVmEY~~GGSL~dlLkk~g--------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILL 820 (1044)
+|..++.+|+|+|||..|||..+|...+ +++..+...++.||+.||.||-++.++||||-..|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9999999999999999999999996432 27888999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHH
Q 001614 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900 (1044)
Q Consensus 821 dedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSL 900 (1044)
.++..|||+||||++-....+++.+ .....-..+|||||.++.++|+.+||||||
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~-------------------------~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKV-------------------------RGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcc-------------------------cCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 9999999999999984322222211 112234679999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 901 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 901 GVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
||+|||+++ |+.||.+.+.++.++.|..+.. + ..|.++|.++.+||..||+.+|.+||+|.++..+|++
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-L-SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc-c-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 999999999 9999999999999999999987 3 4678999999999999999999999999888777753
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=324.11 Aligned_cols=258 Identities=20% Similarity=0.310 Sum_probs=212.5
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECC----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec-
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed- 758 (1044)
+..++|++.+.||+|+||.||+|.+.. ++..|++|.++. .........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC--CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999875 357899998764 2344556788999999999999999999998765
Q ss_pred CCeeEEEEeeccccchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEee
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk~--------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsD 830 (1044)
....+++++|+++|+|.+++... ..+++..+..++.||+.||+|||+++++||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 46789999999999999999653 3588999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-
Q 001614 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909 (1044)
Q Consensus 831 FGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT- 909 (1044)
||+++........ .......++..|+|||++.+..++.++||||||+++|++++
T Consensus 161 ~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDYH-------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCceE-------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9998742111000 00112245678999999988889999999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|+.||...++.++...+..+ ..++ .+..+++++.+++.+||..||.+|||+.++.+.|.
T Consensus 216 g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKDG-YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred CCCCcCcCCHHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 99999988887776655543 2222 34567899999999999999999999887776653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=322.57 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=197.2
Q ss_pred EeeccCCceEEEEEEECC--CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecc
Q 001614 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~--tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~ 770 (1044)
+.||+|+||.||+|.+.. ++..+|+|.++... .......+.+|+.+++.++||||+++++++.....+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998753 45679999876432 22344578899999999999999999999999999999999999
Q ss_pred ccchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 771 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 771 GGSL~dlLkk~g-----~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
+|+|.+++.... ..++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999997532 356677888999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-------CCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-------~ys~KSDIWSLGVILYELLT-Gr~PF~g~ 917 (1044)
........|++.|+|||++.+. .++.++||||||+++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 156 ----------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ----------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 0011234678899999998642 35789999999999999996 99999887
Q ss_pred ChHHHHHhhhcc-CC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 918 SPEIIFDNILNR-KI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 918 s~~ei~qkIl~g-~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
...+........ .. +.+......++.+.++|..|+ .+|.+|||++++...|.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~~ 269 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLSY 269 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhcC
Confidence 766554433322 12 222233457888999999999 689999998888776653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=340.32 Aligned_cols=258 Identities=31% Similarity=0.484 Sum_probs=209.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~----- 760 (1044)
.++|.+.+.||.|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 368999999999999999999999999999999986532 22333456889999999999999999999887543
Q ss_pred -eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 -~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
.+|+||||+.+ +|..++ ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~- 168 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD- 168 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC-
Confidence 46999999964 777665 2468999999999999999999999999999999999999999999999999976310
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 169 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 169 -----------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred -----------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01113467899999999876 468899999999999999999999998877
Q ss_pred hHHHHHhhhccC----------------------CC------CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 919 PEIIFDNILNRK----------------------IP------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 919 ~~ei~qkIl~g~----------------------i~------~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
....+..+.... .+ +....+..+.++.+||.+||+.||.+||+ +.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~l~ 296 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEALE 296 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHHhc
Confidence 555444333210 00 00111356788999999999999999999 788999
Q ss_pred CCCCCCCCcc
Q 001614 971 HPFFKGVNWD 980 (1044)
Q Consensus 971 HPwFk~id~d 980 (1044)
||||+++.+.
T Consensus 297 h~~f~~~~~~ 306 (342)
T cd07879 297 HPYFDSFRDA 306 (342)
T ss_pred Ccchhhcccc
Confidence 9999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.23 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=214.6
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|+..+.||.|+||.||+|+++.++..+|+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44778889999999999999999999999999987543334445567889999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9996 588877753 4568999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
......|++.|+|||.+. ...++.++|||||||++|+|++|..||...+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 167 ------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred ------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 011245889999999985 34578899999999999999999999988766655
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
...+..+..+. ..+..++..+.+||.+||+.+|.+||+ +.+++.|||+....
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~~ 274 (308)
T cd06634 223 LYHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRER 274 (308)
T ss_pred HHHHhhcCCCC-cCcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCccccccC
Confidence 55554444332 123468889999999999999999999 78899999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.39 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=213.6
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--cChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~--~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+|.+.+.||+|+||.||++.+..++..+++|+++.... ........+..|+.+++.++||||+++++++.+...+++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48899999999999999999988888788887765332 2233445677899999999999999999999999999999
Q ss_pred EeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999998864 346899999999999999999999999999999999999975 67999999988642110
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~e 921 (1044)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 159 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 159 --------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 011123457899999999988888999999999999999999999998877766
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
....+..+. .+..+..++.++.++|.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 666665543 23455778899999999999999999999 8889999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.68 Aligned_cols=254 Identities=34% Similarity=0.555 Sum_probs=210.1
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|++.+.||.|++|.||+|.+..+|+.+++|.++... ........+.+|+.++++++||||+++++++.....+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567889999999999999999899999999986533 2233456788999999999999999999999999999999999
Q ss_pred ccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
+++ +|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||.+......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~------- 151 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP------- 151 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC-------
Confidence 975 88888866 357899999999999999999999999999999999999999999999999988642100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+
T Consensus 152 --------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 152 --------------------VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred --------------------cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011224578899999999876 7889999999999999999999999887765554443
Q ss_pred hccCC-------------------CC--------CCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 927 LNRKI-------------------PW--------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 927 l~g~i-------------------~~--------p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..... .+ ......++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 22100 00 0112347889999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.07 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=205.1
Q ss_pred eeccCCceEEEEEEECCCC------cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 694 PISRGAFGRVFLARKRTTG------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tG------k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.||+|+||.||+|++...+ ..+|+|.+.+.. .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 6899999999999986544 689999876422 22345678999999999999999999999999999999999
Q ss_pred eccccchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-----cEEEeecCCcc
Q 001614 768 YLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSK 835 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~-------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-----~VKLsDFGLAk 835 (1044)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999642 3377888999999999999999999999999999999999877 89999999986
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF 914 (1044)
....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 160 ~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~ 214 (269)
T cd05044 160 DIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214 (269)
T ss_pred ccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence 3211000 001122346788999999998889999999999999999998 99999
Q ss_pred CCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
...+..+....+..+.. ...+..+|..+.+||.+||+.+|.+||+++++.+.|+
T Consensus 215 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 215 PALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 88887777666654332 2234678899999999999999999999888877765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=362.90 Aligned_cols=258 Identities=19% Similarity=0.320 Sum_probs=217.7
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 680 ~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
..+.+..+++.+...||+|.||+||+|+|. ..||||+++.. .......+.|.+|+.++++-+|.||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~-~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVD-DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecC-CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 556677888999999999999999999996 46999999754 44566889999999999999999999999999887
Q ss_pred CeeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
.. .||+.+|+|-+|+.+|+-. ..|.....+.|++||++||.|||.++|||||||..||++.+++.|||+||||+.+..
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 9999999999999999743 458889999999999999999999999999999999999999999999999987411
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC---CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
.+ ..........|...|||||++.. .+|++.+||||||+++|||++|..||.
T Consensus 540 --------------~w-----------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 --------------RW-----------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred --------------ee-----------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 11 11223344568899999999964 468999999999999999999999999
Q ss_pred CCChHHHHHhhhccCC--CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 916 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 916 g~s~~ei~qkIl~g~i--~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
..+.+.++-.+-.|.. +......+++.++++|+..||.+++++||.+.++..
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 7777777665555522 222234577889999999999999999999887766
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=362.20 Aligned_cols=268 Identities=24% Similarity=0.330 Sum_probs=199.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCC-cEEEEEE--------------eecccccChhHHHHHHHHHHHHHhcCCCce
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKV--------------LKKLDMIRKNDIERILAERNILITVRNPFV 749 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tG-k~VAVKi--------------IkK~~~~~~~~~e~flrEi~ILs~L~HPNI 749 (1044)
..++|++++.||+|+||+||+|..+... ..++.|. +.+...........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998765332 2222221 111111122345568899999999999999
Q ss_pred EEEeeeeecCCeeEEEEeeccccchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC
Q 001614 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1044)
Q Consensus 750 VkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~-----g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg 824 (1044)
+++++++...+..|+|++++. ++|..++... .......++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 5788777532 2234567888999999999999999999999999999999999
Q ss_pred cEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHH
Q 001614 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1044)
Q Consensus 825 ~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (1044)
.+||+|||++...... ........+||+.|+|||++.+..++.++|||||||++
T Consensus 305 ~vkL~DFGla~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 305 KIVLGDFGTAMPFEKE--------------------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred CEEEEeCCCceecCcc--------------------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 9999999998742100 00112235799999999999999999999999999999
Q ss_pred HHHHhCCCC-CCCC--ChHHHHHhhhcc----CCCCCC-------------------------CCCCCCHHHHHHHHhHc
Q 001614 905 FEFITGIPP-FTAE--SPEIIFDNILNR----KIPWPC-------------------------VPSDMSFEAQDLINRFL 952 (1044)
Q Consensus 905 YELLTGr~P-F~g~--s~~ei~qkIl~g----~i~~p~-------------------------ip~~iS~eLkdLIkkcL 952 (1044)
|||++|..| |... ++...+.++... ...++. ....++.++.++|.+||
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998754 4322 222222222110 000110 01235677888999999
Q ss_pred cCCcCCCCChhhHHHHHcCCCCCCCCcchh
Q 001614 953 IHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982 (1044)
Q Consensus 953 qkDPskRPSadeA~EIL~HPwFk~id~d~L 982 (1044)
+.||.+||| +.++|.||||.....+.+
T Consensus 439 ~~DP~~Rps---a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 439 TFDWHLRPG---AAELLALPLFSAEEEEEI 465 (501)
T ss_pred ccCcccCcC---HHHHhhChhhhcCCchHH
Confidence 999999999 889999999988655544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=322.77 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=211.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
...+|++.+.||+|+||.||+|.++.+|. .+|+|.+.+.. .......+.+|+.++..++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45689999999999999999999877665 58999876532 24455778999999999999999999999987 7
Q ss_pred eeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999764 4689999999999999999999999999999999999999999999999999874211
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s 918 (1044)
... ........+++.|+|||.+....++.++|+||||+++|+|++ |..||.+..
T Consensus 162 ~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 162 DEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred ccc-------------------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 000 000111224678999999988889999999999999999998 999999988
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
..++...+..+.. ...+...+..+.+++.+||..||.+||++.++.+.+
T Consensus 217 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 217 AVEIPDLLEKGER--LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred HHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 8887777665432 223456788999999999999999999976655543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.96 Aligned_cols=256 Identities=28% Similarity=0.412 Sum_probs=225.9
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|.-++.||.|+||.||.+++..+.+.||||.+.-..........+++.|+..|+++.|||+|.+.+||..+.+.||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56677899999999999999999999999988766666666778999999999999999999999999999999999999
Q ss_pred ccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|- |+-.|++.- ..++.+..+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.+.
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------- 176 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------- 176 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----------
Confidence 95 588888763 356899999999999999999999999999999999999999999999999988642
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
...++++|||+|||||++.. +.|+-++||||||++..||.-.++|+.+.+.+-.+.
T Consensus 177 ---------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 177 ---------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred ---------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 12356899999999999864 679999999999999999999999999999988888
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
-|..+..|-. ....+|+.+.+|+..||++-|..||| ..++|.|+|...-...
T Consensus 236 HIAQNesPtL-qs~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 236 HIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLRERPP 287 (948)
T ss_pred HHHhcCCCCC-CCchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhccCCCc
Confidence 8877665422 24678999999999999999999999 7889999998754433
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.86 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=212.6
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecc
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~ 770 (1044)
...+||+|+||.||++....+|..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 346799999999999999999999999987532 23345678999999999999999999999999999999999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCC
Q 001614 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1044)
Q Consensus 771 GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t 850 (1044)
+++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~----------- 168 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----------- 168 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc-----------
Confidence 9999998754 4689999999999999999999999999999999999999999999999998753110
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccC
Q 001614 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930 (1044)
Q Consensus 851 ~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~ 930 (1044)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+....
T Consensus 169 ----------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 232 (292)
T cd06657 169 ----------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232 (292)
T ss_pred ----------------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Confidence 0011123468999999999988888999999999999999999999998877666555544332
Q ss_pred CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 931 i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.+.......+++.+.++|.+||..||.+||+ +.+++.||||...
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 2212223467899999999999999999999 7889999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=321.01 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=208.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~t---Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~ 761 (1044)
..++|.+.+.||.|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999997644 3468999875422 23456789999999999999999999998876 45
Q ss_pred eEEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997644 5899999999999999999999999999999999999999999999999998642110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 161 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 161 SY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred cc--------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 00 00112234578999999988889999999999999999996 9999988887
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
.+....+..+.. +..+..++.++.+||.+||..+|.+|||+.++.+.|
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 215 NDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred HHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 777666655432 234577899999999999999999999977666554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=323.78 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=199.4
Q ss_pred eEEEEeeccCCceEEEEEE----ECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--Cee
Q 001614 689 FEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~----~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~~L 762 (1044)
|++.+.||+|+||+||++. ...++..||+|+++... .......+.+|+.+|+.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4899999999999998865 34568899999986532 223456788999999999999999999987654 358
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||++........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999999764 599999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH--
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 920 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~-- 920 (1044)
.........++..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 163 ------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 163 ------------------------YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred ------------------------hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 000011234567799999998888999999999999999999999998643221
Q ss_pred HHH------------HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIF------------DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~------------qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+.. ......... +..+..++.++.+|+.+||+.||.+|||++++.+.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 110 111111111 2235678899999999999999999999877776653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=352.37 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=227.7
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
-|.++.+||+|+||.||++.++.+|..+|+|.+.- ..+..++..|+.||++++.|+||++|+.|.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 47889999999999999999999999999997753 3467889999999999999999999999999999999999
Q ss_pred eccccchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 768 YLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 768 Y~~GGSL~dlLk-k~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
||..|++.+.++ +..++++..+..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT-------- 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT-------- 180 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh--------
Confidence 999999999997 45789999999999999999999999999999999999999999999999999885311
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
....+.++..|||-|||||++..-.|+.++||||||++..||.-|++||.+..++..+-.|
T Consensus 181 -------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 181 -------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred -------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 1234567889999999999999989999999999999999999999999999988776666
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
-....+--.-|..+|.++.+||++||-++|++|-| |.++++|||+++.
T Consensus 242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNA 289 (502)
T ss_pred cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCC
Confidence 55544332345678999999999999999999999 9999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=327.45 Aligned_cols=261 Identities=28% Similarity=0.508 Sum_probs=210.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCe
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~ 761 (1044)
....++|++.+.||.|+||.||+|.+..+++.||+|.+++.. .......+..|+.++.++. ||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 456789999999999999999999999899999999997532 2233456677877776665 9999999999999999
Q ss_pred eEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||++++++.+||+|||++.....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999985 477777755 4568999999999999999999997 5999999999999999999999999998763110
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC----CCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.
T Consensus 168 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 168 ----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred ----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 00111235788999999987543 7889999999999999999999997
Q ss_pred CCCh-HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 916 AESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 916 g~s~-~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.... .+....+.....+.......++.++.+||.+||..||.+||+ +.+++.||||...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 279 (296)
T cd06618 220 NCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRRY 279 (296)
T ss_pred cchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhcc
Confidence 6433 344444444432211122347889999999999999999999 7889999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.64 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=210.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
+..++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45678999999999999999999865 4667999987642 2345678899999999999999999999887 7789
Q ss_pred EEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
++|||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 357888889999999999999999999999999999999999999999999886321100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ 920 (1044)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 157 --------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred --------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001112345678999999988889999999999999999999 99999988777
Q ss_pred HHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.....+..+. . ...+...+.++.+++.+||+.+|.+||+++++.++|+
T Consensus 211 ~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 211 EVIRALERGY-R-MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred HHHHHHhCCC-C-CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 7666655442 2 2234678899999999999999999999888877764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.38 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=206.9
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
..++|++.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.+++.++||||+++++++... .+|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 456899999999999999999864 5889999988542 1345788999999999999999999998654 5799
Q ss_pred EEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 765 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997643 478899999999999999999999999999999999999999999999998863110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~e 921 (1044)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 153 ---------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 153 ---------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ---------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 0011234568999999988889999999999999999998 999999888877
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
....+..+. . +..+..+++.+.+||.+||+.+|.+||+++++.+.|+
T Consensus 206 ~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 206 VKECVEKGY-R-MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 766665442 2 2234678899999999999999999999888777664
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.07 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=204.4
Q ss_pred EeeccC--CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecc
Q 001614 693 KPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 693 k~LG~G--gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~ 770 (1044)
..||.| +||+||++++..+|+.||+|++.... ......+.+.+|+.+++.++||||++++++|...+.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 99999999999999999999986532 233445788999999999999999999999999999999999999
Q ss_pred ccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCC
Q 001614 771 GGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1044)
Q Consensus 771 GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p 848 (1044)
+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 99999999764 3488999999999999999999999999999999999999999999999986532110000
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 849 ~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
.... .........++..|||||++.+. .++.++|||||||++|+|++|..||.+.........+
T Consensus 157 ------~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 157 ------KAKV--------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ------cccc--------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 0000 00001122456789999999763 4788999999999999999999999877654444333
Q ss_pred hccCCCCC--------------------------------------------CCCCCCCHHHHHHHHhHccCCcCCCCCh
Q 001614 927 LNRKIPWP--------------------------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1044)
Q Consensus 927 l~g~i~~p--------------------------------------------~ip~~iS~eLkdLIkkcLqkDPskRPSa 962 (1044)
.......+ ..+..+++.+.+||.+||+.||.+|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 32211000 011235678999999999999999999
Q ss_pred hhHHHHHcCCCCCCC
Q 001614 963 NGAAEVKAHPFFKGV 977 (1044)
Q Consensus 963 deA~EIL~HPwFk~i 977 (1044)
+.++|+||||+.+
T Consensus 302 --a~e~l~~~~~~~~ 314 (328)
T cd08226 302 --ASSLLSHAFFKQV 314 (328)
T ss_pred --HHHHhhCHHHHHH
Confidence 8889999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=333.42 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=212.1
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEECCC-------CcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k~t-------Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~ 753 (1044)
+.....+|++.+.||+|+||.||++++... +..||+|.++.. ........+.+|+.+++++ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 344456799999999999999999986432 236899987642 2334567889999999999 799999999
Q ss_pred eeeecCCeeEEEEeeccccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 001614 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1044)
Q Consensus 754 gvfed~~~LyLVmEY~~GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeN 817 (1044)
+++...+.+|++|||+++|+|.+++.+.. .++...+..++.||+.||+|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999997532 36777888899999999999999999999999999
Q ss_pred eeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhh
Q 001614 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1044)
Q Consensus 818 ILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDI 897 (1044)
||++.++.+||+|||+++....... ........+++.|+|||++.+..++.++||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred EEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 9999999999999999864210000 001112234578999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 898 WSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||||+++|+|++ |..||.+.+..+....+..... +..+..++.++.+||.+||+.+|.+||++.++.+.|.
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 999999999998 8999999888887777655432 2345678899999999999999999999777666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=333.95 Aligned_cols=274 Identities=27% Similarity=0.401 Sum_probs=213.7
Q ss_pred CCeE-EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChh-----------HHHHHHHHHHHHHhcCCCceEEEee
Q 001614 687 DDFE-IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----------DIERILAERNILITVRNPFVVRFFY 754 (1044)
Q Consensus 687 ~dY~-Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~-----------~~e~flrEi~ILs~L~HPNIVkL~g 754 (1044)
++|. +.+.||.|+||.||+|.+..+|+.||+|.++........ ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457799999999999999999999999998653322100 0124779999999999999999999
Q ss_pred eeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 755 vfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
++...+.+|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 599999988788999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
............ . ...............+++.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 167 ~~~~~~~~~~~~-----------~--~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 167 RRYGYPPYSDTL-----------S--KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred eecccccccccc-----------c--ccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 742211100000 0 00000011122334578999999998764 468899999999999999999999
Q ss_pred CCCCChHHHHHhhhccCC-----CCC--------------------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 914 FTAESPEIIFDNILNRKI-----PWP--------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i-----~~p--------------------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
|.+.+..+....+..... .|+ ......+.++.+||.+||+.+|.+||+ +.++
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~ 310 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---AKEA 310 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---HHHH
Confidence 998877665554432100 000 012345788999999999999999999 8899
Q ss_pred HcCCCCCCC
Q 001614 969 KAHPFFKGV 977 (1044)
Q Consensus 969 L~HPwFk~i 977 (1044)
|.||||++.
T Consensus 311 l~~~~~~~~ 319 (335)
T PTZ00024 311 LKHEYFKSD 319 (335)
T ss_pred hcCcccCCC
Confidence 999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=337.23 Aligned_cols=258 Identities=30% Similarity=0.446 Sum_probs=209.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC----
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~---- 759 (1044)
...++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34588999999999999999999999999999999986532 2233356788999999999999999999988643
Q ss_pred --CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 760 --DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 --~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
..+|++++++ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888887 7899888764 45899999999999999999999999999999999999999999999999987631
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
. .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 171 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 D------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred c------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0 01123467899999999876 5678899999999999999999999987
Q ss_pred CChHHHHHhhhccCC----------------------------CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 917 ESPEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 917 ~s~~ei~qkIl~g~i----------------------------~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
.+.......+..... .+.......++++.+||.+||+.||.+||+ +.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~ 297 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQA 297 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHHH
Confidence 665444333322100 001111246788999999999999999999 8899
Q ss_pred HcCCCCCCC
Q 001614 969 KAHPFFKGV 977 (1044)
Q Consensus 969 L~HPwFk~i 977 (1044)
+.||||.+.
T Consensus 298 l~h~~f~~~ 306 (345)
T cd07877 298 LAHAYFAQY 306 (345)
T ss_pred hcChhhhhc
Confidence 999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=373.88 Aligned_cols=267 Identities=26% Similarity=0.379 Sum_probs=207.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+++|++.+.||+|+||.||+|.+..+|+.||+|+++...........++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999998754333344567899999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 766 MEYLNGGDLYSLLRKV-----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~-----------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 22455677889999999999999999999999999999999999999999999
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF 914 (1044)
+.......... ....................+||+.|||||++.+..++.++|||||||++|+|+||..||
T Consensus 161 k~i~~~~~~~~---------~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 161 IFKKLEEEDLL---------DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred eeccccccccc---------ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 75311110000 000000000001112233467999999999999989999999999999999999999999
Q ss_pred CCCChHHHHHhh-hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh
Q 001614 915 TAESPEIIFDNI-LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (1044)
Q Consensus 915 ~g~s~~ei~qkI-l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa 962 (1044)
.......+.... ......+. ....+++.+.+++.+||+.||.+||+.
T Consensus 232 ~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 232 RRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred CCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCH
Confidence 876554433221 11111111 124688999999999999999999883
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.11 Aligned_cols=254 Identities=36% Similarity=0.561 Sum_probs=210.2
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999987643 2233456778899999999999999999999999999999999
Q ss_pred ccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
++ ++|.+++.+. ..+++..+..++.|++.||+|||++||+|+||+|+||++++++.++|+|||++.....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~-------- 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-------- 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC--------
Confidence 97 5999999876 5799999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkI 926 (1044)
.........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+....+.++
T Consensus 151 -------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 151 -------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred -------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 00011223467889999998776 7889999999999999999999999887765554443
Q ss_pred hcc------------------CCCCCC--------CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 927 LNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 927 l~g------------------~i~~p~--------ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
... ...++. ..+.++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 221 000111 11235788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=338.54 Aligned_cols=258 Identities=31% Similarity=0.491 Sum_probs=213.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe---
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 761 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~--- 761 (1044)
..++|++.+.||.|+||.||+|++..++..||+|++... .........+.+|+.+++.+.||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc-cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 467899999999999999999999999999999988653 2223345677889999999999999999988876654
Q ss_pred ---eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 762 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 762 ---LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
+|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799999875 469999999999999999999999999999999999999999999999999986310
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 01123467889999999865 36788999999999999999999999887
Q ss_pred ChHHHHHhhhccCCC----------------------------CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~----------------------------~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+....+..+...... +.......++.+.+||.+||+.||.+||| +.+++
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~ell 296 (343)
T cd07851 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEAL 296 (343)
T ss_pred ChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHHHh
Confidence 766555544332100 00112346889999999999999999999 88899
Q ss_pred cCCCCCCCC
Q 001614 970 AHPFFKGVN 978 (1044)
Q Consensus 970 ~HPwFk~id 978 (1044)
.||||....
T Consensus 297 ~h~~~~~~~ 305 (343)
T cd07851 297 AHPYLAEYH 305 (343)
T ss_pred cCCCccccC
Confidence 999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.15 Aligned_cols=247 Identities=24% Similarity=0.312 Sum_probs=205.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
++||.|+||.||++.+.. ++.||+|.++.... ......+.+|+.++++++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999877 99999998865322 235578899999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCC
Q 001614 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (1044)
Q Consensus 773 SL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~ 851 (1044)
+|.+++... ..++...+..++.+++.||.|||+++++||||||+|||++.++.+||+|||++........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--------- 148 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--------- 148 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---------
Confidence 999999653 4688899999999999999999999999999999999999999999999999863210000
Q ss_pred CCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccC
Q 001614 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (1044)
Q Consensus 852 ~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~ 930 (1044)
........++..|+|||.+.++.++.++||||||+++|+|++ |..||...........+....
T Consensus 149 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 149 ----------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred ----------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 000112234677999999988889999999999999999999 899998888776666655432
Q ss_pred CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 931 i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
. ...+..++.++.+||.+||+.+|.+||++.++.+.|
T Consensus 213 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 213 -R-MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred -C-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 2 223567889999999999999999999977666554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=333.54 Aligned_cols=261 Identities=31% Similarity=0.456 Sum_probs=207.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCC--CcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeec----CC
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC----RD 760 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~t--Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed----~~ 760 (1044)
+|++.+.||.|+||.||++.+..+ +..||+|.+... .........+.+|+.+++++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc-cccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999888 889999998642 22233456788999999999 59999999986533 24
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+|++|+|+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999986 699999988888999999999999999999999999999999999999999999999999998742110
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 159 ~~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 159 PG-----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred cc-----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 00 00111234578999999998765 5689999999999999999999999987664
Q ss_pred HHHHHhhhcc----------------------------CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~g----------------------------~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
...+..+... ...++......+..+.+||.+||+.||.+||| +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcC
Confidence 3333222210 01112222356889999999999999999999 7789999
Q ss_pred CCCCC
Q 001614 972 PFFKG 976 (1044)
Q Consensus 972 PwFk~ 976 (1044)
|||+.
T Consensus 293 ~~~~~ 297 (332)
T cd07857 293 PYLAI 297 (332)
T ss_pred hhhhh
Confidence 99974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=337.99 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=203.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEE-----CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT 757 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~-----k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfe 757 (1044)
...++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3456899999999999999999985 3457899999986432 233456788999999999 6899999999876
Q ss_pred cC-CeeEEEEeeccccchHHHHHhc-------------------------------------------------------
Q 001614 758 CR-DNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------- 781 (1044)
Q Consensus 758 d~-~~LyLVmEY~~GGSL~dlLkk~------------------------------------------------------- 781 (1044)
.. ..+++|||||++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4689999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCC
Q 001614 782 ------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1044)
Q Consensus 782 ------------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~ 849 (1044)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-------- 233 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-------- 233 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc--------
Confidence 135677788899999999999999999999999999999999999999999986421000
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhhhc
Q 001614 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928 (1044)
Q Consensus 850 t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~ 928 (1044)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||..............
T Consensus 234 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 234 -----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred -----------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 0001112346678999999988889999999999999999997 9999987654333333332
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 929 g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
.... +..+...++++.+++..||+.||.+||++.++.+.|
T Consensus 297 ~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 297 EGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred ccCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2222 223456788999999999999999999966655544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=347.65 Aligned_cols=261 Identities=24% Similarity=0.339 Sum_probs=212.2
Q ss_pred ccccCCCeEEEEeeccCCceEEEEEEEC-----CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeee
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYS 755 (1044)
Q Consensus 682 ~~~si~dY~Ilk~LG~GgFG~VYka~~k-----~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gv 755 (1044)
+.+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .......+.+|+.+|.++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566778999999999999999999964 345689999997532 2333457889999999997 9999999999
Q ss_pred eecCCeeEEEEeeccccchHHHHHhcC-----------------------------------------------------
Q 001614 756 FTCRDNLYLVMEYLNGGDLYSLLRKVG----------------------------------------------------- 782 (1044)
Q Consensus 756 fed~~~LyLVmEY~~GGSL~dlLkk~g----------------------------------------------------- 782 (1044)
+...+.+|+|||||++|+|.+++++.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 001614 783 ---------------------------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1044)
Q Consensus 783 ---------------------------------------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeN 817 (1044)
.++...+..++.||+.||+|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 24566778899999999999999999999999999
Q ss_pred eeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhh
Q 001614 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1044)
Q Consensus 818 ILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDI 897 (1044)
||++.++.+||+|||+++....... ........+++.|||||++.+..++.++||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN-------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc-------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 9999999999999999874211000 001123457889999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 898 WSLGVILYELLT-Gr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
|||||++|||++ |..||......+..........+ +..|..++.++.+||.+||..+|.+||++.++.+.|+
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999998 89999876655554444444333 2345678999999999999999999999877766653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=321.82 Aligned_cols=252 Identities=35% Similarity=0.521 Sum_probs=205.8
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEEEe
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLVmE 767 (1044)
|++.+.||.|+||.||+|....+++.||+|.+..... ........+|+..+.++. ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998899999998865321 122334567999999999 9999999999999999999999
Q ss_pred eccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 789999987654 689999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
........|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||...+......
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 152 ----------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ----------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 001123468899999998854 457889999999999999999999998776655444
Q ss_pred hhhccCC-------------------CCC--------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 925 NILNRKI-------------------PWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 925 kIl~g~i-------------------~~p--------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
++..... .++ ......+..+.+||.+||+.||.+||| +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 3321100 000 011233688999999999999999999 7899999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=317.90 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=200.5
Q ss_pred EeeccCCceEEEEEEECC---CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeee-cCCeeEEEEee
Q 001614 693 KPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLYLVMEY 768 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~---tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfe-d~~~LyLVmEY 768 (1044)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998753 3457999987532 23345678889999999999999999999765 45568999999
Q ss_pred ccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
+++|+|.+++.+. ..++...+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~----- 153 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY----- 153 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc-----
Confidence 9999999999764 3467777888999999999999999999999999999999999999999999863211000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHhh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~qkI 926 (1044)
..........+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+
T Consensus 154 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 154 ------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred ------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 00011123346778999999988889999999999999999999 57788877777766666
Q ss_pred hccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
..+.. +..+..+++.+.+++.+||..+|.+||++.++.+.++.
T Consensus 216 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 216 LQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred hcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 55432 22345678999999999999999999997777665543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=328.35 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=200.1
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHH
Q 001614 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778 (1044)
Q Consensus 699 gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlL 778 (1044)
++|.||.++...+|+.||+|+++.. .........+.+|+.+++.++||||+++++++...+.+|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecc-ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 4455666666778999999998753 234456778999999999999999999999999999999999999999999999
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCC
Q 001614 779 RKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856 (1044)
Q Consensus 779 kk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s 856 (1044)
... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+.........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~------------- 157 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR------------- 157 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc-------------
Confidence 753 45889999999999999999999999999999999999999999999999988632111000
Q ss_pred CCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCC--
Q 001614 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP-- 932 (1044)
Q Consensus 857 ~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~-- 932 (1044)
............++..|+|||++.+ ..++.++|||||||++|+|++|..||..............+..+
T Consensus 158 -------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 158 -------QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred -------ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 0001111234567889999999876 35888999999999999999999999876554332221111100
Q ss_pred -----CC------------------------CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 933 -----WP------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 933 -----~p------------------------~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
++ ..+..++.++.+||.+||+.||.+||| +.++|+||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~~~~~~ 302 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSFFKQCK 302 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCchHhhhc
Confidence 00 011234567889999999999999999 88999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.44 Aligned_cols=266 Identities=33% Similarity=0.521 Sum_probs=212.1
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecC--C
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--D 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~--~ 760 (1044)
...++|++.+.||.|+||.||+|.+..+|+.+|+|.+.+.. ........+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 34678999999999999999999999899999999885422 2233445677899999999 999999999988654 3
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~ 840 (1044)
.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999997 5999998765 7889999999999999999999999999999999999999999999999998742111
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
... ..........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 161 ~~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EEN----------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccc----------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 000 00111223468999999998865 4578899999999999999999999987665
Q ss_pred HHHHHhhhccC----------------------------CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 920 EIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~g~----------------------------i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
......+.... .........++.++.+||.+||+.||.+||| +.+++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il~~ 295 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEALEH 295 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHhhC
Confidence 44333322111 0011122347889999999999999999999 7889999
Q ss_pred CCCCCC
Q 001614 972 PFFKGV 977 (1044)
Q Consensus 972 PwFk~i 977 (1044)
|||++.
T Consensus 296 ~~~~~~ 301 (337)
T cd07852 296 PYVAQF 301 (337)
T ss_pred hhhhhh
Confidence 999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.50 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=207.8
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-------
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------- 759 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~------- 759 (1044)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 68999999999999999999999999999999886533 23456788999999999999999999776654
Q ss_pred -------CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeec
Q 001614 760 -------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDF 831 (1044)
Q Consensus 760 -------~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDF 831 (1044)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999997 589888854 46899999999999999999999999999999999999984 557899999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhC
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTG 910 (1044)
|++.... ... ..........|++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 160 g~~~~~~--~~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 160 GLARIVD--PHY----------------------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred ccceecC--Ccc----------------------ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 9986421 000 00001122357899999998754 5678899999999999999999
Q ss_pred CCCCCCCChHHHHHhhhccC----------------------CC-----CCCCCCCCCHHHHHHHHhHccCCcCCCCChh
Q 001614 911 IPPFTAESPEIIFDNILNRK----------------------IP-----WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g~----------------------i~-----~p~ip~~iS~eLkdLIkkcLqkDPskRPSad 963 (1044)
..||.+.++......+.... .. .......++.++.+||.+||+.||.+|||
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 293 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT-- 293 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC--
Confidence 99998777655444433211 00 00112357889999999999999999999
Q ss_pred hHHHHHcCCCCCCCC
Q 001614 964 GAAEVKAHPFFKGVN 978 (1044)
Q Consensus 964 eA~EIL~HPwFk~id 978 (1044)
+.+++.||||+.+.
T Consensus 294 -~~ell~h~~~~~~~ 307 (342)
T cd07854 294 -AEEALMHPYMSCYS 307 (342)
T ss_pred -HHHHhCCCcccccc
Confidence 88999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=356.43 Aligned_cols=255 Identities=36% Similarity=0.589 Sum_probs=219.9
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeecccc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GG 772 (1044)
++||.|.||+||-|+++.+|+.||||+|.|.+..... ...+.+|+.||+.+.||.||.+--.|++.+.+++|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 6899999999999999999999999999998765554 478999999999999999999999999999999999999664
Q ss_pred chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC---CcEEEeecCCcccccccCcccCCCC
Q 001614 773 DLYSLL-RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINNTIDLSGP 848 (1044)
Q Consensus 773 SL~dlL-kk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded---g~VKLsDFGLAki~~~~~t~dls~p 848 (1044)
=|.-+| .+.+++++...++++.||+.||.|||-++|+|.||||+|||+.+. -++||||||+|+++..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--------- 719 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--------- 719 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---------
Confidence 444444 356789999999999999999999999999999999999999754 3799999999996421
Q ss_pred CCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhc
Q 001614 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928 (1044)
Q Consensus 849 ~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~ 928 (1044)
.....+.+|||.|+|||+|.++.|+..-||||+|||+|--|+|..||... +++-++|.+
T Consensus 720 -------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQN 778 (888)
T KOG4236|consen 720 -------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQN 778 (888)
T ss_pred -------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhc
Confidence 22345789999999999999999999999999999999999999999653 445556666
Q ss_pred cCCCCCCCC-CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC-cch
Q 001614 929 RKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN-WDS 981 (1044)
Q Consensus 929 g~i~~p~ip-~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id-~d~ 981 (1044)
..+-+|.-| ..+++++.+||..+|+..-.+|+| +.+.|.|||+++.. |-+
T Consensus 779 AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~D 830 (888)
T KOG4236|consen 779 AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLD 830 (888)
T ss_pred cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHH
Confidence 665555443 579999999999999999999999 77889999999753 443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.87 Aligned_cols=256 Identities=33% Similarity=0.527 Sum_probs=208.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec-CCeeE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLY 763 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed-~~~Ly 763 (1044)
..++|++.+.||.|+||.||++.+..+|+.||+|.+.+.. ........+.+|+.+++.++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 5678999999999999999999999999999999886532 223345678899999999999999999999866 45789
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|.|||++.++.++|+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999999 5689888864 458888899999999999999999999999999999999999999999999876310
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei 922 (1044)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 160 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 160 -------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred -------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01112357889999999866 5689999999999999999999999987654322
Q ss_pred HHhhhc---------------c-------------CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 923 FDNILN---------------R-------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 923 ~qkIl~---------------g-------------~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+..+.. . ..+.......+++.+.++|.+||+.+|.+||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~~~~ 291 (328)
T cd07856 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAHPYL 291 (328)
T ss_pred HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcCCcc
Confidence 211110 0 01111122357889999999999999999999 7899999999
Q ss_pred CC
Q 001614 975 KG 976 (1044)
Q Consensus 975 k~ 976 (1044)
..
T Consensus 292 ~~ 293 (328)
T cd07856 292 AP 293 (328)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.06 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=200.9
Q ss_pred CCeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec--CC
Q 001614 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RD 760 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~----k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed--~~ 760 (1044)
.+|++.+.||+|+||.||++.. ..++..||+|.+... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5789999999999999999984 456889999988643 34456788999999999999999999987654 34
Q ss_pred eeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
.+++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999754 4689999999999999999999999999999999999999999999999999874211
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
... .........++..|+|||++.+..++.++|||||||++|||++|..|+.....
T Consensus 161 ~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 161 DKE------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred CCc------------------------ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 100 00000112345569999999988899999999999999999998777643221
Q ss_pred HH---------------HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 EI---------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 ~e---------------i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.. ....+......+ ..+..++.++.+||.+||..+|.+|||+.++...|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 10 011122222222 234678899999999999999999999777766553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.46 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=192.5
Q ss_pred EeeccCCceEEEEEEECCCCc-------EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 693 KPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk-------~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
+.||.|+||.||+|.+..++. .||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 369999999999999876554 3888876532 233456788999999999999999999999999999999
Q ss_pred EeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCc--------EEEeecCCccc
Q 001614 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSKI 836 (1044)
Q Consensus 766 mEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~--------VKLsDFGLAki 836 (1044)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 68999998752
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhC-CCCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG-IPPF 914 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTG-r~PF 914 (1044)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|++| ..||
T Consensus 158 ~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 158 VL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 10 1122457889999999986 4578999999999999999998 5777
Q ss_pred CCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
...+...... +..... .+|...+.++.+||.+||+.||.+|||++++.+.
T Consensus 207 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 207 SALDSQKKLQ-FYEDRH---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred hhccHHHHHH-HHHccc---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 7666554333 222222 2345667899999999999999999996655543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=317.37 Aligned_cols=232 Identities=34% Similarity=0.532 Sum_probs=193.3
Q ss_pred CCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHH
Q 001614 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 777 (1044)
Q Consensus 698 GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dl 777 (1044)
|.||.||++++..+|+.||+|.+++.. .+.+|...+....||||+++++++...+.+|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987532 223455555666799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCC
Q 001614 778 LRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857 (1044)
Q Consensus 778 Lkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~ 857 (1044)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9887789999999999999999999999999999999999999999999999999765210
Q ss_pred CCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCC
Q 001614 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 937 (1044)
Q Consensus 858 s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip 937 (1044)
.......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .. .... ..+|
T Consensus 137 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~-----~~~~-~~~~ 198 (237)
T cd05576 137 -----------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN-----THTT-LNIP 198 (237)
T ss_pred -----------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc-----cccc-cCCc
Confidence 0011234577899999998888999999999999999999999988643211 10 0111 1244
Q ss_pred CCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCC
Q 001614 938 SDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 974 (1044)
Q Consensus 938 ~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwF 974 (1044)
..+++.+++||.+||+.||.+||++ ..+.++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 6788999999999999999999995 335899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.25 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=209.8
Q ss_pred CeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccc-------cChhHHHHHHHHHHHHHh-cCCCceEEEeeeeec
Q 001614 688 DFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM-------IRKNDIERILAERNILIT-VRNPFVVRFFYSFTC 758 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~-tGk~VAVKiIkK~~~-------~~~~~~e~flrEi~ILs~-L~HPNIVkL~gvfed 758 (1044)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 678999998864221 223345667889988875 799999999999999
Q ss_pred CCeeEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
.+.+++||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .+|+|+||+|.||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
+..... ........|+..|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 161 ~~~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQP----------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccc----------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 864210 0012234688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 914 F~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|...+.......+...... +.....+++++.+||.+||+.||.+||++.++...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred ccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 9887776666666554433 222336789999999999999999999977766554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=347.05 Aligned_cols=264 Identities=27% Similarity=0.342 Sum_probs=207.1
Q ss_pred CCCCccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001614 676 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 755 (1044)
Q Consensus 676 ~~ss~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gv 755 (1044)
.++..+....+++|.-...||+|+||.||+|.... |..||||.+....... ..+|.+|+.+|.+++|||+|+|+||
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 34455666778999999999999999999999864 5899999776432211 4559999999999999999999999
Q ss_pred eecCC-eeEEEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeeccCCCCceeecCCCcEEEe
Q 001614 756 FTCRD-NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAHDGHIKLT 829 (1044)
Q Consensus 756 fed~~-~LyLVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~G---IIHRDLKPeNILLdedg~VKLs 829 (1044)
|.+.+ ..+||+|||++|+|.++|+... .++|.....|+.+++.||+|||+.. ||||||||+|||+|++.++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 5999999999999999998654 8999999999999999999999864 9999999999999999999999
Q ss_pred ecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCc-cCCCCCCCcccccCCCCCchhhhHHHHHHHHHHH
Q 001614 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 830 DFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~-vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELL 908 (1044)
|||+|+..+.. ....... .||.+|+|||++..+..+.++|||||||+|.||+
T Consensus 220 DFGLa~~~~~~---------------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 220 DFGLAKLGPEG---------------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred CccCcccCCcc---------------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 99999742210 0001112 7999999999999889999999999999999999
Q ss_pred hCCCCCCCCC---h---HHH-HHhhhccCCC---CCCCC-CCCC--HH---HHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 909 TGIPPFTAES---P---EII-FDNILNRKIP---WPCVP-SDMS--FE---AQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 909 TGr~PF~g~s---~---~ei-~qkIl~g~i~---~p~ip-~~iS--~e---LkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||+.|..... . .+. ...+..+... =|.+. ...+ .+ +..+...|++.+|.+||++.++.+.|.
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 9998876432 1 111 1111111111 01111 2223 23 446678999999999999888877773
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=313.77 Aligned_cols=236 Identities=24% Similarity=0.309 Sum_probs=191.8
Q ss_pred EeeccCCceEEEEEEECCCC----------cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCee
Q 001614 693 KPISRGAFGRVFLARKRTTG----------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tG----------k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~L 762 (1044)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 357788765422 125788999999999999999999999888 778
Q ss_pred EEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-------cEEEeecCCc
Q 001614 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-------HIKLTDFGLS 834 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-------~VKLsDFGLA 834 (1044)
++||||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 789999999999999999999999999999999999999887 7999999998
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC--CCCchhhhHHHHHHHHHHHh-CC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFIT-GI 911 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILYELLT-Gr 911 (1044)
.... ......+++.|+|||++.+. .++.++||||||+++|+|++ |.
T Consensus 156 ~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 156 ITVL-------------------------------SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred cccc-------------------------------cccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 6311 01123567789999999876 78999999999999999999 68
Q ss_pred CCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 912 ~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
.||...+.......... .... +......+.+||.+||..+|.+|||+.++.+.
T Consensus 205 ~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 205 EPLSTLSSSEKERFYQD-QHRL---PMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CCcccCCchhHHHHHhc-CCCC---CCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 88877654443333221 1111 12234789999999999999999996665543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=360.07 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=219.7
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc-ccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe--eEEEE
Q 001614 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--LYLVM 766 (1044)
Q Consensus 690 ~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~-~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~--LyLVm 766 (1044)
++...||+|+|.+||+|.+..+|..||.-.++-.. ...+...++|..|+.+|+.|+|||||++|.++.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44568999999999999999999999876554322 2345566899999999999999999999999998776 88999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceeecC-CCcEEEeecCCcccccccCcc
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~G--IIHRDLKPeNILLde-dg~VKLsDFGLAki~~~~~t~ 843 (1044)
|+|..|+|..|+++.+.++...++.|++||+.||.|||++. |||||||.+||+|+. .|.|||+|+|||.+...
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---- 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---- 198 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc----
Confidence 99999999999999999999999999999999999999986 999999999999974 58999999999986321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCC-CChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g-~s~~ei 922 (1044)
......+|||.|||||++. ..|+..+||||||+.++||+|+..||.. .++.++
T Consensus 199 -------------------------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 199 -------------------------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred -------------------------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 1223578999999999987 5899999999999999999999999965 678899
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
++++..|..| ..+..--.+++++||.+||.. ...||| +.++|.||||..
T Consensus 253 YKKV~SGiKP-~sl~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 253 YKKVTSGIKP-AALSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDE 301 (632)
T ss_pred HHHHHcCCCH-HHhhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhcc
Confidence 9998888655 233344578999999999999 999999 999999999986
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.92 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=206.2
Q ss_pred eEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----
Q 001614 689 FEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~---tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~----- 760 (1044)
|.+.+.||+|+||.||+|.+.. ++..||+|++.. ........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecc-ccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998753 578999999864 3334445678899999999999999999999886543
Q ss_pred -eeEEEEeeccccchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 761 -NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 761 -~LyLVmEY~~GGSL~dlLkk~------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
..+++++|+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887532 2478889999999999999999999999999999999999999999999999
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCC
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~ 912 (1044)
+.....+.. ........+++.|++||.+.+..++.++|||||||++|+|++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 874211000 001112345678999999988889999999999999999999 899
Q ss_pred CCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 913 PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
||.+.+.......+..... ...+...+..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred CCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9988887777766655432 2233567899999999999999999999877776654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.71 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=200.9
Q ss_pred CCeEEEEeeccCCceEEEEEEE----CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--C
Q 001614 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~----k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~ 760 (1044)
..|++.+.||+|+||.||++.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3578999999999999999985 4568899999986432 234456799999999999999999999998875 5
Q ss_pred eeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
.+++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 689999999999999999764 3589999999999999999999999999999999999999999999999999874211
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
... .........|+..|+|||++.+..++.++|||||||++|+|+++..|+.....
T Consensus 162 ~~~------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 162 DKE------------------------YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred Ccc------------------------ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 000 00011234577889999999888899999999999999999998776532110
Q ss_pred --------------HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 920 --------------EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 920 --------------~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
............. ...+..++..+.+||.+||+.||.+||+++++.+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 0111111112222 223567899999999999999999999966655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=359.88 Aligned_cols=251 Identities=33% Similarity=0.496 Sum_probs=213.5
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccc
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGS 773 (1044)
+||+|.||+||-|++..|...+|||.+... ..+..+.+.+|+.+.+.|+|.|||+++|++...+.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 699999999999999999999999988642 34566778999999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCcccccccCcccCCCCC
Q 001614 774 LYSLLRK-VGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1044)
Q Consensus 774 L~dlLkk-~g~L--see~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLAki~~~~~t~dls~p~ 849 (1044)
|.++++. .|++ ++..+.+|.+||++||.|||++.|+|||||-+|+||+. .|.+||+|||-++..-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA----------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA----------- 727 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----------
Confidence 9999974 5777 78899999999999999999999999999999999975 6889999999887421
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh
Q 001614 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 850 t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl 927 (1044)
+ -+....++.||..|||||++..+ .|+.++|||||||++.||.||++||.........+--+
T Consensus 728 --g--------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 728 --G--------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred --c--------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 0 11234567899999999999764 58999999999999999999999997664433322211
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 928 ~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
-.--..|.+|..++.++++||.+|+..||.+||+ |.++|..||++.-
T Consensus 792 GmyKvHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred cceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 1111236678899999999999999999999999 8899999999753
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.25 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=207.0
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
..++|+..+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45688999999999999999999987776 46888775422 233345688999999999999999999998754
Q ss_pred eeEEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999997644 588999999999999999999999999999999999999999999999999874210
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s 918 (1044)
.. .........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 162 ~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DE-------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cc-------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00 0001122346788999999998889999999999999999997 999998877
Q ss_pred hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.......+..+. .. ..+...+..+.+++.+||..+|.+||++.++.+.+.
T Consensus 217 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 217 TREIPDLLEKGE-RL-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred HHHHHHHHHCCC-CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 665554443332 22 234567889999999999999999999777655543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=350.70 Aligned_cols=261 Identities=28% Similarity=0.460 Sum_probs=210.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~L 762 (1044)
+.-..|+++++||+||.+.||++.... .+.||+|.+.- ...+......+.+|+..|.+|+ |.+||+||+|-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 445679999999999999999998754 45667765533 2345667789999999999996 89999999999999999
Q ss_pred EEEEeeccccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~-Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
|+||||= .-+|..+|++... ++...++.|..||+.|++++|..||||-||||.|+|+ -.|.+||+|||+|.....+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 9999985 4599999987665 4446889999999999999999999999999999999 46999999999998532211
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC-----------CCchhhhHHHHHHHHHHHhC
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFITG 910 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----------ys~KSDIWSLGVILYELLTG 910 (1044)
+ .-...+.+||+.||+||.+.... .++++||||||||||+|+.|
T Consensus 514 T-------------------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 514 T-------------------------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred c-------------------------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence 1 22345679999999999996433 45789999999999999999
Q ss_pred CCCCCCCC-hHHHHHhhhcc--CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 911 IPPFTAES-PEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 911 r~PF~g~s-~~ei~qkIl~g--~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
+.||.... ...-+..|... .++||.++.. .++.++++.||++||.+||+ +-++|+|||+..+.
T Consensus 569 ktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 569 KTPFGQIINQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWS---IPELLQHPFLQIQP 634 (677)
T ss_pred CCchHHHHHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCC---cHHHhcCccccccc
Confidence 99997654 23334444443 3466666543 34999999999999999999 78899999998743
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=316.71 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=189.4
Q ss_pred EeeccCCceEEEEEEECCC------------CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 693 KPISRGAFGRVFLARKRTT------------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~t------------Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
+.||+|+||.||+|.+... ...+|+|.+... .......+.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986432 235888877542 2334567888999999999999999999999999
Q ss_pred eeEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCc-------EEEeecC
Q 001614 761 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------IKLTDFG 832 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~-------VKLsDFG 832 (1044)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999998875 356899999999999999999999999999999999999987664 8999999
Q ss_pred CcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-CCCCCchhhhHHHHHHHHHHH-hC
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFI-TG 910 (1044)
Q Consensus 833 LAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~KSDIWSLGVILYELL-TG 910 (1044)
++.... ......|++.|+|||++. +..++.++|||||||++|+|+ +|
T Consensus 158 ~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 158 IPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 875310 111245788999999987 467899999999999999998 58
Q ss_pred CCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
..||......+... +...... .....++++.+||.+||+.||.+||++.++.+
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~ 259 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCM---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCcc---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99998765544322 2222222 12334678999999999999999999555433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.96 Aligned_cols=236 Identities=25% Similarity=0.330 Sum_probs=189.1
Q ss_pred eeccCCceEEEEEEECCCC------------------------cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCce
Q 001614 694 PISRGAFGRVFLARKRTTG------------------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tG------------------------k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNI 749 (1044)
.||+|+||.||+|....++ ..||+|++... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 5999999999999864322 35888887542 22344678889999999999999
Q ss_pred EEEeeeeecCCeeEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC----
Q 001614 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---- 824 (1044)
Q Consensus 750 VkL~gvfed~~~LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg---- 824 (1044)
+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 46789999999999999999999999999999999999997654
Q ss_pred ---cEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHH
Q 001614 825 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSV 900 (1044)
Q Consensus 825 ---~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSL 900 (1044)
.+|++|||++.... ......+++.|+|||.+.+ ..++.++|||||
T Consensus 159 ~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 48999999875210 0112357788999999875 568999999999
Q ss_pred HHHHHHHH-hCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 901 GIILFEFI-TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 901 GVILYELL-TGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
||++|+|+ +|..||....+.+....+ ..... .+...++.+.+||.+||+.+|.+||++.++.+
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKERFY-EKKHR---LPEPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHHH-HhccC---CCCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99999995 699999887665543322 22222 22445678999999999999999999655544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=315.17 Aligned_cols=249 Identities=19% Similarity=0.287 Sum_probs=196.2
Q ss_pred eeccCCceEEEEEEECCCC--cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccc
Q 001614 694 PISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tG--k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
.||+|+||.||++....++ ..+++|.++... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 6999999999999764332 345666654322 234567899999999999999999999999999999999999999
Q ss_pred cchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 772 GDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 772 GSL~dlLkk~----g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
|+|.+++.+. ..++...+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~------ 153 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED------ 153 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch------
Confidence 9999999754 235667788899999999999999999999999999999999999999999875311000
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCCh
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~ 919 (1044)
.........|++.|+|||++.. ..++.++|||||||++|+|++ |..||...+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 154 -------------------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred -------------------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0011123568899999999853 235779999999999999997 5789988777
Q ss_pred HHHHHhhhccCC---CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 EIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 ~ei~qkIl~g~i---~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.+.+..+..+.. ..+..+..+++.+.+++..|| .+|.+||+++++.+.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 215 REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 777666554432 123444568899999999999 67999999887777653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=370.05 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=219.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc-----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk-----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed 758 (1044)
......++.+.||+|.||.||.|....-.. .||+|.+++ ..+.+....|++|..+|+.++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 445678899999999999999999864433 489998876 4456788999999999999999999999999999
Q ss_pred CCeeEEEEeeccccchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeec
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk~-------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDF 831 (1044)
....+|++|||.||+|..+|++. ..++......++.||++|++||+++++|||||...|+|++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999865 35888999999999999999999999999999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-C
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-G 910 (1044)
|+|+.....+++... ....-...|||||.+..+.++.++|||||||+|||++| |
T Consensus 847 GlArDiy~~~yyr~~-------------------------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKH-------------------------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchheecc-------------------------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999843332222111 01123458999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
..||.+.+..+++...+.+. ++ ..|..+++.+.++|..||+.+|++||+|..+.+
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-RL-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-RL-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-cc-CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999988777776 43 356899999999999999999999999766555
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.40 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=205.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECC----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec--CC
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RD 760 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed--~~ 760 (1044)
.+|++.+.||+|+||.||++.+.. ++..||+|.++.... ......+.+|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 468888999999999999999753 478999999875332 1356789999999999999999999999877 55
Q ss_pred eeEEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
.+++||||+++|+|.+++.... .++...+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7999999999999999997654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
... .........++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 162 ~~~------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 162 DKD------------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred CCc------------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccc
Confidence 000 00001122455679999999888899999999999999999999999865322
Q ss_pred HH--------------HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 EI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 ~e--------------i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.. ....++......+ .+..++.++.+|+.+||+.+|.+|||+.++.+.|.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred hhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 11 1112222222222 24567889999999999999999999888777664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=381.96 Aligned_cols=260 Identities=36% Similarity=0.569 Sum_probs=221.3
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+++....||.|.||.||.|.+..+|...|+|-++-. .........+.+|..+|..++|||+|++||+-...+..||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq-~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQ-DSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcC-ccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 466677899999999999999999999999988543 2335566778999999999999999999999999999999999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
||++|+|.++++..+..++...+.|..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|.....+ +
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~-~----- 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN-A----- 1388 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc-h-----
Confidence 9999999999998888889999999999999999999999999999999999999999999999998743211 0
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC---CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-H
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEII-F 923 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei-~ 923 (1044)
++-.......+|||.|||||++.+. ....++|||||||++.||+||+.||...+.+-. +
T Consensus 1389 -----------------~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1389 -----------------QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM 1451 (1509)
T ss_pred -----------------hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH
Confidence 0011223467899999999999764 456799999999999999999999987665443 3
Q ss_pred HhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
-.+..+. .|.+|..+|.+.++||..||..||++|.+ +.|+|+|.|-+.
T Consensus 1452 y~V~~gh--~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1452 YHVAAGH--KPQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGKS 1499 (1509)
T ss_pred hHHhccC--CCCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhcccc
Confidence 3443443 36678889999999999999999999999 779999999764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=358.65 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=207.6
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeee-eec---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYS-FTC--- 758 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gv-fed--- 758 (1044)
+.-.++++.+.|.+|||+.||+|+....|..||+|.+-- .++...+.+.+|+.+|++|+ |||||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 344578899999999999999999998889999997643 36778889999999999997 9999999993 221
Q ss_pred ---CCeeEEEEeeccccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceeecCCCcEEEeec
Q 001614 759 ---RDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 759 ---~~~LyLVmEY~~GGSL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~G--IIHRDLKPeNILLdedg~VKLsDF 831 (1044)
...++|.||||.||.|-|++.+ ...|++.++..|+.|+++|+++||... |||||||-+||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1247899999999999999974 356999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHH
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELL 908 (1044)
|.|.-.. ..+.... ...-....-....||.|+|||++. +...++|+|||+|||+||.|+
T Consensus 191 GSatt~~--------------~~~~~~~----e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC 252 (738)
T KOG1989|consen 191 GSATTKI--------------LSPTSAQ----EVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC 252 (738)
T ss_pred ccccccc--------------CCCccHH----HHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH
Confidence 9886210 0000000 000011122345799999999973 567899999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
....||.+... -.|+++.+.+|.. +.++..+++||+.||+.||.+||++-+
T Consensus 253 y~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 253 YFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 99999987543 3577888888865 468999999999999999999999443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.79 Aligned_cols=260 Identities=15% Similarity=0.223 Sum_probs=193.7
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccChhH--------HHHHHHHHHHHHhcCCCceEEEe
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVVRFF 753 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~t---Gk~VAVKiIkK~~~~~~~~--------~e~flrEi~ILs~L~HPNIVkL~ 753 (1044)
..++|++.+.||+|+||.||+|.+..+ +..+|+|+..........+ ......+...+..+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999999877 6677877643211110000 01122334455677899999999
Q ss_pred eeeecCC----eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEe
Q 001614 754 YSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (1044)
Q Consensus 754 gvfed~~----~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLs 829 (1044)
+++.... ..+++++++. .++.+.+......++..++.++.|++.||+|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8766554 3467888774 4777777766667888999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh
Q 001614 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (1044)
Q Consensus 830 DFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT 909 (1044)
|||+|+....+... . ...........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 169 DFGla~~~~~~~~~----------------~----~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 169 DYGIASHFIIHGKH----------------I----EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred EcCCceeeccCCcc----------------c----ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99998743211100 0 000112233579999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-HH--------HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 910 GIPPFTAESP-EI--------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 910 Gr~PF~g~s~-~e--------i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
|..||.+.+. .. ....+..+... ....+..+.++++.|++.+|.+||+++++.+++
T Consensus 229 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 229 IKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCCccccchHHHHHhHHHHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999987632 21 22333333322 245688999999999999999999988776654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=318.78 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=218.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCe
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~ 761 (1044)
...+++.+.+..||.|+.|.|++++.+.+|...|||.+++. .+.++..+++..+.++.+.. +|+||+.+|+|.....
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 35677888899999999999999999999999999999864 35667788999998877665 8999999999999999
Q ss_pred eEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~ 839 (1044)
.++.||.|.. -+..++++ .++++|..+-.+...++.||.||.++ ||||||+||+|||+|+.|++||||||++..+.+
T Consensus 166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999943 55556554 46799999999999999999999965 799999999999999999999999999864321
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc---CCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
. .......|.+.|||||-+. ...|+.++||||||++++||.||..||.+
T Consensus 245 S----------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 245 S----------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred c----------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 1 1122346999999999985 35789999999999999999999999988
Q ss_pred CC-hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 917 ES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 917 ~s-~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.+ ..+++.++++...+......++|+++++|+..||++|+.+||. ..++|+|||+...
T Consensus 297 c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 297 CKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKRY 355 (391)
T ss_pred CCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceeec
Confidence 54 4667777777554322222458999999999999999999999 6688999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=346.74 Aligned_cols=244 Identities=36% Similarity=0.569 Sum_probs=211.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCeeE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~Ly 763 (1044)
..++|.+...+|.|+|+.|..+.+..+++.+++|++.+.. ....+|+.++... +||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678999999999999999999999999999999997642 2234566665555 6999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceee-cCCCcEEEeecCCcccccccCc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILL-dedg~VKLsDFGLAki~~~~~t 842 (1044)
+|||++.||-|.+.+.....+. ..+..|+.+|+.|+.|||++||+||||||+|||+ ++.|+++|+|||+++...
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~---- 467 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE---- 467 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc----
Confidence 9999999999999887766555 7888899999999999999999999999999999 589999999999987311
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH-H
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-I 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~-e 921 (1044)
....+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... +
T Consensus 468 --------------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 468 --------------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred --------------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 1134557899999999999999999999999999999999999999766554 6
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
+..+|..+.. ...+|+++++||++||+.||.+||+ +.+++.||||
T Consensus 522 i~~~i~~~~~-----s~~vS~~AKdLl~~LL~~dP~~Rl~---~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRIQMPKF-----SECVSDEAKDLLQQLLQVDPALRLG---ADEIGAHPWF 566 (612)
T ss_pred HHHhhcCCcc-----ccccCHHHHHHHHHhccCChhhCcC---hhhhccCcch
Confidence 6655544432 3789999999999999999999999 7788999999
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=360.53 Aligned_cols=273 Identities=31% Similarity=0.482 Sum_probs=213.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec-------
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 758 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed------- 758 (1044)
.++|+.+..||+||||.||+++++-+|+.||||.|.... .......+++|+.+|.+|+|||||++|..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 568889999999999999999999999999999986533 45567789999999999999999999865410
Q ss_pred --------------------------------------------------------------------------------
Q 001614 759 -------------------------------------------------------------------------------- 758 (1044)
Q Consensus 759 -------------------------------------------------------------------------------- 758 (1044)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeeEEEEeeccccchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 001614 759 ------------------------R--------DNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 805 (1044)
Q Consensus 759 ------------------------~--------~~LyLVmEY~~GGSL~dlLkk~g~L-see~ar~Ia~QIL~ALaYLHs 805 (1044)
+ ..+||-||||+.-.|.+++...... ....++.++++|+.||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1278999999998888888776554 577889999999999999999
Q ss_pred cCeeeccCCCCceeecCCCcEEEeecCCcccccccC-cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcc
Q 001614 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN-TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE 884 (1044)
Q Consensus 806 ~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~-t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPE 884 (1044)
+|||||||||.||++++++.|||+|||+|+....+. ..+. .. .........+.......+||.-|+|||
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~-~~---------~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQ-DL---------SFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhh-cc---------CccccccCCCCcccccccceeeeecHH
Confidence 999999999999999999999999999998522111 1100 00 000111122233456789999999999
Q ss_pred cccCC---CCCchhhhHHHHHHHHHHHhCCCCCCCC-ChHHHHHhhhccCCCCC-CCCCCCCHHHHHHHHhHccCCcCCC
Q 001614 885 ILLGT---EHGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 885 vL~g~---~ys~KSDIWSLGVILYELLTGr~PF~g~-s~~ei~qkIl~g~i~~p-~ip~~iS~eLkdLIkkcLqkDPskR 959 (1044)
++.+. .|+.|+|||||||||+||+ .||... ....++.++.++.++.+ .++..--+.-..+|.+||+.||.+|
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 99764 4999999999999999998 467543 33455666666766655 1223334556789999999999999
Q ss_pred CChhhHHHHHcCCCCCC
Q 001614 960 LGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 960 PSadeA~EIL~HPwFk~ 976 (1044)
|| |.++|++.||-.
T Consensus 863 Pt---A~eLL~s~llpp 876 (1351)
T KOG1035|consen 863 PT---ATELLNSELLPP 876 (1351)
T ss_pred CC---HHHHhhccCCCc
Confidence 99 889999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.93 Aligned_cols=243 Identities=50% Similarity=0.847 Sum_probs=207.5
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHH
Q 001614 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778 (1044)
Q Consensus 699 gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlL 778 (1044)
+||.||+|.+..+|+.+|+|++....... ....+.+|+..+++++|+||+++++++......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999999889999999987543221 1578999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCC
Q 001614 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (1044)
Q Consensus 779 kk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s 858 (1044)
.....++...+..++.+++.++.|||+.+|+|+||+|.||+++.++.++|+|||++......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~------------------ 140 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG------------------ 140 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc------------------
Confidence 87766899999999999999999999999999999999999999999999999998642100
Q ss_pred CCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCC-CChHHHHHhhhccCCCCCCCC
Q 001614 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCVP 937 (1044)
Q Consensus 859 ~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g-~s~~ei~qkIl~g~i~~p~ip 937 (1044)
.......+++.|++||.+.+..++.++||||||+++|+|++|..||.. .+...+.+.+...........
T Consensus 141 ----------~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (244)
T smart00220 141 ----------GLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE 210 (244)
T ss_pred ----------cccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc
Confidence 022345688899999999888889999999999999999999999987 556666666555544433222
Q ss_pred CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 938 ~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
..++.++.+++.+||..+|.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 228899999999999999999999 8888999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=338.13 Aligned_cols=307 Identities=24% Similarity=0.300 Sum_probs=203.1
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCC----CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeee---
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS--- 755 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~t----Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gv--- 755 (1044)
....++|.+.+.||+|+||.||+|++..+ +..||+|.+.... ..+...++ .+....+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45678999999999999999999999988 8999999875421 11111111 1222222233222221
Q ss_pred ---eecCCeeEEEEeeccccchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCeeecc
Q 001614 756 ---FTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------------LEEDVARIYIAELVLALEYLHSLGIVHRD 812 (1044)
Q Consensus 756 ---fed~~~LyLVmEY~~GGSL~dlLkk~g~--------------------Lsee~ar~Ia~QIL~ALaYLHs~GIIHRD 812 (1044)
......+++||||+++++|.+++..... .....+..++.||+.||.|||+++|+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2455679999999999999999875321 12344667899999999999999999999
Q ss_pred CCCCceeecC-CCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC--
Q 001614 813 LKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-- 889 (1044)
Q Consensus 813 LKPeNILLde-dg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-- 889 (1044)
|||+|||++. ++.+||+|||+|+..... ........+||+.|||||.+...
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~--------------------------~~~~~~~~~~t~~Y~APE~~~~~~~ 334 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG--------------------------INYIPKEFLLDPRYAAPEQYIMSTQ 334 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc--------------------------cccCCcccccCCCccChHHhhccCC
Confidence 9999999986 579999999998732110 01122346789999999976432
Q ss_pred --------------------CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhh-ccCCCC--------C----C-
Q 001614 890 --------------------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL-NRKIPW--------P----C- 935 (1044)
Q Consensus 890 --------------------~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl-~g~i~~--------p----~- 935 (1044)
.++.++|||||||+||||+++..|+... ...+..++ .....+ + .
T Consensus 335 ~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 412 (566)
T PLN03225 335 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDL 412 (566)
T ss_pred CCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhh
Confidence 2345679999999999999977665432 11111111 111100 0 0
Q ss_pred -----CCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhccccchhhhhhhhhhhhHHHHHHH
Q 001614 936 -----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSYHALVKFQVDCRMIRMVA 1010 (1044)
Q Consensus 936 -----ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~~~~s~~~l~kfq~~~~l~~~il 1010 (1044)
.....+....+||.+||++||.+||| +.++|+||||++..+..+...+....... ....+....+...+.
T Consensus 413 ~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 487 (566)
T PLN03225 413 RRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGLSVMQNLRLQLF--RATQQDYGEAAAWVV 487 (566)
T ss_pred hhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCccccccccccccccc--hhhHHHHHHHHHHHH
Confidence 01112334568999999999999999 88999999999877764433222211111 111223344455566
Q ss_pred HHHHH-------hhcHHHHHHHhhcc
Q 001614 1011 TLMLT-------LVTHLQILELRWMN 1029 (1044)
Q Consensus 1011 ~lm~~-------~~~~~qi~eLr~~~ 1029 (1044)
..|.. .+++.|++++++..
T Consensus 488 ~~~~~~~~~~~~~~~e~~~~~~~~~~ 513 (566)
T PLN03225 488 FLMAKSGTEKEGGFTEAQLQELREKE 513 (566)
T ss_pred HHHHhcCCCCCCCccHHHHHHhhhhc
Confidence 66666 56778888877744
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=332.94 Aligned_cols=264 Identities=21% Similarity=0.347 Sum_probs=227.1
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 680 ~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
+++++.-.+.....+||.|.||.||.|.|+.-.-.||||.++.. ....++|+.|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 56666677888899999999999999999998899999998752 34678999999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
..+|||+|||..|+|.+||++.. .++.-....++.||..||.||..+++|||||-..|+|+.++..|||+||||++++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999998654 3677777888889999999999999999999999999999999999999999975
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g 916 (1044)
..+.++.. ....-...|.|||-|....++.++|||+|||+|||+.| |..||.+
T Consensus 416 tgDTYTAH--------------------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTYTAH--------------------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCceecc--------------------------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 33222110 11223567999999998899999999999999999998 9999999
Q ss_pred CChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 917 ~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
.+..+++.-+ ..++++. .|.++++.+.+||..||+++|.+||+|.++-+.++.-|-.
T Consensus 470 idlSqVY~LL-EkgyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 470 IDLSQVYGLL-EKGYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccHHHHHHHH-hcccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 9988887654 4445543 5789999999999999999999999998887777665544
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.23 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=207.7
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC--
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 760 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~-- 760 (1044)
.++-++|++.+.||+|||+.||+++...++..||+|.+.-. ..++++..++|++..++++||||++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 45667899999999999999999999999999999988542 3567889999999999999999999988765544
Q ss_pred ---eeEEEEeeccccchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceeecCCCcEEEeec
Q 001614 761 ---NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 761 ---~LyLVmEY~~GGSL~dlLkk----~g~Lsee~ar~Ia~QIL~ALaYLHs~G--IIHRDLKPeNILLdedg~VKLsDF 831 (1044)
..||+++|...|+|.+.++. ...+++.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 49999999999999999964 346999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC---CCCCchhhhHHHHHHHHHHH
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILYELL 908 (1044)
|.+...... +.+ ... ...-........|..|.|||.+.- ...+.++|||||||+||.|+
T Consensus 174 GS~~~a~i~----i~~---------~~~-----a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQ----IEG---------SRQ-----ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceE----eec---------hHH-----HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 988642110 000 000 000011122346889999999864 34578999999999999999
Q ss_pred hCCCCCCCCCh--HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHH
Q 001614 909 TGIPPFTAESP--EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1044)
Q Consensus 909 TGr~PF~g~s~--~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~ 966 (1044)
.|..||...-. .-+.-.+.++++.+|.-. .+|..+.+||+.||+.||.+||++.++.
T Consensus 236 f~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 236 FGESPFERIYQQGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred HcCCcchHHhhcCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 99999953211 111223445566666543 4899999999999999999999955443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.53 Aligned_cols=264 Identities=29% Similarity=0.483 Sum_probs=207.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec-C
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 759 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed-~ 759 (1044)
....|+.+..||+|.||.||++..+.++. .||+|.++.... .........+|+.+++.++||||+.+..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 35679999999999999999997665543 789998865432 12233567899999999999999999999988 7
Q ss_pred CeeEEEEeeccccchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC----CcEEEee
Q 001614 760 DNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTD 830 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk-----~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded----g~VKLsD 830 (1044)
..+++++||.+. +|+++|+- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999987 99999853 2458999999999999999999999999999999999999877 8999999
Q ss_pred cCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHh
Q 001614 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909 (1044)
Q Consensus 831 FGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLT 909 (1044)
||+++++. +. + .+.......+.|.+|.|||.|.| ..|+.+.|||++|||+.||||
T Consensus 180 lGlaR~~~--~p----------l------------kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 180 LGLARLFN--NP----------L------------KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccHHHHhh--cc----------c------------cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 99998631 10 0 11112345678999999999998 568999999999999999999
Q ss_pred CCCCCCCCCh---------HHHHHhhhc--c---CCCCCCC-----------------------------CCCCCHHHHH
Q 001614 910 GIPPFTAESP---------EIIFDNILN--R---KIPWPCV-----------------------------PSDMSFEAQD 946 (1044)
Q Consensus 910 Gr~PF~g~s~---------~ei~qkIl~--g---~i~~p~i-----------------------------p~~iS~eLkd 946 (1044)
-.+.|.+... ....++|+. + .-.||.+ ....++.+.+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 9888865321 122333332 1 0112210 0124566889
Q ss_pred HHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 947 LINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 947 LIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
|+.+||++||.+|+| +.+.|+|+||..-
T Consensus 316 LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhcc---HHHHhcccccccC
Confidence 999999999999999 7788999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=295.74 Aligned_cols=259 Identities=29% Similarity=0.517 Sum_probs=216.4
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
.+|.-.++||+|.||+||+++++.+++.||+|.++.. ..++......++|+-+|+.++|.|||+++++...+..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrld-dddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEecc-CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 3566778999999999999999999999999998753 333444567899999999999999999999999999999999
Q ss_pred eeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 EY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
|||.. +|..+... .+.++.+.++.++.|+++|+.|+|++++.||||||.|.||+.+|.+|++|||+++.+.
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg------- 152 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG------- 152 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC-------
Confidence 99965 88888864 4679999999999999999999999999999999999999999999999999998421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~ 923 (1044)
.+.......+.|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..+..
T Consensus 153 --------------------ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 153 --------------------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred --------------------CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 011223345679999999999884 58899999999999999987 88889999888887
Q ss_pred Hhhhcc-----CCCCCC------------CC---------CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 924 DNILNR-----KIPWPC------------VP---------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 924 qkIl~g-----~i~~p~------------ip---------~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.+|... .-.||. .| +.++..-++|++++|.-+|.+|++ |+..++||||.+.
T Consensus 213 krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 213 KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCcccccc
Confidence 777541 111222 11 234455679999999999999999 7778999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=327.45 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=213.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
.-+...+.++||+|.||+|.++.-.. +.+||+|.++... .......|..|+++|.+|+|||||.++++|..++.+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34557788999999999999998753 6899999997643 34456899999999999999999999999999999999
Q ss_pred EEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
|+|||++|+|.+++.++ ..+.......++.||+.||+||.+.+++||||.+.|+|++.++++||+|||+++-...+.+
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999999876 3345566677999999999999999999999999999999999999999999984332222
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh--CCCCCCCCChH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPE 920 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT--Gr~PF~g~s~~ 920 (1044)
+.. ....+-..+|||||.+..++++.++|+|+||+++||+++ ...||...+.+
T Consensus 693 y~v-------------------------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 693 YRV-------------------------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred eee-------------------------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 221 122345679999999999999999999999999999865 78999999888
Q ss_pred HHHHhhhc---cC--CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHH
Q 001614 921 IIFDNILN---RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (1044)
Q Consensus 921 ei~qkIl~---g~--i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~E 967 (1044)
++.++... .+ ...+..|.-++..+.+||..||.+|..+||+++++.-
T Consensus 748 ~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 748 QVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 87776532 11 1234466789999999999999999999999876643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=335.59 Aligned_cols=319 Identities=23% Similarity=0.296 Sum_probs=251.6
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk---~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~ 759 (1044)
++......+.++||.|.||+|++|+.+..|+ .||||.++.. ..+....+|+.|+.||-+++||||++|.|+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4566778899999999999999999987774 7999999753 3456678999999999999999999999999999
Q ss_pred CeeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
..+.||+|||++|+|..+|+++ +.|+..++.-+++.|+.||+||-+.|++||||...|||++.+..+|++||||+++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999754 679999999999999999999999999999999999999999999999999998643
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCc--cCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA--VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 915 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~--vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~ 915 (1044)
++.. ....+. .-..+|.|||.+...+++.++||||+|++|||.++ |..||+
T Consensus 783 dd~~--------------------------~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 783 DDPE--------------------------AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred cCCC--------------------------ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 2110 001111 22468999999999999999999999999999887 999999
Q ss_pred CCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC------------CcchhH
Q 001614 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV------------NWDSLA 983 (1044)
Q Consensus 916 g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i------------d~d~L~ 983 (1044)
+.+.++.+..|..+ ++.| -|.++|..+.+||..||++|-.+||.|.++...|. ..+++- .-..+.
T Consensus 837 dmSNQdVIkaIe~g-yRLP-pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD-klIrnP~SLk~~~~~~~r~s~~ll 913 (996)
T KOG0196|consen 837 DMSNQDVIKAIEQG-YRLP-PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD-KLIRNPNSLKTIAPESPRPSQPLL 913 (996)
T ss_pred ccchHHHHHHHHhc-cCCC-CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH-HHhcCchhhcccCCCCCCCccccc
Confidence 99999999887665 3434 35789999999999999999999999988777663 222210 001111
Q ss_pred hhhccccchhhhhhhhhhhhHHHHHHHHHHHHhhcHHHHHHHhhccHHHHH
Q 001614 984 LQKMTQATSYHALVKFQVDCRMIRMVATLMLTLVTHLQILELRWMNAETLQ 1034 (1044)
Q Consensus 984 ~qk~~~~~s~~~l~kfq~~~~l~~~il~lm~~~~~~~qi~eLr~~~~e~l~ 1034 (1044)
-+..+....|.....+....+|.+..-.|+...++..+ ....|+.|-|.
T Consensus 914 d~~~~~~~~f~sv~~WL~aIkm~rY~~~F~~ag~~s~~--~V~q~s~eDl~ 962 (996)
T KOG0196|consen 914 DRSGSDFTPFRSVGDWLEAIKMGRYKEHFAAAGYTSFE--DVAQMSAEDLL 962 (996)
T ss_pred CCCCCCCcccCCHHHHHHHhhhhHHHHHHHhcCcccHH--HHHhhhHHHHH
Confidence 11233334455555666677777777777766554433 23344444443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=335.37 Aligned_cols=257 Identities=33% Similarity=0.549 Sum_probs=224.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeec-----C
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC-----R 759 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed-----~ 759 (1044)
.+-|++.++||.|.+|.||+++.+.+|+..|+|+.... ....+++..|.+||+.+ .|||++.+|++|.- +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 45689999999999999999999999999999997643 33446778899999887 59999999998864 4
Q ss_pred CeeEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
+.+|||||||.|||..|+++.. ..+.|+.+..|++.++.|+.+||.+.+||||||-.|||++.++.|||+|||.+...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 5799999999999999999753 56899999999999999999999999999999999999999999999999987631
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----CCCCchhhhHHHHHHHHHHHhCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIP 912 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILYELLTGr~ 912 (1044)
........+.+|||.|||||++.. ..|+..+|+||||++..||.-|.+
T Consensus 174 ---------------------------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 174 ---------------------------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred ---------------------------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 012335677899999999999964 346779999999999999999999
Q ss_pred CCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 913 PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
|+-+..++..+-.|-....+-...|..++.++.+||..||.+|-.+||+ ..++|.|||++.
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~e 287 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFITE 287 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCcccc
Confidence 9999999988887776665545557789999999999999999999999 889999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=332.97 Aligned_cols=253 Identities=33% Similarity=0.490 Sum_probs=199.1
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC------e
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD------N 761 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~------~ 761 (1044)
.+...+.||+|+||.||+|+++.+|+.||||.+++.. .....+...+|+++|++++|||||+++++-++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4566788999999999999999999999999998754 3345678899999999999999999998866554 4
Q ss_pred eEEEEeeccccchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeec--CCC--cEEEeecCCc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDG--HIKLTDFGLS 834 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~---g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLd--edg--~VKLsDFGLA 834 (1044)
..+|||||+||||..++.+. ..+++.+...++.+++.||.|||++||+||||||.||++- .+| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999743 4699999999999999999999999999999999999984 334 4699999999
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-CCCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
+-.. +.....+.+||+.|.+||++. .+.|+..+|.|||||++|+++||..|
T Consensus 172 rel~----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 172 RELD----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCC----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 8422 223456789999999999998 47899999999999999999999999
Q ss_pred CCCCC----hH-HHHHhhhc--------------cCCCCCC---CCCCCCHH----HHHHHHhHccCCcCCCC--C----
Q 001614 914 FTAES----PE-IIFDNILN--------------RKIPWPC---VPSDMSFE----AQDLINRFLIHDPNQRL--G---- 961 (1044)
Q Consensus 914 F~g~s----~~-ei~qkIl~--------------g~i~~p~---ip~~iS~e----LkdLIkkcLqkDPskRP--S---- 961 (1044)
|.... .. .++..+.. +.+.|.. .|...+.. +...+..+|..+|.+|. +
T Consensus 224 F~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~ 303 (732)
T KOG4250|consen 224 FIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRF 303 (732)
T ss_pred CCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchH
Confidence 95322 12 23322221 1222211 13344443 34577889999999998 4
Q ss_pred hhhHHHHHc
Q 001614 962 ANGAAEVKA 970 (1044)
Q Consensus 962 adeA~EIL~ 970 (1044)
+.+..+||+
T Consensus 304 Fa~~~dIL~ 312 (732)
T KOG4250|consen 304 FAEVDDILN 312 (732)
T ss_pred HHHHHHHHh
Confidence 344555554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=325.05 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=212.5
Q ss_pred CeEEEEeeccCCceEEEEEEECCC--C--cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTT--G--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~t--G--k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...+.+.||.|.||.||.|....- | --||||..+.. ...+..+.|+.|.-+|+.++|||||+++|+|.+. ..|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 445567899999999999987533 2 36889988753 3455678999999999999999999999999765 589
Q ss_pred EEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCc
Q 001614 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t 842 (1044)
||||+++-|.|..||+.. ..++......|+.||+.||+|||+..++||||-..|||+....-|||+|||+++......+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999999865 4688899999999999999999999999999999999999999999999999985332222
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (1044)
Q Consensus 843 ~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~e 921 (1044)
+. .....-...|||||-++-..++.++|||.|||.+||++. |..||.+....+
T Consensus 547 Yk--------------------------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 547 YK--------------------------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred hh--------------------------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 10 111223457999999999999999999999999999988 999999988888
Q ss_pred HHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 922 i~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
.+..|-+|.. +..|+.+|+.+..|+.+||.+||.+||.+.++...|..
T Consensus 601 VI~~iEnGeR--lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 601 VIGHIENGER--LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred eEEEecCCCC--CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 8777766653 33578999999999999999999999999877665544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=327.67 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=216.0
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCc---EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk---~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
+..++..+.+.||+|.||.|++|.|...+. .||||+++.... ......|++|+.+|.+|+|||+++|||+..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--chhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 445667888999999999999999975443 799999975432 2267899999999999999999999999988 6
Q ss_pred eeEEEEeeccccchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
.+.+|||+++.|+|.+.|++ ...|.......|+.||+.||.||.++++|||||-..|+|+.....|||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999987 3468888999999999999999999999999999999999999999999999988543
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~ 917 (1044)
.++. +| .+. ....-...|+|||.|....++.++|||+|||+||||+| |..||.+.
T Consensus 264 ~ned----------------~Y---vm~-----p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 264 ENED----------------MY---VMA-----PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred CCCc----------------ce---Eec-----CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 3322 11 111 11234568999999999999999999999999999999 89999999
Q ss_pred ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHH
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~ 966 (1044)
...+++++|-.+. . ...|..++.++.++++.||..+|.+||||..+.
T Consensus 320 ~g~qIL~~iD~~e-r-LpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 320 RGIQILKNIDAGE-R-LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred CHHHHHHhccccc-c-CCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 9999999987443 2 235689999999999999999999999977553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=313.25 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=207.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC--Cc----eEEEeeeee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PF----VVRFFYSFT 757 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H--PN----IVkL~gvfe 757 (1044)
...++|.+...+|+|.||.|-.+.+..++..||+|+++... ...+..+-|+++|.++.+ |+ +|++.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 44678999999999999999999999999999999997643 344566789999999942 33 888889999
Q ss_pred cCCeeEEEEeeccccchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-------------
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------- 822 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde------------- 822 (1044)
-.+++|||+|.+ |-|++++|.+++ +++-..++.+.+|++++++|||+.+++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999998 669999998754 5889999999999999999999999999999999999842
Q ss_pred -------CCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchh
Q 001614 823 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1044)
Q Consensus 823 -------dg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KS 895 (1044)
+..|+|+|||.|++.. ....+.+-|..|.|||++.+-+++..+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred ceeccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCcc
Confidence 2358999999987421 112456789999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHH---HHHhhhc------------------cCCCCCCCC-----------------
Q 001614 896 DWWSVGIILFEFITGIPPFTAESPEI---IFDNILN------------------RKIPWPCVP----------------- 937 (1044)
Q Consensus 896 DIWSLGVILYELLTGr~PF~g~s~~e---i~qkIl~------------------g~i~~p~ip----------------- 937 (1044)
||||+||||+||.+|...|......+ +++.|+. +.++|+...
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence 99999999999999999998766433 3333332 122222100
Q ss_pred -----CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 938 -----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 938 -----~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.--.++.+||++||.+||.+|+| +.|+|.||||+..
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 001124679999999999999999 8888999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=316.34 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=190.6
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEEC----------------CCCcEEEEEEeecccccCh-----------hHHHHHH
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKR----------------TTGDLFAIKVLKKLDMIRK-----------NDIERIL 735 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k----------------~tGk~VAVKiIkK~~~~~~-----------~~~e~fl 735 (1044)
+...++|.+.++||+|+||.||+|... ..++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456889999999999999999999752 2356899998854211000 0112234
Q ss_pred HHHHHHHhcCCCce-----EEEeeeeec--------CCeeEEEEeeccccchHHHHHhcC--------------------
Q 001614 736 AERNILITVRNPFV-----VRFFYSFTC--------RDNLYLVMEYLNGGDLYSLLRKVG-------------------- 782 (1044)
Q Consensus 736 rEi~ILs~L~HPNI-----VkL~gvfed--------~~~LyLVmEY~~GGSL~dlLkk~g-------------------- 782 (1044)
.|+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 56777777776554 566666643 346899999999999999986421
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCC
Q 001614 783 ----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (1044)
Q Consensus 783 ----~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s 858 (1044)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------------- 363 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------------- 363 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----------------
Confidence 13456788899999999999999999999999999999999999999999986321000
Q ss_pred CCCcccccCcCCccCccCCCCCCCcccccCCC--------------------CC--chhhhHHHHHHHHHHHhCCC-CCC
Q 001614 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--------------------HG--YAADWWSVGIILFEFITGIP-PFT 915 (1044)
Q Consensus 859 ~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~--------------------ys--~KSDIWSLGVILYELLTGr~-PF~ 915 (1044)
........+||.|+|||.+.... |+ .+.||||+||++|+|++|.. ||.
T Consensus 364 ---------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 364 ---------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ---------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 00111234589999999986432 11 24799999999999999875 775
Q ss_pred CCCh-----------HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCc---CCCCChhhHHHHHcCCCCCC
Q 001614 916 AESP-----------EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP---NQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 916 g~s~-----------~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDP---skRPSadeA~EIL~HPwFk~ 976 (1044)
+... ...++.+....+.++ ....+++..++|+.+||..+| .+|+| +.++|+||||..
T Consensus 435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred chhhhhhHHhhccchHHHHHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 4221 112222233344444 235678999999999999876 68999 889999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=338.21 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=188.0
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
..|.....||+|+||.||+|++..+|..||+|.++.... ....|+.++++++|||||+++++|.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 346667789999999999999998999999998864321 1124588899999999999999999999999999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLH---s~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|||++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 99999999999963 788999999999999999999 6699999999999999998888775 66443100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh----
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---- 919 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~---- 919 (1044)
......||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 834 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~ 887 (968)
T PLN00113 834 --------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887 (968)
T ss_pred --------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence 01123689999999999998999999999999999999999999853211
Q ss_pred -HHHHHhhhccC-CC---CCCC------CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 920 -EIIFDNILNRK-IP---WPCV------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 920 -~ei~qkIl~g~-i~---~p~i------p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.+......... .. -+.. +.....++.+++.+||+.||.+|||+.++.+.|+
T Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 11111100000 00 0101 1112235678999999999999999888777664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-34 Score=301.25 Aligned_cols=263 Identities=30% Similarity=0.456 Sum_probs=209.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC------
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~------ 759 (1044)
.+.|.-..+||+|.||+||+++.+.+|++||+|.+-- ...........++|+.+|..|+|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlm-eneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHH-hccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3457777899999999999999999999999985421 111222345678999999999999999999887653
Q ss_pred --CeeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 760 --DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 760 --~~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
..+|+||++|+. +|+-++... ..++...++.++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 248999999987 999998765 5699999999999999999999999999999999999999999999999999975
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
+....- .........+.|.+|.+||.+.| ..|+++.|||..|||+.||.+|.+-|.
T Consensus 174 fs~~~n-----------------------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSKN-----------------------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eecccc-----------------------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 321110 01112345678999999999987 579999999999999999999999999
Q ss_pred CCChHHHHHhhhc--cCC---CCCC--------------C-------------CCCCCHHHHHHHHhHccCCcCCCCChh
Q 001614 916 AESPEIIFDNILN--RKI---PWPC--------------V-------------PSDMSFEAQDLINRFLIHDPNQRLGAN 963 (1044)
Q Consensus 916 g~s~~ei~qkIl~--g~i---~~p~--------------i-------------p~~iS~eLkdLIkkcLqkDPskRPSad 963 (1044)
+.+....+..|.. +.. .||. + |-..++++.+|+.+||..||.+|+.
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~-- 308 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID-- 308 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc--
Confidence 8877655544421 100 0111 1 1223567889999999999999999
Q ss_pred hHHHHHcCCCCCC
Q 001614 964 GAAEVKAHPFFKG 976 (1044)
Q Consensus 964 eA~EIL~HPwFk~ 976 (1044)
+.++|+|.||..
T Consensus 309 -ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 -ADQALNHDFFWK 320 (376)
T ss_pred -hHhhhchhhhhc
Confidence 667799999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=309.11 Aligned_cols=267 Identities=30% Similarity=0.473 Sum_probs=216.5
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccC----hhHHHHHHHHHHHHHhcCCCceEEEeeeeecC-C
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----KNDIERILAERNILITVRNPFVVRFFYSFTCR-D 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~----~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~-~ 760 (1044)
.++|-++..||+|||+.||++.+....+.||+|+-.....++ ........+|.+|.+.|+||.||++|++|.-+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 467889999999999999999999999999999864333322 23345678999999999999999999999754 5
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceeecC---CCcEEEeecCCcc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH---DGHIKLTDFGLSK 835 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~G--IIHRDLKPeNILLde---dg~VKLsDFGLAk 835 (1044)
.+|-|+|||+|.+|.-||+.+..+++..++.|+.||+.||.||.+.. |||.||||.|||+.+ -|.+||.||||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 78999999999999999999999999999999999999999999874 999999999999964 4679999999999
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC----CCCchhhhHHHHHHHHHHHhCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~KSDIWSLGVILYELLTGr 911 (1044)
++..+.+-... | ........||.+|++||++.-+ ..+.++||||+|||+|..+.|+
T Consensus 622 IMdddSy~~vd-----G---------------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGr 681 (775)
T KOG1151|consen 622 IMDDDSYNSVD-----G---------------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGR 681 (775)
T ss_pred hccCCccCccc-----c---------------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccC
Confidence 75432221111 1 1222345799999999998643 4577999999999999999999
Q ss_pred CCCCCCC-hHHHHHh--hh-ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 912 PPFTAES-PEIIFDN--IL-NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 912 ~PF~g~s-~~ei~qk--Il-~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
.||.... ..++++. |+ ...+.||.- +.++.++++||++||++--++|.. +.++-.||||..
T Consensus 682 KPFGhnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyllP 746 (775)
T KOG1151|consen 682 KPFGHNQSQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLLP 746 (775)
T ss_pred CCCCCchhHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhh---HHHHccCccccc
Confidence 9997653 3444332 22 234455543 468999999999999999999998 889999999975
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=302.41 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=196.3
Q ss_pred ccccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHH--hcCCCceEEEeeeee
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRNPFVVRFFYSFT 757 (1044)
Q Consensus 680 ~~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs--~L~HPNIVkL~gvfe 757 (1044)
...++...+..+.+.||+|.||+||+|.|+ |+.||||+|.. .+...+.+|.+|.+ .|+|+||+.+++.-.
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS------RDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecc------cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 466788889999999999999999999998 99999999964 34567888888876 569999999997755
Q ss_pred cCC----eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeeccCCCCceeecCCCc
Q 001614 758 CRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGH 825 (1044)
Q Consensus 758 d~~----~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~--------GIIHRDLKPeNILLdedg~ 825 (1044)
.+. .+|||++|.+.|||+|||.+ ..++.+....++..++.||+|||.. .|.|||||+.|||+.++|.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 443 59999999999999999987 6699999999999999999999953 4999999999999999999
Q ss_pred EEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC----C--CchhhhHH
Q 001614 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----H--GYAADWWS 899 (1044)
Q Consensus 826 VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~----y--s~KSDIWS 899 (1044)
+-|+|+|||...... + ..-....+..+||.+|||||+|...- + -..+||||
T Consensus 355 C~IADLGLAv~h~~~-t----------------------~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSD-T----------------------DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred EEEeeceeeEEeccc-C----------------------CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 999999999742111 0 01122345679999999999996431 1 23789999
Q ss_pred HHHHHHHHHhC----------CCCCCCC-----ChHHHHHhhhccCCCCCCCCCCCC--H---HHHHHHHhHccCCcCCC
Q 001614 900 VGIILFEFITG----------IPPFTAE-----SPEIIFDNILNRKIPWPCVPSDMS--F---EAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 900 LGVILYELLTG----------r~PF~g~-----s~~ei~qkIl~g~i~~p~ip~~iS--~---eLkdLIkkcLqkDPskR 959 (1044)
||.++||++.+ .+||.+. +.+++..-+...+++ |.+|.... + .+..+|+.||..||.-|
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 99999999753 4788654 234554444444443 44443322 2 35678999999999999
Q ss_pred CC
Q 001614 960 LG 961 (1044)
Q Consensus 960 PS 961 (1044)
.|
T Consensus 491 lt 492 (513)
T KOG2052|consen 491 LT 492 (513)
T ss_pred hH
Confidence 99
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=297.79 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=210.7
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHh-cCCCceEEEeeeeecCCee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~-L~HPNIVkL~gvfed~~~L 762 (1044)
...++.+-+..||.|+||+|++..++.+|+..|||.|+... .+.+..+++.|.+...+ -+.||||++||+...++..
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 34456666788999999999999999999999999997643 35567888888887554 4689999999999999999
Q ss_pred EEEEeeccccchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 763 YLVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLk-----k~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
|+.||+|+- ||..+-+ ....++|..+-.+..-.+.||.||-. ..|||||+||+|||++..|.+||||||++..
T Consensus 139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 999999954 6543332 34568999988888899999999986 4799999999999999999999999998753
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF 914 (1044)
... .-....-.|...|||||-+.. ..|+.++|+||||++|||+.||+.||
T Consensus 218 Lv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy 269 (361)
T KOG1006|consen 218 LVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY 269 (361)
T ss_pred HHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence 210 011123468889999999964 45899999999999999999999999
Q ss_pred CCCCh-HHHHHhhhccCCCCCCCCC---CCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 915 TAESP-EIIFDNILNRKIPWPCVPS---DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 915 ~g~s~-~ei~qkIl~g~i~~p~ip~---~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.+.+. .+.+..+..+..+....+. ..+..+.+||..||.+|-..||. ..+++.+||++-.
T Consensus 270 r~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 270 RKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRMY 333 (361)
T ss_pred chHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhhh
Confidence 87654 4555556666655443333 38899999999999999999999 6678999999854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=313.62 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=214.1
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEEC---C----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEE
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKR---T----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRF 752 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k---~----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL 752 (1044)
.+....++..+.+.||.|.||.|++|.-. . ....||||.++... ...+...+..|+.+|+.+. ||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 44555666778889999999999998743 1 14579999987543 2366788999999999985 9999999
Q ss_pred eeeeecCCeeEEEEeeccccchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCC
Q 001614 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (1044)
Q Consensus 753 ~gvfed~~~LyLVmEY~~GGSL~dlLkk~g----------------~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPe 816 (1044)
++++.....+++|+||+..|+|.++++... .++......++.||+.||+||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998655 3888899999999999999999999999999999
Q ss_pred ceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccC--CCCCCCcccccCCCCCch
Q 001614 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG--TPDYLAPEILLGTEHGYA 894 (1044)
Q Consensus 817 NILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vG--Tp~YmAPEvL~g~~ys~K 894 (1044)
|||+..+..+||+|||+|+.......+ ......| ...|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y--------------------------~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYY--------------------------RTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCce--------------------------EecCCCCccceeecCHHHhccCccccc
Confidence 999999999999999999832111110 0011112 335999999999999999
Q ss_pred hhhHHHHHHHHHHHh-CCCCCCCCC-hHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcC
Q 001614 895 ADWWSVGIILFEFIT-GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 895 SDIWSLGVILYELLT-Gr~PF~g~s-~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~H 971 (1044)
+|||||||+|||++| |..||.+.. ..+++..+..|. + ...|..+++++.++|+.||+.+|.+||++.++.+.+.-
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-R-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 999999999999999 899999865 566666454443 3 34568889999999999999999999999888776654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=280.24 Aligned_cols=253 Identities=33% Similarity=0.557 Sum_probs=206.3
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCC--e
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD--N 761 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~--~ 761 (1044)
..++|++.+++|+|.|++||.|.+..++++++||+++. .....+.+|+.||..|. ||||+.+++...++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 67899999999999999999999999999999999874 34578999999999997 999999999988764 5
Q ss_pred eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC-CcEEEeecCCccccccc
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded-g~VKLsDFGLAki~~~~ 840 (1044)
..||+||+++.+...+. ..++.-.++.++.+++.||.|||++||+|||+||.|+|||.. -.++|+|||+|.+..
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC--
Confidence 78999999987766554 458888999999999999999999999999999999999965 469999999997532
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCC-CCCC
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF-TAES 918 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF-~g~s 918 (1044)
+....+..+.+..|--||.+.. +.|+..-|+|||||+|..|+..+-|| .|.+
T Consensus 185 --------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 185 --------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred --------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 1223445677888999999875 67899999999999999999998887 4444
Q ss_pred hHHHHHhhhc---------------------------c--CCCCCCC-----CCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 919 PEIIFDNILN---------------------------R--KIPWPCV-----PSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 919 ~~ei~qkIl~---------------------------g--~i~~p~i-----p~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
..+.+-+|.+ . ..+|..+ ..-.++++.+|+.++|.+|-.+|+|
T Consensus 239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT--- 315 (338)
T KOG0668|consen 239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT--- 315 (338)
T ss_pred CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc---
Confidence 3333222221 0 0111111 1235799999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 001614 965 AAEVKAHPFFKGV 977 (1044)
Q Consensus 965 A~EIL~HPwFk~i 977 (1044)
|.+++.||||..+
T Consensus 316 akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 AKEAMAHPYFAPV 328 (338)
T ss_pred hHHHhcCchHHHH
Confidence 7788999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=316.68 Aligned_cols=246 Identities=32% Similarity=0.430 Sum_probs=197.8
Q ss_pred EEeeccCCceE-EEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEEEeec
Q 001614 692 IKPISRGAFGR-VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 692 lk~LG~GgFG~-VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLVmEY~ 769 (1044)
.+.+|.|+.|+ ||+|... |+.||||.+- ........+|+..|+..+ |||||++|+.-.+...+||..|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHh------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35689999986 7999986 8999999763 234456789999999885 999999999999999999999999
Q ss_pred cccchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC---CC--cEEEeecCCccccccc
Q 001614 770 NGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DG--HIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 770 ~GGSL~dlLkk~g~----Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde---dg--~VKLsDFGLAki~~~~ 840 (1044)
. .+|.++++..+. ......+..+.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++....+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 5 599999987411 111445778899999999999999999999999999986 34 6899999999853221
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCh
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAESP 919 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTG-r~PF~g~s~ 919 (1044)
.. .........||-+|+|||++....-+.++|||||||++|+.++| ..||.+.-.
T Consensus 665 ~s------------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 665 KS------------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred cc------------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 11 11224456799999999999988888899999999999999995 999976533
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
. --+|+++......+...-..++.+||.+|++.+|..||+ |.++|.||||=
T Consensus 721 R--~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlFW 771 (903)
T KOG1027|consen 721 R--QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLFW 771 (903)
T ss_pred h--hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCccC
Confidence 3 346777766544443333338999999999999999999 88999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=299.50 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=207.2
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC------CceEEEeeeeec
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFTC 758 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H------PNIVkL~gvfed 758 (1044)
--+.|.+....|+|-|++|.+|.+...|..||||+|++... ....=+.|++||++|.. -++++++..|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34679999999999999999999999999999999987543 34456789999999963 479999999999
Q ss_pred CCeeEEEEeeccccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeecCCc
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLS 834 (1044)
Q Consensus 759 ~~~LyLVmEY~~GGSL~dlLkk~g---~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDFGLA 834 (1044)
.+++|||+|-+. -+|.++|++.| .+....++.|+.|++.||..|-..||+|.||||.|||+++.. .+||||||.|
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999999884 59999998765 377888999999999999999999999999999999998754 6899999988
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF 914 (1044)
.....++. .....+--|.|||++.|-+|+...|+||+||+||||.||+..|
T Consensus 585 ~~~~enei-----------------------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 585 SFASENEI-----------------------------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cccccccc-----------------------------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 65332221 1112345699999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhhccCCCCCC------------------------------------------------------CC---
Q 001614 915 TAESPEIIFDNILNRKIPWPC------------------------------------------------------VP--- 937 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~i~~p~------------------------------------------------------ip--- 937 (1044)
.|.+...++.-.+.-..+||. +|
T Consensus 636 pG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq 715 (752)
T KOG0670|consen 636 PGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ 715 (752)
T ss_pred CCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence 998876665443321111110 00
Q ss_pred CCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 938 ~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
..+-.++++|+.+||..||++|+| +.++|.||||.+
T Consensus 716 ~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 716 PKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 011225789999999999999999 778899999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=310.43 Aligned_cols=261 Identities=31% Similarity=0.509 Sum_probs=228.2
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeE
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~Ly 763 (1044)
...++|.++..+|.|+||.||+++++.+++..|+|+++.. -..++.-+.+|+-+++-++|||||.+++.|...+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 3457899999999999999999999999999999999743 2445677889999999999999999999999999999
Q ss_pred EEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
++||||.||+|.+.-+-.+++++.++.+.+++.++|++|||+.|=+|||||-.|||+++.|.+|+.|||.+..+ .
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi--t--- 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI--T--- 163 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh--h---
Confidence 99999999999999988899999999999999999999999999999999999999999999999999986421 0
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccc---cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL---~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
....+..+++|||+|||||+. ..+.|...+|||++|+...||---.+|..+..++
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 112345678999999999986 3568999999999999999998888898888887
Q ss_pred HHHHhhhccCCCCCCC--CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 921 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~i--p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.......+..+..|.+ +...++-+.+|++.+|.++|++||+ +..+|.|||...-
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 7776666665554443 3468899999999999999999999 7888999999753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.73 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=207.4
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC---
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~--- 760 (1044)
+...+|.-++.+|.|.- .|..+.+..+++.||+|.+... .......++..+|..++..+.|+||++++.+|.-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34567888899999998 7888888889999999987654 344555678899999999999999999999987654
Q ss_pred ---eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 761 ---~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
..|+|||||.. +|..++. -.++.+.+..++.|++.|++|||+.||+||||||+||++..+..+||.|||+|+..
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 47999999965 9998887 34788999999999999999999999999999999999999999999999999731
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
.. .-.....+.|..|.|||++.+..|...+||||+|||+.||++|...|.+.
T Consensus 169 ~~----------------------------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 DT----------------------------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred Cc----------------------------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 10 01223457889999999999988999999999999999999999999886
Q ss_pred ChHHHHHhhhcc---------------------------CCC---------CCC---CCCCCCHHHHHHHHhHccCCcCC
Q 001614 918 SPEIIFDNILNR---------------------------KIP---------WPC---VPSDMSFEAQDLINRFLIHDPNQ 958 (1044)
Q Consensus 918 s~~ei~qkIl~g---------------------------~i~---------~p~---ip~~iS~eLkdLIkkcLqkDPsk 958 (1044)
+.-+.+.++... ... |+. .+..-+..+++|+.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 644333333210 011 110 01123456889999999999999
Q ss_pred CCChhhHHHHHcCCCCC
Q 001614 959 RLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 959 RPSadeA~EIL~HPwFk 975 (1044)
|.+ +.++|.||||+
T Consensus 301 Ris---v~daL~HPY~~ 314 (369)
T KOG0665|consen 301 RIS---VDDALRHPYIK 314 (369)
T ss_pred ccc---HHHHhcCCeee
Confidence 999 88899999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=286.10 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=211.7
Q ss_pred CCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC-----e
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 761 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~-----~ 761 (1044)
.+.+..+.||.|+||+||.+.+-.+|+.||+|.+... ..+-....++.+|+.+|..++|.|++..++..+... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3455667899999999999999999999999987642 233445678999999999999999999888776553 4
Q ss_pred eEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccC
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~ 841 (1044)
+|+|+|+|.. +|+.+|-....++...++-+++||++||+|||+.+|.||||||.|.|++.|..+||||||+++.-..
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-- 208 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-- 208 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch--
Confidence 7899999954 9999988888899999999999999999999999999999999999999999999999999985211
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCChH
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ 920 (1044)
.........+.|.+|.|||+++| ..|+.+.||||+|||+.|||.++..|...++-
T Consensus 209 ------------------------d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 209 ------------------------RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred ------------------------hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 11223334567899999999998 56899999999999999999999999888776
Q ss_pred HHHHhhhc-----------------------cCCCCCCC--------CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH
Q 001614 921 IIFDNILN-----------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 921 ei~qkIl~-----------------------g~i~~p~i--------p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL 969 (1044)
+.++.|.. +...-|.. +..-..+...++.++|..||.+|++ ..+.+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~A~ 341 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEEAL 341 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhhhc
Confidence 65554432 22222221 1234456778999999999999999 77889
Q ss_pred cCCCCCCC
Q 001614 970 AHPFFKGV 977 (1044)
Q Consensus 970 ~HPwFk~i 977 (1044)
.|++....
T Consensus 342 ~~~~~~e~ 349 (449)
T KOG0664|consen 342 QHRYLEEG 349 (449)
T ss_pred cccccccc
Confidence 99998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-28 Score=240.96 Aligned_cols=212 Identities=44% Similarity=0.742 Sum_probs=183.5
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccch
Q 001614 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL 774 (1044)
||.|++|.||++....+|+.+++|++....... ....+.+|+..++.+.|++|+++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987532211 356799999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCcccccccCcccCCCCCCCC
Q 001614 775 YSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (1044)
Q Consensus 775 ~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLAki~~~~~t~dls~p~t~~ 852 (1044)
.+++... ..++...+..++.+++.++.|||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK----------- 147 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc-----------
Confidence 9999876 56899999999999999999999999999999999999999 8999999999886421000
Q ss_pred CCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCC
Q 001614 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (1044)
Q Consensus 853 ~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i 931 (1044)
.......+...|++||.+... .++.++|+|++|+++|+|
T Consensus 148 ----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 148 ----------------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred ----------------chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 012234578899999999876 788999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCC
Q 001614 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972 (1044)
Q Consensus 932 ~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HP 972 (1044)
..+.+++.+|++.||.+||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 56899999999999999999 66777664
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=300.52 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=209.4
Q ss_pred eEEEEeeccCCceEEEEEEECCCCc----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
....++||.|+||+||+|.|...|+ +||+|++... ........++.|+-+|.+++|||++++++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4456789999999999999976665 7899988653 33445678999999999999999999999998876 889
Q ss_pred EEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcc
Q 001614 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~ 843 (1044)
|++||++|+|.|+++.+ +.+.......|..||++||.|||.++++||||-..|+|+.+-.++||.|||+++.......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~- 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK- 853 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc-
Confidence 99999999999999854 5688889999999999999999999999999999999999999999999999985321110
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei 922 (1044)
+| ......-.+.|||=|.+....|+.++|||||||++|||+| |..||.+....++
T Consensus 854 ------------------ey------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 854 ------------------EY------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred ------------------cc------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 01 1112234578999999999999999999999999999999 9999999999888
Q ss_pred HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhH
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA 965 (1044)
-+-+..+.. ...|+.++-++.-++.+||-.|+..||+|.+.
T Consensus 910 ~dlle~geR--LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 910 PDLLEKGER--LSQPPICTIDVYMVMVKCWMIDADSRPTFKEL 950 (1177)
T ss_pred hHHHhcccc--CCCCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence 776665543 33567899999999999999999999997654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=285.10 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=193.8
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHh--cCCCceEEEeeeeecCC---
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD--- 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~--L~HPNIVkL~gvfed~~--- 760 (1044)
....++.+.||+|.||.||+|+.. ++.||||++.. +..+.|.+|.+|.+. ++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 566788899999999999999876 79999999863 456789999998775 57999999998766555
Q ss_pred -eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CeeeccCCCCceeecCCCcEEEee
Q 001614 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHIKLTD 830 (1044)
Q Consensus 761 -~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~---------GIIHRDLKPeNILLdedg~VKLsD 830 (1044)
.++||++|.+.|+|.+||..+ .+++....+++..+++||+|||+. .|+|||||..||||.+|++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 799999999999999999764 589999999999999999999974 499999999999999999999999
Q ss_pred cCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC-CC-----chhhhHHHHHHH
Q 001614 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HG-----YAADWWSVGIIL 904 (1044)
Q Consensus 831 FGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys-----~KSDIWSLGVIL 904 (1044)
||||..+... .........+||.+|||||+|.+.- +. .+.||||+|.+|
T Consensus 360 FGLAl~~~p~-------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 360 FGLALRLEPG-------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred cceeEEecCC-------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 9999753211 1112233479999999999997632 22 368999999999
Q ss_pred HHHHhCCC------------CCC---C--CChHHHHHhhhccCCCCCCCCCC-----CCHHHHHHHHhHccCCcCCCCCh
Q 001614 905 FEFITGIP------------PFT---A--ESPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGA 962 (1044)
Q Consensus 905 YELLTGr~------------PF~---g--~s~~ei~qkIl~g~i~~p~ip~~-----iS~eLkdLIkkcLqkDPskRPSa 962 (1044)
|||+++.. ||. + .+.+++....+..+.+ |.+|.. -...+++.|..||..||+-|+|+
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R-P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR-PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC-CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 99998643 332 1 1223333333333322 433322 23457899999999999999995
Q ss_pred hhH---HHHHcCCC
Q 001614 963 NGA---AEVKAHPF 973 (1044)
Q Consensus 963 deA---~EIL~HPw 973 (1044)
.=+ ..-+.|+|
T Consensus 494 ~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 494 GCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHHhccC
Confidence 322 23355665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=246.38 Aligned_cols=214 Identities=45% Similarity=0.745 Sum_probs=182.7
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
|.+.+.||.|++|.||++....+++.+|+|.+...... .....+.+|+..+..++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56789999999999999999988999999998753321 2467889999999999999999999999999999999999
Q ss_pred ccccchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCC
Q 001614 769 LNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~-Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~ 847 (1044)
+++++|.+++..... +++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987766 8999999999999999999999999999999999999999999999999887421100
Q ss_pred CCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccc-cCCCCCchhhhHHHHHHHHHHHhCCCCCCC-C-ChHHHHH
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITGIPPFTA-E-SPEIIFD 924 (1044)
Q Consensus 848 p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL-~g~~ys~KSDIWSLGVILYELLTGr~PF~g-~-s~~ei~q 924 (1044)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. . +...+.+
T Consensus 153 --------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 153 --------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred --------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 0012335688899999998 666778899999999999999999999977 3 4446677
Q ss_pred hhhccC
Q 001614 925 NILNRK 930 (1044)
Q Consensus 925 kIl~g~ 930 (1044)
.|..+.
T Consensus 213 ~~~~~~ 218 (225)
T smart00221 213 VWSFGV 218 (225)
T ss_pred HHhcCC
Confidence 766655
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=279.28 Aligned_cols=131 Identities=29% Similarity=0.499 Sum_probs=114.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-----C---CceEEEeeeee
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----N---PFVVRFFYSFT 757 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-----H---PNIVkL~gvfe 757 (1044)
..+|.+.++||.|.|++||++++..+.+.||+|+.+... ...+..+.|+.+|+++. | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 478999999999999999999999999999999997533 34566789999999884 3 36999999987
Q ss_pred cC----CeeEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeec
Q 001614 758 CR----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIA 821 (1044)
Q Consensus 758 d~----~~LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLd 821 (1044)
.. .++|+|+|++ |-+|..+|... ..++...++.|++||+.||.|||. .||||-||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 54 4799999999 77999999764 459999999999999999999996 5999999999999983
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=292.96 Aligned_cols=205 Identities=29% Similarity=0.522 Sum_probs=180.3
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccC-----hhHHHHHHHHHHHHHhcC---CCceEEEee
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVR---NPFVVRFFY 754 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~-----~~~~e~flrEi~ILs~L~---HPNIVkL~g 754 (1044)
.....+|+.++.+|.|+||.|++|.++.+...|++|.|.|.+..- ....-.+-.|+.||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 345678999999999999999999999999999999998865432 222334668999999997 999999999
Q ss_pred eeecCCeeEEEEeec-cccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 755 SFTCRDNLYLVMEYL-NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 755 vfed~~~LyLVmEY~-~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
+|++.+.+||+||-. +|-+|+++|...+.++|.+++.+++|++.|+++||+.||||||||-+|+.++.+|-+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999976 4569999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCC-CchhhhHHHHHHHHHHHhCCC
Q 001614 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 912 (1044)
Q Consensus 834 Aki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILYELLTGr~ 912 (1044)
|... ........+||..|.|||+|.|.+| +..-|||+||++||.++....
T Consensus 717 aa~~-----------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 717 AAYT-----------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred hhhh-----------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 7531 1122346789999999999999887 678999999999999999999
Q ss_pred CCCC
Q 001614 913 PFTA 916 (1044)
Q Consensus 913 PF~g 916 (1044)
||++
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=253.51 Aligned_cols=217 Identities=29% Similarity=0.524 Sum_probs=179.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~L 762 (1044)
...++..-+..||+|+||.|-+.++..+|...|+|.++. ....+...+.++|+++..+. .+|++|.+||.+.....+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~--tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA--TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh--hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 345566677889999999999999999999999999864 33456778899999887665 699999999999999999
Q ss_pred EEEEeeccccchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 763 YLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 763 yLVmEY~~GGSL~dl----Lkk~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
++.||.|.- ||..+ +.+.+.++|..+-.++..++.||.|||++ .|||||+||+||||+.+|+||+||||++...
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999964 77544 44567899999999999999999999976 7999999999999999999999999988642
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC----CCCCchhhhHHHHHHHHHHHhCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPP 913 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g----~~ys~KSDIWSLGVILYELLTGr~P 913 (1044)
.. .-......|...|||||.+.. ..|+.++||||||+++.||.+++.|
T Consensus 200 ~d----------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 200 VD----------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred hh----------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence 10 001122468889999999853 4789999999999999999999999
Q ss_pred CCC-CChHHHHHhhhccCC
Q 001614 914 FTA-ESPEIIFDNILNRKI 931 (1044)
Q Consensus 914 F~g-~s~~ei~qkIl~g~i 931 (1044)
|.. .++.+.+.++.....
T Consensus 252 Y~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 252 YESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred ccccCCHHHHHHHHhcCCC
Confidence 965 466777777776543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=272.22 Aligned_cols=282 Identities=27% Similarity=0.435 Sum_probs=205.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECC---CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCC
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~---tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~ 760 (1044)
..+.|....+||.|+|+.||++.... .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34678999999999999999999877 78899999886532 3467999999999995 899999999999999
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-CCcEEEeecCCcccccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-dg~VKLsDFGLAki~~~ 839 (1044)
...+||||++..+..++... ++-..++.|++.++.||+++|.+|||||||||.|||.+. .+.-.|+|||+|.-...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999888888754 668899999999999999999999999999999999985 46789999999862110
Q ss_pred cC---c-ccCCCCCCCCCCCCCCCCC---------cc----cccCcCCccCccCCCCCCCcccccC-CCCCchhhhHHHH
Q 001614 840 NN---T-IDLSGPETDGIMPSDAHYP---------EY----QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVG 901 (1044)
Q Consensus 840 ~~---t-~dls~p~t~~~~~s~s~~~---------e~----~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~KSDIWSLG 901 (1044)
.. . -..+++..........++. .+ ........-...|||+|.|||++.. +..+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 0000000000000000000 00 0112223345689999999999976 4568899999999
Q ss_pred HHHHHHHhCCCCCCCCCh--------------HHHHHhh-hccC------C----------CC-----------------
Q 001614 902 IILFEFITGIPPFTAESP--------------EIIFDNI-LNRK------I----------PW----------------- 933 (1044)
Q Consensus 902 VILYELLTGr~PF~g~s~--------------~ei~qkI-l~g~------i----------~~----------------- 933 (1044)
||+.-+++++.||-.... .++.+-. +-+. . .|
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999843211 0110000 0000 0 00
Q ss_pred CCC-CCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 934 PCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 934 p~i-p~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
+.. ....+..+.+|+.+||..||.+|+| |++.|.||||...
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~ 387 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEA 387 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcch
Confidence 000 1234557899999999999999999 7888999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=294.03 Aligned_cols=227 Identities=15% Similarity=0.197 Sum_probs=153.8
Q ss_pred hcCC-CceEEEeeee-------ecCCeeEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC
Q 001614 743 TVRN-PFVVRFFYSF-------TCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (1044)
Q Consensus 743 ~L~H-PNIVkL~gvf-------ed~~~LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDL 813 (1044)
.++| +||+.++++| .....++++|||+ +++|+++|.. ...+++..++.+++||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4555 5777777777 2334678889988 5699999975 345999999999999999999999999999999
Q ss_pred CCCceeecCCCcEEEeecCCcccccccCcc-----cCCCCCCCCCCCCC--CCCCccccc-CcCCccCccCCCCCCCccc
Q 001614 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSD--AHYPEYQQT-DNRNRHSAVGTPDYLAPEI 885 (1044)
Q Consensus 814 KPeNILLdedg~VKLsDFGLAki~~~~~t~-----dls~p~t~~~~~s~--s~~~e~~~~-~~~~~~s~vGTp~YmAPEv 885 (1044)
||+||||+..|.+|++|||++.....+... ++.........+.. ......... ........+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999988777887777776532111000 00000000000000 000000000 0011123578999999999
Q ss_pred ccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhH
Q 001614 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1044)
Q Consensus 886 L~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA 965 (1044)
+.+..|+.++|||||||+||||++|.+||.... .....+..... +.......+...+++.+||+.||.+||+ +
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rps---~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRPS---M 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCcC---h
Confidence 999999999999999999999999998876432 12222221111 1111122456778999999999999999 7
Q ss_pred HHHHcCCCCCCC
Q 001614 966 AEVKAHPFFKGV 977 (1044)
Q Consensus 966 ~EIL~HPwFk~i 977 (1044)
.++|+||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 889999999763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=257.33 Aligned_cols=256 Identities=19% Similarity=0.257 Sum_probs=208.4
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCC-----cEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec-C
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 759 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tG-----k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed-~ 759 (1044)
..++++...+-+|.||.||+|.|+... +.|-+|.++. .-.+-....++.|.-++..+.|||+.++.+++.. .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 345777788999999999999887433 3455565543 2234456788999999999999999999887654 4
Q ss_pred CeeEEEEeeccccchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeec
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~--------g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDF 831 (1044)
...++++.++.-|+|..++... ..++..+...++.|++.||+|||..||||.||...|.+||+..+|||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 5678999999999999999721 24777888899999999999999999999999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-C
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-G 910 (1044)
.+++-....++..+... .-....||+||.+.+..|+.++|+|||||+||||+| |
T Consensus 441 aLSRDLFP~DYhcLGDn-------------------------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDN-------------------------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred hhccccCcccccccCCC-------------------------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 99885433332222110 112457999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 911 r~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
+.||...++.++.-.+..|. + ...|.++|+++..+|..||+.+|++||++.++...|.
T Consensus 496 ~~PyaeIDPfEm~~ylkdGy-R-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 496 KLPYAEIDPFEMEHYLKDGY-R-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred CCCccccCHHHHHHHHhccc-e-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 99999999999887776654 3 3356899999999999999999999999888877663
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-25 Score=222.44 Aligned_cols=261 Identities=40% Similarity=0.707 Sum_probs=207.0
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC-ceEEEeeeeecCCeeEEEEe
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP-NIVkL~gvfed~~~LyLVmE 767 (1044)
|.+...||.|+||.||++.+. ..+++|.+.............+.+|..++..+.|+ +|+.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 78999999765443333577899999999999988 79999999988888899999
Q ss_pred eccccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-cEEEeecCCcccccccCcc
Q 001614 768 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g---~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-~VKLsDFGLAki~~~~~t~ 843 (1044)
|+.+++|.+++.... .+....+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887665 799999999999999999999999999999999999999988 7999999998632110000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCh-
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP- 919 (1044)
Q Consensus 844 dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILYELLTGr~PF~g~s~- 919 (1044)
...........||+.|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 159 ---------------------~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 ---------------------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred ---------------------ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 000013356789999999999987 5788899999999999999999999877663
Q ss_pred ---HHHHHhhhccCCC-CCC-CCCCC----CHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 920 ---EIIFDNILNRKIP-WPC-VPSDM----SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 920 ---~ei~qkIl~g~i~-~p~-ip~~i----S~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
......+.....+ ... ..... ...+.+++..++..+|..|.+ ..+...++|...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~~ 280 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLAH 280 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhhC
Confidence 4555544444432 111 11111 257899999999999999999 445555555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=278.58 Aligned_cols=253 Identities=42% Similarity=0.771 Sum_probs=220.6
Q ss_pred eeccCCceEEEEEEE---CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEEEeec
Q 001614 694 PISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~---k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLVmEY~ 769 (1044)
.+|.|.||.|++++. ...|..||+|+.++......... ....|..++..++ ||++|++...|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999987654 34578899999987654433333 6778888888887 999999999999999999999999
Q ss_pred cccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCC
Q 001614 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (1044)
Q Consensus 770 ~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~ 849 (1044)
.||.|+..+.....+++...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~---------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK---------- 149 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh----------
Confidence 9999999999888899999999999999999999999999999999999999999999999999885211
Q ss_pred CCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhcc
Q 001614 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (1044)
Q Consensus 850 t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g 929 (1044)
....|||..|||||++. .+...+|+||||+++++|+||..||.. ++...|+..
T Consensus 150 ---------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 150 ---------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred ---------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 11229999999999998 567899999999999999999999988 677777777
Q ss_pred CCCCCCCCCCCCHHHHHHHHhHccCCcCCCCCh--hhHHHHHcCCCCCCCCcchhHhhhc
Q 001614 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 930 ~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSa--deA~EIL~HPwFk~id~d~L~~qk~ 987 (1044)
...+| ..++..+++++..++.++|.+|... +.+.++++|+||..++|+.+..+..
T Consensus 203 ~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~ 259 (612)
T KOG0603|consen 203 ELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSR 259 (612)
T ss_pred ccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCC
Confidence 66554 6789999999999999999999985 6899999999999999998876543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=227.34 Aligned_cols=161 Identities=25% Similarity=0.267 Sum_probs=128.4
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCC
Q 001614 772 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (1044)
Q Consensus 772 GSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t 850 (1044)
|+|.+++... ..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~------------ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT------------ 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec------------
Confidence 7899999864 45999999999999999999999998 999999999999999 99886421
Q ss_pred CCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHhhhcc
Q 001614 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNILNR 929 (1044)
Q Consensus 851 ~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~-~ei~qkIl~g 929 (1044)
.....||+.|||||++.+..|+.++|||||||++|||++|..||..... ......+...
T Consensus 61 --------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 120 (176)
T smart00750 61 --------------------PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120 (176)
T ss_pred --------------------cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH
Confidence 0112589999999999999999999999999999999999999976543 2333333322
Q ss_pred CCCCC----CCCCCCCH--HHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 930 KIPWP----CVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 930 ~i~~p----~ip~~iS~--eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
..... ..+..++. ++++||.+||+.||.+||+ +.+++.|+|+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 21110 11123333 6999999999999999999 77889999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=248.53 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=198.1
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEee-eeecCCee
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY-SFTCRDNL 762 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~g-vfed~~~L 762 (1044)
..+.|.+.+.||+|-||.+-++.++.++..+++|.+.+.. ..+.+|.+|+.---.| .|.||+.-|+ .|++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 4578999999999999999999999999999999987632 3567888888765555 4899998874 57888889
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC--CCcEEEeecCCccccccc
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde--dg~VKLsDFGLAki~~~~ 840 (1044)
++++||++.|+|..-+... .+-+...+.++.|+++||.|||+.+++|||||.+||||-. .-.|||||||+++.. +
T Consensus 98 vF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--G 174 (378)
T ss_pred EEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--C
Confidence 9999999999999888654 4888999999999999999999999999999999999953 347999999987631 0
Q ss_pred CcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC-----CCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 841 ~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-----~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
. .....-.+..|.+||++... ...+.+|+|.||+++|.+|||++||.
T Consensus 175 ~----------------------------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 T----------------------------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred c----------------------------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 0 01112245678999987432 23678999999999999999999996
Q ss_pred CCCh----HHHHHhhhccC-CCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 916 AESP----EIIFDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 916 g~s~----~ei~qkIl~g~-i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
.... ---+.+...+. ...|.....+++.+..+.++-|..+|++|--..++.......|..
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 4322 11222333222 223445567899999999999999999994444466666666653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-26 Score=272.24 Aligned_cols=255 Identities=49% Similarity=0.843 Sum_probs=206.4
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEE
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyL 764 (1044)
.-.+|..++.|..|+||.||.++++.+.+.+|+|+ .+..+ +++. ++....+|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee--------------
Confidence 45789999999999999999999999999999964 33221 1111 44555566665
Q ss_pred EEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCccc
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~d 844 (1044)
|+-...++..+.++... +.+++|||+.||+|||+||+|.+|..-|++|+.|||+++...+..+..
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 56666676666666544 789999999999999999999999999999999999998765544432
Q ss_pred CCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~q 924 (1044)
+. .+.+..+ ...-.....||||.|.|||++..+.|+..+|||++|+|+|+.+.|+.||.++++++++.
T Consensus 201 l~----eg~I~k~--------t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 201 LK----EGHIEKD--------THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hh----hcchHHH--------HHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 11 1111111 11122345699999999999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcchhHhhhccccc
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQAT 991 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d~L~~qk~~~~~ 991 (1044)
..+...+.|+.-....+++++++|..+|+.+|..|.....+.++.+|+||+.+||..|--++..+.+
T Consensus 269 ~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvp 335 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVP 335 (1205)
T ss_pred hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccc
Confidence 9999999998877788999999999999999999998888999999999999999977666554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=264.06 Aligned_cols=264 Identities=27% Similarity=0.379 Sum_probs=204.9
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeec---ccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 690 ~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK---~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
.....+|.|++|.|+.+......+.++.|.++. ...........+..|+-+-..+.|||++..+..+......+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999888888877777777776542 11111222223677888888999999999888887777777779
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|||++ +|+.++...+.++...+..+++|++.|++|||+.||.||||||+|+++..+|.+||+|||.+.++....
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~----- 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW----- 474 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc-----
Confidence 99999 999999988889999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCChHHHH--
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY-AADWWSVGIILFEFITGIPPFTAESPEIIF-- 923 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~-KSDIWSLGVILYELLTGr~PF~g~s~~ei~-- 923 (1044)
..........+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+..
T Consensus 475 ------------------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 475 ------------------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred ------------------chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh
Confidence 01112345678999999999999988876 689999999999999999999654332221
Q ss_pred HhhhccCCC----CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCCcc
Q 001614 924 DNILNRKIP----WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 924 qkIl~g~i~----~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id~d 980 (1044)
...-..... ...+...++.+.+.+|.+||+.||.+|.| +.+|++.+||+.+.--
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECC 594 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceE
Confidence 111111110 01123457888999999999999999999 8899999999987543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-22 Score=219.35 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=195.9
Q ss_pred CeEEEEeeccCCceEEEEEEECCCC-cEEEEEEeecccccChhHHHHHHHHHHHHHhcCC----CceEEEeeee-ecCCe
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRN----PFVVRFFYSF-TCRDN 761 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tG-k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H----PNIVkL~gvf-ed~~~ 761 (1044)
.|.+.+.||+|+||.||.|.+..++ ..+|+|+........ ...+..|..++..+.. +++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998764 679999876532211 1257788888888863 6888888888 47778
Q ss_pred eEEEEeeccccchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC-----CcEEEeecCCc
Q 001614 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-----GHIKLTDFGLS 834 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded-----g~VKLsDFGLA 834 (1044)
-|+||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 89999998 78999988654 479999999999999999999999999999999999999865 36999999999
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF 914 (1044)
+....... .+ .. ............||..|+++.+..+...+.+.|+||++.++.+|+.|..||
T Consensus 175 r~~~~~~~--------~~-----~~----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 175 RRFKYVGD--------SG-----GN----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccccCC--------CC-----cc----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 72110000 00 00 000111123456999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhh---ccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHc
Q 001614 915 TAESPEIIFDNIL---NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 915 ~g~s~~ei~qkIl---~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~ 970 (1044)
.+........++. ..... .......+.++..+...+-..+...+|....+..++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~ 295 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLT-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK 295 (322)
T ss_pred ccccccchHHHHHHHhhhhcc-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence 7765322222221 11111 1123445678888888888889999999776666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=231.05 Aligned_cols=179 Identities=22% Similarity=0.150 Sum_probs=133.6
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccc--cChhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~-tGk~VAVKiIkK~~~--~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfe 757 (1044)
..+...++|.+.+.||+|+||+||+|+++. +++.||||.+..... ........+.+|+.+|+.++|+||++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 344567889999999999999999999876 677889998653211 1233456789999999999999998533222
Q ss_pred cCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC-CCCceeecCCCcEEEeecCCccc
Q 001614 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 758 d~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDL-KPeNILLdedg~VKLsDFGLAki 836 (1044)
+..|+|||||+|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999732 11 11 1467889999999999999999999 99999999999999999999985
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 888 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g 888 (1044)
..... +.+ ............+++.|+|||++..
T Consensus 162 ~~~~~--------~~~-----------~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRG--------ALY-----------RIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCc--------chh-----------hhhhhhhhhhhhccCccCCcccCCh
Confidence 32110 000 0001112236789999999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=206.43 Aligned_cols=279 Identities=23% Similarity=0.303 Sum_probs=213.6
Q ss_pred cccccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC-CceEEEeeeeecC
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCR 759 (1044)
Q Consensus 681 ~~~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H-PNIVkL~gvfed~ 759 (1044)
...+..+.|.++++||.|+||.+|.|....+|..||||+-+.. .....+.-|..+...|++ ..|..+..++...
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 3446678999999999999999999999999999999975432 123457789999999975 6777788888888
Q ss_pred CeeEEEEeeccccchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC---CcEEEeecCCcc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSK 835 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk-~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded---g~VKLsDFGLAk 835 (1044)
..-.+||+++ |-+|.+++.- ...++...+..++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 8889999998 7799988863 3458889999999999999999999999999999999999743 468999999998
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
...+..+ ..++ +........||..|.+=-...+...+...|+=|+|.+|.++..|..||.
T Consensus 163 ky~d~~t--------~~HI------------pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 163 KYRDIRT--------RQHI------------PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred hhccccc--------cccC------------ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 5332211 1111 1223345679999999888777777889999999999999999999998
Q ss_pred CCCh---HHHHHhhhccCCCCC--CCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHH-------cCCCCCCCCcchhH
Q 001614 916 AESP---EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-------AHPFFKGVNWDSLA 983 (1044)
Q Consensus 916 g~s~---~ei~qkIl~g~i~~p--~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL-------~HPwFk~id~d~L~ 983 (1044)
+... .+-+++|...+...+ .+-.+.|.++.-.+.-|-..--.+-|...-+.++. +|.+=--+||.-+.
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 8654 445666665544322 24467889999888888777777777755444443 33332236788775
Q ss_pred hh
Q 001614 984 LQ 985 (1044)
Q Consensus 984 ~q 985 (1044)
.+
T Consensus 303 qk 304 (341)
T KOG1163|consen 303 QK 304 (341)
T ss_pred HH
Confidence 44
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=208.80 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=199.3
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCee
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~L 762 (1044)
+.--.|+++++||+|+||+++.|++.-+++.||||.-.. ..+...+..|.+..+.|. .+.|..+|.+.+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 344579999999999999999999999999999996543 223456777888888875 69999999999988888
Q ss_pred EEEEeeccccchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC-----cEEEeecCCccc
Q 001614 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSKI 836 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g-~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg-----~VKLsDFGLAki 836 (1044)
.||||++ |-||.|++.-.+ .|+...+..++.|++.-|+|+|++.+|+|||||+|+||...+ .+.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 779988887544 599999999999999999999999999999999999997543 589999999985
Q ss_pred ccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 837 ~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g 916 (1044)
.. .|.+..++|... ..+..||.+||+=-...+...+...|+=|||-++++.|.|.+||.+
T Consensus 179 Yr--------Dp~TkqHIPYrE------------~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 179 YR--------DPKTKQHIPYRE------------HKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hc--------CccccccCcccc------------ccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 32 344445554333 3567899999998888888899999999999999999999999987
Q ss_pred CC---hHHHHHhhhccCCC--CCCCCCCCCHHHHHHHHhHccCCcCCCCChhh
Q 001614 917 ES---PEIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 917 ~s---~~ei~qkIl~g~i~--~p~ip~~iS~eLkdLIkkcLqkDPskRPSade 964 (1044)
.. ..+-+++|-..+.. ...+-.++|.++..-+.-.-..+-.+-|..+-
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 63 45556666443221 11223456666666655555555555566443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=210.98 Aligned_cols=272 Identities=27% Similarity=0.390 Sum_probs=189.2
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCc-----------------------------------EEEEEEeecccccC
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----------------------------------LFAIKVLKKLDMIR 727 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk-----------------------------------~VAVKiIkK~~~~~ 727 (1044)
...+++|+++..||+|..+.||.++...+|. +.|+|.+-.-...+
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 4668899999999999999999887654321 34555443222111
Q ss_pred hh--HHHHHHHHHH------HH--------Hh--------cCCCceEEEeeeeec-------------------------
Q 001614 728 KN--DIERILAERN------IL--------IT--------VRNPFVVRFFYSFTC------------------------- 758 (1044)
Q Consensus 728 ~~--~~e~flrEi~------IL--------s~--------L~HPNIVkL~gvfed------------------------- 758 (1044)
.. ..+.+-+|.- ++ +. -.|||||+++.+|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 10 1111112210 00 11 359999999988754
Q ss_pred --CCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeec--CCC--cEEEeecC
Q 001614 759 --RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDG--HIKLTDFG 832 (1044)
Q Consensus 759 --~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLd--edg--~VKLsDFG 832 (1044)
...+|+||.-++. +|..++-... .+....+.++.|+++|+.|||.+||.|||||.+|||+. +++ .+.|+|||
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 2248999998865 9999986543 66677788899999999999999999999999999994 344 57889999
Q ss_pred CcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC------CCchhhhHHHHHHHHH
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFE 906 (1044)
Q Consensus 833 LAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~------ys~KSDIWSLGVILYE 906 (1044)
.+-- ..+.-+.+ .-........|...-||||+....+ .-.++|.|+.|.+.||
T Consensus 391 CcLA-d~~hGlql--------------------py~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYE 449 (598)
T KOG4158|consen 391 CCLA-DDNHGLQL--------------------PYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYE 449 (598)
T ss_pred eeee-cccccccc--------------------ccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHH
Confidence 7642 11111111 1112233456888899999986422 1348999999999999
Q ss_pred HHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
+++...||+....+-.-... -.+-..|.+|..+++.+++|+..+|+.||++|++.+-|..+|+--.+..-+
T Consensus 450 Ifg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~ 520 (598)
T KOG4158|consen 450 IFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGE 520 (598)
T ss_pred HhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCch
Confidence 99999999885443221111 122345677899999999999999999999999988888887665555443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.9e-21 Score=196.40 Aligned_cols=140 Identities=24% Similarity=0.203 Sum_probs=109.8
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhH-----------------------HHHHHHHHHHHHhcCCCc
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----------------------IERILAERNILITVRNPF 748 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~-----------------------~e~flrEi~ILs~L~HPN 748 (1044)
...||+|+||.||+|... +|+.||+|+++......... .....+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 89999999997642111110 122345999999998776
Q ss_pred eEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeccCCCCceeecCCCcEE
Q 001614 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 749 IVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYL-Hs~GIIHRDLKPeNILLdedg~VK 827 (1044)
+....... . ...+|||||++|++|...+...+.++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPIL-L-KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEE-e-cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 63322221 1 22389999999988876654556799999999999999999999 799999999999999998 57899
Q ss_pred EeecCCcc
Q 001614 828 LTDFGLSK 835 (1044)
Q Consensus 828 LsDFGLAk 835 (1044)
|+|||+|.
T Consensus 158 LiDFG~a~ 165 (190)
T cd05147 158 IIDVSQSV 165 (190)
T ss_pred EEEccccc
Confidence 99999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=202.04 Aligned_cols=234 Identities=27% Similarity=0.373 Sum_probs=151.4
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC-----------CceEEEee--
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-----------PFVVRFFY-- 754 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H-----------PNIVkL~g-- 754 (1044)
.+.....||.|+++.||.+++..||+.+|+|++.-.........+.+.+|.-....+.+ ..++++--
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46678899999999999999999999999999876554444566777776654444322 12222110
Q ss_pred ------eeecC---C-----eeEEEEeeccccchHHHHH---hcCCC--C-HHHH-HHHHHHHHHHHHHHHhcCeeeccC
Q 001614 755 ------SFTCR---D-----NLYLVMEYLNGGDLYSLLR---KVGCL--E-EDVA-RIYIAELVLALEYLHSLGIVHRDL 813 (1044)
Q Consensus 755 ------vfed~---~-----~LyLVmEY~~GGSL~dlLk---k~g~L--s-ee~a-r~Ia~QIL~ALaYLHs~GIIHRDL 813 (1044)
++... . +.+++|+-+ .++|.+++. ..... . .-.+ ..+..|+++.+++||..||+|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11111 1 347788877 458888764 22222 1 1223 234479999999999999999999
Q ss_pred CCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC-----
Q 001614 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----- 888 (1044)
Q Consensus 814 KPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g----- 888 (1044)
+|+|++++.+|.++|+||+..... +. .......+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~--g~----------------------------~~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA--GT----------------------------RYRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET--TE----------------------------EEEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec--Cc----------------------------eeeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999876521 00 0111335578999998743
Q ss_pred ---CCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCC
Q 001614 889 ---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 889 ---~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskR 959 (1044)
-.++.+.|.|+||+++|.|.+|..||....+...... .|.... ++|+.++.||..+|++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2468899999999999999999999986644322221 222223 788999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-20 Score=188.17 Aligned_cols=141 Identities=25% Similarity=0.169 Sum_probs=111.2
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccCh-----------------------hHHHHHHHHHHHHHhcCCCc
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------------------NDIERILAERNILITVRNPF 748 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~-----------------------~~~e~flrEi~ILs~L~HPN 748 (1044)
...||+|+||.||+|.+. +|+.||||+++....... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999986421100 00123467899999999988
Q ss_pred eEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEE
Q 001614 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 749 IVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VK 827 (1044)
|.....+... ..||||||++|+++.........++...+..++.|++.++.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7433333222 248999999998665443344568888999999999999999999 9999999999999998 89999
Q ss_pred EeecCCccc
Q 001614 828 LTDFGLSKI 836 (1044)
Q Consensus 828 LsDFGLAki 836 (1044)
|+|||++..
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=198.17 Aligned_cols=174 Identities=17% Similarity=0.197 Sum_probs=134.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHH------HHHHHHHHHhcCCCceEEEeeeeec
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVRNPFVVRFFYSFTC 758 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~------flrEi~ILs~L~HPNIVkL~gvfed 758 (1044)
..++|++.+.||.|+||.||++.. ++..+|+|+++......+..... +.+|+..+.++.||+|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457899999999999999999755 47789999997644333333333 5789999999999999999888664
Q ss_pred C--------CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEee
Q 001614 759 R--------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (1044)
Q Consensus 759 ~--------~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsD 830 (1044)
. ...++||||++|.+|.++.. +++. .+.+++.+|..||+.|++||||||.||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 4 35799999999999988732 3332 356999999999999999999999999999988 99999
Q ss_pred cCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHH
Q 001614 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (1044)
Q Consensus 831 FGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELL 908 (1044)
||.......... -..++....|+.++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a---------------------------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA---------------------------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh---------------------------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 997653110000 011344556778999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-20 Score=223.17 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=182.0
Q ss_pred CeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccc-ccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEE
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~-~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVm 766 (1044)
+|...+.||.+.|=+|.+|++.+ | .|+||++-+.. ...-....+-+.|++ ....++||++++.-+-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999998863 4 49999987644 233334445555666 66779999999988888888889999
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
+|... +|+|.|..++.+..-+.+.|+.|++.||.-+|..||+|+|||.+||||+.=+.+.|+||..=+.. .
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt--------Y 171 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT--------Y 171 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc--------c
Confidence 99966 99999998888888899999999999999999999999999999999999999999999753321 0
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCC----------C-CCchhhhHHHHHHHHHHHh-CCCCC
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----------E-HGYAADWWSVGIILFEFIT-GIPPF 914 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~----------~-ys~KSDIWSLGVILYELLT-Gr~PF 914 (1044)
.|+.. .+.|..|..+.. --..|.|||-+... . .+++-||||+||++.||++ |++||
T Consensus 172 LPeDN-----Padf~fFFDTSr-------RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 172 LPEDN-----PADFTFFFDTSR-------RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCCCC-----cccceEEEecCC-------ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 11110 111222221111 12359999988542 1 4678999999999999998 78998
Q ss_pred CC-----------CChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHH
Q 001614 915 TA-----------ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 915 ~g-----------~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EI 968 (1044)
.- .+++..+.+|- +..++++|..|++.||.+|.++++..+-
T Consensus 240 ~LSQL~aYr~~~~~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 240 TLSQLLAYRSGNADDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cHHHHHhHhccCccCHHHHHHhCc-------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 42 12222222221 2358999999999999999996554443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=182.68 Aligned_cols=202 Identities=22% Similarity=0.260 Sum_probs=142.5
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccCh-hHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEEEe
Q 001614 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-NDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 690 ~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~-~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLVmE 767 (1044)
.+...|++|+||+||.+.. .+.+++.+.+........ .....+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997765 578888776654332111 12235789999999996 4789888875 44699999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC-CCCceeecCCCcEEEeecCCcccccccCcccCC
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDL-KPeNILLdedg~VKLsDFGLAki~~~~~t~dls 846 (1044)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~---- 147 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR---- 147 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch----
Confidence 9999999765421 1 1346789999999999999999999 79999999999999999999974211000
Q ss_pred CCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 847 ~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILYELLTGr~PF~g~s 918 (1044)
+. ..+..-.... .......+++.|++|+.-.- ..--...++++.|.-+|.++||..|+.+++
T Consensus 148 ------~~---r~L~~rDl~~-llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 ------WM---RLLAREDLRH-LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ------HH---HHHHHHHHHH-HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 0000000000 00112347899999986432 222357899999999999999999987654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=178.51 Aligned_cols=135 Identities=19% Similarity=0.256 Sum_probs=107.0
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-----CCCceEEEeeeeecCC---ee
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-----RNPFVVRFFYSFTCRD---NL 762 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-----~HPNIVkL~gvfed~~---~L 762 (1044)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++++++++.. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346899999999995 6666665 688876532 22346789999999999 5799999999999874 33
Q ss_pred E-EEEee--ccccchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCeeeccCCCCceeecCC----CcEEEee-cCC
Q 001614 763 Y-LVMEY--LNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-EYLHSLGIVHRDLKPDNLLIAHD----GHIKLTD-FGL 833 (1044)
Q Consensus 763 y-LVmEY--~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~AL-aYLHs~GIIHRDLKPeNILLded----g~VKLsD-FGL 833 (1044)
+ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+| ||.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3 78999 5589999999764 46665 35677888777 89999999999999999999743 3799999 554
Q ss_pred c
Q 001614 834 S 834 (1044)
Q Consensus 834 A 834 (1044)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=171.58 Aligned_cols=136 Identities=31% Similarity=0.373 Sum_probs=113.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccC-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEe
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~-----~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmE 767 (1044)
+.||+|++|.||+|.+ +|..+++|......... ......+.+|+.++..+.|++|.....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 58889999765322111 1123467889999999999988776666777778899999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 9999999999865432 7778899999999999999999999999999999 7899999999876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=178.63 Aligned_cols=143 Identities=23% Similarity=0.150 Sum_probs=113.4
Q ss_pred CeEEEEeeccCCceEEEEEE-ECCCCcEEEEEEeecccccC-------------------hh--HHHHHHHHHHHHHhcC
Q 001614 688 DFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIR-------------------KN--DIERILAERNILITVR 745 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~-~k~tGk~VAVKiIkK~~~~~-------------------~~--~~e~flrEi~ILs~L~ 745 (1044)
.|.+.+.||+|+||.||+|. +..+|+.||+|+++...... .. ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 66789999999987532100 00 1134568999999997
Q ss_pred CC--ceEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-eeeccCCCCceeecC
Q 001614 746 NP--FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAH 822 (1044)
Q Consensus 746 HP--NIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~G-IIHRDLKPeNILLde 822 (1044)
+. .+.+++.. ...++||||++|++|.........+....+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 33444432 235899999999888776544455677778899999999999999999 99999999999999
Q ss_pred CCcEEEeecCCcc
Q 001614 823 DGHIKLTDFGLSK 835 (1044)
Q Consensus 823 dg~VKLsDFGLAk 835 (1044)
++.++|+|||++.
T Consensus 184 ~~~i~LiDFg~a~ 196 (237)
T smart00090 184 DGKVVIIDVSQSV 196 (237)
T ss_pred CCCEEEEEChhhh
Confidence 8899999999886
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=203.01 Aligned_cols=197 Identities=24% Similarity=0.375 Sum_probs=158.6
Q ss_pred cccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC---CCceEEEeeeeecC
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCR 759 (1044)
Q Consensus 683 ~~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~---HPNIVkL~gvfed~ 759 (1044)
......|.|.+.||+|+||.||+|.... |+.||+|+=+....+.-. --.+++.+|+ -+.|+.+..++.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3445679999999999999999999876 999999986554332211 1122334444 24566677777777
Q ss_pred CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-------CCcEEEeecC
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFG 832 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-------dg~VKLsDFG 832 (1044)
+.-+||+||.+.|+|.+++...+.+++..+..++.|++..|++||..+|||+||||+|+||.. ..-++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 788999999999999999998888999999999999999999999999999999999999952 2358999999
Q ss_pred CcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCC
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 833 LAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr 911 (1044)
-+.-+ .+. .+.......++|-.+--+|+..|.++++.+|.|.|+.+++-||.|+
T Consensus 847 ~siDm--------------~lf-----------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDM--------------KLF-----------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceee--------------eEc-----------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 87521 111 1223445678899999999999999999999999999999999985
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=165.75 Aligned_cols=133 Identities=29% Similarity=0.323 Sum_probs=106.8
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccC-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~-----~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
.||+|+||.||+|.+ +|..+++|......... .....++.+|+.++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 47889999865322111 11236678999999999987655444444556677999999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7788999999999999999999999999999 89999999998863
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-18 Score=206.44 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=206.3
Q ss_pred CCCeEEEEeeccCCceEEEEEEECC-CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeE
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~-tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~Ly 763 (1044)
...|.+.+.||+|+|+.|-...... ....+|+|.+.... ........+..|..+-+.+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4578888999999999998887643 34467777665432 22334456666888888887 999999999999999999
Q ss_pred EEEeeccccchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceeecCCC-cEEEeecCCcccccc
Q 001614 764 LVMEYLNGGDLYSLL-RKVG-CLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 839 (1044)
Q Consensus 764 LVmEY~~GGSL~dlL-kk~g-~Lsee~ar~Ia~QIL~ALaYLH-s~GIIHRDLKPeNILLdedg-~VKLsDFGLAki~~~ 839 (1044)
++++|..||++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 5554 6788888999999999999999 99999999999999999999 999999999874221
Q ss_pred cCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccC-CCCCCCcccccCC-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG-TPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 840 ~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vG-Tp~YmAPEvL~g~-~ys~KSDIWSLGVILYELLTGr~PF~g~ 917 (1044)
. ..........+| ++.|+|||.+.+. ......|+||.|+++.-+++|..||...
T Consensus 178 ~------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 K------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred c------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 0 011223345678 9999999999884 4477899999999999999999999655
Q ss_pred ChHHH-HHhhhccCCC-CCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 918 SPEII-FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 918 s~~ei-~qkIl~g~i~-~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
..... +......... -...+..++....+++.+++..+|..|.+ ..++..+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 43221 1111111111 12234678899999999999999999999 778899999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=164.08 Aligned_cols=136 Identities=21% Similarity=0.196 Sum_probs=107.3
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccC-------------------hhHHHHHHHHHHHHHhcCCCc-
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-------------------KNDIERILAERNILITVRNPF- 748 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~-------------------~~~~e~flrEi~ILs~L~HPN- 748 (1044)
|.+.+.||.|+||.||++.+. +|+.||||+++...... .........|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 677889999999999999875 79999999876432000 001123678899999998774
Q ss_pred -eEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEE
Q 001614 749 -VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 749 -IVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VK 827 (1044)
++..++ ....++||||++|++|..+... .....++.+++.++.++|+.||+|+||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2346899999999998766431 34567888999999999999999999999999999999999
Q ss_pred EeecCCcc
Q 001614 828 LTDFGLSK 835 (1044)
Q Consensus 828 LsDFGLAk 835 (1044)
|+|||++.
T Consensus 166 liDfg~~~ 173 (198)
T cd05144 166 IIDWPQMV 173 (198)
T ss_pred EEECCccc
Confidence 99999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=181.11 Aligned_cols=208 Identities=24% Similarity=0.296 Sum_probs=160.6
Q ss_pred HHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCe-eeccCCCCce
Q 001614 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGI-VHRDLKPDNL 818 (1044)
Q Consensus 741 Ls~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~ALaYLHs~GI-IHRDLKPeNI 818 (1044)
|+.+.|.|+.++++.+.++..+++|.+||..|+|.|.+... -.++.-....++++|+.||+|||...| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35689999999999999999999999999999999999863 457778888889999999999998876 9999999999
Q ss_pred eecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC-------C
Q 001614 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------H 891 (1044)
Q Consensus 819 LLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-------y 891 (1044)
++|....+||+|||+..+... . .. ........-...|.|||.+.+.. -
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--~---------------~~--------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--T---------------AE--------PEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred eeeeeEEEEechhhhcccccc--c---------------cc--------ccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999999999999764211 0 00 00011112345799999997632 3
Q ss_pred CchhhhHHHHHHHHHHHhCCCCCCCC----ChHHHHHhhhccCC--CCCCCC--CCCCHHHHHHHHhHccCCcCCCCChh
Q 001614 892 GYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKI--PWPCVP--SDMSFEAQDLINRFLIHDPNQRLGAN 963 (1044)
Q Consensus 892 s~KSDIWSLGVILYELLTGr~PF~g~----s~~ei~qkIl~g~i--~~p~ip--~~iS~eLkdLIkkcLqkDPskRPSad 963 (1044)
+.+.||||||++++|+++...||... .+.++...+..+.. ..|.++ ...++++..++..||..+|.+||+++
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 55799999999999999999999753 33456666555222 123222 14566799999999999999999988
Q ss_pred hHHHHHcCCC
Q 001614 964 GAAEVKAHPF 973 (1044)
Q Consensus 964 eA~EIL~HPw 973 (1044)
++...+...+
T Consensus 216 ~i~~~~~~~~ 225 (484)
T KOG1023|consen 216 QIRSKLLTIN 225 (484)
T ss_pred HHHhhhhhhc
Confidence 7776654433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=185.11 Aligned_cols=140 Identities=26% Similarity=0.257 Sum_probs=112.9
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeeccccc-----ChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCC
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~-----~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~ 760 (1044)
...|...+.||+|+||.||++.+. +..+++|........ ......++.+|+.++..++|++|+..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344566789999999999999875 444555543221111 1123457889999999999999988777777777
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
..++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999885 346788999999999999999999999999999 678999999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=153.10 Aligned_cols=136 Identities=24% Similarity=0.280 Sum_probs=97.5
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHH---------------------HHHHHHHHHHhcCCCc--
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---------------------RILAERNILITVRNPF-- 748 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e---------------------~flrEi~ILs~L~HPN-- 748 (1044)
.+.||+|+||.||+|.+. +|+.||||+++........... ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 7999999998753221111111 1135666666664432
Q ss_pred eEEEeeeeecCCeeEEEEeeccccchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcE
Q 001614 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 826 (1044)
Q Consensus 749 IVkL~gvfed~~~LyLVmEY~~GGSL~d-lLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~V 826 (1044)
+.+.+++ ...++||||++|+.+.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444433 23589999999954321 121111 1 16678889999999999999 9999999999999999 8999
Q ss_pred EEeecCCcc
Q 001614 827 KLTDFGLSK 835 (1044)
Q Consensus 827 KLsDFGLAk 835 (1044)
+|+|||.+.
T Consensus 154 ~liDfg~a~ 162 (187)
T cd05119 154 YIIDVPQAV 162 (187)
T ss_pred EEEECcccc
Confidence 999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-16 Score=183.23 Aligned_cols=182 Identities=28% Similarity=0.429 Sum_probs=135.5
Q ss_pred eeEEEEeeccccchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccc
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g---~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~ 837 (1044)
.+||.|++|.-++|.++|.... ..+......++.|++.|+.| +|.+|||+||.||+...+..+||.|||+..-.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999997443 35667888899999999999 99999999999999999999999999997531
Q ss_pred cccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (1044)
Q Consensus 838 ~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g 916 (1044)
.... ............+||+.||+||.+.+..|+.++||||||+||+||+. =..+|.
T Consensus 407 ~~~~---------------------~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e- 464 (516)
T KOG1033|consen 407 DKDE---------------------TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE- 464 (516)
T ss_pred ccCC---------------------cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-
Confidence 1000 00111234456789999999999999999999999999999999996 222222
Q ss_pred CChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCC
Q 001614 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 917 ~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwF 974 (1044)
....+..+..+.++ |....+ .+.-..|+.+||...|.+||+ +.+.--|+|.
T Consensus 465 --r~~t~~d~r~g~ip-~~~~~d-~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 465 --RIATLTDIRDGIIP-PEFLQD-YPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred --HHHhhhhhhcCCCC-hHHhhc-CcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 12233344444443 111122 234568999999999999996 5555556654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.9e-15 Score=137.80 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=111.8
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC--CceEEEeeeeecCCeeEEEEee
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H--PNIVkL~gvfed~~~LyLVmEY 768 (1044)
+.+.||.|.++.||++... +..+++|.+..... ...+.+|+.++..+.| +++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 3578999999999999985 47899998765321 4578899999999976 5899999888888889999999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~---GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
++|+.+..+ +......++.+++.++++||.. +++|+||+|.||++++.+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 4456667788999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=153.58 Aligned_cols=137 Identities=20% Similarity=0.346 Sum_probs=105.4
Q ss_pred Eeec-cCCceEEEEEEECCCCcEEEEEEeecccc----------cChhHHHHHHHHHHHHHhcCCCce--EEEeeeeecC
Q 001614 693 KPIS-RGAFGRVFLARKRTTGDLFAIKVLKKLDM----------IRKNDIERILAERNILITVRNPFV--VRFFYSFTCR 759 (1044)
Q Consensus 693 k~LG-~GgFG~VYka~~k~tGk~VAVKiIkK~~~----------~~~~~~e~flrEi~ILs~L~HPNI--VkL~gvfed~ 759 (1044)
..|| .||.|+||.+... +..+++|.+.+... ........+.+|+.++.++.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 7888888888764 78899998864221 111234578899999999998774 5666654332
Q ss_pred Ce----eEEEEeeccc-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 760 DN----LYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 760 ~~----LyLVmEY~~G-GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
.. .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999997 689988865 3455543 568999999999999999999999999999999999999987
Q ss_pred cc
Q 001614 835 KI 836 (1044)
Q Consensus 835 ki 836 (1044)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 63
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.4e-13 Score=155.08 Aligned_cols=260 Identities=26% Similarity=0.261 Sum_probs=192.6
Q ss_pred CCeEEEEeecc--CCceEEEEEEE--CCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCe
Q 001614 687 DDFEIIKPISR--GAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 687 ~dY~Ilk~LG~--GgFG~VYka~~--k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~ 761 (1044)
..|.+...+|. |.+|.||.+.. ..++..+|+|.=+. ....+....+-++|+...+.++ |+|.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 34566778899 99999999998 88899999996321 1111222334456666666664 9999999999999999
Q ss_pred eEEEEeeccccchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCeeeccCCCCceeecCC-CcEEEeecCCcc
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSK 835 (1044)
Q Consensus 762 LyLVmEY~~GGSL~dlLkk~g~-Lsee~ar~Ia~QIL~----ALaYLHs~GIIHRDLKPeNILLded-g~VKLsDFGLAk 835 (1044)
+|+-+|+|. .+|..+.+.... ++...++..+.+..+ |+.++|+.+++|-|+||.||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999995 689888876655 888999999999999 9999999999999999999999999 789999999876
Q ss_pred cccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 001614 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 836 i~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~ 915 (1044)
.+..++.. ..........|...|++||.+.+ -++...|+|++|.++.+..+|..++.
T Consensus 272 ~i~~~~~~----------------------~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 272 KISDGNFS----------------------SVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred EccCCccc----------------------cceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 42211110 00111122357788999999865 78899999999999999988866553
Q ss_pred CC-ChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 916 AE-SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 916 g~-s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
.. +.. +..+-.+.++ ..+....+.++...+..|+..+|..|++ +..+++|+++...
T Consensus 329 ~g~~~~--W~~~r~~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 329 VGKNSS--WSQLRQGYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSK 385 (524)
T ss_pred CCCCCC--ccccccccCc-hhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccch
Confidence 32 110 0111111111 1223456677777999999999999999 7788999999753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-12 Score=153.63 Aligned_cols=143 Identities=23% Similarity=0.389 Sum_probs=96.1
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc--------------------------cCh-----hHHHH-
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------------------------IRK-----NDIER- 733 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~--------------------------~~~-----~~~e~- 733 (1044)
..+|+. +.||.|++|+||+|+.+.+|+.||||++++.-. .+. +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455666 789999999999999998899999999975310 000 11112
Q ss_pred -----HHHHHHHHHhcC----CCceEEEeeeeec-CCeeEEEEeeccccchHHH--HHhcC----CCCHHHHHHHHHHHH
Q 001614 734 -----ILAERNILITVR----NPFVVRFFYSFTC-RDNLYLVMEYLNGGDLYSL--LRKVG----CLEEDVARIYIAELV 797 (1044)
Q Consensus 734 -----flrEi~ILs~L~----HPNIVkL~gvfed-~~~LyLVmEY~~GGSL~dl--Lkk~g----~Lsee~ar~Ia~QIL 797 (1044)
+.+|...+.++. +.+.+.+-.+|.+ ...-+|||||++|+.|.++ +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 344444444442 3333333233322 3346799999999999875 33333 234444555555554
Q ss_pred HHHHHHHhcCeeeccCCCCceeecCCC----cEEEeecCCccc
Q 001614 798 LALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 836 (1044)
Q Consensus 798 ~ALaYLHs~GIIHRDLKPeNILLdedg----~VKLsDFGLAki 836 (1044)
..|++|+|+||.||+++.+| .++++|||+...
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 58999999999999999888 999999999764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=143.36 Aligned_cols=139 Identities=24% Similarity=0.308 Sum_probs=95.6
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeeccccc--------------------------ChhH-----------HHHHH
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--------------------------RKND-----------IERIL 735 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~--------------------------~~~~-----------~e~fl 735 (1044)
+.||.|++|.||+|+.+ +|+.||||+.+..-.. +... .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 6999999998642100 0000 01245
Q ss_pred HHHHHHHhcC-----CCceEEEeeee-ecCCeeEEEEeeccccchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 001614 736 AERNILITVR-----NPFVVRFFYSF-TCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL-ALEYLHSLG 807 (1044)
Q Consensus 736 rEi~ILs~L~-----HPNIVkL~gvf-ed~~~LyLVmEY~~GGSL~dlLkk~-g~Lsee~ar~Ia~QIL~-ALaYLHs~G 807 (1044)
+|...+.++. +++|. +-.++ ......+|||||++|++|.++.... ...+ ...++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 5666665552 34332 22222 2234468999999999998886532 1222 2334555555 467899999
Q ss_pred eeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 808 IIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
++|+|+||.||+++.++.++++|||++..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 99999999999999999999999999863
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-10 Score=137.92 Aligned_cols=220 Identities=19% Similarity=0.284 Sum_probs=151.0
Q ss_pred EEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCC
Q 001614 705 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784 (1044)
Q Consensus 705 ka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~L 784 (1044)
.|..+.++.+|.|..++.... .......+-+..|+.++||||++++..++..+.+|||+|-+. .|..++.+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 466777889999988865332 234567788889999999999999999999999999999984 6777777644
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcc
Q 001614 785 EEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863 (1044)
Q Consensus 785 see~ar~Ia~QIL~ALaYLH-s~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~ 863 (1044)
...+..-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++.... + ..+
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~--------~-----~~~-------- 160 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS--------G-----FNA-------- 160 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc--------c-----CCc--------
Confidence 6666777889999999998 6689999999999999999999999998765210 0 000
Q ss_pred cccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCCCCCCCCCHH
Q 001614 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFE 943 (1044)
Q Consensus 864 ~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~e 943 (1044)
......--..|..|+.+... +-..|.|.|||++++++.| ++..... ...+..++..
T Consensus 161 ------~~~~~~~~~s~~~P~~~~~s--~~s~D~~~Lg~li~el~ng--~~~~~~~--------------~~~~~~ipk~ 216 (690)
T KOG1243|consen 161 ------PAKSLYLIESFDDPEEIDPS--EWSIDSWGLGCLIEELFNG--SLLTKTD--------------LSNTGKIPKA 216 (690)
T ss_pred ------ccccchhhhcccChhhcCcc--ccchhhhhHHHHHHHHhCc--ccCcchh--------------hhccCccchh
Confidence 00011112235666654321 2457999999999999998 3221111 1112233334
Q ss_pred HHHHHHhHccCCcCCCCC-hhhHHHHHc-CCCCCCC
Q 001614 944 AQDLINRFLIHDPNQRLG-ANGAAEVKA-HPFFKGV 977 (1044)
Q Consensus 944 LkdLIkkcLqkDPskRPS-adeA~EIL~-HPwFk~i 977 (1044)
...+-.+-+--.+.+||. ++-+..++. |.||++.
T Consensus 217 ~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~ 252 (690)
T KOG1243|consen 217 LIELYCKKLGATELKRPNKLRFILECRLLGGFFRND 252 (690)
T ss_pred HHHHHHHHhccccccccchhhHHHHHHhccccccch
Confidence 444444445556777776 222344444 8999874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.9e-12 Score=123.19 Aligned_cols=127 Identities=18% Similarity=0.282 Sum_probs=95.6
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceE-EEeeeeecCCeeEEEEeecc
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIV-kL~gvfed~~~LyLVmEY~~ 770 (1044)
.+.|+.|.++.||+++.. +..|++|+...... ....+..|+.++..+.+.+++ +++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999865 88999998754221 122457888999888665544 3444332 34589999999
Q ss_pred ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCe-----eeccCCCCceeecCCCcEEEeecCCcc
Q 001614 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI-----VHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 771 GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GI-----IHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
|.++.+. . .....++.+++.+|+.||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 0 1123456799999999999985 9999999999998 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.5e-12 Score=147.26 Aligned_cols=251 Identities=26% Similarity=0.246 Sum_probs=184.8
Q ss_pred cCCCeEEEEeeccCCceEEEEEEEC-CCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEEEeeeeecCCee
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 685 si~dY~Ilk~LG~GgFG~VYka~~k-~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVkL~gvfed~~~L 762 (1044)
...+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.... ......-+.|+.+...+ .|.+++..+..+..-++.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4568999999999999999998876 67889999987653322 22223345677777666 489999999888888889
Q ss_pred EEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCC-CcEEEeecCCcccccccC
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 763 yLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLded-g~VKLsDFGLAki~~~~~ 841 (1044)
|+-.|||.++++...+.....+++...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||.......
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-- 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-- 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence 9999999999988777555568888889999999999999999999999999999999886 6789999998752100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCC--CcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL--APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~Ym--APEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
......+.-+++ +|+.+....+..++|++|||..+++.++|.+--....
T Consensus 420 ----------------------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~- 470 (524)
T KOG0601|consen 420 ----------------------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV- 470 (524)
T ss_pred ----------------------------ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc-
Confidence 001112233444 4444455678889999999999999999864322211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCC
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk 975 (1044)
....|..+..+. . .+...++..+.+.++..++..|+. +.++..|.-|.
T Consensus 471 --~~~~i~~~~~p~--~-~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~~ 518 (524)
T KOG0601|consen 471 --QSLTIRSGDTPN--L-PGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEFY 518 (524)
T ss_pred --cceeeecccccC--C-CchHHhhhhhhhhhcCCccccchh---hhhhcccchhh
Confidence 122233343332 2 344478889999999999999999 66666665543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=135.04 Aligned_cols=209 Identities=24% Similarity=0.347 Sum_probs=148.5
Q ss_pred HHHHHhcCCCceEEEeeeeecCC-----eeEEEEeeccccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-
Q 001614 738 RNILITVRNPFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG- 807 (1044)
Q Consensus 738 i~ILs~L~HPNIVkL~gvfed~~-----~LyLVmEY~~GGSL~dlLkk~----g~Lsee~ar~Ia~QIL~ALaYLHs~G- 807 (1044)
+.-|-.+.|.|||+++.++.+.. ...+++|||..|+|..+|++. ..+.....++|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34456678999999998887654 478999999999999999754 35788888999999999999999885
Q ss_pred -eeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccc
Q 001614 808 -IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL 886 (1044)
Q Consensus 808 -IIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL 886 (1044)
|+|+++..+-|++..+|-+|+.---... .++. .............|.++|.|||.=
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s----------------------~h~s-~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS----------------------THPS-VNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc----------------------cchh-hhhhhHhhhhccccCCccccCCcC
Confidence 9999999999999999988875221111 0100 011111222334678999999987
Q ss_pred cCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhH
Q 001614 887 LGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (1044)
Q Consensus 887 ~g~~ys~KSDIWSLGVILYELLTGr~PF-~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA 965 (1044)
.....+.++|||+||+...+|..|..-- .+.+.-+.-..|.+-.+- ... +--+.+|.+||+-.|..||+ +
T Consensus 255 ~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~---len---~lqr~~i~kcl~~eP~~rp~---a 325 (458)
T KOG1266|consen 255 TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG---LEN---GLQRGSITKCLEGEPNGRPD---A 325 (458)
T ss_pred cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee---ccC---ccccCcCcccccCCCCCCcc---h
Confidence 6666778999999999999998876542 222221111122111110 001 12256899999999999999 8
Q ss_pred HHHHcCCCCCCCC
Q 001614 966 AEVKAHPFFKGVN 978 (1044)
Q Consensus 966 ~EIL~HPwFk~id 978 (1044)
.++|.||.+-.+.
T Consensus 326 r~llfHpllfeVh 338 (458)
T KOG1266|consen 326 RLLLFHPLLFEVH 338 (458)
T ss_pred hhhhcCceeeecc
Confidence 8999999976543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-10 Score=121.03 Aligned_cols=138 Identities=22% Similarity=0.174 Sum_probs=99.4
Q ss_pred EeeccCCceEEEEEEECC------CCcEEEEEEeecccc-------------------cChhHHHHH----HHHHHHHHh
Q 001614 693 KPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDM-------------------IRKNDIERI----LAERNILIT 743 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~------tGk~VAVKiIkK~~~-------------------~~~~~~e~f----lrEi~ILs~ 743 (1044)
..||.|--+.||.|.... .+..+|||+++.... ........+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997643 357999999863210 001112223 389999998
Q ss_pred cCC--CceEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeccCCCCceee
Q 001614 744 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLI 820 (1044)
Q Consensus 744 L~H--PNIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYL-Hs~GIIHRDLKPeNILL 820 (1044)
+.. -++...+.+ ..-+|||||+.++.+..-.-+...+++..+..++.+++.+|..| |..||+|+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 455555554 34689999997754432222223456666777889999999999 89999999999999999
Q ss_pred cCCCcEEEeecCCcc
Q 001614 821 AHDGHIKLTDFGLSK 835 (1044)
Q Consensus 821 dedg~VKLsDFGLAk 835 (1044)
. ++.+.|+|||.+.
T Consensus 159 ~-~~~v~iIDF~qav 172 (197)
T cd05146 159 H-DGKVWFIDVSQSV 172 (197)
T ss_pred E-CCcEEEEECCCce
Confidence 6 5789999999886
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-10 Score=112.71 Aligned_cols=140 Identities=20% Similarity=0.256 Sum_probs=104.4
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC--CceEEEeeeeecC---CeeEEEEe
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR---DNLYLVME 767 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H--PNIVkL~gvfed~---~~LyLVmE 767 (1044)
+.||.|.++.||++.... |+.|++|+....... .....+..|..++..+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999998753 689999987543221 134568899999999875 3456666666553 26789999
Q ss_pred eccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------------ 805 (1044)
Q Consensus 768 Y~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs------------------------------------------ 805 (1044)
|++|++|.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999988765432 345666666667777777777763
Q ss_pred --------------cCeeeccCCCCceeecC--CCcEEEeecCCccc
Q 001614 806 --------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 836 (1044)
Q Consensus 806 --------------~GIIHRDLKPeNILLde--dg~VKLsDFGLAki 836 (1044)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23799999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2e-09 Score=112.39 Aligned_cols=133 Identities=29% Similarity=0.314 Sum_probs=98.4
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEe-ecc----cccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVL-KKL----DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiI-kK~----~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
.+++|+-+.+|.+.+. |..+++|.= +|. .+...-...+..+|+.++.++.--.|.--+-++.+++...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999999886 666777752 221 111111235678899999988643333333345566777899999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
++|-.|.+.+... ...++..+-.-+.-||..||+|+||.++||++...+ +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999898765 134566777788889999999999999999997654 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.2e-09 Score=107.86 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=105.4
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEe-----ecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEE
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiI-----kK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLV 765 (1044)
.+..|-+|+-+.|+++.+. |+.+.||.= +.......-...+.++|++.|.++.--.|.--.-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5667889999999999886 888888842 111122222346788999999888643333333345556666899
Q ss_pred Eeeccc-cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC---cEEEeecCCccc
Q 001614 766 MEYLNG-GDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (1044)
Q Consensus 766 mEY~~G-GSL~dlLkk~g--~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg---~VKLsDFGLAki 836 (1044)
|||++| -++.+++.... .........+++.|-+.+.-||.++|||+||..+||++..++ .+.++|||++.+
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47888886542 233333367889999999999999999999999999997665 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3e-07 Score=107.48 Aligned_cols=221 Identities=19% Similarity=0.219 Sum_probs=157.4
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeec----CCeeEEEEeeccc-cc
Q 001614 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYLVMEYLNG-GD 773 (1044)
Q Consensus 699 gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed----~~~LyLVmEY~~G-GS 773 (1044)
...+.|++....+|..|++|.+.-.+.... .....-+++++++.|+|||++.++|.+ +..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 345789999999999999999843222222 233455778999999999999998874 3468999999987 68
Q ss_pred hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCccccc
Q 001614 774 LYSLLRK---------------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 774 L~dlLkk---------------~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~ 838 (1044)
|.++.-. ....++..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+.-|+..+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8877532 1236789999999999999999999999999999999999988889988777654311
Q ss_pred ccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCC-CCCC
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAE 917 (1044)
Q Consensus 839 ~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~P-F~g~ 917 (1044)
.+ . + |-+... .+-|.=.||.++..|.||..- +...
T Consensus 445 ~d---------------------------~-------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d 480 (655)
T KOG3741|consen 445 ED---------------------------P-------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTD 480 (655)
T ss_pred CC---------------------------C-------C-------cchhHH---hhhhHHHHHHHHHHHhhccccccccc
Confidence 00 0 0 112111 257888999999999998532 3333
Q ss_pred ChHHH-HHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCCC
Q 001614 918 SPEII-FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 918 s~~ei-~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~i 977 (1044)
..+.. ...| ....+.+++++|.-+...++.. -+..++....-..||...
T Consensus 481 ~~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vm 530 (655)
T KOG3741|consen 481 STQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVM 530 (655)
T ss_pred chHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHH
Confidence 33333 2222 2457888999999999988885 443344444444566543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.9e-07 Score=102.71 Aligned_cols=132 Identities=14% Similarity=0.108 Sum_probs=91.7
Q ss_pred EEEEEEECCCCcEEEEEEeeccccc---Ch-----hHHHHHHHHHHHHHhcCCC--ceEEEeeeeec-----CCeeEEEE
Q 001614 702 RVFLARKRTTGDLFAIKVLKKLDMI---RK-----NDIERILAERNILITVRNP--FVVRFFYSFTC-----RDNLYLVM 766 (1044)
Q Consensus 702 ~VYka~~k~tGk~VAVKiIkK~~~~---~~-----~~~e~flrEi~ILs~L~HP--NIVkL~gvfed-----~~~LyLVm 766 (1044)
.|+++... |+.|.||........ .. .-...+.+|...+.+|..- .++..+.++.. ...-+|||
T Consensus 37 rvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 35566553 778888865321100 00 0112477888888777421 22233333332 23468999
Q ss_pred eecccc-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecC-------CCcEEEeecCCcc
Q 001614 767 EYLNGG-DLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 835 (1044)
Q Consensus 767 EY~~GG-SL~dlLkk--~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLde-------dg~VKLsDFGLAk 835 (1044)
|++++- +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 89999864 244566777889999999999999999999999999999975 4579999999764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.6e-08 Score=119.30 Aligned_cols=164 Identities=21% Similarity=0.336 Sum_probs=116.4
Q ss_pred HHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCcc
Q 001614 794 AELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872 (1044)
Q Consensus 794 ~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~ 872 (1044)
.+++.|+.|+|.. ++||++|.|++|.++.+|..||+.|+++..... +.. |+... .+.....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~--------~~~---------~p~~~-yd~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG--------PTE---------YPFSE-YDPPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCC--------CCc---------ccccc-CCCCCCh
Confidence 3555999999965 799999999999999999999999998763211 100 11111 1112222
Q ss_pred CccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHH-hhhccCCCCCCCCCCCCHHHHHHHHh
Q 001614 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD-NILNRKIPWPCVPSDMSFEAQDLINR 950 (1044)
Q Consensus 873 s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLT-Gr~PF~g~s~~ei~q-kIl~g~i~~p~ip~~iS~eLkdLIkk 950 (1044)
...-...|.|||++.+...+.++|+||+|+++|-+.. |+.-+...+....+. .........-.....++.++++-+.+
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH
Confidence 2334568999999998788899999999999999984 555554443222211 11112222223447899999999999
Q ss_pred HccCCcCCCCChhhHHHHHcCCCCCCCC
Q 001614 951 FLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 951 cLqkDPskRPSadeA~EIL~HPwFk~id 978 (1044)
++..++..||+ +..++..|||.+..
T Consensus 248 ~l~~~~~~rp~---~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 248 LLNGDSAVRPT---LDLLLSIPFFSDPG 272 (700)
T ss_pred HhcCCcccCcc---hhhhhcccccCCch
Confidence 99999999998 77889999998743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-07 Score=98.17 Aligned_cols=126 Identities=25% Similarity=0.284 Sum_probs=82.5
Q ss_pred EEEEEEECCCCcEEEEEEeeccc-----------------------ccChhHHHHHHHHHHHHHhcCCC--ceEEEeeee
Q 001614 702 RVFLARKRTTGDLFAIKVLKKLD-----------------------MIRKNDIERILAERNILITVRNP--FVVRFFYSF 756 (1044)
Q Consensus 702 ~VYka~~k~tGk~VAVKiIkK~~-----------------------~~~~~~~e~flrEi~ILs~L~HP--NIVkL~gvf 756 (1044)
.||.|.. .+|..+|+|+.+... ...........+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4888886 358899999876311 00111234578899999999764 456665442
Q ss_pred ecCCeeEEEEeecc--ccchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 757 TCRDNLYLVMEYLN--GGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 757 ed~~~LyLVmEY~~--GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaY-LHs~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 66665544322 1244556677788886655 579999999999999999877 999999998
Q ss_pred cc
Q 001614 834 SK 835 (1044)
Q Consensus 834 Ak 835 (1044)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 86
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.8e-07 Score=93.12 Aligned_cols=106 Identities=28% Similarity=0.322 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHHhcCC--CceEEEeeeeecC----CeeEEEEeecccc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 001614 731 IERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYL 803 (1044)
Q Consensus 731 ~e~flrEi~ILs~L~H--PNIVkL~gvfed~----~~LyLVmEY~~GG-SL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYL 803 (1044)
.....+|...+..|.. -.+...+.+.... ...+||||++++. +|.+++......+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4567788888777642 1233333443332 2458999999984 8999998755577788889999999999999
Q ss_pred HhcCeeeccCCCCceeecCCC---cEEEeecCCccc
Q 001614 804 HSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (1044)
Q Consensus 804 Hs~GIIHRDLKPeNILLdedg---~VKLsDFGLAki 836 (1044)
|..||+|+|+++.|||++.++ .+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999997763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.2e-06 Score=96.22 Aligned_cols=233 Identities=17% Similarity=0.233 Sum_probs=148.8
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhc-CCCceEE--------EeeeeecCCe
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR--------FFYSFTCRDN 761 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L-~HPNIVk--------L~gvfed~~~ 761 (1044)
..+.||+|+-+.+|-.-.- ...+.|++.+...-. . .+.+..|... .||-+-. ++|- .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~---~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA---Q---AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchH---H---HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3567999999999965432 234568876533211 1 1222233333 4553322 1111 11223
Q ss_pred eEEEEeeccccc-hHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 762 LYLVMEYLNGGD-LYSLLR------KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 762 LyLVmEY~~GGS-L~dlLk------k~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
+-+.|..++|.. ...+.. ......+..+.+.++.++.+.+.||..|..-+|++++|||+++++.|.|+|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778888887742 223321 1234678889999999999999999999999999999999999999999974321
Q ss_pred ccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCccccc-----CCCCCchhhhHHHHHHHHHHHh
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 909 (1044)
Q Consensus 835 ki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILYELLT 909 (1044)
.+. .+.......+|.+.|.+||.-. +..-+...|.|.||+++++||.
T Consensus 165 qi~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 165 QIN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred eec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 110 1112233468999999999754 3344668999999999999998
Q ss_pred C-CCCCCCCC-------hHHHHHhhhccC-----------CCCCC-C-CCCCCHHHHHHHHhHccC--CcCCCCChh
Q 001614 910 G-IPPFTAES-------PEIIFDNILNRK-----------IPWPC-V-PSDMSFEAQDLINRFLIH--DPNQRLGAN 963 (1044)
Q Consensus 910 G-r~PF~g~s-------~~ei~qkIl~g~-----------i~~p~-i-p~~iS~eLkdLIkkcLqk--DPskRPSad 963 (1044)
| +.||.+.. +-+. .|..+. .+-|. . ..-++++++.|..+|+.. ++.-|||+.
T Consensus 217 ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 6 99997642 1121 122111 11111 1 134788899999999974 356799964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2e-06 Score=94.88 Aligned_cols=137 Identities=23% Similarity=0.231 Sum_probs=101.7
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecc-------ccc----------C--hhHHHHHHHHHHHHHhcCCC--
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-------DMI----------R--KNDIERILAERNILITVRNP-- 747 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~-------~~~----------~--~~~~e~flrEi~ILs~L~HP-- 747 (1044)
+.++.+||-|--+.||.|... .|.++|||.-+-. ... . ........+|+++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346688999999999999875 6999999964321 000 0 11123467899999998754
Q ss_pred ceEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEE
Q 001614 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 748 NIVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VK 827 (1044)
.|.+.+++ +.-.+||||++|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 55554432 4457999999997775442 24566667777788877777799999999999999999999999
Q ss_pred EeecCCcc
Q 001614 828 LTDFGLSK 835 (1044)
Q Consensus 828 LsDFGLAk 835 (1044)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=86.48 Aligned_cols=138 Identities=14% Similarity=0.205 Sum_probs=99.8
Q ss_pred ccCCceEEEEEEECCCCcEEEEEEeecc---cccChhHHHHHHHHHHHHHhcCC--CceEEEeeeeec--C--CeeEEEE
Q 001614 696 SRGAFGRVFLARKRTTGDLFAIKVLKKL---DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTC--R--DNLYLVM 766 (1044)
Q Consensus 696 G~GgFG~VYka~~k~tGk~VAVKiIkK~---~~~~~~~~e~flrEi~ILs~L~H--PNIVkL~gvfed--~--~~LyLVm 766 (1044)
|+||-+-|++.... |..|-+|.-... ....+.....|.+|+..|.+|.. -.+.+...+... + ..-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46788888887654 556778864310 11113456789999999998853 224444422111 1 2368999
Q ss_pred eeccc-cchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCc--EEEeecCCcc
Q 001614 767 EYLNG-GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSK 835 (1044)
Q Consensus 767 EY~~G-GSL~dlLkk~--g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~--VKLsDFGLAk 835 (1044)
|-++| -+|.+++.+. .+.+......++.+++..+.-||+.|+.|+|+.+.||+++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 5899988663 34577777889999999999999999999999999999987777 9999998655
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-07 Score=111.25 Aligned_cols=240 Identities=24% Similarity=0.247 Sum_probs=158.8
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCc-eEEEeeeeecCCeeEEEEe
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPN-IVkL~gvfed~~~LyLVmE 767 (1044)
+.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-++.++..+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 455567889999999998776544443 5554321 33456788999999999 7777777888888999999
Q ss_pred ecccc-chHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEeecCCcccccccCcccC
Q 001614 768 YLNGG-DLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 768 Y~~GG-SL~dlLk-k~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dl 845 (1044)
++.+| +...... ..-.+.+-+....++.-+++++|||+..=+||| ||+..+ +..+..||+.....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L-------- 381 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL-------- 381 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc--------
Confidence 99887 2221111 111233444555667778899999998778998 777754 77899999975421
Q ss_pred CCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHh
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (1044)
Q Consensus 846 s~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qk 925 (1044)
.......+..+|+.|+|||+.....+....|.|++|+-..+|.-|.+|-.. +....-.
T Consensus 382 --------------------~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~ 439 (829)
T KOG0576|consen 382 --------------------TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPM 439 (829)
T ss_pred --------------------CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCC
Confidence 111145567899999999999999999999999999877777777666433 1111111
Q ss_pred hhccCCCCCCCC--CCCCHHH-HHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 926 ILNRKIPWPCVP--SDMSFEA-QDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 926 Il~g~i~~p~ip--~~iS~eL-kdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
+-.+.-. +.+. ...++.. .++...|+..-|..|+. ...++.|.+|++
T Consensus 440 ~g~~p~s-~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfng 489 (829)
T KOG0576|consen 440 IGNGPNS-PMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNG 489 (829)
T ss_pred CCCCCCc-cccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhcc
Confidence 1111100 0000 0011111 14667788888888888 666788888876
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.7e-05 Score=98.20 Aligned_cols=239 Identities=23% Similarity=0.255 Sum_probs=158.2
Q ss_pred eccCCceEEEEEEECCCCc----EEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCe----eEEEE
Q 001614 695 ISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVM 766 (1044)
Q Consensus 695 LG~GgFG~VYka~~k~tGk----~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~----LyLVm 766 (1044)
+..-.+|+++...|...-+ ++-++.=.-........+....-|...+.+..|+|++.++.+...... +.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 6666777777777632111 111110000001122334455567778889999999999887665432 34556
Q ss_pred eeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCC---ceeecCCCcEEEe--ecCCcccccccC
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD---NLLIAHDGHIKLT--DFGLSKIGLINN 841 (1044)
Q Consensus 767 EY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPe---NILLdedg~VKLs--DFGLAki~~~~~ 841 (1044)
++|+.-++.+.+..-+.++...++.+..+++.|++|+|+....|.-|... +.-.+..+.+.++ ||+.+......
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~- 344 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN- 344 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc-
Confidence 88999999999999999999999999999999999999996666555444 4444455566666 88776532211
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCc--hhhhHHHHHHHHHHHhCCCCCCCCCh
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 842 t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~--KSDIWSLGVILYELLTGr~PF~g~s~ 919 (1044)
.......-+..|.|||.+....+.. ..|+|.+|..+..+..|..+-...-
T Consensus 345 ---------------------------~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~- 396 (1351)
T KOG1035|consen 345 ---------------------------EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA- 396 (1351)
T ss_pred ---------------------------ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc-
Confidence 1122234456788999887665554 4799999999999988764421110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCHHHHHHHHhHccCCcCCCCChhhHHHHHcCCCCCC
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkcLqkDPskRPSadeA~EIL~HPwFk~ 976 (1044)
.+.+..+........++..+|+..++++|++ +.+++.|+|.+.
T Consensus 397 -----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~---~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 397 -----------VPVSLLDVLSTSELLDALPKCLDEDSEERLS---ALELLTHPFLRF 439 (1351)
T ss_pred -----------chhhhhccccchhhhhhhhhhcchhhhhccc---hhhhhhchhccc
Confidence 0001111122226778899999999999999 889999999875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.6e-05 Score=84.17 Aligned_cols=141 Identities=21% Similarity=0.304 Sum_probs=89.8
Q ss_pred ccCCCeEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHH------HHHHHHHHHhc---CCCceEEEe-
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITV---RNPFVVRFF- 753 (1044)
Q Consensus 684 ~si~dY~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~------flrEi~ILs~L---~HPNIVkL~- 753 (1044)
+..++|.+.+.+-......|.+..- +|+.+++|..+......+..... ..+++..+.++ .--....++
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3456788888888777776766654 48999999876432111111111 12333333333 222222222
Q ss_pred ----eeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEEEe
Q 001614 754 ----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (1044)
Q Consensus 754 ----gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VKLs 829 (1044)
-.+.-....++||||++|..|.++.. +++. +...|.++|.-||..|+.|+|..|.|+++++++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 22222345678999999988876642 3332 345677889999999999999999999998554 9999
Q ss_pred ecCCcc
Q 001614 830 DFGLSK 835 (1044)
Q Consensus 830 DFGLAk 835 (1044)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=8e-05 Score=76.34 Aligned_cols=138 Identities=28% Similarity=0.383 Sum_probs=82.3
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC--ceEEEeeee---ecCCeeEEEE
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSF---TCRDNLYLVM 766 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP--NIVkL~gvf---ed~~~LyLVm 766 (1044)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+..++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998763 58999986532 3456777888888887532 345555533 2233479999
Q ss_pred eeccccchHH----------------HH---Hhc--C--CCCHHH---H---HHH---------------HHHHHH-HHH
Q 001614 767 EYLNGGDLYS----------------LL---RKV--G--CLEEDV---A---RIY---------------IAELVL-ALE 801 (1044)
Q Consensus 767 EY~~GGSL~d----------------lL---kk~--g--~Lsee~---a---r~I---------------a~QIL~-ALa 801 (1044)
++++|..+.. .+ +.. . .+.... . ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 11 111 0 011000 0 000 111222 333
Q ss_pred HHHh-------cCeeeccCCCCceeec-CCCcEEEeecCCccc
Q 001614 802 YLHS-------LGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKI 836 (1044)
Q Consensus 802 YLHs-------~GIIHRDLKPeNILLd-edg~VKLsDFGLAki 836 (1044)
.++. ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 4599999999999999 667678999998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.9e-05 Score=82.28 Aligned_cols=134 Identities=16% Similarity=0.116 Sum_probs=83.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCc--eEEEeeeeecCCeeEEEEeecc
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYSFTCRDNLYLVMEYLN 770 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPN--IVkL~gvfed~~~LyLVmEY~~ 770 (1044)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+.+....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25568889875311 2345688999998886432 4566777777778899999999
Q ss_pred ccc-hH--------------HHH-------Hhc--CCCCH-HHHHHHHH----------HHHH-HHHHHHh----cCeee
Q 001614 771 GGD-LY--------------SLL-------RKV--GCLEE-DVARIYIA----------ELVL-ALEYLHS----LGIVH 810 (1044)
Q Consensus 771 GGS-L~--------------dlL-------kk~--g~Lse-e~ar~Ia~----------QIL~-ALaYLHs----~GIIH 810 (1044)
|.+ +. ..+ +.. ..... .....+.. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 111 110 00110 00011100 0111 1222221 24789
Q ss_pred ccCCCCceeecCCCcEEEeecCCccc
Q 001614 811 RDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 811 RDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.4e-05 Score=93.56 Aligned_cols=139 Identities=22% Similarity=0.300 Sum_probs=89.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeeccc-----------------------c---cChh-HH----H------HHH
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-----------------------M---IRKN-DI----E------RIL 735 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~-----------------------~---~~~~-~~----e------~fl 735 (1044)
..|+.++-|+||+|+.+. |+.||||+.+..- . .+.. .. + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999975 9999999976410 0 0000 00 1 234
Q ss_pred HHHHHHHhcC-----CCceEEEeeeeecCCeeEEEEeeccccchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhcCe
Q 001614 736 AERNILITVR-----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLHSLGI 808 (1044)
Q Consensus 736 rEi~ILs~L~-----HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlL--kk~g~Lsee~ar~Ia~QIL~ALaYLHs~GI 808 (1044)
+|...+.++. .|+|.--.-+++-...-.|+|||++|-.+.+.. +. ..++...+...+.++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 5555555442 344332222333344568999999999998884 44 3455333222221111 222334799
Q ss_pred eeccCCCCceeecCCCcEEEeecCCcc
Q 001614 809 VHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 809 IHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
+|.|..|.||+++.+|.+-+.|||+..
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCccee
Confidence 999999999999999999999999865
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.8e-05 Score=78.94 Aligned_cols=135 Identities=13% Similarity=0.089 Sum_probs=82.7
Q ss_pred eeccCCc-eEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCceEEEeeeeecCCeeEEEEeeccc
Q 001614 694 PISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 771 (1044)
Q Consensus 694 ~LG~GgF-G~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNIVkL~gvfed~~~LyLVmEY~~G 771 (1044)
.|..|.+ ..||++... +..+.+|+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 789998653 4678888765321 235667888888774 34456677777766678999999999
Q ss_pred cchHHHH-------------------HhcC----CCCHH------HHHHHHH----------------HHHHHHHHH---
Q 001614 772 GDLYSLL-------------------RKVG----CLEED------VARIYIA----------------ELVLALEYL--- 803 (1044)
Q Consensus 772 GSL~dlL-------------------kk~g----~Lsee------~ar~Ia~----------------QIL~ALaYL--- 803 (1044)
.+|.... +... .+... .....+. .+...+..|
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765431 1100 11100 0000000 011111222
Q ss_pred ----HhcCeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 804 ----HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 804 ----Hs~GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
....++|+|+.|.|||+++++.+.|+||+.+.+
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999987789999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00013 Score=80.01 Aligned_cols=136 Identities=25% Similarity=0.214 Sum_probs=92.2
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccChh---------------------HHHHHHHHHHHHHhcC--CCce
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---------------------DIERILAERNILITVR--NPFV 749 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~---------------------~~e~flrEi~ILs~L~--HPNI 749 (1044)
..|+.|--+.||+|.. .++..+|+|+++........ ...-...|+.-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3678888889999875 45889999998642211100 0112356777777764 2333
Q ss_pred EEEeeeeecCCeeEEEEeeccccc-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceeecCCCcEE
Q 001614 750 VRFFYSFTCRDNLYLVMEYLNGGD-LYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 750 VkL~gvfed~~~LyLVmEY~~GGS-L~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs-~GIIHRDLKPeNILLdedg~VK 827 (1044)
.+-+.+. +-.|||||+.... -.-.|.. -.+..+.+..+..++++.|.-|-. .+++|+||..-|||+. ++.+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 3333333 2369999996531 1111111 123344678888899999998887 8999999999999998 89999
Q ss_pred EeecCCcc
Q 001614 828 LTDFGLSK 835 (1044)
Q Consensus 828 LsDFGLAk 835 (1044)
++|||-|.
T Consensus 207 iID~~QaV 214 (268)
T COG1718 207 IIDVSQAV 214 (268)
T ss_pred EEECcccc
Confidence 99999886
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00071 Score=72.43 Aligned_cols=128 Identities=26% Similarity=0.366 Sum_probs=92.6
Q ss_pred CCeEEEEeeccCCc-eEEEEEEECCCCcEEEEEEeecccc---------cCh---------hHHHHHHHHHHHHHhcC--
Q 001614 687 DDFEIIKPISRGAF-GRVFLARKRTTGDLFAIKVLKKLDM---------IRK---------NDIERILAERNILITVR-- 745 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgF-G~VYka~~k~tGk~VAVKiIkK~~~---------~~~---------~~~e~flrEi~ILs~L~-- 745 (1044)
.+++.++.||.|.- |.||+++.. |+.||+|+++.-.. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 999999876 88999999432100 000 12346788888877765
Q ss_pred -CCce--EEEeeeeecC------------------CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001614 746 -NPFV--VRFFYSFTCR------------------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804 (1044)
Q Consensus 746 -HPNI--VkL~gvfed~------------------~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLH 804 (1044)
+.++ |+.+|+..-. ....||.||++... .+.... +.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 4455 8888887322 12467888876643 233333 567888888999
Q ss_pred hcCeeeccCCCCceeecCCCcEEEeecCCc
Q 001614 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 805 s~GIIHRDLKPeNILLdedg~VKLsDFGLA 834 (1044)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 3489999964
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00033 Score=88.14 Aligned_cols=143 Identities=20% Similarity=0.353 Sum_probs=90.1
Q ss_pred EEeeccCCceEEEEEEECCCC--cEEEEEEeecccccChhHHHHHHHHHHHHHhcC-CCce--EEEeeeeecC---CeeE
Q 001614 692 IKPISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFV--VRFFYSFTCR---DNLY 763 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tG--k~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~-HPNI--VkL~gvfed~---~~Ly 763 (1044)
.+.|+.|.+..+|+......+ ..+++|........ .....+.+|+.+|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567899999999998775432 46778765432211 12346789999999995 6654 7777777664 4578
Q ss_pred EEEeeccccchHH--------------------HH---HhcC----CC---------CHHHHHHHHH-------------
Q 001614 764 LVMEYLNGGDLYS--------------------LL---RKVG----CL---------EEDVARIYIA------------- 794 (1044)
Q Consensus 764 LVmEY~~GGSL~d--------------------lL---kk~g----~L---------see~ar~Ia~------------- 794 (1044)
+||||++|..+.+ .+ +... .+ ...++..+..
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 11 1100 00 0112222211
Q ss_pred --HHHHHHHHHHh-----------cCeeeccCCCCceeecCC-Cc-EEEeecCCccc
Q 001614 795 --ELVLALEYLHS-----------LGIVHRDLKPDNLLIAHD-GH-IKLTDFGLSKI 836 (1044)
Q Consensus 795 --QIL~ALaYLHs-----------~GIIHRDLKPeNILLded-g~-VKLsDFGLAki 836 (1044)
.+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||.++.+
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12234556632 249999999999999853 33 57999999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=9.6e-06 Score=103.62 Aligned_cols=200 Identities=20% Similarity=0.128 Sum_probs=137.2
Q ss_pred CCCeEEEEeeccCCceEEEEEEECCCCc-EEEEEEeeccc--ccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecC--C
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGD-LFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (1044)
Q Consensus 686 i~dY~Ilk~LG~GgFG~VYka~~k~tGk-~VAVKiIkK~~--~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~--~ 760 (1044)
...+++.--+|.|.++ ++.|..... -+-+|+.+... ...+...+..+.|+.-++...|+++...+.-.... .
T Consensus 1228 ~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 4556665556655554 444431111 23445443321 12233445566677777778999988765443332 3
Q ss_pred eeEEEEeeccccchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeeccCCCCceeecCCCcEEEeec
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDF 831 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~----g~Lsee~ar~Ia~QIL~ALaYLHs~G-----IIHRDLKPeNILLdedg~VKLsDF 831 (1044)
..|..++|+.+|.+++.|-++ ..+....+.....+.+.+..-+|+.. .+|++||+-|.+|..+-++|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 468999999999999999653 33444444444445477777777652 799999999999999999999999
Q ss_pred CCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCCCCchhhhHHHHHHHHHHHhCC
Q 001614 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (1044)
Q Consensus 832 GLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILYELLTGr 911 (1044)
|+.++.. ..........++|.|++|++.+.-.++.++|+|..|+.+|.+..|.
T Consensus 1385 gLdKIkn---------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1385 GLDKIKN---------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred ccccccC---------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 9988310 1112234567889999999998888888899999999999999888
Q ss_pred CCCC
Q 001614 912 PPFT 915 (1044)
Q Consensus 912 ~PF~ 915 (1044)
.||.
T Consensus 1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred HHHH
Confidence 8874
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0003 Score=74.00 Aligned_cols=131 Identities=24% Similarity=0.343 Sum_probs=94.4
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEee
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY 768 (1044)
.+..+.||+|.+|.||+|.|. |..+|+|+=+.. .....+..|+++|..+.--++-+=+..+. ..++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhh
Confidence 345678999999999999997 789999975432 23467889999999998766654332222 12455999
Q ss_pred ccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC-CCCceeecCCCcEEEeecCCccc
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 769 ~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDL-KPeNILLdedg~VKLsDFGLAki 836 (1044)
+.|-.|.++-... + +.-+..+++.---|-..||-|..| .|..++|..++.+.|+||.-|++
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887665321 2 223445666655677889999999 47777777777999999998763
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00043 Score=73.75 Aligned_cols=72 Identities=15% Similarity=0.164 Sum_probs=45.0
Q ss_pred EeeccCCce-EEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC---ceEEEeeeeecCC---eeEEE
Q 001614 693 KPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFTCRD---NLYLV 765 (1044)
Q Consensus 693 k~LG~GgFG-~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP---NIVkL~gvfed~~---~LyLV 765 (1044)
+.|+.|+.. .||+. +..+++|+.+.. .....+.+|..+|..+... .+..++......+ ..+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 467777766 48875 235778865431 1234788899999877531 2344444433322 35889
Q ss_pred Eeeccccch
Q 001614 766 MEYLNGGDL 774 (1044)
Q Consensus 766 mEY~~GGSL 774 (1044)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00076 Score=81.08 Aligned_cols=137 Identities=24% Similarity=0.361 Sum_probs=86.6
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeecccccC-----------------------------hhH------HHHHHHH
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------------------------KND------IERILAE 737 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~-----------------------------~~~------~e~flrE 737 (1044)
+.||.-+.|.||+++.+. |+.||||+-+.. ... .+- .-+|.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 479999999999999886 999999986431 000 000 0124455
Q ss_pred HHHHHh----cCCCc------eEEEeeeeecCCeeEEEEeeccccchHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 001614 738 RNILIT----VRNPF------VVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLHS 805 (1044)
Q Consensus 738 i~ILs~----L~HPN------IVkL~gvfed~~~LyLVmEY~~GGSL~dl--Lkk~g~Lsee~ar~Ia~QIL~ALaYLHs 805 (1044)
.+...+ +.|-+ |.++|-.+. ..-.|+||||+|..+.|+ |.+.+ ++...+...+.++..- -|=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~--qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLE--QIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHH--HHHh
Confidence 544333 33444 445544333 345899999999877655 44444 4444333222222211 1224
Q ss_pred cCeeeccCCCCceeecC----CCcEEEeecCCccc
Q 001614 806 LGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKI 836 (1044)
Q Consensus 806 ~GIIHRDLKPeNILLde----dg~VKLsDFGLAki 836 (1044)
.|++|.|=.|.||++.. ++.+.+-|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 68999999999999984 55799999998763
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0032 Score=67.08 Aligned_cols=134 Identities=22% Similarity=0.250 Sum_probs=94.0
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeeccc-------------ccChhHHHHHHHHHHHHHhcC------CCceEEEe
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-------------MIRKNDIERILAERNILITVR------NPFVVRFF 753 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~-------------~~~~~~~e~flrEi~ILs~L~------HPNIVkL~ 753 (1044)
..||+|+.-.||.- ..+....||+..... ...........+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999853 335557789887643 001112455666666655554 78899999
Q ss_pred eeeecCCeeEEEEeeccc------cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCC---
Q 001614 754 YSFTCRDNLYLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 824 (1044)
Q Consensus 754 gvfed~~~LyLVmEY~~G------GSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg--- 824 (1044)
|+.++...+-+|+|.+.. -+|.+++... .+++ .. ...+-.-..||-+.+|+.+||+|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 3688888544 4665 32 33344556688899999999999999997433
Q ss_pred -cEEEee-cCCc
Q 001614 825 -HIKLTD-FGLS 834 (1044)
Q Consensus 825 -~VKLsD-FGLA 834 (1044)
.+.|+| ||-.
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 477777 5643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0018 Score=68.30 Aligned_cols=75 Identities=16% Similarity=0.250 Sum_probs=47.6
Q ss_pred EEeeccCCceEEEEEEECC-CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC-ceEEEeeeeecCCeeEEEEeec
Q 001614 692 IKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVMEYL 769 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~-tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP-NIVkL~gvfed~~~LyLVmEY~ 769 (1044)
++.|..|-...+|++.... .++.|++|+...... ..-...+|+.++..+... ..++++..+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4578888889999987543 357899997653211 111234688888888532 2344444332 1 3799999
Q ss_pred cccch
Q 001614 770 NGGDL 774 (1044)
Q Consensus 770 ~GGSL 774 (1044)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.005 Score=68.84 Aligned_cols=77 Identities=12% Similarity=0.008 Sum_probs=55.0
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC---CceEEEeeeeec---CCeeEE
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC---RDNLYL 764 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H---PNIVkL~gvfed---~~~LyL 764 (1044)
-.+.||.|..+.||+.... +..+.+|..+. . .....+..|...|+.+.- ..+.++++++.. .+..+|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3567999999999998643 33577787432 1 123578899999988853 357777877654 356899
Q ss_pred EEeeccccch
Q 001614 765 VMEYLNGGDL 774 (1044)
Q Consensus 765 VmEY~~GGSL 774 (1044)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0076 Score=70.53 Aligned_cols=80 Identities=18% Similarity=0.163 Sum_probs=54.3
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cC---hhHHHHHHHHHHHHHhcC---CCceEEEeeeeecCCeeEE
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IR---KNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~-~~---~~~~e~flrEi~ILs~L~---HPNIVkL~gvfed~~~LyL 764 (1044)
.+.||.|.+..||++.....++.++||.-..... .. +...++...|.+.|..+. ..++++++.+ +++..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864335899997431100 00 124567778888888763 2456667665 4455789
Q ss_pred EEeeccccc
Q 001614 765 VMEYLNGGD 773 (1044)
Q Consensus 765 VmEY~~GGS 773 (1044)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0014 Score=68.94 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=79.8
Q ss_pred HHHHHHHHhcCC-CceEEEeeeeecCCeeEEEEeeccccchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 001614 735 LAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL---LRKVGCLEEDVARIYIAELVLALEYLHS---LG 807 (1044)
Q Consensus 735 lrEi~ILs~L~H-PNIVkL~gvfed~~~LyLVmEY~~GGSL~dl---Lkk~g~Lsee~ar~Ia~QIL~ALaYLHs---~G 807 (1044)
.+|.-+|+.+.+ +++++++|+|- -++|.||...+++... +......++.....++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888986 69999999984 3679999987766532 2222346888999999999999999997 35
Q ss_pred eeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 808 IIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
+.-.|++|+||-++++|.+|++|.....+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.002 Score=69.41 Aligned_cols=133 Identities=20% Similarity=0.197 Sum_probs=76.0
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCce-EEEeeeeecCCeeEEEEeecccc
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNI-VkL~gvfed~~~LyLVmEY~~GG 772 (1044)
.+..|-...+|+.. .+|+.+++|....... ...-...+|..+++.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35667888899887 3477888987543211 000124678888888864323 23333322 36899999986
Q ss_pred chHH--------------HH---HhcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------cCeeeccC
Q 001614 773 DLYS--------------LL---RKVG----CLEE-DVARIYIAEL---------VLALEYLHS--------LGIVHRDL 813 (1044)
Q Consensus 773 SL~d--------------lL---kk~g----~Lse-e~ar~Ia~QI---------L~ALaYLHs--------~GIIHRDL 813 (1044)
.+.. .+ +... +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 11 1111 1111 1222222111 111222221 24899999
Q ss_pred CCCceeecCCCcEEEeecCCccc
Q 001614 814 KPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 814 KPeNILLdedg~VKLsDFGLAki 836 (1044)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0053 Score=67.62 Aligned_cols=76 Identities=12% Similarity=0.077 Sum_probs=47.7
Q ss_pred EEeeccCCceEEEEEEECC------CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCc-eEEEeeeeecCCeeEE
Q 001614 692 IKPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~------tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPN-IVkL~gvfed~~~LyL 764 (1044)
++.|..|-...+|++.... +++.|++|+..... .......+|..++..+.... ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3566677777899887543 25789999875421 12234567888888775322 2344444432 36
Q ss_pred EEeeccccchH
Q 001614 765 VMEYLNGGDLY 775 (1044)
Q Consensus 765 VmEY~~GGSL~ 775 (1044)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.012 Score=65.35 Aligned_cols=140 Identities=21% Similarity=0.235 Sum_probs=81.5
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC--ceEEEeee------eecCC
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRD 760 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP--NIVkL~gv------fed~~ 760 (1044)
...++.++.|....+|++... +..+++|+..... ....+..|..++..|... .+.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 334567788887899988642 4468889775421 123455667777666421 13333321 12235
Q ss_pred eeEEEEeeccccchH-----------HH---HHhc-CCC--------CHHH-----HH----------HHHHHHHHHHHH
Q 001614 761 NLYLVMEYLNGGDLY-----------SL---LRKV-GCL--------EEDV-----AR----------IYIAELVLALEY 802 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~-----------dl---Lkk~-g~L--------see~-----ar----------~Ia~QIL~ALaY 802 (1044)
..+++|+|++|.++. .. ++.. ..+ .... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885431 11 1110 001 0000 00 001123345555
Q ss_pred HHh-------cCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 803 LHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 803 LHs-------~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
+.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 542 579999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.015 Score=63.66 Aligned_cols=136 Identities=19% Similarity=0.167 Sum_probs=82.0
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCC--ceEEEeee------eecCCeeE
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRDNLY 763 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HP--NIVkL~gv------fed~~~Ly 763 (1044)
.+.|..|....+|+... ++..+++|+... .....+..|+.++..+.+- .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 55787888889998864 355799998753 1234566777777777432 24444332 12344578
Q ss_pred EEEeeccccchHH----HH----------Hhc-CCCC--------HHHHH------------HHHHHHHHHHHHHHh---
Q 001614 764 LVMEYLNGGDLYS----LL----------RKV-GCLE--------EDVAR------------IYIAELVLALEYLHS--- 805 (1044)
Q Consensus 764 LVmEY~~GGSL~d----lL----------kk~-g~Ls--------ee~ar------------~Ia~QIL~ALaYLHs--- 805 (1044)
+|++|++|..+.. .. +.. ..+. ..... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 11 110 0000 00000 011122334445443
Q ss_pred ----cCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 806 ----LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 806 ----~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999987778999999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.041 Score=61.16 Aligned_cols=30 Identities=33% Similarity=0.475 Sum_probs=26.1
Q ss_pred cCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 806 ~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866556899999876
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0017 Score=73.80 Aligned_cols=135 Identities=16% Similarity=0.186 Sum_probs=93.9
Q ss_pred eEEEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-----------------cChhH--HHHHHHHHHHHHhcC-CCc
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------------IRKND--IERILAERNILITVR-NPF 748 (1044)
Q Consensus 689 Y~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~-----------------~~~~~--~e~flrEi~ILs~L~-HPN 748 (1044)
+.++++||-|.-+.||.+-+. .|+++++|+-+..+. ..... .-...+|+..|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999875 588999995321110 00111 113467888888875 322
Q ss_pred -eEEEeeeeecCCeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceeecCCCcEE
Q 001614 749 -VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 749 -IVkL~gvfed~~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIHRDLKPeNILLdedg~VK 827 (1044)
|.+.++ .+.-++|||++.|-.|..+-+- ..+..+...+..-|.-|-.+|+||+|.+--||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 333332 2456899999999887655321 12233455666667778899999999999999999999999
Q ss_pred EeecCCc
Q 001614 828 LTDFGLS 834 (1044)
Q Consensus 828 LsDFGLA 834 (1044)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.064 Score=62.28 Aligned_cols=76 Identities=21% Similarity=0.192 Sum_probs=48.4
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecc-cc---cChhHHHHHHHHHHHHHhcC--CCc-eEEEeeeeecCCeeEEEE
Q 001614 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKL-DM---IRKNDIERILAERNILITVR--NPF-VVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 694 ~LG~GgFG~VYka~~k~tGk~VAVKiIkK~-~~---~~~~~~e~flrEi~ILs~L~--HPN-IVkL~gvfed~~~LyLVm 766 (1044)
.||.|....||++.....++.++||.-..- +. .-+-...+..-|...|+... -|. ++++|. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999997543368999963211 11 11234456677888887664 354 444433 3445567999
Q ss_pred eeccc
Q 001614 767 EYLNG 771 (1044)
Q Consensus 767 EY~~G 771 (1044)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.08 Score=60.50 Aligned_cols=142 Identities=18% Similarity=0.229 Sum_probs=82.4
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCC--CceEEEeeeeecCC--eeEEEE
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRD--NLYLVM 766 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~H--PNIVkL~gvfed~~--~LyLVm 766 (1044)
+.+.+..|..-.+|..... ++.+++. ... ............+|+.++..+.- .-+...+++|..+. ..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3334434444445555443 7778887 321 12222344567788888887753 23445566676665 679999
Q ss_pred eeccccch------------------HHHHHhc-----------C---CCCHHHHHHHHH--------------HHHHHH
Q 001614 767 EYLNGGDL------------------YSLLRKV-----------G---CLEEDVARIYIA--------------ELVLAL 800 (1044)
Q Consensus 767 EY~~GGSL------------------~dlLkk~-----------g---~Lsee~ar~Ia~--------------QIL~AL 800 (1044)
+|++|..+ .+.|..- + .....+...+.. ....-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988422 1222110 0 001111111111 122334
Q ss_pred HHHHhc--------CeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 801 EYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 801 aYLHs~--------GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
.||+.+ .++|+|+.+.||+++..+-+-|.||+++.+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 555543 389999999999999988899999999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.072 Score=62.00 Aligned_cols=138 Identities=28% Similarity=0.255 Sum_probs=90.5
Q ss_pred EeeccCCceEEEEEEECCCCcEEEEEEeeccccc---------------------Chh--HHHHHHHHHHHHHhcCCCce
Q 001614 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---------------------RKN--DIERILAERNILITVRNPFV 749 (1044)
Q Consensus 693 k~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~---------------------~~~--~~e~flrEi~ILs~L~HPNI 749 (1044)
..|..|--+.||.+.. .+|..+|||+++..-+. ++. -..-...|++-|.++....|
T Consensus 150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4577888899999876 46888999998642110 000 01123467777887764332
Q ss_pred EEEeeeeecCCeeEEEEeeccccch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceeecCCCcEE
Q 001614 750 VRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIK 827 (1044)
Q Consensus 750 VkL~gvfed~~~LyLVmEY~~GGSL-~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLH-s~GIIHRDLKPeNILLdedg~VK 827 (1044)
..--- ..- ..-.|||+|+.+..- .-.| +...++...+..+-.|++.-|.-|- ..++||.||.--|+|+ .+|.+.
T Consensus 229 P~PeP-IlL-k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly 304 (520)
T KOG2270|consen 229 PCPEP-ILL-KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY 304 (520)
T ss_pred CCCCc-eee-ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence 21000 000 123689999953221 1112 2345777788888888888888775 5689999999999999 678999
Q ss_pred EeecCCcc
Q 001614 828 LTDFGLSK 835 (1044)
Q Consensus 828 LsDFGLAk 835 (1044)
|+|.+-+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99999765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.078 Score=60.64 Aligned_cols=136 Identities=19% Similarity=0.250 Sum_probs=78.3
Q ss_pred EEeeccCCceEEEEEEECC----CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceE-EEeeeeecCCeeEEEE
Q 001614 692 IKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~----tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIV-kL~gvfed~~~LyLVm 766 (1044)
...|..|-.-.+|++.... +++.|++|+..... ...+++ .+|..+++.+..-++. ++++.+... .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3456557788899987532 24689999875422 222222 5788888887643333 344555332 589
Q ss_pred eeccccchHHH--------------H---HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 001614 767 EYLNGGDLYSL--------------L---RKVG------CLEEDVARIYIAEL-----------------VLALEYL--- 803 (1044)
Q Consensus 767 EY~~GGSL~dl--------------L---kk~g------~Lsee~ar~Ia~QI-----------------L~ALaYL--- 803 (1044)
+|+++.+|... + +... ......+..++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665311 1 1111 01122232332211 1112222
Q ss_pred -H----hcCeeeccCCCCceeecC-CCcEEEeecCCcc
Q 001614 804 -H----SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSK 835 (1044)
Q Consensus 804 -H----s~GIIHRDLKPeNILLde-dg~VKLsDFGLAk 835 (1044)
. ...++|+|+++.|||+++ ++.+.++||.++.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999986 4689999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.16 Score=55.82 Aligned_cols=29 Identities=24% Similarity=0.494 Sum_probs=25.6
Q ss_pred cCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 806 ~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.071 Score=59.23 Aligned_cols=30 Identities=37% Similarity=0.626 Sum_probs=25.4
Q ss_pred CeeeccCCCCceeecCCCc-EEEeecCCccc
Q 001614 807 GIVHRDLKPDNLLIAHDGH-IKLTDFGLSKI 836 (1044)
Q Consensus 807 GIIHRDLKPeNILLdedg~-VKLsDFGLAki 836 (1044)
.++|+|+.|.|||++.++. .-|+||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.068 Score=60.66 Aligned_cols=140 Identities=15% Similarity=0.181 Sum_probs=77.5
Q ss_pred CCeEEEEeeccCCceEEEEEEECCC---CcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceE-EEeeeeecCCee
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFTCRDNL 762 (1044)
Q Consensus 687 ~dY~Ilk~LG~GgFG~VYka~~k~t---Gk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIV-kL~gvfed~~~L 762 (1044)
++.++ +.|..|=...+|++..... +..|++|+..... ...+ .-.+|..+++.+..-++- ++++++.. .
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G-- 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G-- 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c--
Confidence 34444 4455577778998875432 3488999875421 1111 224688888887644333 34454432 1
Q ss_pred EEEEeeccccchHH-------HH----------HhcC-C----C-CHHHHHHHHHHH----------------------H
Q 001614 763 YLVMEYLNGGDLYS-------LL----------RKVG-C----L-EEDVARIYIAEL----------------------V 797 (1044)
Q Consensus 763 yLVmEY~~GGSL~d-------lL----------kk~g-~----L-see~ar~Ia~QI----------------------L 797 (1044)
+|.+|++|.+|.. .+ +... + . ....+..+..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899997765421 11 1111 0 1 122222222221 1
Q ss_pred HHHHH----HHhcC----eeeccCCCCceeecC-CCcEEEeecCCcc
Q 001614 798 LALEY----LHSLG----IVHRDLKPDNLLIAH-DGHIKLTDFGLSK 835 (1044)
Q Consensus 798 ~ALaY----LHs~G----IIHRDLKPeNILLde-dg~VKLsDFGLAk 835 (1044)
.-+.. +...+ ++|.|+.+.|||+++ ++.++++||..|.
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11211 21122 799999999999975 5789999999886
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.16 Score=59.76 Aligned_cols=78 Identities=22% Similarity=0.154 Sum_probs=51.4
Q ss_pred EEeeccCCceEEEEEEECCCCcEEEEEEeec---ccccChhHHHHHHHHHHHHHhcC--CCc-eEEEeeeeecCCeeEEE
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDMIRKNDIERILAERNILITVR--NPF-VVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 692 lk~LG~GgFG~VYka~~k~tGk~VAVKiIkK---~~~~~~~~~e~flrEi~ILs~L~--HPN-IVkL~gvfed~~~LyLV 765 (1044)
.+.||.|.-.-||++.....++.++||.-.. ....-+-..++..-|...|+.+. .|. ++++|. .+++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 5679999999999999854457899985321 11111234567778888888764 354 444543 345556789
Q ss_pred Eeeccc
Q 001614 766 MEYLNG 771 (1044)
Q Consensus 766 mEY~~G 771 (1044)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.27 Score=58.06 Aligned_cols=77 Identities=21% Similarity=0.168 Sum_probs=50.8
Q ss_pred EEEeeccCCceEEEEEEECCCCcEEEEEEeecccc-cCh---hHHHHHHHHHHHHHhcC---CCceEEEeeeeecCCeeE
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~-~~~---~~~e~flrEi~ILs~L~---HPNIVkL~gvfed~~~Ly 763 (1044)
..+.||.|....||++... ++.|+||.-..... ... ....+...|...|+.+. ..++.+++.++. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999998863 56789996431111 111 13445555677776654 246777887776 4457
Q ss_pred EEEeeccc
Q 001614 764 LVMEYLNG 771 (1044)
Q Consensus 764 LVmEY~~G 771 (1044)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.63 Score=52.47 Aligned_cols=75 Identities=21% Similarity=0.301 Sum_probs=48.1
Q ss_pred EEEEeeccCCceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC---CCceEEEeeeeecCCeeEEEE
Q 001614 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 690 ~Ilk~LG~GgFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~---HPNIVkL~gvfed~~~LyLVm 766 (1044)
+-.+.|+.|....+|+.. .+++.|.||+-.. .....|..|..-|+.|. --.+.+++.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345679999999999987 5688999997652 22356788888888883 345777888887777779999
Q ss_pred eecccc
Q 001614 767 EYLNGG 772 (1044)
Q Consensus 767 EY~~GG 772 (1044)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.39 Score=56.18 Aligned_cols=79 Identities=18% Similarity=0.167 Sum_probs=45.2
Q ss_pred CeEEEEeeccCCceEEEEEEECCC-CcE-----EEEEEeecccccChhHHHHHHHHHHHHHhcCCCce-EEEeeeeecCC
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTT-GDL-----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRD 760 (1044)
Q Consensus 688 dY~Ilk~LG~GgFG~VYka~~k~t-Gk~-----VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNI-VkL~gvfed~~ 760 (1044)
++++ +.|..|-...+|++..... +.. |.+++... .....-.-.+|+.+++.+...++ .++++.+..
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 3444 4566688889999875432 223 33333211 11111123568888888875444 345555542
Q ss_pred eeEEEEeeccccchH
Q 001614 761 NLYLVMEYLNGGDLY 775 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~ 775 (1044)
++|.||++|-+|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 6999999987653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.58 E-value=0.17 Score=61.03 Aligned_cols=164 Identities=21% Similarity=0.281 Sum_probs=102.9
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeeecC-CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCeee
Q 001614 732 ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810 (1044)
Q Consensus 732 e~flrEi~ILs~L~HPNIVkL~gvfed~-~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~GIIH 810 (1044)
..++--+.+++.+.|+|....+.+-... ....+|||++ +-+|++++..+. +-... +. .+++.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------ccccce
Confidence 4567778899999999999988766543 3578999999 559999987654 21111 11 222222
Q ss_pred ccCCCCceeecCCCcEEEeecCCcccccccCcccCCCCCCCCCCCCCCCCCcccccCcCCccCccCCCCCCCcccccCCC
Q 001614 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (1044)
Q Consensus 811 RDLKPeNILLdedg~VKLsDFGLAki~~~~~t~dls~p~t~~~~~s~s~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 890 (1044)
- || ++.+| -++. +..+..|
T Consensus 91 ~-----~~-------~~~td-~~~t----------------------------------~~~~~~~-------------- 109 (725)
T KOG1093|consen 91 L-----NI-------IYITD-HFLT----------------------------------KYPSPIG-------------- 109 (725)
T ss_pred e-----hh-------hhccc-cccc----------------------------------cCCCCCC--------------
Confidence 1 11 22333 1000 0001111
Q ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHhhhccCCCCC---------CCCCCCCHHHHHHHHhHccCCcCCCCC
Q 001614 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---------CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1044)
Q Consensus 891 ys~KSDIWSLGVILYELLTGr~PF~g~s~~ei~qkIl~g~i~~p---------~ip~~iS~eLkdLIkkcLqkDPskRPS 961 (1044)
+|+||||+|.++.++.-|..-|......+....+.+-...-. .+...++.-...+..+|+-..|..||.
T Consensus 110 --pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 110 --PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred --cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence 399999999999999999887776665555554443221100 011234556678899999999999998
Q ss_pred hhhHHHHHcCCCCCCC
Q 001614 962 ANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 962 adeA~EIL~HPwFk~i 977 (1044)
-.++.+++-|..+
T Consensus 188 ---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 ---PMELSKRCSFTEV 200 (725)
T ss_pred ---hhHHhcCccHHHH
Confidence 5567788888654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.36 E-value=1.2 Score=49.85 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=27.6
Q ss_pred CeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 807 GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.15 Score=53.56 Aligned_cols=30 Identities=43% Similarity=0.752 Sum_probs=21.6
Q ss_pred CeeeccCCCCceee-cCCCcEEEeecCCccc
Q 001614 807 GIVHRDLKPDNLLI-AHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 807 GIIHRDLKPeNILL-dedg~VKLsDFGLAki 836 (1044)
-++|.||.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.87 E-value=0.68 Score=54.21 Aligned_cols=71 Identities=27% Similarity=0.408 Sum_probs=53.8
Q ss_pred CeeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceeecCCCcEEEeecCCccc
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 760 ~~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaYLHs~-GIIHRDLKPeNILLdedg~VKLsDFGLAki 836 (1044)
...|++|++. |++|.- ......+++..|+.+.+..+.-+... .+=|||+...||||+ +|+|.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4567888875 545431 12345677778888877777666654 588999999999999 99999999999984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.60 E-value=3.1 Score=48.03 Aligned_cols=130 Identities=25% Similarity=0.288 Sum_probs=74.2
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcC---CCc---eEEE----eeeeecCCeeEEEEee
Q 001614 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPF---VVRF----FYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 699 gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~---HPN---IVkL----~gvfed~~~LyLVmEY 768 (1044)
.-..+|+.... +..+++|+.+.. . ....+..|...|..|. .|- |..+ +.........+-+++|
T Consensus 37 ~eN~~f~~~~~--~g~~iLki~~~~--~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 37 EENSNFRVQTE--DGRYILKIYRPG--W---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccCceEEEEec--CCCeEEEEecCC--C---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 34568887764 444599988753 2 2344555666666553 222 2221 1222222367889999
Q ss_pred ccccchHH-----HH----------Hh----cC--------CCCHH----HHH---------HHHHHHHHHHHHHHhc--
Q 001614 769 LNGGDLYS-----LL----------RK----VG--------CLEED----VAR---------IYIAELVLALEYLHSL-- 806 (1044)
Q Consensus 769 ~~GGSL~d-----lL----------kk----~g--------~Lsee----~ar---------~Ia~QIL~ALaYLHs~-- 806 (1044)
++|..+.. .+ +. .. ...+. ... ....++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99977662 11 10 00 01111 000 1233444555555542
Q ss_pred ------C--eeeccCCCCceeecCCCc-EEEeecCCcc
Q 001614 807 ------G--IVHRDLKPDNLLIAHDGH-IKLTDFGLSK 835 (1044)
Q Consensus 807 ------G--IIHRDLKPeNILLdedg~-VKLsDFGLAk 835 (1044)
+ +||.|+.|.||+++.+.. +.++|||.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999998875 8999999876
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.75 E-value=1.3 Score=49.17 Aligned_cols=114 Identities=15% Similarity=0.174 Sum_probs=70.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceEEEeeeeecCCeeEEEEeeccccchHHHH
Q 001614 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778 (1044)
Q Consensus 699 gFG~VYka~~k~tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIVkL~gvfed~~~LyLVmEY~~GGSL~dlL 778 (1044)
+-++.-.+..+- .+..+|.++.....- ...-+.++.+++.++. .|+++..- ....+-+|.|+|-.-..
T Consensus 74 gNsTl~~~kt~i--G~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKI--GPLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---- 141 (308)
T ss_pred CceEEEEecccc--chhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----
Confidence 344444444332 344566665433221 1244678888988875 47777622 33457899999843110
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHh--cCeeeccCCCCceeecCCCcEEEeecCC
Q 001614 779 RKVGCLEEDVARIYIAELVLALEYLHS--LGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 779 kk~g~Lsee~ar~Ia~QIL~ALaYLHs--~GIIHRDLKPeNILLdedg~VKLsDFGL 833 (1044)
. ...++.-=+.+|.-.|+ .+.+|+|-.|+|||-|..|.+||.|=+.
T Consensus 142 -----~----~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -----N----FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----c----hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 0 11112222466777884 4699999999999999999999999774
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.36 E-value=5.3 Score=45.45 Aligned_cols=28 Identities=29% Similarity=0.401 Sum_probs=24.0
Q ss_pred cCeeeccCCCCceeecCCCcEEEeecCCcc
Q 001614 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 806 ~GIIHRDLKPeNILLdedg~VKLsDFGLAk 835 (1044)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999876
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.36 E-value=5.5 Score=52.33 Aligned_cols=30 Identities=33% Similarity=0.560 Sum_probs=25.7
Q ss_pred cCeeeccCCCCceeecCCC--cEE-EeecCCcc
Q 001614 806 LGIVHRDLKPDNLLIAHDG--HIK-LTDFGLSK 835 (1044)
Q Consensus 806 ~GIIHRDLKPeNILLdedg--~VK-LsDFGLAk 835 (1044)
.++||.|+++.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 555 99999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.36 E-value=5.2 Score=47.88 Aligned_cols=76 Identities=14% Similarity=0.170 Sum_probs=44.2
Q ss_pred EEEeeccCCceEEEEEEECC--------CCcEEEEEEeecccccChhHHHHHHHHHHHHHhcCCCceE-EEeeeeecCCe
Q 001614 691 IIKPISRGAFGRVFLARKRT--------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFTCRDN 761 (1044)
Q Consensus 691 Ilk~LG~GgFG~VYka~~k~--------tGk~VAVKiIkK~~~~~~~~~e~flrEi~ILs~L~HPNIV-kL~gvfed~~~ 761 (1044)
-++.|..|=.-.+|++.... .++.|.+++..... ...+ .-.+|..+++.+..-.|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 45567667777888887542 15678888875421 1111 234577777766543333 3444442
Q ss_pred eEEEEeeccccch
Q 001614 762 LYLVMEYLNGGDL 774 (1044)
Q Consensus 762 LyLVmEY~~GGSL 774 (1044)
-+.|.+|++|-+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2468999988644
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=83.20 E-value=2.9 Score=49.89 Aligned_cols=61 Identities=30% Similarity=0.300 Sum_probs=42.6
Q ss_pred eeEEEEeeccccchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCeeeccCCCCceeecC
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAH 822 (1044)
Q Consensus 761 ~LyLVmEY~~GGSL~dlLkk~g~Lsee~ar~Ia~QIL~ALaY-LHs~GIIHRDLKPeNILLde 822 (1044)
...++-+|+.|-++..++...+ .+++..+.++.-.+.|+-- |--.+++|.|+.|.||++--
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3567778888988888886433 4455555665555555443 33467999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1044 | ||||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-62 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-62 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-58 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-58 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-57 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-57 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-56 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-56 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-56 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-56 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-56 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-56 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-56 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-56 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-56 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-56 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-56 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-56 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-56 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-56 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-56 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-56 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-56 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-56 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-56 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-56 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-56 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-55 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-55 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-55 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-55 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-55 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-55 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-55 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-55 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-55 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-55 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-55 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-55 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-55 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-55 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-55 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-55 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-55 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-55 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-55 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-55 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-55 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-55 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-55 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-55 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-55 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-55 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-55 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-55 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-55 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-55 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-55 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-55 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-55 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-55 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-55 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-55 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-55 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-55 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-55 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-55 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-55 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-55 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-55 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-55 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-55 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-54 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-54 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-54 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-54 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-54 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-54 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-54 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-54 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-54 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-54 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-53 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-52 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-52 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-52 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-51 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-51 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-51 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-51 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-51 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-51 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-51 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-50 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-50 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-50 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-50 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-50 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-50 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-50 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-50 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-50 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-50 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-50 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-50 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-50 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-50 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-50 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-50 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-50 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-50 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-42 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-42 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-41 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-41 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-41 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-41 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-40 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-40 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-40 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-40 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-39 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-39 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-39 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-39 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-39 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-39 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-39 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-38 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-38 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-38 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-36 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-36 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-35 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-35 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-34 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-34 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-34 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-34 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-34 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-34 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-32 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-31 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-31 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-31 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-31 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-31 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-31 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-31 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-31 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-31 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-30 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-30 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-30 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-30 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-29 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-29 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-29 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-28 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-28 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-27 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-27 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-26 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-26 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-26 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-26 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-26 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-25 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-25 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-25 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-25 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-24 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-24 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-24 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-24 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-24 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-24 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-24 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-23 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-22 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-18 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-14 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 9e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 5e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 |
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-134
Identities = 122/376 (32%), Positives = 190/376 (50%), Gaps = 48/376 (12%)
Query: 617 LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPL 676
++ LV+D +E LL L + E + ++ K + + +
Sbjct: 2 MQQLVLDPGFLGLEPLLD----LLLGVHQELGASELAQDKYVADFL-------QWAEPIV 50
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
+ R DDFEI+K I RGAF V + + + TG ++A+K++ K DM+++ ++
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAE 795
ER++L+ ++ + ++F + LYLVMEY GGDL +LL K G + ++AR Y+AE
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+V+A++ +H LG VHRD+KPDN+L+ GHI+L DFG + T+
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV------------ 218
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------HGYAADWWSVGIILFEFI 908
AVGTPDYL+PEIL +G DWW++G+ +E
Sbjct: 219 --------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 909 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G PF A+S + I++ K + P V + EA+D I R L P RLG GA
Sbjct: 265 YGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAG 323
Query: 967 EVKAHPFFKGVNWDSL 982
+ + HPFF G++WD L
Sbjct: 324 DFRTHPFFFGLDWDGL 339
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 407 bits (1048), Expect = e-134
Identities = 101/326 (30%), Positives = 172/326 (52%), Gaps = 31/326 (9%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+ + + + +DF+ K + G+F V LAR+ T +AIK+L+K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+I++N + + ER+++ + +PF V+ +++F + LY + Y G+L +RK+G
Sbjct: 67 HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
+E R Y AE+V ALEYLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS----- 181
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
++ +S VGT Y++PE+L ++D W++G I
Sbjct: 182 --------------------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
+++ + G+PPF A + +IF I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCE 278
Query: 964 ---GAAEVKAHPFFKGVNWDSLALQK 986
G +KAHPFF+ V W++L Q
Sbjct: 279 EMEGYGPLKAHPFFESVTWENLHQQT 304
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 407 bits (1047), Expect = e-132
Identities = 124/378 (32%), Positives = 194/378 (51%), Gaps = 44/378 (11%)
Query: 615 SKLKALVIDTFGSRIEKLLREKYIL--ACELLDEKSPTSFSKYKENSRLILDSVSQSSGV 672
+L+ ++D + + +L L DE + + + K +
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYL-------EWA 59
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
+ R +DFEI+K I RGAFG V + + + +FA+K+L K +M+++ +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARI 791
ER++L+ + ++ Y+F +NLYLVM+Y GGDL +LL K L E++AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T+
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------- 232
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFE 906
AVGTPDY++PEIL E +G DWWS+G+ ++E
Sbjct: 233 -------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 907 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ G PF AES + I+N K +P +D+S A+DLI R LI RLG NG
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNG 332
Query: 965 AAEVKAHPFFKGVNWDSL 982
+ K HPFF G++WD++
Sbjct: 333 IEDFKKHPFFSGIDWDNI 350
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 399 bits (1029), Expect = e-131
Identities = 111/308 (36%), Positives = 178/308 (57%), Gaps = 35/308 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS I++RDLKP+N+L+ +GHIK+TDFG +K + + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVT-------------------- 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
++ GTPDY+APE++ + + DWWS GI+++E + G PF +
Sbjct: 161 ---------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980
++ ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+
Sbjct: 212 YEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268
Query: 981 SLALQKMT 988
L + +
Sbjct: 269 KLLSRNIE 276
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-127
Identities = 119/322 (36%), Positives = 175/322 (54%), Gaps = 35/322 (10%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
++ R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFY 173
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
AE+VLAL+ +HS+G +HRD+KPDN+L+ GH+KL DFG
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------------- 216
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFI 908
+ + +AVGTPDY++PE+L +G DWWSVG+ L+E +
Sbjct: 217 ---------KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 909 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G PF A+S + I+N K + +P D+S EA++LI FL D RLG NG
Sbjct: 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFL-TDREVRLGRNGVE 325
Query: 967 EVKAHPFFKGVNWDSLALQKMT 988
E+K H FFK W L+
Sbjct: 326 EIKRHLFFKNDQWAWETLRDTV 347
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-126
Identities = 110/310 (35%), Positives = 176/310 (56%), Gaps = 35/310 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K + T
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRT------------------ 195
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 978
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 979 WDSLALQKMT 988
W ++ +K+
Sbjct: 302 WIAIYQRKVE 311
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-126
Identities = 125/324 (38%), Positives = 187/324 (57%), Gaps = 36/324 (11%)
Query: 671 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR 727
G S + E+ + FE+++ + +G +G+VF RK T TG +FA+KVLKK ++R
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 728 K-NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 786
D AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L + G E
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 787 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
D A Y+AE+ +AL +LH GI++RDLKP+N+++ H GH+KLTDFGL K +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-------- 172
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
D H+ GT +Y+APEIL+ + H A DWWS+G ++++
Sbjct: 173 -------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NG 964
+TG PPFT E+ + D IL K+ P ++ EA+DL+ + L + RLGA
Sbjct: 214 MLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGD 270
Query: 965 AAEVKAHPFFKGVNWDSLALQKMT 988
A EV+AHPFF+ +NW+ L +K+
Sbjct: 271 AGEVQAHPFFRHINWEELLARKVE 294
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-125
Identities = 117/327 (35%), Positives = 180/327 (55%), Gaps = 32/327 (9%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+ + L S DF +K I +G+FG+V LAR + +A+KVL+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74
Query: 724 DMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+++K + + I++ERN+L+ V++PF+V +SF D LY V++Y+NGG+L+ L++
Sbjct: 75 AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 134
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
C E AR Y AE+ AL YLHSL IV+RDLKP+N+L+ GHI LTDFGL K +
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---- 190
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
N + GTP+YLAPE+L + DWW +G
Sbjct: 191 -----------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+L+E + G+PPF + + ++DNILN+ + +++ A+ L+ L D +RLGA
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGA 284
Query: 963 -NGAAEVKAHPFFKGVNWDSLALQKMT 988
+ E+K+H FF +NWD L +K+T
Sbjct: 285 KDDFMEIKSHVFFSLINWDDLINKKIT 311
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 382 bits (984), Expect = e-125
Identities = 115/316 (36%), Positives = 177/316 (56%), Gaps = 36/316 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERI 734
E+ FE++K + +G+FG+VFL +K + L+A+KVLKK ++ D R
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRT 73
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L K E+ + Y+A
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
EL LAL++LHSLGI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---------------- 177
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +S GT +Y+APE++ H +ADWWS G+++FE +TG PF
Sbjct: 178 -----------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHP 972
+ + IL K+ P +S EAQ L+ +P RLGA +G E+K H
Sbjct: 227 QGKDRKETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
Query: 973 FFKGVNWDSLALQKMT 988
FF ++W+ L +++
Sbjct: 284 FFSTIDWNKLYRREIH 299
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-123
Identities = 113/308 (36%), Positives = 175/308 (56%), Gaps = 32/308 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS +V+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------------------------ 156
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 157 ---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 981 SLALQKMT 988
+ +K+
Sbjct: 271 DVVQKKLL 278
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-122
Identities = 124/357 (34%), Positives = 197/357 (55%), Gaps = 42/357 (11%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 704
S + + ++ + T + H E+ I++FE++K + GA+G+VF
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 705 LARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILITVRN-PFVVRFFYSFTCR 759
L RK + TG L+A+KVLKK +++K E ER +L +R PF+V Y+F
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
L+L+++Y+NGG+L++ L + E +IY+ E+VLALE+LH LGI++RD+K +N+L
Sbjct: 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ +GH+ LTDFGLSK + + + + GT +
Sbjct: 192 LDSNGHVVLTDFGLSKEFVAD--------------------------ETERAYDFCGTIE 225
Query: 880 YLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIPW 933
Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT + S I IL + P+
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKMT 988
P +MS A+DLI R L+ DP +RLG A E+K H FF+ +NWD LA +K+
Sbjct: 286 ---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-122
Identities = 102/323 (31%), Positives = 176/323 (54%), Gaps = 33/323 (10%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 728
++ VS ++ +++R + DF + + +G+FG+V L+ ++ T +L+A+K+LKK +I+
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 729 NDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
+D+E + E+ +L PF+ + F D LY VMEY+NGGDL +++VG +E
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
A Y AE+ + L +L S GI++RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--------- 172
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
D + GTPDY+APEI+ +G + DWW+ G++L+E
Sbjct: 173 ------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 965
+ G PF E + +F +I+ + + P MS EA + + P +RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271
Query: 966 AEVKAHPFFKGVNWDSLALQKMT 988
++K H FF+ ++W+ L +++
Sbjct: 272 RDIKEHAFFRYIDWEKLERKEIQ 294
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-122
Identities = 118/326 (36%), Positives = 186/326 (57%), Gaps = 34/326 (10%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
+SS + + R ID+FE I+ + +G+FG+V LAR + TGDL+A+KVLKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
+ +D+E + E+ IL RN PF+ + F F D L+ VME++NGGDL ++K +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
E AR Y AE++ AL +LH GI++RDLK DN+L+ H+GH KL DFG+ K G+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------- 175
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
+ + GTPDY+APEIL +G A DWW++G++L+
Sbjct: 176 --------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--- 962
E + G PF AE+ + +F+ ILN ++ + P+ + +A ++ F+ +P RLG+
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQ 272
Query: 963 NGAAEVKAHPFFKGVNWDSLALQKMT 988
G + HPFFK ++W L +++
Sbjct: 273 GGEHAILRHPFFKEIDWAQLNHRQIE 298
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-121
Identities = 109/312 (34%), Positives = 176/312 (56%), Gaps = 33/312 (10%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S + + I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 738 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
+ +L +PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE+
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+L L++LHS GIV+RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------------------ 169
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF
Sbjct: 170 ---------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ E +F +I + P + EA+DL+ + + +P +RLG G +++ HP F+
Sbjct: 221 QDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFRE 275
Query: 977 VNWDSLALQKMT 988
+NW+ L +++
Sbjct: 276 INWEELERKEID 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-119
Identities = 88/322 (27%), Positives = 165/322 (51%), Gaps = 39/322 (12%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
S P E + D FEI++ I +G+FG+V + +K T ++A+K + K + +N++
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
+ E I+ + +PF+V +YSF +++++V++ L GGDL L++ +E+ +++
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
I ELV+AL+YL + I+HRD+KPDN+L+ GH+ +TDF ++ +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--------------- 165
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT 909
+ GT Y+APE+ G + +A DWWS+G+ +E +
Sbjct: 166 -------------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 910 GIPPF---TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G P+ ++ S + I + + PS S E L+ + L +P+QR +
Sbjct: 213 GRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QLS 267
Query: 967 EVKAHPFFKGVNWDSLALQKMT 988
+V+ P+ +NWD++ +++
Sbjct: 268 DVQNFPYMNDINWDAVFQKRLI 289
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-119
Identities = 107/322 (33%), Positives = 175/322 (54%), Gaps = 43/322 (13%)
Query: 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
+ + DF++++ I RG++ +V L R + T ++A+KV+KK + DI+ + E++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 740 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ N PF+V F L+ V+EY+NGGDL +++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
AL YLH GI++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT--- 915
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF
Sbjct: 162 -------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 916 ------AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAA 966
+ + +F IL ++I P +S +A ++ FL DP +RLG G A
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 967 EVKAHPFFKGVNWDSLALQKMT 988
+++ HPFF+ V+WD + +++
Sbjct: 272 DIQGHPFFRNVDWDMMEQKQVV 293
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-118
Identities = 120/358 (33%), Positives = 190/358 (53%), Gaps = 34/358 (9%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIK 693
RE++ A + + + + + S + + L + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL-AKPKHRVTMNEFEYLK 154
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 753
+ +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRD 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATMK 307
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKMT 988
+ P + EA+ L++ L DP QRLG A E+ H FF G+ W + +K++
Sbjct: 368 F---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLS 422
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-116
Identities = 111/360 (30%), Positives = 187/360 (51%), Gaps = 44/360 (12%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
D PT+ + Y + + + + ++T + DF++++ I RG++
Sbjct: 8 HHHDYDIPTTENLYFQGA-MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 760
+V L R + T ++A++V+KK + DI+ + E+++ N PF+V F
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDLK DN+L+
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+GHIKLTD+G+ K GL + GTP+Y
Sbjct: 187 DSEGHIKLTDYGMCKEGL---------------------------RPGDTTSTFCGTPNY 219
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---------AESPEIIFDNILNRKI 931
+APEIL G ++G++ DWW++G+++FE + G PF + + +F IL ++I
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKMT 988
P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD + +++
Sbjct: 280 RIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 365 bits (938), Expect = e-113
Identities = 104/350 (29%), Positives = 182/350 (52%), Gaps = 33/350 (9%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
+E+ F + K ++ +S ++ +++R + DF + + +G+FG
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFG 355
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 760
+V L+ ++ T +L+A+K+LKK +I+ +D+E + E+ +L PF+ + F D
Sbjct: 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
LY VMEY+NGGDL +++VG +E A Y AE+ + L +L S GI++RDLK DN+++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+GHIK+ DFG+ K + D + GTPDY
Sbjct: 476 DSEGHIKIADFGMCKENI---------------------------WDGVTTKTFCGTPDY 508
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDM 940
+APEI+ +G + DWW+ G++L+E + G PF E + +F +I+ + + P M
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSM 565
Query: 941 SFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKMT 988
S EA + + P +RLG G ++K H FF+ ++W+ L +++
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQ 615
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-112
Identities = 88/318 (27%), Positives = 151/318 (47%), Gaps = 40/318 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ D F + + RG FG VF + + TG L+A K L K + ++ + + E+ I
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAEL 796
L V + F+V Y+F + +L LVM +NGGD+ Y++ +E A Y A++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
V LE+LH I++RDLKP+N+L+ DG+++++D GL+
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK------------------ 340
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
GTP ++APE+LLG E+ ++ D++++G+ L+E I PF A
Sbjct: 341 ---------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 917 E----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKA 970
+ + +L + + + P S ++D L DP +RLG ++
Sbjct: 392 RGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 971 HPFFKGVNWDSLALQKMT 988
HP F+ ++W L +T
Sbjct: 449 HPLFRDISWRQLEAGMLT 466
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-109
Identities = 106/356 (29%), Positives = 164/356 (46%), Gaps = 49/356 (13%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
E+ F K+ E+ + + + +++DF + + I RG FG
Sbjct: 152 EICQNLRGDVFQKFIESDK--------FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFG 203
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC 758
V+ RK TG ++A+K L K + K L ER +L V PF+V Y+F
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818
D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+RDLKP N+
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP 878
L+ GH++++D GL+ H++VGT
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKKP-----------------------------HASVGTH 354
Query: 879 DYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNILNRKIPWP 934
Y+APE+L G + +ADW+S+G +LF+ + G PF I L +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL- 413
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKMT 988
P S E + L+ L D N+RLG GA EVK PFF+ ++W + LQK
Sbjct: 414 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 467
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-108
Identities = 105/374 (28%), Positives = 166/374 (44%), Gaps = 50/374 (13%)
Query: 633 LREKYILACELLDEKSPTSFSKYKENSRLILDSVSQ--------SSGVSTPLHSSHKERT 684
+ + + C E+ P ++E +RL + +S S + L ER
Sbjct: 121 VPRQLVTNCTQRLEQGPCK-DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ 179
Query: 685 --SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ + F + + +G FG V + R TG ++A K L+K + ++ L E+ IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLAL 800
V + FVV Y++ +D L LV+ +NGGDL + +G E A Y AE+ L
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
E LH IV+RDLKP+N+L+ GHI+++D GL+ TI
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----------------- 342
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917
VGT Y+APE++ + ++ DWW++G +L+E I G PF
Sbjct: 343 -----------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 974
E + + + S +A+ L ++ L DP +RLG A EVK HP F
Sbjct: 392 IKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 975 KGVNWDSLALQKMT 988
K +N+ L +
Sbjct: 449 KKLNFKRLGAGMLE 462
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-104
Identities = 95/308 (30%), Positives = 152/308 (49%), Gaps = 35/308 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
S K + +++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
I +R+P ++R + F +YL++EY G +Y L+K+ +E YI EL
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
AL Y HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------- 157
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
+ R GT DYL PE++ G H D WS+G++ +EF+ G PPF A +
Sbjct: 158 ------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ + I + + P ++ A+DLI+R L H+P+QR EV HP+ +
Sbjct: 212 YQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITANS 265
Query: 979 WDSLALQK 986
Q
Sbjct: 266 SKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-104
Identities = 94/302 (31%), Positives = 153/302 (50%), Gaps = 35/302 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
T L K + +IDDF+I +P+ +G FG V+LAR++ + A+KVL K + ++ +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
+ E I +R+P ++R + F R +YL++E+ G+LY L+K G +E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
EL AL Y H ++HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+ R + GT DYL PE++ G H D W G++ +EF+ G+PP
Sbjct: 163 -----------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
F + S I+N + + P +S ++DLI++ L + P QRL V HP+
Sbjct: 212 FDSPSHTETHRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPW 265
Query: 974 FK 975
K
Sbjct: 266 VK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-90
Identities = 72/361 (19%), Positives = 141/361 (39%), Gaps = 76/361 (21%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
D +S S + ++ I+D+ II+ +++G F ++ L K +A+K +K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65
Query: 724 DMIRK--------------NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769
+ +K + + E I+ ++N + + T D +Y++ EY+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 770 NGGDLYSLLRKVGCLE--------EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLI 820
+ L+ V + I ++ + Y+H+ I HRD+KP N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+G +KL+DFG S+ ++ + GT ++
Sbjct: 186 DKNGRVKLSDFGESEY-----------------------------MVDKKIKGSRGTYEF 216
Query: 881 LAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWPCVP 937
+ PE +G D WS+GI L+ + PF+ + S +F+NI + I +P
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276
Query: 938 SD----------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981
+ +S E D + FL +P +R+ + + H + N +
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIED 333
Query: 982 L 982
L
Sbjct: 334 L 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 8e-90
Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 38/312 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DFE I + +GAFG+V AR +AIK ++ + + IL+E +L ++ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 747 PFVVRFFYSFTCRDN-------------LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+++ AL Y+HS GI+HRDLKP N+ I ++K+ DFGL+K
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV-------------HR 168
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911
+ + + N SA+GT Y+A E+L GT H D +S+GII FE I
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226
Query: 912 PPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
P T I + + I +P + + +I + HDPN+R GA +
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLN 283
Query: 971 HPFFKGVNWDSL 982
+ + D +
Sbjct: 284 SGWLPVKHQDEV 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-85
Identities = 86/336 (25%), Positives = 131/336 (38%), Gaps = 43/336 (12%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHS-SHKERTSIDDFEIIKPISRGAFGR 702
L ++ S ++ R + S + +P + S E F+ + + G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 703 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761
VF R + G L+A+K K D R LAE V ++P VR ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 762 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
LYL E G L G L E Y+ + +LAL +LHS G+VH D+KP N+ +
Sbjct: 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
G KL DFGL L G P Y
Sbjct: 191 GPRGRCKLGDFGLLVE--------LGTAGA--------------------GEVQEGDPRY 222
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESPEIIFDNILNRKIPWPCVPSD 939
+APE+L G +G AAD +S+G+ + E + P E + + L P +
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAG 276
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+S E + ++ L DP R A + A P +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAE---ALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 1e-84
Identities = 81/298 (27%), Positives = 148/298 (49%), Gaps = 34/298 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
+ I+DF++ + +G+F V+ A TG AIK++ K M + ++R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
I +++P ++ + F + +YLV+E + G++ L+ +V E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ YLHS GI+HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+ + ++ GTP+Y++PEI + HG +D WS+G + + + G PPF +
Sbjct: 160 TQL----KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ + + ++ +PS +S EA+DLI++ L +P RL + V HPF
Sbjct: 216 TVKNTLNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-82
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 33/295 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ S + + + +G F + F T ++FA K++ K +++ + E++ E +I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
++ + VV F F D +++V+E L L ++ L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV----------------- 165
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ D + GTP+Y+APE+L H + D WS+G I++ + G PPF +
Sbjct: 166 ----EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I + P ++ A LI + L DP R E+ FF
Sbjct: 222 ETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-82
Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 33/311 (10%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
++ + + + S + + + +G F + F T ++FA K++ K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 725 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784
+++ + E++ E +I ++ + VV F F D +++V+E L L ++ L
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844
E AR Y+ ++VL +YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV- 191
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
+ D + GTP+Y+APE+L H + D WS+G I+
Sbjct: 192 --------------------EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
Query: 905 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ + G PPF + + I + P ++ A LI + L DP R
Sbjct: 232 YTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---T 285
Query: 965 AAEVKAHPFFK 975
E+ FF
Sbjct: 286 INELLNDEFFT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 4e-78
Identities = 79/310 (25%), Positives = 149/310 (48%), Gaps = 37/310 (11%)
Query: 668 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727
SSGV + + + S++ + ++ I G+FG+ L + G + IK + M
Sbjct: 7 HSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLE 785
K + E E +L +++P +V++ SF +LY+VM+Y GGDL+ + +K +
Sbjct: 65 K-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
ED + ++ LAL+++H I+HRD+K N+ + DG ++L DFG++++ +N+T++L
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL 181
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
+ + +GTP YL+PEI + +D W++G +L+
Sbjct: 182 A-------------------------RACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
E T F A S + + I++ P V S++ + L+++ +P R N
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN-- 272
Query: 966 AEVKAHPFFK 975
+ F
Sbjct: 273 -SILEKGFIA 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 6e-76
Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 49/325 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
SSGV + + + S+ + I+K I G +VF ++AIK + +
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-E 63
Query: 725 MIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
++ E L ++ + ++R + +Y+VME DL S L+K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
++ + Y ++ A+ +H GIVH DLKP N LI DG +KL DFG++
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIAN------- 174
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----------EH 891
M D T + + S VGT +Y+ PE + +
Sbjct: 175 ----------QMQPD--------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINR 950
+D WS+G IL+ G PF +I I++ P + QD++
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKC 275
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFK 975
L DP QR+ E+ AHP+ +
Sbjct: 276 CLKRDPKQRISIP---ELLAHPYVQ 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-75
Identities = 88/349 (25%), Positives = 155/349 (44%), Gaps = 45/349 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++ + + +G+FG V L + + TG A+KV+ K + +K D E +L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + F + YLV E GG+L+ + E A I +++ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--------------------------- 178
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
++ +GT Y+APE+L G + D WS G+IL+ ++G PPF + I
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ K W V S A+DLI + L + P+ R+ A + H + +
Sbjct: 237 KKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYT 289
Query: 979 WDSLALQKMTQATSYHALVKFQVDCRMIRMVATLM-LTLVTHLQILELR 1026
+ +++ + + + +FQ ++ + M L + + EL
Sbjct: 290 KEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT 338
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-73
Identities = 83/303 (27%), Positives = 142/303 (46%), Gaps = 44/303 (14%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
+ +D+E++ I G++GR R+++ G + K L M + + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELV 797
+++P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 798 LALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
LAL+ H ++HRDLKP N+ + ++KL DFGL++I +N+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
+ VGTP Y++PE + + +D WS+G +L+E +P
Sbjct: 174 -------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
PFTA S + + I K +P S E ++I R L R E+ +P
Sbjct: 215 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENP 269
Query: 973 FFK 975
Sbjct: 270 LIL 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 7e-73
Identities = 95/298 (31%), Positives = 146/298 (48%), Gaps = 47/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ + GAF VFL ++R TG LFA+K +KK R + +E E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V + + YLVM+ ++GG+L+ + + G E A + I +++ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL + I +TDFGLSK+ E +GIM
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------EQNGIM--------- 164
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 165 --------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I W + S A+D I L DPN+R + +HP+ G
Sbjct: 217 EKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY---TCEKALSHPWIDG 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 1e-72
Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-- 745
+ I+K I G +VF ++AIK + + ++ E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ ++R + +Y+VME DL S L+K ++ + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GIVH DLKP N LI DG +KL DFG++ M D
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIAN-----------------QMQPD-------- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLGT-----------EHGYAADWWSVGIILFEFITGIPPF 914
T + + S VGT +Y+ PE + + +D WS+G IL+ G PF
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 915 TAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+I I++ P + QD++ L DP QR+ E+ AHP+
Sbjct: 221 QQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHPY 276
Query: 974 FK 975
+
Sbjct: 277 VQ 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 1e-72
Identities = 82/344 (23%), Positives = 134/344 (38%), Gaps = 49/344 (14%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFL 705
S + + R +DS + SS E S+ + I+K I G +VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLY 763
++AIK + + ++ E L ++ + ++R + +Y
Sbjct: 75 VLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
+VME DL S L+K ++ + Y ++ A+ +H GIVH DLKP N LI D
Sbjct: 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VD 190
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883
G +KL DFG++ M D T + + S VG +Y+ P
Sbjct: 191 GMLKLIDFGIAN-----------------QMQPD--------TTSVVKDSQVGAVNYMPP 225
Query: 884 EILLGT-----------EHGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKI 931
E + + +D WS+G IL+ G PF +I I++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
P + QD++ L DP QR+ E+ AHP+ +
Sbjct: 286 EIE-FPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-72
Identities = 88/350 (25%), Positives = 150/350 (42%), Gaps = 47/350 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I+ + +G+FG V + R T +A+KV+ K K D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
N +GT Y+APE+L G + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ K W + S +A+DLI + L P+ R+ A + HP+ + +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYS 284
Query: 979 W-DSLALQKMTQATSYHALVKFQVDCRMIRMVATLMLT-LVTHLQILELR 1026
+ ++ + +FQ + ++ + M + L T + +L
Sbjct: 285 SETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLT 334
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-72
Identities = 69/308 (22%), Positives = 130/308 (42%), Gaps = 39/308 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ DFE I+ + RG FG VF A+ + +AIK ++ + + E+++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 746 NPFVVRFFYSFTCRDN------------LYLVMEYLNGGDLYSLLRK---VGCLEEDVAR 790
+P +VR+F ++ ++ LY+ M+ +L + + E V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
++ A+E+LHS G++HRDLKP N+ D +K+ DFGL ++
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQD-------- 171
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
+ VGT Y++PE + G + + D +S+G+ILFE +
Sbjct: 172 -----EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
P T ++ R + +P + + ++ L P +R A +
Sbjct: 226 -PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI---NIIE 279
Query: 971 HPFFKGVN 978
+ F+ ++
Sbjct: 280 NAVFEDLD 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 1e-71
Identities = 84/359 (23%), Positives = 154/359 (42%), Gaps = 55/359 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----------KNDIERILA 736
+ + ++ + GA+G V L +++ AIKV+KK + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E ++L ++ +P +++ F F + YLV E+ GG+L+ + +E A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+ + YLH IVHRD+KP+N+L+ + +IK+ DFGLS
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----------------- 198
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+ + +GT Y+APE+L ++ D WS G+I++ + G PP
Sbjct: 199 -----------FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 914 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
F ++ + I + K W + S EA++LI L +D N+R A E
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRC---TAEEA 299
Query: 969 KAHPFFKGVNWDSLALQKMTQATSYHALVKFQVDCRMIRMVATLMLT-LVTHLQILELR 1026
+ K + + T + + KF+ ++ + + + L T + EL
Sbjct: 300 LNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELT 358
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 3e-71
Identities = 81/356 (22%), Positives = 137/356 (38%), Gaps = 74/356 (20%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KKLD 724
S L+ + + + I +G++G V +A + T + AIK++ K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 725 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784
I D+ERI E ++ + +P + R + + + LVME +GG L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 785 E----------------------------------------EDVARIYIAELVLALEYLH 804
E + + ++ AL YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 805 SLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+ GI HRD+KP+N L + + IKL DFGLSK + +
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-----------------------FYK 222
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 920
+ + GTP ++APE+L T Y D WS G++L + G PF +
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 921 IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+LN+K+ + + +S A+DL++ L + ++R A HP+
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWIS 335
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 4e-71
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 45/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I+ + +G+FG V + R T +A+KV+ K + D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDH 80
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
N +GT Y+APE+L GT + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ K W + S +A+DLI + L P+ R+ A + HP+ +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 4e-71
Identities = 87/360 (24%), Positives = 149/360 (41%), Gaps = 48/360 (13%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
S++ + T D +++ + + +GAF V +TTG FA K++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT- 64
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+ D +++ E I +++P +VR S YLV + + GG+L+ +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 840
E A I +++ ++ Y HS GIVHR+LKP+NLL+A +KL DFGL+
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---- 180
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
++ D+ H GTP YL+PE+L + D W+
Sbjct: 181 --VN----------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216
Query: 901 GIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHD 955
G+IL+ + G PPF E ++ I W V + EA+ LI+ L +
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVN 272
Query: 956 PNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSYHALVKFQVDCRMIRMVATLMLT 1015
P +R+ A + P+ + + + L KF ++ + T M+
Sbjct: 273 PKKRI---TADQALKVPWICN---RERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIA 326
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 5e-71
Identities = 96/374 (25%), Positives = 167/374 (44%), Gaps = 48/374 (12%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 722
+ Q +TP ++ + + ++ +K + GA+G V L R + T AIK+++K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 723 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+ + ++L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 73 -TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 839
E A + I +++ + YLH IVHRDLKP+NLL+ D IK+ DFGLS +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--- 188
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
+ + +GT Y+APE+L ++ D WS
Sbjct: 189 -------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWS 222
Query: 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 954
+G+ILF + G PPF ++ + I + K W V S A+DLI + L
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQF 278
Query: 955 DPNQRLGANGAAEVKAHPFFKG-VNWDSLALQKMTQATSYHALVKFQVDCRMIRMVATLM 1013
D +R+ A + HP+ K + ++ + A + + KFQ ++ + M
Sbjct: 279 DSQRRI---SAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYM 335
Query: 1014 LT-LVTHLQILELR 1026
+ L + + EL
Sbjct: 336 ASKLTSQEETKELT 349
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 7e-71
Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D++++ + + +GAF V +TTG FA K++ + D +++ E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHR+LKP+NLL+A +KL DFGL+ ++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN------------------- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
D+ H GTP YL+PE+L + D W+ G+IL+ + G PPF E ++
Sbjct: 160 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I W V + EA+ LI+ L +P +R+ A + P+
Sbjct: 217 AQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-70
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 41/296 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D F + + GAFG V L +R++G IK + K + +E+I AE +L ++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLLRKVGCLEEDVARIYIAELVLALEY 802
P +++ F F N+Y+VME GG+L S + L E + +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 803 LHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL----------------------- 176
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ + +A GT Y+APE+ + + D WS G++++ +TG PFT S
Sbjct: 177 -----FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E + ++ + ++ +A DL+ + L DP +R AA+V H +FK
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFK 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-70
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 727 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---- 782
+ E ++L + +P V++++ SF + L +V+E + GDL +++
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ E Y +L ALE++HS ++HRD+KP N+ I G +KL D GL + ++
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSK 189
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
HS VGTP Y++PE + + + +D WS+G
Sbjct: 190 TTA-------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 903 ILFEFITGIPPFTAESPEI--IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQR 959
+L+E PF + + + I P +PSD S E + L+N + DP +R
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 8e-70
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I RG++G V +A ++ T A K + K + D++R E I+ ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P ++R + +F ++YLVME GG+L+ + E A + +++ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+ HRDLKP+N L D +KL DFGL+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--------------------------- 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ + VGTP Y++P++L G +G D WS G++++ + G PPF+A + +
Sbjct: 159 -FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I W V S +A+ LI R L P QR+ + + H +F+
Sbjct: 217 LKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-69
Identities = 94/339 (27%), Positives = 151/339 (44%), Gaps = 53/339 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 741
D++ + K + GA G V LA +R T AIK++ K + + E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+ +P +++ F D Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 802 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 166
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFT 915
+ + GTP YLAPE+L+ + A D WS+G+ILF ++G PPF+
Sbjct: 167 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 916 AES-PEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
+ D I + K W V S +A DL+ + L+ DP R E
Sbjct: 221 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTEEAL 273
Query: 970 AHPFFKGVNWDSLALQKMTQATSYHALVKFQVDCRMIRM 1008
HP+ + + +++ AL + R
Sbjct: 274 RHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRK 312
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-69
Identities = 85/337 (25%), Positives = 150/337 (44%), Gaps = 46/337 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+++++ + + +GAF V K G +A ++ + D +++ E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
G+VHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------E 162
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ + + GTP YL+PE+L +G D W+ G+IL+ + G PPF E ++
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
I W V + EA+DLIN+ L +P++R+ AAE HP+
Sbjct: 223 QQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI---TAAEALKHPWISH-- 273
Query: 979 WDSLALQKMTQATSYHALVKFQVDCRMIRMVATLMLT 1015
S M + + L KF ++ + T+ML
Sbjct: 274 -RSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLA 309
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 7e-69
Identities = 81/325 (24%), Positives = 143/325 (44%), Gaps = 48/325 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 743
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 804 HSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HSL I H DLKP+N+++ IK+ DFGL+ I +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----------------IDFGNEF 174
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 175 ------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ N+ + S A+D I R L+ DP +R+ + HP+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 275
Query: 975 KGVNWDSLALQKMTQATSYHALVKF 999
K + AL + A + KF
Sbjct: 276 KPKD-TQQALSRKASAVNMEKFKKF 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 7e-69
Identities = 80/343 (23%), Positives = 148/343 (43%), Gaps = 52/343 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 743
D ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
V + V+ + R ++ L++E ++GG+L+ L + L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 804 HSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
H+ I H DLKP+N+++ HIKL DFGL+ I
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----------------IEDGVEF 175
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 176 K------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ NI + + S A+D I + L+ + +RL E HP+
Sbjct: 224 QETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276
Query: 975 KGVNWDSLALQK-----MTQATSYHALVKFQVDCRMIRMVATL 1012
V+ +++ + + ++++ ++ + L
Sbjct: 277 TPVDNQQAMVRRESVVNLENFRKQYVRRRWKLSFSIVSLCNHL 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 7e-69
Identities = 87/356 (24%), Positives = 147/356 (41%), Gaps = 58/356 (16%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
S S G L + + D +E+ + I +G F V R TG FA+K++
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 725 MIRKN--DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLL 778
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSK 835
E VA Y+ +++ AL Y H I+HRD+KP +L+A +KL FG++
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895
+ SG G VGTP ++APE++ +G
Sbjct: 182 Q------LGESGLVAGGR---------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINR 950
D W G+ILF ++G PF +F+ I+ K W + S A+DL+ R
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI----SESAKDLVRR 269
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKG------VNWDSLALQKMTQATSYHALVKFQ 1000
L+ DP +R+ E HP+ K ++++ + ++A K +
Sbjct: 270 MLMLDPAERI---TVYEALNHPWLKERDRYAYKIHLPETVEQLRK---FNARRKLK 319
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 9e-69
Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 48/306 (15%)
Query: 684 TSIDDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERN 739
+ ++D E+ + + G F V R++ TG +A K +KK + E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
IL +R+P ++ F + ++ L++E ++GG+L+ L + L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLHS I H DLKP+N+++ + IKL DFG++ I +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN-------- 170
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
GTP+++APEI+ G AD WS+G+I + ++G PF
Sbjct: 171 ------------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212
Query: 916 AESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
E+ + NI + S A+D I R L+ DP +R+ A+
Sbjct: 213 GETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRM---TIAQSLE 265
Query: 971 HPFFKG 976
H + K
Sbjct: 266 HSWIKA 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 63/312 (20%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ DF+ I+ I G FG+VF A+ R G + IK ++ N+ E+ E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNN-EKAEREVKAL 58
Query: 742 ITVRNPFVVRFFYSF----------------TCRDNLYLVMEYLNGGDLYSLL--RKVGC 783
+ + +V + + + L++ ME+ + G L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L++ +A ++ ++Y+HS +++RDLKP N+ + +K+ DFGL + N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
R + GT Y++PE + ++G D +++G+I
Sbjct: 177 K--------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
L E + TA F ++ + I + + L+ + L P R +
Sbjct: 211 LAELLH--VCDTAFETSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 964 GAAEVKAHPFFK 975
E+
Sbjct: 264 ---EILRTLTVW 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-68
Identities = 85/375 (22%), Positives = 162/375 (43%), Gaps = 60/375 (16%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERIL 735
+ K++ D ++I + + G F V R+++TG +A K +KK E I
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 736 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 795
E +IL V +P ++ + R ++ L++E ++GG+L+ L + L E+ A +I +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETD 851
++ + YLH+ I H DLKP+N+++ HIKL DFGL+
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------- 168
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
I + GTP+++APEI+ G AD WS+G+I + ++G
Sbjct: 169 -IEDGVEFK------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 912 PPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
PF ++ + NI + S A+D I + L+ + +RL
Sbjct: 216 SPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRL---TIQ 268
Query: 967 EVKAHPFFKGVNWDSLALQK-----MTQATSYHALVKFQVDCRMIRMVATLMLTLVTHLQ 1021
E HP+ V+ +++ + + +++ ++ +++L HL
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK--------LSFSIVSLCNHLT 320
Query: 1022 ILELRWMNAETLQSL 1036
++ ++ T + L
Sbjct: 321 RSLMKKVHLRTSEDL 335
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-68
Identities = 87/316 (27%), Positives = 149/316 (47%), Gaps = 45/316 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 741
D++ + K + GA G V LA +R T AI+++ K + + E IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+ +P +++ F ++ Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 802 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 291
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 915
+ + GTP YLAPE+L+ A D WS+G+ILF ++G PPF+
Sbjct: 292 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 916 AES-PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ D I + K + +++S +A DL+ + L+ DP R E HP+
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPW 402
Query: 974 FKGVNWDSLALQKMTQ 989
+ + +++
Sbjct: 403 LQDEDMKRKFQDLLSE 418
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-68
Identities = 85/299 (28%), Positives = 145/299 (48%), Gaps = 36/299 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S E+ I ++ ++K I +G F +V LAR TG AIK++ K + ++++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFRE 64
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
I+ + +P +V+ F LYL+MEY +GG+++ L G ++E AR ++V
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
A++Y H IVHRDLK +NLL+ D +IK+ DFG S
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------------- 162
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+ T + G P Y APE+ G + G D WS+G+IL+ ++G PF
Sbjct: 163 ------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
++ + + + +L K +P MS + ++L+ RFL+ +P +R ++ +
Sbjct: 217 QNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWIN 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-68
Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 53/314 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDI----ERILAERNI 740
+++E + + RG V + T +A+K++ ++ E L E +I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----------------------- 173
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 913
GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 174 -----LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 914 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
F ++ I++ W S +DL++RFL+ P +R A E
Sbjct: 229 FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQPQKRY---TAEEA 281
Query: 969 KAHPFFKGVNWDSL 982
AHPFF+ + +
Sbjct: 282 LAHPFFQQYVVEEV 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 5e-68
Identities = 74/322 (22%), Positives = 140/322 (43%), Gaps = 49/322 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 805
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 806 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I H D++P+N++ IK+ +FG ++ + P D
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDNF---- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG-- 976
+NI+N + + + S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQKI 265
Query: 977 VNWDSLALQKMTQATSYHALVK 998
+ ++ + YH L+K
Sbjct: 266 ERVSTKVIRTLKHRRYYHTLIK 287
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-68
Identities = 69/337 (20%), Positives = 121/337 (35%), Gaps = 76/337 (22%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEV 60
Query: 741 LITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAE 795
L + + +V+ F T + L+ME+ G LY++L + L E I + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
+V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------- 165
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGII 903
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 -------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVP 937
+ TG PF ++ + I +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ ++ L D + G + + A
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFD---QFFAETSD 306
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 9e-68
Identities = 99/327 (30%), Positives = 153/327 (46%), Gaps = 56/327 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D FE+ + RGA V+ +++ T +A+KVLKK D + + E +L+ + +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSH 107
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + LV+E + GG+L+ + + G E A + +++ A+ YLH
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL A D +K+ DFGLSKI E +M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----------EHQVLM--------- 207
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 922
+ GTP Y APEIL G +G D WSVGII + + G PF E + +
Sbjct: 208 --------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
Query: 923 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
F ILN + W V S A+DL+ + ++ DP +RL + HP+ G
Sbjct: 260 FRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGK 312
Query: 978 N----WDSLALQKMTQATSYHALVKFQ 1000
A +K+ + ++A K +
Sbjct: 313 AANFVHMDTAQKKLQE---FNARRKLK 336
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-67
Identities = 92/326 (28%), Positives = 146/326 (44%), Gaps = 60/326 (18%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--------- 728
S + ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 729 --------------NDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGG 772
IE++ E IL + +P VV+ D+LY+V E +N G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
+ + L ED AR Y +L+ +EYLH I+HRD+KP NLL+ DGHIK+ DFG
Sbjct: 124 PVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
+S + + + VGTP ++APE L T
Sbjct: 183 VSNE---------------------------FKGSDALLSNTVGTPAFMAPESLSETRKI 215
Query: 893 Y---AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949
+ A D W++G+ L+ F+ G PF E + I ++ + +P P D++ + +DLI
Sbjct: 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLIT 274
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFK 975
R L +P R+ E+K HP+
Sbjct: 275 RMLDKNPESRI---VVPEIKLHPWVT 297
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-67
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 35/299 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
L R+P +++ + + + ++VMEY++GG+L+ + K G +EE AR +++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
A++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 160
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 161 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E +F I +P ++ L+ L DP +R +++ H +FK
Sbjct: 214 EHVPTLFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFK 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 8e-67
Identities = 88/347 (25%), Positives = 136/347 (39%), Gaps = 52/347 (14%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 705
+ + + QS G L + ++ I RG V
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVRN-PFVVRFFYSFTCR 759
R TG FA+K+++ + E E +IL V P ++ S+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
++LV + + G+L+ L + L E R + L+ A+ +LH+ IVHRDLKP+N+L
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ + I+L+DFG S + P + GTP
Sbjct: 233 LDDNMQIRLSDFGFSCH----------------LEPGEKLR------------ELCGTPG 264
Query: 880 YLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-- 931
YLAPEIL + +G D W+ G+ILF + G PPF ++ I+ +
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 932 ---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
W S +DLI+R L DP RL A + HPFF+
Sbjct: 325 SSPEWDDR----SSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-66
Identities = 92/356 (25%), Positives = 151/356 (42%), Gaps = 64/356 (17%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
Q+ GV + + H+ D +E+ + I G++ + T FA+K++ K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---- 57
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
K D E IL+ P ++ + +Y+V E + GG+L + +
Sbjct: 58 SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINN 841
E A + + +EYLH+ G+VHRDLKP N+L + I++ DFG +K
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---- 170
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+ +N + T +++APE+L + A D WS+G
Sbjct: 171 -----------------------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 902 IILFEFITGIPPFTA---ESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 953
++L+ +TG PF ++PE I I + K W V S A+DL+++ L
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLH 263
Query: 954 HDPNQRLGANGAAEVKAHPFFKGVN---------WDSLALQKMTQATSYHALVKFQ 1000
DP+QRL AA V HP+ + D+ L K A +Y AL + Q
Sbjct: 264 VDPHQRL---TAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQ 316
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-66
Identities = 82/328 (25%), Positives = 134/328 (40%), Gaps = 48/328 (14%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
S + T + + + K + RG F V ++TG +A K LKK
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK-RR 66
Query: 726 IRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVG 782
++ IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 839
+ E+ I +++ + YLH IVH DLKP N+L++ G IK+ DFG+S+
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--- 183
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
I +GTP+YLAPEIL A D W+
Sbjct: 184 ---IG----------------------HACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 954
+GII + +T PF E + + NI + + V S A D I L+
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLVK 274
Query: 955 DPNQRLGANGAAEVKAHPFFKGVNWDSL 982
+P +R A +H + + ++++L
Sbjct: 275 NPEKRP---TAEICLSHSWLQQWDFENL 299
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 6e-66
Identities = 45/352 (12%), Positives = 100/352 (28%), Gaps = 87/352 (24%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
+G + S ER + + A + TG+ F + V + N
Sbjct: 58 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 730 DIE-------------------------RILAERNILITVRNPFVVRFFYSFTCRD--NL 762
I+ R + +++ + ++R +
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 763 YLVMEYLN------GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816
+ + + G L S L +++ L LH G+VH L+P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
++++ G + LT F + R +
Sbjct: 236 DIVLDQRGGVFLTGFEHLV-------------------------------RDGARVVSSV 264
Query: 877 TPDYLAPEILL-----------GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ + PE+ T ++ D W++G++++ P T ++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
I ++ + L+ FL + RL + P ++ +
Sbjct: 325 IFRS-------CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-65
Identities = 68/325 (20%), Positives = 119/325 (36%), Gaps = 73/325 (22%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 742 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAEL 796
+ + +V+ F T + L+ME+ G LY++L + L E I + ++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---------------- 165
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGIIL 904
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 ------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 905 FEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVPS 938
+ TG PF ++ + I +
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 939 DMSFEAQDLINRFLIHDPNQRLGAN 963
+ ++ L D + G +
Sbjct: 274 GLQVLLTPVLANILEADQEKCWGFD 298
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-65
Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 56/300 (18%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 751
KP+ G+F + + FA+K+ I K E L P +V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F + + +LVME LNGG+L+ ++K E A + +LV A+ ++H +G+VHR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 812 DLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
DLKP+NLL + IK+ DFG +++ + DN
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL---------------------------KPPDN 163
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEI 921
+ + T Y APE+L + + D WS+G+IL+ ++G PF + S
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 922 IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I I W V S EA+DLI L DPN+RL + ++ + + +
Sbjct: 224 IMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-65
Identities = 71/340 (20%), Positives = 138/340 (40%), Gaps = 47/340 (13%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVF 704
KY D + ++ S+ D ++I++ + GAFG V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 705 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764
++ TG +F K + + K ++ E +I+ + +P ++ +F + + L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 765 VMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH- 822
++E+L+GG+L+ + + + E Y+ + L+++H IVH D+KP+N++
Sbjct: 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 823 -DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 881
+K+ DFGL+ + P + T ++
Sbjct: 186 KASSVKIIDFGLATK----------------LNPDEIV------------KVTTATAEFA 217
Query: 882 APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCV 936
APEI+ G+ D W++G++ + ++G+ PF E N+ + V
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 937 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
S EA+D I L +P +RL + HP+ KG
Sbjct: 278 ----SPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-64
Identities = 74/295 (25%), Positives = 136/295 (46%), Gaps = 39/295 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 923
+ GT Y+APE+L E H D WS GI+L + G P+ +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 924 DNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +K PW + L+++ L+ +P+ R+ ++K ++
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-64
Identities = 75/343 (21%), Positives = 140/343 (40%), Gaps = 47/343 (13%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRV 703
D + K D+ + + D ++I + + GAFG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
+R TG+ FA K + ++D E + E + +R+P +V +F + +
Sbjct: 174 HRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 764 LVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822
++ E+++GG+L+ + + + ED A Y+ ++ L ++H VH DLKP+N++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 823 --DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+KL DFGL+ ++ GT ++
Sbjct: 291 KRSNELKLIDFGLTA----------------------------HLDPKQSVKVTTGTAEF 322
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPC 935
APE+ G GY D WSVG++ + ++G+ PF E+ + N+ + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ S + +D I + L+ DPN R+ + HP+ N
Sbjct: 383 I----SEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGN 418
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-64
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 36/300 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
++ R + + RG+FG V + + TG A+K ++ L++ R ++
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELV----- 102
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+ +P +V + + + + ME L GG L L++++GCL ED A Y+ + +
Sbjct: 103 --ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
LEYLH+ I+H D+K DN+L++ DG L DFG + L +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC--------LQPDGLGKSLL- 211
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
GT ++APE+++G D WS ++ + G P+T
Sbjct: 212 -------------TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 917 ESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I + P +P + I L +P R A E++
Sbjct: 259 YFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA---SAMELRRKVGKA 314
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-64
Identities = 80/317 (25%), Positives = 126/317 (39%), Gaps = 51/317 (16%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDM 725
G TP ++ + + +G FG VF + T AIKV+ + L
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 726 IRKNDIERILAERNILITVRN----PFVVRFFYSFTCRDNLYLVMEY-LNGGDLYSLLRK 780
+D E +L V P V+R F ++ LV+E L DL+ + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 781 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 839
G L E +R + ++V A+++ HS G+VHRD+K +N+LI G KL DFG +
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--- 189
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 898
D Y GT Y PE + + H A W
Sbjct: 190 ---------------LHDEPY-----------TDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 899 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
S+GI+L++ + G PF + IL ++ P+ +S + LI R L P+
Sbjct: 224 SLGILLYDMVCGDIPFERD------QEILEAELH---FPAHVSPDCCALIRRCLAPKPSS 274
Query: 959 RLGANGAAEVKAHPFFK 975
R E+ P+ +
Sbjct: 275 RP---SLEEILLDPWMQ 288
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 7e-64
Identities = 69/310 (22%), Positives = 140/310 (45%), Gaps = 46/310 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ + G FG+V + TG A K++K D E + E +++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ + +F ++++ LVMEY++GG+L+ ++ + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 807 GIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR---------------------------- 238
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
GTP++LAPE++ + D WSVG+I + ++G+ PF ++ +
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 925 NILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979
NIL + + + S EA++ I++ LI + + R+ A+E HP+
Sbjct: 299 NILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKL 351
Query: 980 DSLALQKMTQ 989
S + +
Sbjct: 352 HSRLSAQKKK 361
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-63
Identities = 77/320 (24%), Positives = 133/320 (41%), Gaps = 49/320 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---L 723
+ +T L ++ +++ + G FG V+ + + AIK ++K
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 724 DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEYLNG-GDLYSLLRK 780
D + R+ E +L V + V+R F D+ L++E DL+ + +
Sbjct: 83 DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 781 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 839
G L+E++AR + +++ A+ + H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--- 199
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 898
D Y GT Y PE + HG +A W
Sbjct: 200 ---------------LKDTVY-----------TDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 899 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
S+GI+L++ + G PF E E I + +S E Q LI L P+
Sbjct: 234 SLGILLYDMVCGDIPF--EHDEEIIRGQVF-------FRQRVSSECQHLIRWCLALRPSD 284
Query: 959 RLGANGAAEVKAHPFFKGVN 978
R E++ HP+ + V
Sbjct: 285 RP---TFEEIQNHPWMQDVL 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-63
Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 47/318 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-- 722
++ + + E + + P+ GAFG V+ A + +K +KK
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 723 ---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME-YLNGGDLYSLL 778
I + ++ E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838
+ L+E +A +LV A+ YL I+HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADW 897
+ ++ GT +Y APE+L+G G +
Sbjct: 180 --------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 898 WSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 957
WS+G+ L+ + PF + + I P +S E L++ L P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIH---PPYLVSKELMSLVSGLLQPVPE 264
Query: 958 QRLGANGAAEVKAHPFFK 975
+R ++ P+
Sbjct: 265 RRT---TLEKLVTDPWVT 279
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-63
Identities = 75/295 (25%), Positives = 137/295 (46%), Gaps = 39/295 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF--TAESPEII 922
+ GT Y+APE+L E H D WS GI+L + G P+ ++S +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 923 FDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
D PW + L+++ L+ +P+ R+ ++K ++
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-63
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 37/300 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
+F ++ I G FG VF KR G ++AIK KK D + L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQ 69
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 801
+ VVR+F ++ D++ + EY NGG L + R + +E + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPS 856
Y+HS+ +VH D+KP N+ I+ + +N + DL G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL------GHV-- 181
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 915
T + G +LA E+L H AD +++ + + P
Sbjct: 182 ---------TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I R+ P +P +S E +L+ + DP +R A + H
Sbjct: 233 NGDQ---WHEI--RQGRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVLL 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 6e-63
Identities = 83/296 (28%), Positives = 143/296 (48%), Gaps = 36/296 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ I + I + + G+FG+V LA T A+K + + + + + R+ E +
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L +R+P +++ + T ++ +V+EY GG+L+ + + + ED R + +++ A+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EY H IVHRDLKP+NLL+ + ++K+ DFGLS I
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------------------------ 157
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919
TD ++ G+P+Y APE++ G G D WS GI+L+ + G PF E
Sbjct: 158 ----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+F + + +P +S AQ LI R ++ DP QR+ E++ P+F
Sbjct: 214 PNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFN 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-63
Identities = 92/319 (28%), Positives = 141/319 (44%), Gaps = 49/319 (15%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
+ ++ + PL D ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD--SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA 58
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
I +N ++R E ++R+P +VRF +L ++MEY +GG+LY + G
Sbjct: 59 IDEN-VQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTI 843
ED AR + +L+ + Y HS+ I HRDLK +N L+ + +K+ DFG SK
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------- 167
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGI 902
P S VGTP Y+APE+LL E G AD WS G+
Sbjct: 168 -----SVLHSQP----------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNR------KIPWPCVPSDMSFEAQDLINRFLIHDP 956
L+ + G PF + + R IP +S E LI+R + DP
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADP 263
Query: 957 NQRLGANGAAEVKAHPFFK 975
R+ E+K H +F
Sbjct: 264 ATRI---SIPEIKTHSWFL 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-62
Identities = 63/378 (16%), Positives = 105/378 (27%), Gaps = 77/378 (20%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID----DFEIIKPISR 697
+LL + +E + V + P ++ + + ++++P+
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF---- 753
G VFL R + FA+KV ++++ER+ +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 754 ----------------------YSFTCRDNLYLVMEYLNG--GDLYSLLRKV----GCLE 785
N L+M + L+S L V G
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
I A+L+ L S G+VH PDNL I DG + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------- 242
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGII 903
++ Y E L +A + W +G+
Sbjct: 243 --------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 904 LFEFITGIPPFTAESPEIIFDNILN-----RKIPWP-CVPSDMSFEAQDLINRFLIHDPN 957
++ PF +P I + + + LI RFL D
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 958 QRLGANGAAEVKAHPFFK 975
+RL E P F
Sbjct: 343 RRL---LPLEAMETPEFL 357
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-62
Identities = 75/299 (25%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
L R+P +++ + + ++++VMEY++GG+L+ + K G L+E +R +++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 165
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 166 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +F I + P ++ L+ L DP +R +++ H +FK
Sbjct: 219 DHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFK 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-62
Identities = 82/320 (25%), Positives = 139/320 (43%), Gaps = 60/320 (18%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
D +++ + + GA RV T +A+K+++K ++ + R E +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 746 N-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
V+ F D YLV E + GG + S + K E A + + ++ AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 805 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+ GI HRDLKP+N+L H +K+ DF L I L+G +
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG------IKLNGDCSP---------- 172
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTA 916
+ G+ +Y+APE++ + + D WS+G+IL+ ++G PPF
Sbjct: 173 ----ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 917 E---------------SPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDP 956
++F++I K W + S A+DLI++ L+ D
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRDA 284
Query: 957 NQRLGANGAAEVKAHPFFKG 976
QRL AA+V HP+ +G
Sbjct: 285 KQRL---SAAQVLQHPWVQG 301
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-61
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 39/297 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE-RILAERNILITV 744
I + + + G++G+V T A+K+LKK + R + E + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 745 RNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLAL 800
R+ V++ + +Y+VMEY G + +L V A Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHS GIVH+D+KP NLL+ G +K++ G++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALH---------------- 160
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918
+ ++ G+P + PEI G + G+ D WS G+ L+ TG+ PF ++
Sbjct: 161 ---PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+F+NI +P D DL+ L ++P +R +++ H +F+
Sbjct: 218 IYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-61
Identities = 77/335 (22%), Positives = 124/335 (37%), Gaps = 66/335 (19%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
S + +E+ + + G FG V + TG+ AIK ++ ++ KN ER
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCL 61
Query: 737 ERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEED 787
E I+ + +P VV D L MEY GGDL L + L+E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTID 844
R ++++ AL YLH I+HRDLKP+N+++ K+ D G +K
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-------- 173
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
VGT YLAPE+L ++ D+WS G +
Sbjct: 174 --------------------LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 905 FEFITGIPPFTAESPEIIFDNILNRK--------------------IPWPC-VPSDMSFE 943
FE ITG PF + + + K +P P + ++ +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ + L+ QR + F+ ++
Sbjct: 274 LERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-61
Identities = 49/344 (14%), Positives = 97/344 (28%), Gaps = 76/344 (22%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
+G + S ER + + A + TG+ F + V + N
Sbjct: 63 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 120
Query: 730 DIERILAERNI---LITVRNP------------------------FVVRFFYSFTCRDNL 762
I+++ E L ++N VR +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 763 YLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816
+ + + L S L +++ L LH G+VH L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
++++ G + LT F + P
Sbjct: 241 DIVLDQRGGVFLTGFEHLVR-----------DGASAVSPI---------------GRGFA 274
Query: 877 TPDYLAPEILLGTEHG-----YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
P+ A +L +H +A D W++G+ ++ P T ++ + I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-- 332
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
++ + L+ FL + RL + P ++
Sbjct: 333 -----CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYE 368
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-61
Identities = 57/299 (19%), Positives = 103/299 (34%), Gaps = 37/299 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ I+ + G F V L G +A+K + + D E E ++ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLA 799
++R +L++ + G L++ + ++ L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LE +H+ G HRDLKP N+L+ +G L D G + +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ---------------ACIHVEGS 191
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFTA 916
D + T Y APE+ H D WS+G +L+ + G P+
Sbjct: 192 RQALTLQDWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 917 ESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + ++ P S L+N + DP+QR + +
Sbjct: 249 VFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIP---LLLSQLEA 303
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-60
Identities = 83/330 (25%), Positives = 136/330 (41%), Gaps = 67/330 (20%)
Query: 669 SSGVSTPLHSSHKERTSI-DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
SSG+ ++ ++ DD+++ K + G G+V R TG A+K+L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLR 779
R+ E + P +V + + L ++ME + GG+L+S R
Sbjct: 69 RQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 780 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 836
E A + ++ A+++LHS I HRD+KP+NLL D +KLTDFG +K
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896
T + TP Y+APE+L ++ + D
Sbjct: 181 -----------------------------TTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI----------PWPCVPSDMSFEAQD 946
WS+G+I++ + G PPF + + + I + R+I W V S +A+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 947 LINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
LI L DP +RL + HP+
Sbjct: 267 LIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 86/289 (29%), Positives = 134/289 (46%), Gaps = 43/289 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G +G V+ R + AIK + + D + + E + +++ +V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 811
SF+ + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 812 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
D+K DN+LI + G +K++DFG SK L+G N
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR--------LAG-------------------INPC 179
Query: 871 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT--AESPEIIFDNI 926
+ GT Y+APEI+ GY AAD WS+G + E TG PPF E +F +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV 238
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
K+ P +P MS EA+ I + DP++R A ++ F K
Sbjct: 239 GMFKVH-PEIPESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLK 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-59
Identities = 47/336 (13%), Positives = 94/336 (27%), Gaps = 76/336 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + GAF +V+ A + F +KV K + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERL 121
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAEL 796
++F+ + ++ LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKIGLINNTIDL 845
+ +E +H I+H D+KPDN ++ + + L D G S ID+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDM 233
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
I + T + E+L Y D++ V ++
Sbjct: 234 KLFPKGTIF-----------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 906 EFITGIPPFTAESPEI------------------IFDNILNRKIPWPCVPSDMSFEAQDL 947
+ G F +LN +P + DL
Sbjct: 277 CMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLPSLDL 329
Query: 948 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983
+ + L Q + + +
Sbjct: 330 LRQKLKKVFQQHYTNKI--RALRNRLIVLLLECKRS 363
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-58
Identities = 84/349 (24%), Positives = 138/349 (39%), Gaps = 63/349 (18%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLA 706
P + + ++ Q K+ IDD+++ + + G G+V
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF--FY--SFTCRDN 761
+ T + FA+K+L+ R+ E + P +VR Y + R
Sbjct: 82 FNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 762 LYLVMEYLNGGDLYS--LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
L +VME L+GG+L+S R E A + + A++YLHS+ I HRD+KP+NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 820 IAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
+ +KLTDFG +K + + +
Sbjct: 194 YTSKRPNAILKLTDFGFAKE-----------TTSHNSL-----------------TTPCY 225
Query: 877 TPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----IFDNILNRKI- 931
TP Y+APE+L ++ + D WS+G+I++ + G PPF + + I +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 932 ----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
W V S E + LI L +P QR+ E HP+
Sbjct: 286 FPNPEWSEV----SEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 59/288 (20%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I RG+F V+ T A L+ + K++ +R E +L +++P +VRF+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 755 SFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--I 808
S+ + + LV E + G L + L++ ++ V R + +++ L++LH+ I
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 809 VHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDLK DN+ I G +K+ D GL+
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-----------------------------LKR 183
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ +GTP+++APE + ++ + D ++ G+ + E T P++ +
Sbjct: 184 ASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ E +++I + + ++R ++ H FF+
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-57
Identities = 66/349 (18%), Positives = 123/349 (35%), Gaps = 80/349 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFA-------------------IKVLKKLD--- 724
DFE I+ + RG FG VF A+ + +A +K L KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 725 ---------------------------------MIRKNDIERILAERNILITVRNPFVVR 751
+ + ++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGI 808
+ + LY+ M+ +L + + + E V ++ A+E+LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLKP N+ D +K+ DFGL ++ + T
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP-------------MPAY 230
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
VGT Y++PE + G + + D +S+G+ILFE + T I ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-- 286
Query: 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
R + +P + + + ++ L P +R A ++ + F+ +
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT---DIIENAIFENL 332
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-56
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 43/314 (13%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S+ + DD+E+ + I GA V A + AIK + L+ + ++ +L E
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQ-TSMDELLKE 63
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--------KVGCLEEDVA 789
+ +P +V ++ SF +D L+LVM+ L+GG + +++ K G L+E
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ E++ LEYLH G +HRD+K N+L+ DG +++ DFG+S + D
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGD----- 176
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFI 908
T N+ R + VGTP ++APE + + + AD WS GI E
Sbjct: 177 ---------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 909 TGIPPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
TG P+ P + L P + + +I+ L DP +R
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP- 280
Query: 962 ANGAAEVKAHPFFK 975
AAE+ H FF+
Sbjct: 281 --TAAELLRHKFFQ 292
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-56
Identities = 67/310 (21%), Positives = 103/310 (33%), Gaps = 46/310 (14%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
+ F + GA G + A+K I E
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKR------ILPECFSFADRE 67
Query: 738 RNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAE 795
+L P V+R+F + R Y+ +E L + +K + +
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPET 850
L +LHSL IVHRDLKP N+LI+ ++DFGL K
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK--------------- 171
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEF 907
+ + +R R GT ++APE+L Y D +S G + +
Sbjct: 172 --------KLAVGRHSFSR-RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
I+ G PF + + A++LI + + DP +R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAK 279
Query: 967 EVKAHPFFKG 976
V HPFF
Sbjct: 280 HVLKHPFFWS 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-55
Identities = 81/290 (27%), Positives = 142/290 (48%), Gaps = 36/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ I G+ G V LAR++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
VV + S+ + L+++ME+L GG L ++ +V EE +A + ++ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV-CEAVLQALAYLHAQ 160
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G++HRD+K D++L+ DG +KL+DFG Q +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA----------------------------QIS 192
Query: 867 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ R S VGTP ++APE++ + + D WS+GI++ E + G PP+ ++SP
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ + P +S +D + R L+ DP +R A E+ HPF
Sbjct: 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-55
Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 36/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKN 76
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +V + S+ D L++VMEYL GG L ++ + E +A + E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSN 135
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K DN+L+ DG +KLTDFG Q T
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------------------------QIT 167
Query: 867 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
++ R + VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I P P +S +D +NR L D +R A E+ H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLK 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-55
Identities = 70/323 (21%), Positives = 124/323 (38%), Gaps = 65/323 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ K + G+ G V G A+K + + + L E +L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKR------MLIDFCDIALMEIKLLTESDD 67
Query: 747 -PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-------ARIYIAELVL 798
P V+R++ S T LY+ +E +L L+ +E++ + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKIGLINNTIDL 845
+ +LHSL I+HRDLKP N+L++ + I ++DFGL K
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--------- 177
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-------GYAADWW 898
Q + N ++ GT + APE+L + + + D +
Sbjct: 178 --------------LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 899 SVGIILFEFIT-GIPPFTAESPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
S+G + + ++ G PF + I I + + EA DLI++ + HD
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 956 PNQRLGANGAAEVKAHPFFKGVN 978
P +R A +V HP F +
Sbjct: 284 PLKRP---TAMKVLRHPLFWPKS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 84/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F ++ I +G+FG VF T + AIK++ L+ +++IE I E +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEA-EDEIEDIQQEITVLSQCDS 79
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 138
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
+HRD+K N+L++ G +KL DFG++ G + +T
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQI---------------------- 174
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 925
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 175 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-- 229
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 985
L K P + + S ++ + L +P+ R A E+ H F + L
Sbjct: 230 -LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILRNAKKTSYLT 285
Query: 986 KM 987
++
Sbjct: 286 EL 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 76/321 (23%), Positives = 135/321 (42%), Gaps = 43/321 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 722
S + +G T + + I+D E + + G G+V+ R R TG + A+K ++
Sbjct: 3 SGSSGKQTGYLTI--GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR- 59
Query: 723 LDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 781
K + +RIL + ++++ + P++V+ F +F ++++ ME + R
Sbjct: 60 RS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 782 GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
G + E + +V AL YL G++HRD+KP N+L+ G IKL DFG+S
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG----- 173
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 895
+ D++ + + G Y+APE + ++ A
Sbjct: 174 -----------------------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 896 DWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 954
D WS+GI L E TG P+ + + +L + P S + Q + L
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 955 DPNQRLGANGAAEVKAHPFFK 975
D +R ++ H F K
Sbjct: 271 DHRKRP---KYNKLLEHSFIK 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-53
Identities = 84/298 (28%), Positives = 145/298 (48%), Gaps = 41/298 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +EI+ + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P++V+ ++ L++++E+ GG + +++ ++ L E ++ +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L+ +G I+L DFG+S T+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQ--------------------- 172
Query: 866 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP- 919
R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 173 ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
++ I P PS S E +D + L +P R AA++ HPF +
Sbjct: 229 RVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSI 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-52
Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 84/316 (26%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 62
Query: 740 ILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLRKVGCLEEDVARIY 792
+ P +VR + R L +VME L+GG+L+S R E A
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
A E G ++ + D WS+G+I++ +
Sbjct: 166 -------------------------------FAKET-TGEKYDKSCDMWSLGVIMYILLC 193
Query: 910 GIPPFTAESPEI----IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
G PPF + + I + W V S E + LI L +P QR+
Sbjct: 194 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPTQRM 249
Query: 961 GANGAAEVKAHPFFKG 976
E HP+
Sbjct: 250 ---TITEFMNHPWIMQ 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-52
Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 40/292 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F++++ + G++G V+ A + TG + AIK + ++D++ I+ E +I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDS 83
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+ +HRD+K N+L+ +GH KL DFG++ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------QL 175
Query: 866 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 923
TD R++ +GTP ++APE++ + AD WS+GI E G PP+ P IF
Sbjct: 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
I P P S D + + L+ P QR A ++ HPF +
Sbjct: 236 -MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVR 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 1e-51
Identities = 87/335 (25%), Positives = 138/335 (41%), Gaps = 80/335 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
DDFE I + G G VF + +G + A K++ L+ I+ +I+ E +L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE-IKPAIRNQIIRELQVLHEC 88
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I+HRD+KP N+L+ G IKL DFG+S G + +++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSM-------------------- 186
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 918
+S VGT Y++PE L GT + +D WS+G+ L E G P
Sbjct: 187 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 919 ----------------------------------PEIIFD---NILNRKIP-WPCVPSDM 940
P IF+ I+N P P
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVF 297
Query: 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
S E QD +N+ LI +P +R ++ H F K
Sbjct: 298 SLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-T 743
DD E I + RGA+G V R +G + A+K ++ + + +R+L + +I + T
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-AT-VNSQEQKRLLMDLDISMRT 62
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLY-SLLRKVGCLEEDVARIYIAELVLAL 800
V PF V F+ + ++++ ME ++ Y ++ K + ED+ +V AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 801 EYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
E+LHS L ++HRD+KP N+LI G +K+ DFG+S
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------------------------ 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILFEFITGIPPFT 915
D+ + G Y+APE + + +D WS+GI + E P+
Sbjct: 159 ----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
Query: 916 A-ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
+ +P ++ P P +P+D S E D ++ L + +R E+ HPF
Sbjct: 215 SWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPF 269
Query: 974 FK 975
F
Sbjct: 270 FT 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 67/313 (21%), Positives = 130/313 (41%), Gaps = 46/313 (14%)
Query: 676 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 735
+ + +D + + I RGA+G V + +G + A+K ++ + + + +++L
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-ST-VDEKEQKQLL 68
Query: 736 AERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKV--GCLEEDVAR 790
+ ++++ + P++V+F+ + + ++ ME ++ Y + V + E++
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 791 IYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
V AL +L L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG-------------- 174
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILF 905
Q D+ + G Y+APE + + +D WS+GI L+
Sbjct: 175 --------------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 906 EFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGA 962
E TG P+ + ++ P + F + +N L D ++R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-- 278
Query: 963 NGAAEVKAHPFFK 975
E+ HPF
Sbjct: 279 -KYKELLKHPFIL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-50
Identities = 71/325 (21%), Positives = 119/325 (36%), Gaps = 46/325 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+ + ++ G F V+ A+ +G +A+K L + + I + E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHP 86
Query: 748 FVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 797
+V+F + + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 798 LALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
A++++H I+HRDLK +NLL+++ G IKL DFG + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT------------TISHYPDY 194
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIP 912
S + + R+ TP Y PEI+ G D W++G IL+
Sbjct: 195 SWSAQRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
PF + I+N K P + LI L +P +RL EV
Sbjct: 252 PFEDGAKL----RIVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERLSIA---EVVHQL 303
Query: 973 F----FKGVNWDSLALQKMTQATSY 993
+ VN S + + Q Y
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGY 328
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-50
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----------------------------SIM 204
Query: 867 DNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP-EII 922
N S VGTP ++APE IL E Y D WS+GI E PP + +
Sbjct: 205 APAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +I + P S ++ ++ L P R + + H F
Sbjct: 263 Y-HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 310
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-50
Identities = 62/338 (18%), Positives = 119/338 (35%), Gaps = 73/338 (21%)
Query: 687 DDFEIIKPISRGA--FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+E++ I +G V LAR + TG+ ++ + L+ + + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEY 802
+P +V + +F + L++V ++ G L+ + + E + ++ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+H +G VHR +K ++LI+ DG + L+ + + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQ------------------ 183
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF------ 914
Q+ + +V +L+PE+L GY +D +SVGI E G PF
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 915 -------------------------------------TAESPEIIFDNILNRKIPWPCVP 937
++S N P
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
S + + L +P+ R A+ + H FFK
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFK 338
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-49
Identities = 77/304 (25%), Positives = 134/304 (44%), Gaps = 51/304 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 746 NPFVVRFFYSF------TCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELV 797
+ + ++ +F D L+LVME+ G + L++ K L+E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L +LH ++HRD+K N+L+ + +KL DFG+S ++ T+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG------------- 184
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-----GYAADWWSVGIILFEFITGIP 912
R++ +GTP ++APE++ E+ + +D WS+GI E G P
Sbjct: 185 ------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 913 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
P P +F I P S + Q I L+ + +QR ++ H
Sbjct: 233 PLCDMHPMRALF-LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKH 287
Query: 972 PFFK 975
PF +
Sbjct: 288 PFIR 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 17/274 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + +G FG+ R TG++ +K L + D + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALEYLHS 805
P V++F L + EY+ GG L +++ + R+ A+ + + YLHS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+ I+HRDL N L+ + ++ + DFGL+++ + + P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKP---------- 174
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
D + R++ VG P ++APE++ G + D +S GI+L E I + P +
Sbjct: 175 -DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ R P + + R DP +R
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-44
Identities = 81/352 (23%), Positives = 142/352 (40%), Gaps = 75/352 (21%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
+Q+ G + S+ TSID + I + G +G V+ A T + AIK ++ L+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LE-- 70
Query: 727 RKNDIERI----LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
++ E + + E ++L +++ ++ L+L+ EY DL + K
Sbjct: 71 --HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIG 837
+ V + ++ +L+ + + HS +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-- 185
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 896
+ + H + T Y PEILLG+ H + D
Sbjct: 186 ------------------------AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVD 220
Query: 897 WWSVGIILFEFITGIPPFTAESPEI-----IFD-----------------NILNRKIPWP 934
WS+ I E + P F +S EI IF+ + +
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR 279
Query: 935 ------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
+ + + E DL+ L DP +R+ A A E HP+F ++D
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHNDFD 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 43/308 (13%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFA 716
+ T + + DD +I + I G+FG V A G A
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVA 64
Query: 717 IKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 776
+K+L + D + L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 65 VKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 777 LLRKVGCLEE--DVARIYIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 831
LL K G E+ + R+ +A ++ + YLH+ IVHR+LK NLL+ +K+ DF
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLS++ + + + SA GTP+++APE+L
Sbjct: 184 GLSRL---------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
+D +S G+IL+E T P+ +P + + + +P +++ + +I
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGC 275
Query: 952 LIHDPNQR 959
++P +R
Sbjct: 276 WTNEPWKR 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 3e-44
Identities = 80/326 (24%), Positives = 136/326 (41%), Gaps = 70/326 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITV 744
+ +E I I G++G VF R R TG + AIK K + + + +A R +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 803
++P +V F + L+LV EY + + L + + E + + + + A+ +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H +HRD+KP+N+LI IKL DFG +++ L+GP +Y +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGP--------SDYYDDE 162
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 921
V T Y +PE+L+G G D W++G + E ++G+P + +S ++
Sbjct: 163 -----------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-DVD 210
Query: 922 ----IFDNIL------------------NRKIPWPCVPSD-------MSFEAQDLINRFL 952
I L KIP P +S+ A L+ L
Sbjct: 211 QLYLIR-KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGVN 978
DP +RL HP+F+ +
Sbjct: 270 HMDPTERLTCEQLLH---HPYFENIR 292
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-43
Identities = 69/277 (24%), Positives = 105/277 (37%), Gaps = 52/277 (18%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+E+ I+ G G ++LA + G +K L + +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 748 FVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS+G+V+ DLKP+N+++ + +KL D G I+ G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFG--------------- 235
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
GTP + APEI+ A D ++VG L +P +
Sbjct: 236 ----------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-- 282
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L P S+ L+ R + DP QR
Sbjct: 283 ---GLPEDDPVLKTYD--SYGR--LLRRAIDPDPRQR 312
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILI 742
++ E K I +G FG V R + AIK L D + ++ E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALE 801
+ +P +V+ + + +VME++ GDLY L + ++ + ++ L +E
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 802 YLHSLG--IVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
Y+ + IVHRDL+ N+ + K+ DFGLS+ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------SVHSVS 184
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIP 912
+G ++APE + E Y AD +S +IL+ +TG
Sbjct: 185 ------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 913 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PF S +I F N++ + P +P D +++I DP +R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 86/335 (25%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NI 740
++ +E + + G F V+ AR + T + AIK +K D A R +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 799
L + +P ++ +F + N+ LV +++ DL +++ L + Y+ +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LEYLH I+HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------------------------ 160
Query: 860 YPEYQQTDNRNRHSAVGTPD-----------YLAPEILLGTEH-GYAADWWSVGIILFEF 907
+ G+P+ Y APE+L G G D W+VG IL E
Sbjct: 161 --------------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 908 ITGIPPFTAESPEI-----IFDNIL---NRKI--------------PWPCVP-----SDM 940
+ +P +S ++ IF+ L + +P +P S
Sbjct: 207 LLRVPFLPGDS-DLDQLTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264
Query: 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ DLI + +P R+ A A + +F
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 85/326 (26%), Positives = 139/326 (42%), Gaps = 71/326 (21%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 741
++ + ++ I G +G V+ A+ G+ FA+K ++ L+ + E I + E +IL
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LE----KEDEGIPSTTIREISIL 54
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 800
+++ +V+ + + L LV E+L+ DL LL LE A+ ++ +L+ +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y H ++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------------------------- 148
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
+ + H V T Y AP++L+G++ D WSVG I E + G P F S
Sbjct: 149 -AFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS- 205
Query: 920 EI-----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFL 952
E IF + +P + DL+++ L
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 953 IHDPNQRLGANGAAEVKAHPFFKGVN 978
DPNQR+ A A E H +FK N
Sbjct: 266 KLDPNQRITAKQALE---HAYFKENN 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 46/311 (14%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIK 718
+S S S P +S + + +++I + I +G FG+V+ R G++ AI+
Sbjct: 6 LSLLSARSFPRKAS-QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV-AIR 61
Query: 719 VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778
++ ++ ++ E R+ VV F + +L ++ G LYS++
Sbjct: 62 LIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 779 RKVGCLEEDVARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
R + + IA E+V + YLH+ GI+H+DLK N+ +G + +TDFGL I
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSIS 179
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---- 893
+ G +LAPEI+
Sbjct: 180 GVLQAGRREDKLR----------------------IQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 894 -----AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 948
+D +++G I +E PF + E I + P M E D++
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISDIL 276
Query: 949 NRFLIHDPNQR 959
+ +R
Sbjct: 277 LFCWAFEQEER 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 70/292 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ E+ + + RGAFG V A+ R AIK ++ +++ + + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-----------DVARIYIAE 795
P +V+ + + C + + LVMEY GG LY++L L ++
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ----- 113
Query: 796 LVLALEYLHSL---GIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETD 851
+ YLHS+ ++HRDLKP NLL+ G +K+ DFG + +
Sbjct: 114 ---GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------DIQ 157
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
M + G+ ++APE+ G+ + D +S GIIL+E IT
Sbjct: 158 THMT-----------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 912 PPF--TAESPEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PF I + N R P + ++ + L+ R DP+QR
Sbjct: 201 KPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-43
Identities = 77/345 (22%), Positives = 134/345 (38%), Gaps = 70/345 (20%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILI 742
S++ +E + + G++G V R + TG + A +KK + + + +A R +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLK 79
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALE 801
+R+ +V + YLV E+++ + L L+ V + Y+ +++ +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+ HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAP-----GEVYDDE- 184
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920
V T Y APE+L+G G A D W++G ++ E G P F +S +
Sbjct: 185 -------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-D 230
Query: 921 I-----IFDNILNRKIP--WPCVPS-----------------------DMSFEAQDLINR 950
I I L IP +S DL +
Sbjct: 231 IDQLYHIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQATSYHA 995
L DP++R H FF+ + Q++ A
Sbjct: 290 CLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQELQLKVQKDA 331
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-43
Identities = 83/340 (24%), Positives = 133/340 (39%), Gaps = 91/340 (26%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERIL 735
+S F+ ++ + G + V+ +TTG A+K +K LD IR
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-------- 52
Query: 736 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------LEEDVA 789
E +++ +++ +VR + + L LV E+++ DL + LE ++
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + +L+ L + H I+HRDLKP NLLI G +KL DFGL++
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------------- 156
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFI 908
GI P + E V T Y AP++L+G+ + D WS G IL E I
Sbjct: 157 AFGI-PVNTFSSE------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 909 TGIPPFTAESPEI-----IFD----------------------------NILNRKIPWPC 935
TG P F + + IFD L + +
Sbjct: 204 TGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ D ++ L +P+ RL A A HP+F
Sbjct: 263 KEP-LDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 83/330 (25%), Positives = 139/330 (42%), Gaps = 72/330 (21%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAER 738
+ ++ ++ ++ + G +G V+ A+ G + A+K ++ LD + E I + E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LD----AEDEGIPSTAIREI 70
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELV 797
++L + +P +V L LV E++ DL +L + L++ +IY+ +L+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ + H I+HRDLKP NLLI DG +KL DFGL++
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---------------------- 167
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 916
+ H V T Y AP++L+G++ + D WS+G I E ITG P F
Sbjct: 168 ----AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 917 ESPEI-----IFD-----------------NILNRKIP-WPCVP-----SDMSFEAQDLI 948
+ + IF R + P E DL+
Sbjct: 223 VT-DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ L DPN+R+ A A HP+FK ++
Sbjct: 282 SNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-42
Identities = 80/332 (24%), Positives = 124/332 (37%), Gaps = 78/332 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL---AERNI- 740
+ +E + I GA+G V+ AR +G A LK + + L R +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVA 63
Query: 741 ----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVA 789
L +P VVR + LV E+++ DL + L K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + + + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMAL 176
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
T V T Y APE+LL + + D WSVG I E
Sbjct: 177 T----------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
Query: 910 GIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDMSFE 943
P F S E IFD ++ + +P P +M
Sbjct: 215 RKPLFCGNS-EADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 944 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
L+ L +P++R+ A A + H +
Sbjct: 273 GAQLLLEMLTFNPHKRISAFRALQ---HSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 82/329 (24%), Positives = 134/329 (40%), Gaps = 75/329 (22%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 741
+ +E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLL 55
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 800
+++ +VR L LV E+ + DL L+ ++ + ++ +L+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ HS ++HRDLKP NLLI +G +KL +FGL++ GI P +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI-PVRCYS 159
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT-GIPPFTAES 918
E V T Y P++L G + + D WS G I E G P F
Sbjct: 160 AE------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 919 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 949
IF +L + WP + ++ +DL+
Sbjct: 208 -VDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
L +P QR+ A A + HP+F
Sbjct: 265 NLLKCNPVQRISAEEALQ---HPYFSDFC 290
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 86/335 (25%), Positives = 142/335 (42%), Gaps = 88/335 (26%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD+++++ + RG + VF A T + +K+LK + ++I E IL +R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 89
Query: 747 -PFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
P ++ S LV E++N D L + L + R Y+ E++ A
Sbjct: 90 GPNIITLADIVKDPVSR----TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 142
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y HS+GI+HRD+KP N++I H+ ++L D+GL++ P +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQE------- 186
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF--- 914
Y V + + PE+L+ + Y+ D WS+G +L I PF
Sbjct: 187 -YNVR-----------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 915 ---------------TAESPEII----------FDNILNR--KIPW-PCVPSD----MSF 942
T + + I F++IL R + W V S+ +S
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 943 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
EA D +++ L +D RL A A E HP+F V
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAME---HPYFYTV 326
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 30/278 (10%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILI 742
T + + + + RG G V+ A + A+K++ + R+ E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ P VV LY+ M +NG DL ++LR+ G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H+ G HRD+KP+N+L++ D L DFG++ + + T
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKL------T------------ 190
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
Q + VGT Y+APE + Y AD +++ +L+E +TG PP+ + ++
Sbjct: 191 --QLG-----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
Query: 923 FDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 959
+ +N+ IP P V + +I R + +P R
Sbjct: 244 GAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 44/297 (14%)
Query: 677 HSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
H H R + DD+EI + I G+FG V+ + GD+ A+K+L
Sbjct: 7 HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQ 62
Query: 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 789
++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 790 RIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
I IA + ++YLH+ I+HRDLK +N+ + D +K+ DFGL+
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------ 169
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILF 905
+ + + + G+ ++APE++ + + +D ++ GI+L+
Sbjct: 170 -------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 906 EFITGIPPFTAESP-EIIFDNIL--NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E +TG P++ + + I + + + V S+ + L+ L ++R
Sbjct: 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-42
Identities = 80/330 (24%), Positives = 129/330 (39%), Gaps = 84/330 (25%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAE 737
++ + + + G + V+ + + T +L A+K ++ L+ IR E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR---------E 50
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 796
++L +++ +V +L LV EYL+ DL L G + ++++ +L
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L Y H ++HRDLKP NLLI G +KL DFGL++ S P
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIP-------- 153
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 915
+ + V T Y P+ILLG+ D W VG I +E TG P F
Sbjct: 154 -----------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 916 AESPEI-----IFDNIL---NRKIPWPCVPS----------------------DMSFEAQ 945
+ IF IL + WP + S + +
Sbjct: 203 GST-VEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
DL+ + L + R+ A A + HPFF
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMK---HPFFL 286
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 86/335 (25%), Positives = 134/335 (40%), Gaps = 86/335 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIER----ILAERN 739
+ +E + I GA+G+VF AR + G A LK++ + + R
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRV----QTGEEGMPLSTIRE 61
Query: 740 I-----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEED 787
+ L T +P VVR F L LV E+++ DL + L KV + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ + +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSF 172
Query: 848 PETDGIMPSDAHY-PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
V T Y APE+LL + + D WSVG I E
Sbjct: 173 QMA---------LTSV------------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 907 FITGIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDM 940
P F S ++ I D ++ + +P +D+
Sbjct: 212 MFRRKPLFRGSS-DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 941 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+DL+ + L +P +R+ A A HP+F+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALS---HPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 89/337 (26%), Positives = 131/337 (38%), Gaps = 81/337 (24%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------IRKNDIER 733
+ +E + I +G FG VF AR R TG A LKK+ M +R+ I +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQ 71
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+L N+ + + + C+ ++YLV ++ DL LL V +
Sbjct: 72 LLKHENV-VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETD 851
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL+ L
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL------------- 176
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
++ Y T NR V T Y PE+LLG G D W G I+ E T
Sbjct: 177 ---AKNSQPNRY--T-NR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 911 IPPFTAESPEI-----IFDNIL---NRKIPWPCVPS------------------------ 938
P + E I + ++ WP V +
Sbjct: 226 SPIMQGNT-EQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAY 282
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
A DLI++ L+ DP QR+ ++ A H FF
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 747
++I+ + G V+LA AIK + + K + ++R E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V D YLVMEY+ G L + G L D A + +++ +++ H +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRD+KP N+LI + +K+ DFG++K L ++ +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTN-------------------- 170
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+GT Y +PE G D +S+GI+L+E + G PPF E+ I +
Sbjct: 171 -----HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
Query: 928 NRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 959
+P V D+ ++I R D R
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-41
Identities = 84/340 (24%), Positives = 140/340 (41%), Gaps = 82/340 (24%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERN 739
+ R +D F++ + +G FG V L ++++TG AIK V+ D +N R L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRN---RELQIMQ 71
Query: 740 ILITVRNPFVVR---FFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC----LEEDV 788
L + +P +V+ +FY+ RD L +VMEY+ L+ R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 789 ARIYIAELVLALEYLH--SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDL 845
++++ +L+ ++ LH S+ + HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---------- 180
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 904
+ Y + + Y APE++ G + A D WSVG I
Sbjct: 181 -------KLSPSEPNVAY-----------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 905 FEFITGIPPFTAESP-----EII----------FDNILN----------RKIPW----PC 935
E + G P F ++ EI+ + + IPW
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ EA DL++ L + P +R+ E HP+F
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFD 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 89/334 (26%), Positives = 132/334 (39%), Gaps = 81/334 (24%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+R + K I G+FG V+ A+ +G+L AIK K+ D E I+
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KV----LQDKRFKNRELQIM 101
Query: 742 ITVRNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGC----LEEDVARI 791
+ + +VR FFYS + + L LV++Y+ +Y + R L ++
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
Y+ +L +L Y+HS GI HRD+KP NLL+ +KL DFG +K
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------- 205
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909
+ Y + + Y APE++ G T++ + D WS G +L E +
Sbjct: 206 --QLVRGEPNVSY-----------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 910 GIPPFTAESP-----EII----------------------FDNILNRKIPWP-CVPSDMS 941
G P F +S EII F I + PW
Sbjct: 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRTP 310
Query: 942 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
EA L +R L + P RL E AH FF
Sbjct: 311 PEAIALCSRLLEYTPTARL---TPLEACAHSFFD 341
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 747
+E+ + + G V LAR A+KVL+ D+ R R E + +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 748 FVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H GI+HRD+KP N++I+ +K+ DFG+++ + ++ ++
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVT----------------- 174
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922
QT + +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 175 -QTA-----AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ ++ IP +S + ++ + L +P R
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 45/285 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LDMIRKNDIERILAERNILITVR 745
+ + + I G FG+V+ A GD A+K + D IE + E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P ++ NL LVME+ GG L +L + D+ + ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 806 LG---IVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIGLINNTIDLSGPETDGIM 854
I+HRDLK N+LI +K+TDFGL++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------------------ 165
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ SA G ++APE++ + +D WS G++L+E +TG PF
Sbjct: 166 -----------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + K+ +PS L+ DP+ R
Sbjct: 215 RGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-39
Identities = 79/326 (24%), Positives = 133/326 (40%), Gaps = 61/326 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
DF++ + GA+G V A + TG++ AIK K++ K R L E IL +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFK 67
Query: 746 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
+ ++ F +N +Y++ E + DL+ ++ L +D + +I + + A+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAV 125
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ LH ++HRDLKP NLLI + +K+ DFGL++I + + M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM------ 179
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES- 918
E+ V T Y APE++L ++ A D WS G IL E P F
Sbjct: 180 VEF-----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 919 ---------------PEIIFDNILN-------------RKIPWPCVPSDMSFEAQDLINR 950
+ I + P + ++ + DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 951 FLIHDPNQRLGANGAAEVKAHPFFKG 976
L+ DP +R+ A E HP+ +
Sbjct: 289 MLVFDPAKRI---TAKEALEHPYLQT 311
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 56/296 (18%)
Query: 678 SSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 735
+ H ID + ++ G ++ R + G+ +KVLK D
Sbjct: 2 NKHSG---IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFN 55
Query: 736 AERNILITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA-RIY 792
E L +P V+ + + L+ ++ G LY++L + D + +
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 793 IA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
A ++ + +LH+L I L +++I D +++ +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------------- 161
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFE 906
+Q + P ++APE L +AD WS ++L+E
Sbjct: 162 ------------SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
Query: 907 FITGIPPFTAESP-EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+T PF S EI L R P +P +S L+ + DP +R
Sbjct: 204 LVTREVPFADLSNMEIGMKVALEGLR----PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-39
Identities = 93/327 (28%), Positives = 137/327 (41%), Gaps = 82/327 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ K I G+FG VF A+ + + AIK K+ D E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KV----LQDKRFKNRELQIMRIVKHPN 93
Query: 749 VVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 798
VV FFYS + + L LV+EY+ +Y R + + ++Y+ +L+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 799 ALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+L Y+HS+GI HRD+KP NLL+ G +KL DFG +KI ++ +
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------------LIAGE 196
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916
Y + + Y APE++ G T + D WS G ++ E + G P F
Sbjct: 197 P-NVSY-----------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 917 ESP-----EII----------------------FDNILNRKIPWP-CVPSDMSFEAQDLI 948
ES EII F I R P+ +A DLI
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPDAIDLI 302
Query: 949 NRFLIHDPNQRLGANGAAEVKAHPFFK 975
+R L + P+ RL A E HPFF
Sbjct: 303 SRLLEYTPSARL---TAIEALCHPFFD 326
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 81/358 (22%), Positives = 134/358 (37%), Gaps = 113/358 (31%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ + K + G+FG V +G FA+K K+ D E +I+ + +
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KV----LQDPRYKNRELDIMKVLDHVN 61
Query: 749 VVRFFYSFTCRDN--------------------------------------LYLVMEYLN 770
+++ F + L ++MEY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 771 GGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGH 825
L+ +L+ + ++ IYI +L A+ ++HSLGI HRD+KP NLL+ + D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
+KL DFG +K + Y + + Y APE+
Sbjct: 181 LKLCDFGSAK-----------------KLIPSEPSVAY-----------ICSRFYRAPEL 212
Query: 886 LLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-----EII----------------- 922
+LG TE+ + D WS+G + E I G P F+ E+ II
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH 272
Query: 923 -----FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
F + + W + P A DL+ + L ++P+ R+ E AHPFF
Sbjct: 273 YTEVRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFF 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 83/331 (25%), Positives = 130/331 (39%), Gaps = 75/331 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---------RN 739
+ +KP+ G G VF A AIK K+ + ++ L E N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 740 I-----LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
I ++ + S T +++Y+V EY+ DL ++L + G L E+ AR+++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMY 127
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+L+ L+Y+HS ++HRDLKP NL I D +K+ DFGL++I D
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------------MDPH 174
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912
H E + T Y +P +LL + A D W+ G I E +TG
Sbjct: 175 YSHKGHLSEG-----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 913 PFTAESP----EIIFD-------------------NILN----RKIPWPCVPSDMSFEAQ 945
F ++I + I N P + +S EA
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 946 DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
D + + L P RL A E +HP+
Sbjct: 284 DFLEQILTFSPMDRL---TAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-37
Identities = 81/327 (24%), Positives = 132/327 (40%), Gaps = 76/327 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ + GA+G V A + +G+ AIK KL +++I R E +L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 745 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ F + N YLVM ++ DL ++ E+ + + +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS G+VHRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADA 178
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 179 EMTGY-----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
I + + + + + S +A DL+
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ L D ++RL AA+ HPFF+
Sbjct: 288 KMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 79/354 (22%), Positives = 127/354 (35%), Gaps = 74/354 (20%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 707
S T + LI S S SG PL +RT +++K I +G +G V++ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLV---QRTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 708 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFF----YSFTCRDN 761
R G+ A+KV + E I TV R+ ++ F
Sbjct: 58 WR--GEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 813
LYL+ +Y G LY L+ + + ++ V L +LH+ I HRDL
Sbjct: 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K N+L+ +G + D GL+ E D ++
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVK------FISDTNEVDIPP-----------------NT 205
Query: 874 AVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGI----------PPFTAE 917
VGT Y+ PE+L + + AD +S G+IL+E P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 918 SP-----EIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P E + + + +K P + + L+ H+P RL A
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 79/325 (24%), Positives = 131/325 (40%), Gaps = 67/325 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
+ + I GA+G V A AIK K+ +R L E IL+ R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83
Query: 746 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
+ ++ + +Y+V + + DLY LL+ L D ++ +++ L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+Y+HS ++HRDLKP NLL+ +K+ DFGL+++ D
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFL 188
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
EY V T Y APEI+L ++ + D WSVG IL E ++ P F +
Sbjct: 189 TEY-----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 920 ----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRF 951
I I+N K+PW + + +A DL+++
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKG 976
L +P++R+ + AHP+ +
Sbjct: 298 LTFNPHKRI---EVEQALAHPYLEQ 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-36
Identities = 66/334 (19%), Positives = 114/334 (34%), Gaps = 77/334 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------DIERILAER 738
+ + + IS G++G V + G AIK + + +R+L E
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 739 NILITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIY 792
+L +P ++ F + LYLV E + DL ++ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ ++L L LH G+VHRDL P N+L+A + I + DF L++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADA 188
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911
Y V Y APE+++ + D WS G ++ E
Sbjct: 189 NK------THY-----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 912 PPFTAESP----EIIFD-----------NILN--------------RKIPWPCVPSDMSF 942
F + I + + W V
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 943 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
A DLI + L +P +R+ + HP+F+
Sbjct: 292 VALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 83/326 (25%), Positives = 134/326 (41%), Gaps = 75/326 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ ++ + P+ GA+G V A TG A+K KL ++ I R E +L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 745 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ F + +YLV + G DL ++++ L +D + I +++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ T M
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTADEM---- 186
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 187 --TGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
++I I + K+ + V + A DL+
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFK 975
+ L+ D ++R+ AA+ AH +F
Sbjct: 294 KMLVLDSDKRI---TAAQALAHAYFA 316
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-36
Identities = 75/354 (21%), Positives = 123/354 (34%), Gaps = 104/354 (29%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
+E++K I +G+FG+V A A+K+++ + E IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQD 154
Query: 746 ---NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLAL 800
V+ +FT R+++ + E L +LY L++K + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+ LH I+H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQR 255
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y Y Q+ R Y APE++LG +G D WS+G IL E +TG P
Sbjct: 256 VYT-YIQS----RF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303
Query: 915 ------------------------------------------TAESPEIIFDNILNRKIP 932
T ++ + +R+
Sbjct: 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK 363
Query: 933 WPCVPSDMSFEAQ----------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
P + D + + L DP R+ A HP+ +
Sbjct: 364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA---LRHPWLRR 414
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-36
Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 75/327 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ ++P+ GA+G V A TG AIK KL ++++ R E +L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 745 RNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
R+ V+ + + YLVM ++ G DL L++ L ED + + +++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++ +D+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QADS 180
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 181 EMTGY-----------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
+ I + + K + + ++ S A +L+
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 950 RFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ L+ D QR+ A E AHP+F+
Sbjct: 290 KMLVLDAEQRV---TAGEALAHPYFES 313
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 68/322 (21%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
LD + + K+ LI D + SG PL +RT + + I +G FG V
Sbjct: 5 LDRPFISEGTTLKD---LIYDMTTSGSGSGLPLLV---QRTIARTIVLQESIGKGRFGEV 58
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRDN 761
+ + R G+ A+K+ + E I T +R+ ++ F + +
Sbjct: 59 WRGKWR--GEEVAVKIF------SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 762 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIV 809
L+LV +Y G L+ L + E + ++ L +LH I
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDLK N+L+ +G + D GL+ + T +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVR-----------------------HDSATDTIDI 206
Query: 870 NRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ VGT Y+APE+L + E AD +++G++ +E
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--- 263
Query: 924 DNILNRKIPWP-CVPSDMSFEA 944
++P+ VPSD S E
Sbjct: 264 ------QLPYYDLVPSDPSVEE 279
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-35
Identities = 87/358 (24%), Positives = 134/358 (37%), Gaps = 74/358 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
D +EI I G++G V A + + AIK K+ + ++ I+ RIL E IL +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 745 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
+ VV+ D LY+V+E D L R L E + + L++
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++Y+HS GI+HRDLKP N L+ D +K+ DFGL++ + P + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 918
+ + R V T Y APE++L E+ A D WS+G I E + I A
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 919 P-----------------------------------EIIFD------------------- 924
+IF+
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 925 NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ S +A L+ R L+ +PN+R+ N HPFFK V
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA---HPFFKEV 403
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 62/283 (21%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+RT D +++ + +G +G V+ + G+ A+K+ D + E +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETELY 54
Query: 742 ITV--RNPFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 795
TV R+ ++ F S L+L+ Y G LY L+ RI +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLS 113
Query: 796 LVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ L +LH I HRDLK N+L+ +G + D GL+ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----------- 162
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVG 901
+ + + + VGT Y+APE+L T + D W+ G
Sbjct: 163 ------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
++L+E + + + K P+ VP+D SFE
Sbjct: 211 LVLWEVARRMVS---------NGIVEDYKPPFYDVVPNDPSFE 244
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 75/363 (20%), Positives = 137/363 (37%), Gaps = 101/363 (27%)
Query: 678 SSHKERTSIDDFEIIKP-ISRGAFGRVFLARKR--TTGDLFAIKVLKKLDM----IRKND 730
SS +ER D FE + RG +G V+ A+++ +A+K ++ + R+
Sbjct: 12 SSERER-VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70
Query: 731 IERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------- 783
+ R L N+ I+++ F+ ++L+ +Y DL+ +++
Sbjct: 71 LLRELKHPNV-ISLQKVFLSH------ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 784 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 837
L + + + +++ + YLH+ ++HRDLKP N+L+ + G +K+ D G +++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL- 181
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 896
+ P D V T Y APE+LLG H A D
Sbjct: 182 --------------------FNSPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAID 218
Query: 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNR----KI------P----WPCVPS---- 938
W++G I E +T P F +I N + +I P W +
Sbjct: 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH 278
Query: 939 --------------------------DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
+A L+ + L DP +R+ + A + P
Sbjct: 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---DP 335
Query: 973 FFK 975
+F
Sbjct: 336 YFL 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 72/346 (20%), Positives = 120/346 (34%), Gaps = 81/346 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
F +I+ + G FGRV L + +A+KV++ + E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKIQNDD 92
Query: 746 --NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
N +V++ F D++ L+ E L G LY ++ + + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI-------- 853
YL + + H DLKP+N+L+ K I + ++ GI
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD--GKKIQIYRTKSTGIKLIDFGCA 209
Query: 854 -MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
SD H T R Y APE++L ++D WS G +L E TG
Sbjct: 210 TFKSDYHGS-IINT----RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 913 PFTAES----------------PEII----------FDNILNRKIPWPCVPSDMSF---- 942
F ++ + N K+ WP S ++
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 943 -------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
D + L DP R + H F +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK---HKFLE 360
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 84/337 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 745 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ ++ FT + + +Y+VME + +L +++ L+ + + +++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 183
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y V T Y APE++LG + D WSVG I+ E I G F
Sbjct: 184 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 915 ---------------TAESPEIIFDNILN--------RKIPW------------PCVPSD 939
E + + + +
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ +A+DL+++ L+ D ++R+ E HP+
Sbjct: 291 KASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-34
Identities = 84/356 (23%), Positives = 142/356 (39%), Gaps = 78/356 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
D++ I I RG++G V+LA + T AIK K++ + ++ I+ RIL E IL +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 745 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
++ +++R + D LY+V+E DL L + L E+ + + L+L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++H GI+HRDLKP N L+ D +K+ DFGL++ ++ + P +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 860 YPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
+Q T + V T Y APE++L E+ + D WS G I E + + +
Sbjct: 202 KNLKKQLTSH------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 918 SP--------------------------------EIIFD-----------NILN------ 928
IIF+ NI
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 929 -------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ I +S + +L+ L +PN+R+ + HP+ K V
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDV 368
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 74/357 (20%), Positives = 123/357 (34%), Gaps = 107/357 (29%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP- 747
+ +++ + G F V+LA+ A+K+++ K E E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 76
Query: 748 ----------FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
+++ F + + +V E L G +L +L++K + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 792 YIAELVLALEYLHS-LGIVHRDLKPDNLLIAH------DGHIKLTDFGLSKIGLINNTID 844
+L+L L+Y+H GI+H D+KP+N+L+ IK+ D G +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
D HY QT R Y +PE+LLG G AD WS ++
Sbjct: 186 ---------CWYDEHYTNSIQT----RE-------YRSPEVLLGAPWGCGADIWSTACLI 225
Query: 905 FEFITGIPPFTAESPEI-------------------------------IFDNILNRKI-- 931
FE ITG F + F++ +
Sbjct: 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285
Query: 932 ---PWP---CVPSDMSFEAQ------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
WP + F D ++ L DP +R A G HP+ K
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN---HPWLKD 339
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 33/286 (11%), Positives = 70/286 (24%), Gaps = 60/286 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V R R +V E++ GG L + R + L A + H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
+ D +G L+ + P
Sbjct: 175 -----------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 929 RKIPWPCVPS----DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
P P+ D+ F+ + R + D R + ++
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 87/340 (25%), Positives = 149/340 (43%), Gaps = 64/340 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+E++K + +GA+G V+ + R TG++ A+K K+ +N + R E IL +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 745 RN-PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+V ++ +YLV +Y+ DL++++R LE + + +L+ ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIK 123
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLHS G++HRD+KP N+L+ + H+K+ DFGLS+ + + + P + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP- 919
+ TD V T Y APEILLG T++ D WS+G IL E + G P F S
Sbjct: 184 QPILTD------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 920 ---EIIFD-------------------NILNRKIPWPCVP-------------------- 937
E I ++ +
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 938 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+D + EA DL+++ L +PN+R+ A + HPF
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 75/337 (22%), Positives = 131/337 (38%), Gaps = 84/337 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 745 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ ++ FT + +YLVME + +L +++ L+ + + +++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 220
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y V T Y APE++LG + D WSVG I+ E + F
Sbjct: 221 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 915 ---------------TAESPEIIFDNILN--------RKIPWPCV------------PSD 939
E + + + N + +P +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 328 KASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-33
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIE-RILAERNILITVRN 746
+EI I +G+FG+V A R + AIK++K K + + IE R+L N T
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLH 804
++V F R++L LV E L +LY LLR + ++ R + ++ AL +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 805 S--LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ L I+H DLKP+N+L+ + IK+ DFG S Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------------CQLGQRIY 216
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
Y Q+ R Y +PE+LLG + A D WS+G IL E TG P F+ +
Sbjct: 217 Q-YIQS----RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 71/352 (20%), Positives = 108/352 (30%), Gaps = 95/352 (26%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 733
+EI+ + G FG+V A+K+++ L I++ D E
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
+ V F ++ + E L G + + L++ R
Sbjct: 81 ---KFLC---------VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 846
+L AL +LH + H DLKP+N+L + L + S D
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
+ H T RH Y PE++L D WS+G ILFE
Sbjct: 188 S----ATFDHEHHTT-IVAT----RH-------YRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 907 FITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSD------ 939
+ G F P + +K + W SD
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291
Query: 940 --------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ DL+ R L DP QR+ A HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL---HPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 70/354 (19%), Positives = 116/354 (32%), Gaps = 99/354 (27%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 733
+EI+ + GAFG+V + G A+K++K L+ + D
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
V+ F ++ +V E L G Y +++ G D R
Sbjct: 76 ---TFRC---------VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 846
++ ++ +LHS + H DLKP+N+L + + + + + +D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF- 181
Query: 847 GPETDG--IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
G + H T RH Y APE++L D WS+G IL
Sbjct: 182 -----GSATYDDEHHST-LVST----RH-------YRAPEVILALGWSQPCDVWSIGCIL 224
Query: 905 FEFITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSDMSF- 942
E+ G F P+ + RK + W S +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 943 -------------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
DLI + L +DP +R+ A + HPFF +
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK---HPFFDLL 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 58/282 (20%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-- 743
+D+ ++++ I RG +G V+ A+KV + + + E+NI
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 744 VRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ + + RF + R LVMEY G L L R+ +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122
Query: 799 ALEYLHS---------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
L YLH+ I HRDL N+L+ +DG ++DFGLS
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR------------- 169
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGI 902
+ ++ S VGT Y+APE+L G D +++G+
Sbjct: 170 ------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
I +E + +++ ++ + V + +FE
Sbjct: 224 IYWEIFMR------CTDLFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 53/300 (17%), Positives = 107/300 (35%), Gaps = 69/300 (23%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-- 724
SSGV + ++ ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 7 HHSSGVDLGT-ENLYFQS--MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ 61
Query: 725 -MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLR 779
+ ++ L +++ +++F + + L+L+ + G L L+
Sbjct: 62 SWQNEYEVY-------SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 780 KVGCLEEDVARIYIAELVLALEYLHS----------LGIVHRDLKPDNLLIAHDGHIKLT 829
++ I + L YLH I HRD+K N+L+ ++ +
Sbjct: 115 ANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 886
DFGL+ + + H VGT Y+APE+L
Sbjct: 174 DFGLALKFEAGKSAG-------------------------DTHGQVGTRRYMAPEVLEGA 208
Query: 887 LGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
+ + D +++G++L+E + E +P+ + S E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--------YMLPFEEEIGQHPSLE 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 49/276 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-- 746
+ +I+ + G F V+L+ A+KV+K ++ E L E +L +VRN
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSD 94
Query: 747 ------PFVVRFFYSFT---------CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVA 789
VV+ F C +V E L G L + K L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 790 RIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
+ I +++ L+YLH+ I+H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 849 ETDGIM------------PSDAHYPEYQQTD-------NRNRHSAVGTPDYLAPEILLGT 889
P +A + + D +++ + T Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 890 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ AD WS + FE TG F S E +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
F + K I G FG + L + T + AIK+ K+ ++ E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + +Y C +V+E L G L L + V I I +L+ +EY+HS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAI-QLISRMEYVHS 123
Query: 806 LGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+++RD+KP+N LI G+ I + DF L+K ID + H
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-----YIDPETKK---------HI 169
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 917
P R S GT Y++ LG E D ++G + F+ G P A+
Sbjct: 170 PY------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223
Query: 918 SPEIIFDNILNRKI 931
+ + + I + K
Sbjct: 224 TLKERYQKIGDTKR 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 38/257 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ +Y + LV++ L G L LL G + VA +++ ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK-QMLARVQSIHE 124
Query: 806 LGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+V+RD+KPDN LI + I + DFG+ K T H
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--------------KQHI 170
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 917
P R + + GT Y++ LG E D ++G + F+ G P A
Sbjct: 171 PY------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 918 SPEIIFDNILNRKIPWP 934
+ + ++ I +K P
Sbjct: 225 TNKQKYERIGEKKQSTP 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 58/252 (23%), Positives = 96/252 (38%), Gaps = 36/252 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+ + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + D +VME L G L L + V + +++ +EY+HS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-QMISRIEYIHS 123
Query: 806 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K D + H P
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-----KYRDARTHQ---------HIP- 168
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAESP 919
R + GT Y + LG E D S+G +L F G P A +
Sbjct: 169 -----YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223
Query: 920 EIIFDNILNRKI 931
++ I +K+
Sbjct: 224 RQKYERISEKKM 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D + + I RG FG VF R R L A+K ++ + + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 805
P +VR T + +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N L+ +K++DFG+S+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----------------EEADGVYAA---- 270
Query: 866 TDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
P + APE L + +D WS GI+L+E + G P+
Sbjct: 271 -----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 668 QSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLK 721
G L + T + I+ + G FG+V L T D + A+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 722 KLDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLR 779
E +IL T+ + ++++ +L LVMEY+ G L L
Sbjct: 70 --ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 780 KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
+ I +A+L+L + YLH+ +HRDL N+L+ +D +K+ DFG
Sbjct: 128 R--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
L+K + + DG P + APE L +
Sbjct: 180 LAK--AVPEGHEYYRVREDGDSPV----------------------FWYAPECLKEYKFY 215
Query: 893 YAADWWSVGIILFEFIT 909
YA+D WS G+ L+E +T
Sbjct: 216 YASDVWSFGVTLYELLT 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 66
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 120
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 163
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+P D + ++ + +P + APE L ++ A+D WS G++L+E T
Sbjct: 164 LPQDKEF--FKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 672 VSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDM 725
VS ++ + T + + I+ + G FG+V L R GD A+K LK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PE 61
Query: 726 IRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
N I + E IL + + +V++ + + + L+ME+L G L L K
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--- 118
Query: 784 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ +I + + + ++YL S VHRDL N+L+ + +K+ DFGL+K
Sbjct: 119 ---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK- 174
Query: 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAA 895
+ +D Y Y D+R+ +P + APE L+ ++ A+
Sbjct: 175 ----------------AIETDKEY--YTVKDDRD------SPVFWYAPECLMQSKFYIAS 210
Query: 896 DWWSVGIILFEFIT 909
D WS G+ L E +T
Sbjct: 211 DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 97
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQYT 151
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 194
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
+P D Y Y+ + +P + APE L ++ A+D WS G++L+E T I
Sbjct: 195 LPQDKEY--YKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 913 PFTAESPEIIFDNILNRKIPWP 934
++SP F ++
Sbjct: 247 K--SKSPPAEFMRMIGN-DKQG 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 681 KERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK------------- 722
E +DD + + K I G FG ++LA + A V+K
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELK 85
Query: 723 -LDMIRKNDIERILAERNILITVRNPFVVRF-FYSFTCRDNLYLVMEYLNGGDLYSLLRK 780
+ K D + ER L + P F R ++VME L G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 781 VGCL-EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIG 837
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 145 NGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
N Y E R GT ++ + + G +D
Sbjct: 204 CPNGN--------------HKQYQE------NPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 898 WSVGIILFEFITG 910
+G + ++ G
Sbjct: 244 EILGYCMLRWLCG 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 49/265 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 742
+ I + +G FG V L R GD L A+K L+ ++ D E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF---QREIQILK 79
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
+ + F+V++ R +L LVMEYL G L L++ AR+ + L+L
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLYS 133
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL S VHRDL N+L+ + H+K+ DFGL+K +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK-----------------L 176
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911
+P D Y Y + +P + APE L +D WS G++L+E T
Sbjct: 177 LPLDKDY--YVVREPG------QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 912 PPFTAESPEIIFDNILNRKIPWPCV 936
+ + + +
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRL 253
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-21
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
F + + I G+FG ++L T + AIK+ K ++L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + D LVM+ L G L L + V + +++ +E++HS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD-QMINRVEFVHS 121
Query: 806 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K D S + H P
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----KYRDTSTHQ---------HIPY 167
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---AESP 919
R + GT Y + LG E D S+G +L F+ G P+ A +
Sbjct: 168 ------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
Query: 920 EIIFDNILNRKIPWP 934
+ ++ I +K+
Sbjct: 222 KQKYEKISEKKVATS 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 292
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 331
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY P + APE L +D WS GI+L E T G P+
Sbjct: 332 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 35/232 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ E +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HR+L N L+ + +K+ DFGLS++ D Y
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-----------MTGD----------TYT 374
Query: 865 QTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 375 AHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 375
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 414
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY P + APE L +D WS GI+L E T G P+
Sbjct: 415 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 48/241 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 798
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 914 F 914
+
Sbjct: 220 Y 220
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 46/276 (16%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDL----- 714
+ S L I D +++ PI +G FG ++LA ++ +
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 715 FAIKVLKK-----------LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
+KV K + + L + P Y
Sbjct: 68 CVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY-WGSGLHDKNGKSY 126
Query: 764 --LVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
++M+ G DL + + V ++ + ++ LEY+H VH D+K NLL
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL-RILDILEYIHEHEYVHGDIKASNLL 184
Query: 820 I--AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 877
+ + + L D+GL+ Y + GT
Sbjct: 185 LNYKNPDQVYLVDYGLAYRYCPEGV--------------HKAYAA------DPKRCHDGT 224
Query: 878 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
++ + + G D +G + +++TG P
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 679 SHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRK 728
S + + ++D I + + +G FG V A+ + F A+K+LK D+I
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIAS 66
Query: 729 NDIERILAERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+DIE L E + +P V + + +++ ++ GDL++ L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 783 CLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
E + + LV +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 127 IGENP-FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN---RHSAVGTPDYLAPEILLGTEHG 892
I D Y+Q + +LA E L +
Sbjct: 186 ----------------KIYSGD----YYRQGCASKLPVK--------WLALESLADNLYT 217
Query: 893 YAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928
+D W+ G+ ++E +T G P+ I++ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 48/242 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
D +++ + G+FG V +G A+K LK + + ++ + E N + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ + ++R Y + +V E G L LRK + L
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQV 130
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ YL S +HRDL NLL+A +K+ DFGL + + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQN 174
Query: 857 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D HY P + APE L +A+D W G+ L+E T G
Sbjct: 175 DDHY-----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 913 PF 914
P+
Sbjct: 224 PW 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ E + ++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL N L+ + +K+ DFGLS++
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ I G FG V L + AIK +++ M E + E +++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
P +V+ + + + LV E++ G L LR L+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEG 116
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ YL ++HRDL N L+ + IK++DFG+++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 687 DDFEI--------IKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILA 736
+ + K + G FG V + + A+K+LK + + +LA
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 67
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E N++ + NP++VR ++ LVME G L L++ +++ + ++
Sbjct: 68 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 38/151 (25%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
++ ++K + G FG V L + + D+ A+K++K+ M + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 805
P +V+F+ + +Y+V EY++ G L + LR G E + + ++ + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 48/253 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 798
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 914 FTAESPEIIFDNI 926
+ I +
Sbjct: 220 YDGIPASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 34/152 (22%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ + G FG V++ + A+K LK+ M + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 804
+VR + T ++ +Y++ EY+ G L L+ ++ + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +K + G FG V + R D+ AIK++K+ M + + E +++ + +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + T + ++++ EY+ G L + LR++ R +L+ A
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEA 132
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+EYL S +HRDL N L+ G +K++DFGLS+
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 675 PLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKN 729
P + I+ I K I G G V R R G AIK LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ER 92
Query: 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 789
L+E +I+ +P ++R T +V EY+ G L + LR
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------G 146
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ I +LV + YL LG VHRDL N+L+ + K++DFGLS+ ++ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDD 204
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
D + T G +P + T APE + A+D WS G+
Sbjct: 205 PDAAYTTTGGKIP-------IRWT---------------APEAIAFRTFSSASDVWSFGV 242
Query: 903 ILFEFIT-GIPPF 914
+++E + G P+
Sbjct: 243 VMWEVLAYGERPY 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 34/165 (20%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 739
+D + + +G F ++F +R GD +KVL K +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVL 798
++ + + +V + C D LV E++ G L + L+K + ++ +A +L
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 835
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-19
Identities = 35/157 (22%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ K + G FG V++A + A+K +K M +E LAE N++ T+++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ T ++ +Y++ E++ G L L+ ++ ++ + +L+
Sbjct: 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEG 296
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 51/271 (18%)
Query: 659 SRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--- 715
+ + + S + + E K I G FG V+ +T+
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEI-HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP 75
Query: 716 -AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774
AIK LK + L E I+ + ++R + + ++ EY+ G L
Sbjct: 76 VAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 775 YSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827
LR+ + +LV ++YL ++ VHRDL N+L+ + K
Sbjct: 134 DKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK 187
Query: 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT--P-DYLAPE 884
++DFGLS++ D Y + G P + APE
Sbjct: 188 VSDFGLSRV------------------LEDDPEATY---------TTSGGKIPIRWTAPE 220
Query: 885 ILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
+ + A+D WS GI+++E +T G P+
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 53/255 (20%)
Query: 675 PLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRK 728
+ + T + +K + G FG V G+ IKV++ D +
Sbjct: 2 AMKVLARIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGR 56
Query: 729 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 788
+ + + ++ + +VR +L LV +YL G L +R+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQ------HR 109
Query: 789 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
+ L+ + YL G+VHR+L N+L+ +++ DFG++
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD------ 163
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSV 900
++P D ++ + TP ++A E + ++ + +D WS
Sbjct: 164 -----------LLPPDDKQ--LLYSEAK-------TPIKWMALESIHFGKYTHQSDVWSY 203
Query: 901 GIILFEFIT-GIPPF 914
G+ ++E +T G P+
Sbjct: 204 GVTVWELMTFGAEPY 218
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 46/273 (16%), Positives = 92/273 (33%), Gaps = 52/273 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL--------FAIKVLKK--------LDMIRKNDIE 732
+++ +R G ++ A +T F++K+ K R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNL-YLVMEYLNGGDLYSLLRKVGCL---EEDV 788
++ + L + + +D +LV+ L G L S L E V
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 789 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDLS 846
++ L+ ALE+LH VH ++ +N+ + + L +G +
Sbjct: 162 LQVAC-RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR---------- 210
Query: 847 GPETDGIMPSDAH--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
PS H Y E +R G ++++ ++ G +D S+G +
Sbjct: 211 ------YCPSGKHVAYVE------GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
Query: 905 FEFITGIPP---FTAESPEIIFDNILNRKIPWP 934
+++ G P + +I+ P P
Sbjct: 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 26/197 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKE--RTSIDDFEI-------IKPISRGAFGRVFLARKRTTGD 713
+ S S+ L E + ++D I K + G FG V +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 714 LF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-----YSFTCRDNLYLV 765
A+K +K D + +IE L+E + +P V+R S ++
Sbjct: 61 TSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNL 818
+ ++ GDL++ L LE I + L+ +EYL + +HRDL N
Sbjct: 120 LPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 819 LIAHDGHIKLTDFGLSK 835
++ D + + DFGLSK
Sbjct: 179 MLRDDMTVCVADFGLSK 195
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 57/266 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + + + +G+FG V+ K D AIK + + +R + L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVL 798
VVR + ++ME + GDL S LR +A +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 799 -------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---------------- 186
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYL-----APEILLGTEHGY--AADWWSVGIIL 904
D + +Y + + L +PE L + + +D WS G++L
Sbjct: 187 -----DIYETDYYRKGGKGL---------LPVRWMSPESLK--DGVFTTYSDVWSFGVVL 230
Query: 905 FEFIT-GIPPFTAESPEIIFDNILNR 929
+E T P+ S E + ++
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 673 STPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIR 727
+ +H KE T+I I K + G FG V R + AIK LK
Sbjct: 32 TQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-- 86
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
+ L E +I+ +P ++R T + +V EY+ G L S LRK
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 788 VARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
A+ + +LV ++YL +G VHRDL N+LI + K++DFGL ++
Sbjct: 142 -AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV---- 196
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWS 899
D Y + P + +PE + + A+D WS
Sbjct: 197 --------------LEDDPEAAYTTRGGK-------IPIRWTSPEAIAYRKFTSASDVWS 235
Query: 900 VGIILFEFIT-GIPPF 914
GI+L+E ++ G P+
Sbjct: 236 YGIVLWEVMSYGERPY 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 50/242 (20%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
D+ I + G FG V R AIKVLK+ K D E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ NP++VR + L LVME GG L+ L I ++ +
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQV 119
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++YL VHRDL N+L+ + + K++DFGLSK +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA----------------LGAD 163
Query: 857 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D++Y + P + APE + + +D WS G+ ++E ++ G
Sbjct: 164 DSYY-----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 913 PF 914
P+
Sbjct: 213 PY 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 743
+D + + + G FG V+ A+K KK + E+ ++E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +P +V+ + +++ME G+L L + + + LVL
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQI 122
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 684 TSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIER 733
+S D+EI + I G FG V + + AIK K E+
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREK 62
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
L E + +P +V+ + ++++ME G+L S L+ + +
Sbjct: 63 FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK------YSLDL 115
Query: 794 AELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
A L+L AL YL S VHRD+ N+L++ + +KL DFGLS+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ I +G FG V L R A+K +K + LAE +++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73
Query: 747 PFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 803
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 60/302 (19%)
Query: 647 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
K+ + ++ + + +D + + + + S + I RG FG V+
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHG 108
Query: 707 RKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNL 762
A+K L ++ I ++ + L E I+ +P V+ +
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 763 YLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+V+ Y+ GDL + +R +G VA+ +++L S VHRD
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK--------GMKFLASKKFVHRD 217
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN---- 868
L N ++ +K+ DFGL++ + + +
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARD----------------MYDKE--FDSVHNKTGAKLP 259
Query: 869 -RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926
+ ++A E L + +D WS G++L+E +T G PP+ + I +
Sbjct: 260 VK----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 927 LN 928
L
Sbjct: 310 LQ 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ I RG FG V+ A+K L ++ I ++ + L E I+ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 747 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAE 795
P V+ + +V+ Y+ GDL + +R +G VA+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK----- 139
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++YL S VHRDL N ++ +K+ DFGL++ + + +T +P
Sbjct: 140 ---GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
++A E L + +D WS G++L+E +T G PP+
Sbjct: 196 V----------------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 915 TAESPEIIFDNILN 928
+ I +L
Sbjct: 234 PDVNTFDITVYLLQ 247
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 9e-18
Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 36/246 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 743
+ E+ + I G FG V + + AIK K + E+ L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQ 447
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 802
+P +V+ + ++++ME G+L S L+ L+ +Y +L AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRD+ N+L++ + +KL DFGLS+ + ++
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDST------------------Y 546
Query: 863 YQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920
Y+ + + P ++APE + A+D W G+ ++E + G+ PF
Sbjct: 547 YKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 921 IIFDNI 926
+ I
Sbjct: 600 DVIGRI 605
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
D + + + GAFG+VFLA + L A+K LK + + D E +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELL 71
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVARIY 792
+++ +V+F+ D L +V EY+ GDL LR G + +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 793 IAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+++++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-17
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII- 692
+ + P + + + +D+ S S P K+ D +I
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 693 -KPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
+ G FG V R AIKVLK+ K D E ++ E I+ + NP++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYI 398
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEY 802
VR + L LVME GG L+ L I ++ + ++Y
Sbjct: 399 VRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKY 451
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L VHR+L N+L+ + + K++DFGLSK + D++Y
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA----------------LGADDSYY-- 493
Query: 863 YQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
+ P + APE + + +D WS G+ ++E ++ G P+
Sbjct: 494 ---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
D + + GAFG+VFLA + L A+K LK+ + D E +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELL 97
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYI 793
+++ +VRFF T L +V EY+ GDL LR G + + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 794 AELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+L+ + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + K + G FG+V A R A+K+LK+ ++ +L+E N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 784
V +P V++ + + + L L++EY G L LR+
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 785 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
D + + +L+ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V AR + G AIK +K+ K+D E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 745 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--- 800
+P ++ + R LYL +EY G+L LRK LE D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 801 -------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHS-SHKE-RTSIDDFEIIKPISRGAFGRVFLARKRT 710
SKY + + I D++S S V + + + ++F+ I G FG+V+ R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 711 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTC--RDNLYLVME 767
G A+K IE E L R+P +V + C R+ + L+ +
Sbjct: 63 -GAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGF---CDERNEMILIYK 115
Query: 768 YLNGGDLYSLLRKVGCLEED---VARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
Y+ G+L L R+ I L YLH+ I+HRD+K N+L+ +
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH--SAV-GTPDY 880
K+TDFG+SK G E QT H + V GT Y
Sbjct: 176 FVPKITDFGISKKG-----------------------TELDQT-----HLSTVVKGTLGY 207
Query: 881 LAPEILLGTEHGYA--------ADWWSVGIILFEFITGIPP 913
+ PE Y +D +S G++LFE +
Sbjct: 208 IDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ I +G FG V L R G+ A+K +K + LAE +++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQLRH 245
Query: 747 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 803
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER-ILAERNILITVRNPFVVRFF 753
+ G FG V+ + A+K L + I ++++ E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 754 -YSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEED-VARIYIAELVLA--LEYLHSLGI 808
+S D+L LV Y+ G L L G R IA A + +LH
Sbjct: 97 GFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA-QGAANGINFLHENHH 154
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L+ K++DFGL++ ++ QT
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-----------------------EKFAQTVM 191
Query: 869 RNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+R VGT Y+APE L G T +D +S G++L E ITG+P
Sbjct: 192 TSR--IVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V +A A+K+LK + D+ +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 51/259 (19%), Positives = 94/259 (36%), Gaps = 46/259 (17%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAER 738
ER + I +G FG V+ AIK L ++ ++ +E L E
Sbjct: 19 ERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREG 73
Query: 739 NILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
++ + +P V+ + ++++ Y+ GDL +R + +L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLI 127
Query: 798 L-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+EYL VHRDL N ++ +K+ DFGL++ +++
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHR 186
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909
+P + A E L +D WS G++L+E +T
Sbjct: 187 HARLPV----------------------KWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 910 GIPPFTAESPEIIFDNILN 928
G PP+ P + +
Sbjct: 225 GAPPYRHIDPFDLTHFLAQ 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 654 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLA----- 706
KY+ ++I S P + E+ ++ + K + GAFG+V A
Sbjct: 11 KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 765
K A+K+LK + E +++E I+ + +V + T + ++
Sbjct: 71 GKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--------------EYLHSLGIVHR 811
EY GDL + LR+ + E IA + +L S +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 812 DLKPDNLLIAHDGHIKLTDFGLS 834
D+ N+L+ + K+ DFGL+
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLA 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 23/169 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNIL 741
++ + FG+V+ AIK LK E E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLR 66
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL- 800
+++P VV T L ++ Y + GDL+ L + + + AL
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 801 ---------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
EYL S +VH+DL N+L+ ++K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ K + GAFG+V A K A+K+LK + + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------VGCLEEDVA 789
+ N +V + T ++ EY GDL + LR+ +E+D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+ + +L+ + +L S +HRDL N+L+ H K+ DFGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 31/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 784
NP +V+ + L+ EY+ GDL LR
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 785 EEDVARIYIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ AE + + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ G FG+V +A K A+K+LK + D+ +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL--- 798
+ +VR +++ME + GGDL S LR+ + + + +L+
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 799 ----ALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV---- 797
+ +VR ++++E + GGDL S LR+ + + + +L+
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 798 ---LALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK+ + +++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 742 ITV-RNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK---------VGCLEEDVAR 790
I + + VV + T L +++E+ G+L + LR V +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 791 IYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ + L+ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V LA K A+K+LK + D+ +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 740 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ + ++ + T LY+++EY + G+L L+ + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 799 AL----------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E K + GAFG+V A K A+K+LK+ + E +++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 742 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCL 784
+ + +V + T +YL+ EY GDL + LR
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 785 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
EED+ + +L+ +E+L VHRDL N+L+ H +K+ DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 5e-13
Identities = 45/219 (20%), Positives = 71/219 (32%), Gaps = 56/219 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERN 739
+ + + I G FG VF AIK++ ++ + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 740 IL-----------------ITVRNPFVVRFFY----------------------SFTCRD 760
I I + + V+ Y F D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 761 NLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNL 818
L++V+E+ GG DL + K+ A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 819 LIAHDGHIKLTDFGLSKI------GLINNTIDLSGPETD 851
L+ KL K GL + ID + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D+F + RG FG+V+ R G L A+K LK+ + + +++ E ++ +
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKE-ERTQGGELQ-FQTEVEMISMAVH 86
Query: 747 PFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLA 799
++R F C LV Y+ G + S LR E R IA L A
Sbjct: 87 RNLLRL-RGF-CMTPTERLLVYPYMANGSVASCLR--ERPESQPPLDWPKRQRIA-LGSA 141
Query: 800 --LEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L YLH I+HRD+K N+L+ + + DFGL+K+ +T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------------ 189
Query: 855 PSDAHYPEYQQTDNRNRH--SAV-GTPDYLAPEILLGTEHGYA---ADWWSVGIILFEFI 908
H +AV GT ++APE L G + D + G++L E I
Sbjct: 190 -----------------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELI 229
Query: 909 TGIPPF 914
TG F
Sbjct: 230 TGQRAF 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 1e-12
Identities = 92/661 (13%), Positives = 174/661 (26%), Gaps = 213/661 (32%)
Query: 396 HEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKL--SEIL 453
H +D ++++ E A +C DV + + E +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS--VFED-------AFVDNFDCKDVQDMPKSILSKEEI 51
Query: 454 EQISESCNSSSHP------ILGSPENSRTQSMNSAITYDGYSPKISEWRNK-----GVEG 502
+ I S ++ S +L E + + + + Y +S + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTR 110
Query: 503 MFEDIHEM---DTACIDDSHLGS----LNLRGHLGLKLS-----------GYGASSSTGS 544
M+ + + D ++ L LR L L+L G G +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLIDGVLGSGKTWVALD 169
Query: 545 MTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLAC 604
S F FWL ++ C + + + L
Sbjct: 170 --VCLSYKVQCKMDFKIFWL------------------NLKNCNSPETVLEMLQKLLYQI 209
Query: 605 MHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILD 664
+ HS L I + + + +LL+ K Y+ N L+L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----------------PYE-NCLLVLL 251
Query: 665 SV------------------SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
+V ++ V+ L ++ S+D
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLT----- 299
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV----RFFYSFTCR--- 759
L K LD R D L + NP +
Sbjct: 300 -PDEVKSLLL----KYLDC-RPQD----LPREVLTT---NPRRLSIIAESIRDGLATWDN 346
Query: 760 ------DNLYLVME----YLNGGDLYSLLRKVGCLEEDVARIYIAELVLA---------- 799
D L ++E L + + ++ +I ++L+
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKSD 403
Query: 800 ----LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ LH +V + K + I +++L ++ L + +D
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVD----------- 451
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------T 909
HY + D+ D L P Y + I
Sbjct: 452 ---HYNIPKTFDS----------DDLIPP----YLDQY----------FYSHIGHHLKNI 484
Query: 910 GIPPFTAESPEIIFD-NILNRKI-----PWPCVPSDMSFEAQDLIN--RFLI-HDP-NQR 959
P + D L +KI W S ++ Q L ++ +DP +R
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKFYKPYICDNDPKYER 543
Query: 960 L 960
L
Sbjct: 544 L 544
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 68/541 (12%), Positives = 139/541 (25%), Gaps = 162/541 (29%)
Query: 38 YGVSRPPQKHKQKTVAQ--------------GHVK--LA----NSFTEEVRKGKKIAQWF 77
Y VSR K + G K +A S+ + + KI W
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WL 187
Query: 78 T--------SYISKFNIVSPNTENSGSEDKDVDVEDPRRT-----KLRHEGNHLNEKQSL 124
+ + + + + + D R +LR + L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 125 A--EHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDL--KELLDTLHSRFDAAKEV 180
+V ++K +F +L K LL T RF K+V
Sbjct: 248 LVLLNVQNAKA---WNAF---------------------NLSCKILLTT---RF---KQV 277
Query: 181 VNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLT 240
+ A + L+ + E+ +L + ++ QDL
Sbjct: 278 TDFLSAATTTHI--SLDHHSMTLTP-DEVKS---LLL-KYLDCR-----------PQDL- 318
Query: 241 EKRQQCQVG--LVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVET 298
R+ + ++ + L +K + L +
Sbjct: 319 -PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC------DKLTTIIESSLNVL----- 366
Query: 299 SWVPSPGTAESDLDYASYQK-----ANAKKKISGQQKVSTVPEI----SDCSCSESLDHT 349
E + + +A I + + + S + +
Sbjct: 367 ---------EPAEYRKMFDRLSVFPPSA--HIP-----TILLSLIWFDVIKSDVMVVVNK 410
Query: 350 SENKSVFIEQNFPPQKSQH--YSRMQEQQSHIVE--GRIVEVTKSNCGSPHEQGQSLDGS 405
S+ +Q S Y ++ + + IV+ +
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYL 469
Query: 406 DSVICRICEEVVPISHLESHSYICAYADKCEL-NCLDVDERLLKLSEILEQISESCNSSS 464
D SH+ H + ++ L + +D R L+ ++I
Sbjct: 470 DQYFY---------SHIGHHLKNIEHPERMTLFRMVFLDFRFLE-----QKIRHD----- 510
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGV-EGMFEDI----HEMDTACIDDSH 519
+ N+ +N+ Y P I + N E + I +++ I +
Sbjct: 511 ----STAWNASGSILNTLQQLKFYKPYICD--NDPKYERLVNAILDFLPKIEENLICSKY 564
Query: 520 L 520
Sbjct: 565 T 565
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK + ++ +++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 742 ITVRN-PFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
I + + VV + T L +++E+ G+L + LR + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDA 858
+ +G + DLK I + F K + + D +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 859 HYPEYQ 864
+Q
Sbjct: 196 ICYSFQ 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------------------- 241
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
+ + + R P ++APE + + +D WS G++L+E + G P
Sbjct: 242 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 21/149 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRNPF 748
I +GA + + +V K +LD IRK R E L V++
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVKDFG 400
Query: 749 V-VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ + + DN ++M Y+NG ++ + + I + LH
Sbjct: 401 IPAPYIFDVD-LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEI--------VGKLHKND 451
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
++H DL N + D + + DFGL KI
Sbjct: 452 VIHNDLTTSNFIF--DKDLYIIDFGLGKI 478
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 30/169 (17%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------------- 725
+D I K + G VF +K K
Sbjct: 84 RLVRSGKVDA--IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140
Query: 726 IRKNDIERILAER--NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+ + + A L ++ V + + N ++ME ++ +LY +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYA---WEGNA-VLMELIDAKELYRVR----- 191
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
E+ + ++ + + GIVH DL N+L+ + I + DF
Sbjct: 192 -VENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1044 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-89 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-84 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-82 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-81 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-79 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-78 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-77 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-75 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-74 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-74 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-73 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-72 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-69 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-64 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-62 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-61 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-59 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-55 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 284 bits (728), Expect = 6e-89
Identities = 101/307 (32%), Positives = 169/307 (55%), Gaps = 31/307 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +DF+ K + G+F V LAR+ T +AIK+L+K +I++N + + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ +PF V+ +++F + LY + Y G+L +RK+G +E R Y AE+V ALEY
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-------------------------L 158
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
++ +S VGT Y++PE+L ++D W++G I+++ + G+PPF A + +I
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNW 979
F I+ + + P +A+DL+ + L+ D +RLG G +KAHPFF+ V W
Sbjct: 219 FQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
Query: 980 DSLALQK 986
++L Q
Sbjct: 276 ENLHQQT 282
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (696), Expect = 1e-84
Identities = 92/292 (31%), Positives = 148/292 (50%), Gaps = 35/292 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
R+P ++R + F +YL++EY G +Y L+K+ +E YI EL AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ R + GT DYL PE++ G H D WS+G++ +EF+ G PPF A + + +
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
I + + P ++ A+DLI+R L H+P+QR EV HP+
Sbjct: 215 RISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (687), Expect = 1e-82
Identities = 107/304 (35%), Positives = 172/304 (56%), Gaps = 33/304 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITV 744
I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S GIV+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--------------------------- 153
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF + E +F
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 984
+I + P + EA+DL+ + + +P +RLG +++ HP F+ +NW+ L
Sbjct: 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELER 268
Query: 985 QKMT 988
+++
Sbjct: 269 KEID 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (680), Expect = 2e-81
Identities = 113/308 (36%), Positives = 174/308 (56%), Gaps = 32/308 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS +V+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 156 --ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 980
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 981 SLALQKMT 988
+ +K+
Sbjct: 271 DVVQKKLL 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 260 bits (666), Expect = 1e-79
Identities = 110/306 (35%), Positives = 174/306 (56%), Gaps = 35/306 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S I++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
++ GTPDY+APE++ + + DWWS GI+++E + G PF + ++
Sbjct: 155 ---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 982
ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+ L
Sbjct: 212 KILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 983 ALQKMT 988
+ +
Sbjct: 269 LSRNIE 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 260 bits (666), Expect = 4e-79
Identities = 100/310 (32%), Positives = 155/310 (50%), Gaps = 35/310 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+++DF + + I RG FG V+ RK TG ++A+K L K + K L ER +L V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 745 RN---PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
PF+V Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++H+ +V+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF +
Sbjct: 156 ---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVN 978
+ +P S E + L+ L D N+RLG GA EVK PFF+ ++
Sbjct: 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 979 WDSLALQKMT 988
W + LQK
Sbjct: 273 WQMVFLQKYP 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 3e-78
Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 31/291 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------------------------ 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
R + GT Y+APE+L E H D WS GI+L + G P+ S
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ K + + L+++ L+ +P+ R+ ++K ++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 4e-78
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 39/296 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII + GAFG+V+ A+ + T L A KV+ + ++E + E +IL + +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P +V+ +F +NL++++E+ GG + +++ ++ L E ++ + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L DG IKL DFG+S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN---------------------------T 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976
+ I + P PS S +D + + L + + R +++ HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 256 bits (655), Expect = 1e-77
Identities = 79/336 (23%), Positives = 143/336 (42%), Gaps = 39/336 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
P K +D ++I + + GAFG V +R TG+ FA K + +D E
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKET 69
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIY 792
+ E + +R+P +V +F + + ++ E+++GG+L+ + + + ED A Y
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 129
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPET 850
+ ++ L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------------- 174
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
++ GT ++ APE+ G GY D WSVG++ + ++G
Sbjct: 175 -------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 911 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
+ PF E+ + N+ + S +S + +D I + L+ DPN R+ +
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQAL 278
Query: 970 AHPFFKGVNWDSLALQ-KMTQATSYHALVKFQVDCR 1004
HP+ N Q ++ T +K + D
Sbjct: 279 EHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 1e-75
Identities = 90/299 (30%), Positives = 137/299 (45%), Gaps = 38/299 (12%)
Query: 681 KERTSIDD----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
+ S+ D + + I +GA G V+ A TG AI+ + +K E I+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIIN 66
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E ++ +NP +V + S+ D L++VMEYL GG L ++ + C++E E
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ ALE+LHS ++HRD+K DN+L+ DG +KLTDFG
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------- 164
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+ R + VGTP ++APE++ +G D WS+GI+ E I G PP+
Sbjct: 165 ------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
E+P I P P +S +D +NR L D +R A E+ H F K
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLK 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 250 bits (640), Expect = 2e-75
Identities = 69/329 (20%), Positives = 140/329 (42%), Gaps = 38/329 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
P K+ + D ++I++ + GAFG V ++ TG +F K + + K ++
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
E +I+ + +P ++ +F + + L++E+L+GG+L+ + + E Y
Sbjct: 76 ---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+ + L+++H IVH D+KP+N++ +K+ DFGL+
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT--------------- 177
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
+ + T ++ APEI+ G+ D W++G++ + ++G
Sbjct: 178 -------------KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 911 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969
+ PF E N+ + S +S EA+D I L +P +RL +
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDAL 281
Query: 970 AHPFFKGVNWDSLALQKMTQATSYHALVK 998
HP+ KG + + + ++ +K
Sbjct: 282 EHPWLKGDHSNLTSRIPSSRYNKIRQKIK 310
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 247 bits (632), Expect = 2e-75
Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 45/303 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNI 740
+++E + + RG V + T +A+K++ + E L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 913
Q GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 159 ----QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 914 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 972
F ++ I++ + D S +DL++RFL+ P +R A E AHP
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHP 271
Query: 973 FFK 975
FF+
Sbjct: 272 FFQ 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (633), Expect = 6e-75
Identities = 84/347 (24%), Positives = 137/347 (39%), Gaps = 76/347 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 805
P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP N+L+ G IKL DFG+S Q
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----------------------------Q 154
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ +S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 926 ILNR----------------------------------------KIPWPCVPSD-MSFEA 944
+ P P +PS S E
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 945 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKMTQAT 991
QD +N+ LI +P +R ++ H F K + + + +T
Sbjct: 275 QDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVDFAGWLCST 318
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 1e-74
Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D+E++ I G++GR R+++ G + K L + + + + +++E N+L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLAL 800
P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 801 EYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ H ++HRDLKP N+ + ++KL DFGL++I
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------- 163
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
D + VGTP Y++PE + + +D WS+G +L+E +PPFT
Sbjct: 164 --------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973
A S + + I K P S E ++I R L R E+ +P
Sbjct: 216 AFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 5e-74
Identities = 120/321 (37%), Positives = 186/321 (57%), Gaps = 36/321 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRK-NDIER 733
+ H E+ I++FE++K + GA+G+VFL RK TG L+A+KVLKK +++K E
Sbjct: 15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 734 ILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L + E +IY
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ E+VLALE+LH LGI++RD+K +N+L+ +GH+ LTDFGLS
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS------------------ 176
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG 910
E+ + + GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG
Sbjct: 177 --------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 911 IPPFTAESPEIIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAE 967
PFT + + I R + P P +MS A+DLI R L+ DP +RLG A E
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 968 VKAHPFFKGVNWDSLALQKMT 988
+K H FF+ +NWD LA +K+
Sbjct: 289 IKEHLFFQKINWDDLAAKKVP 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 243 bits (620), Expect = 2e-73
Identities = 87/304 (28%), Positives = 141/304 (46%), Gaps = 37/304 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++ + GAF V LA + T L AIK + K + + + E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +V + +LYL+M+ ++GG+L+ + + G E A I +++ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ +A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 160 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 924 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 982
+ IL + + D+S A+D I + DP +R + HP+ G
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALDK 275
Query: 983 ALQK 986
+ +
Sbjct: 276 NIHQ 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 243 bits (622), Expect = 4e-73
Identities = 109/310 (35%), Positives = 174/310 (56%), Gaps = 35/310 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR------------------------ 190
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 191 ------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 978
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 979 WDSLALQKMT 988
W ++ +K+
Sbjct: 302 WIAIYQRKVE 311
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 240 bits (613), Expect = 3e-72
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG + I
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+S VGTP ++APE++L + G D WS+GI E PP +
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+I + P S ++ ++ L P R + + H F
Sbjct: 224 YHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 1e-70
Identities = 74/318 (23%), Positives = 140/318 (44%), Gaps = 41/318 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 805
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 806 LGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
Q N P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 924 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV--NWD 980
+NI+N + + ++S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQKIERVS 269
Query: 981 SLALQKMTQATSYHALVK 998
+ ++ + YH L+K
Sbjct: 270 TKVIRTLKHRRYYHTLIK 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 3e-69
Identities = 61/301 (20%), Positives = 124/301 (41%), Gaps = 43/301 (14%)
Query: 684 TSIDD--FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
S D + I RG+F V+ T A L+ + K++ +R E +L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEML 62
Query: 742 ITVRNPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+++P +VRF+ S+ + + LV E + G L + L++ ++ V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 798 LALEYLHSLG--IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L++LH+ I+HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +GTP+++APE+ ++ + D ++ G+ + E T P+
Sbjct: 165 -----------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974
+ + + E +++I + + ++R ++ H FF
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 269
Query: 975 K 975
+
Sbjct: 270 Q 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 8e-69
Identities = 76/310 (24%), Positives = 138/310 (44%), Gaps = 39/310 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILIT 743
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 804 HSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HSL I H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ + GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 166 ----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978
+ N+ + S+ S A+D I R L+ DP +R+ + HP+ K +
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKD 278
Query: 979 WDSLALQKMT 988
+
Sbjct: 279 TQQALSSAWS 288
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 222 bits (566), Expect = 3e-66
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 31/289 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +E+ + + G V LAR A+KVL+ + R E + +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 747 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H GI+HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------------------AIA 162
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+ +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 923 FDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970
+ IP +S + ++ + L +P R AAE++A
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 9e-64
Identities = 82/311 (26%), Positives = 139/311 (44%), Gaps = 55/311 (17%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 740 ILITV-RNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIY 792
+ + P +VR + R L +VME L+GG+L+S ++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ T + + + TP Y+APE+L ++ + D WS+G+I++ +
Sbjct: 163 --------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 910 GIPPFTAESP----EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG 964
G PPF + + I + +P S++S E + LI L +P QR+
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---T 265
Query: 965 AAEVKAHPFFK 975
E HP+
Sbjct: 266 ITEFMNHPWIM 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-63
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 49/299 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---RILAERNILIT 743
+++ + G FG V+ + + AIK ++K + ++ R+ E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 744 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLAL 800
V + V+R F D+ L++E DL+ + + G L+E++AR + +++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 801 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 918
+ GT Y PE + HG +A WS+GI+L++ + G PF +
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ I+ ++ + +S E Q LI L P+ R E++ HP+ + V
Sbjct: 214 -----EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-63
Identities = 54/280 (19%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I G+FG V+ + A+K+L ++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ F ++ L +V ++ G LY L + E + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK +N+ + D +K+ DFGL+ + + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------------------KSRW 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEII 922
+ + G+ ++APE++ + + +D ++ GI+L+E +TG P++ +
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
Query: 923 FDNILNRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQR 959
++ R P V S+ + L+ L ++R
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 2e-62
Identities = 76/314 (24%), Positives = 117/314 (37%), Gaps = 58/314 (18%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVRNP 747
E + + G F V+ AR + T + AIK +K D L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
++ +F + N+ LV +++ + L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLKP+NLL+ +G +KL DFGL+K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 868 NRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
NR V T Y APE+L G +G D W+VG IL E + +P +S I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 927 LN-------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IP + S + DLI + +P R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 962 ANGAAEVKAHPFFK 975
A + +F
Sbjct: 273 --TATQALKMKYFS 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-62
Identities = 61/303 (20%), Positives = 119/303 (39%), Gaps = 35/303 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
++ +++D K + G FG V + + A+K+LK + + +LAE
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEA 59
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
N++ + NP++VR ++ LVME G L L++ +++ + ++ +
Sbjct: 60 NVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL--------------------- 157
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917
+ + + + APE + + +D WS G++++E + G P+
Sbjct: 158 ---RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
+ + + P+ E DL+N +D R G + ++ V
Sbjct: 215 KGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
Query: 978 NWD 980
N
Sbjct: 273 NEG 275
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-61
Identities = 76/329 (23%), Positives = 121/329 (36%), Gaps = 65/329 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+ +E + I +G FG VF AR R TG A+K + + ++ L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLL 66
Query: 745 RNPFVVRFFYSFT--------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
++ VV C+ ++YLV ++ L + + + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L Y+H I+HRD+K N+LI DG +KL DFGL++
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-------------------- 166
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915
+ + + + V T Y PE+LLG ++G D W G I+ E T P
Sbjct: 167 ---FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
Query: 916 AESPEIIFDNILN-----------------------------RKIPWPCVPSDMSFEAQD 946
+ + I RK+ A D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 947 LINRFLIHDPNQRLGANGAAEVKAHPFFK 975
LI++ L+ DP QR+ + + H FF
Sbjct: 284 LIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 208 bits (529), Expect = 4e-61
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 59/316 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + E +IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V+ + + L LV E+L+ L G LE A+ ++ +L+ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA---------------------------FGI 152
Query: 867 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R + T Y AP++L+G++ + D WSVG I E + G P F S
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 926 ILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I +PW + DL+++ L DPNQR
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 960 LGANGAAEVKAHPFFK 975
+ A + H +FK
Sbjct: 273 I---TAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-59
Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 59/321 (18%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+++F+ ++ I G +G V+ AR + TG++ A+K ++ D + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 804
+P +V+ + LYLV E+L+ + + + + Y+ +L+ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------F 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
R V T Y APEILLG ++ A D WS+G I E +T F +S
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 924 DNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPN 957
I + + V + + + L+++ L +DPN
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
Query: 958 QRLGANGAAEVKAHPFFKGVN 978
+R+ A AHPFF+ V
Sbjct: 273 KRI---SAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 46/291 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
++ + ++++ I +G FG V L R G+ A+K +K + LAE +++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 745 RNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
R+ +V+ + LY+V EY+ G L LR G L D + ++ A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL VHRDL N+L++ D K++DFGL+K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------------ 153
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920
+ + + + APE L + +D WS GI+L+E + G P+ +
Sbjct: 154 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
+ + P +++ D R +++
Sbjct: 208 DVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-58
Identities = 74/322 (22%), Positives = 127/322 (39%), Gaps = 63/322 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I GA+G V A AIK + + + +R L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 747 PFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ ++ +L G DLY LL+ L D ++ +++ L+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS ++HRDLKP NLL+ +K+ DFGL+++ +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------------------D 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
V T Y APEI+L + + D WSVG IL E ++ P F +
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 922 IFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLI 953
++IL K+PW + + +A DL+++ L
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 954 HDPNQRLGANGAAEVKAHPFFK 975
+P++R+ + AHP+ +
Sbjct: 281 FNPHKRI---EVEQALAHPYLE 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-58
Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 37/299 (12%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAER 738
++ I D E+ G FG V R AIKVLK+ K D E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--GTEKADTEEMMREA 60
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
I+ + NP++VR L LVME GG L+ L K + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916
+ R + + APE + + +D WS G+ ++E ++ G P+
Sbjct: 159 ---LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ I K P + E L++ I+ R + ++
Sbjct: 216 MKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-57
Identities = 82/328 (25%), Positives = 126/328 (38%), Gaps = 64/328 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKN--DIERILAERNIL 741
+ +E + I GA+G+VF AR + G A+K ++ R +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 742 ITVRNPFVVRFFYSFTC-----RDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAE 795
T +P VVR F T L LV E+++ Y + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
+ S V T Y APE+LL + + D WSVG I E P F
Sbjct: 166 ---------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 916 AESPEIIFDNILN------------------------RKIPWPCVPSDMSFEAQDLINRF 951
S IL+ P +D+ +DL+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNW 979
L +P +R+ A +HP+F+ +
Sbjct: 277 LTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 31/280 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNIL 741
D +++ + G+FG V A+K LK + + ++ + E N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLAL 800
++ + ++R + + +V E G L L + G Y ++ +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL S +HRDL NLL+A +K+ DFGL +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL----------------------- 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
+ + APE L +A+D W G+ L+E T G P+ +
Sbjct: 162 -PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I I P P D + +++ + H P R
Sbjct: 221 SQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 4e-57
Identities = 56/304 (18%), Positives = 101/304 (33%), Gaps = 35/304 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 747 P-FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ + D +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 806 LGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+Q R + GT Y + LG E D S+G +L F G P+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 923 FDNILNRK-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK-G 976
P + E +N + + + ++ + F + G
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 977 VNWD 980
++D
Sbjct: 282 FSYD 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-57
Identities = 87/356 (24%), Positives = 133/356 (37%), Gaps = 77/356 (21%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 728
++ V+TP +R + K I G+FG V+ A+ +G+L AIK + +
Sbjct: 4 TTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------ 55
Query: 729 NDIERILAERNILITVRNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLL---R 779
D E I+ + + +VR Y F L LV++Y+ R
Sbjct: 56 -DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 780 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 838
L ++Y+ +L +L Y+HS GI HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADW 897
Q S + + Y APE++ G ++ + D
Sbjct: 172 -------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 898 WSVGIILFEFITGIPPFTAESPEIIFDNILN-------------------------RKIP 932
WS G +L E + G P F +S I+ + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 933 WPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKM 987
W V EA L +R L + P RL E AH FF + ++ L
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNVKLPNG 319
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 196 bits (498), Expect = 2e-56
Identities = 79/339 (23%), Positives = 135/339 (39%), Gaps = 80/339 (23%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
E + DD+++++ + RG + VF A T + +K+LK ++I E IL
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKIL 83
Query: 742 ITVR-NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+R P ++ + LV E++N D L + L + R Y+ E++
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-------------------- 180
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+ + V + + PE+L+ + + Y+ D WS+G +L I PF
Sbjct: 181 --------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 917 ESPEI----------------------------IFDNILNR-------KIPWPCVPSDMS 941
F++IL R + +S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 942 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 980
EA D +++ L +D RL A E HP+F V D
Sbjct: 293 PEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-55
Identities = 81/330 (24%), Positives = 129/330 (39%), Gaps = 71/330 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++P+ GA+G V A TG AIK L + + +R E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 747 PFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
V+ FT + + YLVM ++ G L K L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------------------- 171
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919
+ V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 172 -------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 920 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRF 951
I+ K + + ++ S A +L+ +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 952 LIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981
L+ D QR+ A E AHP+F+ ++
Sbjct: 285 LVLDAEQRV---TAGEALAHPYFESLHDTE 311
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 52/275 (18%), Positives = 110/275 (40%), Gaps = 35/275 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +K + G FG V + R AIK++K+ M + + E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 805
+V+ + T + ++++ EY+ G L + LR + ++ A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------YVLD 152
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ + + + PE+L+ ++ +D W+ G++++E + G P+ + +
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+I + P S + ++ ++R
Sbjct: 213 HIAQGLRLYR--PHLASEKVYTIMYSCWHEKADER 245
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-55
Identities = 57/293 (19%), Positives = 114/293 (38%), Gaps = 42/293 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ + G FG V++ A+K LK+ + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQH 67
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 804
+VR Y+ ++ +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL--------------------------IE 160
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ R A + APE + +D WS GI+L E +T G P+ + +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFF 974
N+ + P + E L+ P R +++ FF
Sbjct: 221 QNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-55
Identities = 61/303 (20%), Positives = 114/303 (37%), Gaps = 58/303 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 741
++ E K + GAFG+V A A+K+LK+ ++ E +++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMM 94
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-------------------- 780
+ + +V + T +YL+ EY GDL + LR
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 781 ---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
+ L + + ++ +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
++ R +A ++APE L + +D
Sbjct: 214 ------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
WS GI+L+E + G+ P+ + F ++ P + E ++ D
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDS 308
Query: 957 NQR 959
+R
Sbjct: 309 RKR 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-55
Identities = 71/317 (22%), Positives = 119/317 (37%), Gaps = 59/317 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+E ++ I G +G VF A+ R T ++ A+K ++ D + L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VR L LV E+ + G L+ ++ + ++ +L+ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA---------------------------FGI 153
Query: 867 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITG-IPPFTAESPEIIFD 924
R + V T Y P++L G + + + D WS G I E P F +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 925 NILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
I V ++ +DL+ L +P Q
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 959 RLGANGAAEVKAHPFFK 975
R+ A E HP+F
Sbjct: 274 RI---SAEEALQHPYFS 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-55
Identities = 61/294 (20%), Positives = 108/294 (36%), Gaps = 42/294 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T AIK LK E L E ++ +R+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLRH 71
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLH 804
+V+ Y+ + +Y+V EY++ G L L A++ + Y+
Sbjct: 72 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+ VHRDL+ N+L+ + K+ DFGL+++ +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARL--------------------------IE 164
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ R A + APE L +D WS GI+L E T G P+ +
Sbjct: 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 975
D + P + DL+ + +P +R ++A +F
Sbjct: 225 DQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFT 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-55
Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 745 RN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCLEED 787
+ P ++ + R LYL +EY G+L LRK L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----------- 176
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
Q + ++A E L + + +D WS G++L+E
Sbjct: 177 -----------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
++ G P+ + +++ + P + E DL+ + P +R
Sbjct: 220 VSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYER 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ I G FG V L D AIK +++ E + E +++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 805
P +V+ + + + LV E++ G L LR L + ++ + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------------------------VLD 153
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ + +PE+ + + +D WS G++++E + G P+ S + +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+I + P S ++N P R
Sbjct: 214 DISTGFRLYK--PRLASTHVYQIMNHCWKERPEDR 246
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (482), Expect = 2e-54
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNI 740
+ I +I + I G FG V + G +K L + L+E +I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 799
+ +P V+ T + ++ E++ G L S LR G + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++YL + VHRDL N+L+ + K++DFGLS+ + D
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----------------FLEDDTS 183
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
P Y + APE + + A+D WS GI+++E ++ G P+ +
Sbjct: 184 DPTYTSALGG-----KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + I P P D L+ D N R
Sbjct: 239 NQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 2e-54
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 59/303 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALM 70
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------- 782
NP +V+ + L+ EY+ GDL LR +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 783 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
L ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 189
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
Y + + ++ PE + + +D
Sbjct: 190 ------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
W+ G++L+E + G+ P+ + E + + + I P + E +L+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLP 283
Query: 957 NQR 959
R
Sbjct: 284 ADR 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 35/288 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 745
+ E+ + I G FG V + + +K + + E+ L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 804
+P +V+ T + ++++ME G+L S L + L+ +Y +L AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S VHRD+ N+L++ + +KL DFGLS+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------------------ME 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ ++APE + A+D W G+ ++E + G+ PF +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971
I N + +P + L+ + +DP++R E+KA
Sbjct: 220 GRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 183 bits (466), Expect = 2e-52
Identities = 48/282 (17%), Positives = 96/282 (34%), Gaps = 36/282 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+++ + I G+FG +F AIK + ++D ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 808 IVHRDLKPDNLLIA-----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESP 919
Q R + + GT Y++ LG E D ++G + F+ G A +
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 920 EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 959
+ ++ I +K P + + E ++ +
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-52
Identities = 55/276 (19%), Positives = 102/276 (36%), Gaps = 30/276 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV-LKKL-DMIRKNDIERILAERNILITV 744
+F+ IK + GAFG V+ G+ I V +K+L + + IL E ++ +V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
NP V R + G L + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ ++A E +L + + +D WS G+ ++E +T G P+ I
Sbjct: 167 ---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P + + ++ + + D + R
Sbjct: 224 SILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSR 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 2e-51
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 35/276 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ ++E L E ++ +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ + V ++ A+EYL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL N L+ + +K+ DFGLS++
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------------------MT 166
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
A + APE L + +D W+ G++L+E T G+ P+ ++
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P + +L+ +P+ R
Sbjct: 227 ELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDR 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-51
Identities = 78/323 (24%), Positives = 127/323 (39%), Gaps = 69/323 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ + P+ GA+G V A TG A+K L + +R E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 747 PFVVRFFYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+HS I+HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920
+ + V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 169 ---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 921 IIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFL 952
IL K+ + V + A DL+ + L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 953 IHDPNQRLGANGAAEVKAHPFFK 975
+ D ++R+ AA+ AH +F
Sbjct: 286 VLDSDKRI---TAAQALAHAYFA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-50
Identities = 68/337 (20%), Positives = 129/337 (38%), Gaps = 80/337 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 744 VRNPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
V + ++ FT + ++YLVME ++ + ++ + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 129
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+++LHS GI+HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------------- 168
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+ V T Y APE++LG + D WSVG I+ E + F
Sbjct: 169 -------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 918 SPEIIFDNILN---------------------------RKIPWPCVPSD----------- 939
++ ++ + +P + D
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 940 -MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN 315
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-50
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 48/311 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + + + +G+FG V+ K AIK + + +R + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----------KVGCLEEDVARI 791
VVR + ++ME + GDL S LR +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
E+ + YL++ VHRDL N ++A D +K+ DFG+
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------ 179
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
Y+ R + +++PE L +D WS G++L+E T
Sbjct: 180 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 912 -PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-- 968
P+ S E + ++ + P + +L+ ++P R
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 969 -KAHPFFKGVN 978
+ P F+ V+
Sbjct: 291 EEMEPGFREVS 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-49
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ K + GAFG+V A K A+K+LK + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----------------- 783
+ N +V + T ++ EY GDL + LR+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 784 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
L+ + + ++ + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI----- 195
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
++ + +A ++APE + + + +D WS GI
Sbjct: 196 --------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L+E + G P+ + F ++ P E D++ DP +R
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 54/298 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V LA A+K+LK + D+ +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEME 70
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------- 783
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 784 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
L ++ +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
+ + + ++APE L + + +D WS G+
Sbjct: 186 --------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+L+E T G P+ E +F + PS+ + E ++ P+QR
Sbjct: 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 56/278 (20%), Positives = 95/278 (34%), Gaps = 32/278 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 742
K I G FG V+ +T+ AIK LK + L E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMG 64
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALE 801
+ ++R + + ++ EY+ G L K G + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL ++ VHRDL N+L+ + K++DFGLS++
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------------------------ 160
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
E + APE + + A+D WS GI+++E +T E
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+N P P D L+ + + +R
Sbjct: 221 EVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 9e-46
Identities = 68/330 (20%), Positives = 123/330 (37%), Gaps = 67/330 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK+ ++ +++E IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 742 ITVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----------------C 783
I + + V + L +++E+ G+L + LR
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L + Y ++ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD------- 183
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
Y+ D + A ++APE + + +D WS G++
Sbjct: 184 ------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225
Query: 904 LFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
L+E + P+ + F L P + E + +P+QR
Sbjct: 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRP-- 282
Query: 963 NGAAEVKAHPFFKGVNWDSLALQKMTQATS 992
+E+ H L + QA +
Sbjct: 283 -TFSELVEH------------LGNLLQANA 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-45
Identities = 55/313 (17%), Positives = 106/313 (33%), Gaps = 67/313 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I +G FG V+ + G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 747 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ F + + L+LV +Y G L+ L + E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 803 LHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
LH I HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIILFEFI 908
+ T + + VGT Y+APE+L + + AD +++G++ +E
Sbjct: 157 ----RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 909 TGIPPFTAESP-------------------EIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949
+++ + L IP + ++
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 950 RFLIHDPNQRLGA 962
+ RL A
Sbjct: 273 ECWYANGAARLTA 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-45
Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 695 ISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
I RG FG V+ A+K L ++ ++ + L E I+ +P V+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 752 FF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 809
+ +V+ Y+ GDL + +R I ++ +++L S V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDL N ++ +K+ DFGL++ + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARD-----------------------MYDKEFDSVH 189
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928
N+ A ++A E L + +D WS G++L+E +T G PP+ + I +L
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ P +++ + R
Sbjct: 250 GRRLLQ--PEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (359), Expect = 1e-37
Identities = 57/348 (16%), Positives = 119/348 (34%), Gaps = 87/348 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-------L 741
+ +++ + G F V+LA+ A+K+++ + + + I + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 742 ITVRNPFVVRFFYSFT--CRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAEL 796
++ +++ F + +++VM + G + + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 797 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 854
+L L+Y+ GI+H D+KP+N+L+ L ++ +G +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +++ T +Y +PE+LLG G AD WS ++FE ITG F
Sbjct: 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 915 TAESPEIIFDNI------------------------------------LNRKIPWPC--- 935
+ + +++ WP
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 936 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977
D + E D ++ L DP +R A + HP+ K
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 3e-19
Identities = 27/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAER---- 738
I K + G VF +K K K+ R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 739 ----NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ + + GIVH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1044 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.66 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=446.40 Aligned_cols=273 Identities=41% Similarity=0.794 Sum_probs=248.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 45899179875513796499999997899599999963244247457999999999999359995678822320278059
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~Ly 763 (1044)
+.+++|++++.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 84474289889831768499999998999899999981565449799999999999998679998877876403564211
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99844166425899984079999999999999999999988559061257999624247972799505775234446744
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~ 843 (1044)
+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~----- 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred CCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCC-----
T ss_conf 100035798605555325677599999999999652113431596224647778476589988882056520035-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 58999888989999999864345767766766898777910002899994024687889999999399999999968998
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~ 923 (1044)
.........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+++
T Consensus 157 ----------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 157 ----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp ----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ----------------------6786205510088996666504898883331022306788998789999996999999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 756215889999999998889999986714894788996--429999829998899932368631
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSa--deA~EIL~HPfFk~i~~e~l~~~k 986 (1044)
..+..+.+.+| ..+|+++++||.+||++||.+|++. ..+.++++||||++++|+.+..++
T Consensus 215 ~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~ 276 (337)
T d1o6la_ 215 ELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276 (337)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred HHHHCCCCCCC---CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHHHHHCC
T ss_conf 99852899898---668999999998666389344225652349999729150369999998478
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=447.70 Aligned_cols=279 Identities=36% Similarity=0.726 Sum_probs=248.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 58991798755137964999999978995999999632442474579999999999993599956788223202780599
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyL 764 (1044)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 99877898898508790999999989997999999865775577789999999999987688886179999998998899
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 98441664258999840799999999999999999999885590612579996242479727995057752344467445
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d 844 (1044)
|||||+||+|.+++...+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~---- 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---- 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC----
T ss_conf 9970489877776531599999999999999999997621650884767741236688853886032102422567----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 89998889899999998643457677667668987779100028999940246878899999993999999999689987
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
.........+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+++.
T Consensus 162 ---------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 220 (288)
T d1uu3a_ 162 ---------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220 (288)
T ss_dssp -----------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ---------------------CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ---------------------76433355567755258440026898966623045699999803889989959999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HHHHCCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 56215889999999998889999986714894788996429---99982999889993236863152300
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA---AEVKAHPFFKGVNWDSLALQKMTQAT 991 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA---~EIL~HPfFk~i~~e~l~~~k~~~~~ 991 (1044)
+|..+...+| ..+++++++||.+||+.||.+|||++++ ..+++||||++++|+.+..+.+|.++
T Consensus 221 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 221 KIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 9971899998---547999999999985579768919789737789876976478998896157999999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=436.42 Aligned_cols=270 Identities=41% Similarity=0.796 Sum_probs=243.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 58991798755137964999999978995999999632442474579999999999993599956788223202780599
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyL 764 (1044)
.+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf 65470888897207680899999989997999999845775488999999999999986369675330356852880056
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 98441664258999840799999999999999999999885590612579996242479727995057752344467445
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d 844 (1044)
|||||+||+|..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEEC------
T ss_conf 76503786322343222211100799999999876554124767705568105038689988983175216712------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 89998889899999998643457677667668987779100028999940246878899999993999999999689987
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++..
T Consensus 156 ------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 156 ------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp ------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ------------------------45643457634359999838999804304653336899975989999969999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 56215889999999998889999986714894788996--4299998299988999323686315
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSa--deA~EIL~HPfFk~i~~e~l~~~k~ 987 (1044)
++..+...+| ..+|++++++|.+||++||.+|++. ..+.++|+||||++++|+.+..++.
T Consensus 212 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~ 273 (316)
T d1fota_ 212 KILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273 (316)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred HHHCCCCCCC---CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHCCC
T ss_conf 9970898899---7789999999999954499766643102199998193514679899983789
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=434.92 Aligned_cols=269 Identities=41% Similarity=0.804 Sum_probs=242.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 58991798755137964999999978995999999632442474579999999999993599956788223202780599
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyL 764 (1044)
.+++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.....+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCC
T ss_conf 72370898896117680899999989998999999826774588999999999999997487727403444432222232
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 98441664258999840799999999999999999999885590612579996242479727995057752344467445
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d 844 (1044)
||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~------ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS------
T ss_pred CCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECC------
T ss_conf 22233466226667515898999999999999998999985998617679999360778978861010333225------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 89998889899999998643457677667668987779100028999940246878899999993999999999689987
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
......+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+...++.
T Consensus 193 ------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 193 ------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp ------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ------------------------66643367635678899717998853311450078999975889989959999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 56215889999999998889999986714894788996--429999829998899932368631
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSa--deA~EIL~HPfFk~i~~e~l~~~k 986 (1044)
+|..+...++ ..+++++.+||.+||+.||.+|+.. ..+.++++||||++++|+.+..++
T Consensus 249 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~ 309 (350)
T d1rdqe_ 249 KIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309 (350)
T ss_dssp HHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTC
T ss_pred HHHCCCCCCC---CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHHHHHCC
T ss_conf 9861798897---668999999999983409986065534549999719051589989998367
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=432.99 Aligned_cols=270 Identities=37% Similarity=0.644 Sum_probs=229.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHH---HHHHHHCCCCCEEEEEEEEECCCE
Q ss_conf 58991798755137964999999978995999999632442474579999999---999993599956788223202780
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrE---ieILkkL~HPNIVkLigvf~d~~~ 761 (1044)
.+++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+| +.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998998
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 59998441664258999840799999999999999999999885590612579996242479727995057752344467
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 762 LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~ 841 (1044)
+|+|||||+||+|.+++.+...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~--- 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--- 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS---
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECC---
T ss_conf 89999914898389998732553278999999999999999997796220444221678588967982201023337---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 44589998889899999998643457677667668987779100028-99994024687889999999399999999968
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 842 s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ 920 (1044)
.......+||+.|||||++.. ..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 159 --------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 159 --------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp --------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred --------------------------CCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf --------------------------886433113455421687603899984410467789999998599988889989
Q ss_pred ---HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---998756215889999999998889999986714894788996--429999829998899932368631
Q 001614 921 ---IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK 986 (1044)
Q Consensus 921 ---ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSa--deA~EIL~HPfFk~i~~e~l~~~k 986 (1044)
.+...+.... +..+..+|+++++||.+||++||.+||+. ..|.++++||||++++|+.+..++
T Consensus 213 ~~~~~~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~ 280 (364)
T d1omwa3 213 DKHEIDRMTLTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 280 (364)
T ss_dssp CHHHHHHHSSSCC---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred HHHHHHHHCCCCC---CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHHHCCC
T ss_conf 9999998604688---8788778999999999985669888088743579999749102378987996288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=432.24 Aligned_cols=258 Identities=36% Similarity=0.648 Sum_probs=235.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 45899179875513796499999997899599999963244247457999999999999359995678822320278059
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~Ly 763 (1044)
..+++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 61537699889851778589999998999499999981688567689999999999998568888885999999899989
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99844166425899984079999999999999999999988559061257999624247972799505775234446744
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 764 LVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~ 843 (1044)
+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----- 157 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 157 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC-----
T ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECC-----
T ss_conf 998504798589887504899999999999999999999998894652202344146689987115556335448-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 58999888989999999864345767766766898777910002899994024687889999999399999999968998
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 844 d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~ 923 (1044)
.......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+++
T Consensus 158 ------------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 158 ------------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp ------------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf ------------------------88523557887634999975899893144046759999983299998889999999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 75621588999999999888999998671489478899642999982999889
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~ 976 (1044)
..+......+| ..+|+++++||.+||+.||.+||| +.++|+||||..
T Consensus 214 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~~ 260 (263)
T d2j4za1 214 KRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 260 (263)
T ss_dssp HHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHHCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCC
T ss_conf 99971899998---668999999999976479768909---999971907078
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=422.50 Aligned_cols=264 Identities=28% Similarity=0.513 Sum_probs=234.2
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 45899179875513796499999997899599999963244247457999999999999359995678822320278059
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~Ly 763 (1044)
..+++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 78657589889840768199999988999899999984524---316999999999998679979992999999899999
Q ss_pred EEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 9984416642589998-4079999999999999999999988559061257999624247--972799505775234446
Q 001614 764 LVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 764 LVmEym~GGSL~dlL~-k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDe--dG~IKLsDFGLAki~~~~ 840 (1044)
+|||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred EEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECC--
T ss_conf 999857998899999762378999999999999999999997569760001546736416889869995452104425--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 74458999888989999999864345767766766898777910002899994024687889999999399999999968
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 841 ~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ 920 (1044)
.........||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 178 --------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 178 --------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp --------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf --------------------------654320006862421889975899872676554659999998598998997999
Q ss_pred HHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCH
Q ss_conf 998756215889999-9999988899999867148947889964299998299988999323
Q 001614 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 981 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i~~e~ 981 (1044)
+++..|......++. .+..+|+++++||.+||+.||.+||| +.++|+||||...++..
T Consensus 232 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCS
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCCCCCC
T ss_conf 999999847889894223589999999999975689667908---99986291328898887
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=425.76 Aligned_cols=269 Identities=40% Similarity=0.800 Sum_probs=238.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCEEEEEEEEECCCEEEE
Q ss_conf 899179875513796499999997899599999963244247457999999999999-3599956788223202780599
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILk-kL~HPNIVkLigvf~d~~~LyL 764 (1044)
+++|.+++.||+|+||+||+|+++.+|+.||+|++++.........+.+..|..++. .++||||+++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 98441664258999840799999999999999999999885590612579996242479727995057752344467445
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d 844 (1044)
|||||+||+|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+++....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~----- 155 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML----- 155 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-----
T ss_pred EEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCC-----
T ss_conf 775037980899864047899999999999999999999868934034765404444899630155530232356-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 89998889899999998643457677667668987779100028999940246878899999993999999999689987
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 845 ~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
........+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+++.
T Consensus 156 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 156 ----------------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp ----------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ----------------------6533454578777689999827998832320112278989873889999989999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH-HHHCCCCCCCCCCCHHHHHHC
Q ss_conf 562158899999999988899999867148947889964299-998299988999323686315
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA-EVKAHPFFKGVNWDSLALQKM 987 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~-EIL~HPfFk~i~~e~l~~~k~ 987 (1044)
++..+...+ |..+|+++++||.+||+.||.+||+ +. ++++||||++++|+.+..++.
T Consensus 214 ~i~~~~~~~---p~~~s~~~~dli~~~L~~dP~~R~s---~~~~l~~hpff~~~~~~~l~~~~~ 271 (320)
T d1xjda_ 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELERKEI 271 (320)
T ss_dssp HHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSBT---TBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred HHHCCCCCC---CCCCCHHHHHHHHHHCCCCCCCCCC---HHHHHHHCCHHCCCCHHHHHHCCC
T ss_conf 997189989---7567999999999965448987838---899998090131589999983689
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=424.27 Aligned_cols=256 Identities=34% Similarity=0.547 Sum_probs=228.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 99179875513796499999997899599999963244247457999999999999359995678822320278059998
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLVm 766 (1044)
++|++.+.||+|+||+||+|+++.+|+.||+|+++.... ...+.+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 053887898128582999999989998999999843017---27999999999998679998805857798899989999
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 44166425899984079999999999999999999988559061257999624247972799505775234446744589
Q 001614 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (1044)
Q Consensus 767 Eym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~s 846 (1044)
|||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------- 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------- 168 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred EECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECC-------
T ss_conf 70379808988641-5999999999999999999999987972267768886887899686425156413213-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Q ss_conf 99888989999999864345767766766898777910002899994024687889999999399999999968998756
Q 001614 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (1044)
Q Consensus 847 ~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~qkI 926 (1044)
........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+.......+
T Consensus 169 --------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 169 --------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp --------------------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred --------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf --------------------666444444477736826644799880120313729999980488998997999999999
Q ss_pred HCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 21588999999999888999998671489478899642999982999889
Q 001614 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 927 l~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~ 976 (1044)
.....+....+..+|+++++||.+||+.||.+||| +.++|+||||+.
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCC
T ss_conf 85799988885537999999999986699668909---999964996577
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=419.56 Aligned_cols=261 Identities=25% Similarity=0.477 Sum_probs=233.0
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 54589917987551379649999999789959999996324424745799999999999935999567882232027805
Q 001614 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 683 ~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~L 762 (1044)
+...++|++.+.||+|+||.||+|+++.+|+.||+|++++.. ......+.+|+.+|+.++|||||+++++|.+...+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 985403599899931778299999998999799999988726---46799999999999867997989199999989999
Q ss_pred EEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCC
Q ss_conf 99984416642589998407-999999999999999999998855906125799962424--797279950577523444
Q 001614 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 763 yLVmEym~GGSL~dlL~k~g-~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILID--edG~IKLsDFGLAki~~~ 839 (1044)
|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 99998289980888898638998999999999999999999997792651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 67445899988898999999986434576776676689877791000289999402468788999999939999999996
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 840 ~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~ 919 (1044)
........||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+.
T Consensus 182 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 182 ----------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp ----------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ----------------------------CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ----------------------------8720100476453489997479989763338989999999968899899799
Q ss_pred HHHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 8998756215889999-999998889999986714894788996429999829998899
Q 001614 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
.+.+..+..+...++. .+..+|+++++||.+||+.||.+||| +.++|+||||++.
T Consensus 234 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 234 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9999999847889893002479999999999975699668918---9999609734888
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=426.68 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=223.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 89917987551379649999999789959999996324424745799999999999935999567882232027805999
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLV 765 (1044)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 7460899897217480999999999997999999845664--12799999999999857998884696540467436798
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 84416642589998407999999999999999999998855906125799962424797279950577523444674458
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~ 845 (1044)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~---- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 157 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC----
T ss_conf 8645898089997537999999999999999999999997598357546899788789987983231422404688----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 9998889899999998643457677667668987779100028999-940246878899999993999999999689987
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-t~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
........+||+.|||||++.+..+ +.++||||+||++|+|++|+.||...+......
T Consensus 158 ---------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~ 216 (271)
T d1nvra_ 158 ---------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216 (271)
T ss_dssp ---------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred ---------------------CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ---------------------65311132557474287286189999971016173799999982997888898599999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 5621588999999999888999998671489478899642999982999889
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~ 976 (1044)
............+..+|+++++||.+||+.||.+||| +.++|+||||+.
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred HHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCC
T ss_conf 9986388878864469999999999976799668909---999961984585
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=422.37 Aligned_cols=259 Identities=34% Similarity=0.583 Sum_probs=232.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 89917987551379649999999789959999996324424745799999999999935999567882232027805999
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLV 765 (1044)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++.+.... .....+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 66669988994065839999999999989999998157731--2899999999999867998999198999989988898
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCCCC
Q ss_conf 84416642589998407999999999999999999998855906125799962424---797279950577523444674
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 766 mEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILID---edG~IKLsDFGLAki~~~~~s 842 (1044)
||||+||+|.+++.+.+.+++..+..++.||+.||.|||+++|+||||||+|||+. .++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC----
T ss_conf 8526898488865303678878999999999999875241305568704630011046888249983154358725----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 45899988898999999986434576776676689877791000289999402468788999999939999999996899
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei 922 (1044)
........+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..++
T Consensus 162 ------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 162 ------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp -----------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------89704400328422591887379998078734515999999859799999899999
Q ss_pred HHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 8756215889999-999998889999986714894788996429999829998899
Q 001614 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 923 ~qkIl~g~i~~p~-ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
...+..+...++. .+..+|+++++||.+||++||.+||| +.|+|+||||++.
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~ 270 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTSS
T ss_pred HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9998616877787666678999999999976089757918---9998629844799
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=418.18 Aligned_cols=267 Identities=28% Similarity=0.499 Sum_probs=237.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEE
Q ss_conf 899179875513796499999997899599999963244247---45799999999999935999567882232027805
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR---KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~---e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~L 762 (1044)
.+.|++++.||+|+||+||+|+++.+|+.||+|++++..... ....+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC----CEEEEECCCCCCCC
Q ss_conf 99984416642589998407999999999999999999998855906125799962424797----27995057752344
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGL 838 (1044)
Q Consensus 763 yLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG----~IKLsDFGLAki~~ 838 (1044)
|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+|++|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCC
T ss_conf 99998677864310010356421557899999999998766625422113330127982589866646964334421057
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028999940246878899999993999999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s 918 (1044)
. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 169 ~----------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 169 F----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp T----------------------------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C----------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
T ss_conf 7----------------------------763122477774309999818999976652214099999970889988999
Q ss_pred HHHHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 68998756215889999-999998889999986714894788996429999829998899932368
Q 001614 919 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 983 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i~~e~l~ 983 (1044)
..+.+..+......++. .+..+|..+++||.+||+.||.+||| +.++|+||||++.+|+...
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCCCHHHHH
T ss_conf 99999999816888870104788999999999986389668919---9999619041888705764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=420.77 Aligned_cols=258 Identities=32% Similarity=0.537 Sum_probs=229.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 99179875513796499999997899599999963244247457999999999999359995678822320278059998
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLVm 766 (1044)
+.|++++.||+|+||.||+|+++.+|..||+|++++.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37598479930778199999999999399999987289---999999999999998679999884988980099589999
Q ss_pred EECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 44166425899984-07999999999999999999998855906125799962424797279950577523444674458
Q 001614 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 767 Eym~GGSL~dlL~k-~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~ 845 (1044)
|||+||+|.+++.+ .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|.....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~------ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------ 162 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH------
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC------
T ss_conf 62799818899986289999999999999999999999988988714070031487899989971612303577------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 999888989999999864345767766766898777910002-----899994024687889999999399999999968
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (1044)
Q Consensus 846 s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ 920 (1044)
........+||+.|||||++. +..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 163 ---------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 163 ---------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp ---------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred ---------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf ---------------------86410010256264799998320257888880665787899999982088999998999
Q ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 998756215889999999998889999986714894788996429999829998899
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
+++.++..+..+....+..+|+++++||.+||+.||.+||| +.++|+||||+..
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~~ 275 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTVD 275 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCCC
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCC
T ss_conf 99999970799877765669999999999976699668919---9999629231889
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=417.64 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=229.3
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 91798755137964999999978995999999632442474579999999999993599956788223202780599984
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (1044)
Q Consensus 688 dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLVmE 767 (1044)
.|+.++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 41664258999840799999999999999999999885590612579996242479727995057752344467445899
Q 001614 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (1044)
Q Consensus 768 ym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~s~ 847 (1044)
||++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC---------
T ss_conf 06999457899737999999999999999999999986897666788421798799978984436533467---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 98889899999998643457677667668987779100028---999940246878899999993999999999689987
Q 001614 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 848 ~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g---~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+...
T Consensus 167 ----------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 167 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp ----------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ----------------------7873134766368899834678886721454558999999987889999979999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 56215889999999998889999986714894788996429999829998899
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
++..+..+.. .+..+|+++++||.+||+.||.+||| +.++|+||||...
T Consensus 225 ~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 225 HIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred HHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHCHHHCCC
T ss_conf 9982899988-87888999999999977379657918---9999719975378
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=425.13 Aligned_cols=262 Identities=31% Similarity=0.521 Sum_probs=223.6
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEE
Q ss_conf 45899179875513796499999997899599999963244247457999999999999359995678822320278059
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~Ly 763 (1044)
+..++|++.+.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 87568889789712778099999998999699999987540--9789999999999998679999994999999899999
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 998441664258999840799999999999999999999885-5906125799962424797279950577523444674
Q 001614 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 764 LVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHs-kGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s 842 (1044)
+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCC----
T ss_conf 9997679986899874249999999999999999999999985999714457799468789989995487762567----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 45899988898999999986434576776676689877791000289999402468788999999939999999996899
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (1044)
Q Consensus 843 ~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei 922 (1044)
.....+.+||+.|||||++.+..|+.++||||+||++|+|++|+.||.+.+..+.
T Consensus 157 -------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 157 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp -------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred -------------------------CCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf -------------------------8862111377141194687589989488899899999999988899899887899
Q ss_pred HH------------------------------------------HHHCCCCCCCCCC-CCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 87------------------------------------------5621588999999-9998889999986714894788
Q 001614 923 FD------------------------------------------NILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 923 ~q------------------------------------------kIl~g~i~~p~ip-~~iS~eLkdLIkkLLq~DPsKR 959 (1044)
.. .+... ..+..+ ..+|.++++||.+||+.||.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC--CCCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 9999887517754577421233322111122235413477887665026--87667644489999999999868994679
Q ss_pred CCHHHHHHHHCCCCCCCCCCCH
Q ss_conf 9964299998299988999323
Q 001614 960 LGANGAAEVKAHPFFKGVNWDS 981 (1044)
Q Consensus 960 PSadeA~EIL~HPfFk~i~~e~ 981 (1044)
|| +.|+|+||||+..+++.
T Consensus 290 ~t---a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 290 AD---LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp CC---HHHHHTSHHHHHHHHSC
T ss_pred CC---HHHHHHCHHHCCCCCCC
T ss_conf 08---99996098647698231
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=410.76 Aligned_cols=252 Identities=24% Similarity=0.456 Sum_probs=218.8
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC----CCEEEE
Q ss_conf 1798755137964999999978995999999632442474579999999999993599956788223202----780599
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 764 (1044)
Q Consensus 689 Y~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d----~~~LyL 764 (1044)
|++.++||+|+||+||+|.++.++..||+|.+.... ......+.+.+|+.+|++++|||||++++++.. ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf 885169700828499999999999599999985122-7989999999999999857999850699998403345888999
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEEC-CCCCEEEEECCCCCCCCCCC
Q ss_conf 9844166425899984079999999999999999999988559--06125799962424-79727995057752344467
Q 001614 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskG--IIHRDLKPeNILID-edG~IKLsDFGLAki~~~~~ 841 (1044)
|||||++|+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC---
T ss_conf 99578989489997513554699999999999999999997899799687674351166799988980057654236---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-HH
Q ss_conf 44589998889899999998643457677667668987779100028999940246878899999993999999999-68
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 920 (1044)
Q Consensus 842 s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s-~~ 920 (1044)
.......+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.. ..
T Consensus 167 --------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 167 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf --------------------------876677553813008988478-99986711007999999987889998765599
Q ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCC
Q ss_conf 9987562158899999999988899999867148947889964299998299988
Q 001614 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 921 ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk 975 (1044)
.+...+..+..+ +..+...++++++||.+||+.||.+||| +.|+|+||||+
T Consensus 220 ~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 220 QIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHHHHHHCCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCC
T ss_conf 999999738998-6567557899999999976379758929---99996775409
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=413.89 Aligned_cols=256 Identities=31% Similarity=0.544 Sum_probs=227.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCEEE
Q ss_conf 8991798755137964999999978995999999632442474579999999999993599956788223202--78059
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLY 763 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d--~~~Ly 763 (1044)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ..+...+.+.+|+.++++++||||+++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT-SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 333799679830889199999999999799999987465-7979999999999999977899982489999917899899
Q ss_pred EEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99844166425899984----079999999999999999999988559-----061257999624247972799505775
Q 001614 764 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 764 LVmEym~GGSL~dlL~k----~g~Lsee~i~~Il~QIL~ALaYLHskG-----IIHRDLKPeNILIDedG~IKLsDFGLA 834 (1044)
+|||||+||+|.+++.+ ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 23444674458999888989999999864345767766766898777910002899994024687889999999399999
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 835 ki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF 914 (1044)
+.... ........+||+.|||||++.+..|+.++|||||||++|+|++|..||
T Consensus 162 ~~~~~---------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 162 RILNH---------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EECCC---------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 32245---------------------------777556677882327999983999993898875278999980188998
Q ss_pred CCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 999968998756215889999999998889999986714894788996429999829998
Q 001614 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfF 974 (1044)
.+.+..++..++..+..+ .++..+|+++++||.+||+.||.+||| +.++|+|||+
T Consensus 215 ~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 215 TAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHCCCC
T ss_conf 998999999999718998--897435999999999976799557918---9999729819
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=400.97 Aligned_cols=261 Identities=31% Similarity=0.507 Sum_probs=231.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC------HHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 899179875513796499999997899599999963244247------457999999999999359-9956788223202
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVR-NPFVVRFFYSFTC 758 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~------e~~ie~ilrEieILkkL~-HPNIVkLigvf~d 758 (1044)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++..... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 78059998441664258999840799999999999999999999885590612579996242479727995057752344
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 759 ~~~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
++.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECC
T ss_conf 76059999768986689999865999999999999999999999987599432346254898689983871240316726
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 46744589998889899999998643457677667668987779100028------999940246878899999993999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 912 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g------~~yt~KSDIWSLGVILYELLTGk~ 912 (1044)
. .......+||+.|+|||++.+ ..++.++||||+||++|+|++|..
T Consensus 162 ~----------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 162 P----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp T----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred C----------------------------CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCC
T ss_conf 8----------------------------872134524678889888605344567889923318565602310322888
Q ss_pred CCCCCCHHHHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 99999968998756215889999-999998889999986714894788996429999829998899
Q 001614 913 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 913 PF~g~s~~ei~qkIl~g~i~~p~-ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
||.+.+.......+..+...++. ....+|+++++||.+||+.||.+||+ +.++|+||||+++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~~ 276 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQY 276 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTT
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHHHH
T ss_conf 98899999999999818988898543468999999999976589668919---9999739787975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=408.20 Aligned_cols=257 Identities=27% Similarity=0.493 Sum_probs=229.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 58991798755137964999999978995999999632442474579999999999993599956788223202780599
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyL 764 (1044)
..++|++.+.||+|+||+||+|.++.+|+.||+|++++.. .....+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 7010588789831778399999998999699999975786----659999999999985799798909899988998899
Q ss_pred EEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCC--CCEEEEECCCCCCCCCCC
Q ss_conf 984416642589998407-99999999999999999999885590612579996242479--727995057752344467
Q 001614 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g-~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDed--G~IKLsDFGLAki~~~~~ 841 (1044)
|||||+||+|.+++.+.+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC---
T ss_conf 99538998088998753899999999999999999999998769975135544434437885189976441110034---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 44589998889899999998643457677667668987779100028999940246878899999993999999999689
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~e 921 (1044)
.........|++.|+|||.+.+..|+.++||||+||++|+|++|..||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH
T ss_conf -------------------------6775321223322234021048777840113027999999982899999989999
Q ss_pred HHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 98756215889999-99999888999998671489478899642999982999889
Q 001614 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 922 i~qkIl~g~i~~p~-ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~ 976 (1044)
++.+|..+...++. .+..+|+++++||.+||+.||.+||| +.++|+||||++
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCC
T ss_conf 99999838999880223678999999999986699668909---999963996566
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.55 Aligned_cols=255 Identities=31% Similarity=0.525 Sum_probs=214.6
Q ss_pred CCCCCEEEEE-EECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCEEEEEEEEEC---
Q ss_conf 4589917987-55137964999999978995999999632442474579999999999993-599956788223202---
Q 001614 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC--- 758 (1044)
Q Consensus 684 i~i~dY~ilk-~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkk-L~HPNIVkLigvf~d--- 758 (1044)
..+++|.+.. .||+|+||.||+|+++.+++.||+|++++. ..+.+|+.++.+ ++||||++++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf 70148798107965454869999998899989999998974--------7799999999986699997829899950346
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC---CCCEEEEECC
Q ss_conf -780599984416642589998407--9999999999999999999988559061257999624247---9727995057
Q 001614 759 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (1044)
Q Consensus 759 -~~~LyLVmEym~GGSL~dlL~k~g--~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDe---dG~IKLsDFG 832 (1044)
...+|+|||||+||+|.+++.+.+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 89789999977899849999986278775799999999999999999997698644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 75234446744589998889899999998643457677667668987779100028999940246878899999993999
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (1044)
Q Consensus 833 LAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~ 912 (1044)
+|+.... .......+||+.|||||++.+..|+.++|||||||++|+|++|..
T Consensus 160 ~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 160 FAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp TCEECCC----------------------------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred EEEECCC----------------------------CCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCC
T ss_conf 1233368----------------------------886432267756379277748988888888764516778865889
Q ss_pred CCCCCCHHHH----HHHHHCCCCCCCCC-CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 9999996899----87562158899999-99998889999986714894788996429999829998899
Q 001614 913 PFTAESPEII----FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 913 PF~g~s~~ei----~qkIl~g~i~~p~i-p~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
||.+.+.... ...+..+...++.. ...+|+++++||.+||++||.+||| +.++|+||||...
T Consensus 212 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~ 278 (335)
T d2ozaa1 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQS 278 (335)
T ss_dssp SCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHTT
T ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHHCC
T ss_conf 988988778899999998538888898543469999999999975699657909---9999709876178
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=397.42 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=217.9
Q ss_pred EEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf 9875513796499999997899599999963244247--45799999999999935999567882232027805999844
Q 001614 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (1044)
Q Consensus 691 ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~--e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLVmEy 768 (1044)
.++.||+|+||+||+|+++.+|+.||+|+++...... ......+.+|+.+++.++|||||++++++...+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 16642589998407999999999999999999998855906125799962424797279950577523444674458999
Q 001614 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (1044)
Q Consensus 769 m~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~s~~ 848 (1044)
|.++++..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~---------- 151 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------- 151 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT----------
T ss_pred HCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCC----------
T ss_conf 3450776554126677899999999999999988631635503577625885377841146576100057----------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 8889899999998643457677667668987779100028-999940246878899999993999999999689987562
Q 001614 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (1044)
Q Consensus 849 ~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~qkIl 927 (1044)
.........+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+.+..+...+|.
T Consensus 152 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 152 -----------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp -----------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -----------------CCCCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf -----------------875543302047333639997267788805643630428999985969999999999999999
Q ss_pred CCCCC--------------------CCC-----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCC
Q ss_conf 15889--------------------999-----9999988899999867148947889964299998299988999
Q 001614 928 NRKIP--------------------WPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 928 ~g~i~--------------------~p~-----ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i~ 978 (1044)
..... ++. ....+++++.+||.+||+.||.+||| |.|+|+||||++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNRP 287 (299)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSSS
T ss_pred HHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCCC
T ss_conf 85189972545210002134430347898867856568999999999976389456908---99996799657899
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=390.27 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=219.6
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 43454589917987551379649999999789959999996324424745799999999999935999567882232027
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 680 ~~~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~ 759 (1044)
..+++..++|++.+.||+|+||+||+|.++.+++.||+|++++.. ...+.+.+|+.+|+.++|||||++++++.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCCCCEECCCCCEEEC
T ss_conf 651745799398659820888089999999999699999977761----0399999999999867999882677527457
Q ss_pred CEEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 8059998441664258999840--79999999999999999999988559061257999624247972799505775234
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (1044)
Q Consensus 760 ~~LyLVmEym~GGSL~dlL~k~--g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~ 837 (1044)
+.+|+|||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 85478763146760677753035541579999999999999788898789305760457689989992898324454653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC-CCC
Q ss_conf 4467445899988898999999986434576776676689877791000289999402468788999999939999-999
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTA 916 (1044)
Q Consensus 838 ~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~P-F~g 916 (1044)
.... ........|++.|||||++.+..|+.++||||||+++|||++|..| |.+
T Consensus 166 ~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 166 TGDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CSSS--------------------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCC--------------------------CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 7887--------------------------22103556654666927872799981043021789999998679988774
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 996899875621588999999999888999998671489478899642999982
Q 001614 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 917 ~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
.+...+...+..+. . +..+..+|+++++||.+||+.||.+|||+.++.+.|+
T Consensus 220 ~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 220 IDLSQVYELLEKDY-R-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp CCHHHHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHCCC-C-CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 25999999985588-8-8887433099999999975779768939999999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.44 Aligned_cols=262 Identities=31% Similarity=0.493 Sum_probs=218.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 89917987551379649999999789959999996324424745799999999999935999567882232027805999
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLV 765 (1044)
+++|++.+.||+|+||+||+|+++.+|+.||+|+++... ........+.+|+.+|++++||||+++++++.+...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999776517723768099999999999799999980222-5758999999999999867998388744533224320378
Q ss_pred EEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 844166425899984-0799999999999999999999885590612579996242479727995057752344467445
Q 001614 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEym~GGSL~dlL~k-~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d 844 (1044)
|||+.++.+...... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~------ 153 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG------ 153 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC------
T ss_pred EEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECC------
T ss_conf 86237744555442025688889999999999999998652889921357114011346762103578613436------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 8999888989999999864345767766766898777910002899-994024687889999999399999999968998
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (1044)
Q Consensus 845 ~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~ 923 (1044)
..........||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+..
T Consensus 154 ---------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 154 ---------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp ---------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ---------------------CCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ---------------------88641001036521541122136657774221033331342796687998988999999
Q ss_pred HHHHCCCCC------------------CCC--------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 756215889------------------999--------999998889999986714894788996429999829998899
Q 001614 924 DNILNRKIP------------------WPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 924 qkIl~g~i~------------------~p~--------ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
.++...... ++. ....++.++++||.+||+.||.+||| +.|+|+||||+++
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGTTC
T ss_pred HHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9999832898333144422242124345432222044416678999999999976399557918---9999678701469
Q ss_pred C
Q ss_conf 9
Q 001614 978 N 978 (1044)
Q Consensus 978 ~ 978 (1044)
+
T Consensus 290 ~ 290 (298)
T d1gz8a_ 290 T 290 (298)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.79 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=220.8
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCC-----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 4345458991798755137964999999978995-----9999996324424745799999999999935-999567882
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1044)
Q Consensus 680 ~~~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk-----~VAIKiIkk~~~~~e~~ie~ilrEieILkkL-~HPNIVkLi 753 (1044)
.++.+..++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++.++ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 44657789939701983078819999998578855420499999966335--8789999999999999715899686877
Q ss_pred EEEECCCEEEEEEEECCCCCHHHHHHHC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Q ss_conf 2320278059998441664258999840-----------------------79999999999999999999988559061
Q 001614 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV-----------------------GCLEEDVARIYIAELVLALEYLHSLGIVH 810 (1044)
Q Consensus 754 gvf~d~~~LyLVmEym~GGSL~dlL~k~-----------------------g~Lsee~i~~Il~QIL~ALaYLHskGIIH 810 (1044)
+++.+.+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+|
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25799962424797279950577523444674458999888989999999864345767766766898777910002899
Q 001614 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (1044)
Q Consensus 811 RDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 890 (1044)
|||||+|||++.++.+||+|||+|+...... .........||+.|||||++.+..
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-------------------------NYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------TSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCCHHCCCCCCCCEEEEEECCCCCCCCCCC-------------------------CEEEECCCCCCCCCCCHHHHCCCC
T ss_conf 5270321443459828985142222045778-------------------------615623435787657838872799
Q ss_pred CCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 9940246878899999993-999999999689987562158899999999988899999867148947889964299998
Q 001614 891 HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 891 yt~KSDIWSLGVILYELLT-Gk~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
|+.++|||||||++|||++ |..||.+.+....+.++.....+ +..|..+|+++++||.+||+.||.+|||+.++.+.|
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9963303000399999983899999998989999999856998-998876789999999997588966893999999997
Q ss_pred C
Q ss_conf 2
Q 001614 970 A 970 (1044)
Q Consensus 970 ~ 970 (1044)
.
T Consensus 322 ~ 322 (325)
T d1rjba_ 322 G 322 (325)
T ss_dssp H
T ss_pred H
T ss_conf 4
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.08 Aligned_cols=264 Identities=30% Similarity=0.442 Sum_probs=216.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCC-CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEC--
Q ss_conf 589917987551379649999999789-959999996324424745799999999999935---99956788223202--
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC-- 758 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~T-Gk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL---~HPNIVkLigvf~d-- 758 (1044)
..++|++++.||+|+||+||+|++..+ ++.||+|+++.... .......+.+|+.+++.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 758979888992155869999999888998999999802324-5167999999999999874258988023663221466
Q ss_pred ---CCEEEEEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf ---780599984416642589998-4079999999999999999999988559061257999624247972799505775
Q 001614 759 ---RDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (1044)
Q Consensus 759 ---~~~LyLVmEym~GGSL~dlL~-k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLA 834 (1044)
...+|++|||+++|.+..... ....+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHH
T ss_conf 66674699999740587144444303789998999999999999999997588983579862789858997542100010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 23444674458999888989999999864345767766766898777910002899994024687889999999399999
Q 001614 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (1044)
Q Consensus 835 ki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF 914 (1044)
.... ........+||+.|+|||++.+..|+.++||||+||++|+|++|+.||
T Consensus 164 ~~~~----------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHHC----------------------------CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCC
T ss_conf 1100----------------------------234577765485114831001798881110003289999998787998
Q ss_pred CCCCHHHHHHHHHCCC------------------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 9999689987562158------------------------8999999999888999998671489478899642999982
Q 001614 915 TAESPEIIFDNILNRK------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 915 ~g~s~~ei~qkIl~g~------------------------i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
.+.+..+...++.... .+....+..+++.+++||.+||++||.+||| +.|+|+
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e~L~ 292 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALS 292 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHHT
T ss_pred CCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHC
T ss_conf 99898999999998407996110532111103330223456454404458999999999987489667918---999966
Q ss_pred CCCCCCCCCC
Q ss_conf 9998899932
Q 001614 971 HPFFKGVNWD 980 (1044)
Q Consensus 971 HPfFk~i~~e 980 (1044)
||||+++++.
T Consensus 293 Hpff~~i~~~ 302 (305)
T d1blxa_ 293 HPYFQDLERC 302 (305)
T ss_dssp SGGGTTCCCC
T ss_pred CHHHCCCHHH
T ss_conf 9634075210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.87 Aligned_cols=261 Identities=31% Similarity=0.494 Sum_probs=221.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----
Q ss_conf 5899179875513796499999997899599999963244247457999999999999359995678822320278----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~---- 760 (1044)
..++|+++++||+|+||+||+|.++.+|+.||+|++++. .........+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 477189988980177819999999999989999998522-2596999999999999986689875479998635765555
Q ss_pred --EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf --059998441664258999840799999999999999999999885590612579996242479727995057752344
Q 001614 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 --~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
.+|+||||| +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|+..
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~- 171 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA- 171 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCEEEEEEECC-CCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC-
T ss_conf 41599998405-521899987-402269999999999999999987378764566851111210012211343102206-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028-99994024687889999999399999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~yt~KSDIWSLGVILYELLTGk~PF~g~ 917 (1044)
.......+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus 172 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 172 -----------------------------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp -----------------------------CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCC
T ss_conf -----------------------------876310245533358899817878996501030038999999786998889
Q ss_pred CHHHHHHHHHCC----------------------------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 968998756215----------------------------8899999999988899999867148947889964299998
Q 001614 918 SPEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g----------------------------~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
+.......+... ...+......+++++.+||.+||..||.+||| +.++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~eiL 299 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 299 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHH
T ss_conf 768999999850378848888653000344331157866655667755689999999999977299557929---99996
Q ss_pred CCCCCCCCCCCH
Q ss_conf 299988999323
Q 001614 970 AHPFFKGVNWDS 981 (1044)
Q Consensus 970 ~HPfFk~i~~e~ 981 (1044)
+||||+++.+..
T Consensus 300 ~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 300 AHPYFESLHDTE 311 (346)
T ss_dssp HSGGGTTTC---
T ss_pred CCHHHCCCCCCC
T ss_conf 396237587766
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.51 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=224.8
Q ss_pred CCCCCEEEEEE-ECCCCCEEEEEEEECCC--CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 45899179875-51379649999999789--9599999963244247457999999999999359995678822320278
Q 001614 684 TSIDDFEIIKP-ISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 i~i~dY~ilk~-LGkGsFG~VYkak~k~T--Gk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~ 760 (1044)
+..++|.+.+. ||+|+||.||+|.++.+ +..||||++++.. .....+.+.+|+.+|++++|||||++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 54447188784873060809999999608976899999988203--97899999999999986799888068656036-8
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 059998441664258999840-7999999999999999999998855906125799962424797279950577523444
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~ 839 (1044)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 07999980789968997521256999999999999999987899868810576764660454688542033134211554
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 6744589998889899999998643457677667668987779100028999940246878899999993-999999999
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s 918 (1044)
... .........||+.|||||++.+..++.++|||||||++|||+| |..||.+.+
T Consensus 162 ~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 162 DDS------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CSC------------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCC------------------------CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC
T ss_conf 343------------------------21135621137433586887279999541232201789999938999999979
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCC
Q ss_conf 689987562158899999999988899999867148947889964299998299988
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk 975 (1044)
..++...+..+.. +..|+.+|+++.+||.+||+.||.+||++.++.+.|+|+|+.
T Consensus 218 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 9999999981899--999976789999999997577976890999999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=383.67 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=220.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCC---EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 458991798755137964999999978995---99999963244247457999999999999359995678822320278
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TGk---~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~ 760 (1044)
+..++|++.+.||+|+||+||+|+++.+++ .+|+|.+... ......+.+.+|+.+|++++|||||++++++...+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 0800427856980278829999999579978899999997844--59899999999999998579988861899996288
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 059998441664258999840-7999999999999999999998855906125799962424797279950577523444
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~ 839 (1044)
.+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 77999972279853002104567999999999999999988988527983576150448988999199888443157567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 6744589998889899999998643457677667668987779100028999940246878899999993-999999999
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s 918 (1044)
.... ..........||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus 181 ~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 181 DTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp -------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCC----------------------CEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
T ss_conf 7776----------------------536502566688300387888369978612144535789999867999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 689987562158899999999988899999867148947889964299998
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
..++...+..+.. +..+..++..+.+||.+||+.||.+||++.++.+.|
T Consensus 239 ~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 239 NQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9999999973788--999742269999999997587976892999999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=385.71 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=222.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----E
Q ss_conf 899179875513796499999997899599999963244247457999999999999359995678822320278----0
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----N 761 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~----~ 761 (1044)
.++|++.+.||+|+||.||+|++..+|+.||+|++++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 59998441664258999840799999999999999999999885590612579996242479727995057752344467
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 762 LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~ 841 (1044)
+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..+++|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCC
T ss_conf 99999778898710112035899999999999999999999985795276346755665754320100344432212354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 44589998889899999998643457677667668987779100028999940246878899999993999999999689
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~e 921 (1044)
.........+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 166 ------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 166 ------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp -------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH
T ss_conf ------------------------43333464257624369999839999966320265289999976979989969999
Q ss_pred HHHHHHCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9875621588999-999999888999998671489478899
Q 001614 922 IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (1044)
Q Consensus 922 i~qkIl~g~i~~p-~ip~~iS~eLkdLIkkLLq~DPsKRPS 961 (1044)
...++.......+ .....+|+++.+||.+||++||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHH
T ss_conf 99999846999971003478999999999986679767773
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.36 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=215.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHH---HHHHHHHHHHHHHHCC--CCCEEEEEEEEECCC
Q ss_conf 89917987551379649999999789959999996324424745---7999999999999359--995678822320278
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILITVR--NPFVVRFFYSFTCRD 760 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~---~ie~ilrEieILkkL~--HPNIVkLigvf~d~~ 760 (1044)
.++|++.+.||+|+||.||+|+++.+|+.||+|++++....... ....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCC-CCEEEEECCCCCCCC
Q ss_conf 05999844166-4258999840799999999999999999999885590612579996242479-727995057752344
Q 001614 761 NLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 ~LyLVmEym~G-GSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDed-G~IKLsDFGLAki~~ 838 (1044)
.+|+||||+.+ +++.+++.+...+++..++.++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECC
T ss_conf 68999983368622899986158999999999999999999999877975566761114774478848977546535324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028999-94024687889999999399999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-t~KSDIWSLGVILYELLTGk~PF~g~ 917 (1044)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.
T Consensus 163 -----------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 -----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp -----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred -----------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC
T ss_conf -----------------------------445566565877479999848997886533255403453675688998873
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCC
Q ss_conf 9689987562158899999999988899999867148947889964299998299988999
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 978 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i~ 978 (1044)
+ .+..+...+ +..+|+++++||.+||+.||.+||| +.++|+||||+++.
T Consensus 214 ~------~i~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 214 E------EIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVL 262 (273)
T ss_dssp H------HHHHCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCC
T ss_pred H------HHHHCCCCC---CCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCCC
T ss_conf 6------776154477---8779999999999976089758939---99985398667887
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.26 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=221.8
Q ss_pred EEEE-EEECCCCCEEEEEEEEC--CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 1798-75513796499999997--89959999996324424745799999999999935999567882232027805999
Q 001614 689 FEII-KPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 689 Y~il-k~LGkGsFG~VYkak~k--~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLV 765 (1044)
+.+. ++||+|+||+||+|.++ .+++.||+|+++... ......+.+.+|+.+|++++|||||++++++.. +.+|+|
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred CEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEE
T ss_conf 700187834587829999998169738599999988010-898999999999999986799898527777505-977999
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 84416642589998407999999999999999999998855906125799962424797279950577523444674458
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~ 845 (1044)
||||++|+|.+++.+...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~--- 162 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--- 162 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---
T ss_pred EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCC---
T ss_conf 97478896899975225789999999999999997668747955677761131023567512341345331343234---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Q ss_conf 9998889899999998643457677667668987779100028999940246878899999993-999999999689987
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s~~ei~q 924 (1044)
.........||+.|||||++.+..++.++||||||+++|||++ |..||.+.+..++..
T Consensus 163 ---------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~ 221 (277)
T d1xbba_ 163 ---------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 221 (277)
T ss_dssp ---------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred ---------------------CCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf ---------------------43224456778420391665379998434430340313289658999999989999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 5621588999999999888999998671489478899642999982999889
Q 001614 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 925 kIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~ 976 (1044)
.+..+.. +..|..+|+++.+||.+||+.||.+||++.++.+.|+|+|+.-
T Consensus 222 ~i~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 222 MLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 9982899--9998656799999999975889768909899999852887504
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.18 Aligned_cols=279 Identities=42% Similarity=0.792 Sum_probs=232.9
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE---CCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEC
Q ss_conf 4589917987551379649999999---789959999996324424-74579999999999993599-956788223202
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRN-PFVVRFFYSFTC 758 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~---k~TGk~VAIKiIkk~~~~-~e~~ie~ilrEieILkkL~H-PNIVkLigvf~d 758 (1044)
+.+++|++++.||+|+||+||+|++ +.+|+.||+|++++.... .....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 45102599989832878399999987658879489999983677210168999999999999864679839996200024
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 78059998441664258999840799999999999999999999885590612579996242479727995057752344
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 759 ~~~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
...+|++|||+.+|+|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf 87300123123411799998730454378888889999999988514998965477320124699988874132022203
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 467445899988898999999986434576776676689877791000289--999402468788999999939999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~--~yt~KSDIWSLGVILYELLTGk~PF~g 916 (1044)
. ..........|++.|+|||.+.+. .++.++|||||||+||+|++|..||.+
T Consensus 181 ~--------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 181 A--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp G--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred C--------------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 4--------------------------44432212223333310687605776887132517777999999768999888
Q ss_pred CCHHHHHHHHHCCCCC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--HHHHHHCCCCCCCCCCCHHHHHHCC
Q ss_conf 9968998756215889-9999999988899999867148947889964--2999982999889993236863152
Q 001614 917 ESPEIIFDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQKMT 988 (1044)
Q Consensus 917 ~s~~ei~qkIl~g~i~-~p~ip~~iS~eLkdLIkkLLq~DPsKRPSad--eA~EIL~HPfFk~i~~e~l~~~k~~ 988 (1044)
.+.......+...... .+.++..+|+++.+||.+||++||.+||++. .+.|+|+||||++++|+.+..++.+
T Consensus 235 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 235 DGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309 (322)
T ss_dssp TTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHHHHHHCCCC
T ss_conf 877779999998335689988654799999999997445898819997450999974972348998899737898
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.24 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=212.6
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCE
Q ss_conf 45458991798755137964999999978995999999632442474579999999999993599956788223202780
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 682 ~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~ 761 (1044)
+.+..++|++.+.||+|+||+||+|+++ ..||||+++.. .......+.+.+|+.++++++|||||++++++.. +.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCS-SCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECC-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CE
T ss_conf 1315451899889830788589999999---98999999734-6998999999999999984799878645679715-58
Q ss_pred EEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 59998441664258999840-79999999999999999999988559061257999624247972799505775234446
Q 001614 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~ 840 (1044)
+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 99999658998889998523578999999999999999988875099951614789979818997887500221333556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 744589998889899999998643457677667668987779100028---99994024687889999999399999999
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (1044)
Q Consensus 841 ~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g---~~yt~KSDIWSLGVILYELLTGk~PF~g~ 917 (1044)
..........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.
T Consensus 158 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ---------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf -------------------------7763125665574317999995056899995315163599999999788998998
Q ss_pred CHHHHHHHHHCCCCCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 96899875621588999---99999988899999867148947889964299998
Q 001614 918 SPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p---~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
+.......+.......+ ..+..+++++.+||.+||+.||.+|||+.++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9699999999658889860003655549999999997588976892999999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=381.58 Aligned_cols=259 Identities=29% Similarity=0.486 Sum_probs=221.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 89917987551379649999999789959999996324424745799999999999935999567882232027805999
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLV 765 (1044)
+++|++.++||+|+||.||+|+++ +|+.||+|+++... ........+.+|+.+|+.++||||+++++++...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 999634318722778189999968-99999999981232-6858999999999999867998687660120467731589
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 84416642589998407999999999999999999998855906125799962424797279950577523444674458
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~ 845 (1044)
++++.++.+..+....+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+|++|||+|....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~------- 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------- 151 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC-------
T ss_pred EEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECC-------
T ss_conf 9740045678998604775144568999999999998605748826787750568689978732366430114-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 9998889899999998643457677667668987779100028-999940246878899999993999999999689987
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (1044)
Q Consensus 846 s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~ei~q 924 (1044)
..........|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+..+...
T Consensus 152 --------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 152 --------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp --------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred --------------------CCCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHH
T ss_conf --------------------676541010243110137887178888841002111758999977979989889899999
Q ss_pred HHHCCC--------------------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 562158--------------------------8999999999888999998671489478899642999982999889
Q 001614 925 NILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 976 (1044)
Q Consensus 925 kIl~g~--------------------------i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~ 976 (1044)
++.... .++......+++.+.+||++||+.||.+||| +.|+|+||||++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCC
T ss_conf 999863899711042123332214333335676466651258999999999986689668909---999856922074
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.34 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=216.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 58991798755137964999999978995999999632442474579999999999993599956788223202780599
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyL 764 (1044)
..++|++.+.||+|+||.||+|+++ ++..||+|++++.. ...+.+.+|+.+++.++||||+++++++..++.+|+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEE
T ss_conf 9699588889820888299999988-99999999987886----768999999999996689975653524315993379
Q ss_pred EEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 98441664258999840-79999999999999999999988559061257999624247972799505775234446744
Q 001614 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~ 843 (1044)
|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~--- 154 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--- 154 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCC---
T ss_conf 99836999189975201347889999999999999877653164310443153266668877686553210023688---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Q ss_conf 589998889899999998643457677667668987779100028999940246878899999993-9999999996899
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1044)
Q Consensus 844 d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s~~ei 922 (1044)
.........||+.|+|||++.+..|+.++||||||+++|||+| |.+||...+..++
T Consensus 155 -----------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 155 -----------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp ---------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred -----------------------CCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf -----------------------733504300176667857860799984033210599999998789888778999999
Q ss_pred HHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 87562158899999999988899999867148947889964299998
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
...+..+... ..|..+++++.+||.+||+.||.+||+++++.+.|
T Consensus 212 ~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 212 VEDISTGFRL--YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9999806888--99543679999999997657976891999999999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.37 Aligned_cols=253 Identities=31% Similarity=0.452 Sum_probs=208.8
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC------CE
Q ss_conf 917987551379649999999789959999996324424745799999999999935999567882232027------80
Q 001614 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------DN 761 (1044)
Q Consensus 688 dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~------~~ 761 (1044)
+|+..++||+|+||+||+|+++.+|+.||+|++.+... ...+|+.+|+.++||||++++++|... .+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 76751698217683999999999997999999881606-------89999999986689898738789974476577318
Q ss_pred EEEEEEECCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 59998441664258999---8407999999999999999999998855906125799962424797-2799505775234
Q 001614 762 LYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIG 837 (1044)
Q Consensus 762 LyLVmEym~GGSL~dlL---~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG-~IKLsDFGLAki~ 837 (1044)
+|+|||||++|.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 99998416886078888631036899999999999999999999986687645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 446744589998889899999998643457677667668987779100028-9999402468788999999939999999
Q 001614 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (1044)
Q Consensus 838 ~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~yt~KSDIWSLGVILYELLTGk~PF~g 916 (1044)
. ........+|++.|+|||++.+ ..|+.++||||+||++|+|++|+.||..
T Consensus 174 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 V----------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp C----------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred C----------------------------CCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCC
T ss_conf 4----------------------------776532002555556827764046888210002465277855028799898
Q ss_pred CCHHHHHHHHHCC-----------------CCCCCC---------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 9968998756215-----------------889999---------99999888999998671489478899642999982
Q 001614 917 ESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 917 ~s~~ei~qkIl~g-----------------~i~~p~---------ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
.+..+.+..+... ...++. .....++++.+||.+||++||.+||| +.|+|+
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~ 302 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEACA 302 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHT
T ss_pred CCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHC
T ss_conf 79999999999974898177654306210110355445674444315689999999999976589557929---999966
Q ss_pred CCCCCCCC
Q ss_conf 99988999
Q 001614 971 HPFFKGVN 978 (1044)
Q Consensus 971 HPfFk~i~ 978 (1044)
||||+++.
T Consensus 303 Hp~f~~~~ 310 (350)
T d1q5ka_ 303 HSFFDELR 310 (350)
T ss_dssp SGGGGGGG
T ss_pred CHHHCCCC
T ss_conf 98452466
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.01 Aligned_cols=265 Identities=28% Similarity=0.374 Sum_probs=219.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-----
Q ss_conf 589917987551379649999999789959999996324424745799999999999935999567882232027-----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~----- 759 (1044)
.+++|++.++||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC-----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 6279889999722748299999998999799999984222-463789999999999998359996606765402465444
Q ss_pred ---CEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ---80599984416642589998407999999999999999999998855906125799962424797279950577523
Q 001614 760 ---DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 760 ---~~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki 836 (1044)
..+|+||||+.++.+..+......+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEE
T ss_conf 45763899985357874101222034433089999999999999885229988567672220366899687631350022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 44467445899988898999999986434576776676689877791000289-99940246878899999993999999
Q 001614 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 915 (1044)
Q Consensus 837 ~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~yt~KSDIWSLGVILYELLTGk~PF~ 915 (1044)
...... .........+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.
T Consensus 167 ~~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 167 FSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCCC-----------------------CCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCC
T ss_conf 355444-----------------------321135660249787428997079998917870067864661744879989
Q ss_pred CCCHHHHHHHHHCCCCCCCCC-C----------------------------CCCCHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 999689987562158899999-9----------------------------99988899999867148947889964299
Q 001614 916 AESPEIIFDNILNRKIPWPCV-P----------------------------SDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (1044)
Q Consensus 916 g~s~~ei~qkIl~g~i~~p~i-p----------------------------~~iS~eLkdLIkkLLq~DPsKRPSadeA~ 966 (1044)
+.+.......+......++.. . ...++++.+||.+||+.||.+||| +.
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---a~ 300 (318)
T d3blha1 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SD 300 (318)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---HH
T ss_pred CCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HH
T ss_conf 989999999999841899825534432034443320133445550334044459989999999987389658909---99
Q ss_pred HHHCCCCCCC
Q ss_conf 9982999889
Q 001614 967 EVKAHPFFKG 976 (1044)
Q Consensus 967 EIL~HPfFk~ 976 (1044)
|+|.||||+.
T Consensus 301 elL~Hpff~~ 310 (318)
T d3blha1 301 DALNHDFFWS 310 (318)
T ss_dssp HHHHSGGGSS
T ss_pred HHHCCHHHCC
T ss_conf 9974950156
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.05 Aligned_cols=262 Identities=28% Similarity=0.467 Sum_probs=216.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EE
Q ss_conf 99179875513796499999997899599999963244247457999999999999359995678822320278----05
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 762 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~----~L 762 (1044)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+++|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 98599789940648099999999999499999980310--9589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99984416642589998407999999999999999999998855906125799962424797279950577523444674
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (1044)
Q Consensus 763 yLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s 842 (1044)
+++++++.+|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEEECCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 9999962598656644058-999999999999999999999978986777876437887999778754570565047776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 4589998889899999998643457677667668987779100028-999940246878899999993999999999689
Q 001614 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 843 ~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g-~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~e 921 (1044)
........+||+.|+|||++.. ..++.++||||+|+++|+|++|..||.+.+...
T Consensus 165 ------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 165 ------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp ------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------CCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHH
T ss_conf ------------------------41010110265200038786047888741010046701337766979978888899
Q ss_pred HHHHHHCC----------------------------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 98756215----------------------------88999999999888999998671489478899642999982999
Q 001614 922 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 973 (1044)
Q Consensus 922 i~qkIl~g----------------------------~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPf 973 (1044)
....+... ..++....+.+++++++||.+||++||.+||| +.++|+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHH
T ss_conf 99987652069975664234332222024467755778777837899999999999976489567908---999861986
Q ss_pred CCCCC
Q ss_conf 88999
Q 001614 974 FKGVN 978 (1044)
Q Consensus 974 Fk~i~ 978 (1044)
|+...
T Consensus 298 ~~~~~ 302 (345)
T d1pmea_ 298 LEQYY 302 (345)
T ss_dssp GTTTC
T ss_pred HCCCC
T ss_conf 55588
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.21 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=217.3
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 34545899179875513796499999997899599999963244247457999999999999359995678822320278
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 681 ~~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~ 760 (1044)
.+.+..++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.++++++|||||++++++.. +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 70038899388679810798289999999-99999999986476----888999999999986799988578731045-9
Q ss_pred EEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 059998441664258999840--799999999999999999999885590612579996242479727995057752344
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~--g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECC
T ss_conf 76999995789828888751478988788999999999999999974895467564225156202440423410147735
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028999940246878899999993-99999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~ 917 (1044)
... ........||+.|||||++.+..++.++||||||+++|||+| |.+||...
T Consensus 161 ~~~--------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 161 DNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp SSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCC--------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 886--------------------------442035677444458289837999824564525799999996898888888
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 968998756215889999999998889999986714894788996429999829998
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 974 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfF 974 (1044)
+..++...+..+.. +..|..+++++.+||.+||+.||.+|||++++.+.|+ +||
T Consensus 215 ~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~-~~f 268 (272)
T d1qpca_ 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE-DFF 268 (272)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH-HHH
T ss_pred CHHHHHHHHHHCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH-HHH
T ss_conf 99999999970688--8896557199999999975889768939999999861-132
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.03 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=215.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-----
Q ss_conf 589917987551379649999999789959999996324424745799999999999935999567882232027-----
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~----- 759 (1044)
..++|+++++||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 3377599889621758599999999999899999988233-697999999999999986489876489989702564345
Q ss_pred -CEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf -8059998441664258999840799999999999999999999885590612579996242479727995057752344
Q 001614 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 -~~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
..+|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCEEEEEEECCCHH-HHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCC
T ss_conf 76269998414467-787650--389999999999999999988652211245677632113654431320102321146
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028999940246878899999993999999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s 918 (1044)
........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 171 ----------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 171 ----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp --------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCC
T ss_conf ----------------------------6655332214655558133147777877433356625789865989988897
Q ss_pred HHHHHHHHHCCC----------------------CCCCCC-----------------CCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 689987562158----------------------899999-----------------99998889999986714894788
Q 001614 919 PEIIFDNILNRK----------------------IPWPCV-----------------PSDMSFEAQDLINRFLIHDPNQR 959 (1044)
Q Consensus 919 ~~ei~qkIl~g~----------------------i~~p~i-----------------p~~iS~eLkdLIkkLLq~DPsKR 959 (1044)
......++.... ...... ....++++.+||++||..||.+|
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 78899999972058987999876566777764175435666421264333543210133379999999999876994579
Q ss_pred CCHHHHHHHHCCCCCCCCCC
Q ss_conf 99642999982999889993
Q 001614 960 LGANGAAEVKAHPFFKGVNW 979 (1044)
Q Consensus 960 PSadeA~EIL~HPfFk~i~~ 979 (1044)
|| |.|+|+||||+..-+
T Consensus 303 ~t---a~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 303 IS---VDDALQHPYINVWYD 319 (355)
T ss_dssp CC---HHHHHTSTTTGGGCC
T ss_pred CC---HHHHHCCCCCCCCCC
T ss_conf 08---999966942087888
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.42 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=222.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 89917987551379649999999789959999996324424745799999999999935999567882232027805999
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyLV 765 (1044)
+++|+++++||+|+||+||+|+++.+|+.||+|+++... ........+.+|+.+|+.++||||+++++++.....++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999786269712868199999999999699999980321-7868999999999999856757888213544444311588
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 84416642589998407999999999999999999998855906125799962424797279950577523444674458
Q 001614 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (1044)
Q Consensus 766 mEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d~ 845 (1044)
++++.+++|..++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|.....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~------ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------ 153 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCC------
T ss_conf 63023322211212356540367899999999998774339986001467612113378266520460110468------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCC-CCCCHHHHH
Q ss_conf 999888989999999864345767766766898777910002899-994024687889999999399999-999968998
Q 001614 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 923 (1044)
Q Consensus 846 s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~-yt~KSDIWSLGVILYELLTGk~PF-~g~s~~ei~ 923 (1044)
.........+++.|+|||++.+.. ++.++||||+||++|+|++|..|| .+.+..+..
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~ 212 (292)
T d1unla_ 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_dssp ---------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred ---------------------CCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf ---------------------87510010344310146675069888804440265418899851899998899999999
Q ss_pred HHHHCCC--------------------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 7562158--------------------------89999999998889999986714894788996429999829998899
Q 001614 924 DNILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 924 qkIl~g~--------------------------i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
.++.... ......+..+++.+.+||.+||+.||.+||| |.|+|+||||+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGSSC
T ss_pred HHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9998611899735513443222113344454431043306568999999999986499668909---9999649534079
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.62 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=217.3
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCC----CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 45899179875513796499999997899----59999996324424745799999999999935999567882232027
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TG----k~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~ 759 (1044)
+..+.|++.+.||+|+||.||+|.++.++ ..||||+++... .......+++|+.++++++|||||++++++...
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 788996861598117790999999968998787999999988445--968999999999999856898783236778338
Q ss_pred CEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 8059998441664258999840-799999999999999999999885590612579996242479727995057752344
Q 001614 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 760 ~~LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
..+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 80389997213574022210234542089999999999985412121234257656442788899849984551030035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 467445899988898999999986434576776676689877791000289999402468788999999939-9999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAE 917 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTG-k~PF~g~ 917 (1044)
.... .........||+.|||||++.+..++.++||||||+++|||++| .+||.+.
T Consensus 162 ~~~~------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 162 DDPE------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp ------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCC------------------------CCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 7876------------------------5267426777734348888704999973556344898999996798865568
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 9689987562158899999999988899999867148947889964299998
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
+..++...+..+.. +..+..++..+.+||.+||+.||.+||++.++.+.|
T Consensus 218 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 218 SNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CHHHHHHHHHCCCC--CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 99999999863578--998504579999999997767976893999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.00 Aligned_cols=258 Identities=30% Similarity=0.432 Sum_probs=218.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-----
Q ss_conf 899179875513796499999997899599999963244247457999999999999359995678822320278-----
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~----- 760 (1044)
.++|+++++||+|+||+||+|+++.+|+.||||++++. .........+.+|+.+|+.++||||+++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH-HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 98718888983178839999999999979999998820-02868999999999999866898742599999634645668
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 05999844166425899984079999999999999999999988559061257999624247972799505775234446
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~ 840 (1044)
..+++++++.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--- 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC---
T ss_pred CEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC---
T ss_conf 64999996258862320022-45309999999999999999997388765166776334554322001321000125---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 7445899988898999999986434576776676689877791000289-999402468788999999939999999996
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~yt~KSDIWSLGVILYELLTGk~PF~g~s~ 919 (1044)
........|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus 172 ---------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 ---------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp ---------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ---------------------------75444434543555835533775678551243205899999768899788988
Q ss_pred HHHHHHHHCCCCCC-----------------------C-----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 89987562158899-----------------------9-----9999998889999986714894788996429999829
Q 001614 920 EIIFDNILNRKIPW-----------------------P-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~-----------------------p-----~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~H 971 (1044)
......+....... + .....+++++++||.+||+.||.+||| +.|+|+|
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL~H 301 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 301 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCC
T ss_conf 9999999973079975773200102445444303557875556626789999999999977588345938---9998559
Q ss_pred CCCCCCC
Q ss_conf 9988999
Q 001614 972 PFFKGVN 978 (1044)
Q Consensus 972 PfFk~i~ 978 (1044)
|||++..
T Consensus 302 p~f~~~~ 308 (348)
T d2gfsa1 302 AYFAQYH 308 (348)
T ss_dssp GGGTTTC
T ss_pred HHHCCCC
T ss_conf 9548799
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=369.43 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=210.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECC--CE
Q ss_conf 5899179875513796499999997899599999963244247457999999999999359-99567882232027--80
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DN 761 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~-HPNIVkLigvf~d~--~~ 761 (1044)
..++|+++++||+|+||+||+|+++.+|+.||+|++++. ....+.+|+.+|+.+. ||||++++++|... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCC
T ss_conf 986718978983174819999998899979999998889------99999999999985157998767999998168771
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCCC
Q ss_conf 599984416642589998407999999999999999999998855906125799962424797-2799505775234446
Q 001614 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG-~IKLsDFGLAki~~~~ 840 (1044)
+|+|||||++|+|..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred EEEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC-
T ss_conf 26888631798589974---68999999999999999998876433443456441237748998366415654266468-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 7445899988898999999986434576776676689877791000289-999402468788999999939999999996
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (1044)
Q Consensus 841 ~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~-~yt~KSDIWSLGVILYELLTGk~PF~g~s~ 919 (1044)
.......+||+.|+|||++.+. .++.++||||+|+++|+|++|..||.....
T Consensus 183 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 183 ---------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp ---------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ---------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf ---------------------------87444322486424761026888888452323354555876048899988760
Q ss_pred H-HHHHHHHC-------------CCC---------------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 8-99875621-------------588---------------------999999999888999998671489478899642
Q 001614 920 E-IIFDNILN-------------RKI---------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (1044)
Q Consensus 920 ~-ei~qkIl~-------------g~i---------------------~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSade 964 (1044)
. .....+.. ... ........+++++.+||++||++||.+|||
T Consensus 236 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t--- 312 (328)
T d3bqca1 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT--- 312 (328)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---
T ss_conf 18999999998788415555542254447430000033343311211552112448999999999986699568908---
Q ss_pred HHHHHCCCCCCCCCCC
Q ss_conf 9999829998899932
Q 001614 965 AAEVKAHPFFKGVNWD 980 (1044)
Q Consensus 965 A~EIL~HPfFk~i~~e 980 (1044)
+.|+|+||||+++.|+
T Consensus 313 a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 AREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHHTSGGGTTSCCC
T ss_pred HHHHHCCCCCCCCCCC
T ss_conf 9999649355887979
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.75 Aligned_cols=251 Identities=21% Similarity=0.341 Sum_probs=217.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf 58991798755137964999999978995999999632442474579999999999993599956788223202780599
Q 001614 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 685 ~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~LyL 764 (1044)
..++|++.++||+|+||+||+|+++ ++..||+|++++... ..+.+++|+.++++++||||+++++++.+...+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
T ss_conf 9699799689820788399999988-998999999874757----78999999999996689860158899850781699
Q ss_pred EEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 9844166425899984-079999999999999999999988559061257999624247972799505775234446744
Q 001614 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k-~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~ 843 (1044)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--- 153 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--- 153 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS---
T ss_pred EEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC---
T ss_conf 99704899388864102467768999999999999999875468434665413588769984798861442023578---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Q ss_conf 589998889899999998643457677667668987779100028999940246878899999993-9999999996899
Q 001614 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (1044)
Q Consensus 844 d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s~~ei 922 (1044)
.........||+.|+|||++.+..++.++||||||+++|||+| |+.||.+.+..++
T Consensus 154 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 154 -----------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp -----------------------SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred -----------------------CCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH
T ss_conf -----------------------722524657887757807863799885210336432467397559999889999999
Q ss_pred HHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 8756215889999999998889999986714894788996429999
Q 001614 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 923 ~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EI 968 (1044)
...+..+.. +..|..++.++.+||.+||+.||.+|||+.++.+.
T Consensus 211 ~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 211 AEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999980797--89965465999999999766897689399999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.68 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=218.6
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCCE--EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEC
Q ss_conf 454589917987551379649999999789959--999996324424745799999999999935-99956788223202
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 758 (1044)
Q Consensus 682 ~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~--VAIKiIkk~~~~~e~~ie~ilrEieILkkL-~HPNIVkLigvf~d 758 (1044)
..+..++|++.+.||+|+||+||+|.++.+|.. ||+|.++.. ......+.+.+|+.+|+++ +||||+++++++..
T Consensus 5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CCCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC
T ss_conf 96687996887798207882899999989996999999997823--3857999999999999862289988367888841
Q ss_pred CCEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC
Q ss_conf 78059998441664258999840----------------79999999999999999999988559061257999624247
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822 (1044)
Q Consensus 759 ~~~LyLVmEym~GGSL~dlL~k~----------------g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDe 822 (1044)
.+.+|+||||+++|+|.+++++. ..+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
T ss_conf 87369999802898699998640355555123101234578999999999999999987663089545550520489868
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 97279950577523444674458999888989999999864345767766766898777910002899994024687889
Q 001614 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (1044)
Q Consensus 823 dG~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGV 902 (1044)
++.+||+|||+|+.... ........||+.|+|||.+.+..|+.++||||||+
T Consensus 163 ~~~~kl~DfG~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGv 214 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 214 (309)
T ss_dssp GGCEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred CCCEEECCCCCCCCCCC----------------------------CCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHH
T ss_conf 87638743443224442----------------------------23455301377555538752699996221531388
Q ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 99999939-99999999689987562158899999999988899999867148947889964299998
Q 001614 903 ILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 903 ILYELLTG-k~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
++|||++| .+||.+.+..++...+..+.. +..+..+++++++||.+||+.||.+||++.++.+.|
T Consensus 215 il~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 215 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 999998368999999999999999982688--888766789999999997678966894999999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=367.02 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=222.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 45899179875513796499999997-----8995999999632442474579999999999993599956788223202
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k-----~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d 758 (1044)
...++|++.+.||+|+||+||+|+++ .++..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf 8988938867982078839999998887657788299999988210--85799999999999996689976552466605
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCC
Q ss_conf 780599984416642589998407------------------------99999999999999999999885590612579
Q 001614 759 RDNLYLVMEYLNGGDLYSLLRKVG------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814 (1044)
Q Consensus 759 ~~~LyLVmEym~GGSL~dlL~k~g------------------------~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLK 814 (1044)
...++++|||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEC
T ss_conf 98038999815899299999852755421000011100121034678898999999999999998554135786854884
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 99624247972799505775234446744589998889899999998643457677667668987779100028999940
Q 001614 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 894 (1044)
Q Consensus 815 PeNILIDedG~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~K 894 (1044)
|+|||++.++.+||+|||+|+...... .........|++.|+|||++.+..|+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~k 222 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTTE 222 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCC-------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCHH
T ss_conf 011689899928983314421136776-------------------------4111577776767679899726889805
Q ss_pred HHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 24687889999999399-99999996899875621588999999999888999998671489478899642999982
Q 001614 895 ADWWSVGIILFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 895 SDIWSLGVILYELLTGk-~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
+||||||+++|||++|. +||.+.+..++...+..+.. +..+..+++++.+||.+||+.||.+|||+.++.+.|+
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 63025236299998068999999899999999973997--8887325299999999974889657939999999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.96 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=213.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCC----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCE
Q ss_conf 8991798755137964999999978995----999999632442474579999999999993599956788223202780
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk----~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~~ 761 (1044)
.++|++++.||+|+||+||+|.+..+|+ .||+|.++.. ......+.+.+|+.++++++|||||++++++.+. .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-C
T ss_conf 899978319820899299999995899889899999996513--4979999999999999867998881589999619-8
Q ss_pred EEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 59998441664258999840-79999999999999999999988559061257999624247972799505775234446
Q 001614 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (1044)
Q Consensus 762 LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~ 840 (1044)
.+++++++.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCC
T ss_conf 36999842687401011133457999999999999999999998769504762120311679987586025522233544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 744589998889899999998643457677667668987779100028999940246878899999993-9999999996
Q 001614 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (1044)
Q Consensus 841 ~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s~ 919 (1044)
.. ........||+.|||||++.+..|+.++||||||+++|||+| |.+||.+.+.
T Consensus 165 ~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 165 EK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp CC---------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred CC-------------------------CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf 45-------------------------32236510586446708874699983565440799999999779999999998
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 8998756215889999999998889999986714894788996429999829
Q 001614 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 971 (1044)
Q Consensus 920 ~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~H 971 (1044)
.++...+..+.. +..|..+++.+.+||.+||+.||.+|||+ .+++.|
T Consensus 220 ~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~---~eil~~ 266 (317)
T d1xkka_ 220 SEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKF---RELIIE 266 (317)
T ss_dssp GGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCH---HHHHHH
T ss_pred HHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCH---HHHHHH
T ss_conf 999999975998--99985568999999998478993469199---999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.05 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=215.9
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 45899179875513796499999997899---599999963244247457999999999999359995678822320278
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TG---k~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~ 760 (1044)
+..++|++.+.||+|+||.||+|++..++ ..||+|.++.. ......+.+.+|+.++++++||||+++++++. .+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CC
T ss_conf 6889969877993078829999999369964499999993656--68799999999999998689999856988995-37
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 059998441664258999840-7999999999999999999998855906125799962424797279950577523444
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~ 839 (1044)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 47999984069807765422478999999999999998775230226744141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 6744589998889899999998643457677667668987779100028999940246878899999993-999999999
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s 918 (1044)
.. ........||+.|+|||++.+..|+.++||||||+++|||++ |.+||.+.+
T Consensus 161 ~~--------------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 161 ST--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CC--------------------------CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
T ss_conf 76--------------------------2330540058310326675169988745244424789999826999988899
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 68998756215889999999998889999986714894788996429999
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EI 968 (1044)
..++...+..+.. +..++.+|+++.+||.+||+.||.+|||+.++.+.
T Consensus 215 ~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 215 NNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp GGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999981899--98987779999999999768797689299999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.82 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=218.9
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 34545899179875513796499999997899599999963244247457999999999999359995678822320278
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 681 ~~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~ 760 (1044)
.+.+..++|++.+.||+|+||+||+|+++. +..||+|+++... ...+.+.+|+.++++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CEECCHHHEEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-C
T ss_conf 607477997984699307980999999999-9999999988044----888999999999986666788689999823-9
Q ss_pred EEEEEEEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 05999844166425899984--0799999999999999999999885590612579996242479727995057752344
Q 001614 761 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k--~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
.+|+|||||++|+|..++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCC
T ss_conf 75999994479943542000035530599999999999999998754114335312307999899929984425554256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 467445899988898999999986434576776676689877791000289999402468788999999939-9999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAE 917 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTG-k~PF~g~ 917 (1044)
.. .........||+.|+|||++....++.++||||||+++|||++| .+||.+.
T Consensus 165 ~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 165 DN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CC--------------------------CCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf 88--------------------------7335245455665458089837998917741323589999986899999888
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC
Q ss_conf 968998756215889999999998889999986714894788996429999829998899
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 977 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i 977 (1044)
+..++...+..+.. +..+..++.++++||.+||+.||.+||+++++.+.| ++||...
T Consensus 219 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L-~~~~~~~ 275 (285)
T d1fmka3 219 VNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL-EDYFTST 275 (285)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH-HTTTSCS
T ss_pred CHHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH-HHHHCCC
T ss_conf 89999999982689--999832379999999997566975891999999987-6662389
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.77 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=221.2
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 434545899179875513796499999997-----89959999996324424745799999999999935-999567882
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (1044)
Q Consensus 680 ~~~~i~i~dY~ilk~LGkGsFG~VYkak~k-----~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL-~HPNIVkLi 753 (1044)
..+.+..++|++.+.||+|+||.||+|++. .+++.||+|+++... .......+.+|+.+++.+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 02637789969854982068829999998066447788699999987424--8779999999999987626999887899
Q ss_pred EEEECCCEEEEEEEECCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
Q ss_conf 23202780599984416642589998407------------------999999999999999999998855906125799
Q 001614 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (1044)
Q Consensus 754 gvf~d~~~LyLVmEym~GGSL~dlL~k~g------------------~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKP 815 (1044)
+++.....+|+|||||++|+|.+++.+.. .+++..+..++.||+.||.|||+++|+||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 96242479727995057752344467445899988898999999986434576776676689877791000289999402
Q 001614 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (1044)
Q Consensus 816 eNILIDedG~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KS 895 (1044)
+|||++.++.+|++|||+++...... ........+||+.|+|||++.+..++.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT-------------------------TSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCCC-------------------------CCEEEEECCCCHHHCCHHHHCCCCCCCCC
T ss_conf 21000025752102340102336788-------------------------61586201359687677886179999740
Q ss_pred HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 46878899999993-9999999996899875621588999999999888999998671489478899642999982
Q 001614 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 896 DIWSLGVILYELLT-Gk~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
||||||+++|||+| |.+||.+.+....+.++.....+ +..+..++..+.+||.+||+.||.+||++.++.+.|+
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 01025899999985899887789989999999866898-8985436599999999975779657929999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.83 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=222.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCC-C--CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 4589917987551379649999999789-9--599999963244247457999999999999359995678822320278
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-G--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~T-G--k~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d~~ 760 (1044)
+..++|++.+.||+|+||+||+|++..+ + ..||+|++++.........+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf 864891997898038883999999988999079999999983555798999999999999986899998789877740-1
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 059998441664258999840-7999999999999999999998855906125799962424797279950577523444
Q 001614 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~ 839 (1044)
.+++|||||++|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 00114654238612544421268999999999999999999875217875205668881565565433256115553035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 6744589998889899999998643457677667668987779100028999940246878899999993-999999999
Q 001614 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (1044)
Q Consensus 840 ~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~s 918 (1044)
... .........|++.|+|||++.+..++.++||||||+++|||+| |..||.+.+
T Consensus 164 ~~~------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 164 NDD------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp -CC------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCC------------------------CCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 887------------------------52654763257310799998379999421566148999999968999999969
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 6899875621588999999999888999998671489478899642999982
Q 001614 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 919 ~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
..++...+......+ ..+..+|+.+.+||.+||+.||.+|||+.++.+.|.
T Consensus 220 ~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 220 GSQILHKIDKEGERL-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp HHHHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 999999998479999-985445399999999976889667929999999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.39 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=222.2
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCC-------CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 34545899179875513796499999997899-------59999996324424745799999999999935-99956788
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 752 (1044)
Q Consensus 681 ~~~i~i~dY~ilk~LGkGsFG~VYkak~k~TG-------k~VAIKiIkk~~~~~e~~ie~ilrEieILkkL-~HPNIVkL 752 (1044)
.+.+..++|.+++.||+|+||.||+|+...++ ..||+|++++.. .......+.+|...+.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEC
T ss_conf 672258996970098516782899999857875556675499999988112--868899999999999981399969734
Q ss_pred EEEEECCCEEEEEEEECCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCC
Q ss_conf 223202780599984416642589998407----------------9999999999999999999988559061257999
Q 001614 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (1044)
Q Consensus 753 igvf~d~~~LyLVmEym~GGSL~dlL~k~g----------------~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPe 816 (1044)
++++.++..+|+|||||++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCC
T ss_conf 65220188689999736999099999860677643222334574346799999999999999998766379786302210
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 62424797279950577523444674458999888989999999864345767766766898777910002899994024
Q 001614 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (1044)
Q Consensus 817 NILIDedG~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSD 896 (1044)
|||++.++.+||+|||+++...... .........|++.|+|||++.++.|+.++|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHID-------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCC-------------------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred CEEECCCCCEEECCCHHHCCCCCCC-------------------------CCCCCCCCCCCHHHHHHHHHCCCCCCCHHH
T ss_conf 2245478976762211101135555-------------------------543146678884663266751798882555
Q ss_pred HHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 6878899999993-999999999689987562158899999999988899999867148947889964299998
Q 001614 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 897 IWSLGVILYELLT-Gk~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
|||||+++|+|++ |.+||.+.+...++..+..+.. +..|..+++++.+||.+||+.||.+|||+.++.+.|
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 477588888740179898999999999999972888--898743529999999997667976793999999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.44 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=227.0
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 4345458991798755137964999999978-----99599999963244247457999999999999359995678822
Q 001614 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (1044)
Q Consensus 680 ~~~~i~i~dY~ilk~LGkGsFG~VYkak~k~-----TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLig 754 (1044)
+.+.+..++|++.+.||+|+||.||+|.++. ++..||||++++.. .......+.+|+.++++++||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 10042689918835982078818999998786447789689999987012--8689999999999999769998841254
Q ss_pred EEECCCEEEEEEEECCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC
Q ss_conf 320278059998441664258999840----------7999999999999999999998855906125799962424797
Q 001614 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (1044)
Q Consensus 755 vf~d~~~LyLVmEym~GGSL~dlL~k~----------g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG 824 (1044)
++.....+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCC
T ss_conf 78428810677760489988999875033211344468879999999999999999987647965432867754035996
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 27995057752344467445899988898999999986434576776676689877791000289999402468788999
Q 001614 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (1044)
Q Consensus 825 ~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVIL 904 (1044)
++||+|||+|+....... ........||+.|+|||.+.+..++.++||||||+++
T Consensus 171 ~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp CEEECCTTCCCGGGGGGC-------------------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEEEEECCCCEECCCCCC-------------------------EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 499942454202357763-------------------------0313402316323788887369988333444378999
Q ss_pred HHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC---CCCCCC
Q ss_conf 999939-999999996899875621588999999999888999998671489478899642999982---999889
Q 001614 905 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKG 976 (1044)
Q Consensus 905 YELLTG-k~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~---HPfFk~ 976 (1044)
|||+|| .+||.+.+..+++..+..+.. +..+..+++.+.+||.+||+.||.+|||+.++.+.|+ +|+|+.
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCCC
T ss_conf 9999689999999899999999980888--8886335399999999975779658939999999978761778757
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.89 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=210.7
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEE
Q ss_conf 345458991798755137964999999978-----9959999996324424745799999999999935-9995678822
Q 001614 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (1044)
Q Consensus 681 ~~~i~i~dY~ilk~LGkGsFG~VYkak~k~-----TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL-~HPNIVkLig 754 (1044)
++.+..++|++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|..++.++ +||||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 5261679979844984167839999998677755578399999986001--71789999999999886149984997411
Q ss_pred EEECC-CEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCC
Q ss_conf 32027-8059998441664258999840----------------799999999999999999999885590612579996
Q 001614 755 SFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (1044)
Q Consensus 755 vf~d~-~~LyLVmEym~GGSL~dlL~k~----------------g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeN 817 (1044)
++... ..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 54047975799998458992999998536666653222023321468999999999999999998873797178677310
Q ss_pred EEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 24247972799505775234446744589998889899999998643457677667668987779100028999940246
Q 001614 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (1044)
Q Consensus 818 ILIDedG~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDI 897 (1044)
||++.++.+||+|||+|+..... ..........||+.|||||++.+..++.++||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDi 219 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219 (299)
T ss_dssp EEECGGGCEEECC------CCSC-------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHH
T ss_pred EEECCCCCEEECCCCCHHHCCCC-------------------------CCCCCCCCEEECCCCCCHHHHHCCCCCCCCCE
T ss_conf 65779982898457520011356-------------------------65222475166721020368646889966322
Q ss_pred HHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 8788999999939-99999999689987562158899999999988899999867148947889964299998
Q 001614 898 WSVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 898 WSLGVILYELLTG-k~PF~g~s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
|||||++|||++| .+||.+.+..+.+..+...... +..+..+++++++||.+||+.||.+|||+.++.+.|
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred EEHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 136789999986889999899989999999963898-888865789999999997677966791999999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.62 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=216.6
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CC
Q ss_conf 45458991798755137964999999978995999999632442474579999999999993599956788223202-78
Q 001614 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RD 760 (1044)
Q Consensus 682 ~~i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d-~~ 760 (1044)
+.+..++|++.+.||+|+||.||+|+++ |..||+|++++. ...+.+.+|+.++++++||||+++++++.. .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf 9557899488579820798089999999--909999998857-----779999999999986789898549878872389
Q ss_pred EEEEEEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 0599984416642589998407--99999999999999999999885590612579996242479727995057752344
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~g--~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~ 838 (1044)
.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECC
T ss_conf 28999963699989999874578888999999999999852321133765536665676014689977632456003447
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028999940246878899999993-99999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLT-Gk~PF~g~ 917 (1044)
.......+++.|+|||++.+..++.++||||||+++|||+| |++||...
T Consensus 155 ------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 155 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf ------------------------------87765566646778178727988858877757999999997899999999
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 9689987562158899999999988899999867148947889964299998
Q 001614 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 969 (1044)
Q Consensus 918 s~~ei~qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL 969 (1044)
+..++...+..+.. +..+..+++++.+||.+||..||.+|||+.++.+.|
T Consensus 205 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 205 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 99999999980899--999765799999999997566976893999999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.05 Aligned_cols=252 Identities=20% Similarity=0.247 Sum_probs=206.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEE
Q ss_conf 79875513796499999997899---5999999632442474579999999999993599956788223202-7805999
Q 001614 690 EIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLYLV 765 (1044)
Q Consensus 690 ~ilk~LGkGsFG~VYkak~k~TG---k~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPNIVkLigvf~d-~~~LyLV 765 (1044)
.+.++||+|+||+||+|.+..++ ..||||.+++. ........+.+|+.+|++++||||+++++++.. +..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 2666981368809999999779987999999998843--69789999999999998678999867867898069943899
Q ss_pred EEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 8441664258999840-799999999999999999999885590612579996242479727995057752344467445
Q 001614 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (1044)
Q Consensus 766 mEym~GGSL~dlL~k~-g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGLAki~~~~~s~d 844 (1044)
||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~-- 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-- 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC--
T ss_pred EEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC--
T ss_conf 987406741442101345404899999999988765200336762577668757677999889910652322556655--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHH
Q ss_conf 899988898999999986434576776676689877791000289999402468788999999939999999-9968998
Q 001614 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIF 923 (1044)
Q Consensus 845 ~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g-~s~~ei~ 923 (1044)
..........||+.|+|||++.+..++.++||||||+++|||++|..||.. .+..++.
T Consensus 186 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~ 244 (311)
T d1r0pa_ 186 ---------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244 (311)
T ss_dssp ---------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH
T ss_pred ---------------------CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf ---------------------53100256555645567688743799974574661999999997899998889999999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 756215889999999998889999986714894788996429999
Q 001614 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (1044)
Q Consensus 924 qkIl~g~i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EI 968 (1044)
..+..+.. +..|..+++++.+||.+||+.||.+||++.++.+.
T Consensus 245 ~~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 245 VYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99980898--89964475999999999768897689399999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=346.97 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=209.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-EEEEEEEEECCCEEEEE
Q ss_conf 99179875513796499999997899599999963244247457999999999999359995-67882232027805999
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 765 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPN-IVkLigvf~d~~~LyLV 765 (1044)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.++|+| |+.+..++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 889996898507880999999988998999999721005-----888999999999703899601799999519877899
Q ss_pred EEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC---CCCEEEEECCCCCCCCCCC
Q ss_conf 84416642589998-4079999999999999999999988559061257999624247---9727995057752344467
Q 001614 766 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 841 (1044)
Q Consensus 766 mEym~GGSL~dlL~-k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDe---dG~IKLsDFGLAki~~~~~ 841 (1044)
|||+. |+|.+.+. ....+++..+..++.|++.||.|||+++|+||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEECC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCC
T ss_conf 98738-71333244306887689999999999999999997994426678766064335777615650467513425544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 44589998889899999998643457677667668987779100028999940246878899999993999999999689
Q 001614 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (1044)
Q Consensus 842 s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s~~e 921 (1044)
.. ...........+||+.|||||++.+..++.++||||||+++|+|++|..||.......
T Consensus 161 ~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 161 TH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CC--------------------CCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHH
T ss_conf 55--------------------4100013577678735329999918998983218861778999984987665530577
Q ss_pred HHHHHH---CCC--CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCC
Q ss_conf 987562---158--899999999988899999867148947889964299998299988
Q 001614 922 IFDNIL---NRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 975 (1044)
Q Consensus 922 i~qkIl---~g~--i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk 975 (1044)
....+. ... .+.+.....+|+++.+||..||+.+|.+||++.++.++|+|+|.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 99999985235678983575347889999999998439955791999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=336.17 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=209.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEECCCEEEE
Q ss_conf 8991798755137964999999978995999999632442474579999999999993599-956788223202780599
Q 001614 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 686 i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~H-PNIVkLigvf~d~~~LyL 764 (1044)
-++|++.+.||+|+||+||+|++..+|+.||+|++..... ...+.+|+++++.+.| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
T ss_conf 9806997998417882999999988997999999750258-----29999999999996489998779999601881179
Q ss_pred EEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC-----CCCEEEEECCCCCCCC
Q ss_conf 984416642589998407-9999999999999999999988559061257999624247-----9727995057752344
Q 001614 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-----DGHIKLTDFGLSKIGL 838 (1044)
Q Consensus 765 VmEym~GGSL~dlL~k~g-~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDe-----dG~IKLsDFGLAki~~ 838 (1044)
||||+ +|+|.+++...+ .++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf 99964-88879999752031106899999999999999999779662667713152347543447956872366057714
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 46744589998889899999998643457677667668987779100028999940246878899999993999999999
Q 001614 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (1044)
Q Consensus 839 ~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVILYELLTGk~PF~g~s 918 (1044)
..... ...........+||+.|||||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 158 DPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCCCC--------------------CCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 67665--------------------4111024676277510267989648888869998983199999986987678853
Q ss_pred H---HHHHHHHHCCC--CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHC
Q ss_conf 6---89987562158--8999999999888999998671489478899642999982
Q 001614 919 P---EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 970 (1044)
Q Consensus 919 ~---~ei~qkIl~g~--i~~p~ip~~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~ 970 (1044)
. ...+..+.... .+.+.....+|+++.+|+..|+..+|.+||++..+.+++.
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 021999999997056799958965799899999999984399300859999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.18 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=192.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHH--HHHHCCCCCEEEEEEEEECCC----
Q ss_conf 99179875513796499999997899599999963244247457999999999--999359995678822320278----
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN--ILITVRNPFVVRFFYSFTCRD---- 760 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEie--ILkkL~HPNIVkLigvf~d~~---- 760 (1044)
.+|.+.+.||+|+||.||+|++. |+.||+|+++.. ....+.+|.+ .+..++||||+++++++....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC--CEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
T ss_conf 68999889820788199999999--989999998720------0467999999999962799868326889983798604
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------CCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 059998441664258999840799999999999999999999885--------590612579996242479727995057
Q 001614 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (1044)
Q Consensus 761 ~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHs--------kGIIHRDLKPeNILIDedG~IKLsDFG 832 (1044)
.+|+|||||++|+|.+++++. .+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 899999646698989998658-9998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHHHH
Q ss_conf 7523444674458999888989999999864345767766766898777910002899------9940246878899999
Q 001614 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFE 906 (1044)
Q Consensus 833 LAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~------yt~KSDIWSLGVILYE 906 (1044)
++........ .........+||+.|||||++.+.. ++.++|||||||++||
T Consensus 154 l~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 154 LAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTT-----------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCC-----------------------CEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHH
T ss_conf 6623467776-----------------------20013552503547678221056545467776750122015999999
Q ss_pred HHHCCCCCCCC---------------CHHHHHHHHHCCCCCCCCCCCC-----CCHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 99399999999---------------9689987562158899999999-----988899999867148947889964299
Q 001614 907 FITGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAA 966 (1044)
Q Consensus 907 LLTGk~PF~g~---------------s~~ei~qkIl~g~i~~p~ip~~-----iS~eLkdLIkkLLq~DPsKRPSadeA~ 966 (1044)
|+||..||... ....+...+.....+ |.++.. ....+.+|+.+||+.||.+|||+.++.
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred HHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 96289988766311241012255643099999987502468-88776557768999999999997606985895999999
Q ss_pred HHH
Q ss_conf 998
Q 001614 967 EVK 969 (1044)
Q Consensus 967 EIL 969 (1044)
+.|
T Consensus 290 ~~L 292 (303)
T d1vjya_ 290 KTL 292 (303)
T ss_dssp HHH
T ss_pred HHH
T ss_conf 999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-45 Score=320.76 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=197.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEEEE
Q ss_conf 99179875513796499999997899599999963244247457999999999999359-----------9956788223
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRFFYS 755 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~-----------HPNIVkLigv 755 (1044)
++|+++++||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+++.+. |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf 8579989975077818999999999979999998343----133689999999999840145555542276764789987
Q ss_pred EECC--CEEEEEEEECCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECCCC-----
Q ss_conf 2027--8059998441664258999---840799999999999999999999885-5906125799962424797-----
Q 001614 756 FTCR--DNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG----- 824 (1044)
Q Consensus 756 f~d~--~~LyLVmEym~GGSL~dlL---~k~g~Lsee~i~~Il~QIL~ALaYLHs-kGIIHRDLKPeNILIDedG----- 824 (1044)
+... ...++++.++..+...... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred EEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCC
T ss_conf 63125652023432000354200000122346786899999999999998887640586465677057056305765644
Q ss_pred -CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf -2799505775234446744589998889899999998643457677667668987779100028999940246878899
Q 001614 825 -HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (1044)
Q Consensus 825 -~IKLsDFGLAki~~~~~s~d~s~~~~~~~~~s~~~~~e~~~~~~~~~~s~vGTp~YmAPEvL~g~~yt~KSDIWSLGVI 903 (1044)
.++++|||.+.... ......+||+.|+|||++.+..|+.++||||+|++
T Consensus 169 ~~~kl~dfg~s~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 218 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 218 (362)
T ss_dssp EEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred CEEEEEECCCCCCCC------------------------------CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHH
T ss_conf 305675314421234------------------------------45422366521057132146677764320123789
Q ss_pred HHHHHHCCCCCCCCCHH------HHHHHHHC--CC------------------------CC-------------CCCCCC
Q ss_conf 99999399999999968------99875621--58------------------------89-------------999999
Q 001614 904 LFEFITGIPPFTAESPE------IIFDNILN--RK------------------------IP-------------WPCVPS 938 (1044)
Q Consensus 904 LYELLTGk~PF~g~s~~------ei~qkIl~--g~------------------------i~-------------~p~ip~ 938 (1044)
+++|++|+.||...... .....+.. +. .. ....+.
T Consensus 219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (362)
T d1q8ya_ 219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298 (362)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCC
T ss_conf 99998788998987554321026899999998379987886245322000132012202432357764442100015674
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCC
Q ss_conf 99888999998671489478899642999982999889993
Q 001614 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 979 (1044)
Q Consensus 939 ~iS~eLkdLIkkLLq~DPsKRPSadeA~EIL~HPfFk~i~~ 979 (1044)
..++++.+||.+||.+||.+||| |.|+|+||||++...
T Consensus 299 ~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 299 DEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCCCC
T ss_conf 35899999999987799457908---999966934078987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=7.6e-23 Score=170.91 Aligned_cols=135 Identities=20% Similarity=0.164 Sum_probs=106.6
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC---------------CHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 17987551379649999999789959999996324424---------------745799999999999935999567882
Q 001614 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---------------RKNDIERILAERNILITVRNPFVVRFF 753 (1044)
Q Consensus 689 Y~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~---------------~e~~ie~ilrEieILkkL~HPNIVkLi 753 (1044)
+.+.++||+|+||+||+|.+. +|+.||+|+++..... .......+.+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEECCCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 23202780599984416642589998407999999999999999999998855906125799962424797279950577
Q 001614 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (1044)
Q Consensus 754 gvf~d~~~LyLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHskGIIHRDLKPeNILIDedG~IKLsDFGL 833 (1044)
+... .+++|||++++.+.+ ++...+..++.|++.++.|||++||+||||||+|||++++ .++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EECC----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECCC
T ss_conf 8628----889999504565420-------0157899999999999999826888983689036114289-899987788
Q ss_pred CCC
Q ss_conf 523
Q 001614 834 SKI 836 (1044)
Q Consensus 834 Aki 836 (1044)
|..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred CCC
T ss_conf 430
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=8.8e-07 Score=61.15 Aligned_cols=143 Identities=14% Similarity=0.103 Sum_probs=92.7
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCEE
Q ss_conf 45899179875513796499999997899599999963244247457999999999999359-99567882232027805
Q 001614 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (1044)
Q Consensus 684 i~i~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~-HPNIVkLigvf~d~~~L 762 (1044)
..+..|+..+..+.++.+.||+... .+..+++|+....... ....+.+|...+..+. +--+.+++.....++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCC---CHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 7513527997678998771899990--8986999984887653---2556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q ss_conf 9998441664258999840799999999999999999999885-------------------------------------
Q 001614 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------- 805 (1044)
Q Consensus 763 yLVmEym~GGSL~dlL~k~g~Lsee~i~~Il~QIL~ALaYLHs------------------------------------- 805 (1044)
|+||++++|.++....... .. ...++.++...+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEECCCCCCCCCCCCC--CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 9999860433435433440--26---999999899999998556842143576446565557789987765555430332
Q ss_pred ----------------------CCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ----------------------5906125799962424797279950577523
Q 001614 806 ----------------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 806 ----------------------kGIIHRDLKPeNILIDedG~IKLsDFGLAki 836 (1044)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 32005799999999844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.26 E-value=3.4e-06 Score=57.12 Aligned_cols=81 Identities=26% Similarity=0.282 Sum_probs=51.6
Q ss_pred EEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC----CHHHHHHHHHHHHHHHHCC--CC-CEEEEEEEEECCCEEEE
Q ss_conf 87551379649999999789959999996324424----7457999999999999359--99-56788223202780599
Q 001614 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI----RKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 692 lk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~----~e~~ie~ilrEieILkkL~--HP-NIVkLigvf~d~~~LyL 764 (1044)
.+.||.|....||++....+++.+++|.-...... .+....+...|...|+.+. -| .+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9844166425
Q 001614 765 VMEYLNGGDL 774 (1044)
Q Consensus 765 VmEym~GGSL 774 (1044)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=0.00011 Score=46.75 Aligned_cols=141 Identities=13% Similarity=0.103 Sum_probs=81.6
Q ss_pred CEEEEEEECCCC-CEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC--CCEEEEEEEEECCCEEEE
Q ss_conf 917987551379-64999999978995999999632442474579999999999993599--956788223202780599
Q 001614 688 DFEIIKPISRGA-FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYL 764 (1044)
Q Consensus 688 dY~ilk~LGkGs-FG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~H--PNIVkLigvf~d~~~LyL 764 (1044)
.++.. .+..|. .+.||+... ..+..+++|...... ...+..|...++.+.. ..+.+++.+..+++..++
T Consensus 12 g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 12 GYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp TCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCEE-ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEE
T ss_conf 98358-7678654775899993-898789999589667------768999999999998659998861322245661599
Q ss_pred EEEECCCCCHHHH--------------HHHCC-------CCC--HHH-HHHH-------------------HHHHHHHHH
Q ss_conf 9844166425899--------------98407-------999--999-9999-------------------999999999
Q 001614 765 VMEYLNGGDLYSL--------------LRKVG-------CLE--EDV-ARIY-------------------IAELVLALE 801 (1044)
Q Consensus 765 VmEym~GGSL~dl--------------L~k~g-------~Ls--ee~-i~~I-------------------l~QIL~ALa 801 (1044)
||++++|.++... +.+.. .+. ... .... .......+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 98744135543221268999999999999873688544887554124688999999875411011340112137999999
Q ss_pred HHHHC-------CEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 98855-------906125799962424797279950577523
Q 001614 802 YLHSL-------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 802 YLHsk-------GIIHRDLKPeNILIDedG~IKLsDFGLAki 836 (1044)
.+... .++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773796589998533265
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.34 E-value=0.0014 Score=39.30 Aligned_cols=78 Identities=18% Similarity=0.264 Sum_probs=50.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEECC-------CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 991798755137964999999978-------99599999963244247457999999999999359-9956788223202
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC 758 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~-------TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~-HPNIVkLigvf~d 758 (1044)
+++++ +.|+.|-.-.+|++.... .+..+.+++..... ......+|..+++.+. +.-..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred CCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC-----HHHHHHHHHHHHHHHHHCCCCCEEEEECCC
T ss_conf 01699-991785334348999688775445789817999659961-----165899999999999757999808998189
Q ss_pred CCEEEEEEEECCCCCH
Q ss_conf 7805999844166425
Q 001614 759 RDNLYLVMEYLNGGDL 774 (1044)
Q Consensus 759 ~~~LyLVmEym~GGSL 774 (1044)
.+|++|++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----CEEEEEECCCCC
T ss_conf ----569997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.0032 Score=36.83 Aligned_cols=130 Identities=13% Similarity=0.181 Sum_probs=70.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC--EEEEE-----EEEECCCEEEEEEEECCCC
Q ss_conf 6499999997899599999963244247457999999999999359995--67882-----2320278059998441664
Q 001614 700 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFF-----YSFTCRDNLYLVMEYLNGG 772 (1044)
Q Consensus 700 FG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~HPN--IVkLi-----gvf~d~~~LyLVmEym~GG 772 (1044)
--.||++.. .+|..|++|+.+... ...+.+..|...+..|.... ++... ..+......+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCEEEEEEC-CCCCEEEEEEECCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCC
T ss_conf 202699983-899979999847877----889999999999999985599878752068980566534799998652776
Q ss_pred CHH----HHH----------HHC----------------------------CCCCHHHHHHHHHHHHHHHHHHHH-----
Q ss_conf 258----999----------840----------------------------799999999999999999999885-----
Q 001614 773 DLY----SLL----------RKV----------------------------GCLEEDVARIYIAELVLALEYLHS----- 805 (1044)
Q Consensus 773 SL~----dlL----------~k~----------------------------g~Lsee~i~~Il~QIL~ALaYLHs----- 805 (1044)
.+. +.+ +.. ..++......+...+-..+..+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 88999999999989999998863035786556778978876656899987476998898999999999999999845456
Q ss_pred --CCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --5906125799962424797279950577523
Q 001614 806 --LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (1044)
Q Consensus 806 --kGIIHRDLKPeNILIDedG~IKLsDFGLAki 836 (1044)
.++||+|+.+.|||++. + ..++||+.+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 8712024788804287838-9-35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.66 E-value=0.055 Score=28.38 Aligned_cols=142 Identities=19% Similarity=0.170 Sum_probs=73.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----CCCEEEEE---EEEEC
Q ss_conf 99179875513796499999997899599999963244247457999999999999359-----99567882---23202
Q 001614 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFF---YSFTC 758 (1044)
Q Consensus 687 ~dY~ilk~LGkGsFG~VYkak~k~TGk~VAIKiIkk~~~~~e~~ie~ilrEieILkkL~-----HPNIVkLi---gvf~d 758 (1044)
+...-.+.|..|---+.|++... +..|++|++.... .. ..+..|..++..+. -|..+... .....
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~ 90 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 90 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CCCEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCCC--CH---HHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEE
T ss_conf 98568523788852673899978--9728999807899--98---89999999987543025554556410489762134
Q ss_pred CCEEEEEEEECCCCCHH--------------HHHHHCC---------CCC------------------HHHHHHHHHHHH
Q ss_conf 78059998441664258--------------9998407---------999------------------999999999999
Q 001614 759 RDNLYLVMEYLNGGDLY--------------SLLRKVG---------CLE------------------EDVARIYIAELV 797 (1044)
Q Consensus 759 ~~~LyLVmEym~GGSL~--------------dlL~k~g---------~Ls------------------ee~i~~Il~QIL 797 (1044)
......++.+..|.... ..++... ... .......+..+.
T Consensus 91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 170 (316)
T d2ppqa1 91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 170 (316)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred ECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_conf 12550245311465533320467888889987645444320245310111012002456777765311412799999998
Q ss_pred HHHHHHH----HCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 9999988----5590612579996242479727995057752
Q 001614 798 LALEYLH----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (1044)
Q Consensus 798 ~ALaYLH----skGIIHRDLKPeNILIDedG~IKLsDFGLAk 835 (1044)
..+.-.. ..|+||+|+.+.||+++.+...-++||+.+.
T Consensus 171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 764204855454503337863656402045412674222123
|